Citrus Sinensis ID: 045989
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.928 | 0.366 | 0.559 | 3e-92 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.816 | 0.304 | 0.618 | 2e-91 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.783 | 0.303 | 0.637 | 9e-90 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.783 | 0.300 | 0.619 | 8e-88 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.776 | 0.313 | 0.642 | 2e-87 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.779 | 0.306 | 0.627 | 2e-87 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.762 | 0.312 | 0.650 | 2e-86 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.783 | 0.316 | 0.633 | 5e-86 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.783 | 0.293 | 0.639 | 2e-84 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.772 | 0.298 | 0.647 | 2e-83 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 338 bits (866), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 164/293 (55%), Positives = 225/293 (76%), Gaps = 19/293 (6%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++L+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + +H++++D +TWE+RL IA+
Sbjct: 462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYT-MTWEVRLHIAI 520
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++GALSYLHSAAS PIYHRDIK+ NILLD++ RAK+SDFGTSRS+ +D+THLTTQV GT
Sbjct: 521 EIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGT 580
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGY+DPEYFQSS+FTEKSDVYSFGVVLVELLTG+KP V +EENR LAA+F++ + ENR
Sbjct: 581 FGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENR 640
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASVLR- 239
+ +++D ++ E ++V++VA +A+RCLN GKKRP M+EV++EL IR+S S +
Sbjct: 641 VLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHI 700
Query: 240 --------QCEEIDFVNYDNARHFKTGSSSTGSFFNSYSSSLRNLSNRESMEP 284
Q E++F + ++ G+++ S FN+ S + S+ E + P
Sbjct: 701 EDDDEEDDQAMELNFNDT-----WEVGATAPASMFNNASPT----SDAEPLVP 744
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (860), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 149/241 (61%), Positives = 199/241 (82%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG+L +++H++ ++ + TW IRL IA+
Sbjct: 493 VILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAI 552
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHS+AS PIYHRD+KS NI+LD+KYRAK+SDFGTSR++ VD THLTT V GT
Sbjct: 553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEYFQSSQFT+KSDVYSFGVVLVEL+TG+K I + ++ENR+LA YF+ + EN+
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENK 672
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASVLRQ 240
LF+++DA++ +V A VA++CLNL G+KRP+M+EV++EL IR G L++
Sbjct: 673 LFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQE 732
Query: 241 C 241
C
Sbjct: 733 C 733
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 9e-90, Method: Compositional matrix adjust.
Identities = 148/232 (63%), Positives = 195/232 (84%), Gaps = 1/232 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++L+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + + ++ +D + +TWE+RL IA+
Sbjct: 470 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYI-MTWEVRLHIAI 528
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++GALSYLHSAAS PIYHRDIK+ NILLD+KY+ K+SDFGTSRS+ +D+THLTTQV GT
Sbjct: 529 EIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGT 588
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGY+DPEYFQSS+FT+KSDVYSFGVVLVEL+TG+ P V++EENR AA+F+ + ENR
Sbjct: 589 FGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENR 648
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+++D ++ E ++V+ VA +AKRCLN GKKRP M+EV++EL IR+S
Sbjct: 649 FLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 143/231 (61%), Positives = 192/231 (83%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG+L +++H+ ++D TWE+RL IAV
Sbjct: 479 VILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAV 538
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHSAAS PIYHRDIKS NI+LD+K+RAK+SDFGTSR++ VD THLTT V GT
Sbjct: 539 DIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGT 598
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEYFQSSQFT+KSDVYSFGVVL EL+TG+K + + ++E R+LA YF + ENR
Sbjct: 599 VGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENR 658
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231
L +++DA++ + +V A +A++CLN+ G+KRP+M++V++EL IR+
Sbjct: 659 LSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 149/232 (64%), Positives = 194/232 (83%), Gaps = 3/232 (1%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++LSQINHRN+VKLLGCCLETEVP+LVYE+IPNG L + +H++ +D + +TWE+RL IAV
Sbjct: 474 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYM-MTWEVRLRIAV 532
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++GALSY+HSAAS PI+HRDIK+ NILLD+KYRAKISDFGTSRS+A D+THLTT V GT
Sbjct: 533 EIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGT 592
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+ V +EE LA YFL+ + ENR
Sbjct: 593 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENR 652
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+++D ++ + E ++V+ VA +A+RCLN G KRP M+EV+++L IR+S
Sbjct: 653 AVDIIDIRI--KDESKQVMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 145/231 (62%), Positives = 194/231 (83%), Gaps = 1/231 (0%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+LSQINHRN+VKL+GCCLETEVP+LVYE IPNG L + +H ++D +TW++RL I+VE
Sbjct: 468 VLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYT-MTWDVRLRISVE 526
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++GAL+YLHSAAS P+YHRD+K+ NILLD+KYRAK+SDFGTSRS+ VD+THLTT V GTF
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTF 586
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
GYLDPEYFQ+SQFT+KSDVYSFGVVLVEL+TG+KP ++ EENR L ++F + + +NR+
Sbjct: 587 GYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRV 646
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+++D+++ E+V+ VA +A+RCL+L GKKRP M+EV++EL IR+S
Sbjct: 647 LDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 147/226 (65%), Positives = 189/226 (83%), Gaps = 1/226 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I+LSQINHRNVVK+LGCCLETEVP+LVYEFIPN +L ++H +ED P++WE+RL IA
Sbjct: 436 ILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSED-FPMSWEVRLCIAC 494
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+ ALSYLHSA SIPIYHRD+KS NILLD+K+RAK+SDFG SRS+A+D THLTT V+GT
Sbjct: 495 EVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGT 554
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEY QS+ FT KSDVYSFGV+L+ELLTG+KP+ L+ +E R L AYFL+ + +R
Sbjct: 555 IGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDR 614
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
L E+LDA++ E ++EEV+ VA +A+RCL+LN + RPTM++V +EL
Sbjct: 615 LHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIEL 660
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 147/232 (63%), Positives = 196/232 (84%), Gaps = 1/232 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++LSQINHRN+VKLLGCCLETEVP+LVYE+IPNG L + +H++++D +TWE+RL IA+
Sbjct: 475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYT-MTWEVRLRIAI 533
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++GAL+Y+HSAAS PI+HRDIK+ NILLD+KYRAK+SDFGTSRS+ +D+THLTT V GT
Sbjct: 534 EIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGT 593
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+ V +EE R LA +FL+ + ENR
Sbjct: 594 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENR 653
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+ +++D ++ E++ E+V+ VA +A++CLN GK RP MKEV+ EL IR+S
Sbjct: 654 VIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 149/233 (63%), Positives = 188/233 (80%), Gaps = 2/233 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHR+VVKLLGCCLETEVP LVYEFIPNG+L Q+IHE+++D TW +RL IAV
Sbjct: 497 VILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTK-TWGMRLRIAV 555
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHSAAS PIYHRDIKS NILLD+KYR K+SDFGTSRS+ +D TH TT + GT
Sbjct: 556 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGT 615
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV-ETEENRSLAAYFLQVINEN 179
GY+DPEY+ SSQ+T+KSDVYSFGVVLVEL+TG+KP+ V ++E R LA +F + EN
Sbjct: 616 VGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKEN 675
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
R FE++DA++ + E+V+ VA +A+RCLN GKKRP M++V +L I AS
Sbjct: 676 RFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 149/230 (64%), Positives = 184/230 (80%), Gaps = 2/230 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
IILSQINHR+VVKLLGCCLETEVP+LVYEFIPNG+L Q++HE+ +D + W +R+ IAV
Sbjct: 500 IILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTAL-WGVRMRIAV 558
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
++SGA SYLH+AA PIYHRDIKS NILLD+KYRAK+SDFGTSRS+++D TH TT + GT
Sbjct: 559 DISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGT 618
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-IRLVETEENRSLAAYFLQVINEN 179
GY+DPEY+ SS FTEKSDVYSFGVVLVEL+TG+KP I L ET+E LA YF + EN
Sbjct: 619 VGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMREN 678
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
RLFE++DA++ + + E+VI VA +A RCL GK RP M+EV+ L I
Sbjct: 679 RLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | ||||||
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.894 | 0.363 | 0.692 | 1e-104 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.915 | 0.653 | 0.654 | 1e-102 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.789 | 0.335 | 0.735 | 1e-100 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.932 | 0.317 | 0.657 | 1e-100 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.783 | 0.310 | 0.754 | 1e-100 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.762 | 0.273 | 0.752 | 1e-99 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.918 | 0.399 | 0.655 | 3e-99 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.783 | 0.321 | 0.719 | 9e-96 | |
| 224053058 | 682 | predicted protein [Populus trichocarpa] | 0.772 | 0.334 | 0.737 | 2e-95 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.783 | 0.224 | 0.719 | 2e-95 |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-104, Method: Compositional matrix adjust.
Identities = 185/267 (69%), Positives = 223/267 (83%), Gaps = 3/267 (1%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVVKL GCCLETEVPLLVYEFIPNG+L QYI + + PITWE+RL IA
Sbjct: 441 VILSQINHRNVVKLTGCCLETEVPLLVYEFIPNGTLFQYIQNPNK-EFPITWEMRLRIAT 499
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+GAL+YLHSAAS+PIYHRDIKS+NILLD+KYRAK++DFGTS+S+A+++TH+TT V+GT
Sbjct: 500 EVAGALAYLHSAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGT 559
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI + + E RSLA YFL + ENR
Sbjct: 560 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSLRSVEERSLATYFLMTMEENR 619
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGAS--VL 238
LFE+LDA+VL+E +EE+I +A +A++CLNLNGKKRP MK VA+EL GIR+S G S +
Sbjct: 620 LFEILDARVLKEGGREEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSSQGVSSTIQ 679
Query: 239 RQCEEIDFVNYDNARHFKTGSSSTGSF 265
+ EE+D+V D + SSSTGS
Sbjct: 680 QDYEEVDYVVGDYTASWDVASSSTGSL 706
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 376 bits (966), Expect = e-102, Method: Compositional matrix adjust.
Identities = 178/272 (65%), Positives = 226/272 (83%), Gaps = 2/272 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVVKLLGCCLE EVPLLVYE+IPNG+L ++IH+Q E + PITW++RL IA
Sbjct: 129 VILSQINHRNVVKLLGCCLEIEVPLLVYEYIPNGTLSEHIHDQNE-EFPITWKMRLQIAT 187
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+GALSYLHSAASIPIYHRDIKS NILLDDKYRAK++DFGTS+S+A+D+THLTT+V+GT
Sbjct: 188 EVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGT 247
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFG+VL+ELLTG+KPI + + E +SLA+YF+ + E+R
Sbjct: 248 FGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIGSGEGKSLASYFIMSMKEDR 307
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA-SVLR 239
L ++LDA+V++E KEE+ +A +AKRC+NLNGKKRPTM EVA+EL IR G +
Sbjct: 308 LSDLLDARVVKEGRKEEINAIAFLAKRCINLNGKKRPTMMEVAMELERIRKCEGDFNAQE 367
Query: 240 QCEEIDFVNYDNARHFKTGSSSTGSFFNSYSS 271
+E+++ + R + S+STGS FN+ +S
Sbjct: 368 NSDEVEYDTIELTRPWDVASTSTGSCFNTNAS 399
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 372 bits (955), Expect = e-100, Method: Compositional matrix adjust.
Identities = 172/234 (73%), Positives = 209/234 (89%), Gaps = 1/234 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVVKL+GCCLETEVPLLVYEFIPNG+L+QYIH E + P+TWE+RL IA
Sbjct: 446 VILSQINHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNE-EFPVTWEMRLRIAT 504
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+GAL+YLH+AAS+PIYHRDIKS+NILLD+KYRAK++DFGTS+S+++D+TH+TT+V+GT
Sbjct: 505 EVAGALAYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGT 564
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI + E RSLA YFL + E+R
Sbjct: 565 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESR 624
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234
LFE+LDA+VL+E +EE+I +A +A++CLNLNGKKRP MK VA+EL GIR+S G
Sbjct: 625 LFEILDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQG 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 372 bits (955), Expect = e-100, Method: Compositional matrix adjust.
Identities = 182/277 (65%), Positives = 223/277 (80%), Gaps = 2/277 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+IL QINHRNVVKLLGCCLETEVPLLVYEFIPNG+L ++IH Q E + PITWEIRL IA
Sbjct: 419 VILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNE-EFPITWEIRLRIAT 477
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+GALSYLHSAAS+PIYHRDIKS NILLDDKYRAK++DFG S+ +A+D+THLTTQV+GT
Sbjct: 478 EVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGT 537
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFG+VL+ELLTG+KPI +EE +SLA+YF+ +NE+R
Sbjct: 538 FGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDR 597
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA-SVLR 239
L ++LDAQV++E+ KEE+ +A +A+RC+NLNGKKRPTM EVA+EL IR G
Sbjct: 598 LSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFGAQE 657
Query: 240 QCEEIDFVNYDNARHFKTGSSSTGSFFNSYSSSLRNL 276
EEI++ + + S ST S N+ +SS +L
Sbjct: 658 NSEEIEYNTIELIGPWDVTSISTDSCLNTNASSSSDL 694
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 175/232 (75%), Positives = 204/232 (87%), Gaps = 1/232 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG+L+Q++H+ +E + PITWE+RL IA+
Sbjct: 448 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSE-EFPITWEMRLRIAI 506
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E ALSYLHSAAS+PIYHRDIKS NILLDDKYRAK+SDFGTS+S+AVD+TH+TT+V+GT
Sbjct: 507 ETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGT 566
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI E RSLA YFL + +NR
Sbjct: 567 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNR 626
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
LFE+LDA+VL+E KEE++ VA +A+RCLNLNGKKRPTM+ V E+ IRAS
Sbjct: 627 LFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 368 bits (945), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 170/226 (75%), Positives = 206/226 (91%), Gaps = 1/226 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVVKLLGCCLET VPLLVYEFIPNG+L ++IH+Q E + PITWE+RL IA+
Sbjct: 575 VILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNE-EFPITWEMRLRIAI 633
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+GALSYLHSAASIPIYHRDIKS NILLDDKYRAK++DFGTS+S+A+D+THLTTQV+GT
Sbjct: 634 EVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGT 693
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFG+VL+ELLTG+KPI +EE +SLA+YF+ +NE+R
Sbjct: 694 FGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDR 753
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
L ++LDAQV++E +KEE+ +A +A+RC+NLNGKKRPTM EVA+EL
Sbjct: 754 LSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 367 bits (943), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 179/273 (65%), Positives = 220/273 (80%), Gaps = 2/273 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+IL QINHRNVVKLLGCCLETEVPLLVYEFIPNG+L ++IH Q E + PITWE+RL IA
Sbjct: 404 VILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNE-EFPITWEMRLRIAT 462
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV GALSYLHS ASIPIYHRDIKS NILLBDKYRAK++DFG S+ +A+D+THLTTQV+GT
Sbjct: 463 EVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGT 522
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFG+VL+ELLTG+KPI + +EE +SLA+YF+ +NE+R
Sbjct: 523 FGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDR 582
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA-SVLR 239
L ++LDAQV++E+ KEE+ +A +A+RC+NLNGKKRPTM EVA+EL IR G
Sbjct: 583 LSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFRAQE 642
Query: 240 QCEEIDFVNYDNARHFKTGSSSTGSFFNSYSSS 272
EEI++ + + S ST S N+ +SS
Sbjct: 643 NFEEIEYNTTELIGPWDVTSISTDSCLNTNASS 675
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 355 bits (912), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 167/232 (71%), Positives = 200/232 (86%), Gaps = 1/232 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVV +LGCCLETEVPLLVYEFI NG+L Q IH+Q + P++WE+RL IA+
Sbjct: 433 VILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIHDQNS-EFPLSWEMRLRIAL 491
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EVSGALSYLHSA SIPIYHRDIKS NILLDDKY+AK+SDFGTSRS+++D+THLTT V+GT
Sbjct: 492 EVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGT 551
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI + E +SLA +F+ + E+R
Sbjct: 552 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESR 611
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
LF++LDA+V++E KE+++T A +A RCLNLNG+KRPTMKEV E+ IR S
Sbjct: 612 LFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053058|ref|XP_002297686.1| predicted protein [Populus trichocarpa] gi|222844944|gb|EEE82491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 354 bits (909), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 169/229 (73%), Positives = 201/229 (87%), Gaps = 1/229 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++LSQINHRNVVKLLGCCLETEVPLLVYEFIPNG+L++YIH+Q ED L ++WE+RL IA+
Sbjct: 397 VVLSQINHRNVVKLLGCCLETEVPLLVYEFIPNGNLYKYIHDQNEDFL-LSWEMRLRIAI 455
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+GALSYLHSA SIPIYHRDIKS NILLD+KYRAK+SDFG+SRS+++D+THLTT V+GT
Sbjct: 456 EVAGALSYLHSATSIPIYHRDIKSTNILLDEKYRAKVSDFGSSRSISIDQTHLTTLVQGT 515
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFGVVLVEL++GQKPI V E RSLA +F+ ++ +NR
Sbjct: 516 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELISGQKPIFSVSQTETRSLATHFIMLMEDNR 575
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
L +VLDA+V + EEVI+VA +AKRCLNLNGK RPTM+EV EL I
Sbjct: 576 LSDVLDARVKEGCQNEEVISVANLAKRCLNLNGKNRPTMREVTSELERI 624
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 354 bits (909), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 167/232 (71%), Positives = 200/232 (86%), Gaps = 1/232 (0%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRNVV +LGCCLETEVPLLVYEFI NG+L Q IH+Q + P++WE+RL IA+
Sbjct: 313 VILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIHDQNS-EFPLSWEMRLRIAL 371
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EVSGALSYLHSA SIPIYHRDIKS NILLDDKY+AK+SDFGTSRS+++D+THLTT V+GT
Sbjct: 372 EVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGT 431
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI + E +SLA +F+ + E+R
Sbjct: 432 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESR 491
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
LF++LDA+V++E KE+++T A +A RCLNLNG+KRPTMKEV E+ IR S
Sbjct: 492 LFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVS 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | ||||||
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.783 | 0.308 | 0.655 | 1.2e-83 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.816 | 0.304 | 0.618 | 3.1e-83 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.783 | 0.316 | 0.633 | 3.2e-81 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.779 | 0.306 | 0.627 | 2.9e-80 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.783 | 0.300 | 0.619 | 6e-80 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.762 | 0.312 | 0.650 | 3.3e-79 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.783 | 0.293 | 0.639 | 4.3e-77 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.772 | 0.298 | 0.647 | 9e-77 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.786 | 0.292 | 0.613 | 2.1e-75 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.786 | 0.295 | 0.600 | 8.4e-74 |
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
Identities = 152/232 (65%), Positives = 200/232 (86%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++L+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + +H++++D +TWE+RL IA+
Sbjct: 462 VVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYT-MTWEVRLHIAI 520
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++GALSYLHSAAS PIYHRDIK+ NILLD++ RAK+SDFGTSRS+ +D+THLTTQV GT
Sbjct: 521 EIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGT 580
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGY+DPEYFQSS+FTEKSDVYSFGVVLVELLTG+KP V +EENR LAA+F++ + ENR
Sbjct: 581 FGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENR 640
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+ +++D ++ E ++V++VA +A+RCLN GKKRP M+EV++EL IR+S
Sbjct: 641 VLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 149/241 (61%), Positives = 199/241 (82%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG+L +++H++ ++ + TW IRL IA+
Sbjct: 493 VILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAI 552
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHS+AS PIYHRD+KS NI+LD+KYRAK+SDFGTSR++ VD THLTT V GT
Sbjct: 553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEYFQSSQFT+KSDVYSFGVVLVEL+TG+K I + ++ENR+LA YF+ + EN+
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENK 672
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASVLRQ 240
LF+++DA++ +V A VA++CLNL G+KRP+M+EV++EL IR G L++
Sbjct: 673 LFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQE 732
Query: 241 C 241
C
Sbjct: 733 C 733
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 3.2e-81, P = 3.2e-81
Identities = 147/232 (63%), Positives = 196/232 (84%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++LSQINHRN+VKLLGCCLETEVP+LVYE+IPNG L + +H++++D +TWE+RL IA+
Sbjct: 475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYT-MTWEVRLRIAI 533
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++GAL+Y+HSAAS PI+HRDIK+ NILLD+KYRAK+SDFGTSRS+ +D+THLTT V GT
Sbjct: 534 EIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGT 593
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
FGY+DPEYF SSQ+T KSDVYSFGVVLVEL+TG+KP+ V +EE R LA +FL+ + ENR
Sbjct: 594 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENR 653
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+ +++D ++ E++ E+V+ VA +A++CLN GK RP MKEV+ EL IR+S
Sbjct: 654 VIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
Identities = 145/231 (62%), Positives = 194/231 (83%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+LSQINHRN+VKL+GCCLETEVP+LVYE IPNG L + +H ++D +TW++RL I+VE
Sbjct: 468 VLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYT-MTWDVRLRISVE 526
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++GAL+YLHSAAS P+YHRD+K+ NILLD+KYRAK+SDFGTSRS+ VD+THLTT V GTF
Sbjct: 527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTF 586
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
GYLDPEYFQ+SQFT+KSDVYSFGVVLVEL+TG+KP ++ EENR L ++F + + +NR+
Sbjct: 587 GYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRV 646
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+++D+++ E+V+ VA +A+RCL+L GKKRP M+EV++EL IR+S
Sbjct: 647 LDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
Identities = 143/231 (61%), Positives = 192/231 (83%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG+L +++H+ ++D TWE+RL IAV
Sbjct: 479 VILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAV 538
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHSAAS PIYHRDIKS NI+LD+K+RAK+SDFGTSR++ VD THLTT V GT
Sbjct: 539 DIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGT 598
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEYFQSSQFT+KSDVYSFGVVL EL+TG+K + + ++E R+LA YF + ENR
Sbjct: 599 VGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENR 658
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231
L +++DA++ + +V A +A++CLN+ G+KRP+M++V++EL IR+
Sbjct: 659 LSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 3.3e-79, P = 3.3e-79
Identities = 147/226 (65%), Positives = 189/226 (83%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I+LSQINHRNVVK+LGCCLETEVP+LVYEFIPN +L ++H +ED P++WE+RL IA
Sbjct: 436 ILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSED-FPMSWEVRLCIAC 494
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV+ ALSYLHSA SIPIYHRD+KS NILLD+K+RAK+SDFG SRS+A+D THLTT V+GT
Sbjct: 495 EVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGT 554
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEY QS+ FT KSDVYSFGV+L+ELLTG+KP+ L+ +E R L AYFL+ + +R
Sbjct: 555 IGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDR 614
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
L E+LDA++ E ++EEV+ VA +A+RCL+LN + RPTM++V +EL
Sbjct: 615 LHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIEL 660
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 776 (278.2 bits), Expect = 4.3e-77, P = 4.3e-77
Identities = 149/233 (63%), Positives = 188/233 (80%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHR+VVKLLGCCLETEVP LVYEFIPNG+L Q+IHE+++D TW +RL IAV
Sbjct: 497 VILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTK-TWGMRLRIAV 555
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHSAAS PIYHRDIKS NILLD+KYR K+SDFGTSRS+ +D TH TT + GT
Sbjct: 556 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGT 615
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE-TEENRSLAAYFLQVINEN 179
GY+DPEY+ SSQ+T+KSDVYSFGVVLVEL+TG+KP+ V ++E R LA +F + EN
Sbjct: 616 VGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKEN 675
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
R FE++DA++ + E+V+ VA +A+RCLN GKKRP M++V +L I AS
Sbjct: 676 RFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 149/230 (64%), Positives = 184/230 (80%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
IILSQINHR+VVKLLGCCLETEVP+LVYEFIPNG+L Q++HE+ +D + W +R+ IAV
Sbjct: 500 IILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTAL-WGVRMRIAV 558
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
++SGA SYLH+AA PIYHRDIKS NILLD+KYRAK+SDFGTSRS+++D TH TT + GT
Sbjct: 559 DISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGT 618
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-IRLVETEENRSLAAYFLQVINEN 179
GY+DPEY+ SS FTEKSDVYSFGVVLVEL+TG+KP I L ET+E LA YF + EN
Sbjct: 619 VGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMREN 678
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
RLFE++DA++ + + E+VI VA +A RCL GK RP M+EV+ L I
Sbjct: 679 RLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 760 (272.6 bits), Expect = 2.1e-75, P = 2.1e-75
Identities = 143/233 (61%), Positives = 187/233 (80%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHR+VVKLLGCCLETEVP+LVYEFI NG+L ++IHE+ D + W +RL IAV
Sbjct: 499 VILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAV 558
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHS+AS PIYHRDIKS NILLD+KYRAK++DFGTSRS+ +D+TH TT + GT
Sbjct: 559 DIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGT 618
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE-TEENRSLAAYFLQVINEN 179
GY+DPEY+QSSQ+TEKSDVYSFGV+L EL+TG KP+ +V+ T+E +LA +F + E
Sbjct: 619 VGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEK 678
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
RL +++DA++ + + E+V+ VA VA +CL+ GKKRP M+EV EL I S
Sbjct: 679 RLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERICTS 731
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 745 (267.3 bits), Expect = 8.4e-74, P = 8.4e-74
Identities = 140/233 (60%), Positives = 187/233 (80%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ILSQINHR+VVKLLGCCLETEVP+LVYEFI NG+L ++IHE+ D + W +RL IAV
Sbjct: 490 VILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAV 549
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++GALSYLHSAAS PIYHRDIKS NILLD+KYRAK++DFGTSRS+ +D+TH TT + GT
Sbjct: 550 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGT 609
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE-TEENRSLAAYFLQVINEN 179
GY+DPEY++SSQ+TEKSDVYSFGV+L EL+TG KP+ +V+ T+E +LA +F + E
Sbjct: 610 VGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKER 669
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
RL +++DA++ +++ E+V+ VA +A +CL+ G+ RP M+EV EL I S
Sbjct: 670 RLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERICTS 722
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 295 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ +++H NVVKLLG C E E +V E++ G L Y+ + ++ L A++
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ + YL S HRD+ + N L+ + KISDFG SR + D + K
Sbjct: 111 IARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENR 180
++ PE + +FT KSDV+SFGV+L E+ T G++P N + Y + N R
Sbjct: 168 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEY---LKNGYR 221
Query: 181 LFEVLDAQVLREAEKEEVIT--VAMVAKRCLNLNGKKRPTMKEVALEL 226
L + + + +C + + RPT E+ L
Sbjct: 222 L------------PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 1e-46
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ +++H N+VKLLG C E E ++V E++P G L Y+ + ++ L A++
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK--ELSLSDLLSFALQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ + YL S HRD+ + N L+ + KISDFG SR + D + K
Sbjct: 112 IARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI 168
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENR 180
++ PE + +FT KSDV+SFGV+L E+ T G++P N + Y + R
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEY---LKKGYR 222
Query: 181 LFEVLDAQVLREAEKEEVIT--VAMVAKRCLNLNGKKRPTMKEVALEL 226
L K + + +C + + RPT E+ L
Sbjct: 223 L------------PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-43
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 32/231 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ +++H N+V+LLG C + E +V E++P G L ++ + E +T + L +A++
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ----- 116
++ + YL S HRD+ + N L+ + KISDFG SR + D +
Sbjct: 111 IAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQV 175
+K ++ PE + +FT KSDV+SFGV+L E+ T G++P + EE +
Sbjct: 168 IK----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE------VLELL 217
Query: 176 INENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
+ RL + + + +C + + RPT E+ +L
Sbjct: 218 EDGYRL----------PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-43
Identities = 58/151 (38%), Positives = 85/151 (56%), Gaps = 9/151 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL ++NH N+VKL G + LV E+ GSL + E + ++ + L I ++
Sbjct: 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQ 100
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+ L YLH S I HRD+K NILLD D + K++DFG S+ + D++ L T V GT
Sbjct: 101 ILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GT 156
Query: 121 FGYLDPE-YFQSSQFTEKSDVYSFGVVLVEL 150
Y+ PE ++EKSD++S GV+L EL
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-42
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL +++H N+V+L+ + + LV E+ G L Y+ P++ + IA++
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQ 106
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L YLHS I HRD+K NILLD+ KI+DFG ++ + + LTT V GT
Sbjct: 107 ILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTP 162
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y+ PE + + K DV+S GV+L ELLTG+ P L +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFS--GENILDQLQLIRRILGPPLE 220
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
E + EA+ + K+CLN + KRPT +E+
Sbjct: 221 FDEPKWSSGSEEAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 8e-42
Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
IL ++ H N+V+L + + LV E+ G L + ++ +ED E R
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED------EARF-Y 102
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
++ AL YLHS I HRD+K NILLD+ K++DFG +R + LTT V
Sbjct: 103 LRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV- 157
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINE 178
GT Y+ PE + + D++S GV+L ELLTG+ P F
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP---------------FPGDDQL 202
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVA--KRCLNLNGKKRPTMKEV 222
LF+ + E I+ ++ L + +KR T +E
Sbjct: 203 LELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 38/239 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL-----PITWEIRL 56
++ ++ H NVV+LLG C E E LV E++ G L Y+ + ++ + L
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
A++++ + YL S HRD+ + N L+ + KISDFG SR + D +
Sbjct: 109 SFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 117 -----VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAA 170
++ ++ PE + FT KSDV+SFGV+L E+ T G P + EE +
Sbjct: 166 GGKLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE 218
Query: 171 YFLQVINENRLFEVLDAQVLREAEKEEVIT--VAMVAKRCLNLNGKKRPTMKEVALELA 227
Y + RL K E + + C L+ + RPT E+ L
Sbjct: 219 Y---LRKGYRL------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL ++NH N++K E +V E+ G L Q I +Q ++ P E L V+
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL YLHS I HRDIK NI L K+ DFG S+ ++ T V GT
Sbjct: 112 LCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTP 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
YL PE Q+ + KSD++S G VL EL T + P E +L L+++
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF------EGENLLELALKILKGQ-- 219
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + +Q E + + L + ++RP++ ++
Sbjct: 220 YPPIPSQYSSE--------LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-33
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 10/158 (6%)
Query: 2 ILSQINHRNVVKLLGCCL-ETEVPLLVY-EFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
ILS + H N+V+ G E + L ++ E++ GSL + +LP IR
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEP-VIRKYTR 108
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA-VDRTHLTTQVK 118
+ G L+YLHS I HRDIK ANIL+D K++DFG ++ + ++ T V+
Sbjct: 109 QILEG-LAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + ++ +D++S G ++E+ TG+ P
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 68/227 (29%), Positives = 96/227 (42%), Gaps = 34/227 (14%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSL----HQYIHEQTEDQLPITWEIRL 56
IL + H N+VK G L+ + +V EF GSL TE Q+
Sbjct: 49 QILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY------ 102
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA--VDRTHLT 114
+ E+ L YLHS I HRDIK+ANILL K+ DFG S ++ R +
Sbjct: 103 -VCKELLKGLEYLHSNGII---HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
GT ++ PE + K+D++S G+ +EL G+ P E + A F
Sbjct: 159 ----GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS-----ELPPMKALFKI 209
Query: 175 VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
N LR EK + K+CL N +KRPT ++
Sbjct: 210 ATN--------GPPGLRNPEKWSDEFKDFL-KKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP--ITWEIRLGIA 59
+L++++ +++ L+ +V E+ NG LH+ + Q LP W + I
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
+ L++LHS I HRDIKS N+ LD KI D G ++ ++ D T+ + G
Sbjct: 112 L----GLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVG 163
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
T YL PE + + EKSDV++ GVVL E TG+ P + + A L++I
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRG- 216
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217
+F + ++ +A + +CL + ++RP
Sbjct: 217 -VFPPVSQMYSQQ--------LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
ILS+INH +VKL +TE L LV E+ P G L ++ E + R A
Sbjct: 46 ILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEER-ARF-YAA 100
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ AL YLHS I +RD+K NILLD K++DFG ++ T GT
Sbjct: 101 EIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGT 156
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
YL PE + + D +S GV+L E+LTG+ P + +E
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 51/161 (31%), Positives = 86/161 (53%), Gaps = 13/161 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-AV 60
+++Q++H +V+L+G C E +LV E P G L +Y+ ++ L A
Sbjct: 49 VMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKR-----REIPVSDLKELAH 102
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V+ ++YL S + HRD+ + N+LL ++++AKISDFG SR++ + G
Sbjct: 103 QVAMGMAYLESKHFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159
Query: 121 F--GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158
+ + PE +F+ KSDV+S+GV L E + G KP
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++H N+++L G L T ++V E P GSL + + I+ AV+
Sbjct: 49 IMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQ 105
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ--VKG 119
++ + YL S I HRD+ + NILL + KI DFG R++ + H + +K
Sbjct: 106 IANGMRYLESKRFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
F + PE ++ F+ SDV+ FGV L E+ T G++P
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-24
Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 11/167 (6%)
Query: 1 IILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
II+ +H NV+ LLG CL +E PL+V ++ +G L +I +T + T + +G
Sbjct: 48 IIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFG 104
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM---AVDRTHLTTQ 116
++V+ + YL AS HRD+ + N +LD+ + K++DFG +R + H T
Sbjct: 105 LQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVET 162
K ++ E Q+ +FT KSDV+SFGV+L EL+T G P V++
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 19/237 (8%)
Query: 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
IL ++H N+VK G C + L+ E++P+GSL Y+ + L +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR---LLLFS 115
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ + YL S I HRD+ + NIL++ + KISDFG ++ + D+ + + G
Sbjct: 116 SQICKGMDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 120 ---TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
F Y PE ++S+F+ SDV+SFGV L EL T P + E R + Q+I
Sbjct: 173 ESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 177 NENRLFEVL-DAQVLREAEK--EEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230
RL E+L + + L +EV + K C + RP+ ++ L + +R
Sbjct: 232 VT-RLLELLKEGERLPRPPSCPDEVY---DLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (248), Expect = 4e-24
Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 18/230 (7%)
Query: 2 ILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
IL+ +NH N+VKL + LV E++ GSL + + + P++ L I
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILA 108
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVK- 118
++ AL YLHS I HRDIK NILLD D K+ DFG ++ + + +
Sbjct: 109 QILSALEYLHSKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 119 ----GTFGYLDPEYFQSSQF---TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAY 171
GT GY+ PE + SD++S G+ L ELLTG P E S A
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG----EKNSSATS 221
Query: 172 FLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
I L + + + + + K+ L + K R +
Sbjct: 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED---QLPITWEIRLGI 58
+++ ++H +VV+LLG CL + L+ + +P G L Y+ ++ Q + W
Sbjct: 62 VMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------ 114
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQV 117
V+++ +SYL + HRD+ + N+L+ KI+DFG ++ + VD
Sbjct: 115 CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVI 176
K ++ E +T KSDV+S+GV + EL+T G KP + E L +
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL------LE 225
Query: 177 NENRLFEVLDAQVLREAEKEEVIT--VAMVAKRCLNLNGKKRPTMKEVALELA 227
RL + + T V MV +C ++ + RPT KE+ E +
Sbjct: 226 KGERL------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-23
Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 43/248 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ------------------ 43
+L Q+NH +V+KL G C + LL+ E+ GSL ++ E
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 44 --TEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101
D+ +T + A ++S + YL A + + HRD+ + N+L+ + + KISDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 102 TSRSMAVDRTHLT-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160
SR + + +++ ++ + ++ E +T +SDV+SFGV+L E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------- 224
Query: 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAM--VAKRCLNLNGKKRPT 218
L I RLF +L + E+ E + M + C KRPT
Sbjct: 225 -------LGGNPYPGIAPERLFNLL--KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT 275
Query: 219 MKEVALEL 226
+++ EL
Sbjct: 276 FADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 27/173 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH----------EQTEDQLPIT 51
+L+ H N+VK G C E + P++V+E++ +G L++++ +T
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 52 WEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT 111
L IAV+++ + YL AS HRD+ + N L+ KI DFG SR +
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV----- 172
Query: 112 HLTT---QVKGT----FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
TT +V G ++ PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 173 -YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-23
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
ILS + H N++ ++ L+ E+ G+L+ I Q E+ L +
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQ 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ A+SY+H A I HRDIK+ NI L K+ DFG S+ + + + T V GT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTP 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
Y+ PE Q ++ KSD+++ G VL ELLT L T + + ++++ N
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLT------LKRTFDATNPLNLVVKIVQGNYT 219
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
V E+I + L + +KRPT EV
Sbjct: 220 PVV-------SVYSSELI---SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-23
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 6/156 (3%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++ H +V+L C E E +V E++ GSL ++ +L + + +A +
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAAQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++YL S I HRD+ + NIL+ + KI+DFG +R + D K
Sbjct: 112 IAEGMAYLESRNYI---HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT KSDV+SFG++L E++T G+ P
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 5e-23
Identities = 56/178 (31%), Positives = 83/178 (46%), Gaps = 29/178 (16%)
Query: 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L+++N H ++KL + E V E+ PNG L QYI + L R A
Sbjct: 54 VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKC-TRF-YAA 109
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-------------- 106
E+ AL YLHS I HRD+K NILLD KI+DFGT++ +
Sbjct: 110 EILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 107 ------AVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
+R + V GT Y+ PE + SD+++ G ++ ++LTG+ P R
Sbjct: 167 NIDSQIEKNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 21/224 (9%)
Query: 2 ILSQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
IL ++ H N+V+ + + +V E+ G L Q I + +++ I E I
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 60 VEVSGALSYLH--SAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
++ AL H S + HRD+K ANI LD K+ DFG ++ + D + T V
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT Y+ PE + EKSD++S G ++ EL P A LQ+ +
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT----------ARNQLQLAS 220
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
+ + + +E EVI K LN++ KRP+ +E
Sbjct: 221 KIKEGKFRRIPYRYSSELNEVI------KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 8e-23
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV- 60
+L + H N+VK +G ++ ++ E+ NGSL Q I P E + + V
Sbjct: 52 LLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFP---ESLVAVYVY 106
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V L+YLH I HRDIK+ANIL K++DFG + + D + V GT
Sbjct: 107 QVLQGLAYLHEQGVI---HRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGT 162
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
++ PE + S + SD++S G ++ELLTG P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-22
Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 26/229 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+++ + H N+V+LLG L+ +V E++ GSL Y+ ++ + IT +LG A++
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALD 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V + YL HRD+ + N+L+ + AK+SDFG ++ + + VK T
Sbjct: 111 VCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT- 166
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENR 180
PE + +F+ KSDV+SFG++L E+ + G+ P + ++ + + V R
Sbjct: 167 ---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPH---VEKGYR 217
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
+ EA + V V K C L+ KRPT K++ +LA I
Sbjct: 218 M----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-22
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 32/226 (14%)
Query: 2 ILSQINHRNVVK-----LLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
IL+ +NH N++ L G L +V E+ P G L + I ++ + + I +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
I +++ L LH I HRD+KSANILL KI D G S+ + + TQ
Sbjct: 107 RIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQ 161
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
+ GT Y+ PE ++ ++ KSD++S G +L E+ T P E RS+ +V
Sbjct: 162 I-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF------EARSMQDLRYKVQ 214
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + ++ + + L + K RP ++
Sbjct: 215 RGK--YPPIPPIYSQDLQN--------FIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-22
Identities = 49/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H N+V+L G C + +V E++ NG L Y+ E+ + E L + +
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSD 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V A+ YL S I HRD+ + N L+ + K+SDFG +R + D+ + K
Sbjct: 109 VCEAMEYLESNGFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155
+ PE F S+F+ KSDV+SFGV++ E+ + K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-22
Identities = 55/164 (33%), Positives = 92/164 (56%), Gaps = 20/164 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGS----LHQYIHEQTEDQLPITWEIRLG 57
+L ++ H N+V+ LG L+ + + E++P GS L+ Y E+ L +R
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETL-----VRNF 111
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ- 116
+ + G L+YLH+ I HRDIK ANIL+D+K KISDFG S+ + + T
Sbjct: 112 VRQILKG-LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 117 ----VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
++G+ ++ PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 5e-22
Identities = 58/162 (35%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI-HEQTEDQLPITWEIRLGIAV- 60
+SQ NH NVVK + + LV ++ GSL + L IA
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-----EAIIATV 107
Query: 61 --EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA--VDRTHLT-T 115
EV L YLHS I HRDIK+ NILL + KI+DFG S S+A DRT
Sbjct: 108 LKEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164
Query: 116 QVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + K+D++SFG+ +EL TG P
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-22
Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 8/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ +I H N+V+LLG C E P ++ EF+ G+L Y+ E ++ + L +A
Sbjct: 55 VMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMAT 111
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
++S A+ YL I HRD+ + N L+ + + K++DFG SR M D K
Sbjct: 112 QISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE ++F+ KSDV++FGV+L E+ T G P
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 46/157 (29%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H N+++L G ++ +++ E++ NGSL +++ E + + T +G+
Sbjct: 58 IMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKF--TVGQLVGMLRG 114
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHLTTQVKGT 120
++ + YL + HRD+ + NIL++ K+SDFG SR + + T+ T K
Sbjct: 115 IASGMKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT SDV+SFG+V+ E+++ G++P
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE-------QTEDQLPITWEI 54
ILS+++ N+ +LLG C ++ E++ NG L+Q++ + + +++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHL 113
L +A +++ + YL S+ HRD+ + N L+ Y KI+DFG SR++ + D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
+ ++ E +FT KSDV++FGV L E+LT
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 35/227 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSL----HQYIHEQTEDQLPITWEIRLG 57
I+ H N+V L + +V E++ GSL Q E Q+
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY------- 120
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ EV L YLHS I HRDIKS NILL K++DFG + + +++ + V
Sbjct: 121 VCREVLQGLEYLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-IRLVETEENRSLAAYFLQVI 176
GT ++ PE + + K D++S G++ +E+ G+ P +R L A FL
Sbjct: 178 -GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE------PPLRALFLITT 230
Query: 177 NENRLFEVLDAQVLREAEK--EEVITVAMVAKRCLNLNGKKRPTMKE 221
L+ EK E +CL + +KRP+ +E
Sbjct: 231 K--------GIPPLKNPEKWSPEFKD---FLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-21
Identities = 73/235 (31%), Positives = 109/235 (46%), Gaps = 37/235 (15%)
Query: 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYI--HEQTEDQLPITWEIRLG 57
IL + H N+VK GCC E + L+ E++P GSL Y+ H+ QL +
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL------- 111
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
A ++ ++YLHS I HRD+ + N+LLD+ KI DFG ++ AV H +V
Sbjct: 112 FAQQICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRV 166
Query: 118 KG-----TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
+ F Y E + ++F+ SDV+SFGV L ELLT + +S F
Sbjct: 167 REDGDSPVFWYA-VECLKENKFSYASDVWSFGVTLYELLT--------HCDSKQSPPKKF 217
Query: 173 LQVI-------NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK 220
++I RL E+L+ + K V ++ K C K RPT +
Sbjct: 218 EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-21
Identities = 71/242 (29%), Positives = 115/242 (47%), Gaps = 28/242 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
IL + H N+VK G C LV E++P GSL Y+ + E + L A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYA 114
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ + YL S + HRD+ + NIL++ + R KI DFG ++ + D+ + + G
Sbjct: 115 SQICKGMEYLGSKRYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171
Query: 120 ---TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
F Y PE S+F+ SDV+SFGVVL EL T ++++ S A F++++
Sbjct: 172 ESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMRMM 222
Query: 177 NENR--------LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228
++ L E+L A + + K C N + +RP+ E+AL++
Sbjct: 223 GNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282
Query: 229 IR 230
IR
Sbjct: 283 IR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-21
Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED---QLPITWEIRLG 57
+I++ ++H ++V+LLG CL + L V + +P+G L Y+HE ++ QL + W
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW----- 114
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ- 116
V+++ + YL + HRD+ + N+L+ KI+DFG +R + D
Sbjct: 115 -CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQV 175
K ++ E +FT +SDV+S+GV + EL+T G KP + T E L
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL------- 223
Query: 176 INENRLFEVLDAQVLREAEKEE-----VITVAMVAKRCLNLNGKKRPTMKEVALELA 227
L + E+ I V MV +C ++ RP KE+A E +
Sbjct: 224 --------------LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 5e-21
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 27/224 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L VVK G + +V E++ GSL + ++ I + IA +
Sbjct: 52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVG---KIPEPVLAYIARQ 107
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L YLH+ I HRDIK +N+L++ K KI+DFG S+ + T V GT
Sbjct: 108 ILKGLDYLHTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTV 164
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
Y+ PE Q ++ +D++S G+ L+E G+ P +
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFP----------------FLPPGQPSF 208
Query: 182 FEVLDAQVLREAEK--EEVITVAMVA--KRCLNLNGKKRPTMKE 221
FE++ A E + CL + KKRP+ E
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-21
Identities = 55/167 (32%), Positives = 93/167 (55%), Gaps = 13/167 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H +V+L G C E LV+EF+ +G L Y+ Q + + E LG+ ++
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLD 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V ++YL S+ I HRD+ + N L+ + K+SDFG +R + D+ +T K
Sbjct: 109 VCEGMAYLESSNVI---HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRS 167
+ PE F S+++ KSDV+SFGV++ E+ + G+ P ENRS
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY------ENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-21
Identities = 49/167 (29%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL Q +H N+VKL+G C++ + +V E +P GSL ++ ++ +++L + + L ++++
Sbjct: 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTV--KKLLQMSLD 101
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT- 120
+ + YL S I HRD+ + N L+ + KISDFG SR ++ +K
Sbjct: 102 AAAGMEYLESKNCI---HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENR 166
+ PE ++T +SDV+S+G++L E + G P + ++ R
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR 205
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-20
Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 46/249 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--LLVYEFIP---NGSLHQYIHEQTEDQLP-ITWEIR 55
+L ++ H N+V+L +V+E++ G L + TE Q+ ++
Sbjct: 51 LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL 110
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
G L YLHS I HRDIK +NIL+++ K++DFG +R + T
Sbjct: 111 EG--------LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 116 QVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
T Y PE ++++ + D++S G +L EL G KPI TE + L+
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQ------LE 212
Query: 175 VI-------NEN--------RLFEVLDAQ-----VLREAEKEEVITVAM-VAKRCLNLNG 213
I + FE L + LRE K + A+ + + L L+
Sbjct: 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDP 272
Query: 214 KKRPTMKEV 222
KKR + +
Sbjct: 273 KKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I+ Q +H ++VKL+G TE P+ +V E P G L Y+ + + L + + +
Sbjct: 60 IMRQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL-QVNKYSLDL--ASLILYSY 114
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
++S AL+YL S HRDI + N+L+ K+ DFG SR + + + ++ K
Sbjct: 115 QLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEE 164
++ PE +FT SDV+ FGV + E+L G KP + V+ +
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 24/231 (10%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI-----HEQTEDQLPITWEIRLG 57
+++H+NVV+LLG C E E ++ E+ G L Q++ ++ P++ + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ +++ + +L +A + HRD+ + N L+ + K+S S+ + +
Sbjct: 122 LCTQIALGMDHLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVI 176
+L PE Q F+ KSDV+SFGV++ E+ T G+ P + EE L +
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRL 231
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227
+L L E + + RC +N K RP+ E+ L
Sbjct: 232 QAGKL-------ELPVPEGCPS-RLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-20
Identities = 48/166 (28%), Positives = 96/166 (57%), Gaps = 10/166 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q+++ +V+++G C E E +LV E G L++++ + +D++ ++ + L +
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVEL--MHQ 103
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
VS + YL + HRD+ + N+LL +++ AKISDFG S+++ D ++ + G +
Sbjct: 104 VSMGMKYLEGKNFV---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 122 --GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEE 164
+ PE +F+ +SDV+S+G+ + E + GQKP + ++ E
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 20/162 (12%)
Query: 2 ILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG-IA 59
IL + N +V G ++ + + E++ GSL + I ++ + ++P E LG IA
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDK-ILKEVQGRIP---ERILGKIA 106
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR----SMAVDRTHLTT 115
V V L+YLH I HRD+K +NIL++ + + K+ DFG S S+A
Sbjct: 107 VAVLKGLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---- 160
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
GT Y+ PE Q + ++ KSD++S G+ L+EL TG+ P
Sbjct: 161 ---GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-20
Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++ H +++L C E +V E + GSL +Y+ L + I +A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V+ ++YL + I HRD+ + N+L+ + K++DFG +R + D K
Sbjct: 112 VASGMAYLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI 168
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE ++F+ KSDV+SFG++L E++T G+ P
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 9e-20
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
IL ++NH +V L + E LV + + G L ++ ++ +E+Q ++
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ------VKF-W 105
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
E+ AL YLHS I HRDIK NILLD++ I+DF + + D LTT
Sbjct: 106 ICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTS 160
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINE 178
GT GY+ PE ++ D +S GV E L G++P R + A
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV- 219
Query: 179 NRLFEVLDAQVLREA 193
L+ + +A
Sbjct: 220 --LYPATWSTEAIDA 232
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 17/169 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI--HEQTED----------QLP 49
++S + H N+V LLG C + + +++E++ +G LH+++ + D +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AV 108
+ L IA++++ + YL +S HRD+ + N L+ + KISDFG SR + +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 109 DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
D + ++ ++ PE +FT +SD++SFGVVL E+ + G +P
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 7/156 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L ++ H++++ L C E ++ E + GSL ++ LP+ + +A +
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV--ASLIDMACQ 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V+ ++YL SI HRD+ + NIL+ + K++DFG +R + + +L++ K +
Sbjct: 113 VAEGMAYLEEQNSI---HRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPY 168
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE F+ KSDV+SFG++L E+ T GQ P
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+++++NH +++++LG E L E++ GS+ + + + +
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDK-YRAKISDFGTSRSMAVDRT---HLTTQV 117
+ LSYLH I HRD+K AN+L+D R +I+DFG + +A T Q+
Sbjct: 112 LLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT ++ PE + Q+ DV+S G V++E+ T + P + + +L
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ E L + LR+ V RCL L + RP +E+
Sbjct: 229 APSIPEHL-SPGLRD-----------VTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-19
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 3 LSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLP--ITWEI 54
+ +H NV+KL+G C E P+++ F+ +G LH ++ LP + +
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
L V+++ + YL + I HRD+ + N +L + ++DFG S+ + +
Sbjct: 115 LLKFMVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171
Query: 115 TQV-KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYF 172
++ K ++ E +T KSDV++FGV + E+ T GQ P VE E
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY---- 227
Query: 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
+ + NRL + D +E+ + M C + K RPT ++ L I
Sbjct: 228 --LRHGNRLKQPEDCL-------DELYDL-MY--SCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 35/238 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------QLPITWEIR 55
++ + N +VV+LLG + L+V E + G L Y+ + + P T +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ +A E++ ++YL A+ HRD+ + N ++ + KI DFG M D
Sbjct: 122 IQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFG----MTRDIYETDY 174
Query: 116 QVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLA 169
KG G L PE + FT KSDV+SFGVVL E+ T ++P
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------------- 221
Query: 170 AYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227
+ + NE L V+D L E + + + C N K RPT E+ L
Sbjct: 222 --YQGLSNEEVLKFVIDGGHLDLPENCPDK-LLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+VK G + E + E+ G+L + + + IR+ ++
Sbjct: 52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---IRV-YTLQ 107
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L+YLHS I HRDIK ANI LD K+ DFG + + + T + +V+
Sbjct: 108 LLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164
Query: 122 G---YLDPEYFQSSQFTEK---SDVYSFGVVLVELLTGQKP 156
G Y+ PE + +D++S G V++E+ TG++P
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 17/176 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY---------IHEQTEDQL--PI 50
+L+ + H+++V+ G C E L+V+E++ +G L+++ I ED +
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVD 109
T L IA +++ + YL AS+ HRD+ + N L+ KI DFG SR + + D
Sbjct: 120 TLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 110 RTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP-IRLVETE 163
+ + ++ PE +FT +SD++SFGVVL E+ T G++P +L TE
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-19
Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H +V+L G C + + +V EF+ NG L Y+ ++ Q ++ ++ L + +
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQD 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V + YL + I HRD+ + N L+ K+SDFG +R + D ++ K
Sbjct: 109 VCEGMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINE-- 178
+ PE F S+++ KSDV+SFGV++ E+ T G+ P E + N +V+
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF---EKKSN-------YEVVEMIS 215
Query: 179 --NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
RL+ K +TV V C + + RPT E+
Sbjct: 216 RGFRLYR----------PKLASMTVYEVMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-19
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 16/160 (10%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVY-EFIPNGSLHQYI--HEQTEDQLPITWEIRLGIA 59
L ++H N+V+ LG TE L ++ E++P GS+ + + + E+QL +R
Sbjct: 62 LKDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-----VRF-FT 114
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQVK 118
+V L+YLHS I HRD+K+ N+L+D KISDFG S+ S + ++
Sbjct: 115 EQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 119 GTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKP 156
G+ ++ PE S ++ K D++S G V++E+ G++P
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H +V+L G C + +V E++ NG L Y+ E + P L + +
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKD 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V ++YL S I HRD+ + N L+DD+ K+SDFG SR + D + K
Sbjct: 109 VCEGMAYLESKQFI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENR 180
+ PE S+F+ KSDV++FGV++ E+ + G+ P E +V R
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------VEKVSQGLR 219
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
L+ R E + M + C + ++RPT +++
Sbjct: 220 LY--------RPHLASEKVYAIMYS--CWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 63/233 (27%), Positives = 112/233 (48%), Gaps = 25/233 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE-QTEDQLPITWEIR----- 55
I+S++ + N+++LLG C+ + ++ E++ NG L+Q++ + + E I
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 56 --LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTH 112
L +AV+++ + YL AS+ HRD+ + N L+ + Y KI+DFG SR++ + D
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL--LTGQKPIRLVETEENRSLAA 170
+ + ++ E +FT SDV++FGV L E+ L ++P L+ E
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE------- 239
Query: 171 YFLQVI-NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
QVI N F Q+ V + RC + + K RPT ++
Sbjct: 240 ---QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 52/155 (33%), Positives = 86/155 (55%), Gaps = 10/155 (6%)
Query: 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
IL + H N+VK G C E L+ EF+P+GSL +Y+ ++ I + +L A
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYA 115
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ--V 117
V++ + YL S + HRD+ + N+L++ +++ KI DFG ++++ D+ + T + +
Sbjct: 116 VQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
+ PE S+F SDV+SFGV L ELLT
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 45/158 (28%), Positives = 87/158 (55%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H N+++L G + + +++ E++ NG+L +Y+ + + +G+
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD--RTHLTTQVKG 119
++ + YL + + HRD+ + NIL++ K+SDFG SR + D T+ T+ K
Sbjct: 116 IAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT SDV+SFG+V+ E+++ G++P
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H +V+ GC + E + E++P GS+ + +T + +
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQ 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT--TQVKG 119
+ + YLHS I HRDIK ANIL D K+ DFG S+ + + T V G
Sbjct: 113 ILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T ++ PE + K+DV+S G +VE+LT + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-18
Identities = 48/160 (30%), Positives = 88/160 (55%), Gaps = 11/160 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ Q+++ +V+++G C E E +LV E G L++++ + +T + + +
Sbjct: 49 VMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKH----VTEKNITELVHQ 103
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
VS + YL + HRD+ + N+LL ++ AKISDFG S+++ D + + G +
Sbjct: 104 VSMGMKYLEETNFV---HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 122 --GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158
+ PE +F+ KSDV+SFGV++ E + GQKP +
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
II Q+ H N+V+ LE + +V + I L ++ + E + T E I V
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
++ AL YLH I HRD+ NI+L + + I+DFG ++ T V GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQK--QPESKLTSVVGT 176
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y PE ++ + EK+DV++FG +L ++ T Q P + SLA +++
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY---STNMLSLA---TKIVEA-- 228
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223
++E L + E V V CL + + RP + +V+
Sbjct: 229 VYEPLPEGMYSE-------DVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 18/229 (7%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEV 62
+ ++ H N+VKL+G C + L++E+I +L + + ++WE R IA+ +
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGI 789
Query: 63 SGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFG 122
+ AL +LH S + ++ I++D K + + D +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----A 843
Query: 123 YLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLF 182
Y+ PE ++ TEKSD+Y FG++L+ELLTG+ P E + S+ + ++ L
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLD 902
Query: 183 EVLDAQVLREA--EKEEVITVAMVAKRCLNLNGKKRPTMKEV--ALELA 227
+D + + + E++ V +A C + RP +V LE A
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-18
Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ-----TEDQLPITWEIR 55
I+L+++ H N+V E +V E+ G L + I+ Q +EDQ+
Sbjct: 51 ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI------- 103
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYR-AKISDFGTSRSMAVDRTHLT 114
L V++S L ++H I HRDIKS NI L AK+ DFG +R + D L
Sbjct: 104 LSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELA 159
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT YL PE Q+ + K+D++S G VL EL T + P
Sbjct: 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-18
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L ++H N+++ LE + ++V E+ P G+L +YI ++ L + L V+
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD--EDTILHFFVQ 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+ AL ++H+ I HRD+K+ NILLD K KI DFG S+ ++ T V GT
Sbjct: 110 ILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGT 164
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y+ PE + + +KSD+++ G VL EL + L E +L A L++++
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELAS------LKRAFEAANLPALVLKIMSGT- 217
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F + + + + + LNL+ KRP + ++
Sbjct: 218 -FAPISDRYSPD--------LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-18
Identities = 61/229 (26%), Positives = 114/229 (49%), Gaps = 31/229 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++++++H+N+V+LLG L + +V E + G+L ++ + + + ++ +++
Sbjct: 52 VMTKLHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLD 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR--SMAVDRTHLTTQVKG 119
V+ + YL S + HRD+ + NIL+ + AK+SDFG +R SM VD + L VK
Sbjct: 109 VAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VKW 163
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINE 178
T PE + +F+ KSDV+S+GV+L E+ + G+ P Y + E
Sbjct: 164 T----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP--------------YPKMSLKE 205
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227
+ E ++ E + V ++ C KKRP+ ++ +L
Sbjct: 206 --VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-18
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 27/183 (14%)
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-- 106
PI EI IAV V L+YL++ I HRDIK +NIL++ + + K+ DFG S +
Sbjct: 99 PIPVEILGKIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156
Query: 107 AVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
++ T + GT Y+ PE Q ++T KSDV+S G+ ++EL G+ P +++
Sbjct: 157 SIADTFV-----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 167 SLAAYFL-----QVINEN--RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219
+ Q++ E RL + LR+ V CL + +RPT
Sbjct: 212 QDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD----------FV-DACLLKDPTERPTP 260
Query: 220 KEV 222
+++
Sbjct: 261 QQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-18
Identities = 46/175 (26%), Positives = 92/175 (52%), Gaps = 23/175 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ------------------ 43
++++ +H N+VKLLG C + L++E++ G L++++ +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 44 TEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS 103
+ LP++ +L IA +V+ ++YL + HRD+ + N L+ + KI+DFG S
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLS 177
Query: 104 RSM-AVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
R++ + D + ++ PE +++T +SDV+++GVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 14/166 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL---------PITW 52
+L+ + H ++VK G C+E + ++V+E++ +G L++++ D + +T
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 53 EIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRT 111
L IA +++ + YL AS HRD+ + N L+ + KI DFG SR + + D
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 112 HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ ++ PE +FT +SDV+S GVVL E+ T G++P
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 20/161 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVY-EFIPNGSLHQYIHEQ---TEDQLPI-TWEIRL 56
+LS++ H N+V+ LG E + L ++ E +P GSL + + + E + + T +I L
Sbjct: 55 LLSKLQHPNIVQYLGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL 113
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
G L YLH ++ HRDIK ANIL+D K++DFG ++ +
Sbjct: 114 G--------LEYLHDRNTV---HRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKS 160
Query: 117 VKGTFGYLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQKP 156
KG+ ++ PE Q + +D++S G ++E+ TG+ P
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 2e-17
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L ++ H N+VKLL LV+E+ L +Y+ ++ L I+ I +
Sbjct: 51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPN-LIKS-IMYQ 106
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L+Y HS I HRD+K NIL++ K++DFG +R+ + T +V T
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TL 162
Query: 122 GYLDPEYFQSSQFTEKS-DVYSFGVVLVELLTGQKPI 157
Y PE S+ + D++S G + E++TG KP+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 2 ILSQINH---RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI 58
+LSQ+ N+ K G L+ ++ E+ GS+ + + I+ IR
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR--- 108
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
EV AL Y+H + HRDIK+ANIL+ + K+ DFG + + + + +T V
Sbjct: 109 --EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV- 162
Query: 119 GTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + K+D++S G+ + E+ TG P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 30/170 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+V+ LG CL+ + EF+P GS+ ++ R G E
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN-------------RFGPLPE 101
Query: 62 ---------VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA----- 107
+ ++YLH+ + HRDIK N++L K+ DFG +R +A
Sbjct: 102 PVFCKYTKQILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+++ + GT ++ PE S + KSD++S G + E+ TG+ P+
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 55/165 (33%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP---ITWEIRLGI 58
++S NH N+VKLLG CL E ++ E + G L Y+ + ++ +T + L I
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDK-YRA----KISDFGTSRSM-AVDRTH 112
++V+ YL I HRD+ + N L+ +K Y A KI DFG +R + D
Sbjct: 112 CLDVAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ ++ PE +FT +SDV+SFGV++ E+LT GQ+P
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL Q +H N+VKL+G C + + +V E +P G ++ ++ +D+L ++ A++
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKF--ALD 101
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT- 120
+ ++YL S I HRD+ + N L+ + KISDFG SR D + ++ +K
Sbjct: 102 AAAGMAYLESKNCI---HRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIP 157
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINEN 179
+ PE +++ +SDV+S+G++L E + G P + ++ R QV
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE------QVEKGY 211
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227
R+ ++ V V +RC + + RP E+ ELA
Sbjct: 212 RM----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP------ITWEIR 55
IL Q + +VK G + +V E+ GS+ I + T L I ++
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTL 109
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
G L YLHS I HRDIK+ NILL+++ +AK++DFG S + D
Sbjct: 110 KG--------LEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRN 157
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQV 175
V GT ++ PE Q + K+D++S G+ +E+ G+ P + + A F+
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI-----HPMRAIFM-- 210
Query: 176 INENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
I L + EK V K CL + ++RP+ +
Sbjct: 211 IPNK------PPPTLSDPEKWSPEFNDFVKK-CLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 17/169 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL------PITWEIR 55
+L+ + H ++VK G C + + ++V+E++ +G L++++ D + P +
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 56 LG------IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AV 108
LG IA +++ + YL AS HRD+ + N L+ KI DFG SR + +
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 109 DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
D + ++ PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-17
Identities = 48/157 (30%), Positives = 90/157 (57%), Gaps = 11/157 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++Q+ H N+V+LLG +E + L +V E++ GSL Y+ ++ + + + L ++
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSL 109
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V A+ YL + + HRD+ + N+L+ + AK+SDFG ++ + + VK T
Sbjct: 110 DVCEAMEYLEANNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 166
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE + +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 167 ----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-17
Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 19/166 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI-HEQTED-------------Q 47
ILS++ N+++LLG C++ + ++ E++ NG L+Q++ +D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 48 LP-ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM 106
LP I++ L +A++++ + YL +S+ HRD+ + N L+ + KI+DFG SR++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 107 -AVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151
A D + + ++ E +FT SDV++FGV L E+L
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-17
Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI---------HEQTEDQLPITWEI 54
S + HRN+V+ LG E + E +P GSL + +EQT I +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT-----IIFYT 114
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA--KISDFGTSRSMAVDRTH 112
+ ++ L YLH I HRDIK N+L+ + Y KISDFGTS+ +A
Sbjct: 115 K-----QILEGLKYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLA-GINP 164
Query: 113 LTTQVKGTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKP 156
T GT Y+ PE + +D++S G +VE+ TG+ P
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 7e-17
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
LSQ + K G L+ ++ E+ GS + D+ I + +R E
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----E 106
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V L YLH I HRDIK+ANILL ++ K++DFG S + + T V GT
Sbjct: 107 VLLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTP 162
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF----LQVIN 177
++ PE + S + EK+D++S G+ +EL G+ P L+ L +I
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP-----------LSDLHPMRVLFLIP 211
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
+N L+ + K+ V CLN + K+RP+ KE
Sbjct: 212 KNNP-PSLEGNKFSKPFKDFV-------SLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L H VVKLL +LV E++P L + + ++ E LP +++
Sbjct: 52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE-ERPLPEA-QVK-SYMRM 107
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ ++Y+H+ I HRD+K AN+L+ KI+DFG +R + + L + T
Sbjct: 108 LLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
Y PE + + ++ D+++ G + ELL G
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-17
Identities = 55/163 (33%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
ILSQ VVKL + + L LV E++P G L + L R+ IA
Sbjct: 46 ILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDV-ARIYIA- 100
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR-------THL 113
E+ AL YLHS I HRD+K NIL+D K++DFG S+ V R
Sbjct: 101 EIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
++ GT Y+ PE ++ D +S G +L E L G P
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 43/152 (28%), Positives = 84/152 (55%), Gaps = 8/152 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ Q+ H +V+L T+ P+ ++ E++ NGSL ++ +T + + +T + +A
Sbjct: 54 LMKQLQHPRLVRLYAVV--TQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAA 109
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++ ++++ I HRD+++ANIL+ + KI+DFG +R + + K
Sbjct: 110 QIAEGMAFIERKNYI---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
+ PE FT KSDV+SFG++L E++T
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 41/234 (17%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED---QLPITWEIRLGIA 59
+ ++H +V+LLG C + L V + P GSL ++ + + Q + W
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------C 115
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVK 118
V+++ + YL + HR++ + NILL +I+DFG + + D + + ++ K
Sbjct: 116 VQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVIN 177
++ E ++T +SDV+S+GV + E+++ G +P +
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM----------------- 215
Query: 178 ENRLFEVLDAQVLREAEKEE-----VITVAMVAKRCLNLNGKKRPTMKEVALEL 226
R EV D +L + E+ I V MV +C ++ RPT KE+A E
Sbjct: 216 --RPHEVPD--LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 47/159 (29%), Positives = 87/159 (54%), Gaps = 11/159 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL-GIAV 60
I+ Q +H N++ L G +++ ++V E++ NGSL ++ + + Q + I+L G+
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTV---IQLVGMLR 113
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD--RTHLTTQVK 118
++ + YL + HRD+ + NIL++ K+SDFG SR + D + T K
Sbjct: 114 GIASGMKYLSDMGYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT SDV+S+G+V+ E+++ G++P
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 20/197 (10%)
Query: 3 LSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHE--QTEDQLPITWEIR--LG 57
L ++H+N++ +L C+E E P ++Y ++ G+L ++ + E P + +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQ 116
+A++++ +SYLH + H+DI + N ++D++ + KI+D SR + H L
Sbjct: 122 MAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFL-- 173
++ E + +++ SDV+SFGV+L EL+T GQ P ++ E +AAY
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDG 235
Query: 174 ----QVIN-ENRLFEVL 185
Q IN + LF V+
Sbjct: 236 YRLAQPINCPDELFAVM 252
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 22/165 (13%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE---QTEDQLPITWEIRLG 57
+I+S+ NH+N+V+L+G E ++ E + G L ++ E + E +T + L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSM-------A 107
A +V+ YL I HRDI + N LL K AKI+DFG +R +
Sbjct: 121 CARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
R L +K ++ PE F FT K+DV+SFGV+L E+ +
Sbjct: 178 GGRAMLP--IK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 64/238 (26%), Positives = 119/238 (50%), Gaps = 28/238 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI--HE-----QTEDQLPITWEI 54
I+S++ N+++LL C+ ++ ++ E++ NG L+Q++ HE + D + I++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHL 113
+ +A +++ + YL +S+ HRD+ + N L+ Y KI+DFG SR++ + D +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT--GQKPIRLVETEENRSLAAY 171
+ ++ E +FT SDV++FGV L E+LT ++P + E
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-------- 240
Query: 172 FLQVI-NENRLFEVLDAQV--LREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
QVI N F QV + A + + M++ C N K+RP+ +E+ L
Sbjct: 241 --QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS--CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I+S + NH N+V LLG C L++ E+ G L ++ + E L T E L +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL--TLEDLLSFSY 148
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V+ +++L S I HRD+ + N+LL KI DFG +R + D ++ VKG
Sbjct: 149 QVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGN 202
Query: 121 ----FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQV 175
++ PE + +T +SDV+S+G++L E+ + G P + + F ++
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKL 256
Query: 176 INENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
I E ++ + I M K C + + KRPT K++
Sbjct: 257 IKEG-------YRMAQPEHAPAEIYDIM--KTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 44/124 (35%), Positives = 60/124 (48%), Gaps = 14/124 (11%)
Query: 47 QLPITWEIRLGIAVEVSGALSYL---HSAASIPIYHRDIKSANILLDDKYRAKISDFGTS 103
Q PI +I + V + AL YL H + HRD+K +NILLD K+ DFG S
Sbjct: 108 QGPIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGIS 162
Query: 104 RSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEK----SDVYSFGVVLVELLTGQKPIRL 159
+ + T+ G Y+ PE K +DV+S G+ LVEL TGQ P +
Sbjct: 163 GRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
Query: 160 VETE 163
+TE
Sbjct: 221 CKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++ + H N+V L L + +V E++ GSL + E D+ I R
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----- 122
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E AL +LHS I HRDIKS NILL K++DFG + +++ +T V GT
Sbjct: 123 ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
++ PE + K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 54/159 (33%), Positives = 90/159 (56%), Gaps = 16/159 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL+++NH +VKL +TE L L+ +F+ G L + ++ TE+ +++
Sbjct: 51 ILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFY 103
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+A E++ AL +LHS + I +RD+K NILLD++ K++DFG S+ ++D
Sbjct: 104 LA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSF 158
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE T+ +D +SFGV++ E+LTG P
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-16
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+LSQ + V K G L+ ++ E++ GS + D+ I +R E
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----E 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK--- 118
+ L YLHS I HRDIK+AN+LL + K++DFG + + TQ+K
Sbjct: 110 ILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNT 160
Query: 119 --GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
GT ++ PE + S + K+D++S G+ +EL G+ P E + FL
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPK 215
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
N E ++ L+E + CLN RPT KE+
Sbjct: 216 NNPPTLEGNYSKPLKE-----------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 33/238 (13%)
Query: 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---------TEDQLP---ITWEIR 55
H+N++ LLG C + ++ E+ G+L +Y+ + Q+P ++++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA-VDRTHLT 114
+ A +V+ + YL S I HRD+ + N+L+ + KI+DFG +R + +D T
Sbjct: 143 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFL 173
T + ++ PE +T +SDV+SFGV+L E+ T G P V EE
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 250
Query: 174 QVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231
LF++L + + M+ + C + +RPT K++ +L I A
Sbjct: 251 -------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-16
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+LSQ + V K G L+ ++ E++ GS + D+ I ++ E
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----E 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L YLHS I HRDIK+AN+LL ++ K++DFG + + + T V GT
Sbjct: 110 ILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTP 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
++ PE Q S + K+D++S G+ +EL G+ P
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-16
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 11 VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE---DQLPITWEIRLGIAVEVSGALS 67
V +LLG CL + V L V + +P G L Y+ E + Q + W V+++ +S
Sbjct: 71 VCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMS 123
Query: 68 YLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ-VKGTFGYLDP 126
YL + + HRD+ + N+L+ KI+DFG +R + +D T K ++
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 127 EYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVL 185
E +FT +SDV+S+GV + EL+T G KP + E + ++L
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----------------IPDLL 224
Query: 186 DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227
+ I V M+ +C ++ + RP +E+ E +
Sbjct: 225 EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 47/240 (19%)
Query: 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH--------------EQTEDQLPITWE 53
H+N++ LLG C + +V E+ +G+L ++ E+ L T +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL--TQK 132
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTH 112
+ A +V+ + +L S I HRD+ + N+L+ + + KI+DFG +R + +D
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAY 171
TT + ++ PE +T +SDV+SFGV+L E+ T G P + EE
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------- 242
Query: 172 FLQVINENRLFEVLDAQVLREAEKEE-----VITVAMVAKRCLNLNGKKRPTMKEVALEL 226
LF+ +L+E + E + + + C + +RPT K++ +L
Sbjct: 243 ---------LFK-----LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-16
Identities = 47/161 (29%), Positives = 89/161 (55%), Gaps = 13/161 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL-GIAV 60
I+ Q +H N++ L G ++ +++ EF+ NG+L ++ Q + Q + I+L G+
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTV---IQLVGMLR 113
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVK 118
++ + YL + + HRD+ + NIL++ K+SDFG SR + D + T+ +
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 119 GTFG--YLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
G + PE +FT SDV+S+G+V+ E+++ G++P
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 50/156 (32%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I++ Q V KL + LV E++ G I +T LP W + IA
Sbjct: 49 IMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDW-AKQYIA- 104
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV + LH I HRDIK N+L+D K++DFG SR+ ++ + GT
Sbjct: 105 EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGT 156
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + SD +S G V+ E L G P
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 33/233 (14%)
Query: 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED---------QLP---ITWEIR 55
H+N++ LLG C + ++ E+ G+L +Y+ + +LP +T++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHLT 114
+ A +V+ + YL S I HRD+ + N+L+ + KI+DFG +R + +D T
Sbjct: 137 VSCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFL 173
T + ++ PE +T +SDV+SFGV+L E+ T G P + EE
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------- 244
Query: 174 QVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
LF++L + + M+ + C + +RPT K++ +L
Sbjct: 245 -------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 33/236 (13%)
Query: 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL------------PITWEIR 55
H+N++ LLG C + ++ E+ G+L +Y+ + + +T++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHLT 114
+ +V+ + YL S I HRD+ + N+L+ + KI+DFG +R + +D T
Sbjct: 140 VSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFL 173
T + ++ PE +T +SDV+SFGV++ E+ T G P + EE
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 247
Query: 174 QVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
LF++L + + M+ + C + RPT K++ +L I
Sbjct: 248 -------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 63/251 (25%), Positives = 118/251 (47%), Gaps = 45/251 (17%)
Query: 8 HRNVVKLLGCCLETEVPLLV-YEFIPNGSLHQYIH-------EQTED-----QLPITWEI 54
H+N++ LLG C + E PL V E+ G+L +++ + T D + ++++
Sbjct: 77 HKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHL 113
+ A +V+ + YL S I HRD+ + N+L+ + KI+DFG +R + +D
Sbjct: 136 LVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYF 172
T+ + ++ PE +T +SDV+SFG+++ E+ T G P + EE
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------- 244
Query: 173 LQVINENRLFEVLDAQVLREAEKEEVIT-----VAMVAKRCLNLNGKKRPTMKEVALELA 227
LF ++LRE + + + + M+ + C + +RPT K++ L
Sbjct: 245 --------LF-----KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
Query: 228 GIRASIGASVL 238
+ A++ L
Sbjct: 292 KVLAAVSEEYL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+++ +++ +V +LLG CL + V L + + +P G L Y+ E ++ I + L V+
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQ 117
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGT 120
++ ++YL + HRD+ + N+L+ KI+DFG ++ + D + + K
Sbjct: 118 IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINEN 179
++ E +T +SDV+S+GV + EL+T G KP + E
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------- 219
Query: 180 RLFEVLDAQVLREAEKEE-----VITVAMVAKRCLNLNGKKRPTMKEVALELA 227
+ +L + E+ I V M+ +C ++ RP +E+ +E +
Sbjct: 220 ------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 61/198 (30%), Positives = 86/198 (43%), Gaps = 41/198 (20%)
Query: 53 EIRLG-IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS----RSMA 107
E LG I++ V L+YL I HRD+K +NIL++ + K+ DFG S SMA
Sbjct: 98 ENILGKISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 155
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI---------- 157
GT Y+ PE Q + +T +SD++S G+ LVE+ G+ PI
Sbjct: 156 -------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 158 ----RLVETEENRSLAAYFLQVINENR---LFEVLDAQVLREAEK-------EEVITVAM 203
+ E E S + R +FE+LD V K +E
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD--F 266
Query: 204 VAKRCLNLNGKKRPTMKE 221
V K CL N K+R +KE
Sbjct: 267 VDK-CLKKNPKERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-15
Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 2 ILSQINHRNVVKLLGCCLE-TEVPLLVY-EFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L + H +V+ GC + E L ++ E++P GS + +Q + +T +
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTRKYT 112
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR---SMAVDRTHLTTQ 116
++ +SYLHS I HRDIK ANIL D K+ DFG S+ ++ + T + +
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS- 168
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
V GT ++ PE + K+DV+S G +VE+LT + P E ++AA F
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP-----WAEYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ--TEDQLPITWEIRLGI 58
+I+ H N+V++ L + +V EF+ G+L + E+Q+ +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-------V 120
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
+ V ALS+LH+ I HRDIKS +ILL R K+SDFG ++ + + V
Sbjct: 121 CLAVLKALSFLHAQGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV- 176
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + D++S G++++E++ G+ P
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ--TEDQLPITWEIRLGI 58
+I+ H+NVV++ L E ++ EF+ G+L + + E+Q+ E
Sbjct: 70 VIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE----- 124
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
V AL YLHS I HRDIKS +ILL R K+SDFG ++ D + V
Sbjct: 125 --SVLQALCYLHSQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV- 178
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + + D++S G++++E++ G+ P
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 54/164 (32%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 2 ILSQINHRNVVKLLGCCL---ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG- 57
I +VK G L + + + + E+ GSL I+++ + + E LG
Sbjct: 52 INKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDS-IYKKVKKRGGRIGEKVLGK 109
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
IA V LSYLHS I HRDIK +NILL K + K+ DFG S L +
Sbjct: 110 IAESVLKGLSYLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSL 159
Query: 118 KGTFG----YLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
GTF Y+ PE Q ++ SDV+S G+ L+E+ + P
Sbjct: 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 36/231 (15%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA- 59
+L + H N+V G L + +V E+ GSL Q I++ T L L IA
Sbjct: 52 SMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLS-----ELQIAY 105
Query: 60 --VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS----RSMAVDRTHL 113
E L+YLH I HRDIK ANILL + K++DFG S ++A ++ +
Sbjct: 106 VCRETLKGLAYLHETGKI---HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI 162
Query: 114 TTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
GT ++ PE + K D+++ G+ +EL Q P + + R+L
Sbjct: 163 -----GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP--MFDLHPMRAL-- 213
Query: 171 YFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
FL + L++ EK + + K+CL + KKRPT +
Sbjct: 214 -FLISKSN------FPPPKLKDKEKWSPVFHDFI-KKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 33/238 (13%)
Query: 1 IILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYI-HEQTEDQ---LPI 50
+ + + +H NV++L+G CL+T P+++ F+ +G LH ++ + + D LP
Sbjct: 52 VCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT 111
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
++ +++ + YL S + I HRD+ + N +L++ ++DFG S+ +
Sbjct: 112 QMLVKF--MTDIASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
Query: 111 THLTTQV-KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSL 168
+ ++ K ++ E +T KSDV+SFGV + E+ T GQ P V EN +
Sbjct: 167 YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEI 223
Query: 169 AAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
Y Q NRL + D + + + C LN K RP+ + + EL
Sbjct: 224 YDYLRQ---GNRLKQPPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 37/234 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH------EQTEDQLPITWEIR 55
++ +VV+LLG + + L+V E + +G L Y+ E + P T +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ +A E++ ++YL++ + HRD+ + N ++ + KI DFG +R D
Sbjct: 122 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDY 174
Query: 116 QVKGTFG-----YLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLA 169
KG G ++ PE + FT SD++SFGVVL E+ + ++P
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP------------- 221
Query: 170 AYFLQVINENRLFEVLDAQVLREAEK-EEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + NE L V+D L + + E +T M + C N K RPT E+
Sbjct: 222 --YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLM--RMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 4 SQINHRNVVKLL--GCCLETEVPLL--VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+++ H N+V LL G E LL V+E++P +L + + + LP RL
Sbjct: 33 ARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETGRL--M 85
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILL---DDKYRAKISDFGTS------RSMAVDR 110
++V AL+ H+ I HRD+K NI++ + AK+ DFG R V
Sbjct: 86 LQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154
TT+V GT Y PE + T SD+Y++G++ +E LTGQ
Sbjct: 143 LTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-15
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++ ++ + N+V L L + +V E++ GSL + E D+ I +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCR 122
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E AL +LH+ I HRDIKS N+LL K++DFG + +++ +T V GT
Sbjct: 123 ECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
++ PE + K D++S G++ +E++ G+ P EN A Y +I N
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY----LNENPLRALY---LIATNG 231
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
E+ + + L ++ RCL ++ +KR + KE+
Sbjct: 232 TPELQNPEKLSPIFRD-------FLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-15
Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ-----TEDQLPITWEI 54
++L+++ H N+V E + L +V E+ G L Q I Q ED + + W +
Sbjct: 50 VLLAKMKHPNIVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFV 107
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
++ + V+ ++H + HRDIKS NI L + K+ DFG++R + +
Sbjct: 108 QMCLGVQ------HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
T V GT Y+ PE +++ + KSD++S G +L EL T + P +
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-15
Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH------EQTEDQLPITWEIR 55
++ + N +VV+LLG + + L++ E + G L Y+ E Q P + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ +A E++ ++YL++ + HRD+ + N ++ + + KI DFG +R D
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174
Query: 116 QVKGTFG-----YLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLA 169
KG G ++ PE + FT SDV+SFGVVL E+ T ++P + + E+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----- 229
Query: 170 AYFLQVINENRLFEVLD--AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
L+ + E L + D +L E + + C N K RP+ E+
Sbjct: 230 --VLRFVMEGGLLDKPDNCPDMLFE-----------LMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 4/155 (2%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L Q++H NV+K L +E +V E G L + I + + I V+
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL ++HS I HRDIK AN+ + K+ D G R + T + V GT
Sbjct: 115 LCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE + + KSD++S G +L E+ Q P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 9/164 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L+ + L C +T+ L V E++ G L +I P A
Sbjct: 48 VLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA----RFYAA 103
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ L +LH I +RD+K N+LLD + KI+DFG + + T+ GT
Sbjct: 104 EIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-TSTFCGT 159
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
Y+ PE + D ++ GV+L E+L GQ P + +E
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L +++H +++L + ++ E++P G L Y+ + L A E
Sbjct: 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASE 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL YLHS I +RD+K NILLD + K++DFG ++ + DRT + GT
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTP 162
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
YL PE QS + D ++ G+++ E+L G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 54/176 (30%), Positives = 87/176 (49%), Gaps = 18/176 (10%)
Query: 2 ILSQINHRNVVKLLGCCLE-TEVPLLVY-EFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L + H +V+ GC + E L ++ E++P GS I +Q + +T +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYT 112
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR---SMAVDRTHLTTQ 116
++ +SYLHS I HRDIK ANIL D K+ DFG S+ ++ + T + +
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS- 168
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
V GT ++ PE + K+DV+S +VE+LT + P E ++AA F
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP-----WAEYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 46/129 (35%), Positives = 66/129 (51%), Gaps = 19/129 (14%)
Query: 36 LHQYIHEQTEDQLPITWEIRLG-IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYR 94
++Y++E + +P E LG IAV AL+YL + I HRD+K +NILLD
Sbjct: 92 FYKYVYEVLKSVIP---EEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGN 146
Query: 95 AKISDFGTS----RSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVVL 147
K+ DFG S S+A T+ G Y+ PE S + +SDV+S G+ L
Sbjct: 147 IKLCDFGISGQLVDSIA------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200
Query: 148 VELLTGQKP 156
E+ TG+ P
Sbjct: 201 YEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP-----ITWEIRL 56
+L ++ H N++ LL LV+EF+ L + I +++ P
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
G L YLHS I HRD+K N+L+ K++DFG +RS +T Q
Sbjct: 114 G--------LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
Query: 117 VKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V T Y PE F + + D++S G + ELL + P
Sbjct: 163 VV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIR-LGI 58
IL +++ R +V L ET+ L LV + G L +I+ E P E R +
Sbjct: 45 KILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFY 100
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
A ++ L +LH I +RD+K N+LLDD +ISD G + + +
Sbjct: 101 AAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
GT GY+ PE Q + D ++ G L E++ G+ P R
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 44/170 (25%), Positives = 91/170 (53%), Gaps = 18/170 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI-----HE----QTEDQLPITW 52
++++++H N+V LLG + + +++E++ G LH+++ H +++ +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 53 EIRLG----IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-A 107
+ G IA++++ + YL S + H+D+ + NIL+ ++ KISD G SR + +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
D + + ++ PE +F+ SD++SFGVVL E+ + G +P
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ + H +V+L + E ++ E++ GSL ++ ++ + I + +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++Y+ I HRD+++AN+L+ + KI+DFG +R + + K
Sbjct: 112 IAEGMAYIERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 168
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE FT KSDV+SFG++L E++T G+ P
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ ++ H +V+L E + +V E++ GSL ++ + L + + + A +
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++Y+ + HRD+++ANIL+ + K++DFG +R + + K
Sbjct: 111 IASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT KSDV+SFG++L EL T G+ P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L ++NH N++KLL LV+EF+ + L++ I ++ Q + + +
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDR---QRGLPESLIKSYLYQ 106
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L++ HS I HRD+K N+L++ + K++DFG +RS T V T
Sbjct: 107 LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTR 162
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
Y PE ++ D++S G + ELL+ +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-14
Identities = 51/155 (32%), Positives = 76/155 (49%), Gaps = 11/155 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL I H +V L G + LV E++P G L ++ + + P R A +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARF-YAAQ 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V AL YLHS I +RD+K N+LLD KI+DFG ++ + RT+ GT
Sbjct: 110 VVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTP 162
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE S + + D ++ G+++ E+L G P
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 2 ILSQINHRNVVKLLGCCLET-EVPLLVY-EFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L + H +V+ GC + E L ++ E +P GS I +Q + +T +
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYT 112
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR---SMAVDRTHLTTQ 116
++ +SYLHS I HRDIK ANIL D K+ DFG S+ ++ + T + +
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
V GT ++ PE + K+D++S G +VE+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-14
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 23/163 (14%)
Query: 3 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP------ITWEIR 55
L ++N H N+VKL E + V+E++ G+L+Q + ++ I ++I
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
G+A ++H +HRD+K N+L+ KI+DFG +R + R T
Sbjct: 110 QGLA--------HIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTD 157
Query: 116 QVKGTFGYLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V T Y PE +S+ ++ D+++ G ++ EL T +P+
Sbjct: 158 YV-STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 7 NHRNVVKLLGCCLETEVPLL-VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGA 65
NH +V L C +TE L V E++ G L H Q + +LP E + E+S A
Sbjct: 54 NHPFLVGL-HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLP--EEHARFYSAEISLA 108
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L+YLH I +RD+K N+LLD + K++D+G + + T+ GT Y+
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIA 164
Query: 126 PEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN--RSLAAYFLQVINENRLFE 183
PE + + D ++ GV++ E++ G+ P +V + +N ++ Y QVI E ++
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 222
Query: 184 VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216
+ + A V K LN + K+R
Sbjct: 223 --------RIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL + NH +VKL + + ++ E+ G L + + + R IA
Sbjct: 46 ILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD--RGLFD-EYTARFYIACV 102
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV-DRTHLTTQVKGT 120
V A YLH+ I +RD+K N+LLD K+ DFG ++ + +T T GT
Sbjct: 103 VL-AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GT 155
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE + + D +S G++L ELLTG+ P
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++ H +V+L E + +V E++ GSL ++ + L + + + A +
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V+ ++Y+ I HRD++SANIL+ D KI+DFG +R + + K
Sbjct: 111 VAAGMAYIERMNYI---HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT KSDV+SFG++L EL+T G+ P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 49/144 (34%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 15 LGCCLETEVPLL-VYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAVEVSGALSYLHSA 72
L C +T+ L V EF+ G L +I ++ D T+ A E+ L +LHS
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSK 115
Query: 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS 132
I +RD+K N++LD KI+DFG + +T GT Y+ PE Q
Sbjct: 116 GII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGL 171
Query: 133 QFTEKSDVYSFGVVLVELLTGQKP 156
++T D +SFGV+L E+L GQ P
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-14
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++ H +V L E + +V EF+ GSL ++ E L + + + A +
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--AAQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++Y+ I HRD+++ANIL+ D KI+DFG +R + + K
Sbjct: 111 IADGMAYIERMNYI---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT KSDV+SFG++L EL+T G+ P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-14
Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ-----TEDQLPITWEIRL 56
+LS + H N+V+ E +V ++ G L++ I+ Q EDQ+ + W +++
Sbjct: 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQI 110
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR----SMAVDRTH 112
+A L ++H I HRDIKS NI L K+ DFG +R ++ + RT
Sbjct: 111 CLA------LKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC 161
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
+ GT YL PE ++ + KSD+++ G VL E+ T
Sbjct: 162 I-----GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-14
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+LSQ + + + G L+ ++ E++ GS + ++ I +R E
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----E 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L YLHS I HRDIK+AN+LL ++ K++DFG + + + T V GT
Sbjct: 110 ILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTP 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
++ PE + S + K+D++S G+ +EL G+ P + + FL N
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP-----NSDLHPMRVLFLIPKNSPPT 220
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
E ++ +E + CLN + + RPT KE+
Sbjct: 221 LEGQYSKPFKE-----------FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + N +V G + E + GSL Q + E I EI +++
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIA 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V L+YL I HRD+K +NIL++ + K+ DFG S + +D + GT
Sbjct: 112 VLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTR 166
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y+ PE Q + ++ +SD++S G+ LVEL G+ PI
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 15 LGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73
L C +TE L V EF+ G L H Q + +LP E + E+S AL++LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLP--EEHARFYSAEISLALNFLHERG 116
Query: 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ 133
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 134 FTEKSDVYSFGVVLVELLTGQKPIRLVETEEN--RSLAAYFLQVINEN-----RLFEVLD 186
+ D ++ GV++ E++ G+ P +V +N ++ Y QVI E R V
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 187 AQVLR 191
+ VL+
Sbjct: 233 SSVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 52/165 (31%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
IL +NH NVVK C + E+ +L+ EF+ GSL H E L
Sbjct: 125 ILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEGT-HIADEQFLA------- 171
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+A ++ ++YLH I HRDIK +N+L++ KI+DFG SR +A +
Sbjct: 172 DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228
Query: 117 VKGTFGYLDPEYFQSSQFTEK-----SDVYSFGVVLVELLTGQKP 156
V GT Y+ PE + D++S GV ++E G+ P
Sbjct: 229 V-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 53/156 (33%), Positives = 81/156 (51%), Gaps = 18/156 (11%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG-IAVEVSGALSYLHSAASIPIYHRDIKS 84
LV ++ G L Q I + + E G + ++V A+ ++HS I HRDIKS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFR-EHEAGLLFIQVLLAVHHVHSKHMI---HRDIKS 171
Query: 85 ANILLDDKYRAKISDFGTSRSMA------VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKS 138
ANILL K+ DFG S+ A V RT GT Y+ PE ++ +++K+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYYVAPEIWRRKPYSKKA 226
Query: 139 DVYSFGVVLVELLTGQKPIRLVETEE--NRSLAAYF 172
D++S GV+L ELLT ++P EE +++LA +
Sbjct: 227 DMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
++L + H +V L TE V +F+ G L + H Q E P E R A
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP---EPRARFYA 102
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E++ AL YLHS I I +RD+K NILLD + ++DFG + + ++ TT G
Sbjct: 103 AEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCG 158
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
T YL PE + + D + G VL E+L G P + E
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 47/139 (33%), Positives = 81/139 (58%), Gaps = 12/139 (8%)
Query: 25 LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV-EVSGALSYLHSAASIPIYHRDIK 83
LL+ E+ G L++ I ++ ++ LP E +G+ ++ AL +HS + HRD+K
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVGLLFYQIVLALDEVHSRK---MMHRDLK 196
Query: 84 SANILLDDKYRAKISDFGTSR----SMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSD 139
SANI L K+ DFG S+ S+++D + + GT YL PE ++ ++++K+D
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 140 VYSFGVVLVELLTGQKPIR 158
++S GV+L ELLT +P +
Sbjct: 254 MWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 27/162 (16%)
Query: 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE----QTEDQLPI--------TWEIR 55
H N++ LLG C L E+ P+G+L ++ + +T+ I + +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
L A +V+ + YL I HRD+ + NIL+ + Y AKI+DFG SR V
Sbjct: 127 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV------- 176
Query: 116 QVKGTFG-----YLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
VK T G ++ E S +T SDV+S+GV+L E+++
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 29 EFIPNGSLHQYIHEQTEDQLPITWEIRLG-IAVEVSGALSYLHSAASIPIYHRDIKSANI 87
EF+ GSL Y ++P E LG IAV V L+YL S + I HRD+K +N+
Sbjct: 79 EFMDGGSLDVY------RKIP---EHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNM 126
Query: 88 LLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147
L++ + + K+ DFG S + + GT Y+ PE Q+ SDV+S G+
Sbjct: 127 LVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKR 207
+EL G+ P ++ + + LQ I + D VL + E V + +
Sbjct: 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------DPPVLPVGQFSEKF-VHFITQ- 235
Query: 208 CLNLNGKKRPTMKEV 222
C+ K+RP + +
Sbjct: 236 CMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 15 LGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73
L C +T L LV E++ G L H Q + +LP E A E+ AL++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLP--EEHARFYAAEICIALNFLHERG 116
Query: 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ 133
I +RD+K N+LLD K++D+G + + T+ GT Y+ PE + +
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 134 FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN-----RLFEVLDAQ 188
+ D ++ GV++ E++ G+ P ++ + + Y QVI E R V +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232
Query: 189 VLR 191
VL+
Sbjct: 233 VLK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-QLPITWEIRLGIAV 60
IL Q +H N+V+L+G C + + +V E + G ++ +TE +L + I+ +
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQ--MVE 101
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+ + YL S I HRD+ + N L+ +K KISDFG SR T +K
Sbjct: 102 NAAAGMEYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158
Query: 121 -FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINE 178
+ PE +++ +SDV+SFG++L E + G P + ++ R
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR------------ 206
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
E ++ V + V + +RC + +RP+ V EL
Sbjct: 207 ----EAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 59/238 (24%), Positives = 110/238 (46%), Gaps = 29/238 (12%)
Query: 3 LSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITW--EI 54
+ + +H NV+KL+G L + +P+++ F+ +G LH ++ + P T +
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHL 113
+ ++++ + YL S I HRD+ + N +L++ ++DFG S+ + + D
Sbjct: 115 LVRFMIDIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYF 172
K +L E + +T SDV++FGV + E++T GQ P VE E +
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IY 225
Query: 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230
+I NRL + D E+V + +C + K RP+ + + +L I
Sbjct: 226 NYLIKGNRLKQPPDCL-------EDVYELMC---QCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-13
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 23/222 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++ + + N+V L L + +V E++ GSL + E D+ I +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCR 122
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E AL +LHS I HRDIKS NILL K++DFG + +++ +T V GT
Sbjct: 123 ECLQALDFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
++ PE + K D++S G++ +E++ G+ P EN A Y +I N
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY----LNENPLRALY---LIATNG 231
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
E+ + + L ++ RCL ++ +R + KE+
Sbjct: 232 TPELQNPERLSAVFRD-------FLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 36/265 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I++ N VV+L C + + L +V E++P G L ++ + +P W
Sbjct: 96 IMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDL---VNLMSNYDVPEKWAKFY--TA 149
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT---HLTTQV 117
EV AL +HS I HRD+K N+LLD K++DFGT M +D T T V
Sbjct: 150 EVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV 204
Query: 118 KGTFGYLDPEYFQSS----QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
GT Y+ PE +S + + D +S GV L E+L G P SL +
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGTYS 257
Query: 174 QVIN-ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNL--NG----KKRPTMKEVALEL 226
++++ +N L D ++ + A+ + A + R + L NG K+ P K
Sbjct: 258 KIMDHKNSLNFPEDVEISKHAKN---LICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNW 314
Query: 227 AGIRASIGASVLRQCEEIDFVNYDN 251
IR + V +ID N+D+
Sbjct: 315 DNIRETAAPVVPELSSDIDSSNFDD 339
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 15 LGCCLETEVPLL-VYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAVEVSGALSYLHSA 72
L C +T+ L V E++ G L +I D+ + A E+ L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFLHKK 115
Query: 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS 132
I +RD+K N+LLD KI+DFG + ++ + GT Y+ PE +
Sbjct: 116 GII---YRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 133 QFTEKSDVYSFGVVLVELLTGQKP 156
++ E D +SFGV+L E+L GQ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-13
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++ + + N+V L L + +V E++ GSL + E D+ I +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCR 123
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E AL +LHS I HRDIKS NILL K++DFG + +++ +T V GT
Sbjct: 124 ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
++ PE + K D++S G++ +E++ G+ P EN A Y +I N
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY----LNENPLRALY---LIATNG 232
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
E L+ EK I + RCL+++ +KR + KE+
Sbjct: 233 TPE------LQNPEKLSAIFRDFL-NRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+I+ H NVV++ L + +V EF+ G+L + ++ I + +
Sbjct: 69 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCL 123
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
V ALS LH+ I HRDIKS +ILL R K+SDFG ++ + + V GT
Sbjct: 124 AVLKALSVLHAQGVI---HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GT 179
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
++ PE + + D++S G++++E++ G+ P
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 4/155 (2%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L Q+NH NV+K L +E +V E G L Q I + + I V+
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ A+ ++HS + HRDIK AN+ + K+ D G R + T + V GT
Sbjct: 115 LCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 170
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE + + KSD++S G +L E+ Q P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 4/155 (2%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L Q+NH NV+K +E +V E G L + I + + I + V+
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL ++HS + HRDIK AN+ + K+ D G R + +T + GT
Sbjct: 115 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTP 170
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE + + KSD++S G +L E+ Q P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 41/231 (17%)
Query: 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-AVEVSGA 65
NH + +L C + V EF+ G L +I + E R A E++ A
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEITSA 108
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L +LH I +RD+K N+LLD + K++DFG + + T+ GT Y+
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIA 164
Query: 126 PEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFE-V 184
PE Q + D ++ GV+L E+L G P E E NE+ LFE +
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF---EAE-------------NEDDLFEAI 208
Query: 185 LDAQVLREA----EKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231
L+ +V+ + +++ M K PTM+ +L L G A
Sbjct: 209 LNDEVVYPTWLSQDAVDILKAFM----------TKNPTMRLGSLTLGGEEA 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L Q+ H N+V L LV+E++ +L + + E + LP +R +
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPD-AVRS-YIWQ 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGT 120
+ A++Y HS I HRDIK NIL+ + K+ DFG +R++ + LT V T
Sbjct: 109 LLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 121 FGYLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQ 154
Y PE + + + DV++ G ++ ELL G+
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLG 57
ILS+ H N+V L ++ EF G+L + E TE Q IR
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQ------IRY- 107
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ ++ AL++LHS I HRD+K+ NILL K++DFG S T +
Sbjct: 108 VCRQMLEALNFLHSHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI 164
Query: 118 KGTFGYLDPEY-----FQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE F+ + + K+D++S G+ L+EL + P
Sbjct: 165 -GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 49/226 (21%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 3 LSQINHRNVVKLLGCCLETEVPL----LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI 58
L +I+ N++K+ G ++ L L+ E+ G L + + ++ + ++++ +L +
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDM 127
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
A++ L L+ + P ++++ S + L+ + Y+ KI G + ++ +
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNV 181
Query: 119 GTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
Y + S++T K D+YS GVVL E+ TG+ P EN + + +I
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF------ENLTTKEIYDLII 235
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
N+N + L E + + + C + + KRP +KE+
Sbjct: 236 NKNNSLK-LPLDCPLE--------IKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 71/261 (27%), Positives = 112/261 (42%), Gaps = 28/261 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I++ N VV+L + +V E++P G L ++ + +P W R A E
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWA-RFYTA-E 150
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V AL +HS I HRD+K N+LLD K++DFGT M + GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 122 GYLDPEYFQSS----QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
Y+ PE +S + + D +S GV L E+L G P SL + +++N
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMN 261
Query: 178 -ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNL--NG----KKRPTMKEVALELAGIR 230
+N L D + +EA+ + A + R + L NG K+ K +R
Sbjct: 262 HKNSLTFPDDNDISKEAKN---LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLR 318
Query: 231 ASIGASVLRQCEEIDFVNYDN 251
++ V +ID N+D+
Sbjct: 319 DTVAPVVPDLSSDIDTSNFDD 339
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI-HEQTEDQLPITWEIRLGIA 59
+I+ +H NVV + L + +V EF+ G+L + H + ++ T +
Sbjct: 71 VIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VC 124
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
+ V ALSYLH+ I HRDIKS +ILL R K+SDFG ++ + + V G
Sbjct: 125 LSVLRALSYLHNQGVI---HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-G 180
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T ++ PE + + D++S G++++E++ G+ P
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE--QTEDQLP----ITWEIR 55
+LS+++H +VK LE + ++ E+ L + E T L W I+
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
L + V Y+H I HRD+K+ NI L + KI DFG SR + + L T
Sbjct: 115 LLLGVH------YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLAT 163
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150
GT Y+ PE + + KSD++S G +L E+
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 49/153 (32%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 15 LGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-AVEVSGALSYLHSA 72
L C +TE + V E+ G L +IH D E R A V L YLH
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFS---EPRAVFYAACVVLGLQYLHEN 120
Query: 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRS-MAVDRTHLTTQVKGTFGYLDPEYFQS 131
I +RD+K N+LLD + KI+DFG + M T+ GT +L PE
Sbjct: 121 K---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTE 175
Query: 132 SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
+ +T D + GV++ E+L G+ P + EE
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 50/153 (32%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 20 ETEVPL-LVYEFIPNGSL--HQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76
+T+ L L+ +++ G L H Y E + E+R+ IA E+ AL +LH +
Sbjct: 75 QTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIA-EIVLALDHLHQ---LG 125
Query: 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ--SSQF 134
I +RDIK NILLD + ++DFG S+ + GT Y+ PE + S
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 135 TEKSDVYSFGVVLVELLTGQKPIRLVETEENRS 167
+ D +S GV+ ELLTG P V+ E+N
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 50/151 (33%), Positives = 70/151 (46%), Gaps = 9/151 (5%)
Query: 15 LGCCLETEVPLL-VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73
L C +T+ L V E++ G L +I + LP A E+ L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHSKG 116
Query: 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ 133
I +RD+K NILLD KI+DFG + + T GT Y+ PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQK 172
Query: 134 FTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
+ D +SFGV+L E+L GQ P + EE
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + N +V G + E + GSL Q + + I +I +++
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIA 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V L+YL I HRD+K +NIL++ + K+ DFG S + +D + GT
Sbjct: 112 VIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTR 166
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y+ PE Q + ++ +SD++S G+ LVE+ G+ PI
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L Q+ H N ++ GC L LV E+ + + S +H++ ++ I I
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-----AICHG 123
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L+YLHS I HRDIK+ NILL + K++DFG++ ++ + + GT
Sbjct: 124 ALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTP 175
Query: 122 GYLDPEY---FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ PE Q+ K DV+S G+ +EL + P+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
IL ++N R VV L ET+ L LV + G L +I+ E E R A
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYA 108
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E+ L LH I +RD+K NILLDD +ISD G + + +T + +V G
Sbjct: 109 AEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-G 163
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
T GY+ PE ++ ++T D ++ G +L E++ GQ P +
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 47/136 (34%), Positives = 66/136 (48%), Gaps = 14/136 (10%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85
+V E++P G L ++ + +P W R A EV AL +HS I HRD+K
Sbjct: 120 MVMEYMPGGDL---VNLMSNYDIPEKWA-RFYTA-EVVLALDAIHSMGFI---HRDVKPD 171
Query: 86 NILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGTFGYLDPEYFQS----SQFTEKSDV 140
N+LLD K++DFGT M + T V GT Y+ PE +S + + D
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 141 YSFGVVLVELLTGQKP 156
+S GV L E+L G P
Sbjct: 231 WSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS----RSMAVDRTHL 113
IAV + AL YLHS S+ HRD+K +N+L++ + K+ DFG S S+A
Sbjct: 108 IAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA------ 159
Query: 114 TTQVKGTFGYLDPEYF----QSSQFTEKSDVYSFGVVLVELLTGQKP 156
T G Y+ PE + KSDV+S G+ ++EL TG+ P
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL +++H +V ++ + + EF+ G L + H + + P ++ E
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPN--DVAKFYHAE 126
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ A YLHS I +RD+K N+LLD+K K++DFG ++ + DRT + GT
Sbjct: 127 LVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGTP 179
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE QS + D ++ GV+L E + G P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 44/131 (33%), Positives = 65/131 (49%), Gaps = 10/131 (7%)
Query: 27 VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-AVEVSGALSYLHSAASIPIYHRDIKSA 85
V +++ G L + H Q E P E R A E++ AL YLHS + I +RD+K
Sbjct: 74 VLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLHS---LNIIYRDLKPE 125
Query: 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGV 145
NILLD + ++DFG + ++ + T+ GT YL PE + + D + G
Sbjct: 126 NILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGA 184
Query: 146 VLVELLTGQKP 156
VL E+L G P
Sbjct: 185 VLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 27/163 (16%)
Query: 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE----QTEDQLP--------ITWEI 54
+H N++ LLG C + E+ P G+L ++ + +T+ +T +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
L A +V+ + YL I HRD+ + N+L+ + +KI+DFG SR V
Sbjct: 121 LLQFASDVATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV------ 171
Query: 115 TQVKGTFG-----YLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
VK T G ++ E S +T KSDV+SFGV+L E+++
Sbjct: 172 -YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 43/156 (27%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ + H +VKL + E ++ EF+ GSL ++ + P+ I + +
Sbjct: 54 VMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++++ I HRD+++ANIL+ KI+DFG +R + + K
Sbjct: 111 IAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE FT KSDV+SFG++L+E++T G+ P
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 9/170 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIR-LGIA 59
IL++++ R +V L +T+ L LV + G L +I+ E+ P E R
Sbjct: 46 ILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYT 103
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ L +LH I +RD+K N+LLD+ +ISD G + + D T G
Sbjct: 104 AQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYAG 159
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV-ETEENRSL 168
T G++ PE Q ++ D ++ GV L E++ + P R E EN+ L
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-------LVYEFIPNGSLHQYIHEQ--TEDQLPITW 52
+L ++H NV+ LL L LV + L+ + Q ++D +
Sbjct: 67 LLKHMDHENVIGLLDVFTPAS-SLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF-- 122
Query: 53 EIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
+ ++ L Y+HSA I HRD+K +NI +++ KI DFG +R +
Sbjct: 123 -----LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--- 171
Query: 113 LTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
+T V T Y PE + + D++S G ++ ELLTG+
Sbjct: 172 MTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 49/193 (25%), Positives = 74/193 (38%), Gaps = 55/193 (28%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-- 58
IL+ + +VKL + E L LV E++P G L + IR +
Sbjct: 54 ILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFP 99
Query: 59 -------AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA---- 107
E+ AL +H I HRDIK NIL+D K++DFG + M
Sbjct: 100 EETARFYIAELVLALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156
Query: 108 ----VDRTHLTTQVK--------------------GTFGYLDPEYFQSSQFTEKSDVYSF 143
++ +H GT Y+ PE + + + + D +S
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216
Query: 144 GVVLVELLTGQKP 156
GV+L E+L G P
Sbjct: 217 GVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-12
Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 15/171 (8%)
Query: 15 LGCCLETEVPLL-VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73
L CC +T+ L V E++ G L I + P R A EV+ AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRF-YAAEVTLALMFLHRHG 116
Query: 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ 133
I +RD+K NILLD + K++DFG + + TT GT Y+ PE Q +
Sbjct: 117 VI---YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 134 FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEV 184
+ D ++ GV++ E++ GQ P E + L F +++++ L+ V
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF---EADNEDDL---FESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 15 LGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73
L C +T L V E++ G L +I + + + P + A E++ L +LHS
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA----VFYAAEIAIGLFFLHSKG 121
Query: 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQVKGTFGYLDPEYFQSS 132
I +RD+K N++LD + KI+DFG + ++ +T T GT Y+ PE
Sbjct: 122 ---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIAPEIIAYQ 176
Query: 133 QFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
+ + D ++FGV+L E+L GQ P + +E
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
A E+ L ++H+ + +RD+K ANILLD+ +ISD G + + + H +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 119 GTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSL 168
GT GY+ PE Q + + +D +S G +L +LL G P R +T++ +
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGSLHQYIHEQTEDQLPITWEIRLGI 58
++L +NH +V+++ + + +V +P + L+ Y+ T+ P+ + L I
Sbjct: 109 MLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL---TKRSRPLPIDQALII 162
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
++ L YLH+ I HRD+K+ NI ++D + I D G ++ V L +
Sbjct: 163 EKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LA 217
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151
GT PE ++ K+D++S G+VL E+L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGSLHQYIHEQTEDQLP----ITWEIR 55
+LSQ+ H N+V E E LL V F G L+ + EQ LP + W
Sbjct: 52 LLSQLKHPNIVAYRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW--- 107
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
V+++ AL YLH I HRD+K+ N+ L K+ D G +R + ++ + +
Sbjct: 108 ---FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMAS 160
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
+ GT Y+ PE F + + KSDV++ G + E+ T
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 18 CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77
+T V + + S E TED P+ + L + +V+ + +L S I
Sbjct: 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI-- 234
Query: 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT----FGYLDPEYFQSSQ 133
HRD+ + N+LL D AKI DFG +R + D ++ VKG ++ PE
Sbjct: 235 -HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCV 290
Query: 134 FTEKSDVYSFGVVLVELLT-GQKP 156
+T +SDV+S+G++L E+ + G+ P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+ +++ L YLH I HRD+K +N+LL DK KI+DFG +R+ + +T +
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 117 VKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V T Y PE + +T D+++ G +L ELL KP+
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 45/241 (18%)
Query: 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH--EQTEDQLPITWEIRLGIAVEVS 63
+NH NV++ LG C+E+ LLV EF P G L Y+ Q+ ++ +A EV+
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVA 110
Query: 64 GALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT-FG 122
L +LH A I H D+ N L KI D+G + + ++T
Sbjct: 111 SGLLWLHQADFI---HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 123 YLDPEYFQSSQ-------FTEKSDVYSFGVVLVEL----------LTGQKPIRLVETEEN 165
+L PE + T+KS+++S GV + EL L+ ++ ++ V E++
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227
Query: 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225
L L + +R +EV+ + C L+ + RPT +EV
Sbjct: 228 IKLPKPQLDLKYSDRWYEVM--------------------QFCW-LDPETRPTAEEVHEL 266
Query: 226 L 226
L
Sbjct: 267 L 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIR-LGIAV 60
IL ++N + VV L + LV + G L +I+ P E R L A
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAA 109
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ L LH ++ +RD+K NILLDD +ISD G + + + GT
Sbjct: 110 EILCGLEDLHRENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGT 164
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
GY+ PE + ++T D + G ++ E++ GQ P R
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI-----HE---QTEDQLPITWEIR 55
S++ H N+V LLG + + +++ + + LH+++ H T+D + +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 56 ----LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDR 110
+ I +++ + +L S + H+D+ + N+L+ DK KISD G R + A D
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
L ++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L Q+ H N ++ GC L+ LV E+ + + S +H++ ++ I I
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHG 129
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L+YLHS I HRDIK+ NILL + + K++DFG++ + + + GT
Sbjct: 130 ALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTP 181
Query: 122 GYLDPEY---FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ PE Q+ K DV+S G+ +EL + P+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 27/160 (16%)
Query: 3 LSQINHRNVVKLLGCC----LETEVPL-LVYEFIPNGSLHQYIHEQTEDQLP---ITWEI 54
L H N+V+LL C + E+ L LV+E + + L Y+ + + LP I +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLM 113
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR----SMAVDR 110
R ++ + +LHS I HRD+K NIL+ + KI+DFG +R MA
Sbjct: 114 R-----QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--- 162
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150
LT+ V T Y PE S + D++S G + EL
Sbjct: 163 --LTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 33/175 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLP-ITWEIRLG 57
I+++I H N++ L+ +E + LV + I L + + + TE Q+ I +I G
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-------- 109
+ V LH HRD+ ANI ++ K KI+DFG +R
Sbjct: 132 LNV--------LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 110 ------RTHLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
R +T++V T Y PE + ++ D++S G + ELLTG KP+
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L Q +H N+V+L G ++V E++ NG+L ++ + E QL +G+
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQ--LMGMLPG 115
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ + YL + H+ + + +L++ KIS F + + + T K
Sbjct: 116 LASGMKYLSEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE Q F+ SDV+SFG+V+ E+++ G++P
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIR-LGIA 59
IL ++N R VV L ET+ L LV + G L +I+ E R + A
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYA 108
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK- 118
E++ L LH I +RD+K NILLDD +ISD G L ++
Sbjct: 109 AEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLG-----------LAVEIPE 154
Query: 119 --------GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
GT GY+ PE ++ ++T D + G ++ E++ G+ P R
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 19 LETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGIAVEVSGALSYLHSAAS 74
+TE L L+ +++ G + +++++ +ED E+R E+ AL +LH
Sbjct: 74 FQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRFYSG-EIILALEHLHK--- 123
Query: 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF 134
+ I +RDIK NILLD + ++DFG S+ + T GT Y+ PE +
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 135 TEKS-DVYSFGVVLVELLTGQKPIRLVETEEN 165
K+ D +S G+++ ELLTG P L E E N
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTL-EGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK----GT 120
AL Y+HS I HRD+K +NILL+ R K++DFG +RS++ + V T
Sbjct: 119 ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 121 FGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y PE S+++T+ D++S G +L E+L G KP+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 49/169 (28%), Positives = 71/169 (42%), Gaps = 31/169 (18%)
Query: 7 NHRNVVKLLGCCLETEVPL------LVYEFIPNGS---LHQYIHEQ----TEDQLPITWE 53
NH N+ G ++ P LV E GS L + + ++ E+ I +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW--IAYI 118
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113
+R E L+YLH I HRDIK NILL K+ DFG S + D T
Sbjct: 119 LR-----ETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLG 168
Query: 114 TTQ-VKGTFGYLDPEYFQSSQ-----FTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + +SDV+S G+ +EL G+ P
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
A E+ L ++H+ + +RD+K ANILLD+ +ISD G + + + H +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 119 GTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
GT GY+ PE Q + +D +S G +L +LL G P R +T++
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLG 57
IL+ NH +VKLLG ++ EF P G++ + E TE Q+ +
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------- 114
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
I ++ AL YLHS + I HRD+K+ N+LL K++DFG S + V
Sbjct: 115 ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSF 170
Query: 118 KGTFGYLDPEY-----FQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + + K+D++S G+ L+E+ + P
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 21/166 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQTEDQLPITWE-IR 55
IL H N++ + L +V + + + LH IH DQ P+T E IR
Sbjct: 57 ILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHS---DQ-PLTEEHIR 110
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA---VDRTH 112
+ + G L Y+HSA + HRD+K +N+L+++ +I DFG +R ++ + +
Sbjct: 111 YFLYQLLRG-LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 113 LTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T+ T Y PE ++T D++S G + E+L G++ +
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
+L I + L +T+ L L+ ++I G L ++ ++ E ++ +I G
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEV----QIYSG 112
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
E+ AL +LH + I +RDIK NILLD ++DFG S+ D
Sbjct: 113 ---EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF 166
Query: 118 KGTFGYLDPEYFQ--SSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165
GT Y+ P+ + + D +S GV++ ELLTG P V+ E+N
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT-VDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 15 LGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73
L C +T L V E++ G L I + + P + A E++ L +LHS
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA----VFYAAEIAIGLFFLHSKG 121
Query: 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ 133
I +RD+K N++LD + KI+DFG + D T GT Y+ PE
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQP 177
Query: 134 FTEKSDVYSFGVVLVELLTGQKP 156
+ + D ++FGV+L E+L GQ P
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL----------LVYEFIPN---GSLHQYIHEQTEDQL 48
IL Q+NHRN+V L + + L LV+E++ + G L + +ED +
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
++ L+Y H + HRDIK +NILL++K + K++DFG +R
Sbjct: 119 K-------SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 109 DRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPI 157
+ + T T Y PE + + DV+S G +L EL T +KPI
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-10
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT----------EDQLPITWEIR- 55
+H N++ LLG C L E+ P+G+L ++ + + T +
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 56 -LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
L A +V+ + YL I HRD+ + NIL+ + Y AKI+DFG SR V
Sbjct: 114 LLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV------ 164
Query: 115 TQVKGTFG-----YLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
VK T G ++ E S +T SDV+S+GV+L E+++
Sbjct: 165 -YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQT----EDQLPITWEIRL 56
IL ++N R VV L ET+ L LV + G L +I+ ++Q I +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY---- 107
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
A E+ L L I +RD+K NILLDD+ +ISD G + + T + +
Sbjct: 108 --AAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGR 161
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
V GT GY+ PE + ++T D + G ++ E++ GQ P R
Sbjct: 162 V-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
IL ++N +V L E++ L LV + G L +I+ E L + I +
Sbjct: 46 ILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY--SA 102
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++ + +LHS + I +RD+K N+LLDD+ ++SD G + + +T TQ GT
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGT 157
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
GY+ PE + ++ D ++ G + E++ G+ P +
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 35/90 (38%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L YLHSA I HRDIK N+L++ KI DFG +R D + TQ T Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 126 PEYFQSSQ-FTEKSDVYSFGVVLVELLTGQ 154
PE S+ +T D++S G + ELL +
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 9/156 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L+ + + L C +T L V E++ G L +I + + + P + A
Sbjct: 53 VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA----VFYAA 108
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+S L +LH I +RD+K N++LD + KI+DFG + VD T GT
Sbjct: 109 EISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGT 164
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE + + D +++GV+L E+L GQ P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 7 NHRNVVKLLGCCLETEVP------LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+HRN+ G ++ P LV EF GS+ I + L W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKG 119
E+ LS+LH I HRDIK N+LL + K+ DFG S + DRT G
Sbjct: 119 EILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 173
Query: 120 TFGYLDPEYFQSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 157
T ++ PE + + KSD++S G+ +E+ G P+
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+S AL +LH I +RD+K NILLD + K++DFG + ++ +T GT
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGT 163
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
Y+ PE S + D +S G ++ ++LTG P T ENR
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF----TAENR 205
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 18/157 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA- 59
+L ++NH N+VKLL + TE L LV+EF+ + L +++ D P++ I L +
Sbjct: 52 LLKELNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-----DASPLS-GIPLPLIK 103
Query: 60 ---VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
++ L++ HS + HRD+K N+L++ + K++DFG +R+ V T +
Sbjct: 104 SYLFQLLQGLAFCHSHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160
Query: 117 VKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLT 152
V T Y PE ++ + D++S G + E++T
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 49/157 (31%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
++L + H +V L E V +++ G L + H Q E E R A
Sbjct: 48 VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFL---EPRARFYA 102
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
EV+ A+ YLHS + I +RD+K NILLD + ++DFG + V+ T+ G
Sbjct: 103 AEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCG 158
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T YL PE + + D + G VL E+L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 10/165 (6%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
++L + H +V L + V ++I G L + H Q E E R A
Sbjct: 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCF---LEPRARFYA 102
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E++ AL YLHS + I +RD+K NILLD + ++DFG + ++ T+ G
Sbjct: 103 AEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCG 158
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
T YL PE + D + G VL E+L G P T E
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 44/166 (26%), Positives = 66/166 (39%), Gaps = 17/166 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I Q+ H N++ + + +V + GS + + LP I I
Sbjct: 51 ITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL-AIAF-ILK 108
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM--------AVDRTH 112
+V AL Y+HS I HR +K+++ILL + +S S SM V
Sbjct: 109 DVLNALDYIHSKGFI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH--D 163
Query: 113 LTTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTGQKP 156
+L PE Q + + EKSD+YS G+ EL G P
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L +I H N ++ GC L LV E+ + + S +H++ ++ I I
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHG 133
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L+YLHS I HRDIK+ NILL + + K++DFG S S+A GT
Sbjct: 134 ALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFG-SASIASPANSFV----GTP 185
Query: 122 GYLDPEY---FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ PE Q+ K DV+S G+ +EL + P+
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 12/137 (8%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85
LV E+ P G L ++ + EDQ + +A E+ A+ +H + HRDIK
Sbjct: 78 LVMEYQPGGDLLSLLN-RYEDQFDEDM-AQFYLA-ELVLAIHSVHQMGYV---HRDIKPE 131
Query: 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKS------D 139
N+L+D K++DFG++ + ++ + GT Y+ PE + K D
Sbjct: 132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 140 VYSFGVVLVELLTGQKP 156
+S GV+ E++ G+ P
Sbjct: 192 WWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ AL YLHS I +RD+K N++LD KI+DFG + D + T GT
Sbjct: 103 EIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGT 158
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + + + D + GVV+ E++ G+ P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 13/161 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIA 59
I++ H N+V G L + + EF GSL H + I + R
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR---- 113
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E L YLHS + HRDIK ANILL D K++DFG S + + + G
Sbjct: 114 -ETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-G 168
Query: 120 TFGYLDPEYF---QSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T ++ PE + + + D+++ G+ +EL Q P+
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 49/180 (27%), Positives = 69/180 (38%), Gaps = 37/180 (20%)
Query: 2 ILSQINHRNVVKLLGCCLE-----TEVPLLVYEFIP------NGSLH-QYIHEQTEDQLP 49
IL ++ H NVV L+ +E VY P +G L +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM--- 106
++ GI YLH I HRDIK+ANIL+D++ KI+DFG +R
Sbjct: 120 YMLQLLEGIN--------YLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 107 --------AVDRTHLTTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T V T Y PE ++T D++ G V E+ T +PI
Sbjct: 169 PPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAV 60
++ + H N+V G L E + E+ GSL H +L I + R
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR----- 113
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E L+YLHS + HRDIK ANILL D K++DFG + + + + GT
Sbjct: 114 ETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GT 169
Query: 121 FGYLDPEYF---QSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ PE ++ + + D+++ G+ +EL Q P+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 4e-10
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGAL 66
++ N +KL + +L+ ++I +G L + + E +L E++ I ++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLS-EAEVKK-IIRQLVEAL 122
Query: 67 SYLHSAASIPIYHRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
+ LH I H DIK N+L D K R + D+G + + + GT Y
Sbjct: 123 NDLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFS 174
Query: 126 PEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
PE + + D ++ GV+ ELLTG+ P + E EE
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L ++ H N ++ GC L LV E+ + + S +H++ ++ I +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHG 123
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L+YLHS I HRD+K+ NILL + K+ DFG++ MA + GT
Sbjct: 124 ALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTP 175
Query: 122 GYLDPEY---FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ PE Q+ K DV+S G+ +EL + P+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD---RTHLTTQVKGTF 121
L YLHSA + HRD+K +NIL++ KI DFG +R + D + LT V T
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TR 170
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y PE SS++T+ D++S G + ELLT KP+
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 10/134 (7%)
Query: 38 QYIHEQTED-----QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK 92
E+ E+ + P+T E + + +V+ + +L S I HRD+ + NILL +
Sbjct: 153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSEN 209
Query: 93 YRAKISDFGTSRSMAVDRTHLTT-QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151
KI DFG +R + D ++ + ++ PE +T +SDV+SFGV+L E+
Sbjct: 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 269
Query: 152 T-GQKPIRLVETEE 164
+ G P V+ +E
Sbjct: 270 SLGASPYPGVQIDE 283
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 43/177 (24%), Positives = 93/177 (52%), Gaps = 31/177 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++SQ++H+++V G C+ + ++V E++ GSL Y+ ++ ++ + I+W +L +A +
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQ 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILL----DDKYRA----KISDFGTS-----RSMAV 108
++ AL +L + H ++ + N+LL D K K+SD G S + + +
Sbjct: 109 LAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILL 165
Query: 109 DRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTG-QKPIRLVETE 163
+R ++ PE ++ Q + +D +SFG L E+ +G KP+ ++++
Sbjct: 166 ER----------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTF 121
L Y+HSA + HRD+K +N+LL+ KI DFG +R + H LT V T
Sbjct: 118 GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-ATR 173
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y PE S +T+ D++S G +L E+L+ +P+
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEY 128
+HS + HRDIK N+LLD +++DFG+ M D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 129 FQS-----SQFTEKSDVYSFGVVLVELLTGQKPI---RLVET 162
Q+ ++ + D +S GV + E+L G+ P LVET
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ AL YLHS + +RDIK N++LD KI+DFG + D + T GT
Sbjct: 103 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 158
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + + + D + GVV+ E++ G+ P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L+Q+N +V L E LV FI G L + H Q E + ++ R A E
Sbjct: 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLS-RARFYTA-E 101
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL LH + +RD+K NILLD + + DFG + + + T GT
Sbjct: 102 LLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTP 157
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE +T+ D ++ GV+L E+LTG P
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLH---QYIHEQTEDQL-PITWEIRLG 57
+L Q+ H N+V L+ LV+E+ + L+ + E + I W+
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ- 111
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
A+++ H I HRD+K NIL+ + + K+ DFG +R + T V
Sbjct: 112 -------AVNFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 118 KGTFGYLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQ 154
T Y PE +Q+ DV++ G V ELLTGQ
Sbjct: 162 -ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR--THLTTQVKGTFG 122
AL Y+H+A ++HRD+K NIL + + KI DFG +R D T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 123 YLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKPI 157
Y PE S S++T D++S G + E+LTG KP+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 13/144 (9%)
Query: 29 EFIPNGSLHQYIHEQTED--QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86
F P+ S ++T+D + P+T E + + +V+ + +L S I HRD+ + N
Sbjct: 148 RFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCI---HRDLAARN 204
Query: 87 ILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT----FGYLDPEYFQSSQFTEKSDVYS 142
ILL + KI DFG +R + D ++ KG+ ++ PE +T +SDV+S
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVR---KGSARLPLKWMAPESIFDKVYTTQSDVWS 261
Query: 143 FGVVLVELLT-GQKPIRLVETEEN 165
FGV+L E+ + G P V+ E
Sbjct: 262 FGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 3 LSQINHRNVVKLLGCCL------ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
L +H N+V+L+ C ET+V L V+E + + L Y+ + LP I+
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTL-VFEHV-DQDLRTYLDKVPPPGLPAE-TIKD 112
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR----SMAVDRTH 112
+ + G L +LH+ I HRD+K NIL+ + K++DFG +R MA+
Sbjct: 113 LMRQFLRG-LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL---- 164
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T V T Y PE S + D++S G + E+ +KP+
Sbjct: 165 --TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 53/198 (26%), Positives = 82/198 (41%), Gaps = 56/198 (28%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL++ ++ VVKL + E L L+ E++P G + + ++ TE+ E R
Sbjct: 54 ILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE------ETRFY 106
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT-- 115
IA E A+ +H I HRDIK N+LLD K K+SDFG + ++H T
Sbjct: 107 IA-ETILAIDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGL--CTGLKKSHRTEFY 160
Query: 116 -------------------------------------QVKGTFGYLDPEYFQSSQFTEKS 138
GT Y+ PE F + + ++
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220
Query: 139 DVYSFGVVLVELLTGQKP 156
D +S GV++ E+L G P
Sbjct: 221 DWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 37/169 (21%)
Query: 7 NHRNVVKLLGCCLETEVP-------LLVYEFIPNGSLHQYIHEQTEDQLP------ITWE 53
H+N+ C + ++ L +YE + LHQ I + L ++
Sbjct: 60 GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIR--SGQPLTDAHFQSFIYQ 113
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-- 111
I G L Y+HSA + HRD+K N+L++ KI DFG +R + +
Sbjct: 114 ILCG--------LKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 112 --HLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPI 157
+T V T Y PE S Q +T+ DV+S G +L ELL G+KP+
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 37/239 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN---GSLHQYIHEQTEDQL-PITWEIRLG 57
+L Q+ H N+V L+ + LV+EF+ + L +Y + E ++ ++I G
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRG 112
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
I + HS I HRDIK NIL+ K+ DFG +R++A T V
Sbjct: 113 IE--------FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV 161
Query: 118 KGTFGYLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQKPI-----------RLVETEEN 165
T Y PE +++ D+++ G ++ E+LTG+ P+ +++ N
Sbjct: 162 -ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGN 219
Query: 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEE------VITVAMVAKRCLNLNGKKRPT 218
L ++ +N LF + ++E E E V +AK+CL ++ RP+
Sbjct: 220 --LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 19/163 (11%)
Query: 7 NHRNVVKLLGCCLETEVP------LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+HRN+ G ++ P LV EF GS+ + + L W I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICR 128
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKG 119
E+ L++LH+ I HRDIK N+LL + K+ DFG S + DRT G
Sbjct: 129 EILRGLAHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 183
Query: 120 TFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKPI 157
T ++ PE + + +SD++S G+ +E+ G P+
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L ++ H N+V L ++ L++EF+ + L +Y+ D LP G ++
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-----DSLPK------GQYMD 99
Query: 62 VSGALSYLHSAASIPIY-------HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
SYL+ ++ HRD+K N+L+D+K K++DFG +R+ + T
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159
Query: 115 TQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPI 157
+V T Y PE S ++ D++S G + E+ T +KP+
Sbjct: 160 HEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 26/183 (14%)
Query: 45 EDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR 104
ED+L + E L + +V+ +S+L S I HRD+ + NILL KI DFG +R
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLAR 262
Query: 105 SMAVDRTHLTTQVKGT----FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159
+ D ++ VKG ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 263 DIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219
+ + + F ++I E + + +E +++ K C + + KRPT
Sbjct: 320 MPVD------SKFYKMIKEGYR---MLSPECAPSEMYDIM------KSCWDADPLKRPTF 364
Query: 220 KEV 222
K++
Sbjct: 365 KQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L Y+HSA + HRD+K +N+LL+ KI DFG +R+ + +T V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 126 PE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
PE S++T DV+S G + ELL G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
IL+ +VKLL + E L E++P G ++ +ED R +
Sbjct: 54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH------ARFYM 107
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
A E+ A+ LH I HRD+K N L+D K++DFG S V + V
Sbjct: 108 A-EMFEAVDALHELGYI---HRDLKPENFLIDASGHIKLTDFGLS-KGIVTYAN---SVV 159
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
G+ Y+ PE + + D +S G +L E L G P
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ AL YLHS ++ +RD+K N++LD KI+DFG + D + T GT
Sbjct: 103 EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGT 159
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + + + D + GVV+ E++ G+ P
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L Y+HSA + HRD+K +NIL+++ KI DFG +R + +T V + Y
Sbjct: 121 LKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRY-YRA 173
Query: 126 PEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPI 157
PE + Q + + D++S G + E+L G KP+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEY 128
+ S + HRDIK N+LLD +++DFG+ + D T + GT Y+ PE
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 129 FQS-----SQFTEKSDVYSFGVVLVELLTGQKPI---RLVET 162
Q+ ++ + D +S GV + E+L G+ P LVET
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 45/207 (21%)
Query: 3 LSQINHRNVVKLLGCCLETEVPL--LVYEFIPNGSLHQYIHEQTE---DQLP------IT 51
L ++ H NVV L+ LE L++++ + L Q I + +P +
Sbjct: 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 52 WEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL----DDKYRAKISDFGTSR--- 104
W+I G+ YLHS + HRD+K ANIL+ ++ KI D G +R
Sbjct: 115 WQILNGV--------HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 105 -----SMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIR 158
+D V T Y PE ++ +T+ D+++ G + ELLT +PI
Sbjct: 164 APLKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIF 216
Query: 159 LVETEENRSLAAYFLQVINENRLFEVL 185
+ + + Q R+FEVL
Sbjct: 217 KGREAKIKKSNPF--QRDQLERIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (137), Expect = 4e-09
Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
++ ++ H+N+V+ + L + ++ EF G L + I + + I + I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 60 VEVSGALSYLHSAASIP----IYHRDIKSANILLDDKYR-----------------AKIS 98
++ AL+Y H+ P + HRD+K NI L R AKI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 99 DFGTSRSMAVDRTHLTTQVKGTFGYLDPEYF--QSSQFTEKSDVYSFGVVLVELLTGQKP 156
DFG S+++ ++ + GT Y PE ++ + +KSD+++ G ++ EL +G+ P
Sbjct: 185 DFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216
A F Q+I+E + L ++ KE + ++ K LNL+ K+R
Sbjct: 243 FH---------KANNFSQLISELKRGPDLP---IKGKSKE----LNILIKNLLNLSAKER 286
Query: 217 PT 218
P+
Sbjct: 287 PS 288
|
Length = 1021 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 14/161 (8%)
Query: 7 NHRNVVKLLGCCLETEVP-----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+H NVVK G + +V LV E GS+ + + + I I E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L +LH +I HRD+K NILL + K+ DFG S + R T V GT
Sbjct: 133 ALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 188
Query: 122 GYLDPEYFQSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 157
++ PE Q + + DV+S G+ +EL G P+
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 55/239 (23%), Positives = 110/239 (46%), Gaps = 48/239 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ Q++H+++V L G C+ ++V EF+ G L ++H +++ +T + +A +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQ 113
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILL-----DDKYRA--KISDFGT-----SRSMAVD 109
++ ALSYL + H ++ + NILL D + K+SD G SR V+
Sbjct: 114 LASALSYLEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE 170
Query: 110 RTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVEL-LTGQKPIRLVETEENRS 167
R ++ PE + S+ + +D +SFG L E+ G+ P++ +++
Sbjct: 171 R----------IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKT 214
Query: 168 LAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
LA E F ++ + KE +A + C+N + +RP + + ++
Sbjct: 215 LA--------EKERFYEGQCMLVTPSCKE----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ AL YLHS + +RD+K N++LD KI+DFG + D + T GT
Sbjct: 103 EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 158
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + + + D + GVV+ E++ G+ P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 26/191 (13%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPIT----WEIRLGIAVEVSGALSYLHSAASIPIYHRD 81
LV ++ G L + + ED+LP + + IA++ L Y+H RD
Sbjct: 78 LVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH---------RD 127
Query: 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-----SQFTE 136
IK NIL+D +++DFG+ + D T ++ GT Y+ PE Q+ ++
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 137 KSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKE 196
+ D +S GV + E+L G+ P SL + +++N F+ AQV +E
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ-FPAQVTDVSEDA 240
Query: 197 EVITVAMVAKR 207
+ + ++ R
Sbjct: 241 KDLIRRLICSR 251
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 1 IILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGSLHQYIHEQTED--QLPITWEIR 55
+ L ++NH N++K+ L T + Y+F L+ +++++ D P+ + R
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQTR 270
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
I ++ A+ Y+H I HRDIK NI L+ + + DFGT+ +R
Sbjct: 271 -AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
GT PE + E +D++S G++L+++L+
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 17 CCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75
C ET+ L +V E++ G + + LP+ R+ A E AL YLH+
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDM-ARMYFA-ETVLALEYLHNYG-- 121
Query: 76 PIYHRDIKSANILLDDKYRAKISDFGTSR-------------SMAVD-RTHLTTQVKGTF 121
I HRD+K N+L+ K++DFG S+ + D R L QV GT
Sbjct: 122 -IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
Y+ PE + + D ++ G++L E L G P +T E F QVI+++
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDTPE-----ELFGQVISDD 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 1 IILSQINHRNVVKLLGC-----CLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWE 53
+++ +NH+N++ LL LE +V LV E + + +L Q I + +
Sbjct: 67 VLMKLVNHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHE------ 118
Query: 54 IRLGIAV-EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
R+ + ++ + +LHSA I HRD+K +NI++ KI DFG +R+
Sbjct: 119 -RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FM 173
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154
+T V T Y PE + E D++S G ++ E++ G
Sbjct: 174 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 7/127 (5%)
Query: 42 EQTED--QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISD 99
+ ED + +T E + + +V+ + +L S I HRD+ + NILL + KI D
Sbjct: 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICD 222
Query: 100 FGTSRSMAVDRTHLTT-QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPI 157
FG +R + D ++ + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 158 RLVETEE 164
V+ +E
Sbjct: 283 PGVKIDE 289
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 3 LSQINHRNVVKLLGCCL------ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
L H NVV+L C ET++ L V+E + + L Y+ + E +P E
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYLDKVPEPGVPT--ETIK 113
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+ ++ L +LHS + HRD+K NIL+ + K++DFG +R + T
Sbjct: 114 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTS 168
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V T Y PE S + D++S G + E+ +KP+
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+V L E LV+E++ + L QY+ + P ++ L +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ LSY+H I HRD+K N+L+ D K++DFG +R+ +V +H + T
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTL 167
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTG 153
Y P+ S++++ D++ G + VE++ G
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 9/147 (6%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85
LV +++ G L + H Q E + + IA E+ AL +LH I +RD+K
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFS-EDRAKFYIA-ELVLALEHLHKY---DIVYRDLKPE 125
Query: 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFG 144
NILLD + DFG S++ D T GT YL PE +T+ D +S G
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 145 VVLVELLTGQKPIRLVETEENRSLAAY 171
V++ E+ G P +T++ A+
Sbjct: 185 VLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 51/172 (29%), Positives = 75/172 (43%), Gaps = 24/172 (13%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHE-----QTEDQLPI 50
I+ S NH NVVK G + + + LV E GS+ + + Q D+ I
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
++ + GAL L + I HRD+K NILL + K+ DFG S + R
Sbjct: 131 SYILY--------GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 111 THLTTQVKGTFGYLDPEYFQSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 157
T V GT ++ PE Q + + DV+S G+ +EL G P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 65/207 (31%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEI------R 55
+L++ + VV L + + L+ EF+P G L + I ++ R
Sbjct: 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTR 104
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS------------ 103
+A E A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 105 FYMA-ECVLAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160
Query: 104 ----------------RSMAVDRTHLTTQVK------------------GTFGYLDPEYF 129
S+AVD +LT K GT Y+ PE F
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220
Query: 130 QSSQFTEKSDVYSFGVVLVELLTGQKP 156
+ ++ D +S G ++ E L G P
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP------ITWEIR 55
+L ++NH N+V+LL LV+EF+ + L +Y+ L +++
Sbjct: 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
GIA Y HS + HRD+K N+L+D + K++DFG +R+ V T
Sbjct: 110 QGIA--------YCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
Query: 116 QVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+V T Y PE S Q++ D++S G + E++ ++P+
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 18/158 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL INH ++++L G + L+ +P Y + + + I +I L I
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC-DI-LAIERS 190
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK--- 118
V A+ YLH I HRDIK+ NI ++ + DFG + VD K
Sbjct: 191 VLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVD----INANKYYG 242
Query: 119 --GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154
GT PE + D++S G+VL E+ T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 1 IILSQINHRNVVKLLGCCL------ETEVPLLVYEFIPNGSLHQYIHEQT--EDQLPITW 52
++L +NH+N++ LL E + LV E + + +L Q IH + E + +
Sbjct: 72 VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLY 130
Query: 53 EIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
++ GI +LHSA I HRD+K +NI++ KI DFG +R+ +
Sbjct: 131 QMLCGI--------KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--F 177
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG 153
+ T T Y PE + E D++S G ++ EL+ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 54/206 (26%), Positives = 82/206 (39%), Gaps = 67/206 (32%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI--- 58
IL++ ++ VVKL + + V ++IP G + ++ IRLGI
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDM-------------MSLLIRLGIFEE 100
Query: 59 ------AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG---------TS 103
E++ A+ +H I HRDIK NIL+D K++DFG S
Sbjct: 101 DLARFYIAELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 104 R-----------SM-------AVDRTHLTT---------------QVKGTFGYLDPEYFQ 130
+ SM +DR L + GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 131 SSQFTEKSDVYSFGVVLVELLTGQKP 156
+ +T+ D +S GV+L E+L GQ P
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYL 124
+++LH I HRD+K++N+LL+++ KI DFG +R T V T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173
Query: 125 DPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
PE + +++ D++S G + ELLT +KP+
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 28/168 (16%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLG 57
IL+ +H N+VKLL ++ EF G++ + E TE Q+ +
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV------- 107
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ + AL+YLH I HRD+K+ NIL K++DFG S + T Q
Sbjct: 108 VCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQR 159
Query: 118 K----GTFGYLDPEYF-----QSSQFTEKSDVYSFGVVLVELLTGQKP 156
+ GT ++ PE + + K+DV+S G+ L+E+ + P
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-08
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 24/200 (12%)
Query: 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL--GIAVEVS 63
+ H N+++ LG C E LLV EF P G L Y+ + +L +T + +A E++
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL-MTPDPTTLQRMACEIA 110
Query: 64 GALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT-QVKGTFG 122
L +LH I H D+ N LL KI D+G S + + ++T Q+
Sbjct: 111 LGLLHLHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 123 YLDPEYFQS-------SQFTEKSDVYSFGVVLVELLT-GQKPIR---------LVETEEN 165
++ PE T++S+V+S GV + EL G +P R E+
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 166 RSLAAYFLQVINENRLFEVL 185
L L++ +R +EV+
Sbjct: 228 LKLPKPRLKLPLSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--------LLVYEFIPN--GSLHQYIHEQTEDQLPIT 51
IL + H NVV L+ C P LV+EF + L + + L
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT--LS-- 119
Query: 52 WEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV--- 108
EI+ + + ++G L Y+H I HRD+K+ANIL+ K++DFG +R+ ++
Sbjct: 120 -EIKKVMKMLLNG-LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 109 -DRTHLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165
T +V T Y PE + D++ G ++ E+ T + PI TE++
Sbjct: 175 SKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLV---YEFIPNGSLHQYIHEQTEDQLPITWEIRLGI 58
IL I+HR ++ L+ +V Y+ L Y+ + P+ E + I
Sbjct: 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYV----DRSGPLPLEQAITI 190
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
+ AL+YLH I HRD+K+ NI LD+ A + DFG + +D T Q
Sbjct: 191 QRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDTPQCY 245
Query: 119 GTFGYLD---PEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
G G L+ PE + K+D++S G+VL E+ +
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 30/107 (28%), Positives = 60/107 (56%), Gaps = 10/107 (9%)
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
+++ +G + +V+ + +L S + HRD+ + N+L+ + KI DFG +R + D
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 110 RTHLTTQVKGT----FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
+++ KG+ ++ PE ++ +T SDV+SFG++L E+ T
Sbjct: 293 SNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 53/235 (22%), Positives = 108/235 (45%), Gaps = 40/235 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++SQ++H+++VKL G C+ E ++V E++ G L ++H + + + + W +L +A +
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQ 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILL-----DDKYR--AKISDFGTSRSMAVDRTHLT 114
++ AL YL + H ++ NIL+ ++ Y K+SD G + + R
Sbjct: 110 LASALHYLEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT-VLSREERV 165
Query: 115 TQVKGTFGYLDPEYFQ--SSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAY 171
++ ++ PE + + T +D +SFG L+E+ + G++P L+
Sbjct: 166 ERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP-----------LSTL 210
Query: 172 FLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
E F D L + E+ + +C + KRP+ + + +L
Sbjct: 211 SSS---EKERFYQ-DQHRLPMPDCAELANLIN---QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 9/125 (7%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTH---LTTQVKGTF 121
L Y+HSA + HRD+K AN+ ++ + KI DFG +R + +H L+ + +
Sbjct: 127 LKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y P + +T+ D+++ G + E+LTG+ E L + V+ E
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 181 LFEVL 185
E+L
Sbjct: 243 RNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 40/154 (25%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+V L E V+E++ + L QY+ + P + +RL +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHP--YNVRLFMFQL 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ G L+Y+H I HRD+K N+L+ K++DFG +R+ ++ +++V T
Sbjct: 113 LRG-LAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TL 167
Query: 122 GYLDPEYFQ-SSQFTEKSDVYSFGVVLVELLTGQ 154
Y P+ ++ ++ D++ G + +E+L GQ
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 11/155 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L + H N+V L + TE L LV+E++ + L QY+ L +++ +
Sbjct: 56 LLKNLKHANIVTLHDI-IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQ 111
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+ G LSY H I HRD+K N+L+++K K++DFG +R+ +V + +V T
Sbjct: 112 LLRG-LSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-T 166
Query: 121 FGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
Y P+ S++++ D++ G +L E+ TG+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 44/165 (26%), Positives = 65/165 (39%), Gaps = 41/165 (24%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85
L+ EF+P G + + ++ +T E E A+ +H I HRDIK
Sbjct: 78 LIMEFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQLGFI---HRDIKPD 130
Query: 86 NILLDDKYRAKISDFG----------------TSRSMAVD------------------RT 111
N+LLD K K+SDFG + S+ D R
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 112 HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
L GT Y+ PE F + + + D +S GV++ E+L G P
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 32/169 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP-----------I 50
+L ++ H N+V+L + LV+E++ + L +++ D P
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHM-----DSSPDFAKNPRLIKTY 107
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA-KISDFGTSRSMAVD 109
++I GIA Y HS + HRD+K N+L+D + A K++DFG +R+ +
Sbjct: 108 LYQILRGIA--------YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156
Query: 110 RTHLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T +V T Y PE S ++ D++S G + E++ QKP+
Sbjct: 157 VRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 49/189 (25%), Positives = 75/189 (39%), Gaps = 41/189 (21%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL + + VVK+ + L+ EF+P G + + ++ D L + IA E
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLS-EEATQFYIA-E 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG-------------------- 101
A+ +H I HRDIK N+LLD K K+SDFG
Sbjct: 110 TVLAIDAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 102 --------------TSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147
+ + +R L GT Y+ PE F + + + D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 148 VELLTGQKP 156
E+L G P
Sbjct: 227 YEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL+ INH V L G + LV EF+ G ++ + P ++ A +
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPN--DVGCFYAAQ 139
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ YL S + I +RD+K N+LLD K++DFG ++ + RT+ + GT
Sbjct: 140 IVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTY---TLCGTP 192
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE + + +D ++ G+ + E+L G P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 48/187 (25%), Positives = 71/187 (37%), Gaps = 37/187 (19%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
IL+ ++H + L +TE L LV ++ P G L + + Q L R A
Sbjct: 54 ILATLDHPFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA- 110
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK-- 118
EV AL YLH I +RD+K NILL + +SDF S+ V ++
Sbjct: 111 EVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV-EPPPVSKALRK 166
Query: 119 ---------------------------GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151
GT Y+ PE D ++ G++L E+L
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 152 TGQKPIR 158
G P +
Sbjct: 227 YGTTPFK 233
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 40/161 (24%), Positives = 80/161 (49%), Gaps = 23/161 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTED-QLP------ITWE 53
++ ++ H N+V+L + TE L LV+E++ + L +Y+ L T++
Sbjct: 51 LMKELKHENIVRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ 108
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113
+ GIA + H + HRD+K N+L++ + K++DFG +R+ +
Sbjct: 109 LLKGIA--------FCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157
Query: 114 TTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTG 153
+ +V T Y P+ S+ ++ D++S G ++ E++TG
Sbjct: 158 SNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYL 124
+L ++H I+HRDIK NIL+ D K++DFG+ R + T+ T Y
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRG--IYSKPPYTEYISTRWYR 165
Query: 125 DPEYFQSSQF-TEKSDVYSFGVVLVELLT 152
PE + + K D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 44/165 (26%), Positives = 90/165 (54%), Gaps = 20/165 (12%)
Query: 1 IILSQINHRNVVKL-----LGCCLETEVPL---LVYEFIPNGSLHQYI--HEQTEDQLPI 50
+I+ +NH N++ L C + E + +V EFIP ++H+Y+ + + LP+
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL 169
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK-YRAKISDFGTSRSMAVD 109
+ ++L + ++ AL+Y+HS I HRD+K N+L+D + K+ DFG+++++
Sbjct: 170 -FLVKL-YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 110 RTHLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTG 153
+ + + + F Y PE ++ +T D++S G ++ E++ G
Sbjct: 225 QRSV-SYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-07
Identities = 43/154 (27%), Positives = 62/154 (40%), Gaps = 31/154 (20%)
Query: 10 NVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT---EDQLPITWEIRLGIAVEVSGAL 66
N+V L + + LV + G L +I + E+ + W A E+ AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RW------AAEMVVAL 98
Query: 67 SYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-------AVDRTHLTTQVKG 119
LH I RD+ NILLDD+ +++ F + AV+
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-------- 147
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG 153
Y PE S+ TE D +S G +L ELLTG
Sbjct: 148 ---YCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 25/91 (27%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYL 124
+++ H + HRD+K N+L+D K KI+D G R+ ++ T ++ T Y
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYR 178
Query: 125 DPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
PE S+ ++ D++S G + E+ Q
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 27/88 (30%), Positives = 50/88 (56%), Gaps = 13/88 (14%)
Query: 77 IYHRDIKSANILLDDKYRAKISDFGTSRSM--AVDRTHLTTQVKGTFGYLDPEYFQS--- 131
I HRD+K N+L++ + K+ DFG S ++ ++ +T++ Q Y+ PE +S
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ-----SYMAPERIKSGGP 178
Query: 132 ---SQFTEKSDVYSFGVVLVELLTGQKP 156
+T +SDV+S G+ ++E+ G+ P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 75/310 (24%), Positives = 115/310 (37%), Gaps = 86/310 (27%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI--- 58
IL++ ++ VVKL + + V ++IP G + + IR+ +
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRMEVFPE 100
Query: 59 ------AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGT---------- 102
E++ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 101 VLARFYIAELTLAIESVHKMGFI---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 103 -----------------------------SRSMAVD----RTH---LTTQVKGTFGYLDP 126
R ++ + H L + GT Y+ P
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217
Query: 127 EYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN-ENRLFEVL 185
E +T+ D +S GV+L E+L GQ P E + L+VIN EN L +
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ------LKVINWENTLH--I 269
Query: 186 DAQVLREAEKEEVIT-VAMVAKRCLNLNG----KKRPTMKEVALELAGIRASIGASVLRQ 240
QV E ++IT + A+ L NG K P EV + IR V +
Sbjct: 270 PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS-SDIRTQPAPYVPKI 328
Query: 241 CEEIDFVNYD 250
+D N+D
Sbjct: 329 SHPMDTSNFD 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 28/165 (16%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQ----YIHEQTED-------QLP 49
+++ +NH+N++ LL F P SL + YI + D Q+
Sbjct: 75 VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
+ E + ++ + +LHSA I HRD+K +NI++ KI DFG +R+
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 178
Query: 110 RTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154
+ + T T Y PE + E D++S G ++ E++ G
Sbjct: 179 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 11/165 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+V L + LV+E++ + L QY+ + +I L +
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFL---YQ 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L+Y H + HRD+K N+L++++ K++DFG +R+ +V + +V T
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TL 168
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQK--PIRLVETE 163
Y P+ SS+++ + D++ G + E+ +G+ P VE E
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 15/96 (15%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG---TFG 122
L Y+H+A I HRD+K N+ +++ KI DFG +R +++ G T
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180
Query: 123 YLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPI 157
Y PE + +T+ D++S G ++ E+LTG KP+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYL 124
L Y+HSA I HRD+K +N+ +++ KI DFG +R + T T Y
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 184
Query: 125 DPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154
PE + + + D++S G ++ ELLTG+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 37/154 (24%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+V L + LV+E++ + L QY+ + ++L +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQL 113
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ G L+Y H + HRD+K N+L++++ K++DFG +R+ ++ + +V T
Sbjct: 114 LRG-LNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TL 168
Query: 122 GYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
Y P+ S+ ++ + D++ G + E+ TG+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L Y+HSA I HRD+K N+ +++ KI DFG +R + T T Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRA 182
Query: 126 PEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154
PE + + + D++S G ++ E+LTG+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 1 IILSQINHRNVVKLLGCCL------ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEI 54
+++ +NH+N++ LL E + LV E + + +L Q I Q+ + E
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI------QMELDHER 120
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
+ ++ + +LHSA I HRD+K +NI++ KI DFG +R+ + +
Sbjct: 121 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMM 175
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151
T T Y PE + E D++S G ++ E++
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 27/181 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIR----- 55
I + + H +V + C + + +I +L + + + L +
Sbjct: 55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 56 -LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
L I ++ + Y+HS + HRD+K NILL I D+G + ++ L
Sbjct: 115 FLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 115 T-----------------QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ GT Y+ PE +E +D+Y+ GV+L ++LT P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 158 R 158
R
Sbjct: 232 R 232
|
Length = 932 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 71/210 (33%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI--- 58
IL++ ++ VV+L + + V ++IP G + + IR+GI
Sbjct: 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRMGIFPE 100
Query: 59 ------AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS--------- 103
E++ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 101 DLARFYIAELTCAVESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 104 ---------RSMAVD-------------------------RTH---LTTQVKGTFGYLDP 126
R ++D R H L + GT Y+ P
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 127 EYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
E + +T+ D +S GV+L E+L GQ P
Sbjct: 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 55/239 (23%), Positives = 108/239 (45%), Gaps = 48/239 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++SQ++H ++ + G C+ ++V EF+ +G L + ++ + ++P+ W+I +A +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKIT--VAQQ 125
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRA-------KISDFGT-----SRSMAVD 109
++ ALSYL + H ++ + NILL A K+SD G SR V+
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE 182
Query: 110 RTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVEL-LTGQKPIRLVETEENRS 167
R ++ PE + + +D +SFG L+E+ G+ P++ E S
Sbjct: 183 R----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK----ERTPS 228
Query: 168 LAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
F + ++RL E + +A + +CL +RP+ + + +L
Sbjct: 229 EKERFYE--KKHRLPEPSCKE------------LATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
L +V+ + +L S + HRD+ + N+LL KI DFG +R + D +++
Sbjct: 240 LSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS- 295
Query: 116 QVKG-TF---GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152
KG TF ++ PE + +T SDV+S+G++L E+ +
Sbjct: 296 --KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 26/78 (33%), Positives = 40/78 (51%)
Query: 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTE 136
I HRDIK N+L+ K+ DFG +R+++ T+ T Y PE + + +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 137 KSDVYSFGVVLVELLTGQ 154
D++S G +L EL GQ
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 13/132 (9%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRTHLT-- 114
++ + YLH+ + HRD+K ANIL+ ++ R KI+D G +R L
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 115 TQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
V TF Y PE ++ +T+ D+++ G + ELLT + PI E+ ++ Y
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHH 231
Query: 174 QVINENRLFEVL 185
+ +R+F V+
Sbjct: 232 DQL--DRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGA 65
+ H N+++ LG C+E LLV+E+ G L Y+ ++ + + +A E++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFG--Y 123
++++H + H D+ N L K+ D+G S ++ T+ +
Sbjct: 112 VTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRW 167
Query: 124 LDPEY---FQ----SSQFTEKSDVYSFGVVLVELL 151
L PE F +++ T+ S+V++ GV L EL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLD 125
L Y+HSA I HRD+K +N+ +++ +I DFG +R + T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRA 183
Query: 126 PEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154
PE + + + D++S G ++ ELL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 26/91 (28%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV-DRTHLTTQVKGTFGYL 124
L+Y H + HRD+K N+L+ ++ K++DFG +R+ +V +T+ V T Y
Sbjct: 116 LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYR 170
Query: 125 DPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
P+ S++++ D++ G + E+ TG+
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 39/167 (23%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIP----------NGSLHQYIHEQTEDQLPIT 51
+L ++ H+N+V+L + LV+E+ NG + I + QL
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL--- 108
Query: 52 WEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT 111
+ G L++ HS + HRD+K N+L++ K++DFG +R+ +
Sbjct: 109 ----------LKG-LAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154
Query: 112 HLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+ +V T Y P+ F + ++ D++S G + EL +P+
Sbjct: 155 CYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 13/132 (9%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRTHLT-- 114
++ + YLH+ + HRD+K ANIL+ ++ R KI+D G +R L
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 115 TQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
V TF Y PE ++ +T+ D+++ G + ELLT + PI E+ ++ +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPFHH 231
Query: 174 QVINENRLFEVL 185
+ +R+F V+
Sbjct: 232 DQL--DRIFSVM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 25/124 (20%)
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLD----------------DKYRAKISDFG 101
I + AL Y H+ + + H D+K NIL++ D R +I D G
Sbjct: 236 IIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 102 TSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161
D H T + T Y PE + +D++S G ++ EL TG+ L +
Sbjct: 294 G----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK---LLYD 346
Query: 162 TEEN 165
T +N
Sbjct: 347 THDN 350
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 19/44 (43%), Positives = 28/44 (63%), Gaps = 3/44 (6%)
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR 104
EV+ AL YLH I HRD+K N+L+ ++ K++DFG S+
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 30/132 (22%), Positives = 55/132 (41%), Gaps = 11/132 (8%)
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
I ++ L Y+H I H DIK NI++D R I D+G + + H+
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 118 ------KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAY 171
+GT Y + + T + D+ S G +++ + P + N AA
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247
Query: 172 --FLQVINENRL 181
F++ ++E ++
Sbjct: 248 CDFIKRLHEGKI 259
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDF---------GTSRSMAVDRTHLTT 115
L+YLH I HR+IK+++IL+ +S G + D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 116 QVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKP 156
V +L PE + + KSD+YS G+ EL TG+ P
Sbjct: 170 SV---LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 28/98 (28%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGT------SRSMAVDRT 111
+A ++ A+ Y+H I HRDIK+ N+L++ + DFG S S T
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-----T 316
Query: 112 HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 149
+ GT PE +T D++S G+V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 42/186 (22%), Positives = 63/186 (33%), Gaps = 31/186 (16%)
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ ++ GAL LH A KS NILL K+ ++ R
Sbjct: 22 VCLQCLGALRELHRQA---------KSGNILLTWDGLLKLDGSVAFKTPEQSR------- 65
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
++ PE Q +TEK+D+YS G+ L E L + P EE R L+A ++N
Sbjct: 66 -PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP----YNEE-RELSAILEILLN 119
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASV 237
+ D L M + C + ++R A A
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFM--RLCASRLPQRREAANHY-------LAHCRALF 170
Query: 238 LRQCEE 243
E
Sbjct: 171 AETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.71 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.65 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.51 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.4 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.92 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.66 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.43 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.43 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.78 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.53 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.72 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.09 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.58 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.43 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.32 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.1 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.73 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.58 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.45 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.91 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.6 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.06 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.73 | |
| PLN02236 | 344 | choline kinase | 92.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.25 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 91.7 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.32 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 91.1 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 89.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 89.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.95 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 86.8 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 86.51 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 85.14 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 85.09 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=325.07 Aligned_cols=207 Identities=26% Similarity=0.377 Sum_probs=176.3
Q ss_pred cccCCCCccccceeeEEEeCCc-cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETEV-PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~-~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H 79 (295)
|+++++|||||++||+|..++. .+|+||||+||+|.+++.... .+++....+++.+|++||.|||+ .+ |+|
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~---IIH 202 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK---IIH 202 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC---eee
Confidence 5788899999999999999995 999999999999999998753 49999999999999999999996 66 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||||+||||+.+|.+||+|||.+..+... ...+++||..|||||.+.+..|+.++||||||+.++|+++|+.||..
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 999999999999999999999999876544 45678899999999999999999999999999999999999999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK-EEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
. ..........+..+.... ....+. ..+.++.+++..||++||.+||+++|+++|.+-.
T Consensus 280 ~-~~~~~~~~~Ll~~Iv~~p----------pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 280 P-NPPYLDIFELLCAIVDEP----------PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred c-CCCCCCHHHHHHHHhcCC----------CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 4 112233444444333322 123333 3777899999999999999999999999998754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=320.70 Aligned_cols=210 Identities=26% Similarity=0.333 Sum_probs=171.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++|+|||||+++++|+..+..||||||++||+|.+.+-... .+.+..-.-+++|++.|+.|||+.| |+|||
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRD 301 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRD 301 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHcC---ccccc
Confidence 6899999999999999999999999999999999999998765 3777777889999999999999999 99999
Q ss_pred CCCCeEEECCC---CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC---CCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF---TEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+|||+..+ ..+||+|||+|+..+ ....+.+.+||+.|.|||++.+..+ ..+.||||+||++|-+++|.+
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 99999999876 679999999999765 4455778899999999999987543 347899999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
||...... .+.. +.+..+++.. ........+.+..++|.+||..||++|||+.|++.|.|-....
T Consensus 380 PFS~~~~~--~sl~----eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 380 PFSEEYTD--PSLK----EQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred CcccccCC--ccHH----HHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99632211 1111 1111121111 1123445667789999999999999999999999999875433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=306.08 Aligned_cols=210 Identities=25% Similarity=0.366 Sum_probs=172.6
Q ss_pred cccCCCCccccceee-EEEeCCc-cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeE
Q 045989 2 ILSQINHRNVVKLLG-CCLETEV-PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI-PIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~-~~~~~~~-~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~-~i~ 78 (295)
||++|+|||||++++ .|.+++. ++||||||++|||...++.....+..+++.++|+++.|++.||..+|...+. .|+
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 689999999999999 5665555 8999999999999999998888888899999999999999999999994321 299
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||||.|||++.+|++||+|||+++.+.... ......+|||.||+||.+.+..|+.++||||+||++|||+.-+.||.
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 99999999999999999999999999765443 33456789999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhh-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAE-KEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
. +.....-.. +..+ ...+.| .-++..+..||..|+..||+.||+...++..+..
T Consensus 230 g------~n~~~L~~K-I~qg---------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 230 G------DNLLSLCKK-IEQG---------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred c------ccHHHHHHH-HHcC---------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3 333222222 2222 122233 5577789999999999999999996666655544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=320.23 Aligned_cols=225 Identities=48% Similarity=0.783 Sum_probs=195.0
Q ss_pred cccCCCCccccceeeEEEeCC-ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|.+++|||||+++|+|.+.+ ..++|+||+++|+|.++++..... .++|.++.+|+.++|+||+|||+...++|+||
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr 201 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHR 201 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence 578999999999999999998 499999999999999999876543 68999999999999999999999987789999
Q ss_pred cCCCCeEEECCCCceEEeeccCcccccc-CcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAV-DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
||||+|||+|.+.++||+|||+|+.... ........ .||.+|+|||+...+..+.|+||||||+++.|+++|+.|...
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 9999999999999999999999975543 22211111 799999999999989999999999999999999999998876
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhh-hhhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVL-REAEK-EEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
...........|.........+.+++|+... ...+. .....+..+..+|++.+|.+||++.+|++.|+.+
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 5544445578888888888899999999876 44443 6788899999999999999999999999988544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=316.81 Aligned_cols=214 Identities=36% Similarity=0.598 Sum_probs=177.3
Q ss_pred cccCCCCccccceeeEEEeCC-ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
||.+++|||||+++|+|.+.. .++|||||+++|+|..+++.. .+..+++..+..|+.||+.|++|||+++. ||||
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHr 167 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHR 167 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeec
Confidence 678899999999999999987 799999999999999999874 22359999999999999999999999985 8999
Q ss_pred cCCCCeEEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhc--cCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 81 DIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ--SSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 81 dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
||||+||||+.++ .+||+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||++|+.||
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf 246 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF 246 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC
Confidence 9999999999997 99999999998665432 2233367999999999999 569999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhcc
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA 235 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~~ 235 (295)
...... .....+... ..+...+..++..+..++.+||..||..||++.+++..|+.+......
T Consensus 247 ~~~~~~------~~~~~v~~~---------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 247 EDLAPV------QVASAVVVG---------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCHH------HHHHHHHhc---------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 744331 112222111 122233444666799999999999999999999999999988776553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=319.77 Aligned_cols=209 Identities=31% Similarity=0.490 Sum_probs=182.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++|+|+|||+++++|..++.++||||||+.|+|.++|+.. .+..+...+.+.++.|||+|++||++++ +||||
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRD 328 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRD 328 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 689999999999999999999999999999999999999872 2335899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|.++||||+++..+||+|||+|+....+.........-+..|.|||.+....++.|+|||||||+||||+| |+.||+..
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred hhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 99999999999999999999999666555555555556789999999999999999999999999999999 99998744
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...+ +.+.+..+.+.+.|..+|..+++++..||+.+|++|||++.+...++.+..
T Consensus 409 sn~e----------------v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 409 SNEE----------------VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CHHH----------------HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 3332 344455556667788899999999999999999999999998888876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=316.79 Aligned_cols=202 Identities=24% Similarity=0.386 Sum_probs=171.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|.++|+|||||+++++|++.++.|||.|+|+.++|..++++.. .+++..++.+++||+.||.|||+++ |+|||
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~~---IiHRD 143 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRD 143 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 4678999999999999999999999999999999999998544 5999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
||..|+|++++.++||+|||+|.....+. ....+.+|||.|+|||++.....+..+||||+||++|-|+.|++||...
T Consensus 144 LKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk- 221 (592)
T KOG0575|consen 144 LKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK- 221 (592)
T ss_pred cchhheeecCcCcEEecccceeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-
Confidence 99999999999999999999998776443 3345667999999999999999999999999999999999999999633
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.....+..+.... . ..|...+.+..+||.++|+.||.+|||+++|+.|-.-
T Consensus 222 -----~vkety~~Ik~~~----Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 222 -----TVKETYNKIKLNE----Y-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----hHHHHHHHHHhcC----c-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 2222222222211 1 1223445568889999999999999999999998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=302.07 Aligned_cols=202 Identities=28% Similarity=0.430 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+.++|||||++++++..++.+|+|||||+||||..+++.+. .+++.++..++.||+.||++||+++ |+|||
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRD 134 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN---IIHRD 134 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 6899999999999999999999999999999999999999865 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCC------CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDK------YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~------~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+|||++.. ..+||+|||+|+.+.. .....+.+|++.|||||++....|+.|+|+||+|+++|++++|++
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~ 212 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKP 212 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCC
Confidence 99999999765 4689999999997763 333556789999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
||.... ..+.+..+-....+.. ..+...+..+.+++...++.+|.+|-+..+.+.+.
T Consensus 213 Pf~a~t------~~eL~~~~~k~~~~~~--------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 213 PFDAET------PKELLLYIKKGNEIVP--------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred CccccC------HHHHHHHHhccccccC--------chhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 997333 2333332222222211 22222333466788888888888887777766553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=310.10 Aligned_cols=203 Identities=24% Similarity=0.390 Sum_probs=171.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+..+|+|||++++.|..++.+|+||||++||+|.+++.... +++.++..|+.+++.||+|||.++ |+|||
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g---IiHrD 394 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG---IIHRD 394 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc---eeeec
Confidence 6889999999999999999999999999999999999998765 899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
||.+|||++.+|.+||+|||++..+..... ...+.+||++|||||++....|+++.||||||++++||+-|.+||-.
T Consensus 395 IKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-- 471 (550)
T KOG0578|consen 395 IKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-- 471 (550)
T ss_pred cccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--
Confidence 999999999999999999999876654433 45667899999999999999999999999999999999999999852
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
......++.+...+.. ....+...+..|.+++.+||+.|+.+|+++.|+|+|.-
T Consensus 472 ----E~PlrAlyLIa~ng~P--------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 472 ----ENPLRALYLIATNGTP--------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred ----CChHHHHHHHhhcCCC--------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 1111122222222211 11223445567999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=294.39 Aligned_cols=201 Identities=27% Similarity=0.383 Sum_probs=168.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||.+++||+||+++-.|++.+++|+|+||+.||.|...|++.. .+++..+.-++++|+.||.|||+.+ |+|||
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRD 150 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG---IIYRD 150 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 6788999999999999999999999999999999999998765 3999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.+|.++|+|||+++..... .....+++||+.|||||++.+..|+.++|.||||+++|||++|.+||..
T Consensus 151 lKPENILLd~~GHi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-- 227 (357)
T KOG0598|consen 151 LKPENILLDEQGHIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-- 227 (357)
T ss_pred CCHHHeeecCCCcEEEeccccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC--
Confidence 9999999999999999999999854332 2334557899999999999999999999999999999999999999963
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP----TMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp----s~~e~~~~l 226 (295)
.+...+...+.... ....+.-.+....++++++|..||++|. .+.+|-+|.
T Consensus 228 ----~~~~~~~~~I~~~k----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 228 ----EDVKKMYDKILKGK----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred ----ccHHHHHHHHhcCc----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 23333333333222 1122233445688899999999999995 666665553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=297.27 Aligned_cols=208 Identities=30% Similarity=0.433 Sum_probs=166.3
Q ss_pred cccCCCCccccceeeEEEeCC--ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETE--VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
||++++|||||+++|...... .++|+|||+++|+|.+++..... .+++..+..+..||++||+|||++| ++|
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH 140 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVH 140 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 688999999999999865554 68999999999999999987653 3999999999999999999999999 999
Q ss_pred ccCCCCeEEECC-CCceEEeeccCcccccc--CcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCC
Q 045989 80 RDIKSANILLDD-KYRAKISDFGTSRSMAV--DRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 80 ~dikp~Nill~~-~~~~kl~Dfg~a~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||||+||||+. ++.+||+|||+++.... ..........||+.|||||++.++ ....++|||||||++.||+||..
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 999999999999 79999999999986653 222224456899999999999863 23359999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
||... ......+..+.... .....+...+....+++.+|+..||++||||.++++|....
T Consensus 221 PW~~~-----~~~~~~~~~ig~~~---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 221 PWSEF-----FEEAEALLLIGRED---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred cchhh-----cchHHHHHHHhccC---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 99643 11111111111111 11133444566689999999999999999999999997543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=286.91 Aligned_cols=217 Identities=22% Similarity=0.333 Sum_probs=172.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++|+|||+|.++.+|.....+++|+|||+. ++.+.+...+.. .+...+.++++|++.|+.|+|+++ ++|||
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRD 126 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRD 126 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcC---eeccc
Confidence 68999999999999999999999999999976 666667766654 899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||||+.++.+||||||+|+.... .....+..+.|.+|.|||.+.+ ..|+.+.||||+||++.||++|.+.|+..
T Consensus 127 IKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 127 IKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred CChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 999999999999999999999997764 3344556678999999999987 68999999999999999999999999765
Q ss_pred chhhcccH-HHH-------HHHHHhhchhh------hhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSL-AAY-------FLQVINENRLF------EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~-~~~-------~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+.... ... ...+.....++ +.-.+.......+..+..+.++++.||+.||++|++.++++.|-
T Consensus 206 SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 206 SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred chHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 44332111 111 11122222221 11122222233334455789999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=300.31 Aligned_cols=201 Identities=29% Similarity=0.415 Sum_probs=169.9
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|.+| .||.|++|+--|.++..+|+|+||+++|+|.+++.+.. .|.+...+.++.||+.||+|||++| ||||
T Consensus 126 ~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G---IIHR 198 (604)
T KOG0592|consen 126 ALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG---IIHR 198 (604)
T ss_pred HHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC---ceec
Confidence 45667 99999999999999999999999999999999999875 4999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcce------------eeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTH------------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
||||+|||++.++.++|+|||.|+.+...... ....++||..|++||++.+...+..+|||+|||++|
T Consensus 199 DlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCily 278 (604)
T KOG0592|consen 199 DLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILY 278 (604)
T ss_pred cCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHH
Confidence 99999999999999999999999877532211 124578999999999999999999999999999999
Q ss_pred HHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 149 ELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 149 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
+|+.|.+||..... ...+.+++.-. -.++...++.+.+|++++|..||.+|+|+.+|-+|.
T Consensus 279 QmlaG~PPFra~Ne------yliFqkI~~l~-----------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 279 QMLAGQPPFRAANE------YLIFQKIQALD-----------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHhcCCCCCccccH------HHHHHHHHHhc-----------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 99999999974432 22233332221 122333345688999999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=290.09 Aligned_cols=213 Identities=26% Similarity=0.365 Sum_probs=169.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
.|+.++||||++++.+|..+..+|+||+||.+|++.+++......+ +.+..+..|+.++++||.|||.+| .+|||
T Consensus 77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G---~IHRd 151 (516)
T KOG0582|consen 77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNG---HIHRD 151 (516)
T ss_pred HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 4678899999999999999999999999999999999999766553 999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--e-eccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--T-TQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||+.||||+.+|.+||+|||.+-.+....... . .+++||++|||||++.. ..|+.|+||||||++..||.+|..|
T Consensus 152 vKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aP 231 (516)
T KOG0582|consen 152 VKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAP 231 (516)
T ss_pred cccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCC
Confidence 99999999999999999999876554332211 2 45689999999999643 4799999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|.....-. .+...+........ -.....+.....+..+.+++..||++||.+|||+++++++-
T Consensus 232 f~k~pPmk------vLl~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 232 FSKYPPMK------VLLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cccCChHH------HHHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 97443221 11112221111000 01111223344555799999999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=297.73 Aligned_cols=213 Identities=22% Similarity=0.333 Sum_probs=169.3
Q ss_pred ccCCC-CccccceeeEEEeCC-ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 3 LSQIN-HRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 3 l~~l~-Hpniv~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
|++|+ ||||+++.+++.+++ .+|+|||||+. +|.++++.+.. .|++..+..|++||++||+|+|++| +.||
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r---~fse~~irnim~QilqGL~hiHk~G---fFHR 134 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNR---LFSESDIRNIMYQILQGLAHIHKHG---FFHR 134 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCC---cCCHHHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 67888 999999999999887 99999999966 99999987633 6999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-cCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-SSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|+||+|||+..+..+||+|||+|+....... .+..+.|.+|+|||++. ...|+.+.||||+|||++|+.+-++.|++
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred cCChhheEecccceeEecccccccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 9999999999999999999999997754433 45567899999999875 46789999999999999999999999986
Q ss_pred cchhhcccHHHHHHHHHhhc----------------hhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 160 VETEENRSLAAYFLQVINEN----------------RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
....+... . +.+++... ..+....+......-...+.++.++|.+|+.+||.+||||.+++
T Consensus 213 ~sE~Dqi~--K-Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 213 ASEIDQIY--K-ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred CcHHHHHH--H-HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 55433211 0 00111100 00111111122222334677899999999999999999999999
Q ss_pred HHHH
Q 045989 224 LELA 227 (295)
Q Consensus 224 ~~l~ 227 (295)
+|.-
T Consensus 290 ~~pf 293 (538)
T KOG0661|consen 290 QHPF 293 (538)
T ss_pred cCcc
Confidence 9863
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=299.43 Aligned_cols=203 Identities=28% Similarity=0.404 Sum_probs=177.2
Q ss_pred cccCCCCccccceeeEEEeCCc-cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEV-PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~-~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++|||||.+.++|..++. ++|||+||+||++.+.+..+. +..+++..++.|+.|++.|+.|||++. |+||
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHR 130 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHR 130 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcc
Confidence 5788999999999999999988 999999999999999998766 446999999999999999999999988 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+.|||++.++.++|+|||+|+.+.... ....+..||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...
T Consensus 131 DlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 131 DLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred cchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 999999999999999999999999877654 2355678999999999999999999999999999999999999999633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
+......++ ......+.+..++.++..+++.||+.+|..||++.+++.+.
T Consensus 210 ------~m~~Li~ki----------~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 210 ------NMSELILKI----------NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ------chHHHHHHH----------hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 222222222 22234566778888899999999999999999999999984
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=303.53 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=174.2
Q ss_pred CcccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 1 ~il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+||+-+.||||++++++++++.++|+|.||++||.|++++-.+. ++++..+.+++.||+.|+.|+|..+ |+||
T Consensus 64 viMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~---icHR 136 (786)
T KOG0588|consen 64 VIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN---ICHR 136 (786)
T ss_pred HHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc---ceec
Confidence 46788899999999999999999999999999999999998765 4999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCC-CCccchhhHHHHHHHHhCCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|+||+|+|++..+++||+|||.|..-. .....++.+|.+.|.|||++.|..|. .++||||.|||||.|++|+.||+
T Consensus 137 DLKpENlLLd~~~nIKIADFGMAsLe~--~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd- 213 (786)
T KOG0588|consen 137 DLKPENLLLDVKNNIKIADFGMASLEV--PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD- 213 (786)
T ss_pred cCCchhhhhhcccCEeeeccceeeccc--CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-
Confidence 999999999999999999999997433 33456677899999999999999985 79999999999999999999996
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
+..+...+.++.. +. -++|...+.++++|+.+||..||.+|.|++||++|.+-.
T Consensus 214 -----DdNir~LLlKV~~-G~----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 214 -----DDNIRVLLLKVQR-GV----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred -----CccHHHHHHHHHc-Cc----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 3333333332222 21 144566677799999999999999999999999998653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=275.65 Aligned_cols=235 Identities=25% Similarity=0.311 Sum_probs=191.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|.+.|+|||||++++.+.+....|||+|+++|++|..-+-.+ +.+++..+-+++.||++||.|+|.++ |||||
T Consensus 63 IC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRD 135 (355)
T KOG0033|consen 63 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRD 135 (355)
T ss_pred HHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 457899999999999999999999999999999997766544 24899999999999999999999999 99999
Q ss_pred CCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||+|+++.. ...+||+|||+|.... .......+.|||.|||||++...+|+..+|||+.||+||-|+.|++||.
T Consensus 136 vkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 136 LKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred CChhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 9999999953 4579999999999776 3344556789999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhccchh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASVL 238 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~~~~~ 238 (295)
.- +....+.++....-- ..........++..+|+++||..||.+|.|+.|.++|.|-..+..-...+
T Consensus 214 ~~------~~~rlye~I~~g~yd-------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~ 280 (355)
T KOG0033|consen 214 DE------DQHRLYEQIKAGAYD-------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAI 280 (355)
T ss_pred Cc------cHHHHHHHHhccccC-------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHh
Confidence 32 222233333222110 01112223445688899999999999999999999999998888888888
Q ss_pred hccccccccccCCCCcccCC
Q 045989 239 RQCEEIDFVNYDNARHFKTG 258 (295)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~ 258 (295)
+..+.++....++++..-.|
T Consensus 281 H~~dtvd~lrkfNarRKLKg 300 (355)
T KOG0033|consen 281 HRQDTVDCLKKFNARRKLKG 300 (355)
T ss_pred hhHHHHHHHHHhhHHHHHHH
Confidence 88888888777777654444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=297.11 Aligned_cols=204 Identities=25% Similarity=0.369 Sum_probs=171.0
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++ ||||+++++++......++|||||.||+|.+++.... .+.+..+..++.|++.|++|+|++| |+||
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g---i~HR 144 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG---IVHR 144 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC---EeeC
Confidence 577888 9999999999999999999999999999999998733 4889999999999999999999999 9999
Q ss_pred cCCCCeEEECCC-CceEEeeccCccccccCcceeeeccccccCCCChhhhccCC-CC-CCccchhhHHHHHHHHhCCCCC
Q 045989 81 DIKSANILLDDK-YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FT-EKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 81 dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~el~~g~~p~ 157 (295)
||||+||+++.+ +++||+|||++.... .......+..||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||
T Consensus 145 DLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF 223 (370)
T KOG0583|consen 145 DLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF 223 (370)
T ss_pred CCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence 999999999999 999999999998664 2334566778999999999999977 86 7899999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEE-VITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
.. ......+..+.... + ..+... +..+..++.+||..||.+|+|+.++++|.|-..
T Consensus 224 ~d------~~~~~l~~ki~~~~-~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 224 DD------SNVPNLYRKIRKGE-F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CC------ccHHHHHHHHhcCC-c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 73 22223333222211 1 111222 556899999999999999999999998888765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=310.96 Aligned_cols=211 Identities=30% Similarity=0.527 Sum_probs=180.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC----------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED----------QLPITWEIRLGIAVEVSGALSYLHS 71 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~Lh~ 71 (295)
+|..++|||||+++|+|.+++.+++|+|||..|||.++|.....+ +.+++..+.+.|+.|||.|++||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 578899999999999999999999999999999999999754211 2238899999999999999999999
Q ss_pred CCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeee-ccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 72 AASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT-QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 72 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
+. +|||||..+|+||.++..+||+|||+++..-........ ...-..+|||||.+..++|+.++||||+||+|||+
T Consensus 622 ~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 622 HH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred Cc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 99 999999999999999999999999999976554443332 44567899999999999999999999999999999
Q ss_pred Hh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 151 LT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 151 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
++ |..||......+ +.+.+..+...+.+..+|.+++.|+..||+.+|.+||+++||-..|...
T Consensus 699 FsyG~QPy~glSn~E----------------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 699 FSYGKQPYYGLSNQE----------------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred hccccCcccccchHH----------------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 99 999986544333 3344444455677888999999999999999999999999999999776
Q ss_pred HH
Q 045989 230 RA 231 (295)
Q Consensus 230 ~~ 231 (295)
..
T Consensus 763 ~~ 764 (774)
T KOG1026|consen 763 AQ 764 (774)
T ss_pred Hh
Confidence 44
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=299.23 Aligned_cols=203 Identities=30% Similarity=0.527 Sum_probs=174.3
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|++|+||||+.+.|+|...--+|||||||..|-|..+|+... .+.......|..+|+.|+.|||.+. |+||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDL 238 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDL 238 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh---Hhhhcc
Confidence 688999999999999999999999999999999999998765 4888999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
|.-||||+.+..+||+|||.++..... .....+.||..|||||++.+.+.++|.|||||||+||||+||..||.....
T Consensus 239 KSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 239 KSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred CCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 999999999999999999998865433 223456799999999999999999999999999999999999999864322
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
. +. ++-+-........+..++.-|.-|++.||+..|+.||++++++.||+-.
T Consensus 317 s------AI---------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 317 S------AI---------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred h------ee---------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 1 11 1111122334456667778899999999999999999999999999654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=268.50 Aligned_cols=187 Identities=28% Similarity=0.421 Sum_probs=161.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+.+.||+++++++.|.+.+.+||||||.+||.|.+++++.. .+++..++-++.||+.||+|||+.+ |++||
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~---iiYRD 169 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLD---IIYRD 169 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 6889999999999999999999999999999999999998765 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
+||+|||+|.+|.+||+|||+|+..... +.+.+|||.|+|||++....|+.++|.|||||++|||+.|.+||....
T Consensus 170 LKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 170 LKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred CChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 9999999999999999999999865432 566789999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
. ...+..+.... -.+|.-.+..+.+|++++|+.|-.+|
T Consensus 246 ~------~~iY~KI~~~~-----------v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 246 P------IQIYEKILEGK-----------VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred h------HHHHHHHHhCc-----------ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2 22222222221 12334444568899999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=285.77 Aligned_cols=218 Identities=24% Similarity=0.300 Sum_probs=172.4
Q ss_pred CcccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 1 IILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 1 ~il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
.||++|+||||+++.+...+. +.+|+|+|||++ ||.-++....- .|++.++..++.|++.||+|+|.+| |+
T Consensus 168 ~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~g---vl 240 (560)
T KOG0600|consen 168 KILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSRG---VL 240 (560)
T ss_pred HHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhcC---ee
Confidence 379999999999999999887 689999999976 99999876443 4999999999999999999999999 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCC
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||.+|||||.+|++||+|||+|+.+........+..+-|.+|.|||.+.+. .|+.+.|+||.|||+.||+.|++.|
T Consensus 241 HRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 241 HRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred eccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 999999999999999999999999998877766667777889999999999875 7999999999999999999999998
Q ss_pred cccchhhcccHHH--------HHHHHHhhchhhhhhhh-----hhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 158 RLVETEENRSLAA--------YFLQVINENRLFEVLDA-----QVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 158 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
+.....+.....- -.|...+ -.....+.+ +...+.....+....+|+..+|..||.+|.||.+++.
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~~~k-LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWPVSK-LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhcccccc-CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 7554332211100 0011000 000011111 1122223344566889999999999999999999988
Q ss_pred HH
Q 045989 225 EL 226 (295)
Q Consensus 225 ~l 226 (295)
.-
T Consensus 400 se 401 (560)
T KOG0600|consen 400 SE 401 (560)
T ss_pred Cc
Confidence 64
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=290.63 Aligned_cols=201 Identities=26% Similarity=0.385 Sum_probs=171.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+++++||.++|+.+..+..+|++||||.||++.+.+.... .+.+..+..++.+++.||.|||.++ .+|||
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrD 136 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK---KIHRD 136 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc---eeccc
Confidence 5788999999999999999999999999999999999998654 2478888889999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
||+.||++..+|.+||+|||++-........ ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....
T Consensus 137 IKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 137 IKAANILLSESGDVKLADFGVAGQLTNTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred ccccceeEeccCcEEEEecceeeeeechhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 9999999999999999999998766544333 367889999999999999899999999999999999999999985322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
. .++...+...........++..+.+++..||++||+.||+|.++++|-
T Consensus 216 P----------------mrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 216 P----------------MRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred c----------------ceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 2 223333333333344446777799999999999999999999999873
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=267.65 Aligned_cols=206 Identities=29% Similarity=0.447 Sum_probs=170.2
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
||+++ .||+|+++.++++++..+++|+|.|+.|.|.+++.... .+++.....|+.|+.+|++|||.++ ||||
T Consensus 75 ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~~---IVHR 147 (411)
T KOG0599|consen 75 ILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHARN---IVHR 147 (411)
T ss_pred HHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHhh---hhhc
Confidence 46665 89999999999999999999999999999999998765 4999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc------CCCCCCccchhhHHHHHHHHhCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS------SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~ 154 (295)
||||+|||++++.+++|+|||+++.+.. .......+|||+|+|||.+.. ..|+...|+|++||++|.++.|.
T Consensus 148 DLKpENILlddn~~i~isDFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 148 DLKPENILLDDNMNIKISDFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred ccChhheeeccccceEEeccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999986543 334556789999999999854 46889999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
+||..-.+ . .+.+.+-.+.. +...+...+.+....+||.+||+.||.+|.|++|++.|.+-.
T Consensus 226 pPFwHRkQ------m-lMLR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 226 PPFWHRKQ------M-LMLRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred CchhHHHH------H-HHHHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 99852111 1 11222222211 112233455667789999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.34 Aligned_cols=211 Identities=29% Similarity=0.473 Sum_probs=163.3
Q ss_pred cccCC-CCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCCC---------------------------------
Q 045989 2 ILSQI-NHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTED--------------------------------- 46 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~--------------------------------- 46 (295)
+|+++ +||||+++++++... ...++||||+++|+|.+++......
T Consensus 63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (338)
T cd05102 63 ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQA 142 (338)
T ss_pred HHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccC
Confidence 35566 899999999998764 4689999999999999999753211
Q ss_pred -------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 47 -------------------------QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 47 -------------------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG 219 (338)
T cd05102 143 SVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFG 219 (338)
T ss_pred CccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecc
Confidence 134788889999999999999999999 9999999999999999999999999
Q ss_pred CccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhc
Q 045989 102 TSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINEN 179 (295)
Q Consensus 102 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 179 (295)
+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+ .+.......
T Consensus 220 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~ 293 (338)
T cd05102 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDG 293 (338)
T ss_pred cccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcC
Confidence 99765332221 1222345678999999998899999999999999999997 999986432211 111111111
Q ss_pred hhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
. ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 294 ~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 294 T---------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred C---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 01112234456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=279.63 Aligned_cols=203 Identities=22% Similarity=0.408 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~ 76 (295)
+|++++||||+++++++.+ ....++||||+++|+|.+++.... .+++.....++.|++.||.|||+. +
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~--- 143 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN--- 143 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC---
Confidence 5789999999999999977 347899999999999999997643 488999999999999999999985 6
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~ 154 (295)
++||||||+||+++.++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred CCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence 8899999999999999999999999987543221 23457899999999976 67899999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
.||...... .....+..... ....+...+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus 220 ~Pf~~~~~~------~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 220 IPFENLTTK------EIYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCHH------HHHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 999743221 11221111110 11122234567999999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.73 Aligned_cols=214 Identities=26% Similarity=0.466 Sum_probs=178.9
Q ss_pred CcccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT---EDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 1 ~il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
++|+.++|||||+++|++......+|++|||+||||..+|+..+ .....++....+.++.|||+|+.||++++ +
T Consensus 747 ~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---f 823 (1025)
T KOG1095|consen 747 LLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---F 823 (1025)
T ss_pred HHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---C
Confidence 47899999999999999999999999999999999999998651 22335889999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcceeeecc-ccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV-KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQK 155 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~ 155 (295)
|||||..+|+||+....+||+|||+|+.+........... .-...|||||.+....++.|+|||||||++||+++ |..
T Consensus 824 vHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~ 903 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGAT 903 (1025)
T ss_pred cCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999995543333322222 44679999999999999999999999999999999 999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
||+..... ..+......+ +.+.|..++..++++|..||+.+|++||++..|++.+..+....
T Consensus 904 PY~~~~n~------~v~~~~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 904 PYPSRSNF------EVLLDVLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCCcchH------HHHHHHHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 99744332 2222222222 44667788889999999999999999999999999887765544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=298.49 Aligned_cols=205 Identities=26% Similarity=0.354 Sum_probs=167.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++..++..|+||||++||+|.+++........++++..+..++.||+.||+|||+.+ |+|||
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrD 194 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRD 194 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECC
Confidence 477899999999999999999999999999999999998765444456899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 195 lkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543222 1233456899999999999999999999999999999999999998632
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.. ...+....... ....+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 275 ~~------~~~~~~~~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 275 SQ------REIMQQVLYGK----------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CH------HHHHHHHHhCC----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 21 11222211111 111222344568999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=286.77 Aligned_cols=199 Identities=28% Similarity=0.430 Sum_probs=172.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++++|||||.++++|+...++|+|.|||.| +|+.++.... .++++.+..++++++.||.|||+.+ |+|||
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd 125 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRD 125 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 68899999999999999999999999999976 9999998755 3999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
+||.||+++..+.+|++|||+|+.+... ........|||.|||||++.+..|+..+|+||+||++||+++|++||-
T Consensus 126 ~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--- 201 (808)
T KOG0597|consen 126 MKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--- 201 (808)
T ss_pred CCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch---
Confidence 9999999999999999999999987654 344556789999999999999999999999999999999999999985
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..++......+..... ..+...+..+..++..+|.+||..|.|..+++.|.
T Consensus 202 ---a~si~~Lv~~I~~d~v-----------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 202 ---ARSITQLVKSILKDPV-----------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ---HHHHHHHHHHHhcCCC-----------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 3333333333332211 22335566799999999999999999999999885
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.12 Aligned_cols=201 Identities=23% Similarity=0.315 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrD 120 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 4678999999999999999999999999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 9999999999999999999998753222 122334569999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.. .....+.... ...+...+..+.+++.+||+.||++|| ++.++++|.+
T Consensus 200 ~~------~~~~~~~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 200 HE------KLFELILMEE-----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HH------HHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 21 1111111110 012223455688999999999999999 8999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=280.87 Aligned_cols=208 Identities=27% Similarity=0.354 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
||++|+|||||+++.+..+ .+.+|||+|||..|.+...-. .+.-+++.++++++.+++.||+|||.++ |+|
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiH 233 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIH 233 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eec
Confidence 7899999999999999986 468999999999887654332 2223899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccC----cceeeeccccccCCCChhhhccCC----CCCCccchhhHHHHHHHH
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVD----RTHLTTQVKGTFGYLDPEYFQSSQ----FTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~ 151 (295)
|||||+|+||+.+|.+||+|||.+..+... .........|||.|+|||.+.++. .+.+.||||+||+||.|+
T Consensus 234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 999999999999999999999998765221 111223357999999999987632 357899999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
.|+.||. +......+..+.+..-. -+-..+....+.+||++||++||..|.+..+|..|+|....
T Consensus 314 fG~~PF~------~~~~~~l~~KIvn~pL~---------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 314 FGQLPFF------DDFELELFDKIVNDPLE---------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hccCCcc------cchHHHHHHHHhcCccc---------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999995 33333344444433211 11112345568999999999999999999999999987654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.13 Aligned_cols=205 Identities=21% Similarity=0.381 Sum_probs=163.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 59 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~~---iiH~d 132 (266)
T cd05064 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEMG---YVHKG 132 (266)
T ss_pred HHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 46788999999999999999999999999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++++|||.+...............++..|+|||.+.+..++.++|||||||++|++++ |..||...
T Consensus 133 ikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 133 LAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999999876543222111222335678999999999999999999999999999875 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...+ ..... ... .....+...+..+.+++.+||+.+|.+||++.+|++.|..
T Consensus 213 ~~~~------~~~~~-~~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 213 SGQD------VIKAV-EDG---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CHHH------HHHHH-HCC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 2221 11111 111 0111233455668999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=258.70 Aligned_cols=216 Identities=23% Similarity=0.266 Sum_probs=168.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++||||+.++++|.+.+.+.+|+||++. +|+.+++.... .++...+..++.++++||+|+|+++ |+|||
T Consensus 54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRD 126 (318)
T KOG0659|consen 54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSKW---ILHRD 126 (318)
T ss_pred HHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhhh---hhccc
Confidence 47889999999999999999999999999966 99999986544 5999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||.|+|++.+|.+||+|||+|+.+......... .+-|.+|.|||.+.|. .|+...||||.||++.||+-|.+-|+..
T Consensus 127 lKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 127 LKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred CCccceEEcCCCcEEeecccchhccCCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 9999999999999999999999988765444333 3679999999998774 7999999999999999999887766544
Q ss_pred chhhcccHHHHHHHHHhh--------chhh-----hhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINE--------NRLF-----EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.+.+.. ...+.....+ ..+. ...............+....+++..||..||.+|+|+.|+++|-.
T Consensus 206 sDidQL--~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 206 SDIDQL--SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred chHHHH--HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 332211 1111110000 0000 011111112233345556799999999999999999999998864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.59 Aligned_cols=218 Identities=20% Similarity=0.218 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||++++.+..+... .. .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~---~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 125 (287)
T cd07848 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PN---GVPPEKVRSYIYQLIKAIHWCHKND---IVHRD 125 (287)
T ss_pred HHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc-CC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 46789999999999999999999999999988766554432 22 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++...............|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 126 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998654333222334568999999999998889999999999999999999999997543
Q ss_pred hhhcccHHHH---------HHHHHhhchhhhhhhh------hhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAY---------FLQVINENRLFEVLDA------QVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..+....... ...............+ ..........+..+.+++.+||+.||++|||++++++|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 2211000000 0000000000000000 000011122456799999999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=277.86 Aligned_cols=204 Identities=24% Similarity=0.346 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||....+|+||+++-+|.+..++|+||||++|||+..+|.... .+++..+..++.+++.|++-||+.| ++|||
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRD 266 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG---YIHRD 266 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 4556889999999999999999999999999999999998766 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccC-----------------------cce----e-------------------ee
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVD-----------------------RTH----L-------------------TT 115 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~-----------------------~~~----~-------------------~~ 115 (295)
|||+|+|||.+|.+||+|||++..+... ... . ..
T Consensus 267 IKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 267 IKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred CChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 9999999999999999999998533210 000 0 00
Q ss_pred ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH
Q 045989 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK 195 (295)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (295)
..+|||.|+|||++.+..|+..+|.||||||+|||+.|.+||..... ......+.+-...... +...
T Consensus 347 StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp------~~T~rkI~nwr~~l~f-------P~~~ 413 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETP------QETYRKIVNWRETLKF-------PEEV 413 (550)
T ss_pred cccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhhhccC-------CCcC
Confidence 14699999999999999999999999999999999999999963322 2222222222111111 1112
Q ss_pred HHHHHHHHHHHHhhccCCCCCC---CHHHHHHHH
Q 045989 196 EEVITVAMVAKRCLNLNGKKRP---TMKEVALEL 226 (295)
Q Consensus 196 ~~~~~~~~li~~cl~~~p~~Rp---s~~e~~~~l 226 (295)
..+.+..+||.+||. ||++|. .+.||-+|.
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 233568899999999 999995 688888876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=272.99 Aligned_cols=208 Identities=27% Similarity=0.491 Sum_probs=166.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
+|++++||||+++++++...+..+++|||+++|+|.+++...... ...+++..++.++.|++.||+||
T Consensus 61 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l 140 (283)
T cd05048 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999999999999999999754211 13478899999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
|+.+ ++|+||||+||+++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|
T Consensus 141 H~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ 217 (283)
T cd05048 141 SSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217 (283)
T ss_pred HhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence 9999 99999999999999999999999999875433221 1223335678899999998888999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||++ |..||......+ .... +. .......+...+..+.+++.+||+.||++||++.+|+++|+
T Consensus 218 el~~~g~~p~~~~~~~~------~~~~-i~---------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 218 EIFSYGLQPYYGFSNQE------VIEM-IR---------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHHcCCCCCCCCCCHHH------HHHH-HH---------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 9998 999986432211 1111 11 11111233455677999999999999999999999999986
Q ss_pred H
Q 045989 228 G 228 (295)
Q Consensus 228 ~ 228 (295)
.
T Consensus 282 ~ 282 (283)
T cd05048 282 S 282 (283)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=269.09 Aligned_cols=207 Identities=27% Similarity=0.447 Sum_probs=165.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 129 (263)
T cd05052 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 129 (263)
T ss_pred HHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecc
Confidence 46789999999999999999999999999999999999875432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 130 lkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred cCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999987654332222222234667999999998899999999999999999998 89998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
...+ ........ .....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 210 ~~~~------~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 210 DLSQ------VYELLEKG----------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHHH------HHHHHHCC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2221 11111110 01112223456699999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=270.45 Aligned_cols=200 Identities=25% Similarity=0.384 Sum_probs=170.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+.|+||||+.++.+|+..+...|||||..+|.|++++.... .+++..+.+++.||..|+.|+|+++ ++|||
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr---VvHRD 178 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNR---VVHRD 178 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc---ceecc
Confidence 7899999999999999999999999999999999999998766 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCC-CCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||.+|||+|.++++||+|||++..+... ....+++|++-|.+||++.+..|. +..|-|||||+||.|+.|..||+.
T Consensus 179 LKLENILLD~N~NiKIADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG- 255 (668)
T KOG0611|consen 179 LKLENILLDQNNNIKIADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG- 255 (668)
T ss_pred cchhheeecCCCCeeeeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-
Confidence 9999999999999999999999766533 335678899999999999999885 789999999999999999999973
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.+....+.++ ..+.+.+.-.+ ....-||++||-.||++|.|+.+|..|.|.
T Consensus 256 -----~Dhk~lvrQI-s~GaYrEP~~P-----------SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 256 -----RDHKRLVRQI-SRGAYREPETP-----------SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----chHHHHHHHh-hcccccCCCCC-----------chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 3333333333 22333332222 235669999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=277.68 Aligned_cols=201 Identities=25% Similarity=0.292 Sum_probs=163.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrD 118 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN---VIYRD 118 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 4678899999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999987532221 22334568999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP---TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~e~~~~l~ 227 (295)
. ........... ...+...+..+.+++.+||+.||.+|| ++.+++.|.+
T Consensus 198 ~------~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 198 V------NEMYRKILQEP-----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred H------HHHHHHHHcCC-----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 1 12222221111 112223445688999999999999997 5788887754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.56 Aligned_cols=219 Identities=22% Similarity=0.266 Sum_probs=163.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+...++|+|++ +++|..++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrD 207 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR---IIHRD 207 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 578999999999999999999999999999 568988886543 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~ 287 (391)
T PHA03212 208 IKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287 (391)
T ss_pred CChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcc
Confidence 99999999999999999999987543222222334579999999999999899999999999999999999998864322
Q ss_pred hhhcc-cHHHHHHHHHhh---c----------hhhhhh---------hhhhh--hhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 162 TEENR-SLAAYFLQVINE---N----------RLFEVL---------DAQVL--REAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 162 ~~~~~-~~~~~~~~~~~~---~----------~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
..+.. .....+..+... . .+.... .+... .......+..+.+++.+||+.||.+|
T Consensus 288 ~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~R 367 (391)
T PHA03212 288 GLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367 (391)
T ss_pred cccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhC
Confidence 11110 001111111000 0 000000 00000 00112345678999999999999999
Q ss_pred CCHHHHHHHHHH
Q 045989 217 PTMKEVALELAG 228 (295)
Q Consensus 217 ps~~e~~~~l~~ 228 (295)
||++|+++|.+-
T Consensus 368 pta~elL~hp~f 379 (391)
T PHA03212 368 PSAEALLDFAAF 379 (391)
T ss_pred CCHHHHhcChhh
Confidence 999999998763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=275.99 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=164.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+++..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++ ++|||
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 126 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE---IVYRD 126 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 5788999999999999999999999999999999999997643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 127 lkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 127 LKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred CCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998755322 223468999999999999889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
. ......+.... ...+...+..+.+++++||+.||.+||+ +.++++|.+-
T Consensus 203 ~------~~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 203 P------FGIYEKILAGK-----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred H------HHHHHHHHhCC-----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 2 11122111111 0112223456889999999999999995 9999988754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.07 Aligned_cols=216 Identities=28% Similarity=0.416 Sum_probs=165.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+. |+|||
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~d 129 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRD 129 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCC
Confidence 4678999999999999999999999999999999999997643 38999999999999999999998532 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 130 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred CChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998754322 1233468999999999999899999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhh------------------------------chhhhhhhh----hhhhhhhHHHHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINE------------------------------NRLFEVLDA----QVLREAEKEEVITVAMVAKR 207 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~----~~~~~~~~~~~~~~~~li~~ 207 (295)
..+ ....+...... .......+. ..........+..+.+++.+
T Consensus 207 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (331)
T cd06649 207 AKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK 283 (331)
T ss_pred HHH---HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH
Confidence 211 10000000000 000000000 00000011245678999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHh
Q 045989 208 CLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 208 cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
||+.||++|||++++++|.+-.
T Consensus 284 ~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 284 CLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred HccCCcccCCCHHHHhcChHHh
Confidence 9999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=278.30 Aligned_cols=200 Identities=24% Similarity=0.350 Sum_probs=159.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++...+..++||||++||+|...+.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~D 121 (321)
T cd05603 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSLN---IIYRD 121 (321)
T ss_pred HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 4678899999999999999999999999999999998886533 4888999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 122 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 122 LKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 99999999999999999999987532221 22334568999999999998899999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH----HHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK----EVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~----e~~~~l 226 (295)
.......+.... ...+...+..+.+++.+||+.+|.+||++. +++++.
T Consensus 201 ------~~~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 201 ------VSQMYDNILHKP-----------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred ------HHHHHHHHhcCC-----------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 112222221110 111223345688999999999999998764 555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=269.12 Aligned_cols=205 Identities=26% Similarity=0.352 Sum_probs=168.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+.++||.++.+|..|+.++..|+|||||+||+|..++++++.+ .++++.++-++.+|+.||+|||..| ||+||
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~--~fse~~aRFYaAEvl~ALEYLHmlG---ivYRD 204 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGK--RFSESAARFYAAEVLLALEYLHMLG---IVYRD 204 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCC--ccchhhHHHHHHHHHHHHHHHHhhc---eeecc
Confidence 688999999999999999999999999999999999999987766 5899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccC----------------------------------cc----------------
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVD----------------------------------RT---------------- 111 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~----------------------------------~~---------------- 111 (295)
|||+||||.++|.+-|+||.++...... ..
T Consensus 205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9999999999999999999976433110 00
Q ss_pred -----eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhh
Q 045989 112 -----HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLD 186 (295)
Q Consensus 112 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (295)
.....++||-.|+|||++.+..-+.+.|.|+|||++|||+.|..||......+ .+..++.....
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~------Tl~NIv~~~l~----- 353 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE------TLRNIVGQPLK----- 353 (459)
T ss_pred cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh------hHHHHhcCCCc-----
Confidence 01122579999999999999999999999999999999999999998544332 23333332211
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHHH
Q 045989 187 AQVLREAEKEEVITVAMVAKRCLNLNGKKRPT----MKEVALEL 226 (295)
Q Consensus 187 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~~~~l 226 (295)
. ......+.++.+||+++|.+||.+|.. +.||-+|.
T Consensus 354 ---F-p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 354 ---F-PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred ---C-CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 1 111245567999999999999999998 88887774
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=279.36 Aligned_cols=199 Identities=24% Similarity=0.319 Sum_probs=163.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 143 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRD 143 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 5678999999999999999999999999999999999997643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 144 LKPENLLLDNKGHVKVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred CCHHHEEECCCCCEEEeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999987553321 23468999999999999999999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
. ......+.... . ..+...+..+.+++.+||+.||.+||+ +.+++.|.+-
T Consensus 220 ~------~~~~~~i~~~~-~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 220 P------FRIYEKILAGR-L----------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred H------HHHHHHHhcCC-c----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 1 11112211111 0 111223345889999999999999986 7999888653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=277.57 Aligned_cols=201 Identities=24% Similarity=0.314 Sum_probs=164.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..|+||||+++|+|.+++.... .+.+..+..++.|++.||+|||+.+ |+|||
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG---IIYRD 125 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 5788999999999999999999999999999999999987543 4788899999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 126 LKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred CCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999987533222 12233468999999999998889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.. .....+.... ...+...+..+.+++.+||+.+|++|| ++.+++.|.+
T Consensus 205 ~~------~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 205 RK------KTIDKILKGK-----------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HH------HHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 21 1122221111 011222345688999999999999999 8999988764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.22 Aligned_cols=212 Identities=25% Similarity=0.457 Sum_probs=169.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
++++++||||+++++++......++||||+++++|.+++..... ....+++..++.++.||+.||+||
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 139 (291)
T cd05094 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL 139 (291)
T ss_pred HHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999999999999999975431 123488999999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
|+++ ++||||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|
T Consensus 140 H~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 216 (291)
T cd05094 140 ASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216 (291)
T ss_pred HhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHH
Confidence 9999 99999999999999999999999999875543221 1122345678899999999889999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+|++ |..||......+ .. ........ ...+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 217 el~t~g~~p~~~~~~~~------~~-~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 217 EIFTYGKQPWFQLSNTE------VI-ECITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHHhCCCCCCCCCCHHH------HH-HHHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 9998 999986433221 11 11111111 1112234456899999999999999999999999998
Q ss_pred HhHHh
Q 045989 228 GIRAS 232 (295)
Q Consensus 228 ~~~~~ 232 (295)
.+...
T Consensus 281 ~~~~~ 285 (291)
T cd05094 281 ALGKA 285 (291)
T ss_pred HHHhh
Confidence 87553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=277.94 Aligned_cols=201 Identities=24% Similarity=0.329 Sum_probs=163.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 120 (328)
T cd05593 48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRD 120 (328)
T ss_pred HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 4678899999999999999999999999999999998886543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 99999999999999999999987532221 12234568999999999998899999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.. .....+.... ...+...+..+.+++.+||+.||++|| ++.++++|.+
T Consensus 200 ~~------~~~~~~~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 200 HE------KLFELILMED-----------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred HH------HHHHHhccCC-----------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 21 1111111110 011223345688999999999999997 8999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=278.40 Aligned_cols=206 Identities=21% Similarity=0.314 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.+ ++|||
T Consensus 54 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 126 (333)
T cd05600 54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG---YIHRD 126 (333)
T ss_pred HHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999999999997543 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 127 lkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 127 LKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred CCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 999999999999999999999875432 2234568999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..+ ....+...... +............+..+.+++.+||..+|.+||++.++++|.+
T Consensus 203 ~~~------~~~~i~~~~~~---~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 203 PNE------TWENLKYWKET---LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred HHH------HHHHHHhcccc---ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 221 11111111000 0000000001233556889999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.09 Aligned_cols=212 Identities=25% Similarity=0.448 Sum_probs=168.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT---------EDQLPITWEIRLGIAVEVSGALSYLHSA 72 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~Lh~~ 72 (295)
+|++++||||+++++++...+..++||||+++++|.+++.... .....+++..++.++.|++.||+|||++
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~ 139 (288)
T cd05093 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139 (288)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999999999999999999997543 1223489999999999999999999999
Q ss_pred CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 73 ~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
+ ++||||||+||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|+
T Consensus 140 ~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 216 (288)
T cd05093 140 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216 (288)
T ss_pred C---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 9 99999999999999999999999999875533221 1122334577899999999888999999999999999999
Q ss_pred h-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 152 T-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
+ |..||...... .....+... .. ...+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 217 t~g~~p~~~~~~~------~~~~~i~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 217 TYGKQPWYQLSNN------EVIECITQG-RV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred hCCCCCCCCCCHH------HHHHHHHcC-Cc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 8 89998533221 111111111 11 0111123456899999999999999999999999998876
Q ss_pred Hh
Q 045989 231 AS 232 (295)
Q Consensus 231 ~~ 232 (295)
..
T Consensus 281 ~~ 282 (288)
T cd05093 281 KA 282 (288)
T ss_pred Hh
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=271.53 Aligned_cols=207 Identities=25% Similarity=0.294 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|..++..... ..+++..++.++.|++.||+|||+.+ |+|||
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER---IVYRD 127 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 56789999999999999999999999999999999988864332 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 128 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 128 LKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987643221 2234568999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
.... .......... .....+...+..+.+|+.+||+.||.+||+ +.++++|.+-
T Consensus 206 ~~~~---~~~~~~~~~~----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 206 ERVK---REEVDRRVKE----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred cchh---HHHHHHHhhc----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 2110 0011111100 011122234556889999999999999997 8999988653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=281.37 Aligned_cols=210 Identities=27% Similarity=0.486 Sum_probs=163.7
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-----------------------------------
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE----------------------------------- 45 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~----------------------------------- 45 (295)
+|+.+ +||||+++++++...+..++|||||++|+|.+++.....
T Consensus 94 il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (374)
T cd05106 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF 173 (374)
T ss_pred HHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccc
Confidence 45677 899999999999999999999999999999999864321
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCc
Q 045989 46 -------------------------------DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYR 94 (295)
Q Consensus 46 -------------------------------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~ 94 (295)
....+++..++.++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~ 250 (374)
T cd05106 174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRV 250 (374)
T ss_pred cccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCe
Confidence 1124788899999999999999999999 999999999999999999
Q ss_pred eEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHH
Q 045989 95 AKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYF 172 (295)
Q Consensus 95 ~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 172 (295)
+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 251 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~ 324 (374)
T cd05106 251 AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KF 324 (374)
T ss_pred EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HH
Confidence 9999999987654332211 222335678999999988899999999999999999997 999986432211 01
Q ss_pred HHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....... .....+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 325 ~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 325 YKMVKRG---------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHcc---------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 00011112345689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.49 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++||||+++++++...+..++||||+.+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 156 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRD 156 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccC
Confidence 5678999999999999999999999999999999999997643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 157 Lkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 157 LKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 9999999999999999999999765322 234468999999999998889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
.. .....+.... . ..+...+..+.+++++||+.||.+|+ +++++++|.+-
T Consensus 233 ~~------~~~~~i~~~~-~----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 233 PL------LIYQKILEGI-I----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred HH------HHHHHHhcCC-C----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 11 1112221111 0 11222334578899999999999995 89999988653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=281.23 Aligned_cols=206 Identities=24% Similarity=0.331 Sum_probs=168.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||..++||+||++++.|...+.+||+.|||.||-+..++-.-.. .+.+.++..+++|++.||.|||++. |+|||
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~~---iIHRD 155 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQN---IIHRD 155 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhcc---hhhhh
Confidence 68899999999999999999999999999999999888765433 5999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||+.|||++-+|.++|+|||.+-... ........+.|||+|||||++. +.+|+.++||||||+.|.||..+.+|
T Consensus 156 LKAGNiL~TldGdirLADFGVSAKn~-~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP 234 (1187)
T KOG0579|consen 156 LKAGNILLTLDGDIRLADFGVSAKNK-STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP 234 (1187)
T ss_pred ccccceEEEecCcEeeecccccccch-hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence 99999999999999999999875432 2234456788999999999874 46899999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ...-..+..+.... | .-...|..++..|.+++++||.+||+.||++.++++|.+.
T Consensus 235 Hhe------lnpMRVllKiaKSe-------P-PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 235 HHE------LNPMRVLLKIAKSE-------P-PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred ccc------cchHHHHHHHhhcC-------C-CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 641 11222222222211 0 0112355677789999999999999999999999998754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=276.93 Aligned_cols=201 Identities=25% Similarity=0.319 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|..++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 120 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 5678999999999999999999999999999999998887543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987532221 12234568999999999998899999999999999999999999986432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.. .......... ...+...+..+.+++.+||+.||.+|| ++.++++|.+
T Consensus 200 ~~------~~~~~~~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 200 HE------RLFELILMEE-----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred HH------HHHHHHhcCC-----------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 21 1111111110 011223445688999999999999998 8999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=272.39 Aligned_cols=214 Identities=24% Similarity=0.424 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC---------------CCCCCCHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE---------------DQLPITWEIRLGIAVEVSGAL 66 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~l 66 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.||+.||
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999999999999999865321 112468889999999999999
Q ss_pred HHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHH
Q 045989 67 SYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGV 145 (295)
Q Consensus 67 ~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 145 (295)
+|||+.+ ++||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+
T Consensus 152 ~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 152 KYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999 999999999999999999999999998755332221 122334578899999998888999999999999
Q ss_pred HHHHHHh--CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 146 VLVELLT--GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 146 ~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
++|+|++ +..||......+ ............. .......+..++..+.+++.+||+.+|.+|||+.+|.
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9999987 556665332211 1111111110000 0000111223455689999999999999999999998
Q ss_pred HHHH
Q 045989 224 LELA 227 (295)
Q Consensus 224 ~~l~ 227 (295)
+.|+
T Consensus 300 ~~l~ 303 (304)
T cd05096 300 AFLT 303 (304)
T ss_pred HHHh
Confidence 8774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.04 Aligned_cols=203 Identities=28% Similarity=0.455 Sum_probs=162.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++||||+.+|+|.+++..... .+++..++.++.||+.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 125 (256)
T cd05113 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRD 125 (256)
T ss_pred HHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 46789999999999999999999999999999999999875432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||.++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 126 l~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred cCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999999987654332222222345678999999988889999999999999999998 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+ ........... ..+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 206 ~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 206 NNSE------TVEKVSQGLRL----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CHHH------HHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 3211 11111111110 11112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=265.61 Aligned_cols=203 Identities=28% Similarity=0.467 Sum_probs=162.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 125 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 57789999999999999999999999999999999999875432 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.++..............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 126 l~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred cCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999987554322222222335668999999988889999999999999999999 89998633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.. ......+...... ..+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 206 ~~------~~~~~~i~~~~~~----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 206 SN------YEVVEMISRGFRL----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CH------HHHHHHHHCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 21 1112222111110 11112334689999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=269.97 Aligned_cols=210 Identities=21% Similarity=0.265 Sum_probs=166.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++.+++..+...++||||+++|+|...+.........+++..+..++.|++.||+|||+.+ |+|||
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 122 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRD 122 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 578899999999999999999999999999999999888654444446899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 123 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 123 LKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543222 2233468999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
.... ........... ....+...+..+.+++.+||+.||++|| +++++++|.+-
T Consensus 202 ~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 202 EKVE--NKELKQRILND-----------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred cchh--HHHHHHhhccc-----------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 1110 00111111000 0112233456689999999999999999 78889888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.90 Aligned_cols=209 Identities=28% Similarity=0.466 Sum_probs=163.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-----------------------------------
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE----------------------------------- 45 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~----------------------------------- 45 (295)
+|+.+ +||||+++++++...+..++|||||++|+|.+++.....
T Consensus 91 il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (375)
T cd05104 91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMD 170 (375)
T ss_pred HHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhh
Confidence 35567 899999999999999999999999999999999975321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEE
Q 045989 46 ------------------------------------DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL 89 (295)
Q Consensus 46 ------------------------------------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill 89 (295)
....+++..++.++.||+.||+|||+.+ ++||||||+||++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill 247 (375)
T cd05104 171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILL 247 (375)
T ss_pred cCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEE
Confidence 1124788899999999999999999999 9999999999999
Q ss_pred CCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhccc
Q 045989 90 DDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRS 167 (295)
Q Consensus 90 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~ 167 (295)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 248 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--- 324 (375)
T cd05104 248 THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--- 324 (375)
T ss_pred ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---
Confidence 999999999999997654332211 122335667999999999999999999999999999998 888886432211
Q ss_pred HHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 168 LAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.+.+...... ....+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 325 ---~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 325 ---KFYKMIKEGY---------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---HHHHHHHhCc---------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1111111110 001112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=277.94 Aligned_cols=206 Identities=21% Similarity=0.323 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~D 127 (330)
T cd05601 54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMG---YVHRD 127 (330)
T ss_pred HHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccc
Confidence 46778999999999999999999999999999999999986533 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc------cCCCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ------SSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+||+++.++.+||+|||++...............||+.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 128 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred CchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 9999999999999999999999866544333334456899999999986 4567899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||..... ...+..+......... ......+..+.+++..||+ +|.+|||+.+++.|.+
T Consensus 208 Pf~~~~~------~~~~~~i~~~~~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 208 PFHEGTS------AKTYNNIMNFQRFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCCCCCH------HHHHHHHHcCCCccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 9963322 1222222222111110 0111234558889999998 9999999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.11 Aligned_cols=206 Identities=22% Similarity=0.398 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+...+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~d 128 (261)
T cd05072 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128 (261)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 46789999999999999999999999999999999999975432 24788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 129 l~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred cchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999998654332222223345678999999988889999999999999999998 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...+ .......... .......+..+.+++.+||..+|++||+++++.+.|+.
T Consensus 209 ~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 209 SNSD------VMSALQRGYR----------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CHHH------HHHHHHcCCC----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2211 1111111100 01112234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=271.27 Aligned_cols=197 Identities=24% Similarity=0.337 Sum_probs=158.9
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
..+||||+++++++..++..++||||++||+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp 124 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 4589999999999999999999999999999999887543 4899999999999999999999999 99999999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhh
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 164 (295)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-- 201 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-- 201 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999999987543222 223345689999999999998999999999999999999999999964322
Q ss_pred cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHH
Q 045989 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK-EVALEL 226 (295)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~~~~l 226 (295)
......+.... ...+...+..+.+++.+||+.||.+||++. ++++|.
T Consensus 202 ----~~~~~~i~~~~-----------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05592 202 ----DELFDSILNDR-----------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHP 249 (316)
T ss_pred ----HHHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence 11222211111 111222345578899999999999999875 665654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.90 Aligned_cols=208 Identities=25% Similarity=0.408 Sum_probs=162.9
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++ +||||+++++++...+..++||||++||+|..++.... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 49 l~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 121 (329)
T cd05588 49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG---IIYRD 121 (329)
T ss_pred HHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 4455 79999999999999999999999999999998886543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 122 lkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred CCHHHeEECCCCCEEECcCccccccccC-CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence 9999999999999999999998743221 112234568999999999999999999999999999999999999996432
Q ss_pred hhh--cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHHHHH
Q 045989 162 TEE--NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT------MKEVALELAG 228 (295)
Q Consensus 162 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps------~~e~~~~l~~ 228 (295)
..+ ......+..+....... ..+...+..+.+++.+||+.||.+||+ +.++++|.+-
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 201 MSDNPDQNTEDYLFQVILEKQI----------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred ccccccccchHHHHHHHHcCCC----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 211 11111122221111110 112233456889999999999999987 7888887543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=273.32 Aligned_cols=214 Identities=21% Similarity=0.307 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++ +|.+++..... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 128 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRD 128 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 46789999999999999999999999999965 99998865432 4788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++....... ......+++.|+|||++.+ ..++.++||||+||++|+|++|..||...
T Consensus 129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 129 LKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred CCHHHEEECCCCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875432221 1233457899999999865 56899999999999999999999999654
Q ss_pred chhhcccHHHHHHHHHhh------------chhhhhhhhhh----hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINE------------NRLFEVLDAQV----LREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+.. ....+.... ........+.. ........+..+.+++.+||+.||.+|||++|+++
T Consensus 208 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 208 TVKEEL---HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CHHHHH---HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 322211 111111000 00000000000 00001122346789999999999999999999988
Q ss_pred HH
Q 045989 225 EL 226 (295)
Q Consensus 225 ~l 226 (295)
|.
T Consensus 285 hp 286 (288)
T cd07871 285 HS 286 (288)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=269.49 Aligned_cols=204 Identities=36% Similarity=0.626 Sum_probs=156.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||++++|++...+..++|+||+++|+|.+++.... ...+++..++.|+.||+.||+|||+++ ++|++
T Consensus 54 ~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~ 128 (259)
T PF07714_consen 54 ILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGN 128 (259)
T ss_dssp HHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccc---ccccc
Confidence 3678899999999999998888999999999999999998762 224899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|+++||+++.++.+||+|||++........ .......+...|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 129 l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 129 LSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp -SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999986632222 22233456788999999998889999999999999999999 7788754
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.... ........... ...+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 209 ~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 209 YDNE------EIIEKLKQGQR----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SCHH------HHHHHHHTTEE----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc------ccccccccccc----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3222 12222211111 122223455688999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.17 Aligned_cols=210 Identities=30% Similarity=0.455 Sum_probs=172.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++|||||+++|+......+++|||+|+||+|.++++.... .++..++..++++.+.||+|||+++ ++|||
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRD 287 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRD 287 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---Ccchh
Confidence 68899999999999999999999999999999999999998765 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeee-ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT-QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|..+|+|++.++.+||+|||+++... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||..
T Consensus 288 IAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 288 IAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred HhHHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 99999999999999999999987543 111111 2235678999999999999999999999999999999 7889874
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
....+ ...++. ....+...+...+..+..++.+||..+|++||++.++.+.++.+.....
T Consensus 366 ~~~~~------v~~kI~---------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 366 MKNYE------VKAKIV---------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCHHH------HHHHHH---------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 43321 122221 1122223334556668889999999999999999999999988765544
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=277.00 Aligned_cols=201 Identities=23% Similarity=0.314 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
++++++||||+++++++..++..++||||+++|+|..++.... .+++..++.++.||+.||+|||+ .+ |+||
T Consensus 48 ~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHr 120 (325)
T cd05594 48 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYR 120 (325)
T ss_pred HHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEec
Confidence 4677899999999999999999999999999999998886543 48999999999999999999997 68 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 121 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 999999999999999999999987533221 1223446899999999999999999999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
... .....+.... ...+...+..+.+++.+||+.||++|+ ++.++++|.+
T Consensus 200 ~~~------~~~~~i~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 200 DHE------KLFELILMEE-----------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred CHH------HHHHHHhcCC-----------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 221 1111111110 011222345688999999999999996 9999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=273.60 Aligned_cols=200 Identities=25% Similarity=0.360 Sum_probs=161.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++.+..++..++||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~d 121 (323)
T cd05575 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN---IIYRD 121 (323)
T ss_pred HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 4577999999999999999999999999999999999887543 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 122 ikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 122 LKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CCHHHeEECCCCcEEEeccCCCcccccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 9999999999999999999998753222 122334568999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH----HHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM----KEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~----~e~~~~l 226 (295)
. ......+.... ...+...+..+.+++.+||+.||.+||++ .++++|.
T Consensus 201 ~------~~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~ 252 (323)
T cd05575 201 T------AEMYDNILNKP-----------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252 (323)
T ss_pred H------HHHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence 2 12222222111 01112234568899999999999999988 4666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=275.98 Aligned_cols=206 Identities=24% Similarity=0.327 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++||||+++++++..++..++||||++||+|.+++... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 167 (370)
T cd05596 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG---FIHRD 167 (370)
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 567889999999999999999999999999999999998653 3788899999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC----CCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS----QFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+|||++.++.+||+|||++...............||+.|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 168 Lkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 168 VKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 999999999999999999999876543332223345699999999998653 4789999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~~ 228 (295)
..... ...+..+......... +.....+..+.+++.+||+.+|.+ |+++.+++.|.+-
T Consensus 248 ~~~~~------~~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 248 YADSL------VGTYSKIMDHKNSLTF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred CCCCH------HHHHHHHHcCCCcCCC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 64322 1222222221110000 111123556889999999999987 9999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=273.10 Aligned_cols=199 Identities=26% Similarity=0.341 Sum_probs=161.2
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
+++++||||+++++++..++..|+||||++||+|...+... .+++..++.++.|++.||+|||+.+ ++||||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdl 127 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDL 127 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 46789999999999999999999999999999999887642 3899999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 128 kp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 128 KLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred CHHHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999987432221 223345689999999999999999999999999999999999999964322
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
. .....+..... ..+...+..+.+++.+||+.||.+|| ++.+++++.+
T Consensus 207 ~------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 207 E------EVFDSIVNDEV-----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred H------HHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 1 11222111110 11222345688999999999999999 6888877753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=269.65 Aligned_cols=210 Identities=23% Similarity=0.341 Sum_probs=158.8
Q ss_pred ccCCCCccccceeeEEEe-----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 3 LSQINHRNVVKLLGCCLE-----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
++.++||||+++++++.. ....++||||+. ++|.+++...... .+++..++.++.|++.||+|||+.+ +
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i 131 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---V 131 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 345689999999999863 456899999995 5999998754332 4889999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||||+||+++.++.+||+|||+++..... .......|++.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 132 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f 209 (290)
T cd07862 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209 (290)
T ss_pred eeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence 99999999999999999999999998765432 2233456899999999998889999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhc------hhhh-------hh---hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 045989 158 RLVETEENRSLAAYFLQVINEN------RLFE-------VL---DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~------~~~~-------~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 221 (295)
......+ .+..+.... .... .. ............+..+.+++.+||+.||++|||+.+
T Consensus 210 ~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 210 RGSSDVD------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred CCCCHHH------HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 7543321 111111100 0000 00 000001111223456789999999999999999999
Q ss_pred HHHHH
Q 045989 222 VALEL 226 (295)
Q Consensus 222 ~~~~l 226 (295)
+++|.
T Consensus 284 ~l~hp 288 (290)
T cd07862 284 ALSHP 288 (290)
T ss_pred HhcCC
Confidence 98764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.80 Aligned_cols=206 Identities=22% Similarity=0.283 Sum_probs=162.8
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ +||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHr 129 (332)
T cd05614 57 VLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG---IVYR 129 (332)
T ss_pred HHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEec
Confidence 45667 68999999999999999999999999999999987543 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
||||+|||++.++.+||+|||+++..............||+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 130 Dlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 130 DIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 9999999999999999999999876543333333345689999999999765 478899999999999999999999963
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
..... ............ + ...+...+..+.+++.+||+.||++|| +++++++|.+
T Consensus 210 ~~~~~--~~~~~~~~~~~~-------~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 210 EGERN--TQSEVSRRILKC-------D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCCC--CHHHHHHHHhcC-------C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 32111 111111111110 0 111223445688999999999999999 8889998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=264.10 Aligned_cols=203 Identities=29% Similarity=0.471 Sum_probs=162.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||++|++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 125 (256)
T cd05059 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125 (256)
T ss_pred HHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 46789999999999999999999999999999999999975433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|++++ |..||...
T Consensus 126 l~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred ccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 99999999999999999999987654322221222234457999999998899999999999999999998 89998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+ ........ .....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 206 ~~~~------~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 206 SNSE------VVESVSAG----------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHH------HHHHHHcC----------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2221 11111110 00111223456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=263.75 Aligned_cols=206 Identities=25% Similarity=0.445 Sum_probs=165.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~d 131 (266)
T cd05033 58 IMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN---YVHRD 131 (266)
T ss_pred HHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 46789999999999999999999999999999999999976433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 132 i~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred CCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 999999999999999999999987642221 11222334678999999998899999999999999999998 9999853
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....+ ......... ..+.+...+..+.+++.+||+.+|++||++.+++++|..+
T Consensus 212 ~~~~~------~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 212 MSNQD------VIKAVEDGY----------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCHHH------HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 32211 111111110 0011223455689999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=268.49 Aligned_cols=209 Identities=26% Similarity=0.455 Sum_probs=165.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT------------EDQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+++++ +||||+++++++..++..++||||+++|+|..++.... .....+++..++.++.|++.||+|
T Consensus 68 ~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred HHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 35567 89999999999999999999999999999999997532 223358899999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+.+ ++|+||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++
T Consensus 148 LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 224 (293)
T cd05053 148 LASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224 (293)
T ss_pred HHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHH
Confidence 99999 9999999999999999999999999998654322111 2222356789999999888999999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|++++ |..||......+ .... .... .....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 225 ~el~~~g~~p~~~~~~~~------~~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 225 WEIFTLGGSPYPGIPVEE------LFKL-LKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHHhcCCCCCCCCCCHHH------HHHH-HHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 99997 889986432221 1111 1111 01112223345688999999999999999999999999
Q ss_pred HHh
Q 045989 227 AGI 229 (295)
Q Consensus 227 ~~~ 229 (295)
+.+
T Consensus 289 ~~~ 291 (293)
T cd05053 289 DRM 291 (293)
T ss_pred HHh
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=266.32 Aligned_cols=207 Identities=28% Similarity=0.479 Sum_probs=165.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC----------CCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT----------EDQLPITWEIRLGIAVEVSGALSYLHS 71 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~Lh~ 71 (295)
+|++++||||+++++++......++||||+++++|.+++.... .....+++..+..++.|++.||+|||+
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 4678999999999999999999999999999999999997542 223347889999999999999999999
Q ss_pred CCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 72 AASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 72 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
++ ++|+||||+||+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|+|
T Consensus 141 ~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 141 QH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred CC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998754322211 12233457789999999999999999999999999999
Q ss_pred Hh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 151 LT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 151 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
++ |..||......+ ...... .. .....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 218 ~~~g~~p~~~~~~~~------~~~~~~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSNEE------VIECIT-QG---------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCHHH------HHHHHH-cC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 999986433221 111111 11 111112234556899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=263.33 Aligned_cols=206 Identities=24% Similarity=0.399 Sum_probs=164.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 128 (261)
T cd05068 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128 (261)
T ss_pred HHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 4678999999999999999999999999999999999997644 224899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||+++...............+..|+|||.+.+..++.++||||||+++++|++ |+.||...
T Consensus 129 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred CCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999998665322211222223457999999988889999999999999999999 99998633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... .......... ....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 209 ~~~------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 209 TNA------EVLQQVDQGY----------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHH------HHHHHHHcCC----------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 211 1111111110 011122345668999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=273.46 Aligned_cols=197 Identities=24% Similarity=0.346 Sum_probs=159.7
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.+||||+++++++...+..|+||||+++|+|..++.... .+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~ 125 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLD 125 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH
Confidence 479999999999999999999999999999999887643 4899999999999999999999999 999999999
Q ss_pred eEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhc
Q 045989 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165 (295)
Q Consensus 86 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 165 (295)
||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-- 202 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-- 202 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--
Confidence 9999999999999999987532221 2233456899999999999889999999999999999999999999643321
Q ss_pred ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHHHH
Q 045989 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM------KEVALELA 227 (295)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~------~e~~~~l~ 227 (295)
.....+..... ..+...+..+.+++.+||+.||.+||++ ++++.|.+
T Consensus 203 ----~~~~~i~~~~~-----------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 203 ----DLFEAILNDEV-----------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred ----HHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 12222211110 1112234568899999999999999998 77776644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=274.80 Aligned_cols=216 Identities=25% Similarity=0.357 Sum_probs=159.0
Q ss_pred cccCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++.... ..|+||||| +++|.+++.... .+++..+..++.|++.||+|||+.+
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--- 123 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN--- 123 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 467899999999999986432 479999999 569999887543 3899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHh
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~ 152 (295)
|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 124 ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999875432211 11234568999999999876 578999999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhh-----------ch---hhhhhhhhh---hhhhhHHHHHHHHHHHHHhhccCCCC
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINE-----------NR---LFEVLDAQV---LREAEKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~---~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~ 215 (295)
|+.||........ ...+...... .. ....+.... ........+..+.+++.+||+.||++
T Consensus 204 g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 280 (338)
T cd07859 204 GKPLFPGKNVVHQ---LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280 (338)
T ss_pred CCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence 9999964332111 0000000000 00 000000000 00001123455789999999999999
Q ss_pred CCCHHHHHHHHHH
Q 045989 216 RPTMKEVALELAG 228 (295)
Q Consensus 216 Rps~~e~~~~l~~ 228 (295)
|||++++++|.+-
T Consensus 281 Rpt~~e~l~hp~f 293 (338)
T cd07859 281 RPTAEEALADPYF 293 (338)
T ss_pred CCCHHHHhcCchh
Confidence 9999999998654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=262.77 Aligned_cols=205 Identities=24% Similarity=0.428 Sum_probs=165.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++......++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~d 129 (261)
T cd05148 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN---SIHRD 129 (261)
T ss_pred HHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 46789999999999999999999999999999999999976432 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++......... .....++..|+|||.+....++.++||||||+++|+|++ |..||...
T Consensus 130 l~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 130 LAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred cCcceEEEcCCceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999999999999999999998765432221 223345678999999988889999999999999999998 89998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ..+...... .....+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 209 ~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 209 NNH------EVYDQITAG----------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CHH------HHHHHHHhC----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 211 111111111 1112223445668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=257.59 Aligned_cols=218 Identities=21% Similarity=0.248 Sum_probs=166.5
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
||.+++|||||.+-.+..- -+..|||||||++ ||..++..... +|.......++.|+++|++|||.++ |+|
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~~w---ilH 200 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHDNW---ILH 200 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhhce---eEe
Confidence 5778999999999998864 3579999999976 99999987653 5899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||||+|+|++..|.+||+|||+|+.++... ...+..+-|.+|.|||.+.+. .|+++.||||+|||+.||+++.+.|.
T Consensus 201 RDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 201 RDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred cccchhheeeccCCcEEecccchhhhhcCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999999887653 335556679999999998775 68999999999999999999999887
Q ss_pred ccchhhcccHHHHHHHHHh-hchhhhhhh---------------hhhhhhhhHH-HHHHHHHHHHHhhccCCCCCCCHHH
Q 045989 159 LVETEENRSLAAYFLQVIN-ENRLFEVLD---------------AQVLREAEKE-EVITVAMVAKRCLNLNGKKRPTMKE 221 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------------~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rps~~e 221 (295)
.....+. +...+..... ...++..+. ......+... .+..-.+|+..+|..||.+|.||.+
T Consensus 280 G~sE~dQ--l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 280 GKSEIDQ--LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCchHHH--HHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 5433221 1111111100 001110000 0000001111 3366788999999999999999999
Q ss_pred HHHHHHHh
Q 045989 222 VALELAGI 229 (295)
Q Consensus 222 ~~~~l~~~ 229 (295)
.++|-+..
T Consensus 358 ~L~h~~F~ 365 (419)
T KOG0663|consen 358 GLKHEYFR 365 (419)
T ss_pred hhcccccc
Confidence 99986543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=275.65 Aligned_cols=206 Identities=24% Similarity=0.332 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..|+||||++||+|.+++... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrD 167 (370)
T cd05621 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRD 167 (370)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 467889999999999999999999999999999999998653 2788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC----CCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS----QFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+|||++.++.+||+|||++...............||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus 168 LKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 999999999999999999999986543333233455799999999998754 3788999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~~ 228 (295)
..... ...+..+......... +.....+..+.+++.+||..++.+ |+++.++++|.+-
T Consensus 248 ~~~~~------~~~~~~i~~~~~~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 248 YADSL------VGTYSKIMDHKNSLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred CCCCH------HHHHHHHHhCCcccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 63321 2222222221110000 011123455788999999855543 8999999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=266.31 Aligned_cols=220 Identities=28% Similarity=0.442 Sum_probs=164.3
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... ...++||||+++++|.+++... .+++..++.++.|++.||+|||+++ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H 130 (283)
T cd05080 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH---YIH 130 (283)
T ss_pred HHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 46789999999999998764 4579999999999999998753 3899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++++|++|..||
T Consensus 131 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 131 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred cccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998765432211 112223566799999998888999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
......... .............+............+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 211 QSPPKKFEE-MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCcchhhh-hhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 543211000 000000000000111111111111223334567999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=264.30 Aligned_cols=217 Identities=27% Similarity=0.355 Sum_probs=164.4
Q ss_pred cccCCCCccccceeeEEEe-----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE-----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|+.++|+||+.+.+++.- -+..|+|+|+| +.+|...++.+. .++...+..+++|++.||.|+|+.+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn--- 145 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN--- 145 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc---
Confidence 5788999999999999875 35789999999 569999998765 3899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccC-cceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+|||+||.|++++.+..+||+|||+|+..... .....+..+.|.+|.|||++.. ..|+.+.||||+|||+.||++|+
T Consensus 146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence 999999999999999999999999999976432 2223455678999999998754 58999999999999999999999
Q ss_pred CCCcccchhhcccHHHHH--------HHHHhhchhhhhh------hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 045989 155 KPIRLVETEENRSLAAYF--------LQVINENRLFEVL------DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK 220 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~ 220 (295)
+-|.+.+........... ...+........+ ++.......+.......+|+.+||..||.+|+|++
T Consensus 226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~ 305 (359)
T KOG0660|consen 226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE 305 (359)
T ss_pred CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence 999755433221111110 0000000000000 01111111223345678999999999999999999
Q ss_pred HHHHHH
Q 045989 221 EVALEL 226 (295)
Q Consensus 221 e~~~~l 226 (295)
|+++|.
T Consensus 306 eAL~hP 311 (359)
T KOG0660|consen 306 EALAHP 311 (359)
T ss_pred HHhcCh
Confidence 999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=265.56 Aligned_cols=207 Identities=25% Similarity=0.445 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------QLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++++||||+++++++..+...++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+
T Consensus 62 ~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-- 139 (277)
T cd05062 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-- 139 (277)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 467889999999999999999999999999999999998753321 224678889999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
++|+||||+||+++.++.++|+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 140 -~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 218 (277)
T cd05062 140 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218 (277)
T ss_pred -cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987543322211 112245778999999998889999999999999999998 7
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..||...... .......... . ...+...+..+.+++.+||+.+|++|||+.|+++.++
T Consensus 219 ~~p~~~~~~~------~~~~~~~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 219 EQPYQGMSNE------QVLRFVMEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCCHH------HHHHHHHcCC-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 8888633221 1111111111 0 0112233456899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=265.73 Aligned_cols=216 Identities=24% Similarity=0.287 Sum_probs=163.7
Q ss_pred cccCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
||++++|||||++.-+|.... ...+||||++. +|.++++.....+..++.-.+.-+.+||++||+|||+.+
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--- 145 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--- 145 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---
Confidence 678999999999999997532 45789999965 999999875444556888888889999999999999999
Q ss_pred eEeccCCCCeEEECCC-CceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCC
Q 045989 77 IYHRDIKSANILLDDK-YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 77 i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~ 154 (295)
||||||||+|+|||.+ |.+||+|||.|+....+... ....-|..|+|||.+.+. .|+.+.||||.||++.||+-|+
T Consensus 146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~ 223 (364)
T KOG0658|consen 146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ 223 (364)
T ss_pred cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC
Confidence 9999999999999966 89999999999977655443 233458899999998775 7999999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchh---------------hhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRL---------------FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
+-|.+....+ ....+.++...... .++.......-.....+.+..+++.++|+.+|.+|.++
T Consensus 224 plFpG~s~~d---QL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~ 300 (364)
T KOG0658|consen 224 PLFPGDSSVD---QLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA 300 (364)
T ss_pred cccCCCCHHH---HHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH
Confidence 9997533222 11111111111100 00100000011233455678999999999999999999
Q ss_pred HHHHHHH
Q 045989 220 KEVALEL 226 (295)
Q Consensus 220 ~e~~~~l 226 (295)
.|++.|.
T Consensus 301 ~~~l~h~ 307 (364)
T KOG0658|consen 301 LEALAHP 307 (364)
T ss_pred HHHhcch
Confidence 9999884
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=260.46 Aligned_cols=218 Identities=21% Similarity=0.304 Sum_probs=165.5
Q ss_pred cccCCCCcc-ccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRN-VVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpn-iv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++|+|+| ||++++++...+ .+++|+||++ -+|..++.........++...+..+++||+.||+|||+++
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~- 140 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG- 140 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 688999999 999999999877 7899999995 4999999876643235777899999999999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhC
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g 153 (295)
|+||||||+||+|+++|.+||+|||+|+....+.. .....++|.+|.|||++.+. .|+...||||+||++.||+++
T Consensus 141 --IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~ 217 (323)
T KOG0594|consen 141 --ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTR 217 (323)
T ss_pred --eecccCCcceEEECCCCcEeeeccchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhC
Confidence 99999999999999999999999999996553332 24456789999999999887 799999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHH-hhchhhhhh-----------h---hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVI-NENRLFEVL-----------D---AQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----------~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
++-|+.....+. ....+.-.- +....+..+ . +...............+++.+||+.+|.+|.|
T Consensus 218 ~~LFpG~se~~q--l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S 295 (323)
T KOG0594|consen 218 RPLFPGDSEIDQ--LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS 295 (323)
T ss_pred CCCCCCCcHHHH--HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC
Confidence 988875544221 111111000 000000000 0 00000000111136889999999999999999
Q ss_pred HHHHHHHH
Q 045989 219 MKEVALEL 226 (295)
Q Consensus 219 ~~e~~~~l 226 (295)
++.++.|.
T Consensus 296 a~~al~h~ 303 (323)
T KOG0594|consen 296 AKGALTHP 303 (323)
T ss_pred HHHHhcCh
Confidence 99999884
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.96 Aligned_cols=205 Identities=25% Similarity=0.333 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|..++||||+++++++.+++..++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ ++|||
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~D 126 (350)
T cd05573 54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKLG---FIHRD 126 (350)
T ss_pred HHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 4678899999999999999999999999999999999998652 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc----------------------------ceeeeccccccCCCChhhhccCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR----------------------------THLTTQVKGTFGYLDPEYFQSSQ 133 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~ 133 (295)
|||+||+++.++.+||+|||++....... ........||+.|+|||++.+..
T Consensus 127 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (350)
T cd05573 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP 206 (350)
T ss_pred CCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99999999999999999999987654332 11223346899999999999999
Q ss_pred CCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 134 FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 134 ~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
++.++|||||||++|+|++|+.||...... .....+........ .+.....+..+.+++.+||. +|
T Consensus 207 ~~~~~DiwSlG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-------~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 207 YGLECDWWSLGVILYEMLYGFPPFYSDTLQ------ETYNKIINWKESLR-------FPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred CCCceeeEecchhhhhhccCCCCCCCCCHH------HHHHHHhccCCccc-------CCCCCCCCHHHHHHHHHHcc-Ch
Confidence 999999999999999999999999643321 11112211000000 00011135568899999998 99
Q ss_pred CCCCC-HHHHHHHHH
Q 045989 214 KKRPT-MKEVALELA 227 (295)
Q Consensus 214 ~~Rps-~~e~~~~l~ 227 (295)
.+||+ +.++++|.+
T Consensus 273 ~~R~~s~~~ll~hp~ 287 (350)
T cd05573 273 EDRLGSFEEIKSHPF 287 (350)
T ss_pred hhcCCCHHHHhcCCC
Confidence 99999 999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=265.25 Aligned_cols=206 Identities=21% Similarity=0.305 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+...++||||++|++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|||
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 120 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD---IVYRD 120 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEcc
Confidence 57789999999999999999999999999999999988865432 24889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||+||++|+|++|..||....
T Consensus 121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 121 MKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999987654322 2233468999999999998889999999999999999999999986432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
... ............. ........+..+.+++.+||+.||.+||+++|+++++
T Consensus 199 ~~~--~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 199 EKV--AKEELKRRTLEDE----------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred chh--hHHHHHHHhhccc----------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 211 0111111111100 0001112345689999999999999999997665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.41 Aligned_cols=200 Identities=26% Similarity=0.343 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 123 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRD 123 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 5788999999999999999999999999999999999986543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 124 LKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred CCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 99999999999999999999987543321 22334568999999999998889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l 226 (295)
.. .....+.... ...+...+..+.+++.+||+.||.+||+ +.+++.+.
T Consensus 203 ~~------~~~~~i~~~~-----------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~ 255 (318)
T cd05582 203 RK------ETMTMILKAK-----------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHP 255 (318)
T ss_pred HH------HHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCC
Confidence 21 1111111110 0112223456889999999999999999 55566553
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=271.54 Aligned_cols=206 Identities=25% Similarity=0.385 Sum_probs=162.0
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+.++ +||||+++++++...+..++||||++||+|..++.... .+++..+..++.||+.||+|||+++ ++|||
T Consensus 49 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrD 121 (327)
T cd05617 49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG---IIYRD 121 (327)
T ss_pred HHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 3455 79999999999999999999999999999998886543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 122 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred CCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 99999999999999999999987432221 12334568999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT------MKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps------~~e~~~~l 226 (295)
............+...... ...+...+..+.+++.+||+.||.+|++ +.++.+|.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 201 DNPDMNTEDYLFQVILEKP----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCcccccHHHHHHHHHhCC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 3222222222222221111 1122223455788999999999999998 45777664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.56 Aligned_cols=210 Identities=28% Similarity=0.476 Sum_probs=165.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC--------------------CCCCCCHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE--------------------DQLPITWEIRLGIAVE 61 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~q 61 (295)
+|++++||||+++++.+..++..++|+||+.+++|.+++..... ....+++..++.++.|
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 135 (290)
T cd05045 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ 135 (290)
T ss_pred HHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence 46789999999999999999999999999999999999864321 1234789999999999
Q ss_pred HHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccc
Q 045989 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 62 i~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
++.||+|||+.+ ++||||||+||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++||
T Consensus 136 i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 212 (290)
T cd05045 136 ISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212 (290)
T ss_pred HHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHH
Confidence 999999999999 9999999999999999999999999987543322211 122345678999999988889999999
Q ss_pred hhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 141 YSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 141 wslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
||||+++++|++ |..||......+ ........ .....+...+..+.+++.+||+.+|++||++
T Consensus 213 ~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 213 WSFGVLLWEIVTLGGNPYPGIAPER-------LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 999999999998 999986432211 11111111 0111122344568899999999999999999
Q ss_pred HHHHHHHHHhH
Q 045989 220 KEVALELAGIR 230 (295)
Q Consensus 220 ~e~~~~l~~~~ 230 (295)
.++++.|+++.
T Consensus 277 ~~i~~~l~~~~ 287 (290)
T cd05045 277 ADISKELEKMM 287 (290)
T ss_pred HHHHHHHHHHH
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=260.37 Aligned_cols=202 Identities=27% Similarity=0.458 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||++|++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~d 126 (256)
T cd08529 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRD 126 (256)
T ss_pred HHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 46789999999999999999999999999999999999986432 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||||+++++|++|..||....
T Consensus 127 l~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 127 IKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred CCcceEEEeCCCCEEEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 1233457889999999999889999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
... ....... ......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 206 ~~~------~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 206 QGA------LILKIIR----------GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHH------HHHHHHc----------CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 211 1111111 11112222445568999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=261.33 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=160.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++......++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 119 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---CIHRD 119 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 46789999999999999999999999999999999999865332 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee-eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||++........... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred cchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999875432211111 11122456999999988889999999999999999998 8888853
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..... ........ .....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 200 ~~~~~------~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 200 LSNQQ------TREAIEQG----------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCHHH------HHHHHHcC----------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 32211 11111110 011122234556899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=263.11 Aligned_cols=207 Identities=25% Similarity=0.443 Sum_probs=162.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++.. ...++++||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ ++|+|
T Consensus 62 ~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~d 134 (279)
T cd05111 62 AMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRN 134 (279)
T ss_pred HHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---Eeccc
Confidence 4578899999999998764 567899999999999999975433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||..
T Consensus 135 lkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 135 LAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999976533221 11223446778999999988889999999999999999998 9999864
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
..... ..+........ ..+..++..+.+++.+||..+|++|||+.|+++.|..+.+
T Consensus 215 ~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 215 MRPHE-------VPDLLEKGERL---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCHHH-------HHHHHHCCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 32211 11111111100 1111233457889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=260.38 Aligned_cols=205 Identities=26% Similarity=0.466 Sum_probs=161.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. ...++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|+|
T Consensus 48 ~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 120 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKD---EITVSNVVELMHQVSMGMKYLEGKN---FVHRD 120 (257)
T ss_pred HHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 4678999999999998864 578999999999999999875332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee--eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT--TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||++........... ....++..|+|||++.+..++.++|||||||++|++++ |..||.
T Consensus 121 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred cchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 999999999999999999999875543322111 11223578999999988889999999999999999996 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.....+ ... ..... .....+...+.++.+++.+||..+|++||++.+|.+.|+..
T Consensus 201 ~~~~~~------~~~-~~~~~---------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 201 KMKGPE------VMS-FIEQG---------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCHHH------HHH-HHHCC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 432211 111 11111 11122233456789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=271.20 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=159.7
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.+||||+++++++..++..++||||+++|+|..++.... .+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~ 125 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 125 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH
Confidence 489999999999999999999999999999998886543 4899999999999999999999999 999999999
Q ss_pred eEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhh-
Q 045989 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE- 164 (295)
Q Consensus 86 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~- 164 (295)
||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 126 Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 204 (329)
T cd05618 126 NVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204 (329)
T ss_pred HEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC
Confidence 9999999999999999987432221 12234568999999999999999999999999999999999999996322211
Q ss_pred -cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHHH
Q 045989 165 -NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT------MKEVALEL 226 (295)
Q Consensus 165 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps------~~e~~~~l 226 (295)
......+......... ...+...+..+.+++.+||+.||++||+ +.++++|.
T Consensus 205 ~~~~~~~~~~~~i~~~~----------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 205 PDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred cccccHHHHHHHHhcCC----------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 1111112222111111 1122234456889999999999999998 46777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=271.92 Aligned_cols=196 Identities=25% Similarity=0.340 Sum_probs=158.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++...+..++||||++||+|.+++.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrD 121 (325)
T cd05602 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRD 121 (325)
T ss_pred HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 3577899999999999999999999999999999999987543 3788889999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 122 lkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 122 LKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999987533221 12334568999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
.. ..+..+.... .......+..+.+++.+||+.+|.+||++.+.
T Consensus 201 ~~------~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 201 TA------EMYDNILNKP-----------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HH------HHHHHHHhCC-----------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 21 1222221111 01112334568899999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.67 Aligned_cols=207 Identities=27% Similarity=0.466 Sum_probs=179.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+.++|||+|+++|+|.....+|||+|||..|+|.++|+..... .++.-.++.++.||..|++||..++ ++|||
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkkn---FIHRD 390 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKKN---FIHRD 390 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHhh---hhhhh
Confidence 689999999999999999999999999999999999999875433 4777788999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|...|+||.++..+|++|||+++.+..+.........-...|.|||-+....++.|+|||+|||+||||.| |..||+..
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 99999999999999999999999988766554444455778999999999999999999999999999998 99998754
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
+..+ +...+......+.+..++..+++|++.||+++|.+||++.|+-+.++.+
T Consensus 471 dlSq----------------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 471 DLSQ----------------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cHHH----------------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 3322 3334444455566777888999999999999999999999999988765
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=270.02 Aligned_cols=197 Identities=24% Similarity=0.332 Sum_probs=160.7
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.+||||+++++++..++..|+||||+++|+|...+.... .+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~ 125 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLD 125 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 489999999999999999999999999999999887543 4889999999999999999999999 999999999
Q ss_pred eEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhc
Q 045989 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165 (295)
Q Consensus 86 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 165 (295)
||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 126 Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-- 202 (321)
T cd05591 126 NILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-- 202 (321)
T ss_pred HeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--
Confidence 9999999999999999987532222 2233456899999999999989999999999999999999999999643321
Q ss_pred ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHHHH
Q 045989 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-------TMKEVALELA 227 (295)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-------s~~e~~~~l~ 227 (295)
.....+..... ..+...+..+.+++.+||+.||++|| ++.++++|.+
T Consensus 203 ----~~~~~i~~~~~-----------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 203 ----DLFESILHDDV-----------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred ----HHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 12222221110 11112344688999999999999999 8999988864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=273.24 Aligned_cols=205 Identities=25% Similarity=0.366 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++||||+++++++..++..++||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~D 126 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG---YIHRD 126 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 5678899999999999999999999999999999999997643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-------------------------------------eeeccccccCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-------------------------------------LTTQVKGTFGYL 124 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------------------------------~~~~~~gt~~y~ 124 (295)
|||+|||++.++.++|+|||++..+...... ......||+.|+
T Consensus 127 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred CCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc
Confidence 9999999999999999999998754321100 011235899999
Q ss_pred ChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHH
Q 045989 125 DPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMV 204 (295)
Q Consensus 125 aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 204 (295)
|||++.+..++.++|||||||++|+|++|..||...... .....+......... ......+..+.++
T Consensus 207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~------~~~~~i~~~~~~~~~-------~~~~~~s~~~~~l 273 (364)
T cd05599 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ------ETYRKIINWKETLQF-------PDEVPLSPEAKDL 273 (364)
T ss_pred CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH------HHHHHHHcCCCccCC-------CCCCCCCHHHHHH
Confidence 999999999999999999999999999999999643221 112222111100000 0011234468889
Q ss_pred HHHhhccCCCCCCC---HHHHHHHHH
Q 045989 205 AKRCLNLNGKKRPT---MKEVALELA 227 (295)
Q Consensus 205 i~~cl~~~p~~Rps---~~e~~~~l~ 227 (295)
+.+|+. +|.+|++ +.++++|.+
T Consensus 274 i~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 274 IKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred HHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 999997 9999997 999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=260.26 Aligned_cols=203 Identities=29% Similarity=0.450 Sum_probs=161.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. .+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|||
T Consensus 49 ~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 120 (257)
T cd05116 49 VMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN---FVHRD 120 (257)
T ss_pred HHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 467889999999999886 456799999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee--eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT--TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||.||+++.++.+||+|||++........... ....++..|+|||.+....++.++|||||||++|||++ |..||.
T Consensus 121 lkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 200 (257)
T cd05116 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK 200 (257)
T ss_pred cchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986654332211 12234578999999988888999999999999999998 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.....+ .... .... .....+...+..+.++|.+||+.||++||++.+|.+.|+.
T Consensus 201 ~~~~~~------~~~~-i~~~---------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 201 GMKGNE------VTQM-IESG---------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCHHH------HHHH-HHCC---------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 432211 1111 1111 1111222345568999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=267.67 Aligned_cols=216 Identities=23% Similarity=0.341 Sum_probs=158.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+...++||||+. ++|.+++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 128 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 5678999999999999999999999999995 688888765432 4888999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++....... .......|++.|+|||++.+ ..++.++||||+||++|+|++|..||...
T Consensus 129 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 129 LKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543221 12233457899999999865 45788999999999999999999999743
Q ss_pred chhhcccHHHHHHHHHhhch--hh------hhhhhh--------hhhh-h-hHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 161 ETEENRSLAAYFLQVINENR--LF------EVLDAQ--------VLRE-A-EKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~--~~------~~~~~~--------~~~~-~-~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
..... .... ......... .+ ....+. .... . ....+..+.+++.+||+.||++|||++++
T Consensus 208 ~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~ 285 (303)
T cd07869 208 KDIQD-QLER-IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285 (303)
T ss_pred ccHHH-HHHH-HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence 22110 0000 000000000 00 000000 0000 0 00122457899999999999999999999
Q ss_pred HHHHH
Q 045989 223 ALELA 227 (295)
Q Consensus 223 ~~~l~ 227 (295)
++|.+
T Consensus 286 l~h~~ 290 (303)
T cd07869 286 LSHEY 290 (303)
T ss_pred hcCcc
Confidence 98865
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.50 Aligned_cols=204 Identities=27% Similarity=0.388 Sum_probs=171.7
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
||+++. |||||.++++|+....+++|||+|.||.|.+.+... .+++..+..++.|++.|++|||+.| |+||
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHr 159 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHR 159 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceec
Confidence 678887 999999999999999999999999999999999876 2899999999999999999999999 9999
Q ss_pred cCCCCeEEECCC----CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 81 DIKSANILLDDK----YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 81 dikp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||||+|+|+... +.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+|
T Consensus 160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~P 237 (382)
T KOG0032|consen 160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPP 237 (382)
T ss_pred cCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCC
Confidence 999999999643 4799999999997765 4456677899999999999999999999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|....... .+..+..... ....+.....+..+.++++.|+..||.+|+|+.++++|.|-
T Consensus 238 F~~~~~~~------~~~~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 238 FWGETEFE------IFLAILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CcCCChhH------HHHHHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 97433221 1112222111 12223344556778999999999999999999999999873
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.99 Aligned_cols=214 Identities=26% Similarity=0.395 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~ 80 (295)
+|++++||||++++++|..++..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. + ++|+
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~ 128 (333)
T cd06650 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHR 128 (333)
T ss_pred HHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEec
Confidence 4678999999999999999999999999999999999997543 488999999999999999999975 6 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 129 dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999998754322 122346899999999999888999999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhh----------------------------chhhhhhhhh---hhhhh-hHHHHHHHHHHHHHh
Q 045989 161 ETEENRSLAAYFLQVINE----------------------------NRLFEVLDAQ---VLREA-EKEEVITVAMVAKRC 208 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~---~~~~~-~~~~~~~~~~li~~c 208 (295)
...+. ...+...... .......... ..... ....+.++.+++.+|
T Consensus 206 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 282 (333)
T cd06650 206 DAKEL---ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKC 282 (333)
T ss_pred chhHH---HHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHh
Confidence 22110 0000000000 0000000000 00000 011345689999999
Q ss_pred hccCCCCCCCHHHHHHHHHH
Q 045989 209 LNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 209 l~~~p~~Rps~~e~~~~l~~ 228 (295)
|+.||++|||+.|+++|.+-
T Consensus 283 L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 283 LIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred ccCCcccCcCHHHHhhCHHH
Confidence 99999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.97 Aligned_cols=207 Identities=26% Similarity=0.440 Sum_probs=161.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
++.++ +||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|
T Consensus 48 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~ 127 (270)
T cd05047 48 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 127 (270)
T ss_pred HHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35667 899999999999999999999999999999999975431 12247899999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
||+.+ ++|+||||+||+++.++.+||+|||++...... ........+..|+|||++....++.++|||||||++|
T Consensus 128 lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 128 LSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 99999 999999999999999999999999998532111 1111122356799999998888999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+|++ |..||..... ...+....... ....+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 203 el~~~g~~pf~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 203 EIVSLGGTPYCGMTC------AELYEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred HHHcCCCCCccccCH------HHHHHHHhCCC----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 9997 9999853221 11111111110 11112223446889999999999999999999999987
Q ss_pred Hh
Q 045989 228 GI 229 (295)
Q Consensus 228 ~~ 229 (295)
.+
T Consensus 267 ~~ 268 (270)
T cd05047 267 RM 268 (270)
T ss_pred Hh
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.09 Aligned_cols=208 Identities=23% Similarity=0.464 Sum_probs=163.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-------------CCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-------------DQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
++++++||||+++++++..+...++||||+++++|.+++..... ....+++..+..++.|++.||+|
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 57889999999999999999999999999999999999864321 12347888999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+++ ++|+||||+||+++.++.+||+|||+++....... .......++..|+|||++.+..++.++|+||||+++
T Consensus 140 lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 140 LSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred HHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999 99999999999999999999999999976543221 112233456789999999888899999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||...... ... ....... ....+...+..+.+++.+||+.+|.+||++.+|+++|
T Consensus 217 ~el~~~g~~p~~~~~~~------~~~-~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQ------EVI-EMVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHcCCCCCCCCCCHH------HHH-HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 99998 88888533211 111 1111111 1112223445688999999999999999999999988
Q ss_pred HH
Q 045989 227 AG 228 (295)
Q Consensus 227 ~~ 228 (295)
.+
T Consensus 281 ~~ 282 (283)
T cd05090 281 RS 282 (283)
T ss_pred hc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=262.17 Aligned_cols=204 Identities=27% Similarity=0.434 Sum_probs=163.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 57 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~d 129 (263)
T cd06625 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM---IVHRD 129 (263)
T ss_pred HHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 4678999999999999999999999999999999999987643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee--eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT--TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|+|+||+++.++.++|+|||+++.......... ....|+..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 130 l~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred CCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999999875432211111 234578899999999998899999999999999999999999863
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.... .......... .....+...+..+.+++.+||..+|.+|||+.+++++.+
T Consensus 210 ~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 210 FEAM------AAIFKIATQP---------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred cchH------HHHHHHhccC---------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 3211 1111111110 111222334456889999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=280.23 Aligned_cols=218 Identities=22% Similarity=0.326 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeC--------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLET--------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++... ..+++||||+++ +|.+++.........+++..++.++.||+.||+|||+.+
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~ 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 57889999999999987532 246799999964 888877654444456899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHH
Q 045989 74 SIPIYHRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~ 151 (295)
|+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 191 ---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 265 (440)
T PTZ00036 191 ---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265 (440)
T ss_pred ---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999998665 79999999998654322 12334689999999998664 6899999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhch---------------hhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENR---------------LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
+|.+||......+. .... .+...... +............+...+..+.+|+.+||+.||.+|
T Consensus 266 tG~~pf~~~~~~~~--~~~i-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 266 LGYPIFSGQSSVDQ--LVRI-IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred hCCCCCCCCChHHH--HHHH-HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999964332111 1111 11100000 000000011111222344678999999999999999
Q ss_pred CCHHHHHHHHHH
Q 045989 217 PTMKEVALELAG 228 (295)
Q Consensus 217 ps~~e~~~~l~~ 228 (295)
||+.|+++|.+-
T Consensus 343 ~ta~e~l~hp~f 354 (440)
T PTZ00036 343 LNPIEALADPFF 354 (440)
T ss_pred cCHHHHhCChhH
Confidence 999999999764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.36 Aligned_cols=212 Identities=25% Similarity=0.335 Sum_probs=168.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++|+||+++|+|.+++.........+++..++.++.|++.||+|||+++ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08228 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRD 131 (267)
T ss_pred HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 467899999999999999999999999999999999998754444446899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 132 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCHHHEEEcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 999999999999999999999876543221 1223457889999999988889999999999999999999999985321
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
. ........ ..... .........+..+.+++.+||+.+|++||++.++++.+++++
T Consensus 211 ~----~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 211 M----NLFSLCQK-IEQCD--------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred c----cHHHHHHH-HhcCC--------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 11111111 11100 011112234566899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=264.34 Aligned_cols=207 Identities=28% Similarity=0.452 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------QLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++......++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 62 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 139 (277)
T cd05032 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-- 139 (277)
T ss_pred HHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467889999999999999999999999999999999999754321 224788899999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
++|+||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|++++ |
T Consensus 140 -i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 218 (277)
T cd05032 140 -FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLA 218 (277)
T ss_pred -ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccC
Confidence 99999999999999999999999999875543221 11223346788999999988889999999999999999998 8
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..||......+ ......... ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 219 ~~p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 219 EQPYQGLSNEE------VLKFVIDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCccCCHHH------HHHHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 99985332211 111111111 11122223566899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.18 Aligned_cols=207 Identities=25% Similarity=0.500 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++... ..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 62 ~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~d 134 (316)
T cd05108 62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERR---LVHRD 134 (316)
T ss_pred HHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcC---eeccc
Confidence 56789999999999999865 57899999999999999986443 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 135 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 135 LAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999998665432221 122234678999999999999999999999999999998 9999864
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
....+ +........ ....+..++..+.+++.+||..+|.+||++.+++..+..+..
T Consensus 215 ~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 215 IPASE-------ISSILEKGE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCHHH-------HHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 32211 111111110 001112234458899999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.66 Aligned_cols=212 Identities=25% Similarity=0.441 Sum_probs=166.7
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+++.+ +||||+++++++......++||||+++|+|.+++...... ...+++..+..++.|++.||+|
T Consensus 73 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 152 (304)
T cd05101 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152 (304)
T ss_pred HHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHH
Confidence 35667 8999999999999999999999999999999999764321 2247888999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+++ ++||||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++
T Consensus 153 LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 229 (304)
T cd05101 153 LASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229 (304)
T ss_pred HHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHH
Confidence 99999 9999999999999999999999999998654322221 2223456789999999888899999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||.... ............ ....+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 230 ~el~~~g~~p~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 230 WEIFTLGGSPYPGIP------VEELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHcCCCCCcccCC------HHHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 99998 788875332 122222111111 1111223455689999999999999999999999999
Q ss_pred HHhHHh
Q 045989 227 AGIRAS 232 (295)
Q Consensus 227 ~~~~~~ 232 (295)
..+...
T Consensus 294 ~~~~~~ 299 (304)
T cd05101 294 DRILTL 299 (304)
T ss_pred HHHHHh
Confidence 876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.52 Aligned_cols=198 Identities=23% Similarity=0.313 Sum_probs=158.6
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
.++||||+++++++..++..|+||||+.||+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp 124 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCH
Confidence 4589999999999999999999999999999999887543 4889999999999999999999999 99999999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhh
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 164 (295)
+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~- 202 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED- 202 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-
Confidence 99999999999999999987432211 2233456899999999999999999999999999999999999999643221
Q ss_pred cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q 045989 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK-EVALELA 227 (295)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~~~~l~ 227 (295)
.....+.... ...+...+..+.+++.+||+.||.+||++. ++++|.+
T Consensus 203 -----~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~ 250 (316)
T cd05620 203 -----ELFESIRVDT-----------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250 (316)
T ss_pred -----HHHHHHHhCC-----------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence 1111111110 011122345588999999999999999984 6665643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.52 Aligned_cols=210 Identities=25% Similarity=0.433 Sum_probs=163.3
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
++.++ +||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||+|
T Consensus 60 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 139 (303)
T cd05088 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 139 (303)
T ss_pred HHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHH
Confidence 35677 899999999999999999999999999999999975431 12357899999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
||+.+ ++||||||+||+++.++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|
T Consensus 140 LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 140 LSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HHhCC---ccccccchheEEecCCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 99999 999999999999999999999999998632111 1111122456799999998888999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+|++ |..||...... ...... ... .....+...+..+.+++.+||+.+|++||++.+++..++
T Consensus 215 ellt~g~~p~~~~~~~------~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 215 EIVSLGGTPYCGMTCA------ELYEKL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHhcCCCCcccCChH------HHHHHH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9998 99998533221 111111 110 001111223446889999999999999999999999998
Q ss_pred HhHHh
Q 045989 228 GIRAS 232 (295)
Q Consensus 228 ~~~~~ 232 (295)
.+...
T Consensus 279 ~~~~~ 283 (303)
T cd05088 279 RMLEE 283 (303)
T ss_pred HHHHh
Confidence 76443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=263.69 Aligned_cols=207 Identities=22% Similarity=0.377 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT------------EDQLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
++++++||||+++++++......++++||+.+++|.+++.... .....+++..++.++.|++.||+||
T Consensus 61 ~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l 140 (283)
T cd05091 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL 140 (283)
T ss_pred HHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999985321 1123478889999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
|+.+ ++||||||+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|
T Consensus 141 H~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 217 (283)
T cd05091 141 SSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW 217 (283)
T ss_pred HHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHH
Confidence 9999 99999999999999999999999999876533221 1223334678899999998888999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||++ |..||...... .....+.... ....+...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus 218 el~~~g~~p~~~~~~~------~~~~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 218 EVFSYGLQPYCGYSNQ------DVIEMIRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHcCCCCCCCCCCHH------HHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 9998 88887533221 1111111111 11223345566899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=275.75 Aligned_cols=208 Identities=26% Similarity=0.460 Sum_probs=182.2
Q ss_pred CcccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 1 ~il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
.||++++||||++++|+|.+. ..|||||.++-|.|..+++.... .++..+...+++||+.||+|||+.. +|||
T Consensus 443 ~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr---fVHR 515 (974)
T KOG4257|consen 443 SIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR---FVHR 515 (974)
T ss_pred HHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc---hhhh
Confidence 378999999999999999875 78999999999999999997766 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
||...||||....-+||+|||+++.+............-...|||||.+.-..++.++|||.|||.+||+++ |..||..
T Consensus 516 DIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 516 DIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 999999999999999999999999887766655555455788999999999999999999999999999988 9999976
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
....+ +.-.+..+.+.+.|..++..++.|+.+||..+|.+||++.++...|..+..
T Consensus 596 vkNsD----------------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 596 VKNSD----------------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ccccc----------------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 55443 222333444567788899999999999999999999999999998877655
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=266.65 Aligned_cols=197 Identities=25% Similarity=0.330 Sum_probs=158.5
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
.++||||+++++++..++..++||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp 124 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKL 124 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCH
Confidence 3599999999999999999999999999999999987543 4889999999999999999999999 99999999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhh
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 164 (295)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~- 202 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE- 202 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-
Confidence 99999999999999999987432221 1223456899999999999989999999999999999999999999643221
Q ss_pred cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHH
Q 045989 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK-EVALEL 226 (295)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~~~~l 226 (295)
.....+.... ...+...+..+.+++.+||+.||.+||++. ++..|.
T Consensus 203 -----~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~ 249 (316)
T cd05619 203 -----ELFQSIRMDN-----------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHP 249 (316)
T ss_pred -----HHHHHHHhCC-----------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence 1111111110 011122344588999999999999999997 666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=258.23 Aligned_cols=204 Identities=26% Similarity=0.440 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++..... .+.+..++.++.|++.||.|||+.+ ++|+|
T Consensus 45 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~d 118 (250)
T cd05085 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118 (250)
T ss_pred HHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 46788999999999999999999999999999999999875432 3789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 119 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred cChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999987543322211122234667999999988889999999999999999998 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.... ......... ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 199 ~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 199 TNQQ------AREQVEKGY----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHH------HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2211 111111110 00112223456899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=265.61 Aligned_cols=213 Identities=24% Similarity=0.453 Sum_probs=166.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+++++ +||||+++++++..++..++||||+++|+|.+++..... ....+++..+..++.|++.||.|
T Consensus 70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 149 (314)
T cd05099 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEY 149 (314)
T ss_pred HHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHH
Confidence 35567 699999999999999999999999999999999976421 12348889999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+++ ++|+||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++
T Consensus 150 lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 226 (314)
T cd05099 150 LESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226 (314)
T ss_pred HHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHH
Confidence 99999 9999999999999999999999999997654322111 1112245679999999888899999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||......+ .+....... ....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 227 ~el~~~g~~p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 227 WEIFTLGGSPYPGIPVEE------LFKLLREGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHHhCCCCCCCCCCHHH------HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999 888885432211 111111110 0111223345688999999999999999999999999
Q ss_pred HHhHHhh
Q 045989 227 AGIRASI 233 (295)
Q Consensus 227 ~~~~~~~ 233 (295)
+.+....
T Consensus 291 ~~~~~~~ 297 (314)
T cd05099 291 DKVLAAV 297 (314)
T ss_pred HHHHHHh
Confidence 8876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=262.06 Aligned_cols=207 Identities=28% Similarity=0.402 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE---DQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++++++||||+++++++.+....++||||++|++|.+++..... ....+++..+..++.||+.||+|||+.+ ++
T Consensus 62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 138 (277)
T cd05036 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FI 138 (277)
T ss_pred HHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 46789999999999999999999999999999999999976432 1234899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCC---ceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 79 HRDIKSANILLDDKY---RAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 79 H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
|+||||+||+++.++ .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 139 H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g 218 (277)
T cd05036 139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG 218 (277)
T ss_pred ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 999999999998654 58999999988653222111 112233567999999998899999999999999999997 9
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..||....... ......... ....+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 219 ~~pf~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 219 YMPYPGRTNQE------VMEFVTGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCHHH------HHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 99986432211 111111111 01122233456899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.70 Aligned_cols=206 Identities=25% Similarity=0.347 Sum_probs=161.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++||||++||+|.+++... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 167 (371)
T cd05622 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRD 167 (371)
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 467789999999999999999999999999999999998653 2788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC----CCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS----QFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++.+||+|||+++..............||+.|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus 168 Lkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 999999999999999999999986543333233455799999999998754 3789999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~~ 228 (295)
.... ....+..+......... ......+..+.+++.+||..++.+ |+++.++++|.+-
T Consensus 248 ~~~~------~~~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 248 YADS------LVGTYSKIMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred CCCC------HHHHHHHHHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 6332 22222222222111110 111234456888999999844433 7899999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=264.39 Aligned_cols=211 Identities=25% Similarity=0.416 Sum_probs=164.0
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
+.++ +||||+++++++...+..++|+||+++++|.+++..... ....+++..++.++.|++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567 799999999999999999999999999999999975331 112488999999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 149 (295)
|+.+ ++||||||+||+++.++.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|+
T Consensus 136 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 210 (297)
T cd05089 136 SEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210 (297)
T ss_pred HHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHH
Confidence 9999 999999999999999999999999998632211 11111123457999999988889999999999999999
Q ss_pred HHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 150 LLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 150 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|++ |..||...... ......... .....+...+..+.+++.+||+.+|.+|||+.++++.|..
T Consensus 211 l~t~g~~pf~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 211 IVSLGGTPYCGMTCA------ELYEKLPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred HHcCCCCCCCCCCHH------HHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 997 99998633221 111111111 1111122344568899999999999999999999999988
Q ss_pred hHHhhc
Q 045989 229 IRASIG 234 (295)
Q Consensus 229 ~~~~~~ 234 (295)
+.....
T Consensus 275 ~~~~~~ 280 (297)
T cd05089 275 MLEARK 280 (297)
T ss_pred HHHhhc
Confidence 765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=266.43 Aligned_cols=213 Identities=27% Similarity=0.459 Sum_probs=166.5
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+++++ +||||+++++++..++..++||||+++|+|.+++...... ...+++..+..++.|++.||+|
T Consensus 76 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 155 (307)
T cd05098 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155 (307)
T ss_pred HHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 34566 7999999999999999999999999999999999764321 1248889999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+.+ ++|+||||+||+++.++.++|+|||+++......... .....++..|+|||++.+..++.++|||||||++
T Consensus 156 lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 232 (307)
T cd05098 156 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 232 (307)
T ss_pred HHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHH
Confidence 99999 9999999999999999999999999987553221111 1112245689999999988899999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||...... ..... .... .....+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 233 ~el~~~g~~p~~~~~~~------~~~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 233 WEIFTLGGSPYPGVPVE------ELFKL-LKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHHcCCCCCCCcCCHH------HHHHH-HHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99998 88888533221 11111 1111 11122223445688999999999999999999999999
Q ss_pred HHhHHhh
Q 045989 227 AGIRASI 233 (295)
Q Consensus 227 ~~~~~~~ 233 (295)
+.+.+..
T Consensus 297 ~~~~~~~ 303 (307)
T cd05098 297 DRILALT 303 (307)
T ss_pred HHHHHHh
Confidence 8876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=266.96 Aligned_cols=214 Identities=25% Similarity=0.444 Sum_probs=167.4
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+++++ +||||+++++++..++..++++||+++|+|.+++..... ....+++..+..++.|++.||+|
T Consensus 70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 149 (334)
T cd05100 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY 149 (334)
T ss_pred HHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 35667 899999999999999999999999999999999975421 12247888999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+++ ++||||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++
T Consensus 150 LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 226 (334)
T cd05100 150 LASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226 (334)
T ss_pred HHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHH
Confidence 99999 9999999999999999999999999987654322111 1222345679999999998999999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||..... ........... ....+...+..+.+++.+||+.+|.+||++.+++++|
T Consensus 227 ~el~~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 227 WEIFTLGGSPYPGIPV------EELFKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHhcCCCCCCCCCH------HHHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99998 8888864322 12222111111 1111223345688999999999999999999999999
Q ss_pred HHhHHhhc
Q 045989 227 AGIRASIG 234 (295)
Q Consensus 227 ~~~~~~~~ 234 (295)
+.+.....
T Consensus 291 ~~~~~~~~ 298 (334)
T cd05100 291 DRVLTVTS 298 (334)
T ss_pred HHHhhhcC
Confidence 88865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=260.20 Aligned_cols=209 Identities=24% Similarity=0.423 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCc------cEEEEeecCCCCHHHHHhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEV------PLLVYEFIPNGSLHQYIHEQT--EDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~------~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++..... .++|+||+++|+|..++.... .....+++..++.++.|++.||+|||+.+
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~ 133 (273)
T cd05035 54 CMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN 133 (273)
T ss_pred HHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3677899999999999876554 799999999999999986543 22235899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
++||||||+||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++
T Consensus 134 ---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 134 ---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred ---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence 9999999999999999999999999998654332211 111234678999999988889999999999999999999
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|..||...... .......... ....+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus 211 ~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 211 RGQTPYPGVENH------EIYDYLRHGN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCCHH------HHHHHHHcCC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88888543221 1111111111 1112233455699999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=267.40 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=161.6
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++.+ +||||+++++++...+..++||||++||+|..++.... .+++..+..++.|++.||+|||+.+ ++|||
T Consensus 49 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~d 121 (318)
T cd05570 49 LALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG---IIYRD 121 (318)
T ss_pred HHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccC
Confidence 3444 79999999999999999999999999999999887643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 122 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 122 LKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred CCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999986432221 12233468999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-----KEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~~~~l~ 227 (295)
.. .....+..... ..+...+..+.+++.+||+.||.+||++ .+++++.+
T Consensus 201 ~~------~~~~~i~~~~~-----------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 201 ED------ELFQSILEDEV-----------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254 (318)
T ss_pred HH------HHHHHHHcCCC-----------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence 21 11111111110 1122334568899999999999999999 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.75 Aligned_cols=210 Identities=24% Similarity=0.408 Sum_probs=164.3
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-----------------------------------
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE----------------------------------- 45 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~----------------------------------- 45 (295)
+|+++. ||||+++++++......++|||||++|+|.+++.....
T Consensus 93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (400)
T cd05105 93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFE 172 (400)
T ss_pred HHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhc
Confidence 456775 99999999999999999999999999999999875321
Q ss_pred ---------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 045989 46 ---------------------------------------------------------DQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 46 ---------------------------------------------------------~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
....+++..+..++.|++.||+|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 252 (400)
T cd05105 173 NKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEF 252 (400)
T ss_pred ccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 01247788889999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+.+ ++|+||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++
T Consensus 253 LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil 329 (400)
T cd05105 253 LASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329 (400)
T ss_pred HHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHH
Confidence 99999 999999999999999999999999998765432221 12223467889999999988899999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||....... .+....... .....+...+..+.+++.+||+.+|++||++.+|.+.|
T Consensus 330 ~ellt~g~~P~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 330 WEIFSLGGTPYPGMIVDS------TFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHHCCCCCCcccchhH------HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 99997 889986332111 111111111 01112233456689999999999999999999999999
Q ss_pred HHh
Q 045989 227 AGI 229 (295)
Q Consensus 227 ~~~ 229 (295)
+.+
T Consensus 395 ~~l 397 (400)
T cd05105 395 ESL 397 (400)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=258.48 Aligned_cols=204 Identities=27% Similarity=0.453 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. ....++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 49 ~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~d 120 (257)
T cd05060 49 VMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH---FVHRD 120 (257)
T ss_pred HHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccC
Confidence 467899999999999876 456799999999999999997654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeee--ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT--QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++........... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 121 i~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~ 200 (257)
T cd05060 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200 (257)
T ss_pred cccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999998866433322111 1123467999999998899999999999999999998 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+.... ....+...+..+.+++.+||..+|.+||++.++++.|.+.
T Consensus 201 ~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 201 EMKGA------EVIAMLESGE----------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCHH------HHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 43221 1111111111 1112223445689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=246.59 Aligned_cols=212 Identities=26% Similarity=0.374 Sum_probs=167.4
Q ss_pred cCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 4 SQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++++||||++++++...+. ..||+++|+..|+|.+.++....++..+++.++++|+.+|++||++||+..+ ++.
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yA 151 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYA 151 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-ccc
Confidence 6789999999999986543 4899999999999999999888777789999999999999999999999984 599
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCccee--------eeccccccCCCChhhhcc---CCCCCCccchhhHHHH
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--------TTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l 147 (295)
||||||.||++++.+.+++.|||.+.......... .....-|..|.|||.+.- ...++++|||||||++
T Consensus 152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 99999999999999999999999987553221110 111235889999999864 4568899999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|.|+.|..||..... .+.++ -..+..+...-+....++..+.+++++||+.||.+||++.+++.++.
T Consensus 232 Ya~mf~~sPfe~~~~-~GgSl------------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQ-QGGSL------------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred HHHHHcCCcchHHhh-cCCeE------------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 999999999963322 11111 01111222222223347778999999999999999999999999887
Q ss_pred Hh
Q 045989 228 GI 229 (295)
Q Consensus 228 ~~ 229 (295)
.+
T Consensus 299 ~L 300 (302)
T KOG2345|consen 299 DL 300 (302)
T ss_pred hh
Confidence 64
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=259.41 Aligned_cols=211 Identities=26% Similarity=0.353 Sum_probs=169.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|+||+++++++..++..++||||+++|+|..++.........+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 131 (267)
T cd08224 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRD 131 (267)
T ss_pred HHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 467889999999999999999999999999999999999765444456899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 132 l~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 132 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cChhhEEECCCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 999999999999999999999875543221 1223457889999999988889999999999999999999999985322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEK-EEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
............ ......+. ..+..+.+++.+||..+|++|||+.+|++.++.++
T Consensus 211 ----~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 211 ----MNLYSLCKKIEK----------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----ccHHHHHhhhhc----------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111111111 01111111 44556899999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.85 Aligned_cols=206 Identities=25% Similarity=0.336 Sum_probs=160.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++.+..++.+++||||++||+|.+++.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG---FIHRD 126 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 5778999999999999999999999999999999999997643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc------------------------------------------ceeeecccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR------------------------------------------THLTTQVKG 119 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~------------------------------------------~~~~~~~~g 119 (295)
|||+||+++.++.+||+|||++..+.... ........|
T Consensus 127 lkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 206 (376)
T cd05598 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVG 206 (376)
T ss_pred CCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCC
Confidence 99999999999999999999975321000 000112468
Q ss_pred ccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHH
Q 045989 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVI 199 (295)
Q Consensus 120 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (295)
|+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+........ .......+.
T Consensus 207 t~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~-------~~~~~~~s~ 273 (376)
T cd05598 207 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE------TQLKVINWETTLH-------IPSQAKLSR 273 (376)
T ss_pred CccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH------HHHHHhccCcccc-------CCCCCCCCH
Confidence 999999999999999999999999999999999999996433221 1111111100000 001112344
Q ss_pred HHHHHHHHhhccCCCCCC---CHHHHHHHHHH
Q 045989 200 TVAMVAKRCLNLNGKKRP---TMKEVALELAG 228 (295)
Q Consensus 200 ~~~~li~~cl~~~p~~Rp---s~~e~~~~l~~ 228 (295)
.+.+++.+|+ .+|.+|+ ++.++++|.+-
T Consensus 274 ~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 274 EASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred HHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 5777888876 4999999 99999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=258.10 Aligned_cols=206 Identities=30% Similarity=0.471 Sum_probs=166.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-----QLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
++++++||||+++++++..+...++||||+++++|.+++...... ...+++..++.++.|++.||+|||+++
T Consensus 49 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--- 125 (262)
T cd00192 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--- 125 (262)
T ss_pred HHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---
Confidence 457789999999999999999999999999999999999875211 235899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQ 154 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~ 154 (295)
++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+....++.++||||||+++|+|++ |.
T Consensus 126 i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 205 (262)
T cd00192 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA 205 (262)
T ss_pred cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999986654321 12233457889999999988889999999999999999999 69
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.||...... ......... .....+...+..+.+++.+||+.+|.+|||+.+++++|
T Consensus 206 ~p~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 206 TPYPGLSNE------EVLEYLRKG----------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCHH------HHHHHHHcC----------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 998644221 111111111 11122233456799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=282.31 Aligned_cols=206 Identities=24% Similarity=0.310 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCC--------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE--------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|..++|+||+++++.+.... .+++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+
T Consensus 84 ~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~ 163 (496)
T PTZ00283 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH 163 (496)
T ss_pred HHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356789999999998876432 368999999999999999865554556899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
|+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 164 ---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt 240 (496)
T PTZ00283 164 ---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240 (496)
T ss_pred ---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987654322 122234568999999999999999999999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+.||.... ....+....... ....+...+..+.+++.+||+.||.+||++.+++.+.
T Consensus 241 G~~Pf~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 241 LKRPFDGEN------MEEVMHKTLAGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred CCCCCCCCC------HHHHHHHHhcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 999996332 222222221111 1122333456689999999999999999999998874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=277.11 Aligned_cols=194 Identities=28% Similarity=0.399 Sum_probs=162.0
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
+||.+++++..|.+.+++|+||||+.||++..+.+.. .+++..+.-++++|+.||.|||+++ |++||||.+|
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdN 498 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDN 498 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhh
Confidence 7999999999999999999999999999944433322 3999999999999999999999999 9999999999
Q ss_pred EEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcc
Q 045989 87 ILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166 (295)
Q Consensus 87 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 166 (295)
||+|..|.+||+|||+++.... ....+.++.||+.|||||++.+..|+.+.|.|||||+||||+.|..||...+.++
T Consensus 499 iLLD~eGh~kiADFGlcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-- 575 (694)
T KOG0694|consen 499 LLLDTEGHVKIADFGLCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-- 575 (694)
T ss_pred eEEcccCcEEecccccccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--
Confidence 9999999999999999986432 2345778899999999999999999999999999999999999999997544333
Q ss_pred cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 045989 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALEL 226 (295)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l 226 (295)
.+..+..... .+|...+.+..+|++++|.++|++|.- +.+|.+|.
T Consensus 576 ----~FdsI~~d~~-----------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 576 ----VFDSIVNDEV-----------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP 625 (694)
T ss_pred ----HHHHHhcCCC-----------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence 3333333322 334455567889999999999999964 46665553
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=274.09 Aligned_cols=202 Identities=26% Similarity=0.344 Sum_probs=156.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.... ...+..+..++.||+.||+|||+.+ |+|||
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 193 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRD 193 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 567899999999999999999999999999999986421 2567788899999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-----CCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+|||++.++.+||+|||+++...... .......||..|+|||++.. ...+.++|||||||++|+|++|+.|
T Consensus 194 lkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p 272 (353)
T PLN00034 194 IKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272 (353)
T ss_pred CCHHHEEEcCCCCEEEcccccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999987654321 11234568999999998743 2345689999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|......+ ........... .....+...+..+.++|.+||+.||++|||+.|+++|.+-
T Consensus 273 f~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 273 FGVGRQGD---WASLMCAICMS----------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred CCCCCCcc---HHHHHHHHhcc----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 97322111 11111111000 0111222345568999999999999999999999998654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=243.02 Aligned_cols=203 Identities=25% Similarity=0.338 Sum_probs=170.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|-+.|+||||++++++|-+....|+++||.++|.|...+...+.. .+++...+.++.|++.||.|+|..+ |+|||
T Consensus 75 Iqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRd 149 (281)
T KOG0580|consen 75 IQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLKR---VIHRD 149 (281)
T ss_pred eecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccCC---cccCC
Confidence 346799999999999999999999999999999999999865544 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|+|++.++.+|++|||-+.... .....+.+||..|.+||...+..++...|+|++|++.||++.|.+||....
T Consensus 150 iKpenlLlg~~~~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 150 IKPENLLLGSAGELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CCHHHhccCCCCCeeccCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 99999999999999999999886544 233556789999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....+.++..-. -..+...+....++|.+|+.++|.+|.+..|++.|.|-.
T Consensus 227 ------~~etYkrI~k~~-----------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 227 ------HSETYKRIRKVD-----------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ------hHHHHHHHHHcc-----------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 112222221111 122344455688999999999999999999999998754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=258.84 Aligned_cols=207 Identities=28% Similarity=0.457 Sum_probs=163.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED---QLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|++++||||+++++++...+..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~ 128 (269)
T cd05044 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FI 128 (269)
T ss_pred HHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 467899999999999999999999999999999999999754321 234788999999999999999999999 99
Q ss_pred eccCCCCeEEECCCC-----ceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 79 HRDIKSANILLDDKY-----RAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 79 H~dikp~Nill~~~~-----~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
|+||||+||+++.++ .++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++
T Consensus 129 H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 208 (269)
T cd05044 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208 (269)
T ss_pred cCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHH
Confidence 999999999999877 8999999998755332211 1122345678999999999899999999999999999998
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..||...... .......... ....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 209 ~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 209 LGQQPYPALNNQ------EVLQHVTAGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCCCCcccCHH------HHHHHHhcCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99998632211 1111111110 11122334567899999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=270.06 Aligned_cols=207 Identities=24% Similarity=0.316 Sum_probs=159.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+.+..++||||++||+|.+++.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrD 126 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG---FIHRD 126 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 5778999999999999999999999999999999999987643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc----------------------------------------------eeee
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT----------------------------------------------HLTT 115 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~----------------------------------------------~~~~ 115 (295)
|||+|||++.++.+||+|||+++....... ....
T Consensus 127 lKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (381)
T cd05626 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206 (381)
T ss_pred CcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence 999999999999999999998753311000 0012
Q ss_pred ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH
Q 045989 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK 195 (295)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (295)
...||+.|+|||++.+..++.++|||||||++|||++|..||......+ ....+......... ....
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~-------~~~~ 273 (381)
T cd05626 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE------TQLKVINWENTLHI-------PPQV 273 (381)
T ss_pred cccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH------HHHHHHccccccCC-------CCCC
Confidence 3469999999999998889999999999999999999999996433211 11111111000000 0111
Q ss_pred HHHHHHHHHHHHh--hccCCCCCCCHHHHHHHHHH
Q 045989 196 EEVITVAMVAKRC--LNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 196 ~~~~~~~~li~~c--l~~~p~~Rps~~e~~~~l~~ 228 (295)
..+..+.+++.+| +..++..||++.+++.|.+-
T Consensus 274 ~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f 308 (381)
T cd05626 274 KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308 (381)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence 2334577888884 45566679999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=259.56 Aligned_cols=209 Identities=25% Similarity=0.453 Sum_probs=161.0
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQT--EDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++... ...++||||+.+|+|.+++.... .....+++..+..++.|++.||+|||+++
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 132 (272)
T cd05075 53 CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS 132 (272)
T ss_pred HHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46788999999999987532 24689999999999999875322 22234899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
|+||||||+||+++.++.++|+|||+++......... .....+++.|+|||...+..++.++||||||+++|+|++
T Consensus 133 ---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 133 ---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred ---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 9999999999999999999999999998654332211 122245678999999998899999999999999999999
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|..||...... ........... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 210 ~g~~p~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 210 RGQTPYPGVENS------EIYDYLRQGNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCCHH------HHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 78888643221 11111111110 011123345689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.86 Aligned_cols=199 Identities=27% Similarity=0.380 Sum_probs=159.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++||||++||+|...+.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~D 121 (325)
T cd05604 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSIN---IVYRD 121 (325)
T ss_pred HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 4677899999999999999999999999999999998886543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 122 lkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 122 LKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 99999999999999999999987432211 12234568999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH----HHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK----EVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~----e~~~~ 225 (295)
. ...+....... . ......+..+.+++.+||+.+|.+||++. ++++|
T Consensus 201 ~------~~~~~~~~~~~-~----------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 201 V------AEMYDNILHKP-L----------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred H------HHHHHHHHcCC-c----------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 2 12222222111 0 01112344578899999999999999875 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=266.97 Aligned_cols=211 Identities=29% Similarity=0.485 Sum_probs=163.1
Q ss_pred cccCC-CCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCCC---------------------------------
Q 045989 2 ILSQI-NHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTED--------------------------------- 46 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~--------------------------------- 46 (295)
+++++ +||||+++++++... ...+++|||+++++|.+++......
T Consensus 63 ~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (337)
T cd05054 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSS 142 (337)
T ss_pred HHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccc
Confidence 34566 899999999988754 5688999999999999998643211
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccC
Q 045989 47 ------------------------QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGT 102 (295)
Q Consensus 47 ------------------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 102 (295)
...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~ 219 (337)
T cd05054 143 ASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 219 (337)
T ss_pred cccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEecccc
Confidence 125789999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhch
Q 045989 103 SRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENR 180 (295)
Q Consensus 103 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 180 (295)
+.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+ .+........
T Consensus 220 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~ 293 (337)
T cd05054 220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGT 293 (337)
T ss_pred chhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccC
Confidence 98654322211 222345678999999999999999999999999999998 999986422111 1111111110
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
....+...+..+.+++.+||+.+|++||++.+++++|+.+.
T Consensus 294 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 294 ---------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred ---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112233456899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=269.17 Aligned_cols=217 Identities=22% Similarity=0.362 Sum_probs=158.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++......++|||++ .++|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 182 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR---PLPIDQALIIEKQILEGLRYLHAQR---IIHRD 182 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 578899999999999999999999999999 4689888865433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC-ccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI-RLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~-~~~ 160 (295)
|||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||+++..|+ ...
T Consensus 183 lkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~ 260 (357)
T PHA03209 183 VKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260 (357)
T ss_pred CCHHHEEECCCCCEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCC
Confidence 99999999999999999999987432221 123346899999999999999999999999999999999865544 321
Q ss_pred chhh---cccHHHHHHHHHhhc-----hhh---------hhhhhhhh---------hhhhHHHHHHHHHHHHHhhccCCC
Q 045989 161 ETEE---NRSLAAYFLQVINEN-----RLF---------EVLDAQVL---------REAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 161 ~~~~---~~~~~~~~~~~~~~~-----~~~---------~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.... .......+....... .+. ..+..... .......+..+.++|.+||+.||+
T Consensus 261 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 340 (357)
T PHA03209 261 PSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340 (357)
T ss_pred CCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcc
Confidence 1110 000011111111100 000 00000000 000011233466799999999999
Q ss_pred CCCCHHHHHHHHH
Q 045989 215 KRPTMKEVALELA 227 (295)
Q Consensus 215 ~Rps~~e~~~~l~ 227 (295)
+|||+.|++.|.+
T Consensus 341 ~Rpta~e~l~hp~ 353 (357)
T PHA03209 341 MRPSAEEILNYPM 353 (357)
T ss_pred cCcCHHHHhcCch
Confidence 9999999999864
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=272.55 Aligned_cols=220 Identities=21% Similarity=0.309 Sum_probs=164.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++......++|||++. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrD 210 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGRG---IIHRD 210 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 5788999999999999999999999999994 68988884332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999876543322 1223456899999999999999999999999999999999999998644
Q ss_pred chhhcccHHHHHHHHHhhchhh----------hh---hhhhhhhhh-------hHHHHHHHHHHHHHhhccCCCCCCCHH
Q 045989 161 ETEENRSLAAYFLQVINENRLF----------EV---LDAQVLREA-------EKEEVITVAMVAKRCLNLNGKKRPTMK 220 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~ 220 (295)
...........+.+........ .. ......... ....+..+.++|.+||..||++|||+.
T Consensus 291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~ 370 (392)
T PHA03207 291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370 (392)
T ss_pred CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence 3221111111111100000000 00 000000000 011234678899999999999999999
Q ss_pred HHHHHHHHh
Q 045989 221 EVALELAGI 229 (295)
Q Consensus 221 e~~~~l~~~ 229 (295)
+++.|.+-.
T Consensus 371 e~l~~p~f~ 379 (392)
T PHA03207 371 DILSLPLFT 379 (392)
T ss_pred HHhhCchhh
Confidence 999997653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.15 Aligned_cols=207 Identities=26% Similarity=0.448 Sum_probs=162.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-----------DQLPITWEIRLGIAVEVSGALSYLH 70 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~Lh 70 (295)
++++++||||+++++++......++||||+++++|.+++..... ....+++..++.++.|++.||+|||
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 139 (280)
T cd05092 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA 139 (280)
T ss_pred HHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999999999999999999999999975431 1124789999999999999999999
Q ss_pred hCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHH
Q 045989 71 SAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 71 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 149 (295)
+.+ ++|+||||+||++++++.++|+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|+
T Consensus 140 ~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05092 140 SLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216 (280)
T ss_pred HCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence 999 9999999999999999999999999987543322111 122335678999999998899999999999999999
Q ss_pred HHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 150 LLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 150 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|++ |..||......+ .......... ...+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 217 l~~~g~~p~~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 217 IFTYGKQPWYQLSNTE------AIECITQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCCCCCCccCCHHH------HHHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 998 899985332211 1111111110 0111233456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=263.75 Aligned_cols=208 Identities=20% Similarity=0.312 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..|+||||++||+|.+++..... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 127 (331)
T cd05597 54 VLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQLG---YVHRD 127 (331)
T ss_pred HHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEECC
Confidence 45678999999999999999999999999999999999975332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-----CCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.+||+|||++...............||+.|+|||++.. ..++.++|||||||++|+|++|+.|
T Consensus 128 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred CCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 99999999999999999999987654333322333468999999999863 4578899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGK--KRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~--~Rps~~e~~~~l~ 227 (295)
|..... ......+......... .......+..+.+++.+||..+++ .||++.++++|.+
T Consensus 208 f~~~~~------~~~~~~i~~~~~~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 208 FYAESL------VETYGKIMNHKEHFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCCCCH------HHHHHHHHcCCCcccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 963221 1222222221111110 011112445688899998865443 4889999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.99 Aligned_cols=201 Identities=23% Similarity=0.356 Sum_probs=169.2
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|+-++|||||++|.+...+..+|+|+|.-++|+|+++|-+... .+.+..+.++++||+.|+.|+|+.+ +|||||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDL 144 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDL 144 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh---hhcccC
Confidence 5667999999999999999999999999999999999987655 3999999999999999999999999 999999
Q ss_pred CCCeEEE-CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCC-CCccchhhHHHHHHHHhCCCCCccc
Q 045989 83 KSANILL-DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 83 kp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||+|+.+ .+-|-+||+|||++-.+. ......+.+|...|-|||++.+..|+ ++.||||||||||.|++|++||...
T Consensus 145 KPENVVFFEKlGlVKLTDFGFSNkf~--PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 145 KPENVVFFEKLGLVKLTDFGFSNKFQ--PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred CcceeEEeeecCceEeeeccccccCC--CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 9999865 567899999999987543 33446677899999999999999997 6789999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+..+.. ..+++= .-..|.-.+.++.+||..||..||.+|.+.++|+.+-|-
T Consensus 223 NDSETL---------------TmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 223 NDSETL---------------TMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred cchhhh---------------hhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 433311 111111 113455667789999999999999999999999887653
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=257.64 Aligned_cols=205 Identities=26% Similarity=0.421 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. ....+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 578899999999999885 4568999999999999999975432 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............++..|+|||...+..++.++||||||+++|+|++ |..||...
T Consensus 128 i~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred CccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999997654332222222345668999999988889999999999999999999 88898632
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ......... .....+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 208 ~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 208 NNR------EVLEQVERG----------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CHH------HHHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 211 111111111 0111223445569999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=258.34 Aligned_cols=212 Identities=25% Similarity=0.330 Sum_probs=168.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..+++|||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08229 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRD 131 (267)
T ss_pred HHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 467889999999999999999999999999999999998754444446899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 132 l~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 132 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCHHHEEEcCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 999999999999999999999875543221 1223458889999999988889999999999999999999999985322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
.. .......... . .. ........+..+.+++.+||+.+|.+|||+.+|++.+..+.
T Consensus 211 ~~----~~~~~~~~~~-~-----~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 211 MN----LYSLCKKIEQ-C-----DY---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ch----HHHHhhhhhc-C-----CC---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11 1111111100 0 00 00111234567999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=280.15 Aligned_cols=208 Identities=24% Similarity=0.348 Sum_probs=166.0
Q ss_pred cccCCC-CccccceeeEE-Ee---C---CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQIN-HRNVVKLLGCC-LE---T---EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~-~~---~---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++|+ |||||.|+|+. .. + -..+|+||||.||.|-+++..+...+ |++..+++|++++++|+++||...
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~ 164 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLK 164 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCC
Confidence 578885 99999999943 21 1 24689999999999999998765543 999999999999999999999987
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee--------eeccccccCCCChhhh---ccCCCCCCccchh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--------TTQVKGTFGYLDPEYF---QSSQFTEKSDVYS 142 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~~Diws 142 (295)
.+|+|||||-+||||+.++..||||||.+.-........ .-...-|+-|+|||.+ .+...++|+|||+
T Consensus 165 -pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 165 -PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred -CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 559999999999999999999999999886433222110 0012468999999987 4567899999999
Q ss_pred hHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 143 FGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 143 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
|||+||-|+....||.... -..+++....-+....++..+.+||+.||+.||.+||++-++
T Consensus 244 LGclLYkLCy~t~PFe~sg-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv 304 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEESG-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV 304 (738)
T ss_pred HHHHHHHHHHhCCCcCcCc-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence 9999999999999996321 112333333333345788889999999999999999999999
Q ss_pred HHHHHHhHH
Q 045989 223 ALELAGIRA 231 (295)
Q Consensus 223 ~~~l~~~~~ 231 (295)
+.++..++.
T Consensus 305 ~~~~~~l~~ 313 (738)
T KOG1989|consen 305 LEEIFELAN 313 (738)
T ss_pred HHHHHHHhc
Confidence 999877654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=262.85 Aligned_cols=207 Identities=27% Similarity=0.467 Sum_probs=164.2
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+++++ +||||+++++++...+..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+
T Consensus 91 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~ 165 (302)
T cd05055 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN---CIHR 165 (302)
T ss_pred HHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eehh
Confidence 45678 899999999999999999999999999999999975332 23899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||+||++|+|++ |..||.
T Consensus 166 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~ 245 (302)
T cd05055 166 DLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245 (302)
T ss_pred hhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999999998765433221 1222345778999999988889999999999999999998 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.....+ .+....... .....+...+..+.+++.+||..+|++|||+.++++.|..
T Consensus 246 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 246 GMPVDS------KFYKLIKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCCchH------HHHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 332211 111111111 0011112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=250.35 Aligned_cols=209 Identities=22% Similarity=0.270 Sum_probs=165.8
Q ss_pred CCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 6 INHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 6 l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
-.|||||.++++|+. .+.+.+|||.++||.|+..++.+... .+++..+..|+.||+.|+.|||+.+ |.|||
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~lH~~n---IAHRD 186 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRYLHSMN---IAHRD 186 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHHHHhcc---hhhcc
Confidence 379999999999875 34678999999999999999876544 6999999999999999999999999 99999
Q ss_pred CCCCeEEEC---CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLD---DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+|+|.. .+..+||+|||+|+..... ....+..-|++|.|||++....|+..+|+||+||++|-|++|.+||-
T Consensus 187 lKpENLLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 187 LKPENLLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred CChhheeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999999996 4567999999999865432 22344556999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
.... ..+..-++..+..+.+ + ...+-....++...++|+.+|..+|.+|.|+.+++.|.|--.
T Consensus 265 S~hg---~aispgMk~rI~~gqy-~-----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 265 SNHG---LAISPGMKRRIRTGQY-E-----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ccCC---ccCChhHHhHhhccCc-c-----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 4432 1111112222222211 0 112223456677899999999999999999999999987643
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=257.59 Aligned_cols=206 Identities=25% Similarity=0.449 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~d 131 (267)
T cd05066 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMG---YVHRD 131 (267)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---Eeehh
Confidence 46788999999999999999999999999999999999975432 4789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeec--cccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ--VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.++|+|||++............. ..++..|+|||.+.+..++.++|+||||+++|++++ |..||.
T Consensus 132 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~ 211 (267)
T cd05066 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 211 (267)
T ss_pred hchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence 99999999999999999999998664433222211 223567999999998889999999999999999886 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.....+ .......... .+.+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 212 ~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 212 EMSNQD------VIKAIEEGYR----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCHHH------HHHHHhCCCc----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 432211 1111111100 011223345688999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=256.19 Aligned_cols=205 Identities=27% Similarity=0.403 Sum_probs=161.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|||++++++++. .+..++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecc
Confidence 577899999999999885 4568999999999999999975432 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............++..|+|||...+..++.++||||||+++|+|++ |..||...
T Consensus 128 l~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997654332222222345678999999988889999999999999999999 89998633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...+ ......... ....+...+..+.+++.+||..||++||++.++++.|+.
T Consensus 208 ~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 208 VNRE------VLEQVERGY----------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CHHH------HHHHHHcCC----------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2111 111111110 001122345668999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=257.77 Aligned_cols=207 Identities=29% Similarity=0.455 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++.. ...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 60 ~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~d 132 (270)
T cd05056 60 IMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESKR---FVHRD 132 (270)
T ss_pred HHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 4678999999999999875 567899999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||+++..............++..|+|||.+....++.++||||||++++++++ |..||...
T Consensus 133 l~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 133 IAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987654432222222234568999999988889999999999999999986 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...+ ........... ..+...+..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 213 ~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 213 KNND------VIGRIENGERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CHHH------HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3221 11111111100 1122345569999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=270.30 Aligned_cols=205 Identities=23% Similarity=0.353 Sum_probs=158.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.++...|+||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrD 126 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRD 126 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4678899999999999999999999999999999999987543 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce----------------------------------------------eee
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH----------------------------------------------LTT 115 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------------------------------------------~~~ 115 (295)
|||+||+++.++.+||+|||+++.+...... ...
T Consensus 127 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (377)
T cd05629 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206 (377)
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence 9999999999999999999998633210000 001
Q ss_pred ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH
Q 045989 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK 195 (295)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (295)
...||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..+......... ....
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~-------p~~~ 273 (377)
T cd05629 207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH------ETYRKIINWRETLYF-------PDDI 273 (377)
T ss_pred ccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH------HHHHHHHccCCccCC-------CCCC
Confidence 245899999999999989999999999999999999999999633221 112222111100000 0001
Q ss_pred HHHHHHHHHHHHhhccCCCCC---CCHHHHHHHHH
Q 045989 196 EEVITVAMVAKRCLNLNGKKR---PTMKEVALELA 227 (295)
Q Consensus 196 ~~~~~~~~li~~cl~~~p~~R---ps~~e~~~~l~ 227 (295)
..+..+.+++.+||. +|.+| +++.+++.|.+
T Consensus 274 ~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 274 HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 233458889999997 66665 69999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.57 Aligned_cols=208 Identities=23% Similarity=0.448 Sum_probs=180.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||.+.+||||++|.|+....+..+||.|||++|+|..+|+.+..+ |.+-++.-+++.|+.|+.||-+.+ +||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~---YVHRD 756 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMN---YVHRD 756 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcC---chhhh
Confidence 789999999999999999999999999999999999999976643 899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeecc--ccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV--KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|.+.||||+.+..+|++|||+++....+.....++. .-..+|.|||.+...+++.++||||+|+++||.++ |..||.
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 999999999999999999999997755443323222 23679999999999999999999999999999988 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
.... ..+..-+..+...+.|.+++..+.+|+..||++|..+||.+.+|+..|.++.+
T Consensus 837 dmSN----------------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 837 DMSN----------------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ccch----------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 3322 12333444555667788899999999999999999999999999999988754
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=256.71 Aligned_cols=202 Identities=24% Similarity=0.369 Sum_probs=162.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~d 125 (255)
T cd08219 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRD 125 (255)
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCC
Confidence 46788999999999999999999999999999999998865332 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||.+........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 126 l~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 126 IKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred CCcceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 999999999999999999999875543221 1223468889999999998889999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
........... .....+...+..+.+++.+||+.||++||++.+++..
T Consensus 205 ------~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 205 ------WKNLILKVCQG----------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------HHHHHHHHhcC----------CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111111111 0111222344568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=257.33 Aligned_cols=206 Identities=24% Similarity=0.436 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 132 (268)
T cd05063 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRD 132 (268)
T ss_pred HHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 46789999999999999999999999999999999999875432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeee--ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT--QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.++|+|||++............ ....+..|+|||++.+..++.++|||||||++|++++ |..||.
T Consensus 133 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred cchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998765432221111 1123457999999988889999999999999999997 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+.... ..+.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 213 ~~~~~------~~~~~i~~~~----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 213 DMSNH------EVMKAINDGF----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred cCCHH------HHHHHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 33221 1222211111 1111223445689999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=265.40 Aligned_cols=215 Identities=22% Similarity=0.299 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++||||+++|+|.+++...... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~d 126 (327)
T cd08227 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHMG---YVHRS 126 (327)
T ss_pred HHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 467789999999999999999999999999999999999754322 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce------eeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g 153 (295)
|||+||+++.++.++++||+........... ......++..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 127 lkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 127 VKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred CChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999865432211100 0112346778999999976 4588999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhh------------------------------------hhhhhhhhHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLD------------------------------------AQVLREAEKEE 197 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~ 197 (295)
..||....... ........ ......+ ...........
T Consensus 207 ~~pf~~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (327)
T cd08227 207 HVPFKDMPATQ------MLLEKLNG-TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTF 279 (327)
T ss_pred CCCCCCcchhH------HHHHHhcC-CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccccccc
Confidence 99996432211 00000000 0000000 00001112234
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 198 VITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 198 ~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+..+.+++.+||+.||++|||+.++++|.+-
T Consensus 280 ~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 280 SPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred CHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 5578999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=262.03 Aligned_cols=207 Identities=25% Similarity=0.301 Sum_probs=164.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++.+..++..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 127 (285)
T cd05605 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER---IVYRD 127 (285)
T ss_pred HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecC
Confidence 56789999999999999999999999999999999988865322 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||++++++.++|+|||++........ .....|+..|+|||++.+..++.++||||+||++|+|++|..||....
T Consensus 128 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 128 LKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 999999999999999999999876432221 223468999999999998889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
... ....+...... .....+...+..+.+++.+||+.||.+|| ++.++++|.+-
T Consensus 206 ~~~---~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 206 EKV---KREEVERRVKE----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred hhh---HHHHHHHHhhh----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 211 00001110000 01122233456689999999999999999 89999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.69 Aligned_cols=206 Identities=25% Similarity=0.388 Sum_probs=162.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++.. ...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~d 127 (262)
T cd05071 54 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127 (262)
T ss_pred HHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 4678899999999998754 567999999999999999975322 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.+...............++..|+|||+..+..++.++||||||+++|+|++ |..||...
T Consensus 128 l~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred cCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999987654333222223346678999999988889999999999999999999 88888633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
...+ ......... ........+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 208 ~~~~------~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 208 VNRE------VLDQVERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ChHH------HHHHHhcCC----------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2211 111111110 0111234456689999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=272.92 Aligned_cols=219 Identities=22% Similarity=0.345 Sum_probs=161.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++..++..++|||++ .++|..++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 285 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGEG---IIHRD 285 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECc
Confidence 578899999999999999999999999999 5699888865432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus 286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 9999999999999999999999765332211 122356899999999999999999999999999999999987665332
Q ss_pred chh-hcccHHHHHHHHHhhchhh-------------hhhhhh--------hhh---hhhHHHHHHHHHHHHHhhccCCCC
Q 045989 161 ETE-ENRSLAAYFLQVINENRLF-------------EVLDAQ--------VLR---EAEKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 161 ~~~-~~~~~~~~~~~~~~~~~~~-------------~~~~~~--------~~~---~~~~~~~~~~~~li~~cl~~~p~~ 215 (295)
... ........+.+++...... ...... ... .........+.+||.+||+.||.+
T Consensus 366 ~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~ 445 (461)
T PHA03211 366 SRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGAR 445 (461)
T ss_pred CcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhh
Confidence 211 1111111122222111100 000000 000 000012235888999999999999
Q ss_pred CCCHHHHHHHHH
Q 045989 216 RPTMKEVALELA 227 (295)
Q Consensus 216 Rps~~e~~~~l~ 227 (295)
|||+.|+++|.+
T Consensus 446 RPsa~elL~hp~ 457 (461)
T PHA03211 446 RPSAAELLRLPL 457 (461)
T ss_pred CcCHHHHhhCcc
Confidence 999999999854
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=255.94 Aligned_cols=202 Identities=27% Similarity=0.465 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEE-eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++||||+++++++. .+...++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 126 (256)
T cd05082 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126 (256)
T ss_pred HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 467899999999999865 45678999999999999999875432 24889999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
||||+||+++.++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 127 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987543221 12234567999999998889999999999999999997 9999863
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ......+... .....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 203 ~~~------~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 203 IPL------KDVVPRVEKG----------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCH------HHHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 221 1111111110 0011122345568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=265.34 Aligned_cols=221 Identities=20% Similarity=0.325 Sum_probs=156.1
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQT-----EDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++++||||+++++++.. +...++||||+. ++|..++.... .....+++..+..++.||+.||+|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 128 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5788999999999999864 456899999994 58988876332 12234889999999999999999999999
Q ss_pred CCeEeccCCCCeEEE----CCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhcc-CCCCCCccchhhHHHH
Q 045989 75 IPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 75 ~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l 147 (295)
|+||||||+|||+ +.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++||||+||++
T Consensus 129 --ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999999999 4567899999999986543221 12234568999999999876 4589999999999999
Q ss_pred HHHHhCCCCCcccchhhcc---cHHHHHHHHHhhch------------------hhhhhhhh---------hhhhhhHHH
Q 045989 148 VELLTGQKPIRLVETEENR---SLAAYFLQVINENR------------------LFEVLDAQ---------VLREAEKEE 197 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~------------------~~~~~~~~---------~~~~~~~~~ 197 (295)
|+|++|.+||......... .....+..+..... ........ .........
T Consensus 207 ~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (317)
T cd07868 207 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 286 (317)
T ss_pred HHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCC
Confidence 9999999999643321110 00011111110000 00000000 000000011
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 198 VITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 198 ~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+.+++.+||+.||.+|||++|+++|.
T Consensus 287 ~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 287 DSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred ChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 23478899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.62 Aligned_cols=207 Identities=29% Similarity=0.466 Sum_probs=158.8
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+++.++||||+++++++.. ++..++||||+.+|+|.+++..... ...+..+..++.|++.||+|||+.+ ++||
T Consensus 49 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 122 (262)
T cd05058 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKK---FVHR 122 (262)
T ss_pred HHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 4678999999999998764 5568999999999999999975433 3677788899999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC-CCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG-QKP 156 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p 156 (295)
||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++| .+|
T Consensus 123 dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 202 (262)
T cd05058 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202 (262)
T ss_pred ccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999998754322111 11123457789999999888899999999999999999995 556
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
|...... ........... ...+...+..+.+++.+||+.+|++||++.++++.++.+.
T Consensus 203 ~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 203 YPDVDSF------DITVYLLQGRR----------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCHH------HHHHHHhcCCC----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 6432211 11111111100 0111123446889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.16 Aligned_cols=211 Identities=25% Similarity=0.447 Sum_probs=165.6
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTED----QLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++.. +...++++||+++++|.+++...... ...+++..++.++.|++.||+|||+.+
T Consensus 61 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--- 137 (280)
T cd05043 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--- 137 (280)
T ss_pred HHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678899999999999876 56789999999999999998764322 145899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQ 154 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~ 154 (295)
++|+||||+||+++.++.+||+|||+++.+....... .....++..|+|||++.+..++.++||||||+++|++++ |+
T Consensus 138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 9999999999999999999999999998654322221 122345678999999998889999999999999999999 99
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
.||......+ ........... ..+...+..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 218 ~p~~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 218 TPYVEIDPFE------MAAYLKDGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCcCcCCHHH------HHHHHHcCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9986432211 11111111100 1112234568999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=256.92 Aligned_cols=196 Identities=23% Similarity=0.433 Sum_probs=154.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++|+|..++..... .+++..++.++.||+.||+|||+.+ ++|||
T Consensus 57 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 130 (262)
T cd05077 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLEDKD---LVHGN 130 (262)
T ss_pred HHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhhhCC---eECCC
Confidence 46788999999999999999999999999999999988865332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc-------eEEeeccCccccccCcceeeeccccccCCCChhhhc-cCCCCCCccchhhHHHHHHHH-h
Q 045989 82 IKSANILLDDKYR-------AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-SSQFTEKSDVYSFGVVLVELL-T 152 (295)
Q Consensus 82 ikp~Nill~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~-~ 152 (295)
|||+||+++.++. ++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ .
T Consensus 131 lkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 131 VCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 9999999986654 899999988654321 2335788899999886 466889999999999999997 5
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|..||......+ ........ . .........+.+++.+||+.||.+||++.+|++++
T Consensus 206 ~~~p~~~~~~~~-------~~~~~~~~-~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 206 GEIPLKDKTLAE-------KERFYEGQ-C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCCCcchhH-------HHHHHhcC-c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 888875322111 00111100 0 00111234588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.87 Aligned_cols=210 Identities=23% Similarity=0.365 Sum_probs=156.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++......++||||+++|+|.+++..........++..++.++.||+.||+|||+.+ ++|||
T Consensus 48 ~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~d 124 (268)
T cd05086 48 PYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSD 124 (268)
T ss_pred HHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 356789999999999999999999999999999999999865433334677888899999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhcc-------CCCCCCccchhhHHHHHHHHh-
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQS-------SQFTEKSDVYSFGVVLVELLT- 152 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~- 152 (295)
|||+||+++.++.++|+|||++....... ........++..|+|||++.. ..++.++||||||+++|+|++
T Consensus 125 ikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 204 (268)
T cd05086 125 LALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFEN 204 (268)
T ss_pred CccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhC
Confidence 99999999999999999999876422111 111223457889999998753 245789999999999999997
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|..||..... ...+........ ....++.. .......+.+++..|| .+|++||++.+|++.|
T Consensus 205 ~~~p~~~~~~------~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 205 AAQPYSHLSD------REVLNHVIKDQQ-VKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCCCCCCCH------HHHHHHHHhhcc-cccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 5667753221 111222211111 11111111 1223456888999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=255.77 Aligned_cols=205 Identities=23% Similarity=0.401 Sum_probs=161.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. .+..+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~d 127 (260)
T cd05067 54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127 (260)
T ss_pred HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccc
Confidence 567899999999999874 4578999999999999999875432 35889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............++..|+|||++....++.++||||||+++|++++ |..||...
T Consensus 128 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654322222223345678999999988889999999999999999998 99998633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ......... .....+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 208 ~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 208 TNP------EVIQNLERG----------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ChH------HHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 211 111111111 0011122334569999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.15 Aligned_cols=214 Identities=25% Similarity=0.436 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-------QLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++++||||+++++++..++..++||||+++++|.+++...... ...+++.+++.++.|++.||+|||+.+
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~- 150 (296)
T cd05095 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN- 150 (296)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 467899999999999999999999999999999999999764321 123778899999999999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT- 152 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~- 152 (295)
++|+||||+||+++.++.++|+|||+++......... .....++..|+|||...+..++.++|||||||++|||++
T Consensus 151 --i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 151 --FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred --eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999987653322211 122234678999999888889999999999999999998
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..||......+. ........... ........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 229 ~~~~p~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 229 CKEQPYSQLSDEQV---IENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCCccccChHHH---HHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 6778753322211 00000000000 000001112234466899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.27 Aligned_cols=202 Identities=26% Similarity=0.351 Sum_probs=165.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||..|+|||+|+|+|+-.+++..+|.||||+||+|.++++... ..++.....+..|++.|++|||++| |||||
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g---IVHRD 1359 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRD 1359 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecC
Confidence 5788999999999999999999999999999999999998654 3677777788999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCC---CCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||.||+++.+|.+|++|||.|......... .....+||+.|||||++.+.. -..+.|||||||++.||+||+.
T Consensus 1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 9999999999999999999999877654311 223467999999999997643 4568999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
||...+.+ . +.+ ..+-.+...+.|...+.+-.+++.+||+.||+.|.++.|++++
T Consensus 1440 PW~~~dne---~--aIM----------y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1440 PWAELDNE---W--AIM----------YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhccch---h--HHH----------hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99644322 1 111 1112222234444566778899999999999999999999877
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=255.14 Aligned_cols=203 Identities=28% Similarity=0.415 Sum_probs=165.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+.+..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 126 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 5778999999999999999999999999999999999997643 225899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 127 l~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred CChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999876543332 2234468999999999988888999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
. ........... ....+...+..+.+++.+||..+|.+||+++++++++
T Consensus 206 ~------~~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 206 P------LNLVVKIVQGN----------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred H------HHHHHHHHcCC----------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 11122211111 1111233455688999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=272.19 Aligned_cols=216 Identities=25% Similarity=0.305 Sum_probs=161.1
Q ss_pred cccCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|+.++||||+++++++.... ..|+|+||+. ++|.+.+.... .+++..+..++.||+.||+|||+.+
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--- 123 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSAG--- 123 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 467889999999999998776 7899999995 58888875432 4899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~ 155 (295)
++||||||+||+++.++.+||+|||+++..............++..|+|||++.+. .++.++||||+||++|+|++|+.
T Consensus 124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 203 (372)
T cd07853 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203 (372)
T ss_pred eeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence 99999999999999999999999999976543332223344678999999998774 47899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhh----------hhhhhh--------hhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLF----------EVLDAQ--------VLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
||......+.. ..+.......... ..+... .........+..+.+++.+||+.||++||
T Consensus 204 pf~~~~~~~~~---~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 204 LFQAQSPIQQL---DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCCCHHHHH---HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 99654322110 0000000000000 000000 00001112245688999999999999999
Q ss_pred CHHHHHHHHHH
Q 045989 218 TMKEVALELAG 228 (295)
Q Consensus 218 s~~e~~~~l~~ 228 (295)
|+.++++|.+-
T Consensus 281 t~~e~l~hp~~ 291 (372)
T cd07853 281 SAADALAHPYL 291 (372)
T ss_pred CHHHHhcCHhh
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=255.14 Aligned_cols=202 Identities=30% Similarity=0.517 Sum_probs=163.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~d 127 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 56789999999999999998999999999999999999975432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.++....... ...++..|+|||.+....++.++||||||++++++++ |..||...
T Consensus 128 i~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred cccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999999876532211 2234667999999988889999999999999999997 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...+ .. ...... .....+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 204 ~~~~------~~-~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 204 PLKD------VV-PHVEKG---------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CHHH------HH-HHHhcC---------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 3221 11 111111 0011122345668999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.37 Aligned_cols=207 Identities=28% Similarity=0.492 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++.. ...++++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 62 ~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~d 134 (279)
T cd05109 62 VMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRD 134 (279)
T ss_pred HHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 4677899999999999975 457899999999999999975432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 135 lkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 135 LAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999998664332221 122234678999999988889999999999999999998 8899864
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
..... . ....... .....+...+..+.+++.+||+.||++||++.++++.+..+..
T Consensus 215 ~~~~~---~----~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 215 IPARE---I----PDLLEKG---------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCHHH---H----HHHHHCC---------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 32211 1 1111111 0111122344568899999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=260.96 Aligned_cols=215 Identities=31% Similarity=0.476 Sum_probs=160.0
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++.. ....++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 58 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~~---i~H 131 (284)
T cd05081 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKR---YVH 131 (284)
T ss_pred HHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 4678999999999998764 3468999999999999999975432 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||+||+++.++.++|+|||++.......... .....++..|+|||++.+..++.++|||||||+++||++|..|+
T Consensus 132 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred ccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 9999999999999999999999998654332211 11122345699999999888999999999999999999987765
Q ss_pred cccchhhcccHHHHHHHHHhhc-------hhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEENRSLAAYFLQVINEN-------RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....... ........ .+.+.+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 212 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 212 CSPPAEF-------MRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcchhh-------hhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 3221110 00000000 00011111111111223445699999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=261.58 Aligned_cols=208 Identities=20% Similarity=0.316 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++..++||||+++++++......++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---iiHrD 127 (332)
T cd05623 54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLH---YVHRD 127 (332)
T ss_pred HHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 45678999999999999999999999999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.+||+|||++...............||+.|+|||++. ...++.++|||||||++|+|++|+.|
T Consensus 128 lkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred CCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 9999999999999999999998754433333333456999999999986 34678999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~ 227 (295)
|.... .......+........ ........+..+.+++.+|+..++.+ |+++.++++|.+
T Consensus 208 f~~~~------~~~~~~~i~~~~~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 208 FYAES------LVETYGKIMNHKERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred CCCCC------HHHHHHHHhCCCcccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 96322 2222222222111000 00111233556888999988654444 689999999854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=269.91 Aligned_cols=205 Identities=23% Similarity=0.324 Sum_probs=158.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++|||||++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG---FIHRD 126 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 5778999999999999999999999999999999999987643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc----------------------------------------------ceeee
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR----------------------------------------------THLTT 115 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~----------------------------------------------~~~~~ 115 (295)
|||+|||++.++.+||+|||++....... .....
T Consensus 127 lKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred CCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 99999999999999999999975321000 00012
Q ss_pred ccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH
Q 045989 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK 195 (295)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (295)
...||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+........ .....
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~-------~p~~~ 273 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL------ETQMKVINWQTSLH-------IPPQA 273 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH------HHHHHHHccCCCcC-------CCCcc
Confidence 246899999999999999999999999999999999999999643221 11111111100000 01111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC---HHHHHHHHH
Q 045989 196 EEVITVAMVAKRCLNLNGKKRPT---MKEVALELA 227 (295)
Q Consensus 196 ~~~~~~~~li~~cl~~~p~~Rps---~~e~~~~l~ 227 (295)
..+..+.+++.+|+ .+|.+|++ +.+++.|.+
T Consensus 274 ~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 274 KLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 23445777888876 49999987 999988754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=267.04 Aligned_cols=206 Identities=25% Similarity=0.337 Sum_probs=157.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+++||||+++++.+.+....|+||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrD 126 (363)
T cd05628 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG---FIHRD 126 (363)
T ss_pred HHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecC
Confidence 4678899999999999999999999999999999999997643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc----------------------------------eeeeccccccCCCChh
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT----------------------------------HLTTQVKGTFGYLDPE 127 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE 127 (295)
|||+|||++.++.+||+|||+++....... .......||+.|+|||
T Consensus 127 lKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 206 (363)
T cd05628 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206 (363)
T ss_pred CCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHH
Confidence 999999999999999999999875432100 0012346999999999
Q ss_pred hhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHH
Q 045989 128 YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKR 207 (295)
Q Consensus 128 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 207 (295)
++.+..++.++|||||||++|+|++|..||..... ...+..+........ +.+ ....+..+.+++.+
T Consensus 207 ~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~ 273 (363)
T cd05628 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP------QETYKKVMNWKETLI-FPP------EVPISEKAKDLILR 273 (363)
T ss_pred HHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCcCccc-CCC------cCCCCHHHHHHHHH
Confidence 99999999999999999999999999999963321 112222221100000 000 01123456778877
Q ss_pred hhc--cCCCCCCCHHHHHHHHH
Q 045989 208 CLN--LNGKKRPTMKEVALELA 227 (295)
Q Consensus 208 cl~--~~p~~Rps~~e~~~~l~ 227 (295)
++. .++..||++.||++|.+
T Consensus 274 l~~~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 274 FCCEWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred HcCChhhcCCCCCHHHHhCCCC
Confidence 554 23345699999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.73 Aligned_cols=214 Identities=25% Similarity=0.460 Sum_probs=163.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-------DQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~- 150 (296)
T cd05051 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN- 150 (296)
T ss_pred HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 46789999999999999999999999999999999999976541 1124899999999999999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT- 152 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~- 152 (295)
++|+||||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 151 --i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 151 --FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred --ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 99999999999999999999999999875433221 11223346778999999988889999999999999999998
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+..||......+ ............ ........+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 229 ~~~~p~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 229 CREQPYEHLTDQQ---VIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCCcChHH---HHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 667775332111 111111100000 000011112233456999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=263.45 Aligned_cols=216 Identities=19% Similarity=0.333 Sum_probs=161.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~d 129 (309)
T cd07872 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRRK---VLHRD 129 (309)
T ss_pred HHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 46789999999999999999999999999965 88888765432 4788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 130 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 130 LKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CCHHHEEECCCCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875432221 1223457899999999865 46789999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhc--hhh---------hhhh-hh----hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN--RLF---------EVLD-AQ----VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~--~~~---------~~~~-~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+.... +....... ..+ .... +. .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 209 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 209 TVEDELHL---IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred ChHHHHHH---HHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 33221110 11100000 000 0000 00 000011123456889999999999999999999999
Q ss_pred HHHH
Q 045989 225 ELAG 228 (295)
Q Consensus 225 ~l~~ 228 (295)
|.+-
T Consensus 286 h~~~ 289 (309)
T cd07872 286 HAYF 289 (309)
T ss_pred Chhh
Confidence 8764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=264.01 Aligned_cols=199 Identities=25% Similarity=0.355 Sum_probs=158.1
Q ss_pred ccCCCC-ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~H-pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+..++| ++|+++++++...+..|+||||++||+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 126 (324)
T cd05587 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRD 126 (324)
T ss_pred HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 455655 578999999999999999999999999999987543 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 127 LKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986432221 12234568999999999999899999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-----KEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~~~~l 226 (295)
.. .....+.... ...+...+..+.+++.+||..||.+|++. .++.+|.
T Consensus 206 ~~------~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp 258 (324)
T cd05587 206 ED------ELFQSIMEHN-----------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA 258 (324)
T ss_pred HH------HHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 21 1122211111 11122334568899999999999999976 6776664
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=254.25 Aligned_cols=211 Identities=26% Similarity=0.388 Sum_probs=157.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++||||+++++++.+....++||||+++|+|.+++..... .....++..+..++.|++.||+|||+.+ ++|+
T Consensus 48 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 124 (269)
T cd05087 48 PYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHS 124 (269)
T ss_pred HHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---Eecc
Confidence 46789999999999999999999999999999999999975432 2234677788899999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccC-------CCCCCccchhhHHHHHHHHh
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSS-------QFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~el~~ 152 (295)
||||+||+++.++.++|+|||+++......... .....++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 125 dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 125 DLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 999999999999999999999987543322211 1223567889999998642 35789999999999999996
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..||......+. ........ ......+. .....+..+.+++.+|| .+|++|||+.+|++.|.
T Consensus 205 ~g~~p~~~~~~~~~------~~~~~~~~-~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 205 LGSQPYRHLSDEQV------LTYTVREQ-QLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCCChHHH------HHHHhhcc-cCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 9999964432211 00011110 00111111 11123345788999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.23 Aligned_cols=197 Identities=24% Similarity=0.267 Sum_probs=156.5
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
+||||+++++++..+...|+||||+++|+|..++.... .+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~N 126 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPEN 126 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 79999999999999999999999999999999887543 4899999999999999999999999 9999999999
Q ss_pred EEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCcccchhhc
Q 045989 87 ILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165 (295)
Q Consensus 87 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 165 (295)
||++.++.++|+|||++....... .......||..|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 127 ili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--- 202 (330)
T cd05586 127 ILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--- 202 (330)
T ss_pred eEECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---
Confidence 999999999999999987532221 122345689999999998754 478999999999999999999999863221
Q ss_pred ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHHHH
Q 045989 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP----TMKEVALELA 227 (295)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp----s~~e~~~~l~ 227 (295)
......+.... . . ......+..+.+++.+||+.||.+|| ++.++++|.+
T Consensus 203 ---~~~~~~i~~~~-~-~--------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 203 ---QQMYRNIAFGK-V-R--------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred ---HHHHHHHHcCC-C-C--------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 11111111111 0 0 00112344578899999999999998 6888888754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=269.40 Aligned_cols=201 Identities=24% Similarity=0.445 Sum_probs=164.3
Q ss_pred cccCCCCccccceeeEEEeCCc--cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETEV--PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~--~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|+.|+||||+++++++.+... ..+|+|.+..|+|..++.+... .....+..|+.||++||.|||++. +||+|
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIH 168 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIH 168 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccc
Confidence 6899999999999999987654 7899999999999999988764 788899999999999999999987 56999
Q ss_pred ccCCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||=+||||+. .|.+||+|+|+|........ ....|||.|||||... ..|++..||||||..++||+|+..||.
T Consensus 169 RDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 169 RDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred cccccceEEEcCCcCceeecchhHHHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 999999999985 48999999999987654432 3368999999999987 789999999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
+=...+..+++++.+.. | ..+..-...++.++|.+||.. ..+|||+.|++++.
T Consensus 245 -----EC~n~AQIYKKV~SGiK------P---~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 245 -----ECTNPAQIYKKVTSGIK------P---AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred -----hhCCHHHHHHHHHcCCC------H---HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 22233334444333321 1 111111223488899999999 99999999999875
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=259.50 Aligned_cols=213 Identities=28% Similarity=0.444 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... ...++||||++|++|.+++..... .+++..++.++.|++.||+|||+++ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~g---i~H 132 (284)
T cd05079 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVH 132 (284)
T ss_pred HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 46789999999999999875 568999999999999999865432 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++++.|.
T Consensus 133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999999999999999999999999865433221 122345677899999998888999999999999999999987664
Q ss_pred cccchhh--------cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEE--------NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....... ............. .......+...+..+.+++.+||+.+|++|||+.++++.++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 213 SSPMTLFLKMIGPTHGQMTVTRLVRVLE---------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccchhhhhcccccccccHHHHHHHHH---------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2211000 0000000000011 0111111223456799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=275.98 Aligned_cols=203 Identities=30% Similarity=0.436 Sum_probs=168.1
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPI--TWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
-++|+|.|||+|+|++.+++++-|.||-++||+|.++++..-. ++ .+.++-.+..||++||.|||++. ||||
T Consensus 626 H~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~---IVHR 699 (1226)
T KOG4279|consen 626 HSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK---IVHR 699 (1226)
T ss_pred HHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc---eeec
Confidence 3678999999999999999999999999999999999986543 35 88999999999999999999999 9999
Q ss_pred cCCCCeEEEC-CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC--CCCCCccchhhHHHHHHHHhCCCCC
Q 045989 81 DIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 81 dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||.+|+||+ ..|.+||+|||.++....-. -.+.++.||.-|||||++..+ .|+.++|||||||++.||.||++||
T Consensus 700 DIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 700 DIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred cccCCcEEEeeccceEEecccccchhhccCC-ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 9999999996 68999999999998765433 345677899999999999764 6899999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
--.... .++.+. .---....+.|.+.+.+...+|.+|+.++|.+||++++++...
T Consensus 779 ~Elgsp----qAAMFk----------VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 779 VELGSP----QAAMFK----------VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred eecCCh----hHhhhh----------hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 522211 111111 1011123456677778899999999999999999999998764
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.74 Aligned_cols=196 Identities=22% Similarity=0.451 Sum_probs=154.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+...++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 52 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 125 (258)
T cd05078 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKG---LTHGN 125 (258)
T ss_pred HHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 46788999999999999999999999999999999999976433 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc--------eEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHh
Q 045989 82 IKSANILLDDKYR--------AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 82 ikp~Nill~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~ 152 (295)
|||+||+++.++. ++++|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 126 lkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 200 (258)
T cd05078 126 VCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200 (258)
T ss_pred CccceEEEecccccccCCCceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence 9999999987664 69999998864432 1234578889999999764 57899999999999999999
Q ss_pred CC-CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 GQ-KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|. .|+....... .. ..... ....+......+.+++.+||+.+|++|||++++++.|
T Consensus 201 g~~~~~~~~~~~~------~~-~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 201 GGDKPLSALDSQK------KL-QFYED-----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCChhhccHHH------HH-HHHHc-----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 85 5553221111 00 00000 0111222334588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=255.65 Aligned_cols=208 Identities=32% Similarity=0.553 Sum_probs=163.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++||||+.+++|.+++.... .+++..++.++.|+++||++||+.+ ++|+|
T Consensus 51 ~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~d 123 (260)
T PF00069_consen 51 ILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSKG---IVHRD 123 (260)
T ss_dssp HHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccc---ccccc
Confidence 3567899999999999999999999999999999999998433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-cCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-SSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.+.... ..........++..|+|||++. +..++.++||||+|+++++|++|..||...
T Consensus 124 ikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 124 IKPENILLDENGEVKLIDFGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp BSGGGEEESTTSEEEESSGTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999987541 2222344456899999999998 788899999999999999999999998744
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
...+. ........... . .... .........+.+++.+||+.||++||++.+++++.+
T Consensus 203 ~~~~~---~~~~~~~~~~~-~----~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 203 NSDDQ---LEIIEKILKRP-L----PSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp SHHHH---HHHHHHHHHTH-H----HHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred cchhh---hhhhhhccccc-c----cccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 11111 11111111100 0 0000 000011256999999999999999999999988753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.70 Aligned_cols=207 Identities=28% Similarity=0.336 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|+||+++++.+..++..++||||+.|++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|||
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 57789999999999999999999999999999999998865432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++||||+||++|+|++|..||....
T Consensus 128 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 128 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCHHHEEECCCCCEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875432221 223468999999999998899999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
..... ......... .....+...+..+.+++.+||+.||.+||| +.|+++|.+-
T Consensus 206 ~~~~~---~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 206 KKIKR---EEVERLVKE----------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred ccchH---HHHHhhhhh----------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 21100 001111000 001112233455889999999999999999 8999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=258.83 Aligned_cols=207 Identities=25% Similarity=0.471 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------------CCCCCCHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------------DQLPITWEIRLGIAVEVS 63 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~ 63 (295)
++++++||||+++++++..+...++||||+++|+|.+++..... ....+++..++.++.|++
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 140 (288)
T cd05050 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA 140 (288)
T ss_pred HHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence 46788999999999999999999999999999999999974321 123478889999999999
Q ss_pred HHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchh
Q 045989 64 GALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYS 142 (295)
Q Consensus 64 ~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 142 (295)
.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++||||
T Consensus 141 ~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (288)
T cd05050 141 AGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA 217 (288)
T ss_pred HHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence 9999999999 999999999999999999999999998754322211 111223466799999998889999999999
Q ss_pred hHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 045989 143 FGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221 (295)
Q Consensus 143 lG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 221 (295)
|||++|+|++ |..||...... ....... .... ...+...+..+.+++.+||+.+|.+|||+.|
T Consensus 218 lG~il~el~~~~~~p~~~~~~~------~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMAHE------EVIYYVR-DGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHH------HHHHHHh-cCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9999999997 87887533221 1111111 1111 1112234456999999999999999999999
Q ss_pred HHHHHH
Q 045989 222 VALELA 227 (295)
Q Consensus 222 ~~~~l~ 227 (295)
+++.|+
T Consensus 282 l~~~l~ 287 (288)
T cd05050 282 INRILQ 287 (288)
T ss_pred HHHHhh
Confidence 999885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=253.15 Aligned_cols=205 Identities=27% Similarity=0.454 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. ...++|+||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 49 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 122 (257)
T cd05040 49 IMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRD 122 (257)
T ss_pred HHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 4678999999999999988 889999999999999999986542 35899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 123 i~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred cCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998866432211 1122346788999999998889999999999999999998 999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.....+ .......... ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 203 ~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 203 GLSGSQ------ILKKIDKEGE---------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCHHH------HHHHHHhcCC---------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 332221 1111111100 00112233456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.63 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=167.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||++||+|.+++... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~d 126 (277)
T cd06640 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK---KIHRD 126 (277)
T ss_pred HHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcC
Confidence 467889999999999999999999999999999999998643 3788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 127 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred CChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999999999876543221 1223457889999999988889999999999999999999999986332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
... ... ..............+..+.+++.+||+.+|.+||++.+++++.+-......
T Consensus 206 ~~~------~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 206 PMR------VLF----------LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred hHh------Hhh----------hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 111 000 001111122334456678999999999999999999999999776554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=254.70 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++++|.+++..... ..+++..+..++.|++.||+|||+++ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~d 128 (261)
T cd05034 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128 (261)
T ss_pred HHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 46789999999999999998999999999999999999976432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............++..|+|||.+.+..++.++||||||++++++++ |+.||...
T Consensus 129 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred cchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654322221222234668999999998889999999999999999998 99998533
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.. ........... ....+...+..+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 209 ~~------~~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 209 TN------REVLEQVERGY----------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CH------HHHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 21 11111111110 001112234568999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=258.11 Aligned_cols=209 Identities=25% Similarity=0.423 Sum_probs=162.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------DQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++++||||+++++++......++||||+++|+|.+++..... ....+....+..++.|++.||.|||+++
T Consensus 62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-- 139 (288)
T cd05061 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-- 139 (288)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 46788999999999999999999999999999999999975321 1233567788999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
++||||||+||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |
T Consensus 140 -i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~ 218 (288)
T cd05061 140 -FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 218 (288)
T ss_pred -CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987543322111 122235678999999998889999999999999999998 7
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..||.....+ ........... ...+...+..+.+++.+||+.+|++|||+.++++.++..
T Consensus 219 ~~p~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 219 EQPYQGLSNE------QVLKFVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCHH------HHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 8888643221 11111111110 011122345699999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.25 Aligned_cols=203 Identities=28% Similarity=0.493 Sum_probs=161.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~d 125 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 46789999999999999999999999999999999999875432 4789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.+...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 126 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred cccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999999999999987554322221222335678999999988889999999999999999998 89998532
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.. ............ . ..+...+..+.+++.+||+.+|++|||+.+++++|
T Consensus 206 ~~------~~~~~~~~~~~~---~-------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 206 SN------SEVVETINAGFR---L-------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CH------HHHHHHHhCCCC---C-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 21 111111111100 0 01112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=255.53 Aligned_cols=201 Identities=27% Similarity=0.490 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~d 131 (267)
T cd06628 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG---IIHRD 131 (267)
T ss_pred HHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 4678999999999999999999999999999999999997643 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-----eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-----LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|+|+||+++.++.++|+|||.++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 132 i~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 211 (267)
T cd06628 132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211 (267)
T ss_pred CCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 9999999999999999999998766422111 11223578899999999888899999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
|....... ....... ......+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 212 ~~~~~~~~------~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 212 FPDCTQLQ------AIFKIGE----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCccHHH------HHHHHhc----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 96432111 1111111 01112223445668999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.71 Aligned_cols=214 Identities=26% Similarity=0.436 Sum_probs=161.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE--------DQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 149 (295)
T cd05097 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149 (295)
T ss_pred HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence 46789999999999999999999999999999999999865321 1123688899999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++++|++
T Consensus 150 ---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 150 ---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred ---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999999998754332211 1222345678999999988889999999999999999998
Q ss_pred --CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 153 --GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 153 --g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+..||......+. ........... ........+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 227 ~~~~~p~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 227 LCKEQPYSLLSDEQV---IENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCCCCcccChHHH---HHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 5667754322210 00000000000 000001111223456999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.31 Aligned_cols=194 Identities=25% Similarity=0.365 Sum_probs=157.0
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
+||+|+++++++...+..++||||+++|+|...+.... .+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 131 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHH
Confidence 68999999999999999999999999999999887543 3889999999999999999999999 9999999999
Q ss_pred EEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcc
Q 045989 87 ILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166 (295)
Q Consensus 87 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 166 (295)
||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 132 ill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--- 207 (323)
T cd05616 132 VMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--- 207 (323)
T ss_pred eEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---
Confidence 999999999999999987533221 1223456899999999999999999999999999999999999999643221
Q ss_pred cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 045989 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-----KEVALE 225 (295)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~~~~ 225 (295)
.....+.... ...+...+..+.+++.+||+.+|.+|++. .++.+|
T Consensus 208 ---~~~~~i~~~~-----------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 208 ---ELFQSIMEHN-----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---HHHHHHHhCC-----------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1122221111 01222344568899999999999999984 666655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=253.33 Aligned_cols=205 Identities=23% Similarity=0.397 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|+||+++++++.. ...+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~d 127 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 5788999999999999987 778999999999999999976432 24788899999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.+...............++..|+|||++....++.++|+|||||++|++++ |..||...
T Consensus 128 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999987654332222223345678999999988889999999999999999998 89998633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...+ ... ...... ....+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 208 ~~~~------~~~-~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 208 SNPE------VIR-ALERGY---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CHHH------HHH-HHhCCC---------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2111 111 111110 001122344568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.81 Aligned_cols=206 Identities=24% Similarity=0.445 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 58 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g---~~H~d 131 (269)
T cd05065 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRD 131 (269)
T ss_pred HHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 46788999999999999999999999999999999999875432 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee-ec-c--ccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT-TQ-V--KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p 156 (295)
|||+||+++.++.++|+|||++........... .. . ..+..|+|||.+.+..++.++|||||||++||+++ |..|
T Consensus 132 l~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p 211 (269)
T cd05065 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211 (269)
T ss_pred cChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCC
Confidence 999999999999999999999875543221111 11 1 12457999999998899999999999999999886 9999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|...... .....+.... ....+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 212 ~~~~~~~------~~~~~i~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 212 YWDMSNQ------DVINAIEQDY----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCCHH------HHHHHHHcCC----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8633221 1111111110 0111223455688999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=253.95 Aligned_cols=196 Identities=22% Similarity=0.425 Sum_probs=153.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++|+|..++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~d 142 (274)
T cd05076 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDKN---LVHGN 142 (274)
T ss_pred HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCC
Confidence 46789999999999999999999999999999999998865322 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCC-------ceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHH-h
Q 045989 82 IKSANILLDDKY-------RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELL-T 152 (295)
Q Consensus 82 ikp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~-~ 152 (295)
|||+||+++..+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +
T Consensus 143 lkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 143 VCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred CCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999997543 4899999987543211 12346788999998865 56899999999999999985 6
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|..||......+. .. ...... ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus 218 g~~p~~~~~~~~~---~~----~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 218 GEVPLKERTPSEK---ER----FYEKKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCCccccChHHH---HH----HHHhcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 8998864322110 01 110000 01111223588899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=263.93 Aligned_cols=215 Identities=24% Similarity=0.322 Sum_probs=156.7
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+++.++||||+++++++...+ ..|+||||+++ +|...+.. .+++..+..++.|++.||+|||+++
T Consensus 73 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~-- 143 (359)
T cd07876 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG-- 143 (359)
T ss_pred HHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467899999999999987543 46999999965 67666642 2788899999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+||+++.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 144 -ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 144 -IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred -cccCCCCHHHEEECCCCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998754322 12233468999999999999999999999999999999999999
Q ss_pred CCcccchhhcc---------cHHHHHHHH-------Hhhchh------hhhhhhh---hhhhhhHHHHHHHHHHHHHhhc
Q 045989 156 PIRLVETEENR---------SLAAYFLQV-------INENRL------FEVLDAQ---VLREAEKEEVITVAMVAKRCLN 210 (295)
Q Consensus 156 p~~~~~~~~~~---------~~~~~~~~~-------~~~~~~------~~~~~~~---~~~~~~~~~~~~~~~li~~cl~ 210 (295)
||......+.. ....+.... ...... .+....- .........+..+.+++.+||+
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 300 (359)
T cd07876 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300 (359)
T ss_pred CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence 99744322100 000000000 000000 0000000 0000011123568899999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 045989 211 LNGKKRPTMKEVALELAG 228 (295)
Q Consensus 211 ~~p~~Rps~~e~~~~l~~ 228 (295)
.||++|||+.|++.|.+-
T Consensus 301 ~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 301 IDPDKRISVDEALRHPYI 318 (359)
T ss_pred cCcccCCCHHHHhcCchh
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.52 Aligned_cols=204 Identities=24% Similarity=0.365 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++++.||||+++++.+..+...++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 70 ~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~d 141 (296)
T cd06654 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141 (296)
T ss_pred HHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 467789999999999999999999999999999999998643 3788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 142 Lkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CCHHHEEEcCCCCEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875432221 1223458899999999998889999999999999999999999986332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ......... . .....+...+..+.+++.+||..+|++||++.+++++.+-
T Consensus 221 ~~~------~~~~~~~~~-~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 221 PLR------ALYLIATNG-T-------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred HHH------hHHHHhcCC-C-------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 111 010111000 0 0001122344568899999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.15 Aligned_cols=203 Identities=26% Similarity=0.379 Sum_probs=163.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++++|.+++... .+++..++.++.|++.|+.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~d 126 (277)
T cd06642 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSER---KIHRD 126 (277)
T ss_pred HHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccC
Confidence 467899999999999999999999999999999999988642 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+|||||++++|++|..||....
T Consensus 127 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred CChheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999987554322 11223457889999999998889999999999999999999999985322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
... .... .. ...........+..+.+++.+||+.+|++||++.+++++.+-.
T Consensus 206 ~~~------~~~~-~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 206 PMR------VLFL-IP---------KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred hhh------HHhh-hh---------cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 111 0000 00 0011112223455688999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=253.22 Aligned_cols=210 Identities=28% Similarity=0.401 Sum_probs=156.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+++.++||||+++++++......++||||+++|+|.+++...... ....++..+..++.|++.||+|||+.+ |+||
T Consensus 48 ~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 124 (269)
T cd05042 48 PYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHS 124 (269)
T ss_pred HHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---Eecc
Confidence 356789999999999999999999999999999999999765422 223567888999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhcc-------CCCCCCccchhhHHHHHHHHh
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQS-------SQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~ 152 (295)
||||+||+++.++.+||+|||++.......... .....++..|+|||++.. ..++.++|||||||++|+|++
T Consensus 125 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05042 125 DLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204 (269)
T ss_pred cccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh
Confidence 999999999999999999999986543222111 122345678999999753 356789999999999999999
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|..||......+ .......... .....+ ..+...+..+.+++..|| .||++|||+++|++.|
T Consensus 205 ~~~~p~~~~~~~~------~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 205 AADQPYPDLSDEQ------VLKQVVREQD-IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCCCCcCCHHH------HHHHHhhccC-ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 788886432211 1111111110 001111 112234456788999998 5999999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=252.96 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=162.2
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++||||+++++.+.. +...++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~ 126 (257)
T cd08223 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH---ILHR 126 (257)
T ss_pred HHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 4678899999999998875 4467999999999999999976432 25899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.++|+|||++........ ......+++.|+|||++.+..++.++|+||||+++++|++|..||...
T Consensus 127 di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred CCCchhEEEecCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999876543222 223345789999999999989999999999999999999999998632
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
. ........... .....+...+..+.+++.+||+.+|.+||++.+++++.
T Consensus 206 ~------~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 206 D------MNSLVYRIIEG----------KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred C------HHHHHHHHHhc----------CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 2 11111111111 11122334556799999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=251.02 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=161.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++||||+++++|.+++..... .+++..+..++.+++.||+|||+++ ++|||
T Consensus 45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~d 118 (251)
T cd05041 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118 (251)
T ss_pred HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---Eehhh
Confidence 46789999999999999999999999999999999999875432 4789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee-eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.++|+|||++........... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 999999999999999999999875542221111 11223567999999988889999999999999999998 8888854
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..... ......... ....+...+..+.+++.+||+.+|.+|||+.|+++.|.
T Consensus 199 ~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 199 MSNQQ------TRERIESGY----------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHH------HHHHHhcCC----------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 33211 111111100 01112234456999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.06 Aligned_cols=215 Identities=29% Similarity=0.432 Sum_probs=163.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
+|++++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++|+
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~ 124 (308)
T cd06615 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK---IMHR 124 (308)
T ss_pred HHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCC---EEEC
Confidence 4678999999999999999999999999999999999997643 48999999999999999999997 46 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CCChHHEEEecCCcEEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999986543221 23346889999999998888999999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhc--------------------hhhhhhhh----hhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 161 ETEENRSLAAYFLQVINEN--------------------RLFEVLDA----QVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
.... ....+....... ...+..+. ..........+..+.+++.+||..+|++|
T Consensus 202 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 278 (308)
T cd06615 202 DAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER 278 (308)
T ss_pred chhh---HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhC
Confidence 2111 110000000000 00000000 00000001134568999999999999999
Q ss_pred CCHHHHHHHHHHh
Q 045989 217 PTMKEVALELAGI 229 (295)
Q Consensus 217 ps~~e~~~~l~~~ 229 (295)
||+.+++++.+-.
T Consensus 279 pt~~~ll~~~~~~ 291 (308)
T cd06615 279 ADLKELTKHPFIK 291 (308)
T ss_pred cCHHHHhcChhhh
Confidence 9999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=260.19 Aligned_cols=208 Identities=20% Similarity=0.312 Sum_probs=161.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++..++||||+++++++..++..|+||||++||+|.+++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrD 127 (331)
T cd05624 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLH---YVHRD 127 (331)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 45678999999999999999999999999999999999976432 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-----CCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.+||+|||++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 128 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred CchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 99999999999999999999987655433333334569999999999875 4678899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~ 227 (295)
|..... ......+........ ........+..+.+++.+||..++++ |++++++++|.+
T Consensus 208 f~~~~~------~~~~~~i~~~~~~~~------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 208 FYAESL------VETYGKIMNHEERFQ------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ccCCCH------HHHHHHHHcCCCccc------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 963321 112222221110000 00111123456888999999866544 578999988854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.85 Aligned_cols=212 Identities=22% Similarity=0.322 Sum_probs=156.9
Q ss_pred cCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 4 SQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+.++||||+++++++... ...++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iv 130 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC---IV 130 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 345899999999998642 45799999996 489998875432 24899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||||+||+++.++.+||+|||+++...... ......|+..|+|||++.+..++.++||||+||++|+|++|.+||.
T Consensus 131 H~dikp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cCCCCHHHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 99999999999999999999999987654221 1233457899999999998899999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhh---chhhh----------hhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINE---NRLFE----------VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.....+. ..... ..... ..... ..............+..+.+++.+||+.||++|||+.+++.|
T Consensus 209 ~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 209 GNSEADQ--LGKIF-DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCCHHHH--HHHHH-HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 4322110 00100 00000 00000 000000111112345568899999999999999999999876
Q ss_pred H
Q 045989 226 L 226 (295)
Q Consensus 226 l 226 (295)
.
T Consensus 286 p 286 (288)
T cd07863 286 P 286 (288)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=267.36 Aligned_cols=210 Identities=24% Similarity=0.435 Sum_probs=164.0
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-----------------------------------
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE----------------------------------- 45 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~----------------------------------- 45 (295)
+|.++. ||||+++++++...+..++||||+++|+|.++++....
T Consensus 93 ~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (401)
T cd05107 93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGS 172 (401)
T ss_pred HHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhh
Confidence 466776 99999999999999999999999999999999975321
Q ss_pred -----------------------------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 045989 46 -----------------------------------------------------------DQLPITWEIRLGIAVEVSGAL 66 (295)
Q Consensus 46 -----------------------------------------------------------~~~~~~~~~~~~i~~qi~~~l 66 (295)
....+++..++.++.|++.||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 252 (401)
T cd05107 173 ESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGM 252 (401)
T ss_pred ccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHH
Confidence 112467788899999999999
Q ss_pred HHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHH
Q 045989 67 SYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGV 145 (295)
Q Consensus 67 ~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 145 (295)
+|||+.+ ++||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+
T Consensus 253 ~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv 329 (401)
T cd05107 253 EFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329 (401)
T ss_pred HHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHH
Confidence 9999998 99999999999999999999999999875432221 1122234678899999998888999999999999
Q ss_pred HHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 146 VLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 146 ~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
++|||++ |..||......+ ......... .....+...+..+.+++.+||..+|.+||++++|++
T Consensus 330 il~e~l~~g~~P~~~~~~~~------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 330 LLWEIFTLGGTPYPELPMNE------QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHcCCCCCCCCCchH------HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999998 888986432211 111111111 001112234556999999999999999999999999
Q ss_pred HHHHh
Q 045989 225 ELAGI 229 (295)
Q Consensus 225 ~l~~~ 229 (295)
.|+.+
T Consensus 395 ~L~~~ 399 (401)
T cd05107 395 LVGDL 399 (401)
T ss_pred HHHHH
Confidence 99865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.74 Aligned_cols=205 Identities=24% Similarity=0.387 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 120 (279)
T cd06619 52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRD 120 (279)
T ss_pred HHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCC
Confidence 467899999999999999999999999999999986542 2688889999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 121 lkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 121 VKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred CCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 9999999999999999999998754322 1233468999999999998889999999999999999999999986433
Q ss_pred hhhcc-cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENR-SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... ............. .+ .......+..+.+++.+||+.+|++||++++++++.+-.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 198 KNQGSLMPLQLLQCIVDED------PP---VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred ccccccchHHHHHHHhccC------CC---CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 22111 1111111111110 00 001112334588999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.94 Aligned_cols=221 Identities=21% Similarity=0.347 Sum_probs=155.7
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQT-----EDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++++||||+++++++.. +...++||||+. ++|.+++.... .....+++..++.++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~- 128 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5678999999999999864 457899999995 58888875321 12235889999999999999999999999
Q ss_pred CCeEeccCCCCeEEE----CCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhcc-CCCCCCccchhhHHHH
Q 045989 75 IPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 75 ~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l 147 (295)
++||||||+||++ +.++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 129 --ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 206 (317)
T cd07867 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence 9999999999999 46678999999999865433211 1233468999999999876 4578999999999999
Q ss_pred HHHHhCCCCCcccchhhccc---HHHHHHHHHhhc-----hhhhh---------hhh----------h---hhhhhhHHH
Q 045989 148 VELLTGQKPIRLVETEENRS---LAAYFLQVINEN-----RLFEV---------LDA----------Q---VLREAEKEE 197 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~-----~~~~~---------~~~----------~---~~~~~~~~~ 197 (295)
|+|++|.+||.......... ............ ..+.. ... . .........
T Consensus 207 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (317)
T cd07867 207 AELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286 (317)
T ss_pred HHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCC
Confidence 99999999996433211100 000010000000 00000 000 0 000001112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 198 VITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 198 ~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+.+++.+||+.||.+|||+.|+++|.
T Consensus 287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 287 DSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred ChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 34578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=274.24 Aligned_cols=223 Identities=19% Similarity=0.255 Sum_probs=159.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++...+..|+|++++ +++|..++..... .........+..++.||+.||+|||+++ |+||
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHr 291 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHR 291 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 578899999999999999999999999999 5588877754321 1122345677889999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC-Ccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-IRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~ 159 (295)
||||+|||++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999999999999986654433333445799999999999999999999999999999999998754 432
Q ss_pred cchhhcccHHHHHHHHHh-h-------chhhhhhhhhhhhhh---------hHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 160 VETEENRSLAAYFLQVIN-E-------NRLFEVLDAQVLREA---------EKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
............+..... . ..+...+........ ....+..+.+++.+||+.||.+|||+.|+
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 221111111111110000 0 000111100000000 00123357788999999999999999999
Q ss_pred HHHHHH
Q 045989 223 ALELAG 228 (295)
Q Consensus 223 ~~~l~~ 228 (295)
+.|.+.
T Consensus 452 L~hp~f 457 (501)
T PHA03210 452 LALPLF 457 (501)
T ss_pred hhChhh
Confidence 998764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=263.67 Aligned_cols=213 Identities=22% Similarity=0.273 Sum_probs=156.9
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|+.++||||+++++++.... ..++||||+++ +|...+.. .+++..++.++.|++.||+|||+++
T Consensus 69 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g-- 139 (355)
T cd07874 69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-- 139 (355)
T ss_pred HHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467889999999999986543 46999999965 77776643 2788999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+||+++.++.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 140 -ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred -cccCCCChHHEEECCCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999754322 12234568999999999999899999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhc---------hhhhhhh----------hhh--------hhhhhHHHHHHHHHHHHHh
Q 045989 156 PIRLVETEENRSLAAYFLQVINEN---------RLFEVLD----------AQV--------LREAEKEEVITVAMVAKRC 208 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~----------~~~--------~~~~~~~~~~~~~~li~~c 208 (295)
||......+. ............ ....... +.. ........+..+.+++.+|
T Consensus 217 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 294 (355)
T cd07874 217 LFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294 (355)
T ss_pred CCCCCCHHHH--HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHH
Confidence 9964332111 000000000000 0000000 000 0001111245678999999
Q ss_pred hccCCCCCCCHHHHHHHHHH
Q 045989 209 LNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 209 l~~~p~~Rps~~e~~~~l~~ 228 (295)
|+.||++|||+.|+++|.+-
T Consensus 295 L~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 295 LVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred hcCCchhcCCHHHHhcCcch
Confidence 99999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=264.85 Aligned_cols=205 Identities=24% Similarity=0.359 Sum_probs=158.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+++||||+++++.+..++..++||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrD 126 (360)
T cd05627 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG---FIHRD 126 (360)
T ss_pred HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccC
Confidence 4678899999999999999999999999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc----------------------------------eeeeccccccCCCChh
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT----------------------------------HLTTQVKGTFGYLDPE 127 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE 127 (295)
|||+||+++.++.++|+|||++........ .......||+.|+|||
T Consensus 127 Lkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 206 (360)
T cd05627 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206 (360)
T ss_pred CCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHH
Confidence 999999999999999999999864422100 0011346899999999
Q ss_pred hhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHH
Q 045989 128 YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKR 207 (295)
Q Consensus 128 ~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 207 (295)
++.+..++.++|||||||++|+|++|..||...... .....+........ ..+ ....+..+.+++.+
T Consensus 207 ~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~------~~~~~i~~~~~~~~-~p~------~~~~s~~~~~li~~ 273 (360)
T cd05627 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ------ETYRKVMNWKETLV-FPP------EVPISEKAKDLILR 273 (360)
T ss_pred HHcCCCCCCcceeccccceeeecccCCCCCCCCCHH------HHHHHHHcCCCcee-cCC------CCCCCHHHHHHHHH
Confidence 999999999999999999999999999999643221 11222211100000 000 01133457788888
Q ss_pred hhccCCCCCC---CHHHHHHHHH
Q 045989 208 CLNLNGKKRP---TMKEVALELA 227 (295)
Q Consensus 208 cl~~~p~~Rp---s~~e~~~~l~ 227 (295)
|+. +|.+|+ ++.++++|.+
T Consensus 274 l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 274 FCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred hcc-ChhhcCCCCCHHHHhcCCC
Confidence 774 999998 4788888854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.54 Aligned_cols=202 Identities=27% Similarity=0.365 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++|+||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 123 (274)
T cd06609 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRD 123 (274)
T ss_pred HHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 467889999999999999999999999999999999998754 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 124 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 124 IKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred CCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 99999999999999999999997665332 12233467889999999998889999999999999999999999986432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKE-EVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ....... . ........ .+..+.+++.+||..+|++|||+++++++.+-
T Consensus 203 ~~~------~~~~~~~-~---------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 203 PMR------VLFLIPK-N---------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred hHH------HHHHhhh-c---------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 111 1111110 0 00011111 44568899999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=263.02 Aligned_cols=213 Identities=23% Similarity=0.297 Sum_probs=157.2
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+++.++||||+++++++... ...|+||||+++ +|...+.. .+++..+..++.|++.||+|||+++
T Consensus 76 ~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-- 146 (364)
T cd07875 76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-- 146 (364)
T ss_pred HHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 46788999999999988643 357999999965 78777743 2788899999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 147 -ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred -eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999997543321 2234468999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhh-chhhhhhhh----------------------hh----hhhhhHHHHHHHHHHHHHh
Q 045989 156 PIRLVETEENRSLAAYFLQVINE-NRLFEVLDA----------------------QV----LREAEKEEVITVAMVAKRC 208 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----------------------~~----~~~~~~~~~~~~~~li~~c 208 (295)
||......+.. .......... ......+.+ .. ...........+.+++.+|
T Consensus 224 pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m 301 (364)
T cd07875 224 LFPGTDHIDQW--NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301 (364)
T ss_pred CCCCCCHHHHH--HHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHh
Confidence 99754322110 0000000000 000000000 00 0000111234688999999
Q ss_pred hccCCCCCCCHHHHHHHHHH
Q 045989 209 LNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 209 l~~~p~~Rps~~e~~~~l~~ 228 (295)
|+.||.+|||+.++++|.+-
T Consensus 302 L~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 302 LVIDASKRISVDEALQHPYI 321 (364)
T ss_pred cCcCcccCCCHHHHhcCccc
Confidence 99999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=253.78 Aligned_cols=205 Identities=25% Similarity=0.330 Sum_probs=161.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++|+||+++++|..++..... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~d 128 (282)
T cd06643 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHENK---IIHRD 128 (282)
T ss_pred HHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 46788999999999999999999999999999999988765322 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.++|+|||++....... .......++..|+|||++. +..++.++||||+||++|+|++|..|
T Consensus 129 lkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 129 LKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred CCcccEEEccCCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 99999999999999999999987543221 1223345889999999984 34578899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|...... ............ ....+...+..+.+++.+||+.+|.+||++.+++++.+
T Consensus 208 ~~~~~~~------~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 208 HHELNPM------RVLLKIAKSEPP--------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ccccCHH------HHHHHHhhcCCC--------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 8643211 111111111000 00112234456899999999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=253.41 Aligned_cols=204 Identities=27% Similarity=0.398 Sum_probs=163.3
Q ss_pred cCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccC
Q 045989 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHRDI 82 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~di 82 (295)
+.++||||+++++++..++..++||||++|++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl 140 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDL 140 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCC
Confidence 45799999999999999999999999999999999986544444568999999999999999999996 56 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
+|+||+++.++.++|+|||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~ 218 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH
Confidence 9999999999999999999987654332 23345688899999999988899999999999999999999999853221
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
. .......... . ........+..+.+++.+||+.||++||++.|+..++.
T Consensus 219 ~------~~~~~~~~~~-~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 L------SLATKIVEAV-Y--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred H------HHHHHHhhcc-C--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 1111111110 0 00011123456899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=252.88 Aligned_cols=207 Identities=29% Similarity=0.478 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. ...++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 62 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~d 134 (279)
T cd05057 62 VMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRD 134 (279)
T ss_pred HHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEecc
Confidence 4678899999999999987 788999999999999999976433 3899999999999999999999998 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee-eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++.......... ....++..|+|||.+....++.++|+||||+++|++++ |..||..
T Consensus 135 i~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999999986543222111 12223568999999988889999999999999999998 9999864
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
....+ ......... ....+...+..+.+++.+||..+|.+||++.++++.+..+..
T Consensus 215 ~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 215 IPAVE------IPDLLEKGE----------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCHHH------HHHHHhCCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 33221 111111111 011112233458889999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=250.74 Aligned_cols=204 Identities=25% Similarity=0.383 Sum_probs=163.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++++||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 51 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~d 124 (256)
T cd06612 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSNK---KIHRD 124 (256)
T ss_pred HHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 46788999999999999999999999999999999999865332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 125 l~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred CCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999876543321 2233457889999999998899999999999999999999999986432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
... ........ .......+...+..+.+++.+||+.+|.+|||+.+++++.
T Consensus 204 ~~~------~~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~ 254 (256)
T cd06612 204 PMR------AIFMIPNK--------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254 (256)
T ss_pred hhh------hhhhhccC--------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence 211 00000000 0000011223445689999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=249.70 Aligned_cols=205 Identities=25% Similarity=0.377 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...+++|||+.+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 126 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHETG---KIHRD 126 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceecC
Confidence 46789999999999999999999999999999999999876422 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC---CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS---QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus 127 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 127 IKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred CChhhEEECCCCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987554321 122334678899999999776 78899999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
....... ....... . ..+. ........+..+.+++.+||..+|.+|||+.+++.+
T Consensus 206 ~~~~~~~------~~~~~~~-~----~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 206 DLHPMRA------LFLISKS-N----FPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCCHHHH------HHHHHhc-c----CCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 4322111 0000000 0 0000 001123445678999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.28 Aligned_cols=208 Identities=25% Similarity=0.442 Sum_probs=163.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQ-----LPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++......++||||+++|+|.+++....... ..+++..+..++.|++.||+|||+.+
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--- 137 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--- 137 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---
Confidence 4678999999999999999899999999999999999997654221 24899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQK 155 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~ 155 (295)
++|+||||+||+++.++.++++|||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~ 217 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986443222222233356778999999988888999999999999999998 788
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||...... ...... ...... ...+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 218 p~~~~~~~------~~~~~~-~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 218 PFYGLSDE------EVLNRL-QAGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CccccchH------HHHHHH-HcCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 88532211 111111 111110 0111233456899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.26 Aligned_cols=216 Identities=21% Similarity=0.368 Sum_probs=160.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||++ ++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 57 ~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~d 129 (301)
T cd07873 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRRK---VLHRD 129 (301)
T ss_pred HHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 4678999999999999999999999999996 599988875432 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus 130 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 130 LKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CCHHHEEECCCCcEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875432221 12233568899999998654 5788999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhh--chhh-hhhh---------hh----hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINE--NRLF-EVLD---------AQ----VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--~~~~-~~~~---------~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+. ...+...... ...+ .... +. .........+..+.++|.+||+.||.+|||+.|+++
T Consensus 209 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 209 TVEEQ---LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CHHHH---HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 32211 0011111000 0000 0000 00 000111123446889999999999999999999999
Q ss_pred HHHH
Q 045989 225 ELAG 228 (295)
Q Consensus 225 ~l~~ 228 (295)
|.+-
T Consensus 286 h~~f 289 (301)
T cd07873 286 HPYF 289 (301)
T ss_pred Cccc
Confidence 8654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.09 Aligned_cols=217 Identities=22% Similarity=0.311 Sum_probs=159.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+. ++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 126 (285)
T cd07861 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRD 126 (285)
T ss_pred HHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 4678899999999999999999999999996 589888865332 235899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++|||||||++++|++|+.||...
T Consensus 127 l~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 127 LKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999987554322 112233568899999988654 5788999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhh-----------chhhhhh---hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINE-----------NRLFEVL---DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+. ........... ....... ............+.++.+++.+||+.||++|||+.+++++.
T Consensus 206 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~ 283 (285)
T cd07861 206 SEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283 (285)
T ss_pred CHHHH--HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence 32110 00000000000 0000000 00000111122455688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=250.44 Aligned_cols=204 Identities=29% Similarity=0.475 Sum_probs=162.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..+++|||+++++|.+++...... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~d 128 (258)
T smart00219 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESKN---FIHRD 128 (258)
T ss_pred HHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcCC---eeecc
Confidence 456789999999999999999999999999999999999764432 2899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||+|+++++|++ |..||...
T Consensus 129 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 129 LAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665432222222336789999999988889999999999999999998 78887532
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
. ............ ....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 209 ~------~~~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 S------NEEVLEYLKKGY----------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C------HHHHHHHHhcCC----------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 111121111111 1111222455699999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=257.22 Aligned_cols=208 Identities=30% Similarity=0.534 Sum_probs=162.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++... ..++++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 62 ~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~d 134 (303)
T cd05110 62 IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERR---LVHRD 134 (303)
T ss_pred HHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccc
Confidence 46788999999999998754 46799999999999999875432 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|++++ |..||..
T Consensus 135 ikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 135 LAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865432221 1122335678999999998899999999999999999997 8899854
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ .......... ...+...+..+.+++.+||..+|++||++.++++.+..+...
T Consensus 215 ~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 215 IPTRE-------IPDLLEKGER---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCHHH-------HHHHHHCCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 32111 1111111110 011122344688999999999999999999999999876433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=252.11 Aligned_cols=203 Identities=23% Similarity=0.366 Sum_probs=170.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||.+++.|+||+|||.+.....+|||||||-.|++.+.++.+.. ++++..+..++...++||+|||... -+|||
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRD 154 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDLK---KIHRD 154 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHHH---HHHhh
Confidence 68899999999999999999999999999999999999986554 5999999999999999999999988 89999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
||+.|||++.+|..||+|||.|-.+... .....+..||+.|||||++..-.|+.++||||||+...||..|++||....
T Consensus 155 IKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 155 IKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred cccccEEEcccchhhhhhccccchhhhh-HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 9999999999999999999998654432 223445679999999999999999999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhh-hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEV-LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.-. .++-+ -.+..--..+..++..+.++++.||-+.|++|-|+.++++|.
T Consensus 234 PMR---------------AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 234 PMR---------------AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred ccc---------------eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 111 11111 011111234566788899999999999999999999999985
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=251.98 Aligned_cols=204 Identities=27% Similarity=0.406 Sum_probs=164.5
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLH-----SAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh-----~~~~ 74 (295)
++++++||||+++++++.. +...+++|||+++++|.+++.........+++..++.++.|++.||+||| +.+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~- 130 (265)
T cd08217 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT- 130 (265)
T ss_pred HHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-
Confidence 4678999999999998864 45679999999999999999875444456899999999999999999999 666
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCC
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
++|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 131 --i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 131 --VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred --ceecCCCHHHEEEecCCCEEEecccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999886644332 123346899999999998888999999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.||...... .... .... ......+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 208 ~p~~~~~~~------~~~~-~~~~---------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 208 PPFTARNQL------QLAS-KIKE---------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CcccCcCHH------HHHH-HHhc---------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 998643311 1111 1111 11122333455678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=255.35 Aligned_cols=217 Identities=20% Similarity=0.282 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..+++|||+++|+|.+++...... .+++..+..++.|++.||+|||+++ |+|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~d 126 (314)
T cd08216 52 TSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSKG---FIHRS 126 (314)
T ss_pred HHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 467889999999999999999999999999999999999864322 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc------eeeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g 153 (295)
|||+||+++.++.++|+|||.+........ .......++..|+|||++.. ..++.++||||+||++|+|++|
T Consensus 127 lk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g 206 (314)
T cd08216 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206 (314)
T ss_pred CCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhC
Confidence 999999999999999999998865432111 11122346778999999876 3588999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhh-------ch-------h--------hhhhhhhhhhhhhHHHHHHHHHHHHHhhcc
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINE-------NR-------L--------FEVLDAQVLREAEKEEVITVAMVAKRCLNL 211 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~-------~~-------~--------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 211 (295)
..||....... ......... .. . ...................+.+++.+||+.
T Consensus 207 ~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (314)
T cd08216 207 HVPFKDMPATQ-----MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281 (314)
T ss_pred CCCCCCCCHHH-----HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence 99997432211 000000000 00 0 000000011122233456788999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 045989 212 NGKKRPTMKEVALELAG 228 (295)
Q Consensus 212 ~p~~Rps~~e~~~~l~~ 228 (295)
||++|||++++++|.+-
T Consensus 282 ~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 282 DPESRPSASQLLNHSFF 298 (314)
T ss_pred CCCcCcCHHHHhcCchH
Confidence 99999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=249.16 Aligned_cols=195 Identities=24% Similarity=0.512 Sum_probs=155.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. ...++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 126 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK---LVHGN 126 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeccc
Confidence 5788999999999999988 778999999999999999986543 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCC-------ceEEeeccCccccccCcceeeeccccccCCCChhhhccC--CCCCCccchhhHHHHHHHHh
Q 045989 82 IKSANILLDDKY-------RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 82 ikp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~ 152 (295)
|||+||+++.++ .++|+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~ 201 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence 999999999887 799999999875433 2223467789999999876 78999999999999999999
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|..||......+ ....+. .... .+......+.+++.+||..+|.+|||+.++++.|
T Consensus 202 ~~~~p~~~~~~~~---~~~~~~---~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 202 NGEEPLSTLSSSE---KERFYQ---DQHR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCcccCCchh---HHHHHh---cCCC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 577775432111 000000 0000 0001115688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=264.78 Aligned_cols=213 Identities=26% Similarity=0.444 Sum_probs=173.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+|+||||++++|+|..++.+++|+||+++|+|.+++.+..... ..-.....|+.||+.|++||.+.+ +||||
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd 662 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRD 662 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhcc
Confidence 5889999999999999999999999999999999999998764322 345566779999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee-eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh--CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT--GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~ 158 (295)
|.+.|+|++.++++||+|||.++.+-....... ...+-...|||||.+..++++.++|+|+||+++||+++ ...||.
T Consensus 663 ~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 663 LATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 999999999999999999999996655444433 33456789999999999999999999999999999876 677876
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
....++... +...+...-........|..++..+++++.+||..+-.+||+++++..+|..
T Consensus 743 ~lt~e~vve---------n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 743 QLTDEQVVE---------NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred hhhHHHHHH---------hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 444332111 1111222222333445667788889999999999999999999999998865
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=284.20 Aligned_cols=208 Identities=24% Similarity=0.412 Sum_probs=159.2
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----C
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS----I 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~----~ 75 (295)
+|++|+|||||+++++|.. ...+||||||+++|+|.+++.........+++..++.|+.||+.||+|||+.+. .
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 5788999999999999865 356899999999999999998654434469999999999999999999998541 2
Q ss_pred CeEeccCCCCeEEECC-----------------CCceEEeeccCccccccCcceeeeccccccCCCChhhhcc--CCCCC
Q 045989 76 PIYHRDIKSANILLDD-----------------KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS--SQFTE 136 (295)
Q Consensus 76 ~i~H~dikp~Nill~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ 136 (295)
+|+||||||+||||+. ...+||+|||++....... ......||+.|+|||++.+ ..++.
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~ 222 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDD 222 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCc
Confidence 3999999999999964 2358999999997654322 1234568999999999854 45889
Q ss_pred CccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 137 KSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 137 ~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
++|||||||++|+|++|..||..... ....+.. +..... ......+..+.+||..||..+|.+|
T Consensus 223 KSDVWSLG~ILYELLTGk~PF~~~~~-----~~qli~~-lk~~p~----------lpi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 223 KSDMWALGCIIYELCSGKTPFHKANN-----FSQLISE-LKRGPD----------LPIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCc-----HHHHHHH-HhcCCC----------CCcCCCCHHHHHHHHHHhcCChhHC
Confidence 99999999999999999999963221 1111111 111100 0011234568899999999999999
Q ss_pred CCHHHHHHHHH
Q 045989 217 PTMKEVALELA 227 (295)
Q Consensus 217 ps~~e~~~~l~ 227 (295)
|++.+++.+.+
T Consensus 287 PSa~QlL~h~~ 297 (1021)
T PTZ00266 287 PSALQCLGYQI 297 (1021)
T ss_pred cCHHHHhccHH
Confidence 99999997654
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=256.47 Aligned_cols=205 Identities=22% Similarity=0.366 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++|+||+++++|..++... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~d 140 (296)
T cd06655 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRD 140 (296)
T ss_pred HHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 467889999999999999999999999999999999988653 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 141 L~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875433221 1223457889999999988889999999999999999999999986433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
... ......... . .....+...+..+.+++.+||..||.+||++.+++++-+-.
T Consensus 220 ~~~------~~~~~~~~~-~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 220 PLR------ALYLIATNG-T-------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred HHH------HHHHHHhcC-C-------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 211 111111000 0 00011223345688899999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=264.92 Aligned_cols=212 Identities=25% Similarity=0.482 Sum_probs=169.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++-+|.||+-+.|+|..... .||+-+|+|.+|+.+++.... .|...+.+.|+.||++|+.|||.++ |+|||
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK~---IIHrD 513 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRD 513 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhh
Confidence 4788899999999999999877 999999999999999997665 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccC-cceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
||..|||+.+++.|||+|||++...... .........|...|||||++.. .+|++++||||||+++|||++|..||
T Consensus 514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 9999999999999999999998644322 2222344567889999999853 47899999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
.....+. .++ .+..+-+ . .........++.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 594 si~~~dq------Iif-mVGrG~l----~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 594 SIQNRDQ------IIF-MVGRGYL----M-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred CCCChhh------eEE-Eeccccc----C-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 7222111 000 0111100 0 011123345677899999999999999999999999988877654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=258.48 Aligned_cols=197 Identities=24% Similarity=0.362 Sum_probs=156.7
Q ss_pred cCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 4 SQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 4 ~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
..+ +||+|+++++++...+..|+||||++||+|..++.... .+++..++.++.|++.||+|||+.+ ++||||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDi 127 (323)
T cd05615 55 ALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDL 127 (323)
T ss_pred HhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 344 56889999999999999999999999999999987543 4899999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.....
T Consensus 128 kp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 128 KLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred CHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999987533221 122334689999999999988899999999999999999999999964322
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-----KEVALE 225 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~~~~ 225 (295)
. .....+.... ...+...+..+.+++.+||+.+|.+|++. .++.+|
T Consensus 207 ~------~~~~~i~~~~-----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 207 D------ELFQSIMEHN-----------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred H------HHHHHHHhCC-----------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1 1122211111 01122334568889999999999999974 556555
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=253.14 Aligned_cols=205 Identities=26% Similarity=0.376 Sum_probs=159.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 59 ~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 131 (267)
T cd06646 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG---KMHRD 131 (267)
T ss_pred HHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999999999986533 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|+||+||++|+|++|..||.
T Consensus 132 l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 132 IKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCHHHEEECCCCCEEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999987653221 1122345788999999884 3457889999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.....+.. ... .... ..+... ......+..+.+++.+||..+|++|||++++++++
T Consensus 211 ~~~~~~~~------~~~-~~~~----~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 211 DLHPMRAL------FLM-SKSN----FQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccchhhhh------eee-ecCC----CCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 32211100 000 0000 000000 01122345689999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=248.87 Aligned_cols=200 Identities=27% Similarity=0.476 Sum_probs=158.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|||
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~d 125 (254)
T cd05083 52 VMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRD 125 (254)
T ss_pred HHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 46789999999999998765 47999999999999999975432 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...... ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 126 l~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 126 LAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred cCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 9999999999999999999998753221 112234567999999988889999999999999999998 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
...+ ... ..... .....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 202 ~~~~------~~~-~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 202 SLKE------VKE-CVEKG---------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CHHH------HHH-HHhCC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 2211 111 11111 001112234566889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.15 Aligned_cols=206 Identities=25% Similarity=0.341 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 128 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSHK---VIHRD 128 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 46789999999999999999999999999999999999876432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.++|+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|+|++|..|
T Consensus 129 l~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p 207 (280)
T cd06611 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207 (280)
T ss_pred CChhhEEECCCCCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999998865433221 223345889999999975 34467899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|...... ........... + ....+...+..+.+++.+||+.+|.+||++.+++++.+-
T Consensus 208 ~~~~~~~------~~~~~~~~~~~------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 208 HHELNPM------RVLLKILKSEP------P--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred cccCCHH------HHHHHHhcCCC------C--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 8643211 11111111100 0 001122344568899999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=254.05 Aligned_cols=203 Identities=27% Similarity=0.395 Sum_probs=156.8
Q ss_pred ccCC-CCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 3 LSQI-NHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++ +||||+++++++... ...++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~-- 131 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-- 131 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4556 799999999999763 457999999999999999876332 24889999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHH
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el 150 (295)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++. +..++.++||||+||++|+|
T Consensus 132 -ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el 209 (272)
T cd06637 132 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209 (272)
T ss_pred -CccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999987543221 1223456889999999986 34578899999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
++|..||....... ... .. .... .........+..+.+++.+||..+|.+|||+.++++|.
T Consensus 210 ~~g~~p~~~~~~~~-----~~~-~~-~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 210 AEGAPPLCDMHPMR-----ALF-LI-PRNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred HhCCCCccccCHHH-----HHH-HH-hcCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 99999985322111 000 00 0000 00011122345689999999999999999999998874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=249.84 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++|+||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~ 126 (256)
T cd08218 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 47889999999999999999999999999999999999875332 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|+|||||++++|++|..||....
T Consensus 127 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred CCHHHEEEcCCCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 999999999999999999999875543221 1223457889999999988889999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
. ........... ....+...+..+.+++.+||+.+|.+||++.+|+++.
T Consensus 206 ~------~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 206 M------KNLVLKIIRGS----------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred H------HHHHHHHhcCC----------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 1 11222221111 1112223455689999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=256.13 Aligned_cols=204 Identities=25% Similarity=0.366 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+..++..++||||+++++|.+++... .+++..++.++.||+.||+|||+.+ ++|||
T Consensus 72 ~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~d 143 (292)
T cd06658 72 IMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG---VIHRD 143 (292)
T ss_pred HHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 467789999999999999999999999999999999988543 3789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875432221 1223458899999999988889999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... .+..... ...+.. ......+..+.+++.+||..||.+|||+.+++++.+.
T Consensus 223 ~~~------~~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 275 (292)
T cd06658 223 PLQ------AMRRIRD------NLPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275 (292)
T ss_pred HHH------HHHHHHh------cCCCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 111 1111100 000000 0111234468889999999999999999999988544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=254.66 Aligned_cols=209 Identities=24% Similarity=0.358 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++|+||+++++|..++... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 71 ~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~d 142 (297)
T cd06659 71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG---VIHRD 142 (297)
T ss_pred HHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 467889999999999999999999999999999999987542 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++++|++|..||....
T Consensus 143 l~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865433221 1223458899999999998889999999999999999999999986332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
..+ ........... ........+..+.+++.+||+.+|.+||++.+++++..-.....
T Consensus 222 ~~~------~~~~~~~~~~~--------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 222 PVQ------AMKRLRDSPPP--------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHH------HHHHHhccCCC--------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 211 11111110000 00011123345888999999999999999999999876554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=251.69 Aligned_cols=204 Identities=27% Similarity=0.396 Sum_probs=158.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+|
T Consensus 59 ~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 131 (267)
T cd06645 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG---KMHRD 131 (267)
T ss_pred HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4678899999999999999999999999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++.++|+|||++....... .......|+..|+|||++. ...++.++|+|||||++|+|++|..||.
T Consensus 132 lkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 132 IKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCHHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 99999999999999999999987554321 1223346899999999974 4558899999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...... ... ...... . .+... ......+..+.+++.+||+.+|++||++.++++|
T Consensus 211 ~~~~~~-----~~~-~~~~~~-~----~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 211 DLHPMR-----ALF-LMTKSN-F----QPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccchh-----hHH-hhhccC-C----CCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 322111 000 000000 0 00000 0001233458899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.46 Aligned_cols=215 Identities=20% Similarity=0.324 Sum_probs=157.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++|+||+. ++|.+++..... .+++..++.++.||++||.|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---i~H~d 124 (284)
T cd07839 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNG---DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRD 124 (284)
T ss_pred HHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 4678899999999999999999999999996 588888764332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||+++....... ......++..|+|||++.+. .++.++|||||||++|+|++|..|+...
T Consensus 125 l~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 125 LKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CCHHHEEEcCCCcEEECccchhhccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 999999999999999999999875543221 12234578899999998764 4689999999999999999998886432
Q ss_pred chhhcccHHHHHHHHHhhch------hhhhhhhh---------hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENR------LFEVLDAQ---------VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...+. .. ........... .....+.. .........+..+.+++.+||+.||.+|||+.++++|
T Consensus 204 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 204 NDVDD-QL-KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCHHH-HH-HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 21110 00 00000000000 00000000 0011112244678899999999999999999999886
Q ss_pred H
Q 045989 226 L 226 (295)
Q Consensus 226 l 226 (295)
.
T Consensus 282 ~ 282 (284)
T cd07839 282 P 282 (284)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=251.37 Aligned_cols=205 Identities=25% Similarity=0.348 Sum_probs=160.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|..++..... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 135 (292)
T cd06644 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMK---IIHRD 135 (292)
T ss_pred HHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeecC
Confidence 46789999999999999999999999999999999888765432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.++|+|||++....... .......++..|+|||++. ...++.++|+|||||++|+|++|..|
T Consensus 136 lkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred CCcceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 99999999999999999999886533221 1123345788999999884 34568899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..... ............ + ....+...+..+.+++.+||..+|++||++.+++++.+
T Consensus 215 ~~~~~~------~~~~~~~~~~~~------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 215 HHELNP------MRVLLKIAKSEP------P--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CccccH------HHHHHHHhcCCC------c--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 853321 111111111100 0 00112233456889999999999999999999988754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.71 Aligned_cols=216 Identities=27% Similarity=0.303 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... +..++||||+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H 128 (287)
T cd06621 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIH 128 (287)
T ss_pred HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 46789999999999998653 4689999999999999988754444456899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 129 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred CCCCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986543222 1233578889999999988999999999999999999999999974
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..... .............. ...... ........+..+.+++.+||+.+|.+|||+.|++++.+-
T Consensus 206 ~~~~~-~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 206 EGEPP-LGPIELLSYIVNMP-NPELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred ccCCC-CChHHHHHHHhcCC-chhhcc---CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 42211 11111111111100 000000 000011245678999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.69 Aligned_cols=217 Identities=23% Similarity=0.323 Sum_probs=160.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||++++.|..++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~d 125 (286)
T cd07847 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRD 125 (286)
T ss_pred HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4678999999999999999999999999999988877765432 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 126 VKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred CChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543221 1223357889999999876 45789999999999999999999999744
Q ss_pred chhhcccH-HHHHHH-------HHhhchhhh---hhhhhh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSL-AAYFLQ-------VINENRLFE---VLDAQV---LREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~-~~~~~~-------~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+.... ...... ......... ...+.. ........+..+.+++.+||+.+|++||++.+++.|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 205 SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 32221100 000000 000000000 000000 0001112356689999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=262.28 Aligned_cols=211 Identities=23% Similarity=0.346 Sum_probs=156.5
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++... ...+++++++ +++|..++... .+++..+..++.|++.||+|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-- 138 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAG-- 138 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 57889999999999988643 3468999998 78998887643 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 139 -ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 213 (343)
T cd07878 139 -IIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213 (343)
T ss_pred -eecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCC
Confidence 999999999999999999999999998754322 233468999999999877 56889999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhc--hhhhhhhh---------------hhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINEN--RLFEVLDA---------------QVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
.||......+. ... +....... .....+.. .............+.+++.+||+.||.+||
T Consensus 214 ~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~ 290 (343)
T cd07878 214 ALFPGNDYIDQ--LKR-IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI 290 (343)
T ss_pred CCCCCCCHHHH--HHH-HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC
Confidence 99964322110 000 00000000 00000000 000000011233478999999999999999
Q ss_pred CHHHHHHHHHH
Q 045989 218 TMKEVALELAG 228 (295)
Q Consensus 218 s~~e~~~~l~~ 228 (295)
|+.+++.|.+-
T Consensus 291 s~~ell~hp~~ 301 (343)
T cd07878 291 SASEALAHPYF 301 (343)
T ss_pred CHHHHhcCcch
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=253.79 Aligned_cols=213 Identities=28% Similarity=0.455 Sum_probs=164.3
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++.. +...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 59 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~---i~H 132 (284)
T cd05038 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR---YIH 132 (284)
T ss_pred HHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4678999999999999987 5578999999999999999976543 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||+||+++.++.++|+|||.+.......... .....++..|+|||.+.+..++.++||||||+++++|++|..|+
T Consensus 133 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 212 (284)
T cd05038 133 RDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212 (284)
T ss_pred CCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCc
Confidence 9999999999999999999999998665322211 11223456799999998888999999999999999999999987
Q ss_pred cccchhhcc--------cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEENR--------SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
......... ........ .+........+...+.++.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 213 QSPPAEFLRMIGIAQGQMIVTRLLE---------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccchhccccccccccccHHHHHH---------HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 532211100 00000111 1111111112233446799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.94 Aligned_cols=206 Identities=26% Similarity=0.305 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|+||+++.+.+..++..++||||+++++|..++..... ..+++..+..++.|++.||.|||+.+ |+|||
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~d 127 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN---TVYRD 127 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 56789999999999999999999999999999999988865332 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 128 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 128 LKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred CCHHHEEECCCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987543221 1233468999999999988899999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
..... ........... ...+...+..+.+++.+||+.||++||+ +.+++.+-+
T Consensus 206 ~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 206 EKVKR--EEVDRRVLETE-----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred HHHHH--HHHHHhhhccc-----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 21110 00001000000 0112223445788999999999999999 778877754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.22 Aligned_cols=204 Identities=24% Similarity=0.445 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 127 (265)
T cd06631 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRD 127 (265)
T ss_pred HHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 4678899999999999999999999999999999999997543 3789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-----ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-----THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|+|+||+++.++.++|+|||++....... ........|+..|+|||++.+..++.++|+||||+++++|++|..|
T Consensus 128 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred cCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence 99999999999999999999987543211 1112234588999999999988899999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|....... ........... ....+...+..+.+++++||+.+|.+||++.+++.+.
T Consensus 208 ~~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 208 LASMDRLA------AMFYIGAHRGL--------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred cccCChHH------HHHHhhhccCC--------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 96332111 01111111000 1112233455689999999999999999999998763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.08 Aligned_cols=215 Identities=23% Similarity=0.305 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++|+||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+|
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 124 (286)
T cd07832 52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRD 124 (286)
T ss_pred HHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 467889999999999999999999999999 999999987544 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............|+..|+|||.+.+. .++.++||||+|+++++|++|.+||...
T Consensus 125 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 999999999999999999999886644332223344688999999998654 4689999999999999999998877543
Q ss_pred chhhcccHHHHHHHHHhhc------------hhhhh----hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN------------RLFEV----LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~------------~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
.... ... ......... ..... .............+..+.+++.+||+.+|.+|||+++++.
T Consensus 205 ~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 205 NDIE--QLA-IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CHHH--HHH-HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 2211 000 000000000 00000 0000001111233467899999999999999999999998
Q ss_pred HH
Q 045989 225 EL 226 (295)
Q Consensus 225 ~l 226 (295)
|.
T Consensus 282 h~ 283 (286)
T cd07832 282 HP 283 (286)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.19 Aligned_cols=207 Identities=25% Similarity=0.345 Sum_probs=158.2
Q ss_pred ccCC-CCccccceeeEEE-----eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 3 LSQI-NHRNVVKLLGCCL-----ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~-----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
++++ +||||+++++++. .++..++||||++|++|.+++.........+++..++.++.|++.||.|||+.+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 144 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--- 144 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5566 7999999999985 345689999999999999988754444446899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-----CCCCCCccchhhHHHHHHHH
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~ 151 (295)
++||||||+||+++.++.++|+|||+++....... ......|+..|+|||++.. ..++.++||||+||++|+|+
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~ 223 (286)
T cd06638 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223 (286)
T ss_pred ccccCCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence 99999999999999999999999999876543221 1223458999999998853 45788999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+|..||....... ......... .+. ...+...+..+.+++.+||+.+|++|||+.|++++++
T Consensus 224 ~g~~p~~~~~~~~------~~~~~~~~~------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 224 DGDPPLADLHPMR------ALFKIPRNP------PPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred cCCCCCCCCchhH------HHhhccccC------CCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 9999986332111 111100000 000 0011123345889999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=254.42 Aligned_cols=206 Identities=24% Similarity=0.329 Sum_probs=162.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++.+..++..++||||+.|++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 128 (316)
T cd05574 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLG---IVYRD 128 (316)
T ss_pred HHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 46788999999999999999999999999999999999875432 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce----------------------------eeeccccccCCCChhhhccCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH----------------------------LTTQVKGTFGYLDPEYFQSSQ 133 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~ 133 (295)
|||+||+++.++.++|+|||++......... ......|+..|+|||++.+..
T Consensus 129 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 208 (316)
T cd05574 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208 (316)
T ss_pred CChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC
Confidence 9999999999999999999988654321110 011235788999999999888
Q ss_pred CCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 134 FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 134 ~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
++.++||||||+++|+|++|..||...... ..+........ ........+..+.+++.+||+.+|
T Consensus 209 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRD------ETFSNILKKEV---------TFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CCchHHHHHHHHHHHHHhhCCCCCCCCchH------HHHHHHhcCCc---------cCCCccccCHHHHHHHHHHccCCH
Confidence 999999999999999999999998633221 11111111110 001111145679999999999999
Q ss_pred CCCCC----HHHHHHHHH
Q 045989 214 KKRPT----MKEVALELA 227 (295)
Q Consensus 214 ~~Rps----~~e~~~~l~ 227 (295)
++||+ +.+++.+.+
T Consensus 274 ~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 274 SKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred hHCCCchhhHHHHHcCch
Confidence 99999 888887754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.64 Aligned_cols=197 Identities=28% Similarity=0.422 Sum_probs=162.2
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|.+++|||++.|-|+|......|+||||| -|+-.+++.-... ++-+..+..|+.+.+.||+|||+.+ .+||||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDi 152 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN---RIHRDI 152 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhc
Confidence 67899999999999999999999999999 5588888875443 5899999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|+.|||+++.|.+||+|||.|..... ...++|||+|||||++. .+.|+-++||||||++-.||...++|+..
T Consensus 153 KAGNILLse~g~VKLaDFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 153 KAGNILLSEPGLVKLADFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred cccceEecCCCeeeeccccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 99999999999999999998865432 34578999999999874 46899999999999999999999999653
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.+. ....+ .+.......-....++..|..++..||++-|.+|||..++++|.
T Consensus 228 MNA-----MSALY----------HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 228 MNA-----MSALY----------HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred chH-----HHHHH----------HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 221 11111 11111111122457788899999999999999999999999874
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.33 Aligned_cols=212 Identities=28% Similarity=0.449 Sum_probs=160.5
Q ss_pred cccCC-CCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCCC---------------------------------
Q 045989 2 ILSQI-NHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTED--------------------------------- 46 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~--------------------------------- 46 (295)
+|.++ +||||+++++++... ...++||||+++|+|.+++......
T Consensus 63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (343)
T cd05103 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSIT 142 (343)
T ss_pred HHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccc
Confidence 35667 789999999988754 4678999999999999998753210
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceE
Q 045989 47 ------------------------------QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAK 96 (295)
Q Consensus 47 ------------------------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~k 96 (295)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k 219 (343)
T cd05103 143 SSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVK 219 (343)
T ss_pred cccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEE
Confidence 123678888999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHH
Q 045989 97 ISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQ 174 (295)
Q Consensus 97 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 174 (295)
|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 220 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~ 293 (343)
T cd05103 220 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 293 (343)
T ss_pred EEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHH
Confidence 9999998764322211 1122345678999999988889999999999999999997 899986432111 0111
Q ss_pred HHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 175 VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
....... ...+...+..+.+++.+||+.+|.+|||+.+|+++|+.+..
T Consensus 294 ~~~~~~~---------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 294 RLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHhccCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111100 01111123458899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=255.36 Aligned_cols=204 Identities=23% Similarity=0.365 Sum_probs=162.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 69 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~d 140 (297)
T cd06656 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRD 140 (297)
T ss_pred HHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 467889999999999999999999999999999999998653 3788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+|||||++|++++|..||....
T Consensus 141 L~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CCHHHEEECCCCCEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875433221 1223457889999999998889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..... . ...... ......+...+..+.+++.+||+.+|++||++.+++++.+-
T Consensus 220 ~~~~~-----~-~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 220 PLRAL-----Y-LIATNG--------TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred cchhe-----e-eeccCC--------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 21100 0 000000 00001122334558889999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.76 Aligned_cols=206 Identities=27% Similarity=0.411 Sum_probs=158.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++|+||+++++|.+++...... ...++..+..++.|++.||+|||+.+ ++|||
T Consensus 58 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~d 133 (268)
T cd06624 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRD 133 (268)
T ss_pred HHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 467899999999999999999999999999999999999764321 11378888999999999999999999 99999
Q ss_pred CCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccC--CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++. ++.++|+|||++........ ......|+..|+|||++.+. .++.++|+||||+++|+|++|..||.
T Consensus 134 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred CCHHHEEEcCCCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999976 67999999999875532221 12233578899999998654 37889999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
....... . ..... ........+...+..+.+++.+||+.+|.+|||+.+++.|.
T Consensus 213 ~~~~~~~----~-~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 213 ELGEPQA----A-MFKVG---------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred cccChhh----h-Hhhhh---------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 3221110 0 00000 00011122333445688999999999999999999998874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=249.15 Aligned_cols=204 Identities=24% Similarity=0.305 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~d 118 (262)
T cd05572 46 ILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG---IIYRD 118 (262)
T ss_pred HHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCC
Confidence 4678899999999999999999999999999999999997643 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 119 l~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999988654332 2223457889999999988889999999999999999999999996443
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
.. ........... ......+...+..+.+++.+||+.+|++||+ ++|+++|.+
T Consensus 197 ~~----~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 197 ED----PMEIYNDILKG---------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred CC----HHHHHHHHhcc---------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 21 11111111110 0111122223556999999999999999999 899988765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=287.38 Aligned_cols=218 Identities=25% Similarity=0.440 Sum_probs=168.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++++|.+.+..++||||+++|+|.++++. +++..+..++.|++.||+|||.....+|+|||
T Consensus 736 ~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 808 (968)
T PLN00113 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808 (968)
T ss_pred HHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence 46789999999999999999999999999999999999952 78999999999999999999965444499999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++..++. ||.+..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 809 lkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 99999999998888775 555432211 112357899999999999999999999999999999999999985322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLR--EAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
. .......+.............+++.... ..+.....++.+++.+||+.+|++|||+.|+++.|+.+.+..
T Consensus 883 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 883 G-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred C-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 1 1233444443333222222233332211 223455667899999999999999999999999998765533
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=246.99 Aligned_cols=201 Identities=27% Similarity=0.477 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++.+..++..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+++ ++|+|
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~d 126 (256)
T cd08220 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL---ILHRD 126 (256)
T ss_pred HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 46789999999999999999999999999999999999976432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCC-CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDK-YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++++|++|..||...
T Consensus 127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred CCHHHEEEcCCCCEEEEccCCCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 99999999855 4689999999876543221 22345788999999998888899999999999999999999998633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
... .......... ....+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 205 ~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 205 NLP------ALVLKIMSGT----------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred chH------HHHHHHHhcC----------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 211 1111111110 111122244568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=251.03 Aligned_cols=210 Identities=29% Similarity=0.441 Sum_probs=164.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
+++.++||||+++++++......++||||+++++|..++.... .+++..+..++.+++.||.|||+ .+ ++|+
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~ 128 (284)
T cd06620 56 IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR---IMHR 128 (284)
T ss_pred HHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC---eecc
Confidence 4677899999999999999999999999999999999887533 48999999999999999999997 46 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.++|+|||++....... .....|+..|+|||++.+..++.++|||||||++|++++|..||...
T Consensus 129 dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 129 DIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred CCCHHHEEECCCCcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999886442221 12346899999999998888999999999999999999999999754
Q ss_pred chhhc-----ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 161 ETEEN-----RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
...+. .............. .........+..+.+++.+||+.||++|||+.|++++++.++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 206 NIDDDGQDDPMGILDLLQQIVQEP---------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred chhhhhhhhhhHHHHHHHHHhhcc---------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 32211 11111111111110 000011124456889999999999999999999999876544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.43 Aligned_cols=208 Identities=22% Similarity=0.338 Sum_probs=162.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~ 80 (295)
++++++||||+++++.+..++..++||||+++++|..++.... ....+++..+..++.|++.||.|||+. + ++|+
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~ 127 (286)
T cd06622 52 ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHR 127 (286)
T ss_pred HHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeC
Confidence 4678999999999999999999999999999999999887532 122589999999999999999999974 7 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC------CCCCCccchhhHHHHHHHHhCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS------QFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~ 154 (295)
||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus 128 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 204 (286)
T cd06622 128 DVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204 (286)
T ss_pred CCCHHHEEECCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence 999999999999999999999987543221 2234578899999998554 3578999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.||...... .....+...... .....+...+..+.+++.+||+.+|.+||++.+++.+.+-.
T Consensus 205 ~pf~~~~~~---~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~ 266 (286)
T cd06622 205 YPYPPETYA---NIFAQLSAIVDG----------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266 (286)
T ss_pred CCCCCcchh---hHHHHHHHHhhc----------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence 998632211 111111111110 11122334556688999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.65 Aligned_cols=203 Identities=26% Similarity=0.371 Sum_probs=166.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++|+||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~ 128 (256)
T cd08530 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRD 128 (256)
T ss_pred HHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCC
Confidence 467889999999999999999999999999999999999775444456899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.+||+|||++...... ......++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 129 l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 129 LKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred CCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765433 2223457889999999999889999999999999999999999986433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..+ ..... . .......+...+..+.+++.+||+.+|++||++.+++++.
T Consensus 206 ~~~------~~~~~-~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 206 MQD------LRYKV-Q---------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred HHH------HHHHH-h---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 211 11111 1 1111122334556699999999999999999999998763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=252.08 Aligned_cols=198 Identities=26% Similarity=0.352 Sum_probs=162.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~d 126 (290)
T cd05580 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD---IVYRD 126 (290)
T ss_pred HHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 4678899999999999999999999999999999999987653 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.+||+|||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 127 l~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 127 LKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765433 233458899999999988888999999999999999999999986433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
. ........... ...+...+..+.+++.+||..||.+|+ +++++++|.+
T Consensus 203 ~------~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 203 P------IQIYEKILEGK-----------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred H------HHHHHHHhcCC-----------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 1 11111111110 011222345688999999999999999 8888888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.15 Aligned_cols=200 Identities=23% Similarity=0.294 Sum_probs=159.5
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
..+||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp 125 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKP 125 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCH
Confidence 4579999999999999999999999999999999887543 4899999999999999999999999 99999999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-cCCCCCCccchhhHHHHHHHHhCCCCCcccchh
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-SSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 163 (295)
+||+++.++.++|+|||++....... .....|+..|+|||.+. +..++.++||||+||++|+|++|..||......
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 202 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (279)
T ss_pred HHEEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc
Confidence 99999999999999999986543221 12345899999999986 456889999999999999999999999643322
Q ss_pred hcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 164 ENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
... ....... ......+...+..+.+++.+||..||.+|| +++++++|.+.
T Consensus 203 ~~~----~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 203 DKH----EIDRMTL----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred CHH----HHHHHhh----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 111 1111100 001122333455689999999999999999 69999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=256.95 Aligned_cols=202 Identities=24% Similarity=0.315 Sum_probs=157.2
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|.+| .|.+|++++|+-..++.+||||||-+ -||..+|..+... .+...++.+..|++.|+.++|.+| |||.|
T Consensus 413 L~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH~~g---IVHSD 485 (677)
T KOG0596|consen 413 LNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIHQHG---IVHSD 485 (677)
T ss_pred HHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHHHhc---eeecC
Confidence 5566 67999999999999999999999884 4999999876543 443488889999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCC-----------CCCCccchhhHHHHHH
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQ-----------FTEKSDVYSFGVVLVE 149 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~e 149 (295)
|||.|+|+-. |.+||+|||+|..+..+... .....+||+.||+||.+.... .+.++||||||||||+
T Consensus 486 LKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 486 LKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 9999998875 58999999999987665443 345668999999999986432 4678999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK-EEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+.|++||...... -.++..+.++..--+++. ....++.++++.||+.||.+||++.++++|.
T Consensus 565 MvYgktPf~~~~n~--------------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 565 MVYGKTPFGQIINQ--------------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HHhcCCchHHHHHH--------------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 99999998632211 011223333322111111 1112289999999999999999999999985
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=247.93 Aligned_cols=202 Identities=26% Similarity=0.429 Sum_probs=157.0
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++.. +...++++||+++++|.+++.... .+++...+.++.|++.||+|||+.+ ++|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H 129 (266)
T cd06651 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM---IVH 129 (266)
T ss_pred HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 5678999999999999875 357789999999999999997543 3788999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCc--ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDR--THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++|+||+||++|+|++|..||
T Consensus 130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf 209 (266)
T cd06651 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209 (266)
T ss_pred CCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence 9999999999999999999999987543211 11112345788999999999888999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...... .......... .....+......+.+++ +||..+|++||+++|+++|.
T Consensus 210 ~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 210 AEYEAM------AAIFKIATQP---------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred cccchH------HHHHHHhcCC---------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 633211 1111111000 01122233344567777 68889999999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.93 Aligned_cols=207 Identities=25% Similarity=0.368 Sum_probs=159.5
Q ss_pred cccCC-CCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQI-NHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+++++ +||||+++++++.... ..++||||+++++|.+++.........+++..++.++.|++.||+|||+.+
T Consensus 55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~- 133 (275)
T cd06608 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK- 133 (275)
T ss_pred HHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 35566 7999999999997654 489999999999999998765433446899999999999999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-----CCCCCCccchhhHHHHHH
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~e 149 (295)
++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||++.. ..++.++||||||+++++
T Consensus 134 --i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 134 --VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred --cccCCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 9999999999999999999999999987543322 22233458899999998753 346789999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|++|..||...... ....+..... .+ ....+...+..+.+++.+||..||.+|||+.+++++.
T Consensus 211 l~~g~~p~~~~~~~------~~~~~~~~~~------~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~ 273 (275)
T cd06608 211 LADGKPPLCDMHPM------RALFKIPRNP------PP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP 273 (275)
T ss_pred HHhCCCCccccchH------HHHHHhhccC------CC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence 99999998532211 1111111110 00 0011223456789999999999999999999998864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=275.90 Aligned_cols=213 Identities=21% Similarity=0.329 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-------QLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
++++++||||+++++++..++..++||||++||+|.+++...... ....++..++.++.||+.||+|||+.+
T Consensus 55 ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G- 133 (932)
T PRK13184 55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG- 133 (932)
T ss_pred HHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 467899999999999999999999999999999999998743211 123566788999999999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-----------------eeeeccccccCCCChhhhccCCCCCC
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-----------------HLTTQVKGTFGYLDPEYFQSSQFTEK 137 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 137 (295)
|+||||||+||+++.++.++|+|||+++....... .......||+.|+|||++.+..++.+
T Consensus 134 --IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k 211 (932)
T PRK13184 134 --VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES 211 (932)
T ss_pred --ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence 99999999999999999999999999976521100 01122468999999999999999999
Q ss_pred ccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 138 SDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 138 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
+|||||||++|+|++|..||....... .... .. ...+... ......+..+.+++.+||+.||++||
T Consensus 212 SDIWSLGVILyELLTG~~PF~~~~~~k------i~~~----~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 212 TDIYALGVILYQMLTLSFPYRRKKGRK------ISYR----DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred hHHHHHHHHHHHHHHCCCCCCCcchhh------hhhh----hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999996422111 0000 00 0001000 01123445688999999999999995
Q ss_pred -CHHHHHHHHHHhHH
Q 045989 218 -TMKEVALELAGIRA 231 (295)
Q Consensus 218 -s~~e~~~~l~~~~~ 231 (295)
+++++.+.|+....
T Consensus 278 ss~eeLl~~Le~~lq 292 (932)
T PRK13184 278 SSVQELKQDLEPHLQ 292 (932)
T ss_pred CHHHHHHHHHHHHHh
Confidence 66777777766544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=248.00 Aligned_cols=206 Identities=26% Similarity=0.475 Sum_probs=162.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++|+||+++++|.+++.... ++++..++.++.|++.||+|||+.+ ++|+|
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~ 128 (268)
T cd06630 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRD 128 (268)
T ss_pred HHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 4678899999999999999999999999999999999997543 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCC-ceEEeeccCccccccCcce---eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKY-RAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|+|+||+++.++ .++|+|||.+......... ......|+..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus 129 i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 208 (268)
T cd06630 129 VKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208 (268)
T ss_pred CCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 999999998775 6999999998765433111 112345788999999998888999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
....... ......+... .......+...+..+.+++.+||..+|.+||++.+++++.
T Consensus 209 ~~~~~~~---~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 209 NAEKHSN---HLALIFKIAS---------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred CCCCCcc---hHHHHHHHhc---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 5332111 1111111100 0111223334556688999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=249.81 Aligned_cols=206 Identities=23% Similarity=0.312 Sum_probs=157.9
Q ss_pred ccCC-CCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 3 LSQI-NHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
++++ +||||+++++++... +..++||||+++++|.+++.........+++..++.++.|++.||+|||+.+
T Consensus 72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 148 (291)
T cd06639 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--- 148 (291)
T ss_pred HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4556 899999999999754 3589999999999999998754444446899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-----CCCCCccchhhHHHHHHHH
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-----QFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~ 151 (295)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+... .++.++|||||||++|+|+
T Consensus 149 ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred eeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 99999999999999999999999999876543221 12234578899999997543 3688999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
+|+.||....... ......... .... ..+......+.+++.+||+.+|++||++.++++|.
T Consensus 228 ~g~~p~~~~~~~~------~~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 228 DGDPPLFDMHPVK------TLFKIPRNP-PPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred hCCCCCCCCcHHH------HHHHHhcCC-CCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 9999986332111 111111110 0000 01122334688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.16 Aligned_cols=217 Identities=24% Similarity=0.317 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++++.+..+.... . .+++..++.++.||+.||+|||+.+ ++|+|
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 125 (288)
T cd07833 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-G---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRD 125 (288)
T ss_pred HHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-C---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 467889999999999999999999999999886666555432 2 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.++|+|||++...............++..|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 126 l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 126 IKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999886654433233345678899999999887 7899999999999999999999998643
Q ss_pred chhhcccHHHHHH--------HHHhhc------hhhhhhhhhh-hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFL--------QVINEN------RLFEVLDAQV-LREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...+......... ...... .......+.. ....+...+..+.+++++||..+|++||++++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 2221100000000 000000 0000000000 001122236779999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=246.54 Aligned_cols=196 Identities=24% Similarity=0.333 Sum_probs=158.5
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
+||||+++++.+..++..++||||+++++|.+++.... .+++..++.++.|+++||.|||+.+ ++|+||||+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 139 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLEN 139 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 79999999999999999999999999999999997643 4899999999999999999999999 9999999999
Q ss_pred EEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhc
Q 045989 87 ILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165 (295)
Q Consensus 87 ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 165 (295)
|+++.++ .++|+|||++....... ...++..|+|||++.+..++.++||||+|+++|+|++|..||......+
T Consensus 140 il~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~- 213 (267)
T PHA03390 140 VLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE- 213 (267)
T ss_pred EEEeCCCCeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-
Confidence 9999988 99999999987554221 2357899999999998889999999999999999999999997332211
Q ss_pred ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q 045989 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-MKEVALELA 227 (295)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~e~~~~l~ 227 (295)
.....+.... . .........+..+.+++.+||+.+|.+||+ ++++++|-+
T Consensus 214 ~~~~~~~~~~--~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 214 LDLESLLKRQ--Q----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred hhHHHHHHhh--c----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 1111111111 0 011122245556899999999999999996 699987743
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=252.48 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=156.1
Q ss_pred ccCC-CCccccceeeEEEe------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 3 LSQI-NHRNVVKLLGCCLE------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++ +||||+++++++.. ....+++|||+.+|+|.+++..... ..+++..++.++.|++.||+|||+.+
T Consensus 66 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~-- 141 (282)
T cd06636 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK-- 141 (282)
T ss_pred HHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4455 79999999999853 4578999999999999999976432 24788899999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHH
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el 150 (295)
++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+. +..++.++|+|||||++|+|
T Consensus 142 -ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el 219 (282)
T cd06636 142 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219 (282)
T ss_pred -cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHH
Confidence 99999999999999999999999999875432211 123346889999999875 34678899999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
++|..||....... . .... .............+..+.+++.+||+.||.+||++.+++++.
T Consensus 220 ~~g~~p~~~~~~~~-----~-~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 220 AEGAPPLCDMHPMR-----A-LFLI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred HhCCCCccccCHHh-----h-hhhH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 99999985322111 0 0000 000001111223455699999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=261.76 Aligned_cols=196 Identities=24% Similarity=0.296 Sum_probs=161.0
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
+..-+||||+++.+.+..+.+.|+|||.+.|+-+.+.+...+. +. ..+..|+++|+.|+.|||++| |+|||+
T Consensus 370 ~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDL 441 (612)
T KOG0603|consen 370 LLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQG---VVHRDL 441 (612)
T ss_pred hhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhcC---eeecCC
Confidence 3445899999999999999999999999999988887765542 33 778889999999999999999 999999
Q ss_pred CCCeEEE-CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 83 KSANILL-DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 83 kp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
||+|||+ +..+.++|+|||.++..... .....-|..|.|||++....|++++|+||||++||+|++|+.||...+
T Consensus 442 kp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 442 KPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred ChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 9999999 58899999999999865544 223345888999999999999999999999999999999999997544
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.. .... ..+... ......+....+|+.+||+.||.+||++.++..|.|.
T Consensus 518 ~~-----~ei~-~~i~~~------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 518 AG-----IEIH-TRIQMP------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ch-----HHHH-HhhcCC------------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 33 1111 111111 1124455668899999999999999999999999877
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=250.11 Aligned_cols=203 Identities=23% Similarity=0.356 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++|+||++|++|.+++... .+++..+..++.|++.||+|||+.+ ++|||
T Consensus 69 ~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 140 (285)
T cd06648 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG---VIHRD 140 (285)
T ss_pred HHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 467889999999999999999999999999999999998762 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 141 l~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred CChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999999999999999998765433221 1223458899999999988889999999999999999999999985322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
. ........... .+. ...+...+..+.+++.+||+.+|++||++.+++++.+
T Consensus 220 ~------~~~~~~~~~~~------~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 220 P------LQAMKRIRDNL------PPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred H------HHHHHHHHhcC------CCC--CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 1 11111111110 000 0011123456999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=254.58 Aligned_cols=216 Identities=19% Similarity=0.280 Sum_probs=161.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||++++++|..++..++|+||+.+++|.+++...... .+++..+..++.|++.||+|||+.+ ++|||
T Consensus 52 ~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrD 126 (328)
T cd08226 52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQNG---YIHRN 126 (328)
T ss_pred HHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 356689999999999999999999999999999999998865332 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce---e---eeccccccCCCChhhhccC--CCCCCccchhhHHHHHHHHhC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH---L---TTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g 153 (295)
|||+||+++.++.++++||+.+......... . .....++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 127 lkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g 206 (328)
T cd08226 127 IKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATG 206 (328)
T ss_pred CCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999754322111100 0 0112346679999999763 478999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchh------------------------------------hhhhhhhhhhhhhHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRL------------------------------------FEVLDAQVLREAEKEE 197 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~ 197 (295)
..||....... ........... ................
T Consensus 207 ~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (328)
T cd08226 207 RVPFQDMLRTQ------MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280 (328)
T ss_pred CCCCCCcChHH------HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhh
Confidence 99996432211 01110000000 0000011111223446
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 198 VITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 198 ~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+..+.+++++||+.||++|||+.++++|.+-
T Consensus 281 ~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 6779999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.16 Aligned_cols=206 Identities=28% Similarity=0.409 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
++++++||||+++++++...+..++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~ 125 (265)
T cd06605 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHR 125 (265)
T ss_pred HHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecC
Confidence 3577899999999999999999999999999999999997653 258999999999999999999999 88 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++||||||+++++|++|..||...
T Consensus 126 dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred CCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999875532221 1256888999999999889999999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKE-EVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.... .............. ....+.. .+..+.++|.+||..+|.+|||+.+++.+.+
T Consensus 203 ~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 203 NDPP-DGIFELLQYIVNEP----------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred cccc-ccHHHHHHHHhcCC----------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 2111 11111111111111 0011111 4556899999999999999999999998865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=250.50 Aligned_cols=208 Identities=26% Similarity=0.382 Sum_probs=161.4
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecc
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHRD 81 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~d 81 (295)
++.++||||+++++++..++..++||||++ |+|.+++.........+++..++.++.|++.||+|||++ + ++|||
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~d 129 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRD 129 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 456799999999999999999999999995 689888876544445689999999999999999999997 7 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc----CCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS----SQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++.+||+|||++....... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus 130 lkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 130 VKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred CCHHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCC
Confidence 99999999999999999999987553221 1222457889999998865 45688999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
...... . ........... + .......+..+.+++.+||..+|.+||++.+++++.+-..
T Consensus 208 ~~~~~~----~-~~~~~~~~~~~------~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 208 DSWKTP----F-QQLKQVVEEPS------P---QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CccccC----H-HHHHHHHhcCC------C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 532211 1 11111111100 0 0001124556899999999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=252.12 Aligned_cols=221 Identities=23% Similarity=0.311 Sum_probs=160.0
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQ-LPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++++++||||+++++++... ...++||||+. ++|.+++....... ..+++..++.++.|++.||+|||+.+ ++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 130 (316)
T cd07842 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VL 130 (316)
T ss_pred HHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 46789999999999999988 78999999996 47887776443322 36899999999999999999999999 99
Q ss_pred eccCCCCeEEECC----CCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHH
Q 045989 79 HRDIKSANILLDD----KYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 79 H~dikp~Nill~~----~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~ 151 (295)
||||||+||+++. ++.+||+|||++........ .......++..|+|||++.+. .++.++|||||||++++|+
T Consensus 131 h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999 99999999999886543322 112234578899999988764 5789999999999999999
Q ss_pred hCCCCCcccchhhcccHHH---HHHHHHh---h------------chhhhh---h-----h-hhhhhhhhH--HHHHHHH
Q 045989 152 TGQKPIRLVETEENRSLAA---YFLQVIN---E------------NRLFEV---L-----D-AQVLREAEK--EEVITVA 202 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~---~~~~~~~---~------------~~~~~~---~-----~-~~~~~~~~~--~~~~~~~ 202 (295)
+|+.||............. .+..... . ...... . . ......... ..+..+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 9999997543322100000 0000000 0 000000 0 0 000000011 3345689
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHH
Q 045989 203 MVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 203 ~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
+++.+||+.||++|||+.++++|.
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCC
Confidence 999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=263.49 Aligned_cols=203 Identities=26% Similarity=0.447 Sum_probs=173.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+|+|||++++||+..+ ..+.+|||.++.|+|.+.|++ ..+..|.......++.||+.|+.||..++ +||||
T Consensus 164 ~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRD 237 (1039)
T KOG0199|consen 164 HMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRD 237 (1039)
T ss_pred HHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhh
Confidence 5789999999999999998 788999999999999999987 33346889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee-e-eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL-T-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|...|+++.....+||+|||+.+.++.....- + ....-...|+|||.+....++.++|+|+|||++|||++ |..||.
T Consensus 238 LAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 238 LAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred hhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 99999999999999999999999776543322 2 22344678999999999999999999999999999999 889986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.....+ +.+.++.+.....+..+++.++++++.||..+|++|||+..|.+.+
T Consensus 318 G~~g~q----------------IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 318 GCRGIQ----------------ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCHHH----------------HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 443322 4445555666677888999999999999999999999999997554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=249.08 Aligned_cols=207 Identities=24% Similarity=0.276 Sum_probs=163.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..|+||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 120 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRD 120 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 46788999999999999999999999999999999999876442 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 121 i~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 121 LKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred CCHHHEEECCCCCEEEccCcchhhhccC--CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999998754331 11223457889999999988889999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
.... ... +...... .....+...+..+.+++.+||+.+|.+|| ++.+++.|.+-
T Consensus 199 ~~~~--~~~-~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 199 EKVE--KEE-LKRRTLE----------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred cccc--HHH-HHhcccc----------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 2110 000 0000000 01112223355689999999999999999 77778877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=245.74 Aligned_cols=201 Identities=25% Similarity=0.390 Sum_probs=161.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 127 (258)
T cd06632 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRD 127 (258)
T ss_pred HHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4678899999999999999999999999999999999987543 4789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC-CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.+||+|||++....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||...
T Consensus 128 l~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 128 IKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred CCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999999987653322 223446889999999987766 899999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
... .......... .....+...+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 206 ~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 206 EGV------AAVFKIGRSK---------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred cHH------HHHHHHHhcc---------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 211 1111111100 01112223345688899999999999999999998763
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=247.34 Aligned_cols=204 Identities=27% Similarity=0.404 Sum_probs=163.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 126 (277)
T cd06641 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRD 126 (277)
T ss_pred HHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC---eecCC
Confidence 467899999999999999999999999999999999998643 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 127 l~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred CCHHhEEECCCCCEEEeecccceecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999999999987553321 11223457889999999988888999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
... .... .... .........+..+.+++.+||+.+|.+||++.++++|.+-..
T Consensus 206 ~~~------~~~~-~~~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 206 PMK------VLFL-IPKN---------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred hHH------HHHH-HhcC---------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 111 1111 1100 111122334556889999999999999999999999865443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=244.74 Aligned_cols=205 Identities=31% Similarity=0.431 Sum_probs=166.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|||++++++.+......++|+||+++++|.+++.........+++..++.++.+++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~d 128 (258)
T cd08215 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRD 128 (258)
T ss_pred HHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---Eeccc
Confidence 467889999999999999999999999999999999999876533446999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||....
T Consensus 129 l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 129 IKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred CChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999999999999999999987654432 22333468889999999988889999999999999999999999985332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
........... .....+...+..+.+++.+||..+|++|||+.+++++.
T Consensus 208 ------~~~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 256 (258)
T cd08215 208 ------LLELALKILKG----------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256 (258)
T ss_pred ------HHHHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence 11111111111 01122223445689999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=250.45 Aligned_cols=205 Identities=25% Similarity=0.308 Sum_probs=158.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++.+..++..++||||++|++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 126 (305)
T cd05609 54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG---IVHRD 126 (305)
T ss_pred HHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc--------------eeeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT--------------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
|||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|+|||||++
T Consensus 127 l~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl 206 (305)
T cd05609 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206 (305)
T ss_pred CchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence 999999999999999999998863211000 011123578889999999888899999999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT---MKEVAL 224 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~e~~~ 224 (295)
|++++|..||..... ............ ..+ ......+..+.+++.+||+.+|++||+ +.++++
T Consensus 207 ~el~~g~~pf~~~~~------~~~~~~~~~~~~----~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 207 YEFLVGCVPFFGDTP------EELFGQVISDDI----EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHHhCCCCCCCCCH------HHHHHHHHhccc----CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 999999999863221 111211111100 000 011123456899999999999999998 566666
Q ss_pred HHH
Q 045989 225 ELA 227 (295)
Q Consensus 225 ~l~ 227 (295)
+.+
T Consensus 273 ~~~ 275 (305)
T cd05609 273 HRF 275 (305)
T ss_pred Ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=245.64 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=158.3
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++.+. ..+++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H 129 (265)
T cd06652 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM---IVH 129 (265)
T ss_pred HHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 46788999999999998764 46789999999999999987543 3788899999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||+||+++.++.++|+|||++........ .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus 130 ~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 209 (265)
T cd06652 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209 (265)
T ss_pred CCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCC
Confidence 99999999999999999999999875432111 1122345788999999998888999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
....... ........ ......+......+.+++.+|+. +|++||++++++++.
T Consensus 210 ~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 210 AEFEAMA------AIFKIATQ---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred CccchHH------HHHHHhcC---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 6322111 11111100 01112233455668889999995 999999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.16 Aligned_cols=216 Identities=21% Similarity=0.315 Sum_probs=158.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+. ++|..++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~ 125 (284)
T cd07860 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRD 125 (284)
T ss_pred HHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4678999999999999999999999999995 589988875432 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC-CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.++|+|||++........ ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 126 l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 126 LKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred CCHHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999875433221 122234688899999886644 588999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhc-hhh----------hh---hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN-RLF----------EV---LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~-~~~----------~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+ ............. ... .. .............+..+.++|.+||+.||.+|||+.++++|.
T Consensus 205 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 205 SEID--QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred CHHH--HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 3211 1111111000000 000 00 000000111112345578999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.42 Aligned_cols=215 Identities=21% Similarity=0.286 Sum_probs=159.2
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++... ...++||||+. ++|.+++..... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 57 ~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H 129 (293)
T cd07843 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNW---ILH 129 (293)
T ss_pred HHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 46788999999999999877 88999999996 599998876443 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||||||+++++|++|..||.
T Consensus 130 ~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 130 RDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred ccCCHHHEEECCCCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999886554321 12234578899999998764 46899999999999999999999986
Q ss_pred ccchhhcccHHHHHHHH----------Hhh------chhhhhhhhhhhhhhhHH-HHHHHHHHHHHhhccCCCCCCCHHH
Q 045989 159 LVETEENRSLAAYFLQV----------INE------NRLFEVLDAQVLREAEKE-EVITVAMVAKRCLNLNGKKRPTMKE 221 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~----------~~~------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rps~~e 221 (295)
.....+.. ....... ... ...............+.. .+..+.+++.+||+.+|++|||+.|
T Consensus 209 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e 286 (293)
T cd07843 209 GKSEIDQL--NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286 (293)
T ss_pred CCChHHHH--HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence 44322110 0000000 000 000000000000111111 3566889999999999999999999
Q ss_pred HHHHH
Q 045989 222 VALEL 226 (295)
Q Consensus 222 ~~~~l 226 (295)
++.+-
T Consensus 287 ll~~~ 291 (293)
T cd07843 287 ALKHP 291 (293)
T ss_pred HhcCC
Confidence 98763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=245.20 Aligned_cols=209 Identities=25% Similarity=0.483 Sum_probs=160.3
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQT--EDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++.... ..++++||+.+|+|..++.... .....+++..++.++.|++.||+|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 467899999999999987532 2378999999999998875432 22234788999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
++||||||+||+++.++.+||+|||+++........ ......+++.|++||.+....++.++|||||||++|+|++
T Consensus 134 ---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 134 ---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred ---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 999999999999999999999999998865432211 1122345678999999988889999999999999999999
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|..||...... ............ ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 211 ~g~~p~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 211 RGQTPYAGVENS------EIYNYLIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCCHH------HHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88888533221 111111111110 11122345689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=244.10 Aligned_cols=207 Identities=26% Similarity=0.418 Sum_probs=161.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 133 (272)
T cd06629 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRD 133 (272)
T ss_pred HHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecC
Confidence 4678899999999999999999999999999999999997652 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCC--CCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+|+||+++.++.++|+|||++........ .......|+..|+|||.+.... ++.++|+||||++++++++|..||.
T Consensus 134 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 134 LKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred CChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999875432211 1122345788999999987654 7899999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..... .. ........ ....+. .......+..+.+++.+||..+|.+|||+.++++|.
T Consensus 214 ~~~~~-----~~-~~~~~~~~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 214 DEEAI-----AA-MFKLGNKR-SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred CcchH-----HH-HHHhhccc-cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 32211 11 11111110 000011 111123456689999999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=244.32 Aligned_cols=209 Identities=29% Similarity=0.403 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++||||+++++.+..++..++|+|++++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~ 127 (267)
T cd06610 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRD 127 (267)
T ss_pred HHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 36789999999999999999999999999999999999976432 124899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|+|+||++++++.++|+|||++......... ......|+..|+|||++... .++.++|+||||+++++|++|..||
T Consensus 128 l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~ 207 (267)
T cd06610 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207 (267)
T ss_pred CCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence 9999999999999999999998765443222 12334688999999998776 7899999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhh-hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLR-EAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...... ..+........ +.... ......+..+.+++.+||+.||++||++.++++|.
T Consensus 208 ~~~~~~------~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p 265 (267)
T cd06610 208 SKYPPM------KVLMLTLQNDP------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265 (267)
T ss_pred cccChh------hhHHHHhcCCC------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence 633221 11111111110 00000 00123456689999999999999999999998873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=263.99 Aligned_cols=207 Identities=19% Similarity=0.249 Sum_probs=152.0
Q ss_pred CCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCC
Q 045989 7 NHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHRDIKS 84 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~dikp 84 (295)
+|++|+++++++... .+.++|||++ |++|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP 260 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKP 260 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 456799999998764 5789999998 789999887543 48999999999999999999998 48 99999999
Q ss_pred CeEEECCCC----------------ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 85 ANILLDDKY----------------RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 85 ~Nill~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
+|||++.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 999998665 499999998753221 223457899999999999999999999999999999
Q ss_pred HHHhCCCCCcccchhhcccHHHHHHHHHhh-----------c---hhhh-------hhhhhhhh-------hhhHHHHHH
Q 045989 149 ELLTGQKPIRLVETEENRSLAAYFLQVINE-----------N---RLFE-------VLDAQVLR-------EAEKEEVIT 200 (295)
Q Consensus 149 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~~-------~~~~~~~~-------~~~~~~~~~ 200 (295)
||++|+.||......+.. ..+...... . .+.. ..++.... .........
T Consensus 337 elltG~~pf~~~~~~~~~---~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (467)
T PTZ00284 337 ELYTGKLLYDTHDNLEHL---HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413 (467)
T ss_pred HHHhCCCCCCCCChHHHH---HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence 999999999754322111 001000000 0 0000 00000000 000012345
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 201 VAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 201 ~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+.+||.+||+.||.+|||++|+++|.+-
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 7899999999999999999999999764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=246.13 Aligned_cols=203 Identities=27% Similarity=0.405 Sum_probs=162.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+..+...++|+||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~d 126 (257)
T cd08225 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK---ILHRD 126 (257)
T ss_pred HHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 46788999999999999999999999999999999999875432 24789999999999999999999999 99999
Q ss_pred CCCCeEEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++ .++|+|||.+........ ......|++.|+|||++.+..++.++|+||||+++++|++|..||...
T Consensus 127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred CCHHHEEEcCCCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999875 569999999876543221 222345889999999998888999999999999999999999998632
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
. ............ ........+..+.+++.+||..+|++|||+.+++++.
T Consensus 206 ~------~~~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 206 N------LHQLVLKICQGY----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred c------HHHHHHHHhccc----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 2 112222211111 0111223345689999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=250.40 Aligned_cols=215 Identities=20% Similarity=0.322 Sum_probs=156.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~---i~H~d 128 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRD 128 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 46789999999999999999999999999974 99998875443 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||+++........ .....++..|+|||++.+ ..++.++||||+|+++|+|++|..||...
T Consensus 129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 129 LKPQNLLISERGELKLADFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred CCHHHEEEcCCCCEEECccccccccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998644322111 122246788999999865 45789999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhc--hhh--------------hhhhhhhhhhhhHHH--HHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN--RLF--------------EVLDAQVLREAEKEE--VITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~--~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
.... .......+..... ... ....+.......... ...+.+++.+||+.+|++|||+.++
T Consensus 208 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~ 285 (291)
T cd07844 208 TDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA 285 (291)
T ss_pred ccHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence 3110 0000000000000 000 000000000000011 1557889999999999999999999
Q ss_pred HHHH
Q 045989 223 ALEL 226 (295)
Q Consensus 223 ~~~l 226 (295)
+.+.
T Consensus 286 l~~~ 289 (291)
T cd07844 286 MKHP 289 (291)
T ss_pred hcCC
Confidence 8763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=259.13 Aligned_cols=210 Identities=22% Similarity=0.277 Sum_probs=158.4
Q ss_pred cccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEE
Q 045989 10 NVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL 89 (295)
Q Consensus 10 niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill 89 (295)
|+|+++++|...+++|||+|.+ .-+|.++++..... .++...++.++.||++||.+||+.+ |||+||||+||||
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL 322 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILL 322 (586)
T ss_pred eEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheee
Confidence 8999999999999999999999 55999999976655 4889999999999999999999999 9999999999999
Q ss_pred CC--CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhccc
Q 045989 90 DD--KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRS 167 (295)
Q Consensus 90 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 167 (295)
.. ...+||+|||.++..... .. ....+..|.|||++.+..|+.+.||||||||+.||++|.+.|+.....+...
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred ccCCcCceeEEecccccccCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 64 347999999999754322 22 5567899999999999999999999999999999999987776544332110
Q ss_pred HH--------HHHHHHHhh-chhhhh-----------------------------hhh-hhh-------hhhhHHHHHHH
Q 045989 168 LA--------AYFLQVINE-NRLFEV-----------------------------LDA-QVL-------REAEKEEVITV 201 (295)
Q Consensus 168 ~~--------~~~~~~~~~-~~~~~~-----------------------------~~~-~~~-------~~~~~~~~~~~ 201 (295)
.. .++.+.... ...+.. ... ... .......-..+
T Consensus 399 ~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F 478 (586)
T KOG0667|consen 399 RIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF 478 (586)
T ss_pred HHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence 00 000000000 000000 000 000 00111334568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 202 AMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 202 ~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.+++++||++||.+|+|+.++++|.+--
T Consensus 479 ~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 479 IDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred HHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 9999999999999999999999997654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=244.36 Aligned_cols=199 Identities=26% Similarity=0.297 Sum_probs=157.4
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
....+||||+++++++..++..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl 123 (260)
T cd05611 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDI 123 (260)
T ss_pred hhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 345689999999999999999999999999999999997543 4899999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
+|+||+++.++.++|+|||+++.... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 124 ~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 124 KPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred CHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999998875432 2234578899999999888889999999999999999999999964322
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH---HHHHHHH
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM---KEVALEL 226 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~---~e~~~~l 226 (295)
. ..+......... .........+..+.+++.+||+.+|++||++ .|++.|.
T Consensus 199 ~------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 199 D------AVFDNILSRRIN-------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred H------HHHHHHHhcccC-------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 1 111111111000 0001111344568999999999999999966 5665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=250.69 Aligned_cols=217 Identities=24% Similarity=0.354 Sum_probs=159.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++|+||+++++|..+..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~ 125 (286)
T cd07846 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHN---IIHRD 125 (286)
T ss_pred HHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999988887765432 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++||||||+++++|++|.+||...
T Consensus 126 l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 126 IKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987654332 22233457889999999875 34688999999999999999999998633
Q ss_pred chhhc-ccHHHHH-------HHHHhhchh------hhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEEN-RSLAAYF-------LQVINENRL------FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~-~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+. ....... ......... ................+..+.+++.+||+.+|++||++.+++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 22110 0000000 000000000 000000000011123456799999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=238.38 Aligned_cols=203 Identities=27% Similarity=0.451 Sum_probs=160.4
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
++.-..|+||+++|+|..+...+|.||.| ...+..++.+... ++++..+-++...+++||.||-+++. |+|||+
T Consensus 145 ~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH~--viHRDv 218 (391)
T KOG0983|consen 145 LKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKHG--VIHRDV 218 (391)
T ss_pred hhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhcc--eeeccc
Confidence 34445799999999999999999999999 4588888876544 59999999999999999999998764 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
||+|||+|..|++||+|||++-.+..+... ....|-+.|||||.+.. ..|+.++||||||+.++||.||+.||..
T Consensus 219 KPSNILlDe~GniKlCDFGIsGrlvdSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 219 KPSNILLDERGNIKLCDFGISGRLVDSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred CccceEEccCCCEEeecccccceeeccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 999999999999999999998766544432 23458899999999864 4789999999999999999999999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
-..+- ..+..+.+... ..++. ....+..|.+++..||.+|+.+||...++++|.
T Consensus 297 c~tdF-----e~ltkvln~eP--P~L~~------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 297 CKTDF-----EVLTKVLNEEP--PLLPG------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCccH-----HHHHHHHhcCC--CCCCc------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 33221 11222222211 11111 111455699999999999999999999999885
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=245.71 Aligned_cols=207 Identities=24% Similarity=0.372 Sum_probs=164.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 68 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~d 141 (286)
T cd06614 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRD 141 (286)
T ss_pred HHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 4678899999999999999999999999999999999998754 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 142 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred CChhhEEEcCCCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765432221 1223457889999999988889999999999999999999999986332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
... ......... ... .......+..+.+++.+||+.+|.+||++.+++++.+-.
T Consensus 221 ~~~------~~~~~~~~~-~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 221 PLR------ALFLITTKG-IPP-------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred HHH------HHHHHHhcC-CCC-------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 211 111111110 000 011112445688999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=246.46 Aligned_cols=201 Identities=22% Similarity=0.284 Sum_probs=159.7
Q ss_pred cCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 045989 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIK 83 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dik 83 (295)
+...||||+++++++...+..++||||+.||+|..++.... .+++..+..++.|++.||+|||+.+ ++|+|||
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~ 124 (278)
T cd05606 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLK 124 (278)
T ss_pred HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCC
Confidence 34689999999999999999999999999999999886533 4899999999999999999999999 9999999
Q ss_pred CCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 84 SANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 84 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
|+||+++.++.++|+|||++....... .....|+..|+|||++.+. .++.++||||+|+++|+|++|..||.....
T Consensus 125 p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 125 PANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred HHHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999987543221 2234689999999998754 689999999999999999999999964322
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
... .. ....... .....+...+..+.+++.+||..+|.+|| ++.+++++.+-
T Consensus 202 ~~~---~~-~~~~~~~----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 202 KDK---HE-IDRMTLT----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred cch---HH-HHHHhhc----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 111 00 0000000 01112223356689999999999999999 99999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.37 Aligned_cols=228 Identities=21% Similarity=0.277 Sum_probs=166.5
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQ-TEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+++.++||||+.+..+|.+ +...++++||.+. +|..+|+-. ......++......|++||+.|+.|||++. |+|
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlH 155 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLH 155 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eee
Confidence 5788999999999999988 7889999999976 999998743 222346899999999999999999999999 999
Q ss_pred ccCCCCeEEECCC----CceEEeeccCccccccCcce--eeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHh
Q 045989 80 RDIKSANILLDDK----YRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 80 ~dikp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~ 152 (295)
|||||.||||..+ |.+||+|+|+++.+...-.. .....+-|.+|.|||.+.+. .|+.+.|||++|||+.||++
T Consensus 156 RDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 156 RDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 9999999999877 89999999999987653322 23345679999999998875 68999999999999999999
Q ss_pred CCCCCcccchhhc---ccHHHHHHHHHhhch-----hh----------hhhhh---hhhhhh--------hHHHHHHHHH
Q 045989 153 GQKPIRLVETEEN---RSLAAYFLQVINENR-----LF----------EVLDA---QVLREA--------EKEEVITVAM 203 (295)
Q Consensus 153 g~~p~~~~~~~~~---~~~~~~~~~~~~~~~-----~~----------~~~~~---~~~~~~--------~~~~~~~~~~ 203 (295)
-.+-|...+..-. ......+.++.+--. .+ ..+.. ...... ....+...++
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 8887754432211 112222222221100 00 00000 000000 0001223688
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 204 VAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 204 li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
|+.++|+.||.+|.|+++.+++.-.....+
T Consensus 316 LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred HHHHHhccCchhhccHHHHhcccccccCCC
Confidence 999999999999999999999875544433
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=243.95 Aligned_cols=205 Identities=26% Similarity=0.378 Sum_probs=165.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
++.+++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|+++||+|||+ .+ ++|+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~ 124 (264)
T cd06623 52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKRH---IIHR 124 (264)
T ss_pred HHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccCC---CccC
Confidence 3567899999999999999999999999999999999997642 48999999999999999999999 99 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 125 ~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCCHHHEEECCCCCEEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999998765433222 22345788999999999888999999999999999999999998644
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKE-EVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
... ............. ....+.. .+..+.+++.+||..+|++||++.+++++.+
T Consensus 204 ~~~---~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 204 GQP---SFFELMQAICDGP----------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred ccc---CHHHHHHHHhcCC----------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 321 1111111111110 1111222 4567999999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=247.89 Aligned_cols=216 Identities=24% Similarity=0.298 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||++||+|||+++ ++|+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 127 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRD 127 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 467889999999999999999999999999 889999997543 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++|+|||||++++|++|.+||...
T Consensus 128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 128 LKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CChhhEEEcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 999999999999999999999876543321 1223346788999998865 45788999999999999999998777533
Q ss_pred chhhcccHHHHHHHHHhh--------chhhhhhh-----hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINE--------NRLFEVLD-----AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
...+. ........... ........ +..........+..+.+++.+||+.+|++|||+.+++++-+
T Consensus 207 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 207 SDIDQ--LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred ccHHH--HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 22110 00110000000 00000000 00001111233567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=245.83 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=159.0
Q ss_pred ccCCC---CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 3 LSQIN---HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 3 l~~l~---Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+++++ ||||+++++++..+...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|
T Consensus 53 l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H 124 (277)
T cd06917 53 LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG---VIH 124 (277)
T ss_pred HHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 44554 999999999999999999999999999999998653 4889999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 125 RDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred CCcCHHHEEEcCCCCEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876544332 2233468889999998865 456899999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK-EEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...... ..... ... ..+ ..+. ..+..+.+++.+||+.||++||++.+++++.+-
T Consensus 204 ~~~~~~------~~~~~-~~~-----~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 204 DVDAFR------AMMLI-PKS-----KPP----RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred CCChhh------hhhcc-ccC-----CCC----CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 432211 11000 000 000 1111 134568899999999999999999999987654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=240.75 Aligned_cols=203 Identities=29% Similarity=0.442 Sum_probs=162.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 50 ~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~d 123 (253)
T cd05122 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRD 123 (253)
T ss_pred HHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCC
Confidence 4678899999999999999999999999999999999987653 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 124 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred CCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999999999876554322 334568889999999988888999999999999999999999986432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
... ....... ..... . ......+..+.+++.+||+.||.+|||+.++++|.
T Consensus 202 ~~~------~~~~~~~-~~~~~-~------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 202 PMK------ALFKIAT-NGPPG-L------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred hHH------HHHHHHh-cCCCC-c------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 111 0100000 00000 0 00111245689999999999999999999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=242.81 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 52 ~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~d 124 (264)
T cd06626 52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRD 124 (264)
T ss_pred HHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4678999999999999999999999999999999999987543 3788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeee---ccccccCCCChhhhccCC---CCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT---QVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+|+||+++.++.+||+|||++............ ...++..|+|||.+.+.. ++.++||||||++++++++|..
T Consensus 125 l~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~ 204 (264)
T cd06626 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204 (264)
T ss_pred CCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCC
Confidence 9999999999999999999998766443322211 345788999999998766 8899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
||...... ......... .. .+. .+.....+..+.+++.+||+.+|.+|||+.+++.+-
T Consensus 205 pf~~~~~~-----~~~~~~~~~-~~-----~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~ 262 (264)
T cd06626 205 PWSELDNE-----FQIMFHVGA-GH-----KPP--IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262 (264)
T ss_pred CccCCcch-----HHHHHHHhc-CC-----CCC--CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 99643211 111111111 00 000 001112245578999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=268.30 Aligned_cols=209 Identities=28% Similarity=0.444 Sum_probs=173.4
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC---CCC---------CCCCHHHHHHHHHHHHHHHHHH
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT---EDQ---------LPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~---~~~---------~~~~~~~~~~i~~qi~~~l~~L 69 (295)
|+.+ +||||+.++|+|..++..++|+||+..|+|..+++..+ .-. ..++....+.+++||+.|++||
T Consensus 355 m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L 434 (609)
T KOG0200|consen 355 LKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL 434 (609)
T ss_pred HHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence 4444 79999999999999999999999999999999998766 000 1388899999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeecccc--ccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG--TFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
++.. ++||||..+|||+..+..+||+|||+++..............| ...|||||.+....|+.++||||||+++
T Consensus 435 ~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 435 ASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILL 511 (609)
T ss_pred hhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHH
Confidence 9999 9999999999999999999999999999665544444333333 4569999999999999999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|||++ |..||....... .+.+.+..+.....|..+..+++++++.||+.+|++||++.++.+.+
T Consensus 512 ~EifsLG~~PYp~~~~~~---------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTE---------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred HHHhhCCCCCCCCCCcHH---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 99999 899986422111 12233444455566777788899999999999999999999999999
Q ss_pred HHh
Q 045989 227 AGI 229 (295)
Q Consensus 227 ~~~ 229 (295)
...
T Consensus 577 ~~~ 579 (609)
T KOG0200|consen 577 EKH 579 (609)
T ss_pred HHH
Confidence 874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=248.00 Aligned_cols=203 Identities=25% Similarity=0.390 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++..++..++|+||+. |+|.+++..... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 68 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~d 140 (307)
T cd06607 68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSHE---RIHRD 140 (307)
T ss_pred HHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4678999999999999999999999999996 578777764332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||.
T Consensus 141 l~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 141 IKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999988654322 2345788999999874 3568889999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...... ......... ........++..+.+++.+||+.+|.+||++.+++.+.+....
T Consensus 216 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 216 NMNAMS------ALYHIAQND---------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CccHHH------HHHHHhcCC---------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 332111 111111000 0011122345678999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=244.99 Aligned_cols=211 Identities=23% Similarity=0.319 Sum_probs=156.5
Q ss_pred ccCC-CCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 3 LSQI-NHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++ +||||+++++++..+ +..++||||+. |+|.+.+..... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---i~H 123 (282)
T cd07831 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRNG---IFH 123 (282)
T ss_pred HhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 4556 599999999999987 88999999996 588888765432 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||+|+||+++. +.+||+|||++........ .....++..|+|||.+.. ..++.++|||||||++|+|++|..||.
T Consensus 124 ~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 124 RDIKPENILIKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred cccCHHHEEEcC-CCeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 999999999999 9999999999876543222 123457889999997644 457889999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHh-----------hchhhhh----hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 159 LVETEENRSLAAYFLQVIN-----------ENRLFEV----LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
.....+. ......... ....... .............+..+.+++.+||+.+|++||++.+++
T Consensus 201 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 201 GTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred CCCHHHH---HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 5432211 011111000 0000000 000001111223467899999999999999999999998
Q ss_pred HHH
Q 045989 224 LEL 226 (295)
Q Consensus 224 ~~l 226 (295)
++.
T Consensus 278 ~~~ 280 (282)
T cd07831 278 RHP 280 (282)
T ss_pred hCC
Confidence 874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.92 Aligned_cols=204 Identities=24% Similarity=0.373 Sum_probs=162.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++|+||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 69 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~d 140 (293)
T cd06647 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 140 (293)
T ss_pred HHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---Eeecc
Confidence 467889999999999999999999999999999999998753 3788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|++++|..||....
T Consensus 141 L~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred CCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998865443222 1223458889999999988889999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.... ........ ......+...+..+.+++.+||..+|.+||++.+++.|-+-
T Consensus 220 ~~~~------~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 220 PLRA------LYLIATNG--------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred hhhh------eeehhcCC--------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 2110 00000000 00001122234568899999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=243.43 Aligned_cols=204 Identities=23% Similarity=0.352 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++......++|+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~ 131 (260)
T cd08222 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRD 131 (260)
T ss_pred HHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccC
Confidence 467889999999999999999999999999999999998764444456899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++. +.++|+|||++....... .......|+..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 132 l~~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 132 LKAKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred CChhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999975 569999999987653322 22233457889999999988888999999999999999999999985321
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
........... .....+...+..+.+++.+||..+|++||++.+++++.
T Consensus 210 ------~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 258 (260)
T cd08222 210 ------FLSVVLRIVEG----------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP 258 (260)
T ss_pred ------HHHHHHHHHcC----------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence 11111111111 11122345556789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=243.97 Aligned_cols=200 Identities=29% Similarity=0.406 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+..+...++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 46 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~d 118 (265)
T cd05579 46 ILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG---IIHRD 118 (265)
T ss_pred HHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCC
Confidence 4678899999999999999999999999999999999997644 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-------eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+|+||+++.++.++|+|||++........ .......++..|+|||......++.++|+||||++++++++|.
T Consensus 119 i~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~ 198 (265)
T cd05579 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGI 198 (265)
T ss_pred CCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 999999999999999999999875433211 1223345788999999998888899999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHH--HHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKE--EVITVAMVAKRCLNLNGKKRPTM---KEVALE 225 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~cl~~~p~~Rps~---~e~~~~ 225 (295)
.||...... ..+....... . ..+.. .+..+.+++.+||+.+|.+|||+ .+++++
T Consensus 199 ~p~~~~~~~------~~~~~~~~~~-~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 199 PPFHGETPE------EIFQNILNGK-I----------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCCCCCHH------HHHHHHhcCC-c----------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 998643321 1121111100 0 01111 25568999999999999999999 655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.02 Aligned_cols=201 Identities=28% Similarity=0.332 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+..+...++|+||+.|++|..++.... .+++..+..++.|+++||.|||+.+ ++|+|
T Consensus 53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~d 125 (258)
T cd05578 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSKG---IIHRD 125 (258)
T ss_pred HHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4678999999999999999999999999999999999997652 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 126 l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 126 IKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred CCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654322 2233457889999999988889999999999999999999999987443
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM--KEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~--~e~~~~ 225 (295)
... ...+...... .....+...+..+.+++.+||+.||.+||++ +|++.+
T Consensus 204 ~~~----~~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 204 RTI----RDQIRAKQET----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ccH----HHHHHHHhcc----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 211 1111111110 1112223344678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=246.12 Aligned_cols=214 Identities=21% Similarity=0.310 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+...++|+||+++ +|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 51 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 123 (283)
T cd05118 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR---GLPESLIKSYLYQLLQGLAFCHSHG---ILHRD 123 (283)
T ss_pred HHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 46788999999999999999999999999965 88888876432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 124 l~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 124 LKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred cCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654432 122234578899999998776 7889999999999999999999998644
Q ss_pred chhhcccHHHHHHHHHhhc--hhh-hhh-------------hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN--RLF-EVL-------------DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~--~~~-~~~-------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+... .. ....... ... ... ............+..+.+++.+||+.||.+||++.+++.
T Consensus 203 ~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 203 SEIDQLF--KI-FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHH--HH-HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 3322100 00 0000000 000 000 000011122345677999999999999999999999988
Q ss_pred HH
Q 045989 225 EL 226 (295)
Q Consensus 225 ~l 226 (295)
+.
T Consensus 280 ~~ 281 (283)
T cd05118 280 HP 281 (283)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=246.15 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=159.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||++++++++..+...++||||+.| +|.+.+..... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 150 (317)
T cd06635 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN---MIHRD 150 (317)
T ss_pred HHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 46788999999999999999999999999964 88877764332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+|+||+++.++.++|+|||++..... .....|+..|+|||.+. ...++.++|||||||++|+|++|..||.
T Consensus 151 L~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 151 IKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CCcccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998764332 12345788999999974 4568899999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
..... .......... .........+..+.+++.+||+.+|.+||++.+++++++....
T Consensus 226 ~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 226 NMNAM------SALYHIAQNE---------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred CccHH------HHHHHHHhcc---------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 32211 1111111111 0111122344568999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=244.71 Aligned_cols=204 Identities=24% Similarity=0.357 Sum_probs=160.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+..++..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 70 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~d 141 (292)
T cd06657 70 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRD 141 (292)
T ss_pred HHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 467889999999999999999999999999999999987543 3789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 142 l~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred CCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998865433221 1223457889999999988888999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ..... .. ...... ......+..+.+++.+||+.+|.+||++.+++++-+-
T Consensus 221 ~~~------~~~~~-~~-----~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 221 PLK------AMKMI-RD-----NLPPKL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred HHH------HHHHH-Hh-----hCCccc--CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence 211 11100 00 000000 0011233457889999999999999999999998553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=242.00 Aligned_cols=206 Identities=17% Similarity=0.238 Sum_probs=152.8
Q ss_pred cCCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 4 SQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
..++|+||+++++.+.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+.+ ++|
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 149 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4678999999999876543 347888887 447777765432 2578889999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcc------eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 153 (295)
|||||+|||++.++.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||++++|++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999976532211 111224689999999999999999999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..||........ .... .... +...+.... ......+..+.+++..|++.+|++||++.++++.+
T Consensus 230 ~~P~~~~~~~~~--~~~~----~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 KLPWKGFGHNGN--LIHA----AKCD-FIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCccccchH--HHHH----hHHH-HHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 999975422110 0000 0000 001111000 01122346689999999999999999999998765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=245.57 Aligned_cols=209 Identities=28% Similarity=0.352 Sum_probs=156.8
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEe
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ-TEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYH 79 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H 79 (295)
+.++ +||||+++++++...+..+++|||+. +++.++.... ......+++..+..++.|++.||+|||+. + ++|
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H 131 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIH 131 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eec
Confidence 4566 49999999999999999999999985 4666654321 11123589999999999999999999975 7 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC---CCCCCccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS---QFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||||+||+++.++.++|+|||++........ .....|+..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence 99999999999999999999999875443221 1233578899999999776 689999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|.... .......+..... .+..........+..+.+++.+||+.+|++|||+.+|+++.+-
T Consensus 210 ~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 210 YPKWN-----SVFDQLTQVVKGD------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred chhcc-----hHHHHHhhhcCCC------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 86332 1111111111110 0111111112345568999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=246.14 Aligned_cols=217 Identities=24% Similarity=0.307 Sum_probs=159.4
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++... +..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H 131 (309)
T cd07845 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF---IIH 131 (309)
T ss_pred HHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 46789999999999999765 46899999996 58988887543 24899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||||+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 132 ~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 132 RDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCCCHHHEEECCCCCEEECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999886543321 1222345788999999865 457899999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhh--chhhh---------h--hhhhh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 159 LVETEENRSLAAYFLQVINE--NRLFE---------V--LDAQV---LREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~--~~~~~---------~--~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
.....+. ...+...... ...+. . ..... ........+..+.++|.+||+.||++|||+.++
T Consensus 211 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i 287 (309)
T cd07845 211 GKSEIEQ---LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287 (309)
T ss_pred CCCHHHH---HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 4332211 1101110000 00000 0 00000 000011135567899999999999999999999
Q ss_pred HHHHHHh
Q 045989 223 ALELAGI 229 (295)
Q Consensus 223 ~~~l~~~ 229 (295)
+.|.+-.
T Consensus 288 l~h~~f~ 294 (309)
T cd07845 288 LESSYFK 294 (309)
T ss_pred hcChhhc
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=250.13 Aligned_cols=215 Identities=21% Similarity=0.304 Sum_probs=158.1
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++++||||+++++++... ...++||||+. ++|.+.+... ++...+..++.|++.||+|||+.+
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g-- 138 (353)
T cd07850 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG-- 138 (353)
T ss_pred HHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 46788999999999998644 35699999995 5888877532 788899999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
++||||||+||+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.
T Consensus 139 -i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 139 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred -eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999999997654322 1233457889999999999999999999999999999999999
Q ss_pred CCcccchhhccc-H--------HHHHHH-------HHhhch------hhhhhhhh----hhhhhhHHHHHHHHHHHHHhh
Q 045989 156 PIRLVETEENRS-L--------AAYFLQ-------VINENR------LFEVLDAQ----VLREAEKEEVITVAMVAKRCL 209 (295)
Q Consensus 156 p~~~~~~~~~~~-~--------~~~~~~-------~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~li~~cl 209 (295)
||.......... . ..+... ...... +.+..... .........+..+.+++.+||
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 996443211000 0 000000 000000 00000000 000001234556889999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 045989 210 NLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 210 ~~~p~~Rps~~e~~~~l~~ 228 (295)
+.||++|||+.|++.+.+-
T Consensus 296 ~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 296 VIDPEKRISVDDALQHPYI 314 (353)
T ss_pred CCChhhCcCHHHHhcChhH
Confidence 9999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=245.76 Aligned_cols=218 Identities=20% Similarity=0.278 Sum_probs=157.2
Q ss_pred cccCC-CCccccceeeEEEeCCc-----cEEEEeecCCCCHHHHHhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEV-----PLLVYEFIPNGSLHQYIHEQTED-QLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~-----~~iv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+++++ +||||+++++++..... .|+||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.+
T Consensus 53 ~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~- 130 (295)
T cd07837 53 LLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG- 130 (295)
T ss_pred HHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 35566 56999999999987665 8999999975 899888754332 346899999999999999999999999
Q ss_pred CCeEeccCCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHh
Q 045989 75 IPIYHRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~ 152 (295)
++||||||+||+++. ++.++|+|||++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 131 --i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 131 --VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred --eeecCCChHHEEEecCCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 999999999999998 889999999998754332211 122346888999998865 457899999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhh-chhhh------------hhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINE-NRLFE------------VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
|..||....... .....+...... ...+. ...+..........+..+.++|.+||..||.+||++
T Consensus 208 g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 208 KQPLFPGDSELQ--QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred CCCCCCCCCHHH--HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 999986432211 011111000000 00000 000000111112345668999999999999999999
Q ss_pred HHHHHHH
Q 045989 220 KEVALEL 226 (295)
Q Consensus 220 ~e~~~~l 226 (295)
.+++.|.
T Consensus 286 ~eil~~~ 292 (295)
T cd07837 286 KAALTHP 292 (295)
T ss_pred HHHhcCC
Confidence 9998774
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=247.46 Aligned_cols=215 Identities=23% Similarity=0.316 Sum_probs=154.9
Q ss_pred cccCCCCccccceeeEEEeCC--------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE--------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
++++++||||+++++++.... ..++||||+. ++|.+.+..... .+++..++.++.|++.||+|||+++
T Consensus 64 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ 139 (310)
T cd07865 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV---KFTLSEIKKVMKMLLNGLYYIHRNK 139 (310)
T ss_pred HHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 467899999999999987654 3499999995 588888865432 4899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccC-CCCCCccchhhHHHHHH
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~e 149 (295)
++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+. .++.++||||||+++|+
T Consensus 140 ---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~e 216 (310)
T cd07865 140 ---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216 (310)
T ss_pred ---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHH
Confidence 999999999999999999999999998765432211 12234578889999988664 46889999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHHHHHhh---c--------hhhhhhh-hhhh-hhh-----hHHHHHHHHHHHHHhhcc
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFLQVINE---N--------RLFEVLD-AQVL-REA-----EKEEVITVAMVAKRCLNL 211 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~-~~~~-~~~-----~~~~~~~~~~li~~cl~~ 211 (295)
|++|..||......... ..+...... . ....... +... ... .......+.++|.+||..
T Consensus 217 l~t~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~ 293 (310)
T cd07865 217 MWTRSPIMQGNTEQHQL---TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293 (310)
T ss_pred HHhCCCCCCCCCHHHHH---HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC
Confidence 99999998644322111 111111000 0 0000000 0000 000 001124567899999999
Q ss_pred CCCCCCCHHHHHHHH
Q 045989 212 NGKKRPTMKEVALEL 226 (295)
Q Consensus 212 ~p~~Rps~~e~~~~l 226 (295)
||.+|||+.++++|.
T Consensus 294 ~P~~R~t~~e~l~h~ 308 (310)
T cd07865 294 DPAKRIDADTALNHD 308 (310)
T ss_pred ChhhccCHHHHhcCC
Confidence 999999999998774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.45 Aligned_cols=220 Identities=22% Similarity=0.323 Sum_probs=159.8
Q ss_pred cccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+|++++||||+++++++.. ....++||||+. ++|.+++.... .+++..++.++.|++.||+|||+.+ +
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---i 128 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSAN---V 128 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5778999999999998863 346899999995 68988886433 3899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 153 (295)
+||||||+||+++.++.+||+|||++......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|
T Consensus 129 vH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g 208 (334)
T cd07855 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR 208 (334)
T ss_pred ecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence 99999999999999999999999998765432211 1123468899999999865 4588999999999999999999
Q ss_pred CCCCcccchhhcccHHHH--------HHHHHhhchhhhhhh---h---hhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 154 QKPIRLVETEENRSLAAY--------FLQVINENRLFEVLD---A---QVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
+.||.............. .........+..... . ..........+..+.+++.+||+.+|++||++
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 288 (334)
T cd07855 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288 (334)
T ss_pred CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999964322111000000 000000000000000 0 00001112245679999999999999999999
Q ss_pred HHHHHHHHHh
Q 045989 220 KEVALELAGI 229 (295)
Q Consensus 220 ~e~~~~l~~~ 229 (295)
.+++.+.+-.
T Consensus 289 ~~~l~~~~~~ 298 (334)
T cd07855 289 EQALQHPFLA 298 (334)
T ss_pred HHHHhChhhh
Confidence 9999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=255.18 Aligned_cols=201 Identities=27% Similarity=0.396 Sum_probs=167.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||+.|+|||||+++.+......+|+||||+.+|.+++++.+... ..+..+..++.|+..|++|+|+++ |||||
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~---ivHrd 180 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN---IVHRD 180 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc---eeccc
Confidence 68899999999999999999999999999999999999987654 555888889999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||++|||++.+.++||+|||++..+.. .....+..|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||...
T Consensus 181 Lk~eNilL~~~mnikIaDfgfS~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 181 LKAENILLDENMNIKIADFGFSTFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred cchhhcccccccceeeeccccceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 999999999999999999999987653 344566789999999999999887 47899999999999999999999744
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...+.+.. .+. . .-..+...+.++.++|+++|.++|.+|++.+++.++-|.
T Consensus 259 ~lk~Lr~r------vl~-g----------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 259 NLKELRPR------VLR-G----------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred ccccccch------hee-e----------eecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 33221110 000 0 001122233458889999999999999999999988654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=245.76 Aligned_cols=206 Identities=24% Similarity=0.297 Sum_probs=168.0
Q ss_pred CcccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 1 ~il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+||++++.|.||.+--+|++.+.+|+|+..|.||||.-+|...... .++++.+.-++.+|+.||++||+.. ||.|
T Consensus 237 ~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~--gF~e~ra~FYAAEi~cGLehlH~~~---iVYR 311 (591)
T KOG0986|consen 237 QILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP--GFDEQRARFYAAEIICGLEHLHRRR---IVYR 311 (591)
T ss_pred HHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC--CCchHHHHHHHHHHHhhHHHHHhcc---eeec
Confidence 3788899999999999999999999999999999999888765543 5999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+||+|||+|+.|+++|+|+|+|..+..... ....+||.+|||||++.+..|+...|.|||||++|||+.|+.||...
T Consensus 312 DLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 312 DLKPENILLDDHGHVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred cCChhheeeccCCCeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 9999999999999999999999997765443 34458999999999999999999999999999999999999999744
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l 226 (295)
...... ..+...+. .....++...+++..+|.+.+|++||.+|. .+.+|-+|.
T Consensus 390 KeKvk~------------eEvdrr~~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 390 KEKVKR------------EEVDRRTL-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred hhhhhH------------HHHHHHHh-cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 332211 00100000 011234455566788999999999999986 455666653
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=242.29 Aligned_cols=212 Identities=21% Similarity=0.294 Sum_probs=155.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|+||+++++++..++..++|+||+. ++|.+.+..... .+.+..+..++.|++.||+|||+.+ ++|+|
T Consensus 56 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 128 (291)
T cd07870 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRD 128 (291)
T ss_pred HHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 4678899999999999999999999999995 688777654332 3778888999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||+++....... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 129 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 129 LKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CChHHEEEcCCCcEEEeccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999875432211 12223468899999998753 5788999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhh---------------chhh-hhhh---hhhhhhh--hHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 161 ETEENRSLAAYFLQVINE---------------NRLF-EVLD---AQVLREA--EKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~---------------~~~~-~~~~---~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
.... ..+...... .... .... +...... ....+..+.+++.+|+..||.+|||+
T Consensus 208 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 208 SDVF-----EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred hhHH-----HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence 3211 111111000 0000 0000 0000000 00123568899999999999999999
Q ss_pred HHHHHHH
Q 045989 220 KEVALEL 226 (295)
Q Consensus 220 ~e~~~~l 226 (295)
.+++.|.
T Consensus 283 ~~~l~h~ 289 (291)
T cd07870 283 QDALLHP 289 (291)
T ss_pred HHHhcCC
Confidence 9998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=244.16 Aligned_cols=215 Identities=22% Similarity=0.320 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++... +..++|+||+++ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++|
T Consensus 51 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h 123 (287)
T cd07840 51 LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILH 123 (287)
T ss_pred HHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 46788999999999999988 899999999964 8988886543 25899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||+|+||++++++.++|+|||++...............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 124 ~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 124 RDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred ccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999988665443222333456888999998765 457899999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhc---h--------hh------hhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 045989 159 LVETEENRSLAAYFLQVINEN---R--------LF------EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~---~--------~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 221 (295)
....... ... ........ . .. ...............+..+.+++.+||..+|.+||++++
T Consensus 204 ~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 204 GSTELEQ--LEK-IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred CCChHHH--HHH-HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 4332111 000 00000000 0 00 000000000111112667899999999999999999999
Q ss_pred HHHHH
Q 045989 222 VALEL 226 (295)
Q Consensus 222 ~~~~l 226 (295)
++++.
T Consensus 281 ~l~~~ 285 (287)
T cd07840 281 ALQHE 285 (287)
T ss_pred HhhCc
Confidence 98764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=250.38 Aligned_cols=215 Identities=23% Similarity=0.316 Sum_probs=158.8
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|+.++||||+++++++... ...++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 57 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--- 128 (337)
T cd07858 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSAN--- 128 (337)
T ss_pred HHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46778999999999988754 35799999995 68988886543 4899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
++|+||||+||+++.++.+||+|||+++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.
T Consensus 129 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred EecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999987654322 22233457889999998865 468899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhh-----------chhhhhhh------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 156 PIRLVETEENRSLAAYFLQVINE-----------NRLFEVLD------AQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
||........ .......... ......+. ...........+..+.+++.+||+.+|++|||
T Consensus 208 pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps 284 (337)
T cd07858 208 LFPGKDYVHQ---LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284 (337)
T ss_pred CCCCCChHHH---HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC
Confidence 9964322110 1111110000 00000000 00001112234566899999999999999999
Q ss_pred HHHHHHHHHH
Q 045989 219 MKEVALELAG 228 (295)
Q Consensus 219 ~~e~~~~l~~ 228 (295)
++++++|.+-
T Consensus 285 ~~ell~h~~~ 294 (337)
T cd07858 285 VEEALAHPYL 294 (337)
T ss_pred HHHHHcCcch
Confidence 9999999543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=243.54 Aligned_cols=216 Identities=22% Similarity=0.308 Sum_probs=158.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||++ ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+|
T Consensus 51 ~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~d 124 (283)
T cd07835 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRD 124 (283)
T ss_pred HHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 3677899999999999999999999999994 699999876542 24899999999999999999999998 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.++|+|||++......... .....++..|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 125 l~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 125 LKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CCHHHEEEcCCCcEEEeecccccccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998755332211 1223468899999987654 5688999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhc-----------hhhhhh---hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN-----------RLFEVL---DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..... ............ ...... ............+..+.+++.+||+.+|.+|||+++++++.
T Consensus 204 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 204 SEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred CHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 32110 011110000000 000000 00000111122345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=237.95 Aligned_cols=212 Identities=25% Similarity=0.351 Sum_probs=158.3
Q ss_pred cCCCCccccceeeEEEeCCc-----cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 4 SQINHRNVVKLLGCCLETEV-----PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~~-----~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++++||||+++++++...+. .+++|||+.+ +|.+++...... .+++..++.++.|++.||+|||+.+ ++
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~ 129 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP--GLPPETIKDLMRQLLRGVDFLHSHR---IV 129 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 45679999999999998776 8999999964 899988754322 4899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.
T Consensus 130 h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred eccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 999999999999999999999999876543221 122347888999999998889999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhch------------hhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENR------------LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.....+ .....+........ .................+..+.+++.+||+.||.+||++.+++.|
T Consensus 208 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 208 GTSEAD--QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCChHH--HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 433221 11111110000000 000000001111122345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=238.85 Aligned_cols=204 Identities=27% Similarity=0.422 Sum_probs=165.4
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++.+... ...++|+||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h 124 (260)
T cd06606 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG---IVH 124 (260)
T ss_pred HHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 46788999999999999988 88999999999999999998654 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++||||||+++++|++|..||.
T Consensus 125 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred cCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765543221 1233467889999999988889999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
... ........... .......+...+..+.+++.+||+.+|++||++.+++.+.
T Consensus 205 ~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 205 ELG-----NPMAALYKIGS---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred CCC-----chHHHHHhccc---------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 443 11111111111 1111122333456799999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=241.38 Aligned_cols=218 Identities=18% Similarity=0.318 Sum_probs=159.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++ +|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~d 125 (284)
T cd07836 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRD 125 (284)
T ss_pred HHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 46788999999999999999999999999975 89888865432 235899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||++++++.++|+|||++........ ......++..|++||.+.+. .++.++|+|||||++|+|++|..||...
T Consensus 126 l~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 126 LKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred CCHHHEEECCCCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875433211 11233568899999988654 5688999999999999999999998643
Q ss_pred chhhccc-HHHH--------HHHHHhhchhhhhh---hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRS-LAAY--------FLQVINENRLFEVL---DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~-~~~~--------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...+... .... +............. ............+..+.+++.+||+.||.+||++.+++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 205 NNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3221100 0000 00000000000000 0001111122345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=249.94 Aligned_cols=214 Identities=23% Similarity=0.325 Sum_probs=156.4
Q ss_pred cccCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
++++++||||+++++++.... ..++|+||+. ++|.+++... .+++..++.++.|++.||+|||+.+
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~--- 126 (336)
T cd07849 56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN--- 126 (336)
T ss_pred HHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 467889999999999876543 5799999995 5888887643 3899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 153 (295)
++||||||+||+++.++.++|+|||++......... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|
T Consensus 127 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G 206 (336)
T cd07849 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206 (336)
T ss_pred eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765432211 1223467899999998754 4688999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhc---hhhhhhhh-----------hh---hhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINEN---RLFEVLDA-----------QV---LREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-----------~~---~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
+.||....... ....+....... ....+... .. ........+..+.+++.+||+.+|++|
T Consensus 207 ~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 283 (336)
T cd07849 207 RPLFPGKDYLH---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283 (336)
T ss_pred CCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence 99996432211 011111111100 00000000 00 000111235568999999999999999
Q ss_pred CCHHHHHHHHH
Q 045989 217 PTMKEVALELA 227 (295)
Q Consensus 217 ps~~e~~~~l~ 227 (295)
||+.++++|.+
T Consensus 284 pt~~e~l~hp~ 294 (336)
T cd07849 284 ITVEEALAHPY 294 (336)
T ss_pred cCHHHHhcCcc
Confidence 99999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=243.12 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=158.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|||++++++++......++||||+. |+|.+.+..... .+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 68 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~d 140 (308)
T cd06634 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 140 (308)
T ss_pred HHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 4678899999999999999999999999996 588887754332 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+|+||+++.++.++|+|||++...... ....++..|+|||.+. ...++.++|||||||++|+|++|..||.
T Consensus 141 l~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 141 VKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999998654321 2345788999999974 3457889999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
.....+ ......... .........+..+.+++.+||+.+|.+||++.+++++.+...
T Consensus 216 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 216 NMNAMS------ALYHIAQNE---------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cccHHH------HHHHHhhcC---------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 332111 011111000 001112234556889999999999999999999999977554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=238.06 Aligned_cols=189 Identities=24% Similarity=0.225 Sum_probs=151.8
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
...||||+++++++......++||||++||+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp 113 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNP 113 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCH
Confidence 4479999999999999999999999999999999987643 3899999999999999999999999 99999999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhh
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 164 (295)
+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+.......
T Consensus 114 ~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~ 189 (237)
T cd05576 114 NNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189 (237)
T ss_pred HHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc
Confidence 9999999999999999987654322 122345678999999988888999999999999999999998864221110
Q ss_pred cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 045989 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-----KEVALE 225 (295)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~~~~ 225 (295)
... .....+...+..+.+++.+||+.||++||++ .+++.|
T Consensus 190 ------------~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 190 ------------NTH---------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred ------------ccc---------cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 000 0001122234568899999999999999996 555544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=253.76 Aligned_cols=222 Identities=27% Similarity=0.408 Sum_probs=168.7
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
||++++|||||+++++-+... ...+|||||.||+|...++. ++....+++...+.++.+++.||.|||+++
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~-- 140 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG-- 140 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 689999999999999877544 56899999999999999975 444556999999999999999999999999
Q ss_pred CeEeccCCCCeEEEC----CCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHH
Q 045989 76 PIYHRDIKSANILLD----DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 76 ~i~H~dikp~Nill~----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el 150 (295)
|+||||||.||++- .....||+|||.|+....+. .....+||..|++||.... ..|+..+|.|||||++|+.
T Consensus 141 -IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~c 217 (732)
T KOG4250|consen 141 -IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYEC 217 (732)
T ss_pred -ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHH
Confidence 99999999999983 33457999999999765443 5677889999999999984 8899999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhch--hhh--------hhhhhh----hhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENR--LFE--------VLDAQV----LREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~--------~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
+||..||......... ...++......+ ... .+.... ...........+...+..+|..+|++|
T Consensus 218 aTG~lPF~p~~~pk~~--~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~ 295 (732)
T KOG4250|consen 218 ATGELPFIPFGGPKNN--KEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKR 295 (732)
T ss_pred hccCCCCCcCCCcccc--chhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHh
Confidence 9999999765433211 111222221111 000 000000 122233455567888999999999999
Q ss_pred C--CHHHHHHHHHHhHH
Q 045989 217 P--TMKEVALELAGIRA 231 (295)
Q Consensus 217 p--s~~e~~~~l~~~~~ 231 (295)
. ...++...+..+..
T Consensus 296 ~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 296 GHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCCcchHHHHHHHHHh
Confidence 8 77777777666543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=241.45 Aligned_cols=217 Identities=19% Similarity=0.282 Sum_probs=157.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+...++||||++ ++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~d 127 (294)
T PLN00009 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRD 127 (294)
T ss_pred HHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 4678999999999999999999999999995 588888764332 23678889999999999999999999 99999
Q ss_pred CCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|+|+||+++. ++.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||..
T Consensus 128 l~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred CCcceEEEECCCCEEEEcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999985 55799999999875433211 1223356889999998866 3578999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhh-chhh----------h---hhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINE-NRLF----------E---VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~-~~~~----------~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
....+. ....+...... ...+ . ..............+..+.+++.+||+.+|++||++.+++++
T Consensus 207 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 207 DSEIDE--LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCHHHH--HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 332111 00000000000 0000 0 000000001112234568899999999999999999999987
Q ss_pred HH
Q 045989 226 LA 227 (295)
Q Consensus 226 l~ 227 (295)
.+
T Consensus 285 ~~ 286 (294)
T PLN00009 285 EY 286 (294)
T ss_pred ch
Confidence 54
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=236.47 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=162.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|||++++++++...+..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 124 (254)
T cd06627 52 LLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQG---VIHRD 124 (254)
T ss_pred HHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCC
Confidence 3678899999999999999999999999999999999987652 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+|++|+++++|++|..||....
T Consensus 125 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 125 IKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred CCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999999998865443321 233457889999999988888999999999999999999999986332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.. ......... .....+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 204 ~~------~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 204 PM------AALFRIVQD----------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HH------HHHHHHhcc----------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11 111111100 1111222335568899999999999999999999865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=237.29 Aligned_cols=202 Identities=26% Similarity=0.380 Sum_probs=158.8
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
++++++||||+++++++... +..++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~---i~H 129 (264)
T cd06653 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM---IVH 129 (264)
T ss_pred HHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 46788999999999998764 46889999999999999987543 3788999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|+|||||+++++++|..||
T Consensus 130 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 209 (264)
T cd06653 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209 (264)
T ss_pred CCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999875532111 1112345889999999998888899999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...... ....+.. ........+...+..+.+++.+||. +|..||++.+++.|.
T Consensus 210 ~~~~~~------~~~~~~~---------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 210 AEYEAM------AAIFKIA---------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred CccCHH------HHHHHHH---------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 632211 1111111 1111122344455679999999999 579999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=247.81 Aligned_cols=217 Identities=27% Similarity=0.374 Sum_probs=157.1
Q ss_pred cccCC-CCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQI-NHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+++++ +||||+++++++... ...++||||+. ++|..++... .+.+..++.++.|++.||+|||+.+ ++
T Consensus 59 ~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~ 129 (337)
T cd07852 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VI 129 (337)
T ss_pred HHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 45678 999999999998754 36899999996 5999888653 3788999999999999999999999 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcc----eeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhC
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRT----HLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 153 (295)
|+||||+||+++.++.+||+|||++........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 130 H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg 209 (337)
T cd07852 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209 (337)
T ss_pred cCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence 999999999999999999999999876543321 12233468899999998765 4578899999999999999999
Q ss_pred CCCCcccchhhcccHH-HHH-------HHHHhhc---hhhhhhhhh---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 154 QKPIRLVETEENRSLA-AYF-------LQVINEN---RLFEVLDAQ---VLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~-~~~-------~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
+.||......+..... ... ....... ......... .........+..+.+++.+||+.+|++|||+
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH
Confidence 9998643322110000 000 0000000 000000000 0001111245678999999999999999999
Q ss_pred HHHHHHHH
Q 045989 220 KEVALELA 227 (295)
Q Consensus 220 ~e~~~~l~ 227 (295)
.+++++.+
T Consensus 290 ~~il~~~~ 297 (337)
T cd07852 290 EEALEHPY 297 (337)
T ss_pred HHHhhChh
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=236.68 Aligned_cols=199 Identities=25% Similarity=0.329 Sum_probs=165.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|...+||.+..+--+|...+++|+||||..||.|.-++.+.. .+++...+.+..+|+.||.|||+++ ||.||
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRD 293 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRD 293 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC---eeeee
Confidence 5788999999999999999999999999999999998887644 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
+|.+|.|+|.+|.+||+|||+++.-.. ....+.+++|||.|+|||++....|+.+.|.|.+||++|||++|+.||...+
T Consensus 294 lKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 294 LKLENLLLDKDGHIKITDFGLCKEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred chhhhheeccCCceEeeecccchhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 999999999999999999999986433 3445677899999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~ 225 (295)
. .. +++.+-... ..+|...+.+...|+..+|.+||.+|. .++||.+|
T Consensus 373 h------~k----------LFeLIl~ed-~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 373 H------EK----------LFELILMED-LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred h------hH----------HHHHHHhhh-ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 2 22 222221111 123444455577899999999999994 46777665
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=243.93 Aligned_cols=214 Identities=25% Similarity=0.335 Sum_probs=156.0
Q ss_pred cccCCCCccccceeeEEEeCC----------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 045989 2 ILSQINHRNVVKLLGCCLETE----------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS 71 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~----------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~ 71 (295)
++++++||||+++++++.... ..++|+||+++ ++...+.... ..+++..++.++.|++.||+|||+
T Consensus 59 ~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~ 134 (302)
T cd07864 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK 134 (302)
T ss_pred HHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467889999999999987654 78999999975 7777776542 248999999999999999999999
Q ss_pred CCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHH
Q 045989 72 AASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 72 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el 150 (295)
.+ ++|+||||+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++++|
T Consensus 135 ~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 135 KN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred CC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 99 9999999999999999999999999987654332222223346788999998865 3568899999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchh-----------hhhhhhh-----hhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRL-----------FEVLDAQ-----VLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
++|++||......+ ....+......... ....+.. .........+..+.+++.+||+.+|.
T Consensus 212 ~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 288 (302)
T cd07864 212 FTKKPIFQANQELA---QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPS 288 (302)
T ss_pred HhCCCCCCCCChHH---HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChh
Confidence 99999986432211 11111111100000 0000000 00001112355689999999999999
Q ss_pred CCCCHHHHHHH
Q 045989 215 KRPTMKEVALE 225 (295)
Q Consensus 215 ~Rps~~e~~~~ 225 (295)
+||++.+++.+
T Consensus 289 ~Rp~~~~il~~ 299 (302)
T cd07864 289 KRCTAEEALNS 299 (302)
T ss_pred hCCCHHHHhcC
Confidence 99999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=262.78 Aligned_cols=226 Identities=25% Similarity=0.354 Sum_probs=182.0
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|.--+.+-|++++-+|.++.++|+||||++||||-.++.... .+++..+..++..|+-||.-||+.| +|||||
T Consensus 129 mv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDi 201 (1317)
T KOG0612|consen 129 MVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDI 201 (1317)
T ss_pred HHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccC
Confidence 344467889999999999999999999999999999998655 4999999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc----c-CCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ----S-SQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
||+|||+|..|.+||+|||.+-.+..+........+|||.|++||++. + +.|+..+|.||+||++|||+.|..||
T Consensus 202 KPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 202 KPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred CcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 999999999999999999999888877777777789999999999984 3 57899999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHH-------H
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT---MKEVALEL-------A 227 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~e~~~~l-------~ 227 (295)
- ..++...+..+.+....+... .....+....+||.+.+. +|+.|.. +.++-.|. .
T Consensus 282 Y------adslveTY~KIm~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 282 Y------ADSLVETYGKIMNHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred h------HHHHHHHHHHHhchhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 5 445555555555553322221 113366778899999887 7888887 99998886 3
Q ss_pred HhHHhhccchhhcccccccccc
Q 045989 228 GIRASIGASVLRQCEEIDFVNY 249 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
.++...++-+.....+.+..+|
T Consensus 348 ~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 348 NIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred hhhhcCCCCCCcCCCCCccccc
Confidence 3455544444444444444444
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=248.18 Aligned_cols=213 Identities=26% Similarity=0.341 Sum_probs=162.5
Q ss_pred cccCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
++++++||||+++++++.... ..|+||||+. ++|.+++.... .+++..++.++.|++.||+|||+.+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g--- 123 (330)
T cd07834 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN--- 123 (330)
T ss_pred HHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 467889999999999998775 7899999996 58988886543 5899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g 153 (295)
++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+. .++.++|+||||+++|+|++|
T Consensus 124 i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g 203 (330)
T cd07834 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203 (330)
T ss_pred eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999986654321 122334578899999999887 789999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhh--------------chhhhhhh------hhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINE--------------NRLFEVLD------AQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
..||......+. ...+... ......+. ...........+..+.+++.+||+.+|
T Consensus 204 ~~pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 277 (330)
T cd07834 204 KPLFPGRDYIDQ------LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277 (330)
T ss_pred CCCcCCCCHHHH------HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence 999965432211 1111100 00000000 000011112245668999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 045989 214 KKRPTMKEVALELAG 228 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~ 228 (295)
.+||++.+++.+.+-
T Consensus 278 ~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 278 KKRITADEALAHPYL 292 (330)
T ss_pred hhCCCHHHHHhCccH
Confidence 999999999998644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=241.69 Aligned_cols=205 Identities=23% Similarity=0.279 Sum_probs=158.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++.++ +||||+++++.+..+...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|+
T Consensus 57 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~ 129 (288)
T cd05583 57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLG---IIYR 129 (288)
T ss_pred HHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 35667 69999999999999999999999999999999987532 4889999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC--CCCCccchhhHHHHHHHHhCCCCCc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||+|+||+++.++.++|+|||+++..............|+..|+|||.+.+.. .+.++|+||||+++++|++|..||.
T Consensus 130 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999998765433322223345789999999987654 7889999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..... ............. ....+...+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 210 ~~~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 210 VDGEQ--NSQSEISRRILKS-----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred cCccc--chHHHHHHHHHcc-----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 32111 1111111111110 0111222345588999999999999999977665544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=241.63 Aligned_cols=200 Identities=26% Similarity=0.391 Sum_probs=156.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|||++++++++......|+||||+. |+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 74 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~l~~~~~~~~~~qi~~al~~LH~~g---i~H~d 146 (313)
T cd06633 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN---MIHRD 146 (313)
T ss_pred HHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4678899999999999999999999999995 588887765332 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+|+||+++.++.++|+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 147 l~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 147 IKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred CChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998764321 22346888999999984 3567889999999999999999999985
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...... ......... . ........+..+.+++.+||+.+|.+||++.+++.+.+-
T Consensus 222 ~~~~~~------~~~~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 222 NMNAMS------ALYHIAQND-S--------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred CCChHH------HHHHHHhcC-C--------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 332111 111111100 0 001111233458889999999999999999999988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=240.66 Aligned_cols=201 Identities=28% Similarity=0.444 Sum_probs=162.2
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++ ||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+
T Consensus 54 ~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~ 126 (280)
T cd05581 54 VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG---IIHR 126 (280)
T ss_pred HHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 356777 9999999999999999999999999999999997654 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcc-------------------eeeeccccccCCCChhhhccCCCCCCccch
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRT-------------------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVY 141 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 141 (295)
||+|+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|+|
T Consensus 127 dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~ 206 (280)
T cd05581 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLW 206 (280)
T ss_pred CCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHH
Confidence 9999999999999999999999876543221 122334578899999999888899999999
Q ss_pred hhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH--
Q 045989 142 SFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-- 219 (295)
Q Consensus 142 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-- 219 (295)
|||++++++++|..||..... ...+..... .....+...+..+.+++.+||+.+|.+||++
T Consensus 207 slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 207 ALGCIIYQMLTGKPPFRGSNE------YLTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred HHHHHHHHHHhCCCCCCCccH------HHHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999999999999999864331 111111111 0111222335568899999999999999999
Q ss_pred --HHHHHHH
Q 045989 220 --KEVALEL 226 (295)
Q Consensus 220 --~e~~~~l 226 (295)
+++++|.
T Consensus 270 ~~~~ll~~~ 278 (280)
T cd05581 270 GYDELKAHP 278 (280)
T ss_pred CHHHHhcCC
Confidence 8887763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.56 Aligned_cols=203 Identities=21% Similarity=0.267 Sum_probs=172.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||..++.|.||++|--|.++++.|++||-|=||.|+..++++. .|...+...++..+++|++|||+++ |+.||
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRD 545 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRKG---IIYRD 545 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhcC---ceecc
Confidence 5778889999999999999999999999999999999998765 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|++++.+|-+||.|||+|+..+.. ..+.+++||+.|.|||++.+...+.++|.||||+++|||++|.+||...+
T Consensus 546 LKPENllLd~~Gy~KLVDFGFAKki~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 546 LKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred CChhheeeccCCceEEeehhhHHHhccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999999999999999999977654 45778899999999999999999999999999999999999999997443
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
.- ..+..+.... -.-..|........++|+++...+|.+|.- +.+|-+|-|-
T Consensus 624 pm------ktYn~ILkGi---------d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 624 PM------KTYNLILKGI---------DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred hH------HHHHHHHhhh---------hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 21 1122222221 122344555566888999999999999975 7788888664
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=246.43 Aligned_cols=216 Identities=22% Similarity=0.300 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+. |+|.+++.... .+++.....++.|++.||+|||+.+ ++|+|
T Consensus 73 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~d 144 (335)
T PTZ00024 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKWY---FMHRD 144 (335)
T ss_pred HHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 4678999999999999999999999999996 59999886533 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-------------ceeeeccccccCCCChhhhccC-CCCCCccchhhHHHH
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-------------THLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVL 147 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l 147 (295)
|+|+||+++.++.++|+|||++....... ........++..|+|||.+.+. .++.++|+|||||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 99999999999999999999987654111 1111223467889999998764 468899999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchh-----------hh---hhhhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRL-----------FE---VLDAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
|+|++|..||......+. .. .+......... .. ...+..........+..+.+++.+||+.+|
T Consensus 225 ~el~tg~~p~~~~~~~~~--~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 301 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQ--LG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301 (335)
T ss_pred HHHHhCCCCCCCCCHHHH--HH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence 999999999974433211 00 01000000000 00 000000111112234568899999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 045989 214 KKRPTMKEVALELAG 228 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~ 228 (295)
++|||+.+++.+.+-
T Consensus 302 ~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 302 LERISAKEALKHEYF 316 (335)
T ss_pred hhccCHHHHhcCccc
Confidence 999999999988754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=239.50 Aligned_cols=206 Identities=25% Similarity=0.309 Sum_probs=159.6
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ +||||+++++.+..+...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~ 129 (290)
T cd05613 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG---IIYR 129 (290)
T ss_pred HHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 35667 68999999999999999999999999999999987543 4889999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC--CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||+|+||+++.++.++|+|||++...............|+..|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus 130 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999876543322223345688999999998653 46789999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.... ............... ...+...+..+.+++.+||+.+|.+|| ++.+++.+.+
T Consensus 210 ~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 210 VDGE--KNSQAEISRRILKSE-----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred cCCc--cccHHHHHHHhhccC-----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 3211 111111111111110 011223445688999999999999997 7888877643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.60 Aligned_cols=199 Identities=30% Similarity=0.391 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++.+..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~ 118 (250)
T cd05123 46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG---IIYRD 118 (250)
T ss_pred HHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4678899999999999999999999999999999999997653 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+...+.++|+||||+++|++++|..||....
T Consensus 119 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 119 LKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999987654322 12334457889999999988888999999999999999999999986432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM---KEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~---~e~~~~ 225 (295)
. .......... ....+...+..+.+++++||..||++||++ ++++.|
T Consensus 198 ~------~~~~~~~~~~-----------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 198 R------KEIYEKILKD-----------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred H------HHHHHHHhcC-----------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 2 1111111110 011222224568899999999999999999 666554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=237.46 Aligned_cols=217 Identities=24% Similarity=0.330 Sum_probs=160.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++|+||+. ++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 51 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~ 123 (282)
T cd07829 51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRD 123 (282)
T ss_pred HHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4677899999999999999999999999996 599999986532 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||||||++++++++|..||...
T Consensus 124 l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 124 LKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred CChheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999876543221 12223457789999998766 7899999999999999999999998643
Q ss_pred chhhccc-HHH-------HHHHHHhhc----hhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENRS-LAA-------YFLQVINEN----RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~~-~~~-------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+... ... ..+...... ..................+..+.+++.+||+.+|++||++.+++.+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 3211100 000 000000000 00000000000011112255699999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=239.19 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=154.9
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHRDIKS 84 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~dikp 84 (295)
..||||+++++++......++||||+ +++|.+++..... .+++..+..++.|++.||+|||+ .+ ++||||+|
T Consensus 71 ~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p 143 (296)
T cd06618 71 HDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKP 143 (296)
T ss_pred cCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcH
Confidence 36999999999999999999999999 4588888765433 58999999999999999999997 47 99999999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC----CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ----FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...
T Consensus 144 ~nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 144 SNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HHEEEcCCCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999875533221 12234778899999987553 788999999999999999999998642
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ............. . . ......+..+.+++.+||..||.+||++.+++.+.+-
T Consensus 222 ~~~-----~~~~~~~~~~~~~-~-~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 222 KTE-----FEVLTKILQEEPP-S-L------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred hhH-----HHHHHHHhcCCCC-C-C------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 211 1111111111100 0 0 0011234568999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=236.68 Aligned_cols=216 Identities=22% Similarity=0.328 Sum_probs=158.1
Q ss_pred ccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++++ ||||+++++++..++..++||||+ +|+|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+|
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~d 124 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRD 124 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 45677 999999999999999999999999 789999887643 224899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|+|+||+++.++.++|+|||++........ .....++..|+|||++.. ..++.++|+||||+++++|++|..||...
T Consensus 125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 125 LKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred CChhhEEEcCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 999999999999999999999875543221 223457889999998754 45789999999999999999999998644
Q ss_pred chhhcc-cHHH---------HHHHHHhhchhhhhhhh---hhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 161 ETEENR-SLAA---------YFLQVINENRLFEVLDA---QVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 161 ~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...+.. .... +.............+.. ..........+..+.+++.+||+.+|++|||++|++.+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 321110 0000 00000000000000000 000111111245689999999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=238.24 Aligned_cols=215 Identities=23% Similarity=0.298 Sum_probs=153.7
Q ss_pred cccCCCCccccceeeEEEeCC--------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE--------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
++++++||||+++++++.... .+++|+||+. ++|...+.... ..+++..+..++.|+++||+|||+.+
T Consensus 60 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~ 135 (311)
T cd07866 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH 135 (311)
T ss_pred HHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 467889999999999886533 4699999995 47877776432 24899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce----------eeeccccccCCCChhhhccC-CCCCCccchh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH----------LTTQVKGTFGYLDPEYFQSS-QFTEKSDVYS 142 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 142 (295)
++|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+. .++.++||||
T Consensus 136 ---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 212 (311)
T cd07866 136 ---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG 212 (311)
T ss_pred ---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHH
Confidence 999999999999999999999999998755332111 11223568889999987654 5789999999
Q ss_pred hHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhch---------hhhhh-------hhhhhhhhhHHHHHHHHHHHH
Q 045989 143 FGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR---------LFEVL-------DAQVLREAEKEEVITVAMVAK 206 (295)
Q Consensus 143 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-------~~~~~~~~~~~~~~~~~~li~ 206 (295)
|||++|+|++|.+||........ ............ +.... .+.............+.+++.
T Consensus 213 lG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 289 (311)
T cd07866 213 IGCVFAEMFTRRPILQGKSDIDQ---LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS 289 (311)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHH
Confidence 99999999999999864332211 000111000000 00000 000000011122356889999
Q ss_pred HhhccCCCCCCCHHHHHHHH
Q 045989 207 RCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 207 ~cl~~~p~~Rps~~e~~~~l 226 (295)
+||+.||.+|||+.+++.+.
T Consensus 290 ~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 290 KLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred HHcccCcccCcCHHHHhcCC
Confidence 99999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=244.27 Aligned_cols=207 Identities=24% Similarity=0.345 Sum_probs=156.8
Q ss_pred cccCCCCccccceeeEEEeCCc------cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEV------PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~------~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++++||||+++++++...+. .++|+||+ +++|.+++... .+++..++.++.|++.||+|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g-- 138 (343)
T cd07851 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAG-- 138 (343)
T ss_pred HHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4678899999999998876554 89999999 77999988752 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
++|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|++++|+
T Consensus 139 -i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 139 -IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred -eecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998755332 223457889999999865 36789999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhc-----hh---------hhhhh---h---hhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINEN-----RL---------FEVLD---A---QVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-----~~---------~~~~~---~---~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.||....... ....+.... .+ ...+. . ..........+..+.+++.+||+.+|.
T Consensus 214 ~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~ 287 (343)
T cd07851 214 TLFPGSDHID------QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287 (343)
T ss_pred CCCCCCChHH------HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh
Confidence 9996432211 111111000 00 00000 0 000011112356789999999999999
Q ss_pred CCCCHHHHHHHHH
Q 045989 215 KRPTMKEVALELA 227 (295)
Q Consensus 215 ~Rps~~e~~~~l~ 227 (295)
+|||+.+|++|.+
T Consensus 288 ~Rpt~~ell~h~~ 300 (343)
T cd07851 288 KRITAAEALAHPY 300 (343)
T ss_pred hCCCHHHHhcCCC
Confidence 9999999998854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=228.74 Aligned_cols=215 Identities=20% Similarity=0.296 Sum_probs=164.0
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
.|+||++++++|+++..+|+|||-|.||.|...|.++. .+++..+..+..+|+.||.|||.+| |.|||+||+|
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPEN 206 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPEN 206 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccc
Confidence 69999999999999999999999999999999998765 4999999999999999999999999 9999999999
Q ss_pred EEECCCC---ceEEeeccCccccccCcc------eeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHh
Q 045989 87 ILLDDKY---RAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 87 ill~~~~---~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~ 152 (295)
||....+ .+||+||.+..-+..... -...+.+|+..|||||++. ...|+.++|.||||+|+|-|++
T Consensus 207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 9996544 589999988754432211 1123457899999999874 2468999999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhh---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAE---KEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|.+||.....++=..-..-.- ..-...+++-+..+...... ...+.+..+++..+|..++.+|.++.+++.|.|.-
T Consensus 287 GYpPFvG~Cg~dCGWdrGe~C-r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~ 365 (463)
T KOG0607|consen 287 GYPPFVGHCGADCGWDRGEVC-RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ 365 (463)
T ss_pred CCCCccCccCCcCCccCCCcc-HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence 999997665433111000000 01112233333333332222 23456788899999999999999999999987653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=231.60 Aligned_cols=204 Identities=20% Similarity=0.277 Sum_probs=158.1
Q ss_pred ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEEC
Q 045989 11 VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD 90 (295)
Q Consensus 11 iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~ 90 (295)
+|.+.++|+-.++.|||+|.+ |.++.+++...... +++..++..+++|++++++|||+.+ ++|.||||+||++.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~--~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfv 226 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYI--PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFV 226 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCcc--ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEe
Confidence 577778899999999999999 77999999875443 6899999999999999999999999 99999999999983
Q ss_pred --------------------CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 91 --------------------DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 91 --------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
.+..++|+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||+|+
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 13458999999997543332 445689999999999999999999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhh--------------------------------hhhhhhhHHHH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDA--------------------------------QVLREAEKEEV 198 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~ 198 (295)
++|...|...+..+ ....+.++..+.+..-+... ...........
T Consensus 303 ytG~~LFqtHen~E---HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 303 YTGETLFQTHENLE---HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred eccceecccCCcHH---HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 99999887554222 22334433332221111111 00111123345
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 199 ITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 199 ~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..+.+|+++||..||.+|+|+.|++.|..
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 67999999999999999999999998863
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=240.31 Aligned_cols=210 Identities=23% Similarity=0.352 Sum_probs=154.6
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++++||||+++++++... ...+++++++ +++|.+++... .+++..++.++.|++.||+|||+.+
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~-- 140 (345)
T cd07877 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-- 140 (345)
T ss_pred HHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46788999999999998643 3468888887 78998887643 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
++||||||+||+++.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 141 -ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 141 -IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred -eeecCCChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998754321 223457889999999866 46788999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHh--hchhhhhhhhh---------------hhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVIN--ENRLFEVLDAQ---------------VLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
.||........ ... ...... .......+... .........+..+.+++.+||+.||.+||
T Consensus 216 ~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 216 TLFPGTDHIDQ--LKL-ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred CCCCCCCHHHH--HHH-HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 99864332110 000 000000 00000000000 00000011245688999999999999999
Q ss_pred CHHHHHHHHH
Q 045989 218 TMKEVALELA 227 (295)
Q Consensus 218 s~~e~~~~l~ 227 (295)
++.+++.|.+
T Consensus 293 t~~e~l~h~~ 302 (345)
T cd07877 293 TAAQALAHAY 302 (345)
T ss_pred CHHHHhcChh
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=240.10 Aligned_cols=214 Identities=23% Similarity=0.347 Sum_probs=156.3
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++||||++++++|.. ....++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ ++|+
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~ 132 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG---VVHR 132 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 4678999999999999876 56789999999 66998888643 3788888999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 133 dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 133 DLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred CCCHHHEeECCCCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998744221 123456888999998765 5689999999999999999999999964
Q ss_pred cchhhcccH---------HHHHHHHHhhch--hhhhhhhhh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 160 VETEENRSL---------AAYFLQVINENR--LFEVLDAQV---LREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 160 ~~~~~~~~~---------~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
......... ..+......... +........ ........+..+.+++.+||+.+|++|||+.+++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 432111000 000000000000 000000000 000111234678999999999999999999999988
Q ss_pred HHH
Q 045989 226 LAG 228 (295)
Q Consensus 226 l~~ 228 (295)
.+-
T Consensus 289 ~~~ 291 (328)
T cd07856 289 PYL 291 (328)
T ss_pred Ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=233.50 Aligned_cols=208 Identities=29% Similarity=0.458 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
|-+.|.||-||++|++|.- ...+|-|+|||+|.+|.-++.... .+++..+..|+.||+.||.||.+.. .+|+|.
T Consensus 520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHY 594 (775)
T KOG1151|consen 520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHY 594 (775)
T ss_pred hhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeee
Confidence 4578999999999999974 567899999999999999998765 4899999999999999999999986 569999
Q ss_pred cCCCCeEEEC---CCCceEEeeccCccccccCcc------eeeeccccccCCCChhhhcc----CCCCCCccchhhHHHH
Q 045989 81 DIKSANILLD---DKYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQS----SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 81 dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l 147 (295)
||||.|||+. .-|.+||+|||+++.+..... ..+....||++|++||.+.- ...+.|.||||+|||+
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 9999999995 347899999999998865332 33455679999999998853 3568899999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhh-hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLR-EAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|..+.|+.||.....-. +++....+ +...... +..+..+.+...+|++||+...++|....++..+.
T Consensus 675 yQClYGrKPFGhnqsQQ---------dILqeNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 675 YQCLYGRKPFGHNQSQQ---------DILQENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred hhhhccCCCCCCchhHH---------HHHhhhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence 99999999997432211 11111111 1111100 11122344577899999999999999988876553
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=240.13 Aligned_cols=216 Identities=22% Similarity=0.299 Sum_probs=153.9
Q ss_pred ccCC-CCccccceeeEEEeC----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 3 LSQI-NHRNVVKLLGCCLET----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
++++ +||||+++++.+... ...++++||+. ++|.+++.... .+++..++.++.||+.||+|||+.+ +
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---i 126 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSAN---V 126 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 4556 699999999976533 45789999984 69998886433 4899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 153 (295)
+||||||+||+++.++.++|+|||+++........ ......|+..|+|||.+.+ ..++.++||||+||++|++++|
T Consensus 127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred ccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999765432211 1223468999999998765 4688999999999999999999
Q ss_pred CCCCcccchhhccc---------HHHHHHHHHhhchhhhhh------hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 154 QKPIRLVETEENRS---------LAAYFLQVINENRLFEVL------DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 154 ~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
..||.......... ........... ...... ............+..+.+++.+||+.||.+|||
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 285 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC
Confidence 99986433211000 00000000000 000000 000000011112456889999999999999999
Q ss_pred HHHHHHHHH
Q 045989 219 MKEVALELA 227 (295)
Q Consensus 219 ~~e~~~~l~ 227 (295)
+.+++++.+
T Consensus 286 ~~~ll~~~~ 294 (332)
T cd07857 286 VEEALEHPY 294 (332)
T ss_pred HHHHhcChh
Confidence 999998865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=238.44 Aligned_cols=212 Identities=23% Similarity=0.323 Sum_probs=156.3
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++..+. ..++||||+ +++|..++... .+++..++.++.|++.||+|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~g-- 138 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAG-- 138 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 478899999999999997654 358999999 77999888642 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
++||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|.
T Consensus 139 -i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 139 -IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred -eecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998754322 223457889999999876 45789999999999999999999
Q ss_pred CCCcccchhhcccHHHHH----------HHHHhhchhhhh---h---hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 155 KPIRLVETEENRSLAAYF----------LQVINENRLFEV---L---DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
.||....... ...... ............ + ............+..+.+++.+||+.||.+|||
T Consensus 214 ~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 214 PLFKGHDHLD--QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred CCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence 9986432211 000000 000000000000 0 000001111233456889999999999999999
Q ss_pred HHHHHHHHHH
Q 045989 219 MKEVALELAG 228 (295)
Q Consensus 219 ~~e~~~~l~~ 228 (295)
+.+++.+.+-
T Consensus 292 ~~~~l~~~~~ 301 (343)
T cd07880 292 AAEALAHPYF 301 (343)
T ss_pred HHHHhcCccH
Confidence 9999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=238.99 Aligned_cols=206 Identities=22% Similarity=0.337 Sum_probs=152.3
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
++++++||||+++++++.... ..++|+||+. .+|..++.. .+++..+..++.|++.||+|||+.+
T Consensus 67 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~-- 137 (342)
T cd07879 67 LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSAG-- 137 (342)
T ss_pred HHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 467889999999999987643 4599999995 477776521 3889999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
++||||||+||+++.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 138 -i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred -cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998754321 223457888999999876 46889999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhc-----hh---------hhhh------hhhhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINEN-----RL---------FEVL------DAQVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-----~~---------~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.||....... .+....... .. .... ............+..+.+++.+||+.||.
T Consensus 213 ~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 286 (342)
T cd07879 213 TLFKGKDYLD------QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD 286 (342)
T ss_pred CCCCCCCHHH------HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChh
Confidence 9996432111 111111100 00 0000 00000000112345688999999999999
Q ss_pred CCCCHHHHHHHHH
Q 045989 215 KRPTMKEVALELA 227 (295)
Q Consensus 215 ~Rps~~e~~~~l~ 227 (295)
+||++.+++.|-+
T Consensus 287 ~R~~~~e~l~h~~ 299 (342)
T cd07879 287 KRLTATEALEHPY 299 (342)
T ss_pred hCcCHHHHhcCcc
Confidence 9999999998843
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=241.03 Aligned_cols=212 Identities=23% Similarity=0.336 Sum_probs=153.1
Q ss_pred cccCCCCccccceeeEEEeC--------------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLET--------------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALS 67 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--------------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~ 67 (295)
+|++++||||+++++++... ...++||||+. ++|.+++... .+++..++.++.||+.||+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~ 128 (342)
T cd07854 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLK 128 (342)
T ss_pred HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHH
Confidence 46788999999999877654 35789999996 5898887543 3889999999999999999
Q ss_pred HHHhCCCCCeEeccCCCCeEEECC-CCceEEeeccCccccccCccee--eeccccccCCCChhhhcc-CCCCCCccchhh
Q 045989 68 YLHSAASIPIYHRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQS-SQFTEKSDVYSF 143 (295)
Q Consensus 68 ~Lh~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 143 (295)
|||+.+ ++||||||+||+++. ++.++|+|||+++......... .....++..|+|||.+.. ..++.++|||||
T Consensus 129 ~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred HHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 999999 999999999999974 5678999999987553221111 122357889999998754 567889999999
Q ss_pred HHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhc---------hhh----hhhh------hhhhhhhhHHHHHHHHHH
Q 045989 144 GVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN---------RLF----EVLD------AQVLREAEKEEVITVAMV 204 (295)
Q Consensus 144 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~----~~~~------~~~~~~~~~~~~~~~~~l 204 (295)
||++|+|++|+.||......+. ........ ... .... ...........+..+.++
T Consensus 206 Gvil~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 206 GCIFAEMLTGKPLFAGAHELEQ------MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 9999999999999964332110 00000000 000 0000 000001111234568899
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHH
Q 045989 205 AKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 205 i~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+.+||+.||.+|||+.+++.|.+-
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCcc
Confidence 999999999999999999988654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=228.31 Aligned_cols=186 Identities=27% Similarity=0.395 Sum_probs=158.0
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
+-|.+++++..|..-+++|+||||+.||+|.-.+++... +.+..+.-++.+|+-||-|||++| |+.||||.+|
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDN 480 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 480 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccc
Confidence 568999999999999999999999999999999987653 888889999999999999999999 9999999999
Q ss_pred EEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcc
Q 045989 87 ILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166 (295)
Q Consensus 87 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 166 (295)
|+++..|.+||+|||+++.-... ...+.++.||+.|+|||++...+|+.+.|.||+||+||||+.|++||..-+.+
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--- 556 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--- 556 (683)
T ss_pred eEeccCCceEeeecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence 99999999999999999864433 33456778999999999999999999999999999999999999999743332
Q ss_pred cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
..+..+.+.. -.+|...+.+...+++..|.++|.+|.
T Consensus 557 ---elF~aI~ehn-----------vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 557 ---ELFQAIMEHN-----------VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---HHHHHHHHcc-----------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2333332222 145566667788899999999999995
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=262.75 Aligned_cols=201 Identities=19% Similarity=0.168 Sum_probs=144.4
Q ss_pred ccCCCC-ccccceeeEE-------EeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 3 LSQINH-RNVVKLLGCC-------LETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 3 l~~l~H-pniv~~~~~~-------~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
.+.++| +||++++|+| .....++.++||+ +++|.+++.... ..+++..++.++.||++||+|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 356788 7999999998 3334678889988 669999997432 24899999999999999999999999
Q ss_pred CCeEeccCCCCeEEECCC-------------------CceEEeeccCccccccCc---------------ceeeeccccc
Q 045989 75 IPIYHRDIKSANILLDDK-------------------YRAKISDFGTSRSMAVDR---------------THLTTQVKGT 120 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt 120 (295)
|+||||||+||||+.. +.+|++|||+++...... ........||
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999654 445666666654321100 0001113578
Q ss_pred cCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHH
Q 045989 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVIT 200 (295)
Q Consensus 121 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (295)
+.|+|||++.+..|+.++|||||||++|||++|.+|+.... ..+..... ....+. .......
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~-----~~~~~~-----~~~~~~~ 240 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRH-----RVLPPQ-----ILLNWPK 240 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHH-----hhcChh-----hhhcCHH
Confidence 89999999999999999999999999999999888753110 00100000 001111 0111233
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 201 VAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 201 ~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...++.+||+++|.+||++.|+++|.+-
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 5678899999999999999999987653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=249.49 Aligned_cols=207 Identities=29% Similarity=0.505 Sum_probs=175.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+|+|||+++++++|.... +.||++|+++|+|.++++..+. .+-....+.|++||++|+.|||++. +||||
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr---lVHrd 823 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRD 823 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc---hhhhh
Confidence 688999999999999999876 8899999999999999987655 4888999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|..+||||..-..+||.|||+++......... .....-.+.|||-|.+....|+.++|||||||++||++| |..|+..
T Consensus 824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 99999999999999999999999776543322 222233678999999999999999999999999999999 9999875
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...++ +...+..+.+...|+.++..++.++.+||..|++.||+++++...+..+.+
T Consensus 904 i~~~e----------------I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 904 IPAEE----------------IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCHHH----------------hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 54443 222333333456677788889999999999999999999999998877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=222.89 Aligned_cols=202 Identities=30% Similarity=0.427 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|+||+++++++......++++||+.+++|.+++..... +++..++.++.+++.++.|||+.+ ++|+|
T Consensus 40 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~ 112 (244)
T smart00220 40 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR----LSEDEARFYARQILSALEYLHSNG---IIHRD 112 (244)
T ss_pred HHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHcC---eecCC
Confidence 35678999999999999999999999999999999999876442 789999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|||+||++++++++|..||....
T Consensus 113 i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 190 (244)
T smart00220 113 LKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD 190 (244)
T ss_pred cCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654332 2334457889999999988888999999999999999999999986421
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.. .... +......... .......+..+.+++.+||..+|++||++.+++++
T Consensus 191 ~~-----~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 191 QL-----LELF-KKIGKPKPPF-------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cH-----HHHH-HHHhccCCCC-------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 11 1111 1111110000 00000044568999999999999999999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=223.39 Aligned_cols=214 Identities=23% Similarity=0.368 Sum_probs=176.3
Q ss_pred cccCCCCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhh----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|..+.|||+..+.+++.++ ...++++.++..|+|..++... ....+.+.-.+...++.|++.|++|||+++
T Consensus 340 lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--- 416 (563)
T KOG1024|consen 340 LLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--- 416 (563)
T ss_pred HHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---
Confidence 45678899999999998764 5678999999999999999832 222334777888999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQ 154 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~ 154 (295)
|+|.||..+|++|++...+||+|-.+++..-... .........+..||+||.+.+..|+.++|+||||+++|||++ |+
T Consensus 417 ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~ 496 (563)
T KOG1024|consen 417 VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK 496 (563)
T ss_pred cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999998654332 223333345788999999999999999999999999999999 99
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
.||...+..+ ....+..+.+...|..+|.++..++.-||...|++||++++++.-|......+.
T Consensus 497 ~PyaeIDPfE----------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 497 LPYAEIDPFE----------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred CCccccCHHH----------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 9986444333 223344455566778899999999999999999999999999999987766553
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=247.16 Aligned_cols=203 Identities=24% Similarity=0.341 Sum_probs=166.6
Q ss_pred ccCCCCccccceeeEEEe-----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 3 LSQINHRNVVKLLGCCLE-----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+....|||++.++|+|.. ++.+|+|||||.||+..++++... +..+.|..+..|++.++.|+.+||.+. +
T Consensus 70 ~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---v 144 (953)
T KOG0587|consen 70 KKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---V 144 (953)
T ss_pred HhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---e
Confidence 344589999999999974 457899999999999999998765 556999999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-----CCCCCccchhhHHHHHHHHh
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-----QFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~ 152 (295)
+|||||-.|||++.++.+||.|||++....... ....+..||+.|||||++... .|+..+|+||||++..||.-
T Consensus 145 iHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 145 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred eeecccCceEEEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 999999999999999999999999987654332 334556799999999998653 47789999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhh-hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLD-AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|.+|+..... -..++.+.. |......+..+..+|.++|..||.+|..+||++.++++|.
T Consensus 224 G~PPl~DmHP---------------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 224 GAPPLCDMHP---------------MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred CCCCccCcch---------------hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 9999752211 111222221 2222234677888999999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=217.74 Aligned_cols=226 Identities=19% Similarity=0.293 Sum_probs=164.2
Q ss_pred cccCCCCccccceeeEEEeC--------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLET--------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
||..|+|+|++.++..|... ..+|+||.+|++ +|.-++..... .++...+.+++.+++.||.|+|...
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~k 144 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRNK 144 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHhh
Confidence 57789999999999998642 358999999976 99999976543 4899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHH
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~e 149 (295)
|+|||+||+|+||+.++.+||+|||+++.+...... ..+..+-|.+|.+||.+.+ ..|+++.|||.-||++.|
T Consensus 145 ---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimae 221 (376)
T KOG0669|consen 145 ---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAE 221 (376)
T ss_pred ---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHH
Confidence 999999999999999999999999999766433221 1334456999999998876 578999999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHH--------HHHhhchhhhhhh-----hhhhhhh-----hHHHHHHHHHHHHHhhcc
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFL--------QVINENRLFEVLD-----AQVLREA-----EKEEVITVAMVAKRCLNL 211 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~li~~cl~~ 211 (295)
|+++.+-+.....-........+. .....-.+.+-+. ....... +-.-.....+|+..++..
T Consensus 222 Mwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 222 MWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL 301 (376)
T ss_pred HHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence 999988775433222111111111 0011111111110 0000000 000122577899999999
Q ss_pred CCCCCCCHHHHHHHHHHhHHhhc
Q 045989 212 NGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 212 ~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
||.+|+++.+++.|-....+...
T Consensus 302 DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 302 DPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCcchHhhhchhhhhcCCcc
Confidence 99999999999999876655444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=234.23 Aligned_cols=152 Identities=28% Similarity=0.449 Sum_probs=133.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||..-+.+-||+|+-.|.+++.+|+||+|++||++..+|.+.. .|++..++.++.++..|+++.|+.| +||||
T Consensus 682 ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG---FIHRD 754 (1034)
T KOG0608|consen 682 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG---FIHRD 754 (1034)
T ss_pred hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecc
Confidence 5677788999999999999999999999999999999998765 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccc--c-Ccce--------------------------------------eeeccccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMA--V-DRTH--------------------------------------LTTQVKGT 120 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~--~-~~~~--------------------------------------~~~~~~gt 120 (295)
|||+|||||.+|.+||+|||++.-+. . .+.. .....+||
T Consensus 755 iKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt 834 (1034)
T KOG0608|consen 755 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGT 834 (1034)
T ss_pred cCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence 99999999999999999999985331 0 0000 01124699
Q ss_pred cCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 121 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
+.|+|||++....|+..+|.||.|||||||+.|++||-..
T Consensus 835 ~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 835 PNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred CcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCC
Confidence 9999999999999999999999999999999999999543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=249.11 Aligned_cols=96 Identities=29% Similarity=0.421 Sum_probs=88.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++......|+||||+.|++|.+++.... .+++..++.++.||+.||+|||..+ |+|||
T Consensus 57 ~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrD 129 (669)
T cd05610 57 ALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG---IIHRD 129 (669)
T ss_pred HHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 4567899999999999999999999999999999999997543 3788999999999999999999998 99999
Q ss_pred CCCCeEEECCCCceEEeeccCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
|||+|||++.++.+||+|||+++
T Consensus 130 LKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 130 LKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred ccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=222.89 Aligned_cols=210 Identities=25% Similarity=0.357 Sum_probs=159.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhh-hCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE-QTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+.-+.||||+++|++...+..||.||.|+ .+|..+... ...++..++++.+-+|....+.||.||-+.-. |+||
T Consensus 116 ~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHR 192 (361)
T KOG1006|consen 116 VMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHR 192 (361)
T ss_pred HHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhc
Confidence 3566688999999999999999999999995 488776642 22223358999999999999999999988753 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|+||+|||++..|.+||+|||++-.+..+-. .+.-.|-..|||||-+.. ..|+.++|+||||++|+|+.||..||+
T Consensus 193 DvKPSNILldr~G~vKLCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 193 DVKPSNILLDRHGDVKLCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred cCChhheEEecCCCEeeecccchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 9999999999999999999999854432221 122357788999999864 358999999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.+.. ...++.++.....-.-..+ ......+..+..+|.-||.+|..+||.+.++.++.
T Consensus 271 ~w~s-----vfeql~~Vv~gdpp~l~~~-----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 271 KWDS-----VFEQLCQVVIGDPPILLFD-----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred hHHH-----HHHHHHHHHcCCCCeecCc-----ccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 5543 2222333333221111001 11123556689999999999999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=205.15 Aligned_cols=215 Identities=20% Similarity=0.300 Sum_probs=159.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++|.|||+++++.-.++.+-+|+|||+ .+|..+...... .+..+....++.|+++||.|.|+++ +.|||
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng---~~d~~~~rsfmlqllrgl~fchshn---vlhrd 126 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRD 126 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhh---hhhcc
Confidence 5789999999999999999999999999995 499998876544 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
+||+|.+|+.+|.+|++|||+++.++.+-.. ....+-|.+|.+|.++.+. -|+...|+||-||++.|+.. |++.|+.
T Consensus 127 lkpqnllin~ngelkladfglarafgipvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 127 LKPQNLLINRNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred CCcceEEeccCCcEEecccchhhhcCCceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 9999999999999999999999977654322 2334568999999999876 57899999999999999988 5555653
Q ss_pred cchhhcccHHHHHHHHHhh--chhhh---hhhhhhhhhh---------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINE--NRLFE---VLDAQVLREA---------EKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.+..+ .....++..... ..... ..+-.....+ -+.....-.+++.++|.-+|.+|.++++.++|
T Consensus 206 ~dvdd--qlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 206 NDVDD--QLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcHHH--HHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 33222 111122211111 00000 0000000000 11122235788999999999999999998877
Q ss_pred H
Q 045989 226 L 226 (295)
Q Consensus 226 l 226 (295)
.
T Consensus 284 p 284 (292)
T KOG0662|consen 284 P 284 (292)
T ss_pred c
Confidence 4
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=225.05 Aligned_cols=218 Identities=24% Similarity=0.392 Sum_probs=160.2
Q ss_pred CCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------C
Q 045989 5 QINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA------S 74 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------~ 74 (295)
.|+|+||++++++-.... .+++|++|.+.|+|.++|..+. ++|....+++..+++||+|||+.- +
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~K 334 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHK 334 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCC
Confidence 689999999999987655 7899999999999999999765 899999999999999999999764 3
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCC-CC-----CCccchhhHHHH
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQ-FT-----EKSDVYSFGVVL 147 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~~l 147 (295)
++|+|||||..||||.+++...|+|||+|..+...... .....+||.+|||||++.+.- +. .+.||||+|.++
T Consensus 335 p~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 335 PPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred CccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 57999999999999999999999999999877543322 233468999999999997642 22 468999999999
Q ss_pred HHHHhCCCCCcc--cchhh---------cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 148 VELLTGQKPIRL--VETEE---------NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 148 ~el~~g~~p~~~--~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
|||++....+.. ....+ ....... +..+-..+....+...-. ....+.-+.+.+..||..|++.|
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m-q~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeAR 490 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM-QELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEAR 490 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH-HHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhh
Confidence 999996554321 11000 1111111 111111111011110000 01234568999999999999999
Q ss_pred CCHHHHHHHHHHhHH
Q 045989 217 PTMKEVALELAGIRA 231 (295)
Q Consensus 217 ps~~e~~~~l~~~~~ 231 (295)
.|+.=+.+.++.+..
T Consensus 491 LTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 491 LTAGCVEERMAELMM 505 (534)
T ss_pred hhhHHHHHHHHHHhc
Confidence 999999988877643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=218.26 Aligned_cols=195 Identities=26% Similarity=0.404 Sum_probs=160.4
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
-+||.+|.++..|.+...+++|.||++||+|.-..++++ .++++.+..+..+|+.||.|||++| |+.||+|.+
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg---iiyrdlkld 380 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLD 380 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeecccc
Confidence 389999999999999999999999999999988877665 3999999999999999999999999 999999999
Q ss_pred eEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch-hh
Q 045989 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET-EE 164 (295)
Q Consensus 86 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~-~~ 164 (295)
|+|++..|.+||+|+|.++.... ....+.++.||+.|+|||++.+..|....|.|+|||+++||+.|+.||+.... ..
T Consensus 381 nvlldaeghikltdygmcke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred ceEEccCCceeecccchhhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 99999999999999999886433 34456678899999999999999999999999999999999999999985432 22
Q ss_pred cccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
......++.+++-...+ ..|...+.....+++.-|++||.+|..
T Consensus 460 d~ntedylfqvilekqi----------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 460 DMNTEDYLFQVILEKQI----------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ccchhHHHHHHHhhhcc----------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 23344444444433322 112222334566899999999999853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=216.92 Aligned_cols=213 Identities=24% Similarity=0.338 Sum_probs=158.9
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|..++|+||++++.+|.-.+ ..|+|||+|+ ++|..++.. .+.-.++..+++|++.|++|||+.+
T Consensus 68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~-- 138 (369)
T KOG0665|consen 68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG-- 138 (369)
T ss_pred hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc--
Confidence 467789999999999997543 5699999995 599999873 2667888999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+||++..+..+||.|||+|+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||+.|..
T Consensus 139 -IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V 215 (369)
T KOG0665|consen 139 -IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV 215 (369)
T ss_pred -eeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE
Confidence 999999999999999999999999999854322 34566778999999999999889999999999999999999998
Q ss_pred CCcccchhhcc---------cHHHHHHHHHhhchhh-------------hhhhhhh---hhhhhHHHHHHHHHHHHHhhc
Q 045989 156 PIRLVETEENR---------SLAAYFLQVINENRLF-------------EVLDAQV---LREAEKEEVITVAMVAKRCLN 210 (295)
Q Consensus 156 p~~~~~~~~~~---------~~~~~~~~~~~~~~~~-------------~~~~~~~---~~~~~~~~~~~~~~li~~cl~ 210 (295)
-|.+....+.- .-..++.+.....+.. +.+.... ..+.+........+++.+||.
T Consensus 216 lf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv 295 (369)
T KOG0665|consen 216 LFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV 295 (369)
T ss_pred EecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc
Confidence 88633221100 0000111111111000 0000000 001111233457889999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 045989 211 LNGKKRPTMKEVALEL 226 (295)
Q Consensus 211 ~~p~~Rps~~e~~~~l 226 (295)
.||++|.++++++.|.
T Consensus 296 i~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 296 IDPEKRISVDDALRHP 311 (369)
T ss_pred cChhhcccHHHHhcCC
Confidence 9999999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=236.99 Aligned_cols=200 Identities=19% Similarity=0.225 Sum_probs=135.5
Q ss_pred EeCCccEEEEeecCCCCHHHHHhhhCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 19 LETEVPLLVYEFIPNGSLHQYIHEQTED----------------QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 19 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
..+...++|+||+.+++|.+++...... ........+..++.|++.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 3456789999999999999998753210 001123456789999999999999999 999999
Q ss_pred CCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccC----------------------CCCCCcc
Q 045989 83 KSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS----------------------QFTEKSD 139 (295)
Q Consensus 83 kp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 139 (295)
||+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57999999999986544433344456789999999976422 2345679
Q ss_pred chhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhc----hhhhhhhhhhhh------hhhHHHHHHHHHHHHHhh
Q 045989 140 VYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN----RLFEVLDAQVLR------EAEKEEVITVAMVAKRCL 209 (295)
Q Consensus 140 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl 209 (295)
||||||++|||+++..|+... ...+........ .......+.... ...........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999877664311 111111110000 000001110000 000111223568999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 045989 210 NLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 210 ~~~p~~Rps~~e~~~~l~~ 228 (295)
+.||++|||+.++++|.+-
T Consensus 435 ~~dP~kR~ta~e~L~Hpff 453 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYF 453 (566)
T ss_pred cCCcccCCCHHHHhCCcCc
Confidence 9999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=238.99 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=152.4
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
+|||||++++.-.++...||+.|.|.. +|.+++............-..+.++.|+++||++||+.+ ||||||||+|
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQN 636 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQN 636 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCce
Confidence 899999999999999999999999966 999999874111111111345778999999999999988 9999999999
Q ss_pred EEECC---C--CceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC-CCCCc
Q 045989 87 ILLDD---K--YRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG-QKPIR 158 (295)
Q Consensus 87 ill~~---~--~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~ 158 (295)
|||+. + ..++|+|||+++......... ..+..||-+|+|||++....-+.++||||+||++|+.++| ..||.
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99975 2 478999999999886654332 3456799999999999988888899999999999999985 88986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.... ... .+.....-...+.+ . .++ ...+||.+|+..+|..||+|.+|+.|.
T Consensus 717 d~~~-------R~~-NIl~~~~~L~~L~~-----~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 717 DSLE-------RQA-NILTGNYTLVHLEP-----L-PDC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred chHH-------hhh-hhhcCccceeeecc-----C-chH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 3221 111 11211111111111 0 111 578899999999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=200.42 Aligned_cols=169 Identities=24% Similarity=0.256 Sum_probs=126.5
Q ss_pred CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee
Q 045989 34 GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113 (295)
Q Consensus 34 g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 113 (295)
|+|.+++..... .+++..++.++.|++.||+|||+.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999975432 4999999999999999999999876 999999999999999 99987554321
Q ss_pred eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhh
Q 045989 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREA 193 (295)
Q Consensus 114 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (295)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............... .+.. ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~---~~~~-~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPAD---DPRD-RSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccC---Cccc-ccc
Confidence 2588999999999999999999999999999999999999853221 111111111111000 0000 011
Q ss_pred hHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 194 EKEEVI--TVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 194 ~~~~~~--~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
+..... .+.+++.+||..+|.+||++.++++++.....
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 122222 58999999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=201.25 Aligned_cols=155 Identities=28% Similarity=0.410 Sum_probs=133.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++....|.+|.++|.....+..||.||.|+. +|..+...-..++..+++..+-+|+..++.||.|||++-+ ++|||
T Consensus 98 ~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRD 174 (282)
T KOG0984|consen 98 IMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRD 174 (282)
T ss_pred hccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhcc
Confidence 45667889999999999999999999999955 9999988777777789999999999999999999999753 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc----CCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS----SQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||+|||++..|.+|+||||++-.+..+-.. +-..|-..|||||.+.. ..|+.++||||||+.+.||.+++.||
T Consensus 175 vKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 175 VKPSNILINYDGQVKICDFGISGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred CCcceEEEccCCcEEEcccccceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 9999999999999999999998655433221 11347788999998853 47899999999999999999999999
Q ss_pred cccc
Q 045989 158 RLVE 161 (295)
Q Consensus 158 ~~~~ 161 (295)
+.+.
T Consensus 253 ~~w~ 256 (282)
T KOG0984|consen 253 ESWG 256 (282)
T ss_pred cccC
Confidence 7554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=240.35 Aligned_cols=183 Identities=26% Similarity=0.373 Sum_probs=133.9
Q ss_pred CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 22 EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 22 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
..+||=||||+.-.|.+++++..-. -.....|+++.+|++||+|+|+.| ++||||||.|||+++++.+||+|||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccc
Confidence 4579999999987777777665421 147889999999999999999999 9999999999999999999999999
Q ss_pred Cccccc-----------------cCcceeeeccccccCCCChhhhccCC---CCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 102 TSRSMA-----------------VDRTHLTTQVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 102 ~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
+|+... .......+..+||.-|+|||++.+.. |+.|+||||||+|++||+. ||...
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts- 818 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS- 818 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch-
Confidence 998721 00111234567999999999997754 9999999999999999985 45311
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
..-.. ....+....+... ..+..+....=..+|++|++.||.+||||.|++..
T Consensus 819 ----MERa~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 819 ----MERAS-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ----HHHHH-HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 11111 1111111111111 12223333345679999999999999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=226.63 Aligned_cols=204 Identities=24% Similarity=0.321 Sum_probs=162.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||.+++||.||.+.-.|++.+..++|||-+. |+..+.+-.... ..+++.....++.||+.||.|||-++ |+|+|
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCD 689 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCD 689 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeecc
Confidence 6889999999999999999999999999995 566666543322 24889888999999999999999999 99999
Q ss_pred CCCCeEEECCC---CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+|||+... ..+||+|||+|+.++... .....+||+.|+|||++.+..|+..-||||.|||+|--++|..||.
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecchhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 99999999654 479999999999876433 3456789999999999999999999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
-.+. +.. ++.+..... ......+.+....++|..+|+..-++|-|....+.|.|-
T Consensus 768 EdEd-----Ind---QIQNAaFMy-------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 768 EDED-----IND---QIQNAAFMY-------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred Cccc-----hhH---Hhhcccccc-------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 3221 111 111111111 112233445568889999999999999999998888654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=212.63 Aligned_cols=216 Identities=25% Similarity=0.354 Sum_probs=160.1
Q ss_pred CCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCC
Q 045989 5 QINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-----AASI 75 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-----~~~~ 75 (295)
.|+|+||+.++++-..++ .+|+|++|.+.|+|+++|.+.. ++.....+++..++.||++||. +|++
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence 369999999999877554 5799999999999999998754 8999999999999999999995 4567
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCC----C--CCCccchhhHHH
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQ----F--TEKSDVYSFGVV 146 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~~ 146 (295)
.|.|||||..||||.+++...|+|+|+|......... .....+||.+|||||++...- + -..+||||||++
T Consensus 336 aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred hhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 7999999999999999999999999999865543222 133457999999999996531 1 246899999999
Q ss_pred HHHHHhC----------CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 147 LVELLTG----------QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 147 l~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
+||++-. .+||...... ....+.+.+++-..++...++.. -...+....+.++++.||..||..|
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~--DPs~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPS--DPSFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCC--CCCHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhh
Confidence 9999762 2454322211 11111222222222222111111 1123456678999999999999999
Q ss_pred CCHHHHHHHHHHhH
Q 045989 217 PTMKEVALELAGIR 230 (295)
Q Consensus 217 ps~~e~~~~l~~~~ 230 (295)
.|+-.+-+.|.++.
T Consensus 491 ltALriKKtl~~l~ 504 (513)
T KOG2052|consen 491 LTALRIKKTLAKLS 504 (513)
T ss_pred hHHHHHHHHHHHHh
Confidence 99999988887664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=226.05 Aligned_cols=205 Identities=26% Similarity=0.373 Sum_probs=162.0
Q ss_pred CcccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 1 ~il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++.++|||||.|++.+..++.+||+||||.||+|++..+... ++++.++...++..++|++|||+.+ -+||
T Consensus 64 ~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g---k~hR 136 (829)
T KOG0576|consen 64 GMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG---KIHR 136 (829)
T ss_pred eeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC---cccc
Confidence 36788999999999999999999999999999999999887654 5999999999999999999999999 8899
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhh---ccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYF---QSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||-.||++++.+.+|++|||.+-.++..- .....+.||++|||||+. ....|..++|||++|+...|+-.-++|-
T Consensus 137 diKGanilltd~gDvklaDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 137 DIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred cccccceeecccCceeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 999999999999999999999876554322 234567899999999987 3467999999999999999998877773
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
..... ....+ .... ...++.. ..-...+...|-++++.++.++|++||+++.++.|
T Consensus 216 fdlhp-----mr~l~--LmTk----S~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 216 FDLHP-----MRALF--LMTK----SGFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cccch-----HHHHH--Hhhc----cCCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 21110 00000 0000 0011111 11223456678899999999999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=219.73 Aligned_cols=207 Identities=19% Similarity=0.191 Sum_probs=141.8
Q ss_pred ccceeeEEEe--------CCccEEEEeecCCCCHHHHHhhhCCC--------------------CCCCCHHHHHHHHHHH
Q 045989 11 VVKLLGCCLE--------TEVPLLVYEFIPNGSLHQYIHEQTED--------------------QLPITWEIRLGIAVEV 62 (295)
Q Consensus 11 iv~~~~~~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi 62 (295)
+++++++|.. .+..++||||+++++|.++++..... ...+++..+..++.|+
T Consensus 239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql 318 (507)
T PLN03224 239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318 (507)
T ss_pred hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence 4677787763 34679999999999999998743210 1124677889999999
Q ss_pred HHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC---------
Q 045989 63 SGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ--------- 133 (295)
Q Consensus 63 ~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------- 133 (295)
+.||.|||+.+ |+||||||+||+++.++.+||+|||++...............+++.|+|||.+....
T Consensus 319 ~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~ 395 (507)
T PLN03224 319 LTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA 395 (507)
T ss_pred HHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhh
Confidence 99999999999 999999999999999999999999999755433222222234578999999875422
Q ss_pred -----------C--CCCccchhhHHHHHHHHhCCC-CCcccchhhc--c--cHHHHHHHHHhhchhhhhhhhhhhhhhhH
Q 045989 134 -----------F--TEKSDVYSFGVVLVELLTGQK-PIRLVETEEN--R--SLAAYFLQVINENRLFEVLDAQVLREAEK 195 (295)
Q Consensus 134 -----------~--~~~~DiwslG~~l~el~~g~~-p~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (295)
+ ..+.||||+||++++|++|.. |+........ . ......++....... .-....
T Consensus 396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~--------~~~~~d 467 (507)
T PLN03224 396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY--------DFSLLD 467 (507)
T ss_pred hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC--------Cccccc
Confidence 1 234799999999999999875 6542211100 0 000000111111100 001122
Q ss_pred HHHHHHHHHHHHhhccCC---CCCCCHHHHHHHHHH
Q 045989 196 EEVITVAMVAKRCLNLNG---KKRPTMKEVALELAG 228 (295)
Q Consensus 196 ~~~~~~~~li~~cl~~~p---~~Rps~~e~~~~l~~ 228 (295)
..+....+++.+||..+| .+|+|+.|+++|.+-
T Consensus 468 ~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 468 RNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred ccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 334568899999999766 789999999998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=190.77 Aligned_cols=170 Identities=36% Similarity=0.600 Sum_probs=147.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++|++|+++++++......++++|+++|++|.+++.... ..+++..++.++.+++.++.+||+.+ ++|+|
T Consensus 44 ~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~d 117 (215)
T cd00180 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRD 117 (215)
T ss_pred HHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 3677899999999999999999999999999899999998653 24889999999999999999999999 99999
Q ss_pred CCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|+|.||+++. ++.++|+|||.+........ ......+...|++||.+... .++.+.|+|++|++++++
T Consensus 118 l~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred CCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 9999999999 89999999999875543321 12234578889999999877 788999999999999999
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..+.+++.+|++.+|.+||++.++++++
T Consensus 188 ---------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2377899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=198.61 Aligned_cols=215 Identities=24% Similarity=0.335 Sum_probs=155.5
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|...+|.||+..++...-. ..+|+|+|.+. .+|.+++-. .+.++...+.-+++||++||.|||+.+
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~--- 176 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN--- 176 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---
Confidence 34567999999999887643 25688999984 488877643 225888999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|.||||||.|.||+.+..+||+|||+++.........++..+-|.+|.|||++.+. .|+.+.||||.||++.|++..+.
T Consensus 177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrI 256 (449)
T KOG0664|consen 177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKI 256 (449)
T ss_pred hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhh
Confidence 99999999999999999999999999997665555555666779999999999875 79999999999999999998887
Q ss_pred CCcccchhhcccHHHHHHHHHhhchh-----------hhhhhhhh-hhhh--------hHHHHHHHHHHHHHhhccCCCC
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRL-----------FEVLDAQV-LREA--------EKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-~~~~--------~~~~~~~~~~li~~cl~~~p~~ 215 (295)
.|......+..+.. .+....... ..++.... .... +...-.+...+...++..||++
T Consensus 257 LFQAq~PiqQL~lI---tdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dk 333 (449)
T KOG0664|consen 257 LFQAAGPIEQLQMI---IDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDK 333 (449)
T ss_pred hhhccChHHHHHHH---HHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcc
Confidence 77644333221111 111111000 00111000 0000 0111223566778899999999
Q ss_pred CCCHHHHHHHHH
Q 045989 216 RPTMKEVALELA 227 (295)
Q Consensus 216 Rps~~e~~~~l~ 227 (295)
|.+..+.+.++.
T Consensus 334 ris~~~A~~~~~ 345 (449)
T KOG0664|consen 334 RISVEEALQHRY 345 (449)
T ss_pred cccHhhhccccc
Confidence 999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=212.54 Aligned_cols=147 Identities=25% Similarity=0.401 Sum_probs=131.7
Q ss_pred cccCCC---CccccceeeEEEeCCccEEEEeec-CCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQIN---HRNVVKLLGCCLETEVPLLVYEFI-PNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~---Hpniv~~~~~~~~~~~~~iv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
||.+|+ |+||+|++++|++++++||+||.- +|.+|++++..++. +.+..+..|+.||+-|+++||..+ |
T Consensus 619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~~---i 691 (772)
T KOG1152|consen 619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQG---I 691 (772)
T ss_pred HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccccC---c
Confidence 577787 999999999999999999999984 46699999987764 899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p 156 (295)
||||||-+|+.++.+|-+||+|||.+....... ...++||..|.|||++.+..| +..-|||++|++||.++....|
T Consensus 692 vhrdikdenvivd~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred eecccccccEEEecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 999999999999999999999999987665443 445689999999999999888 5678999999999999998888
Q ss_pred Cc
Q 045989 157 IR 158 (295)
Q Consensus 157 ~~ 158 (295)
|-
T Consensus 769 yy 770 (772)
T KOG1152|consen 769 YY 770 (772)
T ss_pred Cc
Confidence 73
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=199.96 Aligned_cols=209 Identities=24% Similarity=0.307 Sum_probs=151.8
Q ss_pred ccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 9 RNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 9 pniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
..||++++.|.. +.++|||+|++ |.+|..+|.....+ .++...+.+|++||+.||.|||+++. |+|.||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCc
Confidence 479999999985 45899999999 88999999876555 48889999999999999999999874 99999999
Q ss_pred CeEEECCC------------------------------------------------------------------------
Q 045989 85 ANILLDDK------------------------------------------------------------------------ 92 (295)
Q Consensus 85 ~Nill~~~------------------------------------------------------------------------ 92 (295)
+|||+..+
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 99998100
Q ss_pred --------------------------------------------------------------------------------
Q 045989 93 -------------------------------------------------------------------------------- 92 (295)
Q Consensus 93 -------------------------------------------------------------------------------- 92 (295)
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence
Q ss_pred --------------CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 93 --------------YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 93 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
..+||+|||-|+..... .+.-..|..|.|||++.+..|+..+||||++|+++||+||...|.
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe 452 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE 452 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence 00234444433332111 112246888999999999999999999999999999999999987
Q ss_pred ccchhh---cccHHHHHHHHHhhch------------------------------hhhhhhhhhhhhhhHHHHHHHHHHH
Q 045989 159 LVETEE---NRSLAAYFLQVINENR------------------------------LFEVLDAQVLREAEKEEVITVAMVA 205 (295)
Q Consensus 159 ~~~~~~---~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~li 205 (295)
....+. ..+..+.+.......+ +.+++.. .-..+.+.+.++.+++
T Consensus 453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~e--KY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIE--KYEWSEEDAQQFSDFL 530 (590)
T ss_pred CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHH--HhCCCHHHHHHHHHHH
Confidence 654332 1112222211111110 0111111 1123456788899999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHH
Q 045989 206 KRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 206 ~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.-||+.+|++||||.+.++|.|-
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred HHHHhcCccccccHHHHhcCccc
Confidence 99999999999999999999874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=183.93 Aligned_cols=213 Identities=22% Similarity=0.308 Sum_probs=154.8
Q ss_pred cccCCC-CccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQIN-HRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
||..|. ||||++++++..+. ....+|+||+++.+...+... ++...+..++.++++||.|+|+.| |.
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~G---Im 154 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMG---IM 154 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcC---cc
Confidence 567775 99999999999864 567899999999887776643 777888899999999999999999 99
Q ss_pred eccCCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCC
Q 045989 79 HRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 79 H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||.|++++. ...++|+|+|+|..+....... -.+.+..|--||.+.+ ..|+.+-|+|||||++..|+..+.|
T Consensus 155 HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkep 232 (338)
T KOG0668|consen 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 232 (338)
T ss_pred cccCCcceeeechhhceeeeeecchHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCc
Confidence 9999999999985 4579999999998765443322 2245778899999876 4578899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhh-------hhhhh----------------hhhhHHHHHHHHHHHHHhhccCC
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVL-------DAQVL----------------REAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~----------------~~~~~~~~~~~~~li~~cl~~~p 213 (295)
|........ .+.. +..+.....+...+ ++... .+...-...+..+++.++|..|-
T Consensus 233 FFhG~dN~D-QLVk-IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 233 FFHGHDNYD-QLVK-IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred ccCCCCCHH-HHHH-HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 864432211 1111 11111111111111 11100 00111133568899999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 045989 214 KKRPTMKEVALELAG 228 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~ 228 (295)
.+|+|++|...|...
T Consensus 311 qeRlTakEam~HpyF 325 (338)
T KOG0668|consen 311 QERLTAKEAMAHPYF 325 (338)
T ss_pred ccccchHHHhcCchH
Confidence 999999999988643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=207.58 Aligned_cols=209 Identities=20% Similarity=0.237 Sum_probs=156.1
Q ss_pred cccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEE
Q 045989 10 NVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL 89 (295)
Q Consensus 10 niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill 89 (295)
|.++++-.|...+++|||+|.+ ..+|.+++.... ....+.......++.|+.-||..|-..+ |+|.||||+||||
T Consensus 495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 6889999999999999999999 669999998754 3445888899999999999999999999 9999999999999
Q ss_pred CCC-CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccH
Q 045989 90 DDK-YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSL 168 (295)
Q Consensus 90 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 168 (295)
++. ..+||||||.|.....+. .+...-+..|.|||++.|..|+...|+||.||.||||+||+..|+.........+
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 865 578999999987554332 2223345679999999999999999999999999999999998875443221111
Q ss_pred HHHHH-----HHHhhch---------------------------hhhhhhh-----------hhhhhhhHHHHHHHHHHH
Q 045989 169 AAYFL-----QVINENR---------------------------LFEVLDA-----------QVLREAEKEEVITVAMVA 205 (295)
Q Consensus 169 ~~~~~-----~~~~~~~---------------------------~~~~~~~-----------~~~~~~~~~~~~~~~~li 205 (295)
..-.. .++..+. +...+.| +....-.......|.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 10000 0000000 0001111 112222334566799999
Q ss_pred HHhhccCCCCCCCHHHHHHHH
Q 045989 206 KRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 206 ~~cl~~~p~~Rps~~e~~~~l 226 (295)
..||..||++|.|..++++|.
T Consensus 727 dkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHhccChhhcCCHHHHhcCC
Confidence 999999999999999999885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=185.74 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=143.2
Q ss_pred CCccccceeeE-EEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 7 NHRNVVKLLGC-CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 7 ~Hpniv~~~~~-~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.|.||+.-+++ |+..+..++++||++-|+|.+-+.... +.+.....++.|++.||.|+|+++ +||||||.+
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~e 150 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAE 150 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccc
Confidence 57788877754 777788899999999999999887643 888888999999999999999999 999999999
Q ss_pred eEEEC--CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-----CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 86 NILLD--DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-----QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 86 Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||- +..++||+|||+.+..+.. .....-+-.|.+||.+... ...+.+|+|.||++++.+++|..||.
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred eEEEecCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 99994 3458999999998754322 2222345678999987432 34678999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR---PTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---ps~~e~~~~l~~ 228 (295)
... ........|......... .-|. .....+..+..+.++-|..++++| .+++...+.+|.
T Consensus 227 ka~-~~d~~Y~~~~~w~~rk~~----~~P~----~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 227 KAS-IMDKPYWEWEQWLKRKNP----ALPK----KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred hhh-ccCchHHHHHHHhcccCc----cCch----hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 332 223333333322111110 1111 122233446778889999999999 444444444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=180.35 Aligned_cols=150 Identities=37% Similarity=0.552 Sum_probs=130.7
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
+++++|+|++++++++......++++||+++++|.+++...... +++..++.++.+++.++.+||+.+ ++|+||
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di 124 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSLG---IVHRDL 124 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 56779999999999999999999999999999999999865421 788999999999999999999998 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhh-ccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+|.||+++.++.++|+|||.+...............++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus 125 ~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 125 KPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred CHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999886654321122334578889999998 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-26 Score=207.63 Aligned_cols=209 Identities=21% Similarity=0.282 Sum_probs=165.3
Q ss_pred cCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 045989 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIK 83 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dik 83 (295)
.+++|||++..+..+.+.....-+||||++ +|..++.... .+....+..++.|++.|+.|+|..| +.|||+|
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK 447 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLK 447 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCc
Confidence 578999999998888877666666999999 9999997652 3788888999999999999999999 9999999
Q ss_pred CCeEEECCCCceEEeeccCccccccCcc---eeeeccccccCCCChhhhccCCCCC-CccchhhHHHHHHHHhCCCCCcc
Q 045989 84 SANILLDDKYRAKISDFGTSRSMAVDRT---HLTTQVKGTFGYLDPEYFQSSQFTE-KSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 84 p~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~p~~~ 159 (295)
++|+++..++.+||+|||.+..+..... ......+|...|+|||++.+..|.+ ..||||.|+++..|.+|+.||..
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 9999999999999999999886654333 3455678999999999999999985 57999999999999999999987
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
....+.... ...... ..-............+.....+|.+||+.+|.+|.|+++|++.-|-
T Consensus 528 a~~~~~~~~-----~~~~~~---~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 528 AKKSDNSFK-----TNNYSD---QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ccccccchh-----hhcccc---ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 665544320 000000 0001111223334455567889999999999999999999987664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=185.23 Aligned_cols=210 Identities=23% Similarity=0.345 Sum_probs=150.9
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
-+.||+++.+++..++...+|+||+++-...+++.. ++...+..+++.++.||+++|++| |+||||||.|
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsN 162 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSN 162 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccc
Confidence 578999999999999999999999999888888764 778899999999999999999999 9999999999
Q ss_pred EEECC-CCceEEeeccCccccccC-------------------------------------------cceeeeccccccC
Q 045989 87 ILLDD-KYRAKISDFGTSRSMAVD-------------------------------------------RTHLTTQVKGTFG 122 (295)
Q Consensus 87 ill~~-~~~~kl~Dfg~a~~~~~~-------------------------------------------~~~~~~~~~gt~~ 122 (295)
++.+. .+.-.|.|||+|...... .........||++
T Consensus 163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G 242 (418)
T KOG1167|consen 163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG 242 (418)
T ss_pred cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence 99985 467899999998721000 0001112459999
Q ss_pred CCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCcccchhhcc--cHHHHH-----HH-HHhhch--hhh--------
Q 045989 123 YLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR--SLAAYF-----LQ-VINENR--LFE-------- 183 (295)
Q Consensus 123 y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~-----~~-~~~~~~--~~~-------- 183 (295)
|.|||++... ..++++||||.|||+..+++++.||......-.. .+...+ .+ ..-.+. +++
T Consensus 243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~ 322 (418)
T KOG1167|consen 243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP 322 (418)
T ss_pred CCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence 9999998654 5688999999999999999999998543321110 000000 00 000000 000
Q ss_pred -------hhh-hh---------hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 184 -------VLD-AQ---------VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 184 -------~~~-~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
-++ .. .......-.+..+++++.+|++.||.+|.|+++.++|.
T Consensus 323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 000 00 00011112334689999999999999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=180.85 Aligned_cols=218 Identities=24% Similarity=0.454 Sum_probs=162.7
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|+.+.|.|+.+++|.+..+...++|.+||..|+|.+.+.... ..+++.....++.+|+.||+|||... . .+|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeee
Confidence 678999999999999999999999999999999999998733 34899999999999999999999976 1 299999
Q ss_pred CCCeEEECCCCceEEeeccCccccccC-cceeeeccccccCCCChhhhccCC-------CCCCccchhhHHHHHHHHhCC
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGTFGYLDPEYFQSSQ-------FTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~~l~el~~g~ 154 (295)
+..|++++....+||+|||+....... .........-..-|.|||.+.+.. .+.+.||||+|++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998654320 011111122345699999997641 466799999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
.||......... .+.+.++.+ .....+.|...... .....+..+++.||..+|..||+++++-..+..+..
T Consensus 156 ~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999764433322 222222222 01111122211111 333368889999999999999999999887765543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=166.00 Aligned_cols=207 Identities=21% Similarity=0.238 Sum_probs=156.2
Q ss_pred ccccceeeEE-EeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeE
Q 045989 9 RNVVKLLGCC-LETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANI 87 (295)
Q Consensus 9 pniv~~~~~~-~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Ni 87 (295)
+++.++++.. .....-+|||+.+ |.+|.++..... ...++..+...++.|++.+|++||+.| ++||||||+|+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~ 153 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENF 153 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHe
Confidence 5889999999 4777889999999 899999887665 335999999999999999999999999 99999999999
Q ss_pred EECCC-----CceEEeeccCcc--ccccCcce------e-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC
Q 045989 88 LLDDK-----YRAKISDFGTSR--SMAVDRTH------L-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 88 ll~~~-----~~~kl~Dfg~a~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 153 (295)
++... ..+.|.|||+++ .+...... . .....||..|.++.+..+...+.+.|+||++.++.+++.|
T Consensus 154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 99754 469999999998 43222211 1 2245699999999999999999999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
..||........ ...+....... .........+..+.++...+-..+..++|....+...+.......
T Consensus 234 ~LPW~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 234 SLPWEALEMTDL---KSKFEKDPRKL---------LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred CCCCccccccch---HHHHHHHhhhh---------ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 999965443221 11111100000 000011223344666777777799999999999999987765554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=164.76 Aligned_cols=197 Identities=20% Similarity=0.257 Sum_probs=142.3
Q ss_pred CCCccccceeeEEEe---------------------------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHH
Q 045989 6 INHRNVVKLLGCCLE---------------------------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI 58 (295)
Q Consensus 6 l~Hpniv~~~~~~~~---------------------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i 58 (295)
-+|||||++.++|.+ +..+|+||.-++. +|..++..+. .+.-...-+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~ 346 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVI 346 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHH
Confidence 389999999988853 2357999999966 9999997654 667777889
Q ss_pred HHHHHHHHHHHHhCCCCCeEeccCCCCeEEEC--CCC--ceEEeeccCccccccCc-----ceeeeccccccCCCChhhh
Q 045989 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLD--DKY--RAKISDFGTSRSMAVDR-----THLTTQVKGTFGYLDPEYF 129 (295)
Q Consensus 59 ~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~--~~~--~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~ 129 (295)
+.|+++|+.|||++| |.|||+|.+|||+. +++ .+.|+|||.+--..... ........|....||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999999 99999999999994 333 57899999764322211 1111223467789999998
Q ss_pred ccCC------CCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHH
Q 045989 130 QSSQ------FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAM 203 (295)
Q Consensus 130 ~~~~------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (295)
...+ --.|+|.|+.|.+.||+++...||-. ..+-..+... .........+..++..+.+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~--------------Yqe~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRT--------------YQESQLPALPSRVPPVARQ 488 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhh--------------hhhhhCCCCcccCChHHHH
Confidence 6432 13589999999999999999999853 1111111111 1122334455566677999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHH
Q 045989 204 VAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 204 li~~cl~~~p~~Rps~~e~~~~l 226 (295)
++..+|+.||.+|++..-....+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999876554443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=159.83 Aligned_cols=201 Identities=22% Similarity=0.351 Sum_probs=152.6
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|+-..||||+.+++.|....++.++..||+-|+|+.+++.... .-..-.++.+++.+++.|++|||+..++ |.---+
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~-ipr~~l 317 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYL 317 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhc
Confidence 4556899999999999999999999999999999999986542 3467788999999999999999998754 555568
Q ss_pred CCCeEEECCCCceEEe--eccCccccccCcceeeeccccccCCCChhhhccCCC---CCCccchhhHHHHHHHHhCCCCC
Q 045989 83 KSANILLDDKYRAKIS--DFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF---TEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 83 kp~Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~p~ 157 (295)
....++|+++...+|. |-.++. ......-.+.||+||.+...+- -.++|+|||++++||+.|...||
T Consensus 318 ns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 318 NSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred ccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 8999999998877664 322221 1122234788999999976543 35799999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.....-+-. .++.-.+.....++..+..+.+++.-|+..||.+||.+..++-.|+++
T Consensus 390 adlspmecg---------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 390 ADLSPMECG---------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCchhhh---------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 744322100 011111222334445556688899999999999999999999888765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-20 Score=161.94 Aligned_cols=215 Identities=30% Similarity=0.395 Sum_probs=158.1
Q ss_pred ccCCCCc-cccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQINHR-NVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~Hp-niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++.+.|+ +|+++.+.+......+++++++.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd 126 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRD 126 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 5677777 7999999998777789999999999999777654321 24889999999999999999999999 99999
Q ss_pred CCCCeEEECCCC-ceEEeeccCccccccCcce-----eeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHh
Q 045989 82 IKSANILLDDKY-RAKISDFGTSRSMAVDRTH-----LTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 82 ikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~ 152 (295)
+||+||+++..+ .++++|||.++........ ......|+..|+|||.+.+ ..++...|+|++|++++++++
T Consensus 127 ~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred CCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999988 7999999998755433221 2355679999999999987 578899999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
|..||...... ................ .................+.+++..++..+|..|.+..+....
T Consensus 207 ~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 207 GLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 99996544321 0001111111111000 000000000001223457889999999999999999887776
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=172.97 Aligned_cols=178 Identities=26% Similarity=0.405 Sum_probs=130.9
Q ss_pred CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 22 EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 22 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
..+||.|++|.-.+|.+++.+.... ...++.....++.|++.|++| ++ .+|+|+||.||+...+..+||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 3589999999999999999754322 246788899999999999999 77 9999999999999999999999999
Q ss_pred CccccccCc-----ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHH
Q 045989 102 TSRSMAVDR-----THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQV 175 (295)
Q Consensus 102 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 175 (295)
+........ ....+...||..||+||++.+..|+.++||||||++++|++. -..++. ....+..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~d- 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLTD- 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhhh-
Confidence 987665433 233455679999999999999999999999999999999997 222221 0001111
Q ss_pred HhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 176 INENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
+..+.+ ++ ....+++ .=+.++.+++.+.|.+||++.++.-+
T Consensus 472 ~r~g~i----p~----~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 472 IRDGII----PP----EFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred hhcCCC----Ch----HHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhh
Confidence 111111 11 1111111 13568999999999999966655443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-22 Score=184.83 Aligned_cols=198 Identities=21% Similarity=0.306 Sum_probs=146.4
Q ss_pred cCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 045989 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIK 83 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dik 83 (295)
+.++|||.+++.-+...++..|||=+|..+ +|++.+..++ .+..-....|+.|++.||..+|+.| |+|||||
T Consensus 76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIK 147 (1431)
T KOG1240|consen 76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIK 147 (1431)
T ss_pred HhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccc
Confidence 346899999998888888888999999955 9999998766 4777788889999999999999999 9999999
Q ss_pred CCeEEECCCCceEEeeccCccccc--cCcce----eeeccccccCCCChhhhccC----------C-CCCCccchhhHHH
Q 045989 84 SANILLDDKYRAKISDFGTSRSMA--VDRTH----LTTQVKGTFGYLDPEYFQSS----------Q-FTEKSDVYSFGVV 146 (295)
Q Consensus 84 p~Nill~~~~~~kl~Dfg~a~~~~--~~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~~ 146 (295)
.+||||+.=+=+.|+||..-+..- .+... ...+......|+|||-+... . .+++-||||+||+
T Consensus 148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV 227 (1431)
T KOG1240|consen 148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV 227 (1431)
T ss_pred cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence 999999998889999998765432 22211 12223345679999987431 2 6778999999999
Q ss_pred HHHHHh-CCCCCcccchhhcccHHHHHHH-HHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 147 LVELLT-GQKPIRLVETEENRSLAAYFLQ-VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 147 l~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
+.||++ |++||.... +.++-.. ......+.+.+. ...++.++..|++.||.+|.++++.++
T Consensus 228 iaELf~Eg~PlF~LSQ------L~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 228 IAELFLEGRPLFTLSQ------LLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred HHHHHhcCCCcccHHH------HHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHH
Confidence 999988 788885321 1111000 000111111111 113788999999999999999999988
Q ss_pred HH
Q 045989 225 EL 226 (295)
Q Consensus 225 ~l 226 (295)
.-
T Consensus 291 ~y 292 (1431)
T KOG1240|consen 291 KY 292 (1431)
T ss_pred hh
Confidence 74
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=155.23 Aligned_cols=164 Identities=21% Similarity=0.356 Sum_probs=110.3
Q ss_pred cEEEEeecCCCCHHHHHhh---hCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeec
Q 045989 24 PLLVYEFIPNGSLHQYIHE---QTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDF 100 (295)
Q Consensus 24 ~~iv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Df 100 (295)
.+++|+-+ -+||.+++.. .......+....+..+..|+++.+++||..| ++|+||+|+|++++.+|.++|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 36788888 4599888652 2222223555666777899999999999999 999999999999999999999999
Q ss_pred cCccccccCcceeeeccccccCCCChhhhccC--------CCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHH
Q 045989 101 GTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS--------QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172 (295)
Q Consensus 101 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 172 (295)
+.....+.. ......+..|.+||..... .++.+.|.|+||+++|.|+++..||.....+.....
T Consensus 190 ~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 190 SSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 877644321 1113456789999987542 478899999999999999999999975533321111
Q ss_pred HHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
...... +.+..+..||..+|+.||.+|
T Consensus 262 ----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 122333 667779999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-21 Score=168.34 Aligned_cols=182 Identities=25% Similarity=0.293 Sum_probs=148.9
Q ss_pred ccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+...+ ||.+|+++-.++.+..+++++++..||+|...+.... .+.+.....+...++-+++++|+.+ +++||
T Consensus 50 l~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~---iiyrd 122 (612)
T KOG0603|consen 50 LAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG---IAYRD 122 (612)
T ss_pred HhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH---HHHhc
Confidence 44454 9999999999999999999999999999998887654 3777777788899999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
+|++||+++.+|.+++.|||+++........ +||..|||||++. ....+.|.||+|+++++|++|..||..
T Consensus 123 ~k~enilld~~Ghi~~tdfglske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred ccccceeecccCccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--
Confidence 9999999999999999999999865443322 6899999999998 567889999999999999999999863
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
..+..+.. .....+...+....+++..++..+|.+|.-.
T Consensus 194 --------~~~~~Il~-----------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 --------DTMKRILK-----------AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --------HHHHHHhh-----------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11111111 1123455556667889999999999999654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-18 Score=142.37 Aligned_cols=214 Identities=16% Similarity=0.227 Sum_probs=164.7
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
.-+.|..++-|..++.+=.+|+|.+ |.+|++++.-... .|+..+...++.|++.-++|+|++. +|.|||||+|
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdN 154 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDN 154 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 3478888888888888888999999 9999999876554 3999999999999999999999999 9999999999
Q ss_pred EEECC-----CCceEEeeccCccccccCccee------eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 87 ILLDD-----KYRAKISDFGTSRSMAVDRTHL------TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 87 ill~~-----~~~~kl~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
+||.. ...+.++|||+|+.+....+.. .....||..||+-....+.+-+.+.|+-|||-++.+.+-|..
T Consensus 155 FLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL 234 (449)
T KOG1165|consen 155 FLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 234 (449)
T ss_pred eeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence 99963 3468999999999886554332 234569999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhcc
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA 235 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~~ 235 (295)
||..........- +.++-+..+. ......-...|.++...++-.-..+-.+-|..+-+...+..+.+..+.
T Consensus 235 PWQGLKA~tnK~k---YeKIGe~Kr~------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 235 PWQGLKADTNKEK---YEKIGETKRS------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ccccccCcchHHH---HHHhcccccc------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 9986554332211 1111111111 111122233455677777777788889999999888888777776664
Q ss_pred c
Q 045989 236 S 236 (295)
Q Consensus 236 ~ 236 (295)
.
T Consensus 306 t 306 (449)
T KOG1165|consen 306 T 306 (449)
T ss_pred c
Confidence 4
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-19 Score=152.84 Aligned_cols=113 Identities=22% Similarity=0.189 Sum_probs=87.1
Q ss_pred cccCCCCccccc-eeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVK-LLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~-~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++|+||++ +++ .+..++||||++|++|... . . .. ...++.|+++||.|||+.+ |+||
T Consensus 74 iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~--~-----~~---~~~~~~~i~~aL~~lH~~g---IiHr 135 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R--P-----HG---DPAWFRSAHRALRDLHRAG---ITHN 135 (365)
T ss_pred HHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C--c-----cc---hHHHHHHHHHHHHHHHHCC---CeeC
Confidence 578899999985 443 2467999999999999632 1 1 11 1457889999999999999 9999
Q ss_pred cC-CCCeEEECCCCceEEeeccCccccccCccee-------eeccccccCCCChhhhccC
Q 045989 81 DI-KSANILLDDKYRAKISDFGTSRSMAVDRTHL-------TTQVKGTFGYLDPEYFQSS 132 (295)
Q Consensus 81 di-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 132 (295)
|| ||+|||++.++.++|+|||+++.+....... ..+..+++.|.|||.+...
T Consensus 136 DL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 136 DLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99 9999999999999999999998664322110 1345678889999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=136.49 Aligned_cols=211 Identities=19% Similarity=0.235 Sum_probs=156.9
Q ss_pred ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEE
Q 045989 9 RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANIL 88 (295)
Q Consensus 9 pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nil 88 (295)
..|..+..+..+..+-.+||+.+ |.+|.+++.-... .++..+.+-++-|++.-++|+|.++ ++||||||+|+|
T Consensus 71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFL 143 (341)
T KOG1163|consen 71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFL 143 (341)
T ss_pred CCCchhhhhccccccceeeeecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCcccee
Confidence 45566667777888889999999 9999999875433 3889999999999999999999999 999999999999
Q ss_pred ECC---CCceEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 89 LDD---KYRAKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 89 l~~---~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
..- ...+.++|||+++.+....+. ......||..|.+--...+...+.+.|+-|+|.++.++--|..||..
T Consensus 144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 963 357899999999877543322 12335699999998888888889999999999999999999999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhcc
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA 235 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~~ 235 (295)
........-.+ .+.+... .......-...|.++...+.-|-..--++-|...-+.+.+.-+...+..
T Consensus 224 lka~tk~QKyE----kI~EkK~-----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 224 LKAATKKQKYE----KISEKKM-----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred cchhhHHHHHH----HHHHhhc-----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 54322111111 1111100 0011122233455688899999999999999998888777766665543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.5e-18 Score=134.10 Aligned_cols=139 Identities=16% Similarity=0.120 Sum_probs=104.6
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++|+ |++|++++++ ...+++|||+.|.+|...+.. . ...++.|++.+|+++|+.| |+||
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~G---IvHr 115 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCG---VAHN 115 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCc---CccC
Confidence 577884 4889999886 346999999999998654321 0 1346789999999999999 9999
Q ss_pred cC-CCCeEEECCCCceEEeeccCccccccCcce----e--------eeccccccCCCChhhhccC-CCC-CCccchhhHH
Q 045989 81 DI-KSANILLDDKYRAKISDFGTSRSMAVDRTH----L--------TTQVKGTFGYLDPEYFQSS-QFT-EKSDVYSFGV 145 (295)
Q Consensus 81 di-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~ 145 (295)
|| ||+||+++.++.++|+|||++......... . ......++.|++|+...-- ..+ ...+.++.|+
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 99 799999999999999999999854432210 0 0112357888888865432 233 4567889999
Q ss_pred HHHHHHhCCCCCc
Q 045989 146 VLVELLTGQKPIR 158 (295)
Q Consensus 146 ~l~el~~g~~p~~ 158 (295)
-+|.++|++.+..
T Consensus 196 ~~~~~~~~~~~~~ 208 (218)
T PRK12274 196 PVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHhccCCcc
Confidence 9999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-18 Score=157.76 Aligned_cols=138 Identities=28% Similarity=0.374 Sum_probs=107.0
Q ss_pred HHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc--------------eeeeccccccCCCChhh
Q 045989 63 SGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--------------HLTTQVKGTFGYLDPEY 128 (295)
Q Consensus 63 ~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~gt~~y~aPE~ 128 (295)
+.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+.+....... ...++.+||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 77999999999 99999999999999999999999998875432111 11234579999999999
Q ss_pred hccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHh
Q 045989 129 FQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRC 208 (295)
Q Consensus 129 ~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 208 (295)
+....|+...|.|++|+|+|+.+.|..||.... .++.+..++.....+. +.....+.+..+++.++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdt------peelfg~visd~i~wp--------E~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------PEELFGQVISDDIEWP--------EEDEALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCC------HHHHHhhhhhhhcccc--------ccCcCCCHHHHHHHHHH
Confidence 999999999999999999999999999997443 3334444444332211 11222334588899999
Q ss_pred hccCCCCCC
Q 045989 209 LNLNGKKRP 217 (295)
Q Consensus 209 l~~~p~~Rp 217 (295)
|+.+|.+|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999993
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-18 Score=137.43 Aligned_cols=120 Identities=14% Similarity=0.243 Sum_probs=92.2
Q ss_pred ccCCCCccccceeeEEEeC--------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 3 LSQINHRNVVKLLGCCLET--------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~--------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+.+++||+|..+.+++... +..++||||++|.+|.++.. +++ ..+.+++.+|..+|+.|
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g- 155 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG- 155 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-
Confidence 5678999999999987643 35789999999999988732 333 24569999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
++|||+||+||+++.++ ++|+|||........... ..++....|..++|+|+||+.+..+.
T Consensus 156 --i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 156 --MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999999999988 999999987643211110 01333445678999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.5e-16 Score=125.31 Aligned_cols=94 Identities=18% Similarity=0.192 Sum_probs=71.0
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecc
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYL-HSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-h~~~~~~i~H~d 81 (295)
|.++.++++.....+ ... ..+|||||++|+++........ .++...+..++.|++.+|.|+ |+.+ |+|||
T Consensus 73 l~~l~~~~v~~p~~~-~~~-~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrD 143 (190)
T cd05147 73 LKRLVTAGIPCPEPI-LLK-SHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDCR---LVHAD 143 (190)
T ss_pred HHHHHHCCCCCCcEE-Eec-CCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 445556665433322 222 2389999998877765432211 488899999999999999999 6888 99999
Q ss_pred CCCCeEEECCCCceEEeeccCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSM 106 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~ 106 (295)
|||+||+++ ++.++|+|||++...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=153.96 Aligned_cols=205 Identities=24% Similarity=0.306 Sum_probs=155.8
Q ss_pred CccccceeeEEEeCCccEEEEeecCCCCHHHHHh-hhCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCC
Q 045989 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH-EQTEDQLPITWEIRLGIAVEVSGALSYLH-SAASIPIYHRDIKSA 85 (295)
Q Consensus 8 Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh-~~~~~~i~H~dikp~ 85 (295)
|+|++.+++.....+..+++++|.+|+++...+. .... ..+......++.|+..++.|+| ..+ +.|+||||+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~ 153 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPS 153 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCcccc---cccCCCCCc
Confidence 9999999999999999999999999999998883 2211 2555666778999999999999 888 999999999
Q ss_pred eEEECCCC-ceEEeeccCcccccc--Ccceeeecccc-ccCCCChhhhccCC-CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 86 NILLDDKY-RAKISDFGTSRSMAV--DRTHLTTQVKG-TFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 86 Nill~~~~-~~kl~Dfg~a~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|.+++.++ .++++|||+|..+.. ..........| ++.|+|||...+.. ..+..|+||.|+++.-+++|..||...
T Consensus 154 n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 154 NSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 99999999 999999999987655 33334455568 99999999998854 467899999999999999999999765
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
...+.. ...|... ... ..............+++.+++..+|..|.+.+++-..-+...
T Consensus 234 ~~~~~~-~~~~~~~---~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGR-YSSWKSN---KGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccc-ceeeccc---ccc--------cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 444311 1111100 000 001111222334677899999999999999999877655443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.1e-16 Score=125.37 Aligned_cols=87 Identities=15% Similarity=0.202 Sum_probs=69.7
Q ss_pred CCccccceeeEEEeCC---ccE-EEEee--cCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEe
Q 045989 7 NHRNVVKLLGCCLETE---VPL-LVYEF--IPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGAL-SYLHSAASIPIYH 79 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~---~~~-iv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l-~~Lh~~~~~~i~H 79 (295)
.||||++++|+++++. ..+ +|+|| +.+|+|.+++.+.. +++. ..++.|++.++ +|||+++ |+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~---Ivh 128 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR---IVT 128 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC---Eee
Confidence 6899999999999874 333 78999 55799999996532 5555 35678888887 9999999 999
Q ss_pred ccCCCCeEEECC----CCceEEeeccCc
Q 045989 80 RDIKSANILLDD----KYRAKISDFGTS 103 (295)
Q Consensus 80 ~dikp~Nill~~----~~~~kl~Dfg~a 103 (295)
|||||+||+++. +..++|+||+.+
T Consensus 129 rDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 129 MELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999999974 347999995433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.9e-16 Score=122.23 Aligned_cols=94 Identities=21% Similarity=0.231 Sum_probs=72.8
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHH-HhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY-IHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
+.++.|++|.....+... ..++||||++|+++... +... .++......++.|++.++.++|+ .| |+||
T Consensus 73 l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHr 142 (190)
T cd05145 73 LKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEAG---LVHG 142 (190)
T ss_pred HHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 445667776444443332 24899999988755433 3321 36788899999999999999999 88 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMA 107 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~ 107 (295)
||||+||+++ ++.++|+|||++....
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999999 7899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.9e-15 Score=140.52 Aligned_cols=139 Identities=22% Similarity=0.255 Sum_probs=117.6
Q ss_pred cccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEE
Q 045989 10 NVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL 89 (295)
Q Consensus 10 niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill 89 (295)
-|..+..++.-.+..++|+||.+.|+|.+++.... ..++...+.+.+|++..++.||..+ |||+||||+|.||
T Consensus 755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll 827 (974)
T KOG1166|consen 755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLL 827 (974)
T ss_pred chHHHHHHHccCCcceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEe
Confidence 34555555566777899999999999999998433 4889999999999999999999999 9999999999999
Q ss_pred C-------CCCceEEeeccCccccccC-cceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 90 D-------DKYRAKISDFGTSRSMAVD-RTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 90 ~-------~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
. ....++|+|||.+..+..- ........++|-.+-.+|...|..++.++|-|.|+.+++-|+.|+.
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3 3446899999999876532 2334566778999999999999999999999999999999999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-16 Score=130.69 Aligned_cols=202 Identities=21% Similarity=0.305 Sum_probs=142.5
Q ss_pred cCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 4 SQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
.++.|-|||+.+.++.+.+ ...++.||+..|+|..+|++.......+......+|+.||+.||.|||+.. ++|+
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppii 200 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPII 200 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cccc
Confidence 3567999999999987644 468899999999999999987766667888888999999999999999987 4599
Q ss_pred eccCCCCeEEECCCCceEEeeccCcccccc----CcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCC
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAV----DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+++.-+.|++..++-+|++--. ...... ..........+-++|.+||.-.....+.++|||+||....+|..+.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999999885321 111110 0111111234678899999876667788999999999999998876
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.--...... ......... ....+.... -..++.+|++.+|..||++++++.|+
T Consensus 280 iq~tnseS~--~~~ee~ia~------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 280 IQSTNSESK--VEVEENIAN------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eccCCCcce--eehhhhhhh------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 431111000 000000000 000000111 13378899999999999999998875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.4e-14 Score=114.14 Aligned_cols=91 Identities=24% Similarity=0.356 Sum_probs=79.1
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
+..+.|++|+....++......++||||++|++|.+++.... . .+..++.+++.+|.++|+.+ ++|+|+
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl 121 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAG---IIHGDL 121 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 456778888888888777788999999999999999986421 2 77889999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccc
Q 045989 83 KSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
+|.||+++ ++.++|+|||.+..
T Consensus 122 ~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 122 TTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccEEEE-CCCEEEEECCcccC
Confidence 99999999 78899999998753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.3e-14 Score=129.10 Aligned_cols=88 Identities=23% Similarity=0.338 Sum_probs=77.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|++|+....++......++||||++|++|.+++. ....++.+++.+|.+||+.+ ++|||
T Consensus 389 ~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrD 453 (535)
T PRK09605 389 LLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGD 453 (535)
T ss_pred HHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCC
Confidence 4678899999988888877778899999999999999885 23568899999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
|||+||++ .++.++|+|||+++.
T Consensus 454 lkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 454 LTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CChHHEEE-ECCcEEEEeCccccc
Confidence 99999999 677999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=111.11 Aligned_cols=88 Identities=24% Similarity=0.357 Sum_probs=73.5
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
+..+.|+++.....++......++||||++|++|.+++.... . .++.+++.+|.+||+.+ ++|+|+
T Consensus 51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g---i~H~Dl 116 (199)
T TIGR03724 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG---IVHGDL 116 (199)
T ss_pred HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC---eecCCC
Confidence 456777776666666666777899999999999998875421 1 68899999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccc
Q 045989 83 KSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
+|.||+++ ++.+++.|||++..
T Consensus 117 ~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 117 TTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CcceEEEE-CCcEEEEECCCCcC
Confidence 99999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-13 Score=113.16 Aligned_cols=92 Identities=22% Similarity=0.337 Sum_probs=72.2
Q ss_pred cccCCCCccc--cceeeEEEeCCc----cEEEEeecCC-CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNV--VKLLGCCLETEV----PLLVYEFIPN-GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpni--v~~~~~~~~~~~----~~iv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
++.+|+|++| ++.+++...... .++|||+++| .+|.+++... .++.. .+.+++.+|.+||+.|
T Consensus 93 ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G- 162 (239)
T PRK01723 93 LLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG- 162 (239)
T ss_pred HHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC-
Confidence 3556777774 677777554322 3599999997 6999888642 24443 3568999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
|+|+||||.|||++.++.++|+|||.+..
T Consensus 163 --I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 163 --VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred --CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999988999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-12 Score=117.95 Aligned_cols=137 Identities=19% Similarity=0.244 Sum_probs=104.9
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|+.++||||++|++.++..+.+|||+|-+. .|..++... ........+.||+.||.|||..+. ++|++|
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv 131 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKEEVCLGLFQILAALSFLNDDCN--LVHGNV 131 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHHHHHHHHHHHHHHHHHHhccCC--eeeccE
Confidence 678999999999999999999999999984 677777653 345566688999999999987653 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 153 (295)
.-+.|+|+..|..||++|.++........ ......---.|..|+.+.... -..|.|-|||++++++.|
T Consensus 132 ~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 132 CKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999987753321111 111111222356666543322 346999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.8e-13 Score=110.13 Aligned_cols=77 Identities=21% Similarity=0.221 Sum_probs=63.2
Q ss_pred ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccC
Q 045989 23 VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGT 102 (295)
Q Consensus 23 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 102 (295)
..++||||++|++|........ .+.......++.|++.++++||+.+. ++|+||||+||+++ ++.++|+|||.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~ 194 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQ 194 (237)
T ss_pred CceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChh
Confidence 3589999999888766542221 35566678899999999999999874 99999999999999 78999999998
Q ss_pred cccc
Q 045989 103 SRSM 106 (295)
Q Consensus 103 a~~~ 106 (295)
+...
T Consensus 195 a~~~ 198 (237)
T smart00090 195 SVEL 198 (237)
T ss_pred hhcc
Confidence 8643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.9e-13 Score=105.95 Aligned_cols=73 Identities=23% Similarity=0.191 Sum_probs=61.6
Q ss_pred CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 22 EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 22 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
...++||||++|++|...... .....++.+++.++.++|+.+ ++|+||||+||+++.++.++|+|||
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECC
Confidence 455899999999998765421 234568899999999999999 9999999999999999999999999
Q ss_pred Cccccc
Q 045989 102 TSRSMA 107 (295)
Q Consensus 102 ~a~~~~ 107 (295)
.+....
T Consensus 171 ~~~~~~ 176 (198)
T cd05144 171 QMVSTD 176 (198)
T ss_pred ccccCC
Confidence 986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-12 Score=115.98 Aligned_cols=195 Identities=21% Similarity=0.259 Sum_probs=143.8
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccC
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSG----ALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~l~~Lh~~~~~~i~H~di 82 (295)
.|+|.++.+..++..+..++-+|+| +.+|.++...... .++...++..+.+... ||..+|..+ ++|-|+
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~ 248 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDL 248 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---cccccc
Confidence 6899999999999999999999999 6788888875543 3788888889999988 999999999 999999
Q ss_pred CCCeEEECCC-CceEEeeccCccccccCcce----eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 83 KSANILLDDK-YRAKISDFGTSRSMAVDRTH----LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 83 kp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
||.||+...+ ...+++|||+...+...... ......|...|++||... ..++...|||++|.++.+...+..+.
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999999 89999999998877654321 122336788999999985 45789999999999999988866543
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...... .|. ...... ...++-.....++...+..+++.+|..|+++..+..+
T Consensus 328 ~~g~~~------~W~--~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 328 SVGKNS------SWS--QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cCCCCC------Ccc--cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 211000 000 000000 0011111122234558889999999999998887654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.26 E-value=1e-11 Score=94.79 Aligned_cols=92 Identities=25% Similarity=0.300 Sum_probs=75.2
Q ss_pred ccCCCC--ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 3 LSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 3 l~~l~H--pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++.++| ++++++++++...+..+++|||+.|+.+..+ +......++.++++++++||.....+++|+
T Consensus 45 ~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~ 113 (155)
T cd05120 45 LQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113 (155)
T ss_pred HHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEec
Confidence 345544 5888999888888889999999988766543 345566788999999999998643349999
Q ss_pred cCCCCeEEECCCCceEEeeccCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
|++|.||++++.+.+++.|||.+..
T Consensus 114 Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 114 DLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCCcceEEEECCcEEEEEecccccC
Confidence 9999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.2e-12 Score=118.97 Aligned_cols=193 Identities=25% Similarity=0.306 Sum_probs=138.8
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
.||-++...-.+......+++++|+.+++|...++... ..+..-....+..+..+++|||... +.|+|++|.|
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~ 934 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDS 934 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccc
Confidence 34555554444555678899999999999999988655 2455555667778889999999987 8999999999
Q ss_pred EEECCCCceEEeeccCccccccC-----------------------cc-------eeeeccccccCCCChhhhccCCCCC
Q 045989 87 ILLDDKYRAKISDFGTSRSMAVD-----------------------RT-------HLTTQVKGTFGYLDPEYFQSSQFTE 136 (295)
Q Consensus 87 ill~~~~~~kl~Dfg~a~~~~~~-----------------------~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ 136 (295)
++...++..+++|||.....+.- .. .......||+.|.+||...+.....
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999843322110 00 0112246899999999999999999
Q ss_pred CccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 137 KSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 137 ~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
.+|.|+.|+++++.++|.+||...... ..+..+.+...- ....+...+....+++...+..+|.+|
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq------~~f~ni~~~~~~--------~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQ------QIFENILNRDIP--------WPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchh------hhhhccccCCCC--------CCCCccccChhhhhhhhhhhccCchhc
Confidence 999999999999999999998633222 122222221111 112223344557789999999999999
Q ss_pred CCHH
Q 045989 217 PTMK 220 (295)
Q Consensus 217 ps~~ 220 (295)
..+.
T Consensus 1081 ~~a~ 1084 (1205)
T KOG0606|consen 1081 LGAK 1084 (1205)
T ss_pred cCcc
Confidence 7766
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.9e-11 Score=108.63 Aligned_cols=192 Identities=19% Similarity=0.228 Sum_probs=138.0
Q ss_pred CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCe
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~N 86 (295)
.|.++++++..+......|+=-|||+++++...+.-.. .+.+..++.+..|++.++.++|+.. ++|+|+||+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~----~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psn 396 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ----MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSN 396 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHHHH----hcCcchhhhhHHHHHhccccccchh---hhcccccccc
Confidence 67889999999998888899999999998877663222 3778888999999999999999988 9999999999
Q ss_pred EEECCC-CceEEeeccCccccccCcceeeeccccccCCC--ChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchh
Q 045989 87 ILLDDK-YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYL--DPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163 (295)
Q Consensus 87 ill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 163 (295)
|++..+ +..+++|||....+.... ....++.++. ++.......+..+.|+++||.-+.+..++..--.....
T Consensus 397 i~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~- 471 (524)
T KOG0601|consen 397 ILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ- 471 (524)
T ss_pred eeeccchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-
Confidence 999886 788999999876432211 1112233333 55566667788999999999999999987653211100
Q ss_pred hcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 164 ENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
+ ..+..+.....+ .....+..+.+.++..++..||.+.++..+.+..
T Consensus 472 -------~-----------~~i~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 -------S-----------LTIRSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------c-----------eeeecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 000011111111 1114577788999999999999999987776544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-10 Score=92.25 Aligned_cols=74 Identities=22% Similarity=0.268 Sum_probs=58.3
Q ss_pred ccEEEEeecCCCCHHH-HHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCeEEECCCCceEEeec
Q 045989 23 VPLLVYEFIPNGSLHQ-YIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHRDIKSANILLDDKYRAKISDF 100 (295)
Q Consensus 23 ~~~iv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~dikp~Nill~~~~~~kl~Df 100 (295)
..++||||++|+.+.. .+.... .. ..+..++.+++.++.++|. .+ ++|+||||+||+++ ++.++|+||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEEC
Confidence 4589999999854321 111111 11 5677899999999999999 88 99999999999999 889999999
Q ss_pred cCcccc
Q 045989 101 GTSRSM 106 (295)
Q Consensus 101 g~a~~~ 106 (295)
|.+...
T Consensus 159 g~a~~~ 164 (187)
T cd05119 159 PQAVEI 164 (187)
T ss_pred cccccc
Confidence 998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-09 Score=94.30 Aligned_cols=180 Identities=21% Similarity=0.284 Sum_probs=126.8
Q ss_pred ccCCCCccccceeeEEEe----CCccEEEEeecCC-CCHHHHHhhhCCC-----------CCCCCHHHHHHHHHHHHHHH
Q 045989 3 LSQINHRNVVKLLGCCLE----TEVPLLVYEFIPN-GSLHQYIHEQTED-----------QLPITWEIRLGIAVEVSGAL 66 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~-g~L~~~l~~~~~~-----------~~~~~~~~~~~i~~qi~~~l 66 (295)
++++.|+|||++.++|.. +..+++|++|+++ ++|.++....... +...++..+|.++.|+..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 578999999999999984 3467999999885 6888776543322 23478899999999999999
Q ss_pred HHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHH
Q 045989 67 SYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVV 146 (295)
Q Consensus 67 ~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~ 146 (295)
.++|+.| +.-+-+.|.+|+++.+.+++|...|+......+.. |.+ .-..+-|.-.||.+
T Consensus 407 ~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------~~l---e~~Qq~D~~~lG~l 465 (655)
T KOG3741|consen 407 YSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------EPL---ESQQQNDLRDLGLL 465 (655)
T ss_pred HHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------cch---hHHhhhhHHHHHHH
Confidence 9999999 88899999999999999999988776543322220 111 11346789999999
Q ss_pred HHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 147 LVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 147 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
++.|.+|..--.. ...... .........++..+++++.-....++++ -++.+++.++
T Consensus 466 l~aLAt~~~ns~~-----~d~~~~-----------------s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 466 LLALATGTENSNR-----TDSTQS-----------------SHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHhhccccccc-----ccchHH-----------------HHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 9999998543100 000000 0011223344555777888888888877 6777777665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4e-09 Score=90.69 Aligned_cols=209 Identities=15% Similarity=0.174 Sum_probs=134.9
Q ss_pred cEEEEeecCCC-CHHHHHhh--hCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeec
Q 045989 24 PLLVYEFIPNG-SLHQYIHE--QTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDF 100 (295)
Q Consensus 24 ~~iv~e~~~~g-~L~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Df 100 (295)
.-++|+.+.|. -+..++.. +........|......+..++.+.+-||+.| .+-+|++++|+||++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 45777777664 23333321 1222334789999999999999999999999 899999999999999999999986
Q ss_pred cCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhC-CCCCcccchhh-c-ccHHHHH
Q 045989 101 GTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTG-QKPIRLVETEE-N-RSLAAYF 172 (295)
Q Consensus 101 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~-~-~~~~~~~ 172 (295)
..-... .........+|...|.+||.-. +..-+...|.|.||+++++++.| +.||....... . ...+.-+
T Consensus 162 Dsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 162 DSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 544332 2233344557899999999754 33456789999999999999885 88987543221 1 1111000
Q ss_pred H--HHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHhHHhhccch
Q 045989 173 L--QVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNL--NGKKRPTMKEVALELAGIRASIGASV 237 (295)
Q Consensus 173 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--~p~~Rps~~e~~~~l~~~~~~~~~~~ 237 (295)
. ......+-.....+..........+..+..+..+|+.. ++.-|||++.-+..|..+++.+.+..
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 0 00000000000000001111122344577788899874 46789999999999988887776543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-10 Score=105.55 Aligned_cols=160 Identities=21% Similarity=0.230 Sum_probs=108.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeee--------ccccccC
Q 045989 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT--------QVKGTFG 122 (295)
Q Consensus 51 ~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~gt~~ 122 (295)
.-+....=+.+++.|+.|+|...+ +||++|.|++|.++.++..||+.|+.+............ .......
T Consensus 97 aTe~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~ 174 (700)
T KOG2137|consen 97 ATEDGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLN 174 (700)
T ss_pred cccHhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcc
Confidence 334444455677799999999764 999999999999999999999999987644332111110 1123567
Q ss_pred CCChhhhccCCCCCCccchhhHHHHHHHHhCCCC-CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHH
Q 045989 123 YLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITV 201 (295)
Q Consensus 123 y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (295)
|.|||++.+...+.++|+||+||++|.+..|..+ +....... ..-+.. ..+...........+.++
T Consensus 175 f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~~---------~~~~~~~~~~s~~~p~el 241 (700)
T KOG2137|consen 175 FLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFSR---------NLLNAGAFGYSNNLPSEL 241 (700)
T ss_pred cccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhhh---------cccccccccccccCcHHH
Confidence 9999999998889999999999999999954443 32221111 000000 011111112234556678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 045989 202 AMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 202 ~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.+=+.+++..++.-||++.++...
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhhcc
Confidence 889999999999999987776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.2e-09 Score=84.13 Aligned_cols=85 Identities=16% Similarity=0.185 Sum_probs=62.4
Q ss_pred cccceeeEEEeCCccEEEEeecCCCCHHH-HHhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCeE
Q 045989 10 NVVKLLGCCLETEVPLLVYEFIPNGSLHQ-YIHEQTEDQLPITWEIRLGIAVEVSGALSYL-HSAASIPIYHRDIKSANI 87 (295)
Q Consensus 10 niv~~~~~~~~~~~~~iv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-h~~~~~~i~H~dikp~Ni 87 (295)
++.+.+++ ..-+|||||+.++.+.. .+... .++......+..+++.+|..| |+.+ ++|+|+++.||
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NI 156 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNM 156 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 45555554 45689999996543321 22221 245556677889999999999 8888 99999999999
Q ss_pred EECCCCceEEeeccCccccc
Q 045989 88 LLDDKYRAKISDFGTSRSMA 107 (295)
Q Consensus 88 ll~~~~~~kl~Dfg~a~~~~ 107 (295)
+++. +.+.|+|||.+....
T Consensus 157 L~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEC-CcEEEEECCCceeCC
Confidence 9974 679999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.6e-09 Score=81.49 Aligned_cols=72 Identities=29% Similarity=0.440 Sum_probs=60.0
Q ss_pred EEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEE
Q 045989 18 CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKI 97 (295)
Q Consensus 18 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl 97 (295)
..+.....|+|||++|..|.+.+... ...++..+-.-+.-||..| |+|+|+.++||++...+ +.+
T Consensus 68 dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~ 132 (204)
T COG3642 68 DVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYF 132 (204)
T ss_pred EEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEE
Confidence 34556677999999998998888754 1346677777888999999 99999999999998875 999
Q ss_pred eeccCcc
Q 045989 98 SDFGTSR 104 (295)
Q Consensus 98 ~Dfg~a~ 104 (295)
+|||++.
T Consensus 133 IDfGLg~ 139 (204)
T COG3642 133 IDFGLGE 139 (204)
T ss_pred EECCccc
Confidence 9999986
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-09 Score=94.96 Aligned_cols=78 Identities=19% Similarity=0.288 Sum_probs=60.4
Q ss_pred CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCCCeEeccCCCCeEEECCCCceEEee
Q 045989 21 TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSG-ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISD 99 (295)
Q Consensus 21 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~-~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~D 99 (295)
....++||||++|++|.++....... .. ...++..++. .+..+|..| ++|+|++|.||+++.++.++++|
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~---~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liD 300 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAG---LD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALD 300 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcC---CC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEe
Confidence 34568999999999998876532211 22 2345555555 478899999 99999999999999999999999
Q ss_pred ccCccccc
Q 045989 100 FGTSRSMA 107 (295)
Q Consensus 100 fg~a~~~~ 107 (295)
||++....
T Consensus 301 fG~~~~l~ 308 (437)
T TIGR01982 301 FGIVGRLS 308 (437)
T ss_pred CCCeeECC
Confidence 99987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-09 Score=83.16 Aligned_cols=79 Identities=25% Similarity=0.236 Sum_probs=57.7
Q ss_pred ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCeEE
Q 045989 11 VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA--SIPIYHRDIKSANIL 88 (295)
Q Consensus 11 iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~--~~~i~H~dikp~Nil 88 (295)
+.+++.+.. ...++||||++|.++... . . ....++.+++++|+.||..+ ...++|+|++|.||+
T Consensus 55 ~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil 120 (170)
T cd05151 55 GPKLYYFDP--ETGVLITEFIEGSELLTE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFL 120 (170)
T ss_pred CCceEEEeC--CCCeEEEEecCCCccccc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEE
Confidence 344554432 345899999999877543 0 1 11235678999999999987 122599999999999
Q ss_pred ECCCCceEEeeccCcc
Q 045989 89 LDDKYRAKISDFGTSR 104 (295)
Q Consensus 89 l~~~~~~kl~Dfg~a~ 104 (295)
++ ++.++++||+.+.
T Consensus 121 ~~-~~~~~liDf~~a~ 135 (170)
T cd05151 121 LD-DGRLWLIDWEYAG 135 (170)
T ss_pred EE-CCeEEEEeccccc
Confidence 99 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.6e-08 Score=83.21 Aligned_cols=88 Identities=18% Similarity=0.253 Sum_probs=68.9
Q ss_pred cceeeEEEe-----CCccEEEEeecCCC-CHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 12 VKLLGCCLE-----TEVPLLVYEFIPNG-SLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 12 v~~~~~~~~-----~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
++.+++... ....++|+|++++. +|.+++...... .........++.+++..+.-||..| |+|+|+++.
T Consensus 93 P~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~--~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~ 167 (268)
T PRK15123 93 MTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN--PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYIC 167 (268)
T ss_pred CCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChh
Confidence 444555543 23468999999875 799988643221 3566777889999999999999999 999999999
Q ss_pred eEEECC-------CCceEEeeccCcc
Q 045989 86 NILLDD-------KYRAKISDFGTSR 104 (295)
Q Consensus 86 Nill~~-------~~~~kl~Dfg~a~ 104 (295)
|||++. +..+.|+||+.+.
T Consensus 168 NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 168 HFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred hEEEeccccCCCCCceEEEEECCccc
Confidence 999975 4678999999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.7e-08 Score=78.00 Aligned_cols=88 Identities=22% Similarity=0.327 Sum_probs=71.8
Q ss_pred ccceeeEEEeCC----ccEEEEeecCCC-CHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 11 VVKLLGCCLETE----VPLLVYEFIPNG-SLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 11 iv~~~~~~~~~~----~~~iv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
+.+.+++.+... ..++|+|++++. +|.+++..... .+......++.+++..++-||..| |+|+|+++.
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~ 147 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPS 147 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcc
Confidence 456666666533 348999999874 79999876432 556677889999999999999999 999999999
Q ss_pred eEEECCCC---ceEEeeccCccc
Q 045989 86 NILLDDKY---RAKISDFGTSRS 105 (295)
Q Consensus 86 Nill~~~~---~~kl~Dfg~a~~ 105 (295)
|||++.+. .+.++||+.++.
T Consensus 148 NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 148 NILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cEEEeCCCCceeEEEEcchhcee
Confidence 99999887 899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-07 Score=73.24 Aligned_cols=83 Identities=27% Similarity=0.344 Sum_probs=63.9
Q ss_pred EEEeCCccEEEEeecCC-CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCC--
Q 045989 17 CCLETEVPLLVYEFIPN-GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY-- 93 (295)
Q Consensus 17 ~~~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~-- 93 (295)
++.+...-.|+|||++| .++.+++...... .........++..|-+.+.-||.++ ++|+||..+||++..++
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence 34455566799999976 4888888765543 1233333678889999999999999 99999999999996554
Q ss_pred -ceEEeeccCcc
Q 045989 94 -RAKISDFGTSR 104 (295)
Q Consensus 94 -~~kl~Dfg~a~ 104 (295)
.+.++|||++.
T Consensus 153 ~~~~lIdfgls~ 164 (229)
T KOG3087|consen 153 ITPILIDFGLSS 164 (229)
T ss_pred CceEEEeecchh
Confidence 45899999975
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-08 Score=92.21 Aligned_cols=77 Identities=17% Similarity=0.159 Sum_probs=53.0
Q ss_pred CCccEEEEeecCCCCHHHHH--hhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCC----c
Q 045989 21 TEVPLLVYEFIPNGSLHQYI--HEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY----R 94 (295)
Q Consensus 21 ~~~~~iv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~----~ 94 (295)
....++||||++|+.+.++- .........+....+..++.|+ ...| ++|+|+||.||+++.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCe
Confidence 34567999999999998753 2211111113333333344444 4577 99999999999999887 9
Q ss_pred eEEeeccCccccc
Q 045989 95 AKISDFGTSRSMA 107 (295)
Q Consensus 95 ~kl~Dfg~a~~~~ 107 (295)
+++.|||+.....
T Consensus 303 i~llDFGivg~l~ 315 (537)
T PRK04750 303 YIALDFGIVGSLN 315 (537)
T ss_pred EEEEecceEEECC
Confidence 9999999887553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.2e-07 Score=73.44 Aligned_cols=91 Identities=22% Similarity=0.301 Sum_probs=67.6
Q ss_pred ccccceeeEEEeC---CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------
Q 045989 9 RNVVKLLGCCLET---EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA------------ 73 (295)
Q Consensus 9 pniv~~~~~~~~~---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~------------ 73 (295)
.++.+++.+.... +..++||||++|.++...+.. ..++......++.+++++|..||+..
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~ 131 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRP 131 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCC
Confidence 3467777776654 266899999999887665431 13666777777888888888887531
Q ss_pred -----------------------------------------CCCeEeccCCCCeEEECC--CCceEEeeccCcc
Q 045989 74 -----------------------------------------SIPIYHRDIKSANILLDD--KYRAKISDFGTSR 104 (295)
Q Consensus 74 -----------------------------------------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~ 104 (295)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 132 GGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 6678999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.8e-07 Score=72.77 Aligned_cols=83 Identities=28% Similarity=0.328 Sum_probs=52.0
Q ss_pred cccceeeEEEeCCccEEEEeecC--CCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeccCCCCe
Q 045989 10 NVVKLLGCCLETEVPLLVYEFIP--NGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSY-LHSAASIPIYHRDIKSAN 86 (295)
Q Consensus 10 niv~~~~~~~~~~~~~iv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~-Lh~~~~~~i~H~dikp~N 86 (295)
++.+.+++- .-+|||||++ |..+..+.... ++......++.+++..+.. +|..| ++|+|+.+.|
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~N 137 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYN 137 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTS
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhh
Confidence 455555442 3479999998 65554443322 1123345567778775555 57888 9999999999
Q ss_pred EEECCCCceEEeeccCcccc
Q 045989 87 ILLDDKYRAKISDFGTSRSM 106 (295)
Q Consensus 87 ill~~~~~~kl~Dfg~a~~~ 106 (295)
|+++.+ .+.|+|||.+...
T Consensus 138 Ilv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 138 ILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EEEETT-CEEE--GTTEEET
T ss_pred EEeecc-eEEEEecCcceec
Confidence 999988 9999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.40 E-value=1e-06 Score=69.81 Aligned_cols=98 Identities=27% Similarity=0.353 Sum_probs=75.3
Q ss_pred cccCCCC-ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~H-pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|..+++ +++++++|+|-. ++|.||...+++..... ....-...+|..+.+|+.++++.+++|+....-.+.-.
T Consensus 12 ll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc 86 (188)
T PF12260_consen 12 LLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC 86 (188)
T ss_pred HHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 4566666 699999999943 57899997766543200 00011136899999999999999999998543348999
Q ss_pred cCCCCeEEECCCCceEEeeccCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
|++|+|+-+++++++|+.|...+.
T Consensus 87 Dv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 87 DVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred ecchHHeEEeCCCcEEEEechhcc
Confidence 999999999999999999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-07 Score=85.67 Aligned_cols=143 Identities=22% Similarity=0.229 Sum_probs=106.0
Q ss_pred cccCCCCcc-ccceeeEEEeCCccEEEEeecCCC-CHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRN-VVKLLGCCLETEVPLLVYEFIPNG-SLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpn-iv~~~~~~~~~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|.+++||| .+.+++.++-+...+++++++.++ +........ ...+...+...++..-.++++++|+.- -+|
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~ 359 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHSSY---KVH 359 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh---hHhhhhhhhhhhhhhhccccccccccc---ccC
Confidence 477899999 888888888888999999999877 222111111 112444455566677778899999875 578
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+| ||+.++ +..+.+||+....+.... ......+++.|+|||+.....+....|.|++|+-..++.-|.+|-
T Consensus 360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 360 RD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 88 666655 688999999876543322 344567899999999999999999999999998777777776664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-06 Score=69.52 Aligned_cols=66 Identities=26% Similarity=0.379 Sum_probs=51.6
Q ss_pred ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccC
Q 045989 23 VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGT 102 (295)
Q Consensus 23 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~ 102 (295)
..++||||++|..|.++.. +.+ .+...+.+++.-||+.| ++|+|.+|.|++++++ .+++.||+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~ 180 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQG 180 (229)
T ss_pred EEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcc
Confidence 4468999999987766532 222 24456778899999999 9999999999999965 499999986
Q ss_pred cc
Q 045989 103 SR 104 (295)
Q Consensus 103 a~ 104 (295)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.7e-06 Score=78.92 Aligned_cols=189 Identities=19% Similarity=0.216 Sum_probs=129.0
Q ss_pred ccCCCCccccceeeEEEeCCc----cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 3 LSQINHRNVVKLLGCCLETEV----PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~----~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+.+..|+|++.++.+-.+... ..+..++|..-++...+.... .++..+.+.+..++.+|++|+|+.. ..
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~~~---l~ 308 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHSLS---LE 308 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHHhc---cc
Confidence 457799999999999876543 345668888888888887654 4888999999999999999999986 66
Q ss_pred eccCCCC---eEEECCCCceEEe--eccCccccccCcceeeeccccccCCCChhhhccCCCCC--CccchhhHHHHHHHH
Q 045989 79 HRDIKSA---NILLDDKYRAKIS--DFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTE--KSDVYSFGVVLVELL 151 (295)
Q Consensus 79 H~dikp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~~l~el~ 151 (295)
|.-+... +--++..+...++ ||+............ ....+..+.+||......+.. ..|+|.+|.....+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 6555444 3334555566666 888776554332211 122355677888776665544 479999999999998
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
.|..+-..... ....++. .......+...+|+..++++|+++.+++.+.
T Consensus 387 ~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 387 QGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 87654211000 0000000 0001366688899999999999999998875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.2e-05 Score=64.25 Aligned_cols=77 Identities=23% Similarity=0.241 Sum_probs=63.3
Q ss_pred ccEEEEeecCC-CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCc--eEEee
Q 045989 23 VPLLVYEFIPN-GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYR--AKISD 99 (295)
Q Consensus 23 ~~~iv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~--~kl~D 99 (295)
..+||+|-++| -+|.+++...... ..+......++.+|+..++-||..| +.|+|+.+.||+++.++. ++++|
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 35799998753 5888888654322 3577778899999999999999999 999999999999986666 99999
Q ss_pred ccCcc
Q 045989 100 FGTSR 104 (295)
Q Consensus 100 fg~a~ 104 (295)
|.-++
T Consensus 174 lEk~r 178 (216)
T PRK09902 174 LEKSR 178 (216)
T ss_pred hhccc
Confidence 98665
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.7e-07 Score=90.64 Aligned_cols=154 Identities=12% Similarity=-0.020 Sum_probs=113.0
Q ss_pred cCCCCccccceeeEEE--eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEe
Q 045989 4 SQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA--SIPIYH 79 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~--~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~--~~~i~H 79 (295)
+..+|+++.....-.. +....+++++|+.+|.+.+.+....++..++...-......+...+..-+|... ....+|
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence 3467888877666554 345678999999999999999877666555544433323333244444444332 234799
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+++|+.|.+|..+.+++++++|+.+... +.....+...+++.|++|++...-.++.++|+|..|+.+|....|..+|.
T Consensus 1364 ~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999999998322 22333445567889999999988899999999999999999988887763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=3.8e-05 Score=63.14 Aligned_cols=70 Identities=19% Similarity=0.178 Sum_probs=51.3
Q ss_pred CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 22 EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 22 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
+.-.+|||+++|-.|...- +.......++..|++-+.-+-+.| +||+|+.+-||+++++|.+.++||-
T Consensus 180 nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCc
Confidence 4457999999886654432 122333445556666666666778 9999999999999999999999995
Q ss_pred Cc
Q 045989 102 TS 103 (295)
Q Consensus 102 ~a 103 (295)
-+
T Consensus 248 Q~ 249 (304)
T COG0478 248 QA 249 (304)
T ss_pred cc
Confidence 44
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00091 Score=54.75 Aligned_cols=28 Identities=21% Similarity=0.266 Sum_probs=24.9
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 379999999999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0002 Score=64.05 Aligned_cols=156 Identities=22% Similarity=0.292 Sum_probs=85.7
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+++.++|+|+..++++-.. ..+..+|+|++ +.+|.+.+..+.... . ++ + .++ +.|-
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~--~----------s~---~----~~~---~~~~ 91 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD--E----------SL---L----AHG---VLHL 91 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch--h----------hh---c----ccc---ccee
Confidence 4678899999999998764 34578999999 679999987654211 0 00 0 112 3231
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
| ..+.+| .++.. | |- ...+|+|||++|.++.++.-|...+...
T Consensus 92 -----~-------~~~~td-~~~t~-----------------~--~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLTK-----------------Y--PS-----PIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred -----h-------hhhccc-ccccc-----------------C--CC-----CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 1 223333 00000 0 00 1114999999999999999887655322
Q ss_pred chhhcccHHHHHHHHHh-hchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 161 ETEENRSLAAYFLQVIN-ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
...+ ....+..... ....... .............+.++...|+-..|..||...++.
T Consensus 135 ~~s~---~l~~i~k~~~~d~~~~~~---a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 135 TESE---YLEILLKYYTDDQELLST---AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHH---HHHHHHHhccCchhHHHH---HHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 1111 0000111000 0000000 011133445566788999999999998888655443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0011 Score=54.80 Aligned_cols=29 Identities=24% Similarity=0.265 Sum_probs=25.7
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.||+++++....|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899998663
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00092 Score=54.56 Aligned_cols=75 Identities=24% Similarity=0.329 Sum_probs=53.2
Q ss_pred EEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCeEEECCCCceEEeeccCc
Q 045989 25 LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHRDIKSANILLDDKYRAKISDFGTS 103 (295)
Q Consensus 25 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 103 (295)
.+||||+.. .- ...-.-+...+.......+..++++.+.-|-. .+ +||+||..-|||+. ++.+.|+|++-|
T Consensus 142 VLvMEfIg~-~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~Qa 213 (268)
T COG1718 142 VLVMEFIGD-DG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQA 213 (268)
T ss_pred eEEEEeccC-CC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccc
Confidence 699999843 21 11111111123333566778888898888888 66 99999999999999 789999999977
Q ss_pred cccc
Q 045989 104 RSMA 107 (295)
Q Consensus 104 ~~~~ 107 (295)
....
T Consensus 214 V~~~ 217 (268)
T COG1718 214 VTID 217 (268)
T ss_pred cccC
Confidence 6443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0013 Score=60.12 Aligned_cols=79 Identities=22% Similarity=0.262 Sum_probs=55.6
Q ss_pred CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeec
Q 045989 21 TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDF 100 (295)
Q Consensus 21 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Df 100 (295)
.+...++|||++|-.+.+...-... .++...+...+.++ -+..+-..| +.|.|.+|.||+++.++.+.+.||
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~--f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRA--FLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHH--HHHHHHhcC---ccccCCCccceEEecCCcEEEEcC
Confidence 4566899999999888877432222 24433333333322 244455567 999999999999999999999999
Q ss_pred cCccccc
Q 045989 101 GTSRSMA 107 (295)
Q Consensus 101 g~a~~~~ 107 (295)
|+.....
T Consensus 310 Gi~g~l~ 316 (517)
T COG0661 310 GIVGRLD 316 (517)
T ss_pred cceecCC
Confidence 9876553
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0049 Score=49.21 Aligned_cols=83 Identities=22% Similarity=0.277 Sum_probs=60.4
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCC------CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPN------GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
...+.+|.+++|+.+++...-+|+|.+.+ .+|.+++.... ++. .. ...+-+-..||-+++ |+
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~---~~~L~~f~~~l~~~~---Iv 140 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-EL---RQALDEFKRYLLDHH---IV 140 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HH---HHHHHHHHHHHHHcC---Ce
Confidence 34578899999999999999999998654 36778875432 444 33 333445567888888 99
Q ss_pred eccCCCCeEEECCCC----ceEEee
Q 045989 79 HRDIKSANILLDDKY----RAKISD 99 (295)
Q Consensus 79 H~dikp~Nill~~~~----~~kl~D 99 (295)
.+|++|.||++..+. .+.|.|
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEe
Confidence 999999999996432 455655
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0021 Score=58.75 Aligned_cols=78 Identities=18% Similarity=0.211 Sum_probs=53.6
Q ss_pred CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECC----CCceEE
Q 045989 22 EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDD----KYRAKI 97 (295)
Q Consensus 22 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~----~~~~kl 97 (295)
....++||||+|.-+.++-.-... .++...+..-+.++. ++.|-..| ++|+|=+|.||++.. +..+.+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHhcC---CccCCCCCCcEEEecCCCCCccEEE
Confidence 356899999999766555332222 255554444443332 44455667 999999999999984 668999
Q ss_pred eeccCccccc
Q 045989 98 SDFGTSRSMA 107 (295)
Q Consensus 98 ~Dfg~a~~~~ 107 (295)
.|||+.....
T Consensus 347 lDhGl~~~is 356 (538)
T KOG1235|consen 347 LDHGLYAVIS 356 (538)
T ss_pred Eccccccccc
Confidence 9999987554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0045 Score=60.54 Aligned_cols=30 Identities=23% Similarity=0.280 Sum_probs=23.9
Q ss_pred CeEeccCCCCeEEECCC--CceEEeeccCccc
Q 045989 76 PIYHRDIKSANILLDDK--YRAKISDFGTSRS 105 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~--~~~kl~Dfg~a~~ 105 (295)
.+||+|+++.||+++.+ ...-|.||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 39999999999999853 3357899987653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.013 Score=50.63 Aligned_cols=72 Identities=22% Similarity=0.200 Sum_probs=56.8
Q ss_pred CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 22 EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 22 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
...|++|++- |++|...- ...++++..++++.+..+.-+..+- +.-|||+.-.||+|+ +|++-|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 4567788876 55553321 2467788889999998888887764 489999999999999 9999999999
Q ss_pred Cccc
Q 045989 102 TSRS 105 (295)
Q Consensus 102 ~a~~ 105 (295)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9883
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.021 Score=48.75 Aligned_cols=68 Identities=16% Similarity=0.120 Sum_probs=38.5
Q ss_pred ccEEEEeecCCCCHHHHHh-hhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCeEEECC
Q 045989 23 VPLLVYEFIPNGSLHQYIH-EQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHRDIKSANILLDD 91 (295)
Q Consensus 23 ~~~iv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~dikp~Nill~~ 91 (295)
.-.||++...+ +-.++-. ...+.++..-..-+..+..|++.-.-.+.+. +....+|.||||+||||-+
T Consensus 249 GnIIIfPLArc-Sadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 249 GNIIIFPLARC-SADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred CcEEEEehhhc-ccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 34678887543 2221111 1111222234455667888887655445333 3455999999999999943
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.043 Score=46.95 Aligned_cols=30 Identities=27% Similarity=0.443 Sum_probs=26.3
Q ss_pred CCeEeccCCCCeEEECCC----CceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLDDK----YRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~ 104 (295)
..++|+|+.|.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 459999999999999985 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.11 Score=44.51 Aligned_cols=27 Identities=15% Similarity=0.235 Sum_probs=20.9
Q ss_pred CCeEeccCCCCeEEECCC-Cc-eEEeecc
Q 045989 75 IPIYHRDIKSANILLDDK-YR-AKISDFG 101 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~-~~-~kl~Dfg 101 (295)
..++|+|+.+.||+++.+ +. +.|.|..
T Consensus 193 psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 193 CVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CeeEeCCCCcccEEECCCCCceEEEECch
Confidence 349999999999999865 33 5677764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.025 Score=48.33 Aligned_cols=66 Identities=21% Similarity=0.268 Sum_probs=49.2
Q ss_pred ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeecc
Q 045989 23 VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101 (295)
Q Consensus 23 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg 101 (295)
.-++|||++.|-.|..+-+- ....+ +...++.-+--|-.+| +||+|++-=||+|.+++.++++||-
T Consensus 182 RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred ceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeech
Confidence 44789999988777654432 22222 3344455566677888 9999999999999999999999995
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.035 Score=47.67 Aligned_cols=81 Identities=19% Similarity=0.211 Sum_probs=43.8
Q ss_pred EEEEeecCCCCHHHHHhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCeEEECCC----------
Q 045989 25 LLVYEFIPNGSLHQYIHEQ-TEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHRDIKSANILLDDK---------- 92 (295)
Q Consensus 25 ~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~dikp~Nill~~~---------- 92 (295)
.||++...+ +-.++-... .+-++..-..-+..+..|++.-.--+.+. +....+|.||||+||||-++
T Consensus 247 IIIfPLA~~-Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 247 IIIFPLARC-SADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred EEEEehhhc-chhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 578887543 222221111 11122233344556777775332214333 24459999999999999322
Q ss_pred --------CceEEeeccCcccc
Q 045989 93 --------YRAKISDFGTSRSM 106 (295)
Q Consensus 93 --------~~~kl~Dfg~a~~~ 106 (295)
-..+|.||.+++..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 23567788777644
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.053 Score=46.56 Aligned_cols=30 Identities=23% Similarity=0.297 Sum_probs=26.1
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
..++|+|+++.||+++.++...|.||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 349999999999999988877899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.03 Score=44.09 Aligned_cols=28 Identities=14% Similarity=0.275 Sum_probs=24.8
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
..+|+|+.|.||++++++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 379999999999998877 8899999774
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.059 Score=44.16 Aligned_cols=29 Identities=28% Similarity=0.460 Sum_probs=25.6
Q ss_pred CeEeccCCCCeEEECC-CCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDD-KYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~-~~~~kl~Dfg~a~ 104 (295)
.++|+|+.+.||+++. ++.+.|+||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.047 Score=44.88 Aligned_cols=30 Identities=27% Similarity=0.462 Sum_probs=25.3
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
..++|+|+.|.||+++.....-|.||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 348999999999999877666799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.1 Score=44.81 Aligned_cols=28 Identities=32% Similarity=0.434 Sum_probs=24.3
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999988 678899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.088 Score=44.26 Aligned_cols=46 Identities=24% Similarity=0.265 Sum_probs=34.2
Q ss_pred HHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 58 i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.+..+-.++.-++... ..+||+|+.|.|++.++.+.++|+||..|.
T Consensus 137 ~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 4444444555555441 239999999999999999999999998664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.1 Score=44.94 Aligned_cols=29 Identities=21% Similarity=0.297 Sum_probs=25.3
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
++||+|+.|.||+++.+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999977666899999764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.074 Score=45.31 Aligned_cols=29 Identities=24% Similarity=0.334 Sum_probs=25.8
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.||++++++.+.|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 49999999999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.037 Score=44.97 Aligned_cols=30 Identities=33% Similarity=0.479 Sum_probs=20.6
Q ss_pred CCeEeccCCCCeEEEC-CCCceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLD-DKYRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~ 104 (295)
..++|+|+.|.||+++ .++.+.|.||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3499999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.043 Score=44.27 Aligned_cols=29 Identities=28% Similarity=0.481 Sum_probs=20.7
Q ss_pred CeEeccCCCCeEEE-CCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILL-DDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill-~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.055 Score=45.08 Aligned_cols=28 Identities=18% Similarity=0.309 Sum_probs=24.6
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.||++++++ +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 389999999999999876 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.06 E-value=0.1 Score=42.22 Aligned_cols=40 Identities=25% Similarity=0.152 Sum_probs=33.6
Q ss_pred HHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCc
Q 045989 63 SGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS 103 (295)
Q Consensus 63 ~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 103 (295)
+++|.-.|+..+ ..+|+|..|+||+-|+.|.+||.|-+..
T Consensus 151 i~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhh
Confidence 467888896542 3999999999999999999999998743
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.73 E-value=0.32 Score=42.16 Aligned_cols=28 Identities=32% Similarity=0.574 Sum_probs=25.1
Q ss_pred eEeccCCCCeEEECCCCc-eEEeeccCcc
Q 045989 77 IYHRDIKSANILLDDKYR-AKISDFGTSR 104 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~-~kl~Dfg~a~ 104 (295)
+||+|+.|.||+++.... +-+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899999764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.38 E-value=0.23 Score=43.42 Aligned_cols=29 Identities=24% Similarity=0.470 Sum_probs=25.2
Q ss_pred CeEeccCCCCeEEECC-CCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDD-KYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~-~~~~kl~Dfg~a~ 104 (295)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999986 4689999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.25 E-value=0.29 Score=42.11 Aligned_cols=29 Identities=14% Similarity=0.291 Sum_probs=26.6
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.+||+|+.+.|++++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 49999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.42 Score=38.12 Aligned_cols=29 Identities=24% Similarity=0.346 Sum_probs=24.3
Q ss_pred CeEeccCCCCeEEECCCC-----ceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKY-----RAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~-----~~kl~Dfg~a~ 104 (295)
.++|||+.+.||++..++ .+.+.||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 389999999999997543 58899998764
|
subfamily of choline kinases |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=91.70 E-value=0.66 Score=37.11 Aligned_cols=75 Identities=29% Similarity=0.453 Sum_probs=51.3
Q ss_pred cCCCCccc--cceeeEEEeCC------------------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHH
Q 045989 4 SQINHRNV--VKLLGCCLETE------------------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVS 63 (295)
Q Consensus 4 ~~l~Hpni--v~~~~~~~~~~------------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~ 63 (295)
+.+.+.++ |+++|+..-.. ...||.||.+... .+.... +.++.
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~ 174 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQML 174 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHH
Confidence 34455566 88888874221 1357888876643 122222 34667
Q ss_pred HHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCc
Q 045989 64 GALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS 103 (295)
Q Consensus 64 ~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a 103 (295)
+-+..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 175 ~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 7788899999 999999999975 4588899854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.32 E-value=0.17 Score=42.73 Aligned_cols=29 Identities=24% Similarity=0.549 Sum_probs=24.3
Q ss_pred CeEeccCCCCeEEECCCCc-eEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYR-AKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~-~kl~Dfg~a~ 104 (295)
.++|+|++|.||++++++. .-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999997554 5699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.10 E-value=0.6 Score=36.51 Aligned_cols=67 Identities=16% Similarity=0.139 Sum_probs=46.9
Q ss_pred EEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC-CCeEEECCCCceEEeeccCc
Q 045989 25 LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIK-SANILLDDKYRAKISDFGTS 103 (295)
Q Consensus 25 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dik-p~Nill~~~~~~kl~Dfg~a 103 (295)
++.|||+.|-.|.+..... . .+-+..+++.---|...| |-|+.|. |...++.+++.+.|+||..|
T Consensus 88 ~i~me~i~G~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccch
Confidence 4669999998888776531 1 123345666666677777 9999996 55555555559999999988
Q ss_pred cc
Q 045989 104 RS 105 (295)
Q Consensus 104 ~~ 105 (295)
+.
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 63
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.80 E-value=0.3 Score=42.47 Aligned_cols=29 Identities=24% Similarity=0.400 Sum_probs=24.9
Q ss_pred CeEeccCCCCeEEECC-CCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDD-KYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~-~~~~kl~Dfg~a~ 104 (295)
-++|+|+.+.||++++ ++.++++||..|-
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 3899999999999975 4689999998763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.34 E-value=0.75 Score=41.00 Aligned_cols=29 Identities=17% Similarity=0.339 Sum_probs=24.6
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
..++|||+.+.||++..+ .++++||..+.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 349999999999999876 58999997664
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.32 E-value=0.35 Score=41.58 Aligned_cols=40 Identities=15% Similarity=0.333 Sum_probs=32.0
Q ss_pred HHHHHhCC-----CCCeEeccCCCCeEEECCCCceEEeeccCccc
Q 045989 66 LSYLHSAA-----SIPIYHRDIKSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 66 l~~Lh~~~-----~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
..+|+.+- ...++|+|+.+.|++++..+.+-|.||+.+..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 44555443 24599999999999999998899999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.95 E-value=1 Score=45.44 Aligned_cols=29 Identities=34% Similarity=0.571 Sum_probs=24.4
Q ss_pred CeEeccCCCCeEEECCCC--ceE-EeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKY--RAK-ISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~--~~k-l~Dfg~a~ 104 (295)
.+||+|+++.||+++.++ .+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999999775 454 99999764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.80 E-value=1.5 Score=38.10 Aligned_cols=27 Identities=26% Similarity=0.362 Sum_probs=22.8
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.+||+|+.+.||+++ + .+.|.||+-+.
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 389999999999995 3 57899999764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=86.51 E-value=2 Score=36.99 Aligned_cols=88 Identities=13% Similarity=0.083 Sum_probs=50.5
Q ss_pred ccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc--ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhH
Q 045989 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR--LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEK 195 (295)
Q Consensus 118 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (295)
.+...|.+|+.-.....+...|++++|++-.+.+. +.--. .....+..-+...+... + ..
T Consensus 28 ~r~~~~~~pv~~~~ts~s~~~s~~~~eIleesp~~-rw~krreqv~qrdvPgid~v~lam----------d-------~e 89 (458)
T KOG1266|consen 28 MRYMSYIAPVGENATSLSSADSEDESEILEESPCG-RWGKRREQVGQRDVPGIDDVYLAM----------D-------TE 89 (458)
T ss_pred cccccccCCccccccccCcccccchhhhhccCchh-hhhhhhhhccCCCCCchHHHHHHh----------h-------hc
Confidence 45677999998887778888999999987555442 11100 00000111111111100 0 01
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 196 EEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 196 ~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
...+-..+.++.|+.+||+.||...+++
T Consensus 90 ~g~evvwneVq~~~rK~~~~qeek~~~v 117 (458)
T KOG1266|consen 90 EGVEVVWNEVQFSERKNPKEQEEKRRAV 117 (458)
T ss_pred cCchhhHHHHHHHHhcChhhCHHHHHHH
Confidence 1112267789999999999999876654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=85.14 E-value=4.5 Score=33.27 Aligned_cols=33 Identities=27% Similarity=0.481 Sum_probs=26.1
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHH
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLH 37 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~ 37 (295)
+-+--.|.+++.+..+.++.|+|+||++-|.+.
T Consensus 67 ~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 67 RSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred hcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 334456888899999999999999999876554
|
|
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=85.09 E-value=1.1 Score=39.14 Aligned_cols=85 Identities=14% Similarity=0.197 Sum_probs=43.6
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCC-CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPN-GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIK 83 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dik 83 (295)
...||++++. .+-.+++.+.+.++.-+. -++.. +. ..+...+++++.+|..--.++++ -+|--++
T Consensus 19 ~~~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~-i~-------~~~~~eklr~~~ni~~l~~~~~~-----~~~f~l~ 84 (359)
T PF10140_consen 19 KEHDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEE-IK-------KLDKSEKLRLLINIAALKEHLNS-----RYTFILH 84 (359)
T ss_dssp GS--TTB--E-EEEE-SSEEEEEE---TTSEEGGG-GG-------GS-HHHHHHHHHHGGGGGGGGGS-----SEE---S
T ss_pred hccCcccCCc-eEEEeCCEEEEEEEcCcccCcHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceeEEEe
Confidence 3478888884 555556665555554332 22222 21 26778888888885443333333 5788999
Q ss_pred CCeEEECCCCceEEeeccCc
Q 045989 84 SANILLDDKYRAKISDFGTS 103 (295)
Q Consensus 84 p~Nill~~~~~~kl~Dfg~a 103 (295)
|+|++++.++.+++.-.|+-
T Consensus 85 P~Nl~fd~~~~p~i~hrGi~ 104 (359)
T PF10140_consen 85 PENLVFDKNLMPKILHRGIK 104 (359)
T ss_dssp GGGEEE-TTS-EEES--EET
T ss_pred chheEEcCCCCEEEEEcCCc
Confidence 99999999999999877653
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 295 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 3e-94
Identities = 89/229 (38%), Positives = 135/229 (58%), Gaps = 6/229 (2%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
LS H ++V L+G C E +L+Y+++ NG+L ++++ + ++WE RL I +
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV-DRTHLTTQVKGT 120
+ L YLH+ I HRD+KS NILLD+ + KI+DFG S+ D+THL+T VKGT
Sbjct: 148 AARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+DPEYF + TEKSDVYSFGVVL E+L + I E +LA + ++ N +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV--ALELA 227
L +++D + + E + A +CL L+ + RP+M +V LE A
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 7e-91
Identities = 82/228 (35%), Positives = 134/228 (58%), Gaps = 4/228 (1%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++S HRN+++L G C+ LLVY ++ NGS+ + E+ E Q P+ W R IA+
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L+YLH I HRD+K+ANILLD+++ A + DFG ++ M TH+TT V+GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI--RLVETEENRSLAAYFLQVINEN 179
G++ PEY + + +EK+DV+ +GV+L+EL+TGQ+ + +++ L + ++ E
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV--ALE 225
+L ++D + + EEV + VA C + +RP M EV LE
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 6e-88
Identities = 80/233 (34%), Positives = 130/233 (55%), Gaps = 8/233 (3%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++++ H N+V+LLG + + LVY ++PNGSL + + P++W +R IA
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQ 140
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV-DRTHLTTQVKG 119
+ +++LH I HRDIKSANILLD+ + AKISDFG +R+ +T +T+++ G
Sbjct: 141 GAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
T Y+ PE + T KSD+YSFGVVL+E++TG + + L ++ +E
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEE 254
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+ E + + +A+ V + VA +CL+ KRP +K+V L + AS
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-60
Identities = 51/255 (20%), Positives = 94/255 (36%), Gaps = 36/255 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
L + H N+++ +G L+ F GSL ++ ++W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125
Query: 58 IAVEVSGALSYLHSAASI-------PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
IA ++ L+YLH I HRDIKS N+LL + A I+DFG + +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 111 THL-TTQVKGTFGYLDPEYFQSS-----QFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
+ T GT Y+ PE + + + D+Y+ G+VL EL +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA----DGP 241
Query: 165 NRSLAAYFLQVINENRLFEVLDAQVLRE----------AEKEEVITVAMVAKRCLNLNGK 214
F + I ++ E + V+ + + + + + C + + +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 215 KRPTMKEVALELAGI 229
R + V + +
Sbjct: 302 ARLSAGCVGERITQM 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 6e-60
Identities = 70/237 (29%), Positives = 115/237 (48%), Gaps = 24/237 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
LS++NH N+VKL G CL P+ LV E+ GSL+ +H E T + +
Sbjct: 54 QLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCL 109
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYR-AKISDFGTSRSMAVDRTHLTTQVKG 119
+ S ++YLHS + HRD+K N+LL KI DFGT+ + TH+T KG
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KG 165
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
+ ++ PE F+ S ++EK DV+S+G++L E++T +KP E V N
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAFRIMWAVHNGT 221
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGAS 236
R +++ K + + RC + + +RP+M+E+ + + +
Sbjct: 222 RP------PLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-58
Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 18/231 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++ H N+V +G + +V E++ GSL++ +H+ + + RL +A +
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYD 145
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V+ ++YLH+ + PI HR++KS N+L+D KY K+ DFG SR A + GT
Sbjct: 146 VAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTP 203
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
++ PE + EKSDVYSFGV+L EL T Q+P RL
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRL 258
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
++ R + VA + + C KRP+ + L + S
Sbjct: 259 ------EIPRNLNPQ----VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-57
Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+S +NH N+VKL G P +V EF+P G L+ + ++ PI W ++L + ++
Sbjct: 76 IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLD 130
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDK-----YRAKISDFGTSRSMAVDRTHLTTQ 116
++ + Y+ + + PI HRD++S NI L AK++DFG S+ H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSG 185
Query: 117 VKGTFGYLDPEYF--QSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
+ G F ++ PE + +TEK+D YSF ++L +LTG+ P E + +
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINM 241
Query: 175 VINEN-RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
+ E R + + + V + C + + KKRP + EL+ +
Sbjct: 242 IREEGLRP------TIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-56
Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 33/237 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ + + H N++ L G CL+ LV EF G L++ + + I +I + AV+
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQ 113
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYR--------AKISDFGTSRSMAVDRTHL 113
++ ++YLH A +PI HRD+KS+NIL+ K KI+DFG +R RT
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTK 171
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
+ G + ++ PE ++S F++ SDV+S+GV+L ELLTG+ P A
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAY 224
Query: 174 QVINEN-RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
V L + + A + + C N + RP+ + +L I
Sbjct: 225 GVAMNKLAL------PIPSTCPEP----FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-54
Identities = 49/235 (20%), Positives = 94/235 (40%), Gaps = 31/235 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
L +H NV+ +LG C P + ++P GSL+ +HE T + + A
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFA 117
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++++ +++LH+ I + S ++++D+ A+IS S +
Sbjct: 118 LDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMY 170
Query: 120 TFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
++ PE Q +D++SF V+L EL+T + P + S ++V
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVA 224
Query: 177 NEN-RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230
E R + V+ + K C+N + KRP + L ++
Sbjct: 225 LEGLRP------TIPPGISPH----VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-50
Identities = 46/238 (19%), Positives = 86/238 (36%), Gaps = 35/238 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
Q H NVV +G C+ ++ +L+ + + + IA E
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQE 138
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV----DRTHLTTQV 117
+ + YLH+ I H+D+KS N+ D+ + I+DFG V R
Sbjct: 139 IVKGMGYLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 118 KGTFGYLDPEYFQSSQ---------FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSL 168
G +L PE + F++ SDV++ G + EL + P + +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAE 249
Query: 169 AAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
A + + + + +E ++ + C ++RPT ++ L
Sbjct: 250 AIIW--QMGTGMKPNLSQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L + H N++ +G T L +V ++ SL+ ++H E + + + IA
Sbjct: 73 VLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHAS-ETKFE--MKKLIDIAR 127
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA-VDRTHLTTQVKG 119
+ + + YLH+ I HRD+KS NI L + KI DFG + + +H Q+ G
Sbjct: 128 QTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 120 TFGYLDPE---YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
+ ++ PE S+ ++ +SDVY+FG+VL EL+TGQ P + V
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMVG 239
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
+ ++ + + ++ CL +RP+ + E+
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLM------AECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-49
Identities = 54/249 (21%), Positives = 101/249 (40%), Gaps = 33/249 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ + H NV+K +G + + + E+I G+L I W R+ A +
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKD 116
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT------- 114
++ ++YLHS + I HRD+ S N L+ + ++DFG +R M ++T
Sbjct: 117 IASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 115 ------TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSL 168
V G ++ PE + EK DV+SFG+VL E++ +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYLPRT 229
Query: 169 AAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228
+ L V + + + + RC +L+ +KRP+ ++ L
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPP----------SFFPITVRCCDLDPEKRPSFVKLEHWLET 279
Query: 229 IRASIGASV 237
+R + +
Sbjct: 280 LRMHLAGHL 288
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-47
Identities = 56/267 (20%), Positives = 100/267 (37%), Gaps = 43/267 (16%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
+ + H N+ + + LLV E+ PNGSL +Y+ T W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSC 114
Query: 57 GIAVEVSGALSYLHSAASI------PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
+A V+ L+YLH+ I HRD+ S N+L+ + ISDFG S + +R
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 111 -------THLTTQVKGTFGYLDPEYFQSS-------QFTEKSDVYSFGVVLVELLTGQKP 156
+ GT Y+ PE + + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLRE-----------AEKEEVITVAMVA 205
+ E+ +A F + + FE + V RE V ++
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 206 KRCLNLNGKKRPTMKEVALELAGIRAS 232
+ C + + + R T + +A +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 48/255 (18%), Positives = 90/255 (35%), Gaps = 36/255 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+ H N++ + + + L+ + GSL+ Y+ T + L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLR 109
Query: 58 IAVEVSGALSYLHSAASI-----PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
I + ++ L++LH I HRD+KS NIL+ + I+D G + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 113 L---TTQVKGTFGYLDPE------YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163
L GT Y+ PE ++ D+++FG+VL E+ +VE
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 164 ENRSLAAYFLQVINENRLFEVLDAQV-------LREAEKEEVITVAMVA--KRCLNLNGK 214
+ ++ V N+ ++ + + ++ K C N
Sbjct: 230 K----PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 215 KRPTMKEVALELAGI 229
R T + L I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-46
Identities = 53/259 (20%), Positives = 93/259 (35%), Gaps = 38/259 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+ H N++ + ++ L+ ++ NGSL+ Y+ T + + L
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLK 138
Query: 58 IAVEVSGALSYLHSAASI-----PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
+A L +LH+ I HRD+KS NIL+ I+D G + D
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 113 L---TTQVKGTFGYLDPE------YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163
+ GT Y+ PE Q +D+YSFG++L E+ +VE
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE-- 256
Query: 164 ENRSLAAYFLQVINENRLFEVLDAQVLRE----------AEKEEVITVAMVAKRCLNLNG 213
+ ++ + +E + V + + E + + + C N
Sbjct: 257 ---EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 214 KKRPTMKEVALELAGIRAS 232
R T V LA + S
Sbjct: 314 ASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-44
Identities = 50/260 (19%), Positives = 98/260 (37%), Gaps = 36/260 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+ H N++ + + LV ++ +GSL Y++ T +T E +
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIK 143
Query: 58 IAVEVSGALSYLHS-----AASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
+A+ + L++LH I HRD+KS NIL+ I+D G +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 113 LT---TQVKGTFGYLDPE------YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163
+ GT Y+ PE + + +++D+Y+ G+V E+ + E
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 164 ENRSLAAYFLQVINENRLFEVLDAQVLRE---------AEKEEVITVAMVAKRCLNLNGK 214
+ Y+ V ++ + E+ ++ E + +A + + C NG
Sbjct: 264 Q----LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 215 KRPTMKEVALELAGIRASIG 234
R T + L+ + G
Sbjct: 320 ARLTALRIKKTLSQLSQQEG 339
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 18/241 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L Q+NH NV+K +E +V E G L + I + + I V+
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL ++HS + HRDIK AN+ + K+ D G R + T + V GT
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTP 200
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
Y+ PE + + KSD++S G +L E+ Q P + +L + ++ +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEQCD-- 254
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASVLRQC 241
+ L + E ++ + C+N + +KRP + V ++A + AS L
Sbjct: 255 YPPLPSDHYSEELRQ-------LVNMCINPDPEKRPDVTYV-YDVAKRMHACTASSLEHH 306
Query: 242 E 242
Sbjct: 307 H 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-38
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L ++ H N+V+ ++ L V E+ G L I + T+++ + E L +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 60 VEVSGALSYLHS--AASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+++ AL H + HRD+K AN+ LD K K+ DFG +R + D + T V
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT Y+ PE + EKSD++S G +L EL P S ++
Sbjct: 178 -GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIRE 230
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F + + E + + R LNL RP+++E+
Sbjct: 231 GK--FRRIPYRYSDELNE--------IITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 24/222 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIR-LGIAV 60
+L+ + H N+V+ E +V ++ G L + I+ Q E + L V
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ---EDQILDWFV 132
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
++ AL ++H I HRDIKS NI L ++ DFG +R + + GT
Sbjct: 133 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GT 188
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
YL PE ++ + KSD+++ G VL EL T + E S+ L++I+ +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF------EAGSMKNLVLKIISGS- 241
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F + + + + N + RP++ +
Sbjct: 242 -FPPVSLHYSYDLRS--------LVSQLFKRNPRDRPSVNSI 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 43/161 (26%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+++ +++ +V +LLG CL + V L+ + +P G L Y+ E +D + + L V+
Sbjct: 70 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH-KDNIGS--QYLLNWCVQ 125
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ----- 116
++ ++YL + HRD+ + N+L+ KI+DFG ++ + + +
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+K E +T +SDV+S+GV + EL+T G KP
Sbjct: 183 IKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-34
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 25/241 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGSLHQYI--HEQTEDQLPITWEIRLG 57
IL + H +++K GCC + LV E++P GSL Y+ H QL L
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-------LL 138
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
A ++ ++YLH+ I HRD+ + N+LLD+ KI DFG ++++ + +
Sbjct: 139 FAQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 118 KGTF--GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQ 174
G + PE + +F SDV+SFGV L ELLT A
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--G 253
Query: 175 VINENRLFEVLDA-QVLREAEK--EEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231
+ RL E+L+ + L +K EV + M K C RPT + + L +
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHL-M--KNCWETEASFRPTFENLIPILKTVHE 310
Query: 232 S 232
Sbjct: 311 K 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 4 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVS 63
SQ++H+N+V ++ E + LV E+I +L +YI P++ + + ++
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQIL 121
Query: 64 GALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT--QVKGTF 121
+ + H I HRDIK NIL+D KI DFG ++ A+ T LT V GT
Sbjct: 122 DGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTV 176
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y PE + E +D+YS G+VL E+L G+ P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 6/156 (3%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +I H N+V+LLG C ++ EF+ G+L Y+ + ++ ++ + L +A +
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQ 326
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+S A+ YL I HR++ + N L+ + + K++DFG SR M D K
Sbjct: 327 ISSAMEYLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE ++F+ KSDV++FGV+L E+ T G P
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-33
Identities = 52/228 (22%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+L + H N+V+ T +LV E + +G+L Y+ + ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRS 133
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQ 116
++ L +LH+ + PI HRD+K NI + KI D G + + R
Sbjct: 134 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKA 189
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
V GT ++ PE ++ ++ E DVY+FG+ ++E+ T + P E ++ A + +V
Sbjct: 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY-----SECQNAAQIYRRVT 243
Query: 177 NENR---LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
+ + +V +V +E+I + C+ N +R ++K+
Sbjct: 244 SGVKPASFDKVAIPEV------KEII------EGCIRQNKDERYSIKD 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL Q +H N+V+L+G C + + +V E + G ++ + + + L + +
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGD 221
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ + YL S I HRD+ + N L+ +K KISDFG SR A D + +
Sbjct: 222 AAAGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQV 277
Query: 122 GY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE +++ +SDV+SFG++L E + G P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 65/246 (26%), Positives = 119/246 (48%), Gaps = 26/246 (10%)
Query: 2 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
IL + H N+VK G C L L+ E++P GSL Y+ + ++++ L
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIK--LLQYT 120
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ + YL + I HRD+ + NIL++++ R KI DFG ++ + D+ + G
Sbjct: 121 SQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 120 TF--GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
+ PE S+F+ SDV+SFGVVL EL T E+++S A F+++I
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY--------IEKSKSPPAEFMRMIG 229
Query: 178 ENRLFEVLDAQVLREAEKEEV--------ITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
++ +++ ++ + + M+ C N N +RP+ +++AL + I
Sbjct: 230 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
Query: 230 RASIGA 235
R ++
Sbjct: 290 RDNMAG 295
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 11/157 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++Q+ H N+V+LLG +E + L +V E++ GSL Y+ ++ + + + L ++
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSL 296
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V A+ YL + HRD+ + N+L+ + AK+SDFG ++ + + VK T
Sbjct: 297 DVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 353
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE + +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 354 ----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 53/237 (22%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL----------------LVYEFIPNGSLHQYIHEQTE 45
L++++H N+V GC + + EF G+L Q+I ++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 46 DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRS 105
++L + L + +++ + Y+HS + +RD+K +NI L D + KI DFG S
Sbjct: 117 EKLDK--VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 106 MAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165
+ T+ KGT Y+ PE S + ++ D+Y+ G++L ELL ET +
Sbjct: 172 L--KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSK- 226
Query: 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F + + + ++ D + + ++ ++ L+ + RP E+
Sbjct: 227 ------FFTDLRDGIISDIFDKK-EK-----TLL------QKLLSKKPEDRPNTSEI 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+ ++HRN+++L G L P+ +V E P GSL + + + + AV
Sbjct: 74 AMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAV 128
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V+ + YL S I HRD+ + N+LL + KI DFG R++ + H Q
Sbjct: 129 QVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 121 FGY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP---------IRLVETEENR 166
+ PE ++ F+ SD + FGV L E+ T GQ+P + ++ E R
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ ++H ++V+LLG C LV +++P GSL ++ + L ++ L V+
Sbjct: 68 AIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQH-RGALGP--QLLLNWGVQ 123
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ----- 116
++ + YL + HR++ + N+LL + +++DFG + + D L
Sbjct: 124 IAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+K E ++T +SDV+S+GV + EL+T G +P
Sbjct: 181 IKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+++ +++ +V +LLG CL L+ + +P G L Y+ E ++ I + L V+
Sbjct: 70 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQ 125
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ----- 116
++ ++YL + HRD+ + N+L+ KI+DFG ++ + + +
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+K E +T +SDV+S+GV + EL+T G KP
Sbjct: 183 IKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 67/244 (27%), Positives = 117/244 (47%), Gaps = 26/244 (10%)
Query: 2 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
IL + H N+VK G C L L+ E++P GSL Y+ + E I L
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYT 151
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ + YL + I HRD+ + NIL++++ R KI DFG ++ + D+ + + G
Sbjct: 152 SQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 120 TF--GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
+ PE S+F+ SDV+SFGVVL EL T E+++S A F+++I
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY--------IEKSKSPPAEFMRMIG 260
Query: 178 ENRLFEVLDAQVLREAEKEEV--------ITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
++ +++ ++ + + M+ C N N +RP+ +++AL + I
Sbjct: 261 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
Query: 230 RASI 233
R +
Sbjct: 321 RDQM 324
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 37/245 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGSLHQYI----HEQTEDQLPITWEIR 55
IL + H N+VK G C E L+ EF+P+GSL +Y+ ++ Q
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ------- 128
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
L AV++ + YL S + HRD+ + N+L++ +++ KI DFG ++++ D+ + T
Sbjct: 129 LKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 185
Query: 116 QVKGTF--GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYF 172
+ + PE S+F SDV+SFGV L ELLT + +
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245
Query: 173 LQVINENRLFEVLDAQVLREAEK--------EEVITVAMVAKRCLNLNGKKRPTMKEVAL 224
Q+ +++ L+E ++ +EV + M ++C R + + +
Sbjct: 246 -QMTVT----RLVNT--LKEGKRLPCPPNCPDEVYQL-M--RKCWEFQPSNRTSFQNLIE 295
Query: 225 ELAGI 229
+
Sbjct: 296 GFEAL 300
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 42/154 (27%), Positives = 62/154 (40%), Gaps = 11/154 (7%)
Query: 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSG 64
++ +VV + + I L + Q P+ + I ++
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGS 145
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT--QVKGTFG 122
AL H+A HRD+K NIL+ A + DFG + A LT GT
Sbjct: 146 ALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLY 200
Query: 123 YLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
Y+ PE F S T ++D+Y+ VL E LTG P
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I+ +H NV+ LLG CL +E L V ++ +G L +I +T + T + +G +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 135
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V+ + YL S + HRD+ + N +LD+K+ K++DFG +R + + T
Sbjct: 136 QVAKGMKYLASKKFV---HRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKT 190
Query: 121 FGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
L E Q+ +FT KSDV+SFGV+L EL+T G P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 50/158 (31%), Positives = 89/158 (56%), Gaps = 10/158 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q+++ +V+L+G C + +LV E G LH+++ + E+ I + +
Sbjct: 63 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 118
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
VS + YL + HRD+ + N+LL +++ AKISDFG S+++ D ++ T + G +
Sbjct: 119 VSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 122 --GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +F+ +SDV+S+GV + E L+ GQKP
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H N+++L G + ++V E++ NGSL ++ + Q T +G+
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQF--TIMQLVGMLRG 159
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V + YL + HRD+ + N+L+D K+SDFG SR + D T G
Sbjct: 160 VGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 122 GYL--DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE F+ SDV+SFGVV+ E+L G++P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-32
Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 11/157 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++Q+ H N+V+LLG +E + L +V E++ GSL Y+ ++ + + + L ++
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSL 124
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V A+ YL + HRD+ + N+L+ + AK+SDFG ++ + + VK T
Sbjct: 125 DVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 181
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE + +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 182 ----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-32
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYI--HEQTEDQLPITWEI 54
+ +H NV++LLG C+E P+++ F+ G LH Y+ I +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
L V+++ + YL ++ HRD+ + N +L D ++DFG S+ + +
Sbjct: 149 LLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-- 203
Query: 115 TQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+G + E +T KSDV++FGV + E+ T G P
Sbjct: 204 --RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-32
Identities = 55/163 (33%), Positives = 87/163 (53%), Gaps = 15/163 (9%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
II+ +H NV+ LLG CL +E L V ++ +G L +I +T + T + +G
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFG 198
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++V+ + +L AS HRD+ + N +LD+K+ K++DFG +R + +
Sbjct: 199 LQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNK 253
Query: 120 TFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
T L E Q+ +FT KSDV+SFGV+L EL+T G P
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 2 ILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGSLHQYIHEQ----TEDQLPITWEIR 55
IL ++ +VK G L LV E++P+G L ++ +L
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL------- 129
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
L + ++ + YL S + HRD+ + NIL++ + KI+DFG ++ + +D+ +
Sbjct: 130 LLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 116 QVKGTF--GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ G + PE + F+ +SDV+SFGVVL EL T K
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 48/158 (30%), Positives = 87/158 (55%), Gaps = 11/158 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ Q+++ +V+++G C E +LV E G L++Y+ + + + + + +
Sbjct: 71 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQ 125
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
VS + YL + + HRD+ + N+LL ++ AKISDFG S+++ D + Q G +
Sbjct: 126 VSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 122 --GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +F+ KSDV+SFGV++ E + GQKP
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 14/160 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +I H N+V+LLG C ++ EF+ G+L Y+ + ++ ++ + L +A +
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQ 119
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD--RTHLTTQ--V 117
+S A+ YL I HRD+ + N L+ + + K++DFG SR M D H + +
Sbjct: 120 ISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
K T PE ++F+ KSDV++FGV+L E+ T G P
Sbjct: 177 KWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 23/167 (13%)
Query: 1 IILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYI----HEQTEDQLPITWEIR 55
+++ +NH NV+ L+G L E +P ++ ++ +G L Q+I T L
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL------- 126
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ ++V+ + YL + HRD+ + N +LD+ + K++DFG +R + +
Sbjct: 127 ISFGLQVARGMEYLAEQKFV---HRDLAARNCMLDESFTVKVADFGLARD--ILDREYYS 181
Query: 116 QVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ L E Q+ +FT KSDV+SFGV+L ELLT G P
Sbjct: 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 19/167 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI------HEQTEDQLPITWEIR 55
++ + N +VV+LLG + + L++ E + G L Y+ P +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ +A E++ ++YL + HRD+ + N ++ + + KI DFG +R + +
Sbjct: 141 IQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--- 194
Query: 116 QVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
KG G L PE + FT SDV+SFGVVL E+ T ++P
Sbjct: 195 -RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 45/158 (28%), Positives = 86/158 (54%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H N+++L G + + +++ E++ NG+L +++ E+ + + + +G+
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEF--SVLQLVGMLRG 155
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ + YL + + HRD+ + NIL++ K+SDFG SR + D T G
Sbjct: 156 IAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 122 GY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE +FT SDV+SFG+V+ E++T G++P
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYI--HEQTEDQLPITWE 53
+ + +H +V KL+G L + +P+++ F+ +G LH ++ E+ + +
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113
+ V+++ + YL +S HRD+ + N +L + ++DFG SR + +
Sbjct: 138 TLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY- 193
Query: 114 TTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+G L E + +T SDV++FGV + E++T GQ P
Sbjct: 194 ---RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 48/248 (19%), Positives = 92/248 (37%), Gaps = 36/248 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPIT-WEIRL 56
+ NH N+++L+ CL L+ F G+L I + +T +I L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-L 137
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG---------TSRSMA 107
+ + + L +H+ HRD+K NILL D+ + + D G A
Sbjct: 138 WLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
+ Q T Y PE F E++DV+S G VL ++ G+ P +
Sbjct: 195 LTLQDWAAQR-CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------D 247
Query: 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224
+ + +N+L + +++ + ++ +RP + +
Sbjct: 248 MVFQKGDSVALAVQNQLSIPQSPRHSSAL--WQLL------NSMMTVDPHQRPHIPLLLS 299
Query: 225 ELAGIRAS 232
+L ++
Sbjct: 300 QLEALQPP 307
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 4 SQINHRNVVKLL--GC--CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+ +NH +V + G +P +V E++ +L +H + P+T + + +
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVI 122
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT--QV 117
+ AL++ H I HRD+K ANI++ K+ DFG +R++A +T V
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT YL PE + +SDVYS G VL E+LTG+ P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 43/157 (27%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ ++ H +V+L +E P+ +V E++ GSL ++ + E + + +A
Sbjct: 315 VMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAA 370
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++ ++Y+ + HRD+++ANIL+ + K++DFG +R + + K
Sbjct: 371 QIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT KSDV+SFG++L EL T G+ P
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 43/157 (27%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ ++ H +V+L +E P+ +V E++ GSL ++ + E + + +A
Sbjct: 232 VMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAA 287
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++ ++Y+ + HRD+++ANIL+ + K++DFG +R + + K
Sbjct: 288 QIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE +FT KSDV+SFG++L EL T G+ P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H N+++L G +++ ++V E++ NGSL ++ + + Q T +G+
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQF--TVIQLVGMLRG 155
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ + YL + HRD+ + NIL++ K+SDFG R + D T G
Sbjct: 156 IASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 122 GYL--DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE +FT SDV+S+G+VL E+++ G++P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 49/244 (20%), Positives = 94/244 (38%), Gaps = 45/244 (18%)
Query: 2 ILSQINHRNVVKLLGCCLE---------TEVPLLVY---EFIPNGSLHQYIHEQTEDQLP 49
L+++ H +V+ LE + + +Y + +L +++ + +
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
+ L I ++++ A+ +LHS + HRD+K +NI K+ DFG +M D
Sbjct: 116 -ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 110 RTHLTTQVK-----------GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
T GT Y+ PE + ++ K D++S G++L ELL P
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF- 227
Query: 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218
T+ R L + + F L Q ++ + L+ + +RP
Sbjct: 228 --STQMERVRT---LTDVRNLK-FPPLFTQKYPCEYV--MV------QDMLSPSPMERPE 273
Query: 219 MKEV 222
+
Sbjct: 274 AINI 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 49/158 (31%), Positives = 88/158 (55%), Gaps = 10/158 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q+++ +V+L+G C + +LV E G LH+++ + E+ I + +
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 444
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
VS + YL + HR++ + N+LL +++ AKISDFG S+++ D ++ T + G +
Sbjct: 445 VSMGMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 122 GY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE +F+ +SDV+S+GV + E L+ GQKP
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ ++H ++VKL+G E E ++ E P G L Y+ ++ L + + +++
Sbjct: 66 IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKV--LTLVLYSLQ 121
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ A++YL S + HRDI NIL+ K+ DFG SR ++
Sbjct: 122 ICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRL 176
Query: 122 --GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
++ PE +FT SDV+ F V + E+L+ G++P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 20/164 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLP-ITWEIRLG 57
+ ++ +V L G E + E + GSL Q I + ED+ + G
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEG 162
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK-YRAKISDFGTSRSMAVDRTHLTTQ 116
L YLH+ + H D+K+ N+LL RA + DFG + + D +
Sbjct: 163 --------LEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 117 ----VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
+ GT ++ PE K D++S +++ +L G P
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-30
Identities = 48/159 (30%), Positives = 87/159 (54%), Gaps = 13/159 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ Q+ H+ +V+L T+ P+ + E++ NGSL ++ +T + +T L +A
Sbjct: 61 LMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAA 116
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++ ++++ I HRD+++ANIL+ D KI+DFG +R ++ T +
Sbjct: 117 QIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAK 171
Query: 121 FGY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
F PE FT KSDV+SFG++L E++T G+ P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-30
Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ +++H +VK G C + +V E+I NG L Y+ + + L + +
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYD 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ----- 116
V +++L S I HRD+ + N L+D K+SDFG +R + D ++++
Sbjct: 113 VCEGMAFLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFP 168
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
VK + PE F +++ KSDV++FG+++ E+ + G+ P
Sbjct: 169 VKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 11/158 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H +V+L G CLE LV EF+ +G L Y+ Q E LG+ ++
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAA--ETLLGMCLD 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V ++YL A I HRD+ + N L+ + K+SDFG +R + D T+ F
Sbjct: 113 VCEGMAYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKF 167
Query: 122 GY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
PE F S+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ Q +H ++VKL+G E ++ E G L ++ + + L + + A +
Sbjct: 69 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDL--ASLILYAYQ 124
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+S AL+YL S + HRDI + N+L+ K+ DFG SR M + ++ K
Sbjct: 125 LSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 24/172 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY-----------IHEQTEDQLPI 50
+L+ + H+++V+ G C E L+V+E++ +G L+++ + P+
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
L +A +V+ + YL A + HRD+ + N L+ KI DFG SR +
Sbjct: 156 GLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYS 210
Query: 111 THLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
T G L PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 211 TDYYR--VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYI----HEQTEDQLPITWEIRLG 57
++ ++H +V+L G C + ++ E++ NG L Y+ H QL L
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-------LE 124
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ +V A+ YL S + HRD+ + N L++D+ K+SDFG SR V T+ V
Sbjct: 125 MCKDVCEAMEYLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSV 179
Query: 118 KGTFGY--LDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
F PE S+F+ KSD+++FGV++ E+ + G+ P
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 50/249 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-------------LVYEFIPNGSLHQYIHEQTEDQL 48
+L+ +NH+ VV+ LE + + E+ NG+L+ IH + L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NL 111
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-- 106
+ + ++ ALSY+HS I HRD+K NI +D+ KI DFG ++++
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 107 ------------AVDRTHLTTQVKGTFGYLDPEYFQ-SSQFTEKSDVYSFGVVLVELLTG 153
+LT+ + GT Y+ E + + EK D+YS G++ E++
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNG 213
T R ++ + + F + EK ++I + ++ +
Sbjct: 228 ------FSTGMERVNI--LKKLRSVSIEFPPDFDDNKMKVEK-KII------RLLIDHDP 272
Query: 214 KKRPTMKEV 222
KRP + +
Sbjct: 273 NKRPGARTL 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 25/173 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------------IHEQTEDQLP 49
+L+ + H ++VK G C + + ++V+E++ +G L+++ + + +
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
+ L IA +++ + YL AS HRD+ + N L+ KI DFG SR +
Sbjct: 130 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 110 RTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ G L PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 187 DYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 33/181 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY--------------------IH 41
+L Q+NH +V+KL G C + LL+ E+ GSL +
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 42 EQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101
D+ +T + A ++S + YL A + + HRD+ + NIL+ + + KISDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 102 TSRSMAVDRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQK 155
SR + + ++ VK + G + E +T +SDV+SFGV+L E++T G
Sbjct: 196 LSRDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 156 P 156
P
Sbjct: 252 P 252
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ + H +VKL T+ P+ ++ EF+ GSL ++ ++++ + +
Sbjct: 236 VMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSA 291
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+++ ++++ I HRD+++ANIL+ KI+DFG +R + + K
Sbjct: 292 QIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ PE FT KSDV+SFG++L+E++T G+ P
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 19/167 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE---QTEDQLPITWEIRLGI 58
I+S+ NH+N+V+ +G L++ ++ E + G L ++ E + + L +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLD---DKYRAKISDFGTSRSMAVDRTHLTT 115
A +++ YL HRDI + N LL AKI DFG +R + R
Sbjct: 146 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYYR 200
Query: 116 QVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
KG L PE F FT K+D +SFGV+L E+ + G P
Sbjct: 201 --KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH------EQTEDQL-PITWEI 54
+ + H+N+V+ LG E + E +P GSL + + E + T +I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHL 113
G L YLH I HRDIK N+L++ KISDFGTS+ +A
Sbjct: 132 LEG--------LKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 114 TTQVKGTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKP 156
T GT Y+ PE + + +D++S G ++E+ TG+ P
Sbjct: 181 ET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ Q +H ++VKL+G E V ++ E G L ++ + + L + + A +
Sbjct: 444 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDL--ASLILYAYQ 499
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+S AL+YL S + HRDI + N+L+ K+ DFG SR M + ++ K
Sbjct: 500 LSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 48/230 (20%), Positives = 77/230 (33%), Gaps = 44/230 (19%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRL 56
H V+L E + L E SL Q+ E Q+
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-------W 160
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
G + AL++LHS + H D+K ANI L + R K+ DFG +
Sbjct: 161 GYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEV 215
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF---- 172
+G Y+ PE Q + +DV+S G+ ++E+ +
Sbjct: 216 QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL--------------PHGGEG 260
Query: 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
Q + + L A + E V+ L + K R T + +
Sbjct: 261 WQQLRQGYLPPEFTAGLSSEL--RSVL------VMMLEPDPKLRATAEAL 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-29
Identities = 39/173 (22%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------------IHEQTEDQLP 49
+ +++ H NVV LLG + + +++ + +G LH++ + +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
+ + + +++ + YL +S + H+D+ + N+L+ DK KISD G R +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 110 RTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ L PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 182 DYY----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------------IHEQTEDQL 48
++ I H+N++ LLG C + ++ E+ G+L +Y +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
+T++ + +++ + YL AS HRD+ + N+L+ + KI+DFG +R +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 109 DRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ K T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 210 IDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++S+++H+++V G C+ + +LV EF+ GSL Y+ + ++ + I W+ L +A +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWK--LEVAKQ 121
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYR--------AKISDFGTSRSMAVDRTHL 113
++ A+ +L I H ++ + NILL + K+SD G S ++ + + L
Sbjct: 122 LAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDIL 177
Query: 114 TTQVKGTFGYLDPEYFQ-SSQFTEKSDVYSFGVVLVELLT-GQKP 156
++ PE + +D +SFG L E+ + G KP
Sbjct: 178 QERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 53/236 (22%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 2 ILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
L+++ + +++L + + +V E N L+ ++ ++ + WE +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDP-WERKS-YW 133
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQV 117
+ A+ +H I H D+K AN L+ D K+ DFG + M D T +QV
Sbjct: 134 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 118 KGTFGYLDPEYFQSS-----------QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
GT Y+ PE + + + KSDV+S G +L + G+ P +
Sbjct: 190 -GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIIN 244
Query: 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ +I+ N E D + E + ++V+ K CL + K+R ++ E+
Sbjct: 245 QISKLH-AIIDPNHEIEFPD---IPEKDLQDVL------KCCLKRDPKQRISIPEL 290
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 19/167 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHE---QTEDQLPITWEIRLGI 58
I+S+ NH+N+V+ +G L++ ++ E + G L ++ E + + L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLD---DKYRAKISDFGTSRSMAVDRTHLTT 115
A +++ YL HRDI + N LL AKI DFG +R + +
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY--- 240
Query: 116 QVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
KG L PE F FT K+D +SFGV+L E+ + G P
Sbjct: 241 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------------IHEQTEDQL 48
++ I H+N++ LLG C + ++ E+ G+L +Y +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
+T++ + +++ + YL AS HRD+ + N+L+ + KI+DFG +R +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 109 DRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ K T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 256 IDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 27/175 (15%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGSLHQY------------IHEQTEDQ 47
IL I +H NVV LLG C + PL+V EF G+L Y + + +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 48 LPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA 107
+T E + + +V+ + +L AS HRD+ + NILL +K KI DFG +R +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 108 VDRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
D + V+ L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 200 KDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 35/160 (21%), Positives = 67/160 (41%), Gaps = 21/160 (13%)
Query: 2 ILSQINHRNVVKLL-----GCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
L+++ H ++V++ V +V E++ SL + + + +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAI 185
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+E+ ALSYLHS + + D+K NI+L ++ + K+ D G +
Sbjct: 186 AYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NS-FGY 236
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
+ GT G+ PE ++ T +D+Y+ G L L
Sbjct: 237 LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 39/236 (16%)
Query: 2 ILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
L+++ +++L + + +V E N L+ ++ ++ + WE +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDP-WERKS-YW 161
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQV 117
+ A+ +H I H D+K AN L+ D K+ DFG + M D T +QV
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 118 KGTFGYLDPEYFQSS-----------QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
G Y+ PE + + + KSDV+S G +L + G+ P +
Sbjct: 218 -GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIIN 272
Query: 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ +I+ N E D + E + ++V+ K CL + K+R ++ E+
Sbjct: 273 QISKLH-AIIDPNHEIEFPD---IPEKDLQDVL------KCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 54/236 (22%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 2 ILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
L+++ +++L + + +V E N L+ ++ ++ + WE +
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDP-WERKS-YW 114
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQV 117
+ A+ +H I H D+K AN L+ D K+ DFG + M D T +QV
Sbjct: 115 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 118 KGTFGYLDPEYFQ-----------SSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
GT Y+ PE + S+ + KSDV+S G +L + G+ P +
Sbjct: 171 -GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIIN 225
Query: 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ +I+ N E D + E + ++V+ K CL + K+R ++ E+
Sbjct: 226 QISKLH-AIIDPNHEIEFPD---IPEKDLQDVL------KCCLKRDPKQRISIPEL 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY----------IHEQTEDQLPI 50
I+S + H N+V LLG C L++ E+ G L +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
+ L + +V+ +++L AS HRD+ + N+LL + + AKI DFG +R + D
Sbjct: 162 STRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 111 THLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ + L PE +T +SDV+S+G++L E+ + G P
Sbjct: 219 NY----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 29/174 (16%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------------IHEQTEDQL 48
+L ++ +H N++ LLG C L E+ P+G+L +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
++ + L A +V+ + YL + HRD+ + NIL+ + Y AKI+DFG SR V
Sbjct: 138 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 109 DRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
VK T G L E S +T SDV+S+GV+L E+++ G P
Sbjct: 195 -------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------------IHEQTEDQL 48
++ I H+N++ LLG C + ++ E+ G+L +Y + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
++ + + A +V+ + YL AS HRD+ + N+L+ + KI+DFG +R +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 109 DRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
+ K T G L PE +T +SDV+SFGV+L E+ T G P
Sbjct: 244 IDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY--------------IHEQTED 46
+LS + NH N+V LLG C L++ E+ G L + +D
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 47 QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM 106
+L + E L + +V+ +++L AS HRD+ + NILL KI DFG +R +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 107 AVDRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156
D + V L PE + +T +SDV+S+G+ L EL + G P
Sbjct: 196 KNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 43/181 (23%), Positives = 86/181 (47%), Gaps = 33/181 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY--------------------IH 41
++++ ++ N+VKLLG C + L++E++ G L+++
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 42 EQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101
+ P++ +L IA +V+ ++YL + HRD+ + N L+ + KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 102 TSRSMAVDRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQK 155
SR++ + + PE +++T +SDV+++GVVL E+ + G +
Sbjct: 220 LSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 156 P 156
P
Sbjct: 276 P 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 33/181 (18%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY-------------------IH 41
+++Q+ +H N+V LLG C + L++E+ G L Y
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 42 EQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101
E+ ED +T+E L A +V+ + +L HRD+ + N+L+ KI DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 102 TSRSMAVDRTHLTTQVKGTFGYL-----DPEYFQSSQFTEKSDVYSFGVVLVELLT-GQK 155
+R + D + V L PE +T KSDV+S+G++L E+ + G
Sbjct: 218 LARDIMSD----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 156 P 156
P
Sbjct: 274 P 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRL 56
I Q+ H ++++L E + LV E NG +++Y+ + +E+ E R
Sbjct: 64 IHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN------EARH 116
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+ ++ + YLHS I HRD+ +N+LL KI+DFG + + + T
Sbjct: 117 FMH-QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE S +SDV+S G + LL G+ P
Sbjct: 173 C-GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 42/232 (18%), Positives = 87/232 (37%), Gaps = 33/232 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ + +N V L + + +L +++ + + L I ++
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC-LHIFIQ 172
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK--- 118
++ A+ +LHS + HRD+K +NI K+ DFG +M D T
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 119 --------GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
GT Y+ PE + ++ K D++S G++L ELL T+ R
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERVR-- 281
Query: 171 YFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + + + + +E ++ + L+ + +RP ++
Sbjct: 282 -IITDVRNLKFPLLFTQKYPQEH---MMV------QDMLSPSPTERPEATDI 323
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I S + H N+++L G + L+ E+ P G++++ + + E
Sbjct: 62 IQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTAT- 113
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
E++ ALSY HS + HRDIK N+LL KI+DFG S A
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC- 168
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT YL PE + EK D++S GV+ E L G+ P
Sbjct: 169 -GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I++ I + + G + + ++YE++ N S+ ++ T I + +
Sbjct: 96 IITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 61 ----EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
V + SY+H+ +I HRD+K +NIL+D R K+SDFG S M + +
Sbjct: 155 CIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS- 210
Query: 117 VKGTFGYLDPEYFQSSQFT--EKSDVYSFGVVLVELLTGQKP 156
+GT+ ++ PE+F + K D++S G+ L + P
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 30/228 (13%), Positives = 62/228 (27%), Gaps = 23/228 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGSLHQYIHE---QTEDQLPITWEIRL 56
++ + +L + V LL+ + L +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRGDEGILALH 197
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+ ++ + L S + H N+ + R + D +
Sbjct: 198 ILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV----GTRGPA 250
Query: 117 VKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
Y E+ +S FT + + G+ + + P LV S L+
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 175 VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
V + L + + +I R LN + ++R E
Sbjct: 311 VPGTDSLAFGSCTPLPDFV--KTLI------GRFLNFDRRRRLLPLEA 350
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 48/255 (18%)
Query: 2 ILSQINHRNVVKLLGC--CLETEVPLLVYEFIPNGSLHQYIHEQ------TEDQLPITWE 53
+L ++NH+N+VKL T +L+ EF P GSL+ + E E E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES------E 113
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVD 109
+ + +V G +++L I HR+IK NI+ D + K++DFG +R + D
Sbjct: 114 FLI-VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-D 168
Query: 110 RTHLTTQVKGTFGYLDPEYFQSS--------QFTEKSDVYSFGVVLVELLTGQKPIRLVE 161
+ GT YL P+ ++ + ++ D++S GV TG P R
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR--P 225
Query: 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVA--------------KR 207
E R ++I + Q + + +
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 208 CLNLNGKKRPTMKEV 222
L + +K +
Sbjct: 286 ILEADQEKCWGFDQF 300
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I + H++VV G E + +V E SL + + TE E R
Sbjct: 94 IHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP------EARY- 145
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
++ YLH + HRD+K N+ L++ KI DFG + + D +
Sbjct: 146 YLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-L 201
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + + DV+S G ++ LL G+ P
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I + H++VV G E + +V E SL + + TE E R
Sbjct: 68 IHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP------EARY- 119
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
++ YLH + HRD+K N+ L++ KI DFG + + D +
Sbjct: 120 YLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-L 175
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + + DV+S G ++ LL G+ P
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 17/164 (10%), Positives = 49/164 (29%), Gaps = 12/164 (7%)
Query: 2 ILSQINHRNVVKLLGC----CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
++ + ++++ + + L + + + + + RL
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 215
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ ++V L+ LH + H ++ +I+LD + ++ F +
Sbjct: 216 LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRG 272
Query: 118 KGTFGYLDPEYFQSSQ-----FTEKSDVYSFGVVLVELLTGQKP 156
Q T D ++ G+ + + P
Sbjct: 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I S + H N++++ + L+ EF P G L++ + Q + +
Sbjct: 67 IQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSATFME- 121
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E++ AL Y H + HRDIK N+L+ K KI+DFG S R GT
Sbjct: 122 ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GT 175
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + EK D++ GV+ E L G P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETE-------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEI 54
I+ ++NH NVV + +PLL E+ G L +Y+++ E+ +
Sbjct: 65 IMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGP 122
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD---DKYRAKISDFGTSRSMAVDRT 111
+ ++S AL YLH I HRD+K NI+L + KI D G ++ + D+
Sbjct: 123 IRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQG 177
Query: 112 HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
L T+ GT YL PE + ++T D +SFG + E +TG +P
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 2 ILSQINHRNVVKLLGC--CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L ++NH+N+VKL T +L+ EF P GSL+ + E + + L +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVL 118
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRTHLTT 115
+V G +++L I HR+IK NI+ D + K++DFG +R + D +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS 174
Query: 116 QVKGTFGYLDPEYFQSS--------QFTEKSDVYSFGVVLVELLTGQKP 156
GT YL P+ ++ + ++ D++S GV TG P
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 47/232 (20%), Positives = 94/232 (40%), Gaps = 31/232 (13%)
Query: 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L + + H NV++ + + + E +L +Y+ ++ L + +
Sbjct: 70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG---LEPITLLQ 125
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDK-----YRAKISDFGTSRSMAVDRTHLT- 114
+ + L++LHS I HRD+K NIL+ +A ISDFG + +AV R +
Sbjct: 126 QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 115 -TQVKGTFGYLDPEYFQSSQF---TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
+ V GT G++ PE T D++S G V +++ +
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----- 237
Query: 171 YFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ L + + +E + ++ + ++ +KRP+ K V
Sbjct: 238 -ANILLGACSLDCLHPEKHEDVIARELI-------EKMIAMDPQKRPSAKHV 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 39/166 (23%), Positives = 61/166 (36%), Gaps = 19/166 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV- 60
+ NH N+V + +V F+ GS I D + IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYI 133
Query: 61 --EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
V AL Y+H + HR +K+++IL+ + +S ++ SM
Sbjct: 134 LQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 119 ------GTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKP 156
+L PE Q + + KSD+YS G+ EL G P
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 29/168 (17%), Positives = 55/168 (32%), Gaps = 16/168 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAV 60
L +K L +LV E G+L I+ + + + + A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA-----------KISDFGTSRSMAV- 108
+ + +H I H DIK N +L + + + D G S M +
Sbjct: 180 RMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 109 DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
+ + T T G+ E + + + D + + +L G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-24
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 35/231 (15%)
Query: 1 IILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG-I 58
I + ++ V G E +V + E + + SL ++ + + I E LG I
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDV-WICMELM-DTSLDKFYKQVIDKGQTIP-EDILGKI 114
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
AV + AL +LHS S+ I HRD+K +N+L++ + K+ DFG S + VD
Sbjct: 115 AVSIVKALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA- 170
Query: 119 GTFGYLDPE----YFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
G Y+ PE ++ KSD++S G+ ++EL + P
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD---------------- 214
Query: 175 VINENRLFEVLDAQVLREA--EKEEVITVAMVA--KRCLNLNGKKRPTMKE 221
+ F+ L V + + + V +CL N K+RPT E
Sbjct: 215 --SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 3e-24
Identities = 25/240 (10%), Positives = 63/240 (26%), Gaps = 52/240 (21%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--LLVYEFI--PNGSLHQYIHEQTEDQLPITWEIRLG 57
++ + ++++ + V +Y + + + + + + RL
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ ++V L+ LH + H ++ +I+LD + ++ F
Sbjct: 211 LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----S 262
Query: 118 KGTFGYLDPEYFQSSQ-----------FTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
+ G+ PE T D ++ G+V+ + P
Sbjct: 263 SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---------- 312
Query: 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
A E + + L + R +
Sbjct: 313 ---------------ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-24
Identities = 42/242 (17%), Positives = 83/242 (34%), Gaps = 47/242 (19%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
H +VV+ E + L+ E+ GSL I E + +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLD-------------------DKYRAKISDFG 101
+V L Y+HS + + H DIK +NI + +K KI D G
Sbjct: 123 QVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 102 TSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160
++ + +G +L E Q + K+D+++ + +V + R
Sbjct: 180 HVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
Query: 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK 220
+ I + R + + +E E++ K ++ + ++RP+
Sbjct: 235 DQ----------WHEIRQGR-LPRIPQVLSQEF--TELL------KVMIHPDPERRPSAM 275
Query: 221 EV 222
+
Sbjct: 276 AL 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 7e-24
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
+L + N +V G + E + GSL Q + + E L +
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------V 136
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS----RSMAVDRTHLT 114
++ V L+YL I HRD+K +NIL++ + K+ DFG S SMA + +
Sbjct: 137 SIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFV- 191
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRS 167
GT Y+ PE Q + ++ +SD++S G+ LVE+ G+ PI + +E
Sbjct: 192 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ--TEDQLPITWEIRLGIA 59
++ + + N+V L L + +V E++ GSL + E E Q+ +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VC 122
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E AL +LHS I HRDIKS NILL K++DFG + +++ +T V G
Sbjct: 123 RECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
T ++ PE + K D++S G++ +E++ G+ P + R+L +L I N
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL---YL--IATN 231
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
L+ EK I + RCL ++ +KR + KE
Sbjct: 232 ------GTPELQNPEKLSAIFRDFLN-RCLEMDVEKRGSAKE 266
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ--TEDQLPITWEIRLGIA 59
+LSQ + V K G L+ ++ E++ GS + E Q+ I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------IL 125
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E+ L YLHS I HRDIK+AN+LL + K++DFG + + + T V G
Sbjct: 126 REILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-G 181
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T ++ PE + S + K+D++S G+ +EL G+ P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 59/234 (25%), Positives = 91/234 (38%), Gaps = 37/234 (15%)
Query: 1 IILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG-I 58
+++ + +V+ G E + + E + Y + + I E LG I
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIP-EEILGKI 130
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
+ AL++L I HRDIK +NILLD K+ DFG S + VD T
Sbjct: 131 TLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDA- 186
Query: 119 GTFGYLDPEYFQSSQ----FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
G Y+ PE S + +SDV+S G+ L EL TG+ P +
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------------ 234
Query: 175 VINENRLFEVLDAQVLREA-----EKEEVITVAMVA--KRCLNLNGKKRPTMKE 221
+F+ L V + +E + + + CL + KRP KE
Sbjct: 235 ------VFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 51/247 (20%), Positives = 98/247 (39%), Gaps = 42/247 (17%)
Query: 7 NHRNVVKLLGCCLETEVP-------LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
H N+V+ + L+ + G L +++ ++ E + P++ + L I
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIF 142
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK- 118
+ A+ ++H PI HRD+K N+LL ++ K+ DFG++ +++ + + +
Sbjct: 143 YQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 119 ----------GTFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165
T Y PE EK D+++ G +L L Q P E+
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----EDG 256
Query: 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225
L ++N D Q +I + L +N ++R ++ EV +
Sbjct: 257 AKLR-----IVNGKYSIPPHDTQ---YTVFHSLI------RAMLQVNPEERLSIAEVVHQ 302
Query: 226 LAGIRAS 232
L I A+
Sbjct: 303 LQEIAAA 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-23
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIR-LGIAV 60
+SQ +H N+V + + LV + + GS+ I + + IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 61 ---EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
EV L YLH I HRD+K+ NILL + +I+DFG S +A +V
Sbjct: 126 ILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 118 KGTF-G---YLDPEYF-QSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
+ TF G ++ PE Q + K+D++SFG+ +EL TG P + + L
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--YHKYPPMKVL---M 237
Query: 173 LQVIN-----ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
L + N E + + + ++ ++ M++ CL + +KRPT E
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRK------MISL-CLQKDPEKRPTAAE 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-23
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ--TEDQLPITWEIRLGIA 59
I+ H NVV++ L E ++ EF+ G+L + + E+Q+ +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VC 147
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
V AL+YLH+ I HRDIKS +ILL R K+SDFG ++ D + V G
Sbjct: 148 EAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-G 203
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T ++ PE S + + D++S G++++E++ G+ P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 44/235 (18%)
Query: 1 IILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRL 56
++L + +V+ G + T+V + E + + Q E L
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGK------ 128
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+ V + AL YL + I HRD+K +NILLD++ + K+ DFG S + VD
Sbjct: 129 -MTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRS 184
Query: 117 VKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAY 171
G Y+ PE + ++DV+S G+ LVEL TGQ P + +T+
Sbjct: 185 A-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------- 235
Query: 172 FLQVINENRLFEVLDAQVLREA---EKEEVITVAMVA--KRCLNLNGKKRPTMKE 221
FEVL + E + + K CL + +KRP +
Sbjct: 236 ----------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLG 57
I+ Q + +VVK G + +V E+ GS+ I + TED+
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE---------- 126
Query: 58 IAV---EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
IA L YLH I HRDIK+ NILL+ + AK++DFG + +
Sbjct: 127 IATILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
T + GT ++ PE Q + +D++S G+ +E+ G+ P + R++ F+
Sbjct: 184 TVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP--YADIHPMRAI---FM- 236
Query: 175 VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221
I N R+ E V + CL + ++R T +
Sbjct: 237 -IPTN------PPPTFRKPELWSDNFTDFVKQ-CLVKSPEQRATATQ 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 52/250 (20%), Positives = 104/250 (41%), Gaps = 46/250 (18%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYI---HEQTEDQLPITWEIRL 56
+L++ +H NV++ C T+ L + E N +L + + E+ +
Sbjct: 61 LLTESDDHPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK-------------YRAKISDFGTS 103
+ +++ +++LHS + I HRD+K NIL+ R ISDFG
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 104 RSMAVDRTHLTTQVK---GTFGYLDPEYFQSSQF-------TEKSDVYSFGVVLVELLT- 152
+ + ++ T + GT G+ PE + S T D++S G V +L+
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLN 212
G+ P ++ + + + + + + D ++ EA ++I + ++ +
Sbjct: 236 GKHPF----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT--DLI------SQMIDHD 283
Query: 213 GKKRPTMKEV 222
KRPT +V
Sbjct: 284 PLKRPTAMKV 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 53/161 (32%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQ-LPITWEIRL 56
I+ +NH N+VKL +ETE L L+ E+ G + Y+ E + +I
Sbjct: 67 IMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI-- 123
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
VS A+ Y H I HRD+K+ N+LLD KI+DFG S L
Sbjct: 124 -----VS-AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAF 173
Query: 117 VKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
G Y PE FQ ++ + DV+S GV+L L++G P
Sbjct: 174 C-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 34/228 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
+L ++H N++KL + LV E G L I + E I
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-------AVI 141
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTT 115
+V ++YLH I HRD+K N+LL+ K KI DFG S +
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMK 196
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQV 175
+ GT Y+ PE + + EK DV+S GV+L LL G P ++ +V
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG------GQTDQEILRKV 249
Query: 176 INENRLFEVLD-AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F+ + V A K+ + K+ L + ++R + ++
Sbjct: 250 EKGKYTFDSPEWKNVSEGA-KDLI-------KQMLQFDSQRRISAQQA 289
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 52/157 (33%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
IL ++N R VV L ET+ L LV + G L +I+ + P E R A
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYA 292
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E+ L LH I +RD+K NILLDD +ISD G + + +T G
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVG 347
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T GY+ PE ++ ++T D ++ G +L E++ GQ P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLG 57
IL+ +H +VKLLG ++ EF P G++ + E TE Q+ +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------- 121
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ ++ AL++LHS I HRD+K+ N+L+ + +++DFG S + +
Sbjct: 122 VCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 118 KGTFGYLDPE-----YFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE + + + K+D++S G+ L+E+ + P
Sbjct: 179 -GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 34/228 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
+L Q++H N++KL + LV E G L I + +E I
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-------ARI 131
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTT 115
+V ++Y+H I HRD+K N+LL+ K +I DFG S + +
Sbjct: 132 IRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKD 187
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQV 175
++ GT Y+ PE + + EK DV+S GV+L LL+G P + +V
Sbjct: 188 KI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN------GANEYDILKKV 239
Query: 176 INENRLFEVLD-AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
FE+ +V A K+ + ++ L R + ++
Sbjct: 240 EKGKYTFELPQWKKVSESA-KDLI-------RKMLTYVPSMRISARDA 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
+L ++H N++KL + + LV EF G L + I + E I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-------ANI 151
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTT 115
++ + YLH I HRDIK NILL++K KI DFG S + D L
Sbjct: 152 MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRD 207
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQV 175
++ GT Y+ PE + + EK DV+S GV++ LL G P ++ +V
Sbjct: 208 RL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFG------GQNDQDIIKKV 259
Query: 176 INENRLFEVLD-AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F+ D + EA KE + K L + KR T +E
Sbjct: 260 EKGKYYFDFNDWKNISDEA-KELI-------KLMLTYDYNKRCTAEEA 299
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-20
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 2 ILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGSLHQYIHEQ--TED-------QLP 49
IL +++H NVVKL L E + +V+E + G + + + +ED L
Sbjct: 89 ILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQARFYFQDL- 146
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
+ G + YLH I HRDIK +N+L+ + KI+DFG S
Sbjct: 147 ------------IKG-IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 110 RTHLTTQVKGTFGYLDPEYFQSSQFT---EKSDVYSFGVVLVELLTGQKP 156
L+ V GT ++ PE ++ + DV++ GV L + GQ P
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-20
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
IL ++NH ++K+ + E +V E + G L + E +L
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA------TCKL-Y 244
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILL---DDKYRAKISDFGTSRSMAVDRTHLTT 115
++ A+ YLH I HRD+K N+LL ++ KI+DFG S+ + + + + T
Sbjct: 245 FYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT 300
Query: 116 QVKGTFGYLDPEYFQSSQF---TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
GT YL PE S D +S GV+L L+G P F
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------F 344
Query: 173 LQVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + L + Q+ E V+ A + L ++ K R T +E
Sbjct: 345 SEHRTQVSLKD----QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-19
Identities = 52/170 (30%), Positives = 69/170 (40%), Gaps = 33/170 (19%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TED-------QLP 49
I +NH NVVK G L E+ G L I E QL
Sbjct: 57 CINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL- 114
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
++ + YLH I HRDIK N+LLD++ KISDFG + +
Sbjct: 115 ------------MA-GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 110 RT--HLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
L GT Y+ PE + +F E DV+S G+VL +L G+ P
Sbjct: 159 NRERLLNKMC-GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 8/157 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
IL++++ R +V L ET+ L LV + G + +I+ ED E R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYT 295
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ L +LH I +RD+K N+LLDD +ISD G + + +T G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-G 351
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T G++ PE ++ D ++ GV L E++ + P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 15/163 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L + R + +L + E L LV E+ G L + + +++P R +A
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEM-ARFYLA- 169
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ A+ +H + HRDIK NILLD +++DFG+ + D T + GT
Sbjct: 170 EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 121 FGYLDPEYFQSSQFTEKSDVY-------SFGVVLVELLTGQKP 156
YL PE Q+ + Y + GV E+ GQ P
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 44/233 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
+L +++H N++KL E +V E G L I ++ +E
Sbjct: 74 LLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------AR 125
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSMAVDRTHLT 114
I +V ++Y+H I HRD+K NILL+ K KI DFG S + +
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MK 181
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
++ GT Y+ PE + + + EK DV+S GV+L LL+G P F
Sbjct: 182 DRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP---------------F-Y 223
Query: 175 VINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
NE + + V + + + T++ AK + L + R T +
Sbjct: 224 GKNEYDILKRVETGKY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
++S+++H VKL + + L + NG L +YI + E R
Sbjct: 83 VMSRLDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFY 135
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS-RSMAVDRTHLTTQ 116
A E+ AL YLH I HRD+K NILL++ +I+DFGT+ +
Sbjct: 136 TA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + SD+++ G ++ +L+ G P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 52/170 (30%), Positives = 69/170 (40%), Gaps = 33/170 (19%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TED-------QLP 49
I +NH NVVK G L E+ G L I E QL
Sbjct: 57 CINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL- 114
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
++ + YLH I HRDIK N+LLD++ KISDFG + +
Sbjct: 115 ------------MA-GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 110 RT--HLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
L GT Y+ PE + +F E DV+S G+VL +L G+ P
Sbjct: 159 NRERLLNKMC-GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 47/165 (28%), Positives = 69/165 (41%), Gaps = 29/165 (17%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRLG 57
L ++ H N ++ GC L LV E+ GS + E +
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE---------- 155
Query: 58 IAV---EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
IA L+YLHS I HRD+K+ NILL + K+ DFG++ MA +
Sbjct: 156 IAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--- 209
Query: 115 TQVKGTFGYLDPE---YFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT ++ PE Q+ K DV+S G+ +EL + P
Sbjct: 210 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 49/234 (20%), Positives = 90/234 (38%), Gaps = 38/234 (16%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I+L H N++ L + + +V E + G L I Q +E E
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER------EAS-A 120
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA----KISDFGTSRSMAVDRTHL 113
+ ++ + YLH+ + HRD+K +NIL D+ +I DFG ++ + + L
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
T T ++ PE + + D++S GV+L +LTG P +
Sbjct: 178 MTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---------- 226
Query: 174 QVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + + +V+ AK + L+++ +R T V
Sbjct: 227 ---TPEEILARIGSGKF--SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-19
Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 24/170 (14%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL------LVYEFIPNGSLHQYIHEQTEDQLPITWEI 54
+L + +HRN+ G ++ P LV EF GS+ I + L W
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-- 130
Query: 55 RLGIAV---EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT 111
IA E+ LS+LH I HRDIK N+LL + K+ DFG S +
Sbjct: 131 ---IAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 112 HLTTQVKGTFGYLDPEYFQSSQFTE-----KSDVYSFGVVLVELLTGQKP 156
T + GT ++ PE + + KSD++S G+ +E+ G P
Sbjct: 185 RRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L + + + L + + L LV ++ G L + + ED+LP R +A
Sbjct: 127 VLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-ARFYLA- 182
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ A+ +H + HRDIK NIL+D +++DFG+ + D T ++ GT
Sbjct: 183 EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 121 FGYLDPEYFQSSQFTEKS-----DVYSFGVVLVELLTGQKP 156
Y+ PE Q+ + + D +S GV + E+L G+ P
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 37/232 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I + H ++V+LL ++ L +V+EF+ L I ++ + + +
Sbjct: 79 ICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDRTHLTTQV 117
++ AL Y H I HRD+K +LL K + K+ FG + + +V
Sbjct: 138 QILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT ++ PE + + + DV+ GV+L LL+G P F
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP---------------FYG--T 236
Query: 178 ENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ RLFE +++ + + ++ AK R L L+ +R T+ E
Sbjct: 237 KERLFE----GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 28/230 (12%), Positives = 61/230 (26%), Gaps = 48/230 (20%)
Query: 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEV 62
LS+I+ V ++L L+V E+I GSL + + + +
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSL 138
Query: 63 SGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFG 122
+ A H A + + + + +
Sbjct: 139 AAAADAAHRA---GVALSIDHPSRVRVSIDGDVVL---------------------AYPA 174
Query: 123 YLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLF 182
+ + D+ G L LL + P+ + A +
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG---- 220
Query: 183 EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+ ++ + ++ VA R + +G R + + A
Sbjct: 221 QPIEPADIDRDIPFQISAVAA---RSVQGDGGIRSAS-TLLNLMQQATAV 266
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 54/239 (22%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I + H N+V+L E L+++ + G L + I + +E
Sbjct: 63 ICRLLKHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---------- 111
Query: 58 IAVE----VSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDR 110
A + A+ + H + HR++K N+LL K + K++DFG + + ++
Sbjct: 112 -ASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
GT GYL PE + + + D+++ GV+L LL G P +E
Sbjct: 168 QAWFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW----DE------ 216
Query: 171 YFLQVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+++RL++ Q+ + E TV AK + L +N KR T E
Sbjct: 217 ------DQHRLYQ----QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 50/237 (21%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
+L +++H N++KL ET + LV E + G L I E+ +E
Sbjct: 101 VLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERD---------- 149
Query: 58 IAVE----VSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDR 110
A + + A++YLH I HRD+K N+L KI+DFG S+ V+
Sbjct: 150 -AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEH 203
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
L V GT GY PE + + + D++S G++ LL G +P
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP-------------- 249
Query: 171 YFLQVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
F + +F +L+ + V++ AK + + L+ KKR T +
Sbjct: 250 -FYDERGDQFMFRRILNCEY--YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-18
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
IL ++NH ++K+ + E +V E + G L + E +L
Sbjct: 68 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA------TCKL-Y 119
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTT 115
++ A+ YLH I HRD+K N+LL + KI+DFG S+ + + + + T
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT 175
Query: 116 QVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
GT YL PE S + D +S GV+L L+G P F
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------F 219
Query: 173 LQVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + L + Q+ E V+ A + L ++ K R T +E
Sbjct: 220 SEHRTQVSLKD----QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 9e-18
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 2 ILSQIN---HRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEI 54
+LS ++ +V + T L + + + G LH ++ + +E +
Sbjct: 242 MLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD------M 294
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114
R A E+ L ++H+ + +RD+K ANILLD+ +ISD G + + + H
Sbjct: 295 RFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 348
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKS-DVYSFGVVLVELLTGQKP 156
V GT GY+ PE Q + S D +S G +L +LL G P
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 60/236 (25%), Positives = 92/236 (38%), Gaps = 40/236 (16%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
L H N+VKL + LV E + G L + I ++ +E +
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE---------- 107
Query: 58 IAVEV----SGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDR 110
A + A+S++H + HRD+K N+L D+ KI DFG +R D
Sbjct: 108 -ASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
L T T Y PE + + E D++S GV+L +L+GQ P + +RSL
Sbjct: 164 QPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ----SHDRSLTC 218
Query: 171 YFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
I + + E E V+ AK L ++ KR M +
Sbjct: 219 TSAVEIMKK----IKKGDF--SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
+L H + L +T L V E+ G L + H E E R
Sbjct: 201 VLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS---EDRARFYG 254
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E+ AL YLHS ++ +Y RD+K N++LD KI+DFG + + G
Sbjct: 255 AEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCG 311
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T YL PE + + + D + GVV+ E++ G+ P
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 44/233 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
+L +I H N+V L E+ LV + + G L I E+ TE +
Sbjct: 59 VLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEK------DAS-L 110
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILL---DDKYRAKISDFGTSRSMAVDRTHLT 114
+ +V A+ YLH I HRD+K N+L ++ + I+DFG S+ +++ +
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIM 164
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
+ GT GY+ PE +++ D +S GV+ LL G P EE
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY----EE---------- 210
Query: 175 VINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
E++LFE + + E E ++ AK L + +R T ++
Sbjct: 211 --TESKLFEKIKEGYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I+ + H +V L + E + +V + + G L ++ + E+ ++L
Sbjct: 68 IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET------VKLF 120
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
I E+ AL YL + I HRD+K NILLD+ I+DF + + + T +
Sbjct: 121 IC-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--M 174
Query: 118 KGTFGYLDPEYFQSSQFTEKS---DVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
GT Y+ PE F S + S D +S GV ELL G++P + + ++ + F
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGS-LHQYIHEQ---TEDQLPITWEIRL 56
ILS++ H N++K+L E + LV E +G L +I E
Sbjct: 82 ILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP------LASY 134
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
I ++ A+ YL I HRDIK NI++ + + K+ DFG++ + T
Sbjct: 135 -IFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTF 189
Query: 117 VKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
GT Y PE + + + +++S GV L L+ + P
Sbjct: 190 C-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 2 ILSQINHR--NVVKLLGCCLETEVPL-LVYEFI-PNGSLHQYIHEQ---TEDQLPITWEI 54
+L +++ V++LL E L+ E P L +I E+ E+
Sbjct: 99 LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE------LA 151
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHL 113
R +V A+ + H+ + HRDIK NIL+D ++ K+ DFG+ + T
Sbjct: 152 R-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVY 205
Query: 114 TTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
T GT Y PE+ + ++ + V+S G++L +++ G P
Sbjct: 206 TDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 25/225 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L ++H N++K+ E + +V E G L + I ++ +
Sbjct: 73 VLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDRTHLTTQV 117
++ AL+Y HS + H+D+K NIL D KI DFG + H T
Sbjct: 132 QMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA 187
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT Y+ PE F+ T K D++S GVV+ LLTG P SL +
Sbjct: 188 -GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF------TGTSLEEVQQKATY 239
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + V + +A + + K+ L + ++RP+ +V
Sbjct: 240 KEPNYAVECRPLTPQA-VDLL-------KQMLTKDPERRPSAAQV 276
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 32/167 (19%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TED-------QLPI 50
L H +++KL + T +V E++ G L YI + E Q+
Sbjct: 64 NLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI-- 120
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
+S A+ Y H + HRD+K N+LLD AKI+DFG S M+ D
Sbjct: 121 -----------LS-AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DG 164
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
L T G+ Y PE + + D++S GV+L LL G P
Sbjct: 165 EFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 47/235 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I ++ H N+V+L + E LV++ + G L + I + +E +
Sbjct: 58 ICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEA------DAS-H 109
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDRTHLT 114
++ +++Y HS I HR++K N+LL K + K++DFG + + D
Sbjct: 110 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWH 165
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
GT GYL PE + +++ D+++ GV+L LL G P +E
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW----DE---------- 210
Query: 175 VINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+++RL+ Q+ + E TV AK L +N KKR T +
Sbjct: 211 --DQHRLYA----QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TED-------QLP 49
I + H N+V+ + T L ++ E+ G L++ I +ED QL
Sbjct: 68 INHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL- 125
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY--RAKISDFGTSRSMA 107
+S +SY HS I HRD+K N LLD R KI DFG S+S
Sbjct: 126 ------------LS-GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
+ + + V GT Y+ PE ++ + +DV+S GV L +L G P
Sbjct: 170 LH-SQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 17/165 (10%)
Query: 2 ILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWE-I 54
I+ +++H N+V+L + EV L LV +++P ++++ + + + +
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHL 113
+L ++ +L+Y+HS I HRDIK N+LLD D K+ DFG+++ +
Sbjct: 159 KL-YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-N 213
Query: 114 TTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+ + + Y PE F ++ +T DV+S G VL ELL GQ PI
Sbjct: 214 VSYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 47/233 (20%), Positives = 90/233 (38%), Gaps = 44/233 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I+ ++H N+++L E + LV E G L + + + E +
Sbjct: 59 IMKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRES------DAA-R 110
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK---YRAKISDFGTSRSMAVDRTHLT 114
I +V A++Y H + HRD+K N L K+ DFG + + +
Sbjct: 111 IMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MR 166
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
T+V GT Y+ P+ + + + D +S GV++ LL G P
Sbjct: 167 TKV-GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS----AP---------- 210
Query: 175 VINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
++ + + + +++ + V+ A+ R L + K+R T +
Sbjct: 211 --TDSEVMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 5e-17
Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 13/126 (10%)
Query: 37 HQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAK 96
+ + + +T E + + +V+ + +L AS HRD+ + NILL +K K
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 233
Query: 97 ISDFGTSRSMAVDRTHLTTQVKGTFGYLD-----PEYFQSSQFTEKSDVYSFGVVLVELL 151
I DFG +R + D + V+ L PE +T +SDV+SFGV+L E+
Sbjct: 234 ICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
Query: 152 T-GQKP 156
+ G P
Sbjct: 290 SLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 17/44 (38%), Positives = 25/44 (56%), Gaps = 1/44 (2%)
Query: 7 NHRNVVKLLGCCLETEVPLLV-YEFIPNGSLHQYIHEQTEDQLP 49
+H NVV LLG C + PL+V EF G+L Y+ + + +P
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSL--HQYIHEQTEDQLPITWEIRLGI 58
I++ N VV+L + + L +V E++P G L ++ E R
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW------ARFYT 174
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVK 118
A EV AL +HS + HRD+K N+LLD K++DFGT M +
Sbjct: 175 A-EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 119 GTFGYLDPEYFQS----SQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE +S + + D +S GV L E+L G P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-17
Identities = 61/249 (24%), Positives = 106/249 (42%), Gaps = 46/249 (18%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
+L Q HRNV++L+ E + LV+E + GS+ +IH++ E +
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE---------- 112
Query: 58 IAVEV----SGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSM---- 106
A V + AL +LH+ I HRD+K NIL + + KI DF +
Sbjct: 113 -ASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 107 ---AVDRTHLTTQVKGTFGYLDPE-----YFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158
+ L T G+ Y+ PE ++S + ++ D++S GV+L LL+G P
Sbjct: 169 DCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
Query: 159 LVETEENRSLAAYFLQVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNG 213
+ +N LFE + + + E ++ ++ AK + L +
Sbjct: 228 -GRCGSDCGWDRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDA 284
Query: 214 KKRPTMKEV 222
K+R + +V
Sbjct: 285 KQRLSAAQV 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-17
Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 35/172 (20%)
Query: 2 ILSQINHRNVVKLLG-CCLETEVPL-LVYEFIPNGS--LHQYIHEQ--TED-------QL 48
+L ++ H+NV++L+ E + + +V E+ G + + E+ QL
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
+ G L YLHS I H+DIK N+LL KIS G + ++
Sbjct: 119 -------------IDG-LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 109 DRT--HLTTQVKGTFGYLDPEYFQSSQFTE--KSDVYSFGVVLVELLTGQKP 156
T G+ + PE K D++S GV L + TG P
Sbjct: 162 FAADDTCRTSQ-GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 55/239 (23%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
I ++ H N+V+L + E LV++ + G L + I + +E
Sbjct: 81 ICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEAD---------- 129
Query: 58 IAVE----VSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDR 110
A + +++Y HS I HR++K N+LL K + K++DFG + + +
Sbjct: 130 -ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--ND 183
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
+ GT GYL PE + +++ D+++ GV+L LL G P +E
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW----DE------ 233
Query: 171 YFLQVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+++RL+ Q+ + E TV AK L +N KKR T +
Sbjct: 234 ------DQHRLYA----QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 48/233 (20%), Positives = 92/233 (39%), Gaps = 43/233 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYI----HEQTEDQLPITWEIRL 56
I++Q++H ++ L E + + L+ EF+ G L I ++ +E + + +R
Sbjct: 101 IMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE--VINYMR- 156
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA--KISDFGTSRSMAVDRTHLT 114
+ L ++H + I H DIK NI+ + K + KI DFG + + +
Sbjct: 157 ----QACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVK 208
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
T + PE +D+++ GV+ LL+G P F
Sbjct: 209 VTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAG 252
Query: 175 VINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
++ + V E +++ +V+ AK L +KR T+ +
Sbjct: 253 E-DDLETLQNVKRCDW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 54/270 (20%), Positives = 91/270 (33%), Gaps = 71/270 (26%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H N+ +L + + LV E G L ++ +D + +
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 62 VSG------------------------------------ALSYLHSAASIPIYHRDIKSA 85
AL YLH+ I HRDIK
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 86 NILLDDK--YRAKISDFGTSRSMAV----DRTHLTTQVKGTFGYLDPEYFQSSQ--FTEK 137
N L + K+ DFG S+ + +TT+ GT ++ PE ++ + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPK 256
Query: 138 SDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFE-VLDAQVLREAEKE 196
D +S GV+L LL G P F V N+ VL+ ++ E
Sbjct: 257 CDAWSAGVLLHLLLMGAVP---------------FPGV-NDADTISQVLNKKL--CFENP 298
Query: 197 EVITVAMVAK----RCLNLNGKKRPTMKEV 222
++ +A+ LN N +R
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 46/234 (19%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGI 58
+L +++H N++KL ++ +V E G L I ++ +E I
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARI 126
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMAVDRTHLTT 115
+V ++Y+H I HRD+K NILL+ K + KI DFG S + +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKD 182
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQV 175
++ GT Y+ PE + + + EK DV+S GV+L LL+G P +
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY----GK----------- 225
Query: 176 INENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
NE + + +V + + T++ AK + L + R T +
Sbjct: 226 -NEYDILK----RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 7 NHRNVVKLLGCCLETEVPL-LVYEF-IPNGSLHQYIHEQ---TEDQLPITWEIRLGIAVE 61
H V++LL ET+ LV E +P L YI E+ E R +
Sbjct: 96 GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG------PSR-CFFGQ 147
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGT 120
V A+ + HS + HRDIK NIL+D + AK+ DFG+ + T GT
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GT 201
Query: 121 FGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
Y PE+ Q+ + V+S G++L +++ G P
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 2 ILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPNGSLHQYI--HEQTEDQLPITWE 53
I+ + H NVV L EV L LV E++P ++++ + + + +P+
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML-L 142
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTH 112
I+L ++ +L+Y+HS I HRDIK N+LLD K+ DFG+++ +
Sbjct: 143 IKL-YMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP- 197
Query: 113 LTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQ 154
+ + + Y PE F ++ +T D++S G V+ EL+ GQ
Sbjct: 198 NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 52/234 (22%), Positives = 94/234 (40%), Gaps = 44/234 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL Q+ H NV+ L E + L+ E + G L ++ ++ +E++ T I+
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEE--ATSFIK-- 122
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRTHL 113
++ ++YLH+ I H D+K NI+L K+ DFG + + D
Sbjct: 123 ---QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF 175
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 174 QVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + + ++E + +AK + L +KR T++E
Sbjct: 220 GD-TKQETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYI----HEQTEDQLPITWEIRL 56
+++Q++H N+++L E++ + LV E++ G L I + TE ++
Sbjct: 139 VMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TILFMK- 194
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA--KISDFGTSRSMAVDRTHLT 114
++ + ++H I H D+K NIL ++ KI DFG +R R L
Sbjct: 195 ----QICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLK 246
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT +L PE + +D++S GV+ LL+G P
Sbjct: 247 VNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 24/166 (14%)
Query: 2 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRL 56
IL +++ H N+++L ET LV++ + G L Y+ E+ +E E R
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK------ETR- 127
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
I + + LH I HRD+K NILLDD K++DFG S + L
Sbjct: 128 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 117 VKGTFGYLDPEYFQSSQF------TEKSDVYSFGVVLVELLTGQKP 156
GT YL PE + S ++ D++S GV++ LL G P
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-16
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 44/234 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL +I H N++ L E + + L+ E + G L ++ E+ TED+ T ++
Sbjct: 61 ILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDE--ATQFLK-- 115
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA----KISDFGTSRSMAVDRTHL 113
++ + YLHS I H D+K NI+L DK K+ DFG + +
Sbjct: 116 ---QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF 168
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 212
Query: 174 QVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + + ++E + +AK R L + K+R T+ +
Sbjct: 213 GE-TKQETLTNISAVNY--DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 47/167 (28%), Positives = 70/167 (41%), Gaps = 32/167 (19%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TED-------QLPI 50
L H +++KL + T + +V E++ G L YI + E Q+
Sbjct: 69 NLKLFRHPHIIKLYQ-VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI-- 125
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
+S + Y H + HRD+K N+LLD AKI+DFG S M+
Sbjct: 126 -----------LS-GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
L T G+ Y PE + + D++S GV+L LL G P
Sbjct: 171 -FLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-16
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGSLHQYIHEQTEDQ--LPITWE 53
++ +NH+N++ LL + +V E + +L Q I + + + + ++
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113
+ G + +LHSA I HRD+K +NI++ KI DFG +R+ + +
Sbjct: 136 MLCG--------IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFM 182
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T T Y PE + E D++S G ++ E++ G +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 51/239 (21%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRL 56
IL Q+ H +++ L+ E+ + LV++ + G L Y+ E+ +E E R
Sbjct: 152 ILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK------ETR- 203
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
I + A+S+LH+ I HRD+K NILLDD + ++SDFG S + L
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LREL 259
Query: 117 VKGTFGYLDPEYFQSSQF------TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
GT GYL PE + S ++ D+++ GV+L LL G P
Sbjct: 260 C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW----HR------ 308
Query: 171 YFLQVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + ++ + E + K R L ++ + R T ++
Sbjct: 309 ------RQILMLR----MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 45/233 (19%), Positives = 86/233 (36%), Gaps = 43/233 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRL 56
+S + H +V L E + + ++YEF+ G L + + ++ +ED+ +R
Sbjct: 207 TMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--AVEYMR- 262
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK--YRAKISDFGTSRSMAVDRTHLT 114
+V L ++H H D+K NI+ K K+ DFG + + + +
Sbjct: 263 ----QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVK 314
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
GT + PE + +D++S GV+ LL+G P F
Sbjct: 315 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---------------FGG 358
Query: 175 VINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
N++ V + ++ K + L + R T+ +
Sbjct: 359 -ENDDETLRNVKSCDW--NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 54/159 (33%), Positives = 87/159 (54%), Gaps = 16/159 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL ++NH +VKL +TE L L+ +F+ G L + ++ TE+ ++
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED------VKFY 131
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+A E++ AL +LHS I +RD+K NILLD++ K++DFG S+ ++D
Sbjct: 132 LA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE T+ +D +SFGV++ E+LTG P
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 48/236 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL Q+ H N++ L E + L+ E + G L ++ ++ +E++ T I+
Sbjct: 68 ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEE--ATSFIK-- 122
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK----YRAKISDFGTSRSMAVDRTHL 113
++ ++YLH+ I H D+K NI+L DK K+ DFG + + D
Sbjct: 123 ---QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 174 QVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + + ++E + +AK + L +KR T++E
Sbjct: 220 G-DTKQETLA----NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 47/254 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ----TEDQLPITWEIRL 56
IL+ HRN++ L E+ L +++EFI + + I+ E + I +
Sbjct: 54 ILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNERE--IVSYVH- 109
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA--KISDFGTSRSMAVDRTHLT 114
+V AL +LHS I H DI+ NI+ + + KI +FG +R +
Sbjct: 110 ----QVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFR 161
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
Y PE Q + +D++S G ++ LL+G P FL
Sbjct: 162 LLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FLA 205
Query: 175 VINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEVALE---L 226
++ E +++A+ ++E +++ A R L K R T E AL+ L
Sbjct: 206 E-TNQQIIENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE-ALQHPWL 261
Query: 227 AGIRASIGASVLRQ 240
+ V+R
Sbjct: 262 KQKIERVSTKVIRT 275
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 40/166 (24%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 2 ILSQINHRNVVKLL------GCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWE- 53
L+ ++H N+V+L G ++ L +V E++P+ +LH+ Q+
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTH 112
I++ ++ ++ LH S+ + HRDIK N+L++ K+ DFG+++ ++ +
Sbjct: 131 IKV-FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 113 LTTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+ + Y PE F + +T D++S G + E++ G+ PI
Sbjct: 189 VAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 44/234 (18%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL +I H NV+ L E + + L+ E + G L ++ E+ TE++ T ++
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEE--ATEFLK-- 121
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA----KISDFGTSRSMAVDRTHL 113
++ + YLHS I H D+K NI+L D+ KI DFG + +
Sbjct: 122 ---QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEF 174
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 175 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 218
Query: 174 QVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ V E E E + +AK R L + KKR T+++
Sbjct: 219 GD-TKQETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
+L H + L +T L V E+ G L + H E E R
Sbjct: 58 VLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT---EERARFYG 111
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQVK 118
E+ AL YLHS + +RDIK N++LD KI+DFG + ++ T
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 166
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT YL PE + + + D + GVV+ E++ G+ P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 16/162 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
+L+ +H N++ L + E P LV E + L Q IH+Q ++ I+ +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ---RIVISPQHIQ 137
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
+ L LH A + HRD+ NILL D I DF +R D + T
Sbjct: 138 YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHY 193
Query: 117 VKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V Y PE Q FT+ D++S G V+ E+ K +
Sbjct: 194 V-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-15
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGSLHQYIHEQTEDQLP--ITWE 53
++ +NH+N++ LL + LV E + +L Q I + + + + ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ 172
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113
+ G + +LHSA I HRD+K +NI++ KI DFG +R+ +
Sbjct: 173 MLCG--------IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMM 220
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T V T Y PE + E D++S G ++ E++ K +
Sbjct: 221 TPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-15
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL ++ H +V L+ +T L L+ E++ G L + + ED
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------ACFY 126
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+A E+S AL +LH I +RD+K NI+L+ + K++DFG + ++ +T
Sbjct: 127 LA-EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTF 181
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE S D +S G ++ ++LTG P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 4e-15
Identities = 37/162 (22%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP-----ITWEIRL 56
+L ++ H+N+V+L + LV+EF L +Y D P +++
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
G+ + HS + HRD+K N+L++ K+++FG +R+ + + +
Sbjct: 113 GLG--------FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 117 VKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V T Y P+ F + ++ D++S G + EL +P+
Sbjct: 162 VV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 52/167 (31%), Positives = 74/167 (44%), Gaps = 33/167 (19%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TED-------QLPI 50
L + H +++KL + T + +V E+ G L YI E+ TED Q+
Sbjct: 62 YLKLLRHPHIIKLYD-VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI-- 117
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
+ A+ Y H I HRD+K N+LLDD KI+DFG S M D
Sbjct: 118 -----------IC-AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDG 161
Query: 111 THLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKP 156
L T G+ Y PE + + DV+S G+VL +L G+ P
Sbjct: 162 NFLKTSC-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 9/159 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL--GIA 59
++ ++ H N+V+L LV+EF+ N L +Y+ +T P E+ L
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ L++ H I HRD+K N+L++ + + K+ DFG +R+ + +++V
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV- 170
Query: 120 TFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T Y P+ S ++ D++S G +L E++TG KP+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGSLHQYIHEQ--TEDQL-PITW 52
+L + H NV+ LL E LV F+ L + + + ED++ + +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVY 135
Query: 53 EIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
++ G L Y+H+A I HRD+K N+ +++ KI DFG +R +
Sbjct: 136 QMLKG--------LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD---SE 181
Query: 113 LTTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+T V T Y PE ++T+ D++S G ++ E++TG K +
Sbjct: 182 MTGYV-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 38/157 (24%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N+V L + LV+E++ L QY+ + + + + ++L +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMH-NVKLFLFQL 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ G L+Y H + HRD+K N+L++++ K++DFG +R+ ++ +V T
Sbjct: 110 LRG-LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TL 164
Query: 122 GYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y P+ S+ ++ + D++ G + E+ TG +P+
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 16/155 (10%)
Query: 7 NHRNVVKLLGCCL--ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSG 64
N++ L + P LV+E + N Q T+ IR + E+
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD------IRFYM-YEILK 141
Query: 65 ALSYLHSAASIPIYHRDIKSANILLDDKYRA-KISDFGTSRSMAVDRTHLTTQVKGTFGY 123
AL Y HS I HRD+K N+++D ++R ++ D+G + + +V + +
Sbjct: 142 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYF 196
Query: 124 LDPEYFQSSQFTEKS-DVYSFGVVLVELLTGQKPI 157
PE Q + S D++S G +L ++ ++P
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 52/234 (22%), Positives = 86/234 (36%), Gaps = 42/234 (17%)
Query: 2 ILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLP---ITWEIRL 56
+L V+ L E + L+ E+ G + + + + + I+
Sbjct: 81 VLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK- 138
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY---RAKISDFGTSRSMAVDRTHL 113
++ + YLH I H D+K NILL Y KI DFG SR + L
Sbjct: 139 ----QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACEL 190
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
+ GT YL PE T +D+++ G++ LLT P F+
Sbjct: 191 REIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP---------------FV 234
Query: 174 QVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + + V + +E +V+ +A L N +KRPT +
Sbjct: 235 GE-DNQETYLNISQVNV--DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 27/166 (16%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGSLHQYIHEQ--TEDQL-PITW 52
+L + H NV+ LL LV + L+ + Q T+D + + +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIY 139
Query: 53 EIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
+I G L Y+HSA I HRD+K +N+ +++ KI DFG +R A
Sbjct: 140 QILRG--------LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA---DE 185
Query: 113 LTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+T V T Y PE + + D++S G ++ ELLTG + +
Sbjct: 186 MTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-14
Identities = 39/157 (24%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L +++H N+V L+ LV+EF+ L + + ++ + L + +I++ +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDS-QIKI-YLYQ 127
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ +++ H I HRD+K N+L++ K++DFG +R+ + T +V T
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TL 183
Query: 122 GYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
Y P+ S +++ D++S G + E++TG KP+
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGSLHQYIHEQ-TEDQL-PITWE 53
+L + H NV+ LL LV F+ L + + + +E+++ + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ 134
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL 113
+ G L Y+HSA + HRD+K N+ +++ KI DFG +R +
Sbjct: 135 MLKG--------LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEM 180
Query: 114 TTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T V T Y PE + + D++S G ++ E+LTG K +
Sbjct: 181 TGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 50/245 (20%), Positives = 86/245 (35%), Gaps = 56/245 (22%)
Query: 1 IILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQ-----TEDQLPIT 51
++V +L L++ E + G L I E+ TE +
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE---- 129
Query: 52 WEIRLGIAVEV----SGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSR 104
A E+ A+ +LHS I HRD+K N+L K + K++DFG ++
Sbjct: 130 -------AAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 105 SMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE 164
+ L T T Y+ PE ++ + D++S GV++ LL G P
Sbjct: 180 E--TTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-------- 228
Query: 165 NRSLAAYFLQVINENRLFEVLDAQVLR---EAEKEEVITVAMVAK----RCLNLNGKKRP 217
F + + ++ E V+ AK L + +R
Sbjct: 229 -------F-YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280
Query: 218 TMKEV 222
T+ +
Sbjct: 281 TITQF 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRL 56
+ Q NH +V L C +TE L V E++ G L ++ Q E+ R
Sbjct: 62 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA------RF 114
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTT 115
A E+S AL+YLH I +RD+K N+LLD + K++D+G + + T T+
Sbjct: 115 YSA-EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS 168
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + + D ++ GV++ E++ G+ P
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 3 LSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
L H NVV+L+ C + LV+E + L Y+ + LP I+
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE-TIKD- 124
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ + L +LH+ I HRD+K NIL+ K++DFG +R + LT V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVV 180
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T Y PE S + D++S G + E+ KP+
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
IL +N +VKL + L +V E++ G + ++ +E R
Sbjct: 94 ILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFY 146
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
A ++ YLHS + +RD+K N+L+D + +++DFG A T +
Sbjct: 147 AA-QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTL 198
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT L PE S + + D ++ GV++ E+ G P
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 2 ILSQINHRN-VVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L I +V L +TE L L+ ++I G L + H ++ +++ +
Sbjct: 111 VLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHE-VQIYVG 166
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
E+ AL +LH I +RDIK NILLD ++DFG S+ D T G
Sbjct: 167 -EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 120 TFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRS 167
T Y+ P+ + + D +S GV++ ELLTG P + + +++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI-A 59
+L+ + L C +T L V E++ G L H Q + E A
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFK---EPHAVFYA 448
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQVK 118
E++ L +L S I +RD+K N++LD + KI+DFG + ++ T T
Sbjct: 449 AEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFC 503
Query: 119 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + + D ++FGV+L E+L GQ P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRL 56
+ Q NH +V L C +TE L V E++ G L ++ Q E+ R
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH------ARF 157
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTT 115
A E+S AL+YLH I +RD+K N+LLD + K++D+G + + T T+
Sbjct: 158 YSA-EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TS 211
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + + D ++ GV++ E++ G+ P
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-14
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP-----ITWEIRL 56
IL ++ H N+VKL + +LV+E + L + + ++
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
GIA Y H + HRD+K N+L++ + KI+DFG +R+ + T +
Sbjct: 112 GIA--------YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 117 VKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+ T Y P+ S +++ D++S G + E++ G P+
Sbjct: 161 IV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 3 LSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
L H NVV+L C + LV+E + L Y+ + E +P I+
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TIKD- 124
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+ ++ L +LHS + HRD+K NIL+ + K++DFG +R + LT+ V
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVV 180
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T Y PE S + D++S G + E+ KP+
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 26/168 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQ--TEDQL-PITWE 53
IL + H N++ + + +V + + L++ + Q + D + ++
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ 136
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH- 112
I G L Y+HSA + HRD+K +N+LL+ KI DFG +R D H
Sbjct: 137 ILRG--------LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 113 --LTTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
LT V T Y PE S +T+ D++S G +L E+L+ +PI
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 53/159 (33%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI- 58
ILS NH + +L CC +T L V EF+ G L H Q + E R
Sbjct: 76 ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD---EARARFY 129
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQV 117
A E+ AL +LH I +RD+K N+LLD + K++DFG + + T T
Sbjct: 130 AAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATF 184
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE Q + D ++ GV+L E+L G P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-13
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLG 57
+LS + H ++++ G + + ++ ++I G L + + +
Sbjct: 59 MLSIVTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV------AKFY 111
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
A EV AL YLHS I +RD+K NILLD KI+DFG ++ D T+
Sbjct: 112 AA-EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY----- 161
Query: 118 KGTF-G---YLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
T G Y+ PE + + + D +SFG+++ E+L G P
Sbjct: 162 --TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI- 58
++ H + + C +T+ L V E++ G L H Q+ + R
Sbjct: 70 VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFD---LSRATFY 123
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQV 117
A E+ L +LHS I +RD+K NILLD KI+DFG + +M D T
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTF 178
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE ++ D +SFGV+L E+L GQ P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI- 58
++L + H +V L +T L V ++I G L + H Q E E R
Sbjct: 91 VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFL---EPRARFY 144
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTS-RSMAVDRTHLTTQV 117
A E++ AL YLHS I +RD+K NILLD + ++DFG ++ + T T+
Sbjct: 145 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTF 199
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT YL PE + D + G VL E+L G P
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 32/132 (24%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWE-IRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84
++ E++P+ +LH+ + I I + ++ A+ ++HS I HRDIK
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHSLG---ICHRDIKP 169
Query: 85 ANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPE-YFQSSQFTEKSDVYS 142
N+L++ K+ DFG+++ + + + Y PE ++++T D++S
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYI-CSRFYRAPELMLGATEYTPSIDLWS 227
Query: 143 FGVVLVELLTGQ 154
G V EL+ G+
Sbjct: 228 IGCVFGELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI- 58
+L+ + +L C +T L V E++ G L H Q + E
Sbjct: 73 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFK---EPHAVFY 126
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR-SMAVDRTHLTTQV 117
A E++ L +L S I +RD+K N++LD + KI+DFG + ++ T T
Sbjct: 127 AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTF 181
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
GT Y+ PE + + D ++FGV+L E+L GQ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 21/160 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP------ITWEIR 55
+L Q+ H N+V LL LV+E+ + ++ + ++ + +P ITW+
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTL 112
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ + H HRD+K NIL+ K+ DFG +R + +
Sbjct: 113 QAVN--------FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161
Query: 116 QVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQ 154
+V T Y PE +Q+ DV++ G V ELL+G
Sbjct: 162 EV-ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 46/199 (23%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 2 ILSQINHRNVVKLLGCCLE-TEVPL-LVYEFIPNGSLHQYIH-----EQTEDQLPITWEI 54
+L ++ H NV+ L L + + L++++ + L I + + + + +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA----KISDFGTSRSMAV-- 108
+ ++ + YLH+ + HRD+K ANIL+ + KI+D G +R
Sbjct: 130 VKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 109 -DRTHLTTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
L V TF Y PE + +T+ D+++ G + ELLT +PI E+ +
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 244
Query: 167 SLAAYFLQVINENRLFEVL 185
+ Y + +R+F V+
Sbjct: 245 TSNPYHHDQL--DRIFNVM 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 43/180 (23%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQ--TED-------Q 47
IL H N++ + ++ E + LH+ I Q ++D Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQ 120
Query: 48 LPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA 107
+R A+ LH + + HRD+K +N+L++ K+ DFG +R +
Sbjct: 121 T-----LR---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 108 VDRTHLTTQVKGTFG---------YLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
+ G Y PE S++++ DV+S G +L EL +PI
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP------ITWEIR 55
+L Q+ H N+V LL C + + LV+EF+ + ++ + E + L ++I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQII 134
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
GI + HS I HRDIK NIL+ K+ DFG +R++A
Sbjct: 135 NGIG--------FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 116 QVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQ 154
+V T Y PE ++ + DV++ G ++ E+ G+
Sbjct: 184 EVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL--------LVYEFIPNGSLHQYIHEQTEDQLPITWE 53
IL + H NVV L+ C P LV++F + L + + ++ E
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLS-E 125
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV----D 109
I+ + + L Y+H I HRD+K+AN+L+ K++DFG +R+ ++
Sbjct: 126 IKR-VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 110 RTHLTTQVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
T +V T Y PE + D++ G ++ E+ T PI
Sbjct: 182 PNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 38/163 (23%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPIT-WEIRLGIAV 60
+L ++ HRN+++L L++E+ N L +Y+ + ++ I+ +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM----DKNPDVSMRVIKSFLYQ 140
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA-----KISDFGTSRSMAVDRTHLTT 115
++G +++ HS HRD+K N+LL + KI DFG +R+ + T
Sbjct: 141 LING-VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 116 QVKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
++ T Y PE S ++ D++S + E+L P+
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 26/169 (15%)
Query: 1 IILSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGSLHQYIHEQ-----TEDQLPI 50
+ ++V+++ E L+V E + G L I ++ TE +
Sbjct: 107 LHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS- 164
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMA 107
I + A+ YLHS I I HRD+K N+L K K++DFG ++
Sbjct: 165 ------EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
+ LTT T Y+ PE ++ + D++S GV++ LL G P
Sbjct: 216 SHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 20/162 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP-----ITWEIRL 56
+L +++H N++ LL LV++F+ L I + + P
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ 116
G+ YLH I HRD+K N+LLD+ K++DFG ++S T Q
Sbjct: 124 GLE--------YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 117 VKGTFGYLDPEY-FQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
V T Y PE F + + D+++ G +L ELL P
Sbjct: 173 VV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 36/178 (20%)
Query: 2 ILSQINHRNVVKLL------GCCLETEVPL--------LVYEFIPNGSLHQYIHEQ--TE 45
I+ +++H N+VK+ G L +V +V E++ L + + E
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLE 119
Query: 46 DQLP-ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK-YRAKISDFGTS 103
+ +++ G L Y+HSA + HRD+K AN+ ++ + KI DFG +
Sbjct: 120 EHARLFMYQLLRG--------LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 104 RSMAVDRTH---LTTQVKGTFGYLDPE-YFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157
R M +H L+ + T Y P + +T+ D+++ G + E+LTG K +
Sbjct: 169 RIMDPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 34/186 (18%), Positives = 69/186 (37%), Gaps = 43/186 (23%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQ---TEDQL-PITW 52
IL+++ +++L + ++ +V E + L + TE+ + I +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILY 136
Query: 53 EIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
+ LG +++H + I HRD+K AN LL+ K+ DFG +R++ ++
Sbjct: 137 NLLLG--------ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 113 LTTQVKGTFGYLDP----------EY------------FQSSQFTEKSDVYSFGVVLVEL 150
P + +T+ D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 151 LTGQKP 156
L +
Sbjct: 246 LNMLQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 47/189 (24%), Positives = 71/189 (37%), Gaps = 63/189 (33%)
Query: 7 NHRNVVKLLGCCLETEVPL--------LVYEFIPNGSLHQYIHEQ--TED-------QLP 49
H N+V LL V LV++++ LH I QL
Sbjct: 67 GHENIVNLL------NVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQL- 118
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD 109
I+ + YLHS + HRD+K +NILL+ + K++DFG SRS
Sbjct: 119 ----IK---------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 110 RTHLTTQVKGTFGYLDP---------EY------------FQSSQFTEKSDVYSFGVVLV 148
R + +Y S+++T+ D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 149 ELLTGQKPI 157
E+L G KPI
Sbjct: 223 EILCG-KPI 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 41/193 (21%), Positives = 69/193 (35%), Gaps = 52/193 (26%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGSLHQYIHEQTEDQLP------I 50
IL+++NH +VVK+L + +V +V E + + T L +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR--TPVYLTELHIKTL 161
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR 110
+ + +G + Y+HSA I HRD+K AN L++ K+ DFG +R++
Sbjct: 162 LYNLLVG--------VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 111 THLTTQVKGTFGYLDP---------------EY------------FQSSQFTEKSDVYSF 143
+ + +TE DV+S
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
Query: 144 GVVLVELLTGQKP 156
G + ELL K
Sbjct: 271 GCIFAELLNMIKE 283
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 41/193 (21%)
Query: 2 ILSQINHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGSLHQYIHEQTE 45
IL + + NV+ +L C+ E LL +YE I +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPL-- 201
Query: 46 DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA--KISDFGTS 103
+R A + L LH I H D+K NILL + R+ K+ DFG+S
Sbjct: 202 --------VRK-FAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249
Query: 104 RSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163
+ + T ++ F Y PE +++ D++S G +L ELLTG P L+ E
Sbjct: 250 ---CYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG-YP--LLPGE 302
Query: 164 ENRSLAAYFLQVI 176
+ A ++++
Sbjct: 303 DEGDQLACMIELL 315
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 35/165 (21%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 7 NHRNVVKLLGC-----------CLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIR 55
+++KLL + E +L +L I + +P+ + ++
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VL------GENLLALIKKYEHRGIPLIY-VK 134
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA------KISDFGTSRSMAVD 109
I+ ++ L Y+H I I H DIK N+L++ KI+D G +
Sbjct: 135 Q-ISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLGNACW---Y 188
Query: 110 RTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154
H T ++ Y PE + + +D++S ++ EL+TG
Sbjct: 189 DEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 41/194 (21%)
Query: 2 ILSQINHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGSLHQYIHEQTE 45
+L +N +V L CL E +L +Y+ + T
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLL----------RNTN 150
Query: 46 DQ-LPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA--KISDFGT 102
+ + + R A ++ AL +L + + I H D+K NILL + R+ KI DFG+
Sbjct: 151 FRGVSLN-LTRK-FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207
Query: 103 SRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162
S + ++ F Y PE + D++S G +LVE+ TG +P L
Sbjct: 208 S---CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EP--LFSG 260
Query: 163 EENRSLAAYFLQVI 176
++V+
Sbjct: 261 ANEVDQMNKIVEVL 274
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 62/325 (19%), Positives = 92/325 (28%), Gaps = 125/325 (38%)
Query: 2 ILSQI--------NHRNVVKLLGC-----------CLETEVPLLVYEFIPNG-SLHQYIH 41
+L + N VV+LL C+ V+E G L ++I
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWII 136
Query: 42 EQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILL------------ 89
+ LP+ I +V L YLH+ I H DIK NILL
Sbjct: 137 KSNYQGLPL--PCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAA 192
Query: 90 -------------------------------------DDKYRAKISDFGTSRSMAVDRTH 112
+K + KI+D G + + T
Sbjct: 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE 252
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK----------------- 155
T Y E S + +D++S + EL TG
Sbjct: 253 DIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
Query: 156 ----------PIRLVETEENRSLAAYF--------LQVINENRLFEVLDAQVLREAEKEE 197
P +L+ + +F + + LFEVL + E +EE
Sbjct: 309 ALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLKHITKLKPWGLFEVLVEK--YEWSQEE 364
Query: 198 VITVAMVAKRCLNLNGKKRPTMKEV 222
L L +KR T E
Sbjct: 365 AAGFTDFLLPMLELIPEKRATAAEC 389
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 38/230 (16%), Positives = 70/230 (30%), Gaps = 73/230 (31%)
Query: 15 LGCCLETEVPL-----LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYL 69
L C E L L+Y+ PN D I+L I + L L
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPN-------WTSRSDHSS---NIKLRI-HSIQAELRRL 237
Query: 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD---RTHLTTQVKGTFGYLDP 126
+ + ++ ++L + AK + A + + LTT+ K +L
Sbjct: 238 -------LKSKPYENCLLVLLNVQNAKAWN-------AFNLSCKILLTTRFKQVTDFLSA 283
Query: 127 EYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLD 186
+ L + +E +SL L+ ++
Sbjct: 284 ATTTH-------------ISLDHHSMT------LTPDEVKSL---LLKYLD-------CR 314
Query: 187 AQVL-REAEKEEVITVAMVAKRC----------LNLNGKKRPTMKEVALE 225
Q L RE ++++A+ ++N K T+ E +L
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 47/240 (19%), Positives = 76/240 (31%), Gaps = 66/240 (27%)
Query: 1 IILSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGSLHQYIHEQ-----TEDQLPI 50
+ ++V+++ E L+V E + G L I ++ TE +
Sbjct: 63 LHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS- 120
Query: 51 TWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---KISDFGTSRSMA 107
I + A+ YLHS I HRD+K N+L K K++DFG
Sbjct: 121 ------EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG------ 165
Query: 108 VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRS 167
+ G Y + D++S GV++ LL G P +
Sbjct: 166 -----FAKETTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFY----SNHGL 204
Query: 168 LAAYFLQVINENRLFE-VLDAQVLREAEKEEVITVAMVAK----RCLNLNGKKRPTMKEV 222
+ + Q E E V+ K L +R T+ E
Sbjct: 205 --------AISPGMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 45/210 (21%), Positives = 73/210 (34%), Gaps = 58/210 (27%)
Query: 2 ILSQINHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGSLHQYIHEQTE 45
+L +I + V + C+ E LL +EF+ + Y
Sbjct: 69 VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPH-- 124
Query: 46 DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA---------- 95
+R +A ++ AL +LH H D+K NIL +
Sbjct: 125 --------VRH-MAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 96 ---------KISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVV 146
+++DFG++ D H TT V Y PE + + DV+S G +
Sbjct: 173 EKSVKNTSIRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCI 228
Query: 147 LVELLTGQKPIRLVETEENRSLAAYFLQVI 176
L E G L +T ENR +++
Sbjct: 229 LFEYYRG-FT--LFQTHENREHLVMMEKIL 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-05
Identities = 21/132 (15%), Positives = 42/132 (31%), Gaps = 22/132 (16%)
Query: 26 LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85
+V EF G + + + + I +++ +L+ + S+ HRD+
Sbjct: 139 IVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 86 NILLDDKYRAKISDFGTSRSMAVD--------------RTHLTTQVKGTFGYLDPEYFQS 131
N+LL K+ +S + R V +D + F
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT- 250
Query: 132 SQFTEKSDVYSF 143
+ D+Y
Sbjct: 251 GDGDYQFDIYRL 262
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 56/215 (26%), Positives = 79/215 (36%), Gaps = 63/215 (29%)
Query: 2 ILSQINHR-----NVVKLLGC-------CLETEVPLL---VYEFIPNGSLHQYIHEQTED 46
IL +I + N+VK G CL E L +YE I + Y
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITR---NNYN------ 132
Query: 47 QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRA----------- 95
I +I+L +E+ AL+YL + H D+K NILLDD Y
Sbjct: 133 GFHIE-DIKL-YCIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTD 187
Query: 96 --------------KISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVY 141
K+ DFG + + + + Y PE + + SD++
Sbjct: 188 GKKIQIYRTKSTGIKLIDFGCA---TFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMW 243
Query: 142 SFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
SFG VL EL TG L T E+ A +I
Sbjct: 244 SFGCVLAELYTG-SL--LFRTHEHMEHLAMMESII 275
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 5/59 (8%)
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKI--SDFGTSRSMAVDRTH 112
L + + + L Y+H + H DIK+AN+LL K ++ +D+G S + H
Sbjct: 154 LQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 39/209 (18%), Positives = 76/209 (36%), Gaps = 56/209 (26%)
Query: 2 ILSQINHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGSLHQYIHEQTE 45
+L +N V++L C+ E LL Y+FI + ++
Sbjct: 64 VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE---NGFL----- 113
Query: 46 DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRS 105
+ IR +A ++ ++++LHS H D+K NIL + + R
Sbjct: 114 -PFRLD-HIRK-MAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 106 MAVDRTHLTTQVK----GTFGYLD---PEYFQS-----------SQFTEKSDVYSFGVVL 147
RT + +K G+ Y D + +++ DV+S G +L
Sbjct: 168 E---RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224
Query: 148 VELLTGQKPIRLVETEENRSLAAYFLQVI 176
+E G + T +++ A +++
Sbjct: 225 IEYYLG-FT--VFPTHDSKEHLAMMERIL 250
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 5/59 (8%)
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKI--SDFGTSRSMAVDRTH 112
L +++ + L Y+H + H DIK++N+LL+ K ++ D+G + + H
Sbjct: 155 LQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 12/59 (20%), Positives = 28/59 (47%), Gaps = 5/59 (8%)
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKI--SDFGTSRSMAVDRTH 112
L +A + AL +LH + H ++ + NI +D + ++++ + +G + H
Sbjct: 162 LQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.51 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.61 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.7 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.95 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.11 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.3 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 89.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 89.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 88.66 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.21 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.38 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=360.48 Aligned_cols=212 Identities=24% Similarity=0.426 Sum_probs=175.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT---------EDQLPITWEIRLGIAVEVSGALSYLHSA 72 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~Lh~~ 72 (295)
+|++++|||||+++|+|.+++..+||||||++|+|.++++... .....+++..+..++.||+.||+|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6889999999999999999999999999999999999997642 2234599999999999999999999999
Q ss_pred CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 73 ~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
+ |+||||||+||||+.++.+||+|||+++......... .....||+.|||||++.+..|+.++|||||||++|||+
T Consensus 148 ~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 148 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999998654433322 23346899999999999999999999999999999999
Q ss_pred h-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 152 T-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
| |+.||..... ...+..+.... ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 225 t~G~~Pf~~~~~------~~~~~~i~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 225 TYGKQPWYQLSN------NEVIECITQGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TTTCCTTTTSCH------HHHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCH------HHHHHHHHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8 8999974332 22222222211 12233445667999999999999999999999999998876
Q ss_pred Hh
Q 045989 231 AS 232 (295)
Q Consensus 231 ~~ 232 (295)
+.
T Consensus 289 ~~ 290 (299)
T 4asz_A 289 KA 290 (299)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=355.51 Aligned_cols=214 Identities=24% Similarity=0.407 Sum_probs=166.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++.+ +.++||||||+||+|.+++..... .+++..+..|+.||+.||+|||+++ |+|||
T Consensus 85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~---IiHRD 157 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKN---IIHRD 157 (307)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCc
Confidence 5789999999999998864 578999999999999999975433 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||||+.++.+||+|||+|+...... ........||+.|||||++.+ ..|+.++|||||||++|||++|+.||
T Consensus 158 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp CCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 99999999999999999999998654322 233445679999999999964 35899999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
...... ..+......... .......+..++..+.+|+.+||+.||++|||+.||+++|+.++..+
T Consensus 238 ~~~~~~------~~~~~~~~~~~~-----~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 238 SHINNR------DQIIFMVGRGYA-----SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTCCCH------HHHHHHHHTTCC-----CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCChH------HHHHHHHhcCCC-----CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 643221 111111111100 00111223345567999999999999999999999999998876554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=357.07 Aligned_cols=211 Identities=22% Similarity=0.280 Sum_probs=171.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++.+|||||||+||+|.+++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 175 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR---ILHGD 175 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 6889999999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCC-ceEEeeccCccccccCcce----eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKY-RAKISDFGTSRSMAVDRTH----LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||||+.++ .+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||++|+.|
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999987 6999999999876433211 12335799999999999999999999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
|......+ . +..+...... ....+...+..+.++|.+||++||.+|||+.|++++|.......
T Consensus 256 f~~~~~~~---~---~~~i~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 256 WTQYFRGP---L---CLKIASEPPP--------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp STTTCCSC---C---HHHHHHSCCG--------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCHHH---H---HHHHHcCCCC--------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 96432221 1 1122221110 11233345567899999999999999999999999998766544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=359.84 Aligned_cols=212 Identities=25% Similarity=0.456 Sum_probs=168.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-----------DQLPITWEIRLGIAVEVSGALSYLH 70 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~Lh 70 (295)
+|++++|||||+++|+|.+++..+||||||++|+|.++++.... ...++++..++.|+.||+.||+|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 68899999999999999999999999999999999999976432 1235899999999999999999999
Q ss_pred hCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHH
Q 045989 71 SAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 71 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 149 (295)
+.+ |+||||||+||||+.++.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++||
T Consensus 176 ~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 999 99999999999999999999999999986543322 22344579999999999999999999999999999999
Q ss_pred HHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 150 LLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 150 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|+| |+.||...... ..+..+.... ....+..++..+.+|+.+||+.||++|||+.||+++|+.
T Consensus 253 llt~G~~Pf~~~~~~------~~~~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNT------EAIDCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHTTSCCTTCSSCHH------HHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCHH------HHHHHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 999 89999743322 2222222211 112333456679999999999999999999999999988
Q ss_pred hHHh
Q 045989 229 IRAS 232 (295)
Q Consensus 229 ~~~~ 232 (295)
+.+.
T Consensus 317 l~~~ 320 (329)
T 4aoj_A 317 LAQA 320 (329)
T ss_dssp HHHS
T ss_pred HhhC
Confidence 7653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=358.60 Aligned_cols=209 Identities=22% Similarity=0.377 Sum_probs=173.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
+|++++|||||+++|+|.+++..+||||||++|+|.+++..... ....+++..+..|+.||+.||+||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999999999999999999999999975421 123589999999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
|+++ |+||||||+||||+.++.+||+|||+++...... ........||+.|||||++.+..|+.++|||||||++|
T Consensus 162 H~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 9999 9999999999999999999999999998654332 22334557999999999999999999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||+| |..||...... .....+... ...+.+..++..+.+|+.+||+.||++|||+.||+++|+
T Consensus 239 El~t~g~~Pf~~~~~~------~~~~~i~~~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQ------DVVEMIRNR----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHTTTCCTTTTCCHH------HHHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH------HHHHHHHcC----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9998 89999744322 222222221 122334456677999999999999999999999999987
Q ss_pred Hh
Q 045989 228 GI 229 (295)
Q Consensus 228 ~~ 229 (295)
..
T Consensus 303 a~ 304 (308)
T 4gt4_A 303 AW 304 (308)
T ss_dssp TS
T ss_pred hc
Confidence 53
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=362.61 Aligned_cols=206 Identities=25% Similarity=0.359 Sum_probs=171.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++|+|||||++++++.+++.+|||||||+||+|.+++..... ..+++..++.|+.||+.||+|||+++ |+|||
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 150 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK---ILHRD 150 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETT
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 57889999999999999999999999999999999999975432 24799999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||||+.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 151 lKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~- 228 (350)
T 4b9d_A 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG- 228 (350)
T ss_dssp CCGGGEEECTTCCEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred CCHHHEEECCCCCEEEcccccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-
Confidence 99999999999999999999998654321 2234567999999999999999999999999999999999999999643
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.....+..+..... ...+...+..+.+||.+||+.||++|||+.|+++|.+-.
T Consensus 229 -----~~~~~~~~i~~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 229 -----SMKNLVLKIISGSF----------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp -----SHHHHHHHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred -----CHHHHHHHHHcCCC----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 22333333333221 112223455689999999999999999999999987643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=355.66 Aligned_cols=204 Identities=24% Similarity=0.327 Sum_probs=169.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++|||||+++++|.+++.+|||||||+||+|.+++... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 195 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 195 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 578999999999999999999999999999999999999753 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||||+.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|.+||....
T Consensus 196 lKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 196 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCHHHEEECCCCCEEEecCcCceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 99999999999999999999998765432 22445679999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
....+..+..... + ........+..+.+||.+||+.||++|||+.|+++|.+-
T Consensus 275 ------~~~~~~~i~~~~~------~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 275 ------PLKAMKMIRDNLP------P--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp ------HHHHHHHHHHSSC------C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ------HHHHHHHHHcCCC------C--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 2222222222110 0 001122344568999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=351.87 Aligned_cols=202 Identities=25% Similarity=0.389 Sum_probs=170.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++|||||+++++|.+++.+|||||||+||+|.+++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 157 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRD 157 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 6889999999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+|+.+.... .......+||+.|||||++.+..|+.++|||||||++|+|++|+.||...
T Consensus 158 lKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765432 23345668999999999999999999999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
. ....+..+..... ..+...+..+.+||.+||+.||++|||++|++.+-+
T Consensus 238 ~------~~~~~~~i~~~~~-----------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 238 N------EGLIFAKIIKLEY-----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp S------HHHHHHHHHHTCC-----------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred C------HHHHHHHHHcCCC-----------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 2 2233333332211 112233456899999999999999999999765543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=343.64 Aligned_cols=203 Identities=23% Similarity=0.442 Sum_probs=162.6
Q ss_pred cccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+|++|+|||||+++++|.. ++.+|||||||+||+|.+++.... .+++..+..|+.||+.||+|||+++. +|
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~~-~I 152 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTP-PI 152 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSS-CC
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCC-CE
Confidence 5789999999999999975 346899999999999999998754 48999999999999999999999863 49
Q ss_pred EeccCCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 78 YHRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 78 ~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
+||||||+||||+. ++.+||+|||+|+..... ......||+.|||||++.+ .|+.++|||||||++|||++|+.|
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~P 228 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999974 789999999999754322 2345679999999999875 699999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|.... ........+..... ....+...+..+.+||.+||+.||++|||+.|+++|.+
T Consensus 229 f~~~~-----~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 229 YSECQ-----NAAQIYRRVTSGVK---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp TTTCS-----SHHHHHHHHTTTCC---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCC-----cHHHHHHHHHcCCC---------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 96322 11222222222111 01112223345889999999999999999999998865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=357.96 Aligned_cols=204 Identities=24% Similarity=0.327 Sum_probs=169.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++|||||+++++|.+++.+|||||||+||+|.+++... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRD 272 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 272 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 678999999999999999999999999999999999999754 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||||+.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus 273 iKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 273 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCHHHEEEcCCCCEEEecCccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 99999999999999999999998765432 23445679999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
....+..+...... . .......+..+.+||.+||+.||++|||+.|+++|.+-
T Consensus 352 ------~~~~~~~i~~~~~~-~-------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 352 ------PLKAMKMIRDNLPP-R-------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp ------HHHHHHHHHHSCCC-C-------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ------HHHHHHHHHcCCCC-C-------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 22222222221100 0 01112234568999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=347.10 Aligned_cols=201 Identities=26% Similarity=0.327 Sum_probs=167.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++.+|||||||+||+|.+++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 151 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRD 151 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 6889999999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+|+...... .......||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus 152 lKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 152 LKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp CCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCHHHeEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 99999999999999999999998643322 22345679999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
....+..+..... ..+...+..+.+||.+||+.||++||| ++|+++|.+
T Consensus 231 ------~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 231 ------RKETMTMILKAKL-----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp ------HHHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred ------HHHHHHHHHcCCC-----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 2223333322210 122234556899999999999999998 578887754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=339.26 Aligned_cols=200 Identities=26% Similarity=0.354 Sum_probs=158.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++.+||||||| +|+|.+++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 137 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK---IVHRD 137 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 578899999999999999999999999999 789999997644 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+|+..... .......||+.|+|||++.+..| +.++||||+||++|+|++|+.||...
T Consensus 138 iKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 138 LKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp CCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChHHeEECCCCCEEEeecCCCeecCCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999865432 22345679999999999998876 57999999999999999999999632
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.....+..+..... ..+...+..+.+++.+||+.||++|||+.|+++|.|-
T Consensus 216 ------~~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 216 ------SIPVLFKNISNGVY-----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp ------SHHHHHHHHHHTCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred ------CHHHHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 22223333222211 1122334568899999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=352.03 Aligned_cols=213 Identities=29% Similarity=0.439 Sum_probs=172.2
Q ss_pred cccCCCC-ccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINH-RNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALS 67 (295)
Q Consensus 2 il~~l~H-pniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~ 67 (295)
+|++++| ||||+++|+|.+. +.++||||||++|+|.++++.... .+..+++..+..++.||+.||+
T Consensus 120 il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~ 199 (353)
T 4ase_A 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 199 (353)
T ss_dssp HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHH
Confidence 4667755 9999999999764 578999999999999999976432 1335899999999999999999
Q ss_pred HHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHH
Q 045989 68 YLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVV 146 (295)
Q Consensus 68 ~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~ 146 (295)
|||+++ |+||||||+|||++.++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+
T Consensus 200 yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~ 276 (353)
T 4ase_A 200 FLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 276 (353)
T ss_dssp HHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred hHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHH
Confidence 999999 99999999999999999999999999987654433 33445678999999999999999999999999999
Q ss_pred HHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 147 LVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 147 l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
+|||+| |..||......+ .+...+.. ......+..++.++.+++.+||+.||++|||+.+|+++
T Consensus 277 l~El~t~G~~Pf~~~~~~~------~~~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 277 LWEIFSLGASPYPGVKIDE------EFCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTTTSCCSSTTCCCSH------HHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH------HHHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999998 999997433211 11111111 11122333455679999999999999999999999999
Q ss_pred HHHhHHh
Q 045989 226 LAGIRAS 232 (295)
Q Consensus 226 l~~~~~~ 232 (295)
|+.+.+.
T Consensus 342 L~~llq~ 348 (353)
T 4ase_A 342 LGNLLQA 348 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=338.02 Aligned_cols=222 Identities=23% Similarity=0.320 Sum_probs=165.9
Q ss_pred cccCCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----
Q 045989 2 ILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA---- 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~---- 73 (295)
++.+++|||||++++++.+++ .+|||||||+||+|.++++... +++..+..++.|++.||+|||+++
T Consensus 50 ~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~ 124 (303)
T 3hmm_A 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQ 124 (303)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred HHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence 356889999999999998754 5799999999999999997643 899999999999999999999871
Q ss_pred -CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccC------CCCCCccchhh
Q 045989 74 -SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSS------QFTEKSDVYSF 143 (295)
Q Consensus 74 -~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Diwsl 143 (295)
.++|+||||||+||||+.++.+||+|||+++........ ......||+.|||||++.+. .++.++|||||
T Consensus 125 ~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred CCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 123999999999999999999999999999866443322 12345799999999999764 36789999999
Q ss_pred HHHHHHHHhCCCCCcccchhhc--------ccHHHHHHHHHhhchhhhhhhhhhhh-hhhHHHHHHHHHHHHHhhccCCC
Q 045989 144 GVVLVELLTGQKPIRLVETEEN--------RSLAAYFLQVINENRLFEVLDAQVLR-EAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 144 G~~l~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
||++|||++|.+||......+. ......+........+ ++.... ....+.+..+.+|+.+||+.||+
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~ 280 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence 9999999999887753322110 0111111221111111 111111 11234566789999999999999
Q ss_pred CCCCHHHHHHHHHHhHHh
Q 045989 215 KRPTMKEVALELAGIRAS 232 (295)
Q Consensus 215 ~Rps~~e~~~~l~~~~~~ 232 (295)
+|||+.||++.|+.+.+.
T Consensus 281 ~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 281 ARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GSCCHHHHHHHHHHHHHC
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=330.79 Aligned_cols=204 Identities=22% Similarity=0.351 Sum_probs=151.7
Q ss_pred cccCCCCccccceeeEEEeCC------------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETE------------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
+|++|+|||||+++++|.+.+ .+|||||||+||+|.+++..... .....+..++.++.||+.||+||
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~yl 134 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFL 134 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999997644 36999999999999999976432 11256677899999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-----------eeeccccccCCCChhhhccCCCCCCc
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-----------LTTQVKGTFGYLDPEYFQSSQFTEKS 138 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~ 138 (295)
|+++ |+||||||+|||++.++.+||+|||+|+........ .....+||+.|||||++.+..|+.++
T Consensus 135 H~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~ 211 (299)
T 4g31_A 135 HSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211 (299)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHH
T ss_pred HHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHH
Confidence 9999 999999999999999999999999999876432211 12345799999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 139 DVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 139 DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
|||||||++|||++ ||.... .....+..... . .........+..+.+++.+||+.||.+|||
T Consensus 212 DiwSlGvilyell~---Pf~~~~-----~~~~~~~~~~~-~---------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps 273 (299)
T 4g31_A 212 DIFSLGLILFELLY---PFSTQM-----ERVRTLTDVRN-L---------KFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273 (299)
T ss_dssp HHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHHT-T---------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHcc---CCCCcc-----HHHHHHHHHhc-C---------CCCCCCcccCHHHHHHHHHHcCCChhHCcC
Confidence 99999999999996 664211 01111111111 0 111222333445678999999999999999
Q ss_pred HHHHHHHHH
Q 045989 219 MKEVALELA 227 (295)
Q Consensus 219 ~~e~~~~l~ 227 (295)
+.|+++|.+
T Consensus 274 ~~eil~h~~ 282 (299)
T 4g31_A 274 AINIIENAV 282 (299)
T ss_dssp HHHHHTSGG
T ss_pred HHHHhcCHh
Confidence 999988743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=324.30 Aligned_cols=214 Identities=21% Similarity=0.311 Sum_probs=158.2
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ +|||||+++++|.+++++|+|||||+||+|.+++. .+++..+..++.||+.||+|||++| |+||
T Consensus 72 ~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHR 141 (361)
T 4f9c_A 72 CLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHR 141 (361)
T ss_dssp HHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeC
Confidence 35556 79999999999999999999999999999999984 2899999999999999999999999 9999
Q ss_pred cCCCCeEEECCC-CceEEeeccCccccccCc---------------------------ceeeeccccccCCCChhhhccC
Q 045989 81 DIKSANILLDDK-YRAKISDFGTSRSMAVDR---------------------------THLTTQVKGTFGYLDPEYFQSS 132 (295)
Q Consensus 81 dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~ 132 (295)
||||+|||++.+ +.+||+|||+|+...... .......+||+.|+|||++.+.
T Consensus 142 DiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 142 DVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 999999999876 799999999997543221 1112345799999999999775
Q ss_pred -CCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhch-------------------------hhhhhh
Q 045989 133 -QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR-------------------------LFEVLD 186 (295)
Q Consensus 133 -~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~ 186 (295)
.|+.++||||+||++|||++|+.||.....+.. ....+........ ..+.+.
T Consensus 222 ~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~--~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 222 PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT--ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 589999999999999999999999964332110 0000000000000 000000
Q ss_pred ------hh---------hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 187 ------AQ---------VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 187 ------~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+. .........+.++.+|+.+||+.||++|||++|+++|.+
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 300 GMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 00 000001123456889999999999999999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=327.27 Aligned_cols=213 Identities=22% Similarity=0.318 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
||++++|||||++++++... +.+|||||||+ |+|.+++.... .+++..+..++.||+.||+|||+++
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~~-- 178 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSAQ-- 178 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 57889999999999998643 57899999995 68999997543 5999999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCc---ceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHH
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR---THLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~ 151 (295)
|+||||||+|||++.++.+||+|||+++.+.... .......+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus 179 -iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 179 -VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp -CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred -CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 9999999999999999999999999998664321 2234456899999999998875 5689999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhh---ch--hhhh------------hhhh---hhhhhhHHHHHHHHHHHHHhhcc
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINE---NR--LFEV------------LDAQ---VLREAEKEEVITVAMVAKRCLNL 211 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~------------~~~~---~~~~~~~~~~~~~~~li~~cl~~ 211 (295)
+|++||......+ .+..+... .. .... +... .........+..+.+||.+||+.
T Consensus 258 ~G~~pF~g~~~~~------~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 331 (398)
T 4b99_A 258 ARRQLFPGKNYVH------QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRF 331 (398)
T ss_dssp HTSCSSCCSSHHH------HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCS
T ss_pred HCCCCCCCCCHHH------HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcC
Confidence 9999997433221 12111110 00 0000 0000 00011112345688999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 045989 212 NGKKRPTMKEVALELAG 228 (295)
Q Consensus 212 ~p~~Rps~~e~~~~l~~ 228 (295)
||.+|||+.|+++|.+-
T Consensus 332 dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 332 EPSARISAAAALRHPFL 348 (398)
T ss_dssp STTTSCCHHHHTTSGGG
T ss_pred ChhHCcCHHHHhcCHhh
Confidence 99999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=341.46 Aligned_cols=203 Identities=22% Similarity=0.273 Sum_probs=167.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++|||||+++++|.+.+.+|||||||+||+|.+++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 245 ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRD 317 (689)
T 3v5w_A 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRD 317 (689)
T ss_dssp HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 3567899999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||||+.+|.+||+|||+|+...... ....+||+.|||||++.. ..|+.++|||||||++|||++|.+||...
T Consensus 318 LKPeNILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 318 LKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CchHHeEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998764332 345689999999999964 57999999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
...+ .......+.... ...+...+..+.+||.+||+.||.+|++ +.||.+|.+-
T Consensus 395 ~~~~---~~~i~~~i~~~~-----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 395 KTKD---KHEIDRMTLTMA-----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp GCCC---HHHHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred ChHH---HHHHHHhhcCCC-----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 2221 112222211111 1122234556899999999999999998 7999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=337.51 Aligned_cols=206 Identities=19% Similarity=0.244 Sum_probs=169.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++|+|||||+++++|.+++.+|||||||+||+|.+++..... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHRD 280 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 280 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 57889999999999999999999999999999999999965432 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCC--CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDK--YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+|||++.+ +.+||+|||+++.+.... ......||+.|||||++.+..|+.++|||||||++|+|++|..||..
T Consensus 281 lKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp CCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CChhhccccCCCCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999854 899999999998765432 33455799999999999999999999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ...+..+...... .........+..+.+||.+||+.||.+|||+.|+++|.|-
T Consensus 359 ~~~------~~~~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 359 END------DETLRNVKSCDWN-------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp SSH------HHHHHHHHTTCCC-------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred cCH------HHHHHHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 322 2223332222110 0111122334568899999999999999999999998763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=308.98 Aligned_cols=228 Identities=38% Similarity=0.626 Sum_probs=190.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++.........+++..++.++.|++.||+|||+++ ++|||
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 164 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRD 164 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCC
Confidence 578899999999999999999999999999999999999766544456999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999997644322 22233446899999999999889999999999999999999999999765
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
...+......+.........+...+++..........+..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 544444444444444444444455555555556677888999999999999999999999999999887543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=308.27 Aligned_cols=224 Identities=37% Similarity=0.664 Sum_probs=190.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA---ASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~---~~~~i~ 78 (295)
+|++++||||+++++++...+..++||||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---iv 156 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---II 156 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EE
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eE
Confidence 57889999999999999999999999999999999999988766666799999999999999999999999 7 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999999999999999999999998766555555555679999999999998889999999999999999999999996
Q ss_pred ccch--hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVET--EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.... ........+..............+.......+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 3321 122333444444444444555555555556677888899999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=297.55 Aligned_cols=210 Identities=25% Similarity=0.455 Sum_probs=170.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~d 133 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMN---IIHRD 133 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 57889999999999999999999999999999999999986433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee-------------eeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL-------------TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
|||+||+++.++.+||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|
T Consensus 134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 213 (310)
T 3s95_A 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213 (310)
T ss_dssp CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999998654332211 11456899999999999999999999999999999
Q ss_pred HHHhCCCCCcccchhhcc---cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 149 ELLTGQKPIRLVETEENR---SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 149 el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
+|++|..|+......... ...... ....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 214 el~~g~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~ 276 (310)
T 3s95_A 214 EIIGRVNADPDYLPRTMDFGLNVRGFL-----------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276 (310)
T ss_dssp HHHHTCCSSTTTSCBCTTSSBCHHHHH-----------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCcchhhhHHHHhhhhhccc-----------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999998643222110 111100 011122334458899999999999999999999999
Q ss_pred HHHhHHhhc
Q 045989 226 LAGIRASIG 234 (295)
Q Consensus 226 l~~~~~~~~ 234 (295)
|+.++..+.
T Consensus 277 L~~l~~~~~ 285 (310)
T 3s95_A 277 LETLRMHLA 285 (310)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhcc
Confidence 999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=305.24 Aligned_cols=213 Identities=25% Similarity=0.448 Sum_probs=172.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+|+++ +||||+++++++...+..|+||||+++|+|.+++...... ...+++..++.++.||+.||+|
T Consensus 139 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 218 (370)
T 2psq_A 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218 (370)
T ss_dssp HHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 46677 8999999999999999999999999999999999865421 2247899999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+++ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 219 LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 295 (370)
T 2psq_A 219 LASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295 (370)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHH
Confidence 99999 99999999999999999999999999986543222 122334578899999999999999999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|||++ |..||......+ ........ .....+..++..+.+++.+||+.||.+|||+.|++++|
T Consensus 296 ~ellt~g~~p~~~~~~~~------~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 296 WEIFTLGGSPYPGIPVEE------LFKLLKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHHHTTSCCSSTTCCGGG------HHHHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCHHH------HHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999 999997543222 11111111 11122334455699999999999999999999999999
Q ss_pred HHhHHhh
Q 045989 227 AGIRASI 233 (295)
Q Consensus 227 ~~~~~~~ 233 (295)
+.+....
T Consensus 360 ~~il~~~ 366 (370)
T 2psq_A 360 DRILTLT 366 (370)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=301.07 Aligned_cols=221 Identities=24% Similarity=0.354 Sum_probs=169.1
Q ss_pred cccCCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q 045989 2 ILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA----- 72 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~----- 72 (295)
+|++++||||+++++++.... ..++||||+++|+|.+++.... +++..++.++.|++.||+|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~ 145 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLK 145 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 578899999999999998754 3699999999999999997643 89999999999999999999998
Q ss_pred -----CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhcc-----CCCCCCccch
Q 045989 73 -----ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQS-----SQFTEKSDVY 141 (295)
Q Consensus 73 -----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Diw 141 (295)
+ |+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||
T Consensus 146 ~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 222 (322)
T 3soc_A 146 DGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222 (322)
T ss_dssp TEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHH
T ss_pred cccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhH
Confidence 8 999999999999999999999999999765443322 2233568999999999986 3456788999
Q ss_pred hhHHHHHHHHhCCCCCcccchhhcccHHH---------HHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccC
Q 045989 142 SFGVVLVELLTGQKPIRLVETEENRSLAA---------YFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLN 212 (295)
Q Consensus 142 slG~~l~el~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 212 (295)
||||++|+|++|+.||............. ..............+.. .......+..+.+++.+||+.|
T Consensus 223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~d 299 (322)
T 3soc_A 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHD 299 (322)
T ss_dssp HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCC
Confidence 99999999999999997543322111111 11111111111000000 0112245567999999999999
Q ss_pred CCCCCCHHHHHHHHHHhHHhh
Q 045989 213 GKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 213 p~~Rps~~e~~~~l~~~~~~~ 233 (295)
|++|||+.++++.|+.+++..
T Consensus 300 P~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 300 AEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999887643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=294.34 Aligned_cols=204 Identities=24% Similarity=0.364 Sum_probs=167.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++||+|.+++... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 70 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~D 141 (297)
T 3fxz_A 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141 (297)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCC
Confidence 467899999999999999999999999999999999999764 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 142 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 2334569999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ........... ....+...+..+.+++.+||+.||++|||+.|+++|.+-
T Consensus 221 ~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 221 PLR------ALYLIATNGTP--------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp HHH------HHHHHHHHCSC--------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHH------HHHHHHhCCCC--------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 211 11111111100 001122344568899999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=293.41 Aligned_cols=208 Identities=28% Similarity=0.479 Sum_probs=170.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 131 (269)
T 4hcu_A 58 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 131 (269)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 46789999999999999999999999999999999999976443 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 132 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999998654433333334456788999999999999999999999999999999 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
... .......... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 212 ~~~------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 212 SNS------EVVEDISTGF----------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CHH------HHHHHHHTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH------HHHHHHhcCc----------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 222 2222222111 111122234568999999999999999999999999988765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=299.30 Aligned_cols=209 Identities=27% Similarity=0.434 Sum_probs=168.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++||+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 176 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRD 176 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 57889999999999999999999999999999999999975433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 177 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999876543222 2223346778999999998899999999999999999999 999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
.....+ ....+... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 257 ~~~~~~------~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 257 NMTNRD------VISSVEEG----------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp TSCHHH------HHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCCHHH------HHHHHHcC----------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 433221 12111111 11122233455689999999999999999999999999887654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=291.85 Aligned_cols=208 Identities=26% Similarity=0.445 Sum_probs=171.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 129 (268)
T 3sxs_A 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRD 129 (268)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred HHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 46788999999999999999999999999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 130 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp CSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 99999999999999999999998765544444444556788999999998889999999999999999999 99999644
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...+ .......... ...+...+..+.+++.+||+.||.+|||+.+++++|+.+++
T Consensus 210 ~~~~------~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 210 TNSE------VVLKVSQGHR----------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CHHH------HHHHHHTTCC----------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ChHH------HHHHHHcCCC----------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 3221 1111111111 11112234468899999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.75 Aligned_cols=209 Identities=24% Similarity=0.416 Sum_probs=169.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++|||
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 238 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcc
Confidence 57889999999999999999999999999999999999986543 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceee-eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLT-TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++.......... ....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976433221111 11235778999999998889999999999999999998 9999974
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ .. ...... .....+..++..+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus 319 ~~~~~------~~-~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 319 LSNQQ------TR-EFVEKG---------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp SCHHH------HH-HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH------HH-HHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 43221 11 111111 11122233455689999999999999999999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=291.32 Aligned_cols=209 Identities=27% Similarity=0.445 Sum_probs=164.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||++|++|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 64 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~D 136 (294)
T 4eqm_A 64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRD 136 (294)
T ss_dssp HHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4678999999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 137 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 137 IKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp CCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998665443333445579999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-TMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-s~~e~~~~l~~~ 229 (295)
.. ........... +..........+..+.+++.+||+.||.+|| ++.++.+.|..+
T Consensus 217 ~~------~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 217 AV------SIAIKHIQDSV------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HH------HHHHHHHSSCC------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred hH------HHHHHHhhccC------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 21 11111111110 0011122233455689999999999999998 888888888654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=291.85 Aligned_cols=208 Identities=26% Similarity=0.404 Sum_probs=157.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. ++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 69 ~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 141 (281)
T 1mp8_A 69 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR---FVHRD 141 (281)
T ss_dssp HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 467899999999999984 5678999999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 142 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 142 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp CSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 99999999999999999999998665433333334456789999999998999999999999999999996 99999744
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
...+ ....+.... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 222 ~~~~------~~~~i~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 222 KNND------VIGRIENGE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CGGG------HHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH------HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 3322 111111111 1112233455689999999999999999999999999887654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=295.97 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=166.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++||+|.+++.... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 67 ~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrD 139 (328)
T 3fe3_A 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRD 139 (328)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccC
Confidence 4678999999999999999999999999999999999997654 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCC-CCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++....... ......||+.|+|||++.+..+. .++|||||||++|+|++|..||...
T Consensus 140 lkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 140 LKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp CCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997654332 23445799999999999888775 7899999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.. ......+..... ..+...+..+.+++.+||+.||.+|||+.|+++|.+-
T Consensus 218 ~~------~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 218 NL------KELRERVLRGKY-----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp SH------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CH------HHHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 22 222222221110 1122234558899999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=294.17 Aligned_cols=212 Identities=28% Similarity=0.474 Sum_probs=171.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC--------------------CCCCCCHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE--------------------DQLPITWEIRLGIAVE 61 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~q 61 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|
T Consensus 79 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred HHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 47889999999999999999999999999999999999986543 1234899999999999
Q ss_pred HHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccc
Q 045989 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 62 i~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
++.||+|||+++ ++||||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||
T Consensus 159 i~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 235 (314)
T 2ivs_A 159 ISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235 (314)
T ss_dssp HHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhH
Confidence 999999999999 999999999999999999999999999865443322 2233457888999999998889999999
Q ss_pred hhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 141 YSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 141 wslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
||||+++|+|++ |..||....... . . ...... .....+...+..+.+++.+||+.||.+|||+
T Consensus 236 ~slG~il~el~t~g~~p~~~~~~~~---~---~-~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 236 WSFGVLLWEIVTLGGNPYPGIPPER---L---F-NLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGG---H---H-HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHH---H---H-HHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999 999996443322 1 1 111111 1112223345568999999999999999999
Q ss_pred HHHHHHHHHhHHh
Q 045989 220 KEVALELAGIRAS 232 (295)
Q Consensus 220 ~e~~~~l~~~~~~ 232 (295)
.+++++|+.+...
T Consensus 300 ~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 300 ADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhh
Confidence 9999999887543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=291.68 Aligned_cols=208 Identities=25% Similarity=0.418 Sum_probs=170.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|||
T Consensus 72 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 145 (283)
T 3gen_A 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRD 145 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 46789999999999999999999999999999999999976433 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 146 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp CSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999998654433222333456788999999999999999999999999999998 99999644
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...+ ....+.... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 226 ~~~~------~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 226 TNSE------TAEHIAQGL----------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CHHH------HHHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChhH------HHHHHhccc----------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 3221 111111111 111122234568899999999999999999999999988754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=297.13 Aligned_cols=210 Identities=22% Similarity=0.302 Sum_probs=168.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++|||||+||+|.+.+.........+++..++.++.||+.||+|||+++ |+|||
T Consensus 79 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrD 155 (351)
T 3c0i_A 79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRD 155 (351)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 467889999999999999999999999999999999888765544456899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc---eEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYR---AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 156 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CSGGGEEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHHeEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 9999999986654 9999999998665432 22334569999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.... ..+..+...... ..+. .....+..+.+++.+||+.||++|||+.++++|.+-.
T Consensus 235 ~~~~-------~~~~~i~~~~~~---~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 235 GTKE-------RLFEGIIKGKYK---MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp SSHH-------HHHHHHHHTCCC---CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CcHH-------HHHHHHHcCCCC---CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 4221 112222111100 0111 1112345689999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=294.69 Aligned_cols=207 Identities=26% Similarity=0.315 Sum_probs=168.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++||+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~g---ivH~D 127 (321)
T 1tki_A 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 46788999999999999999999999999999999999975432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECC--CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDD--KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 128 lkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 9999999987 7899999999998664332 23445689999999999988889999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
... ......+....... .. ......+..+.+++.+||..||.+|||+.|+++|.+-.
T Consensus 206 ~~~------~~~~~~i~~~~~~~---~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 206 ETN------QQIIENIMNAEYTF---DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp SSH------HHHHHHHHHTCCCC---CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCH------HHHHHHHHcCCCCC---Ch----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 322 12222222211100 00 11122345689999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=303.43 Aligned_cols=213 Identities=24% Similarity=0.363 Sum_probs=170.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE---DQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|++++||||+++++++......++||||++||+|.+++..... ....+++..++.++.||+.||+|||+++ |+
T Consensus 127 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 203 (367)
T 3l9p_A 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FI 203 (367)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 46788999999999999999999999999999999999987542 2235899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCC---ceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 79 HRDIKSANILLDDKY---RAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 79 H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
||||||+|||++.++ .+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 204 HrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 283 (367)
T 3l9p_A 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283 (367)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999554 59999999997543221 122334567899999999999999999999999999999998 9
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
..||...... .....+.... ....+...+..+.+++.+||+.||.+|||+.+|+++|+.+....
T Consensus 284 ~~pf~~~~~~------~~~~~i~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 284 YMPYPSKSNQ------EVLEFVTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CCSSTTCCHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCHH------HHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 9999643221 2222222211 11122234456899999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=297.82 Aligned_cols=205 Identities=22% Similarity=0.314 Sum_probs=167.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++||+|.+++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 140 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFD 140 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 5788999999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC----ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKY----RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 999999998776 79999999998654322 233456999999999999989999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...... ..+..+...... .+. ......+..+.++|.+||..||.+|||+.|+++|.+-
T Consensus 219 ~~~~~~------~~~~~i~~~~~~---~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 219 LGDTKQ------ETLANITAVSYD---FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp CCSSHH------HHHHHHHTTCCC---CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCCHH------HHHHHHHhcCCC---CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 643221 222222211100 011 1112334568899999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=302.10 Aligned_cols=214 Identities=26% Similarity=0.445 Sum_probs=173.1
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+|+++ +||||+++++++..++..++||||+++|+|.+++...... ...+++..++.++.||+.||+|
T Consensus 127 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 206 (382)
T 3tt0_A 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206 (382)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 35566 9999999999999999999999999999999999865421 2358999999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+.+ |+||||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 207 LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 283 (382)
T 3tt0_A 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283 (382)
T ss_dssp HHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred HHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHH
Confidence 99999 99999999999999999999999999986543322 223334578899999999999999999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||...... .....+.... ....+...+..+.+++.+||+.||++|||+.+++++|
T Consensus 284 ~ellt~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 284 WEIFTLGGSPYPGVPVE------ELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHHTTSCCSSTTCCHH------HHHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHH------HHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999 99999643322 1221111111 1112223445689999999999999999999999999
Q ss_pred HHhHHhhc
Q 045989 227 AGIRASIG 234 (295)
Q Consensus 227 ~~~~~~~~ 234 (295)
+.+.....
T Consensus 348 ~~~~~~~~ 355 (382)
T 3tt0_A 348 DRIVALTS 355 (382)
T ss_dssp HHHHHHSC
T ss_pred HHHHHHHh
Confidence 99876554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=293.55 Aligned_cols=202 Identities=25% Similarity=0.312 Sum_probs=167.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++||+|..++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 58 ~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 130 (337)
T 1o6l_A 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRD 130 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCc
Confidence 4678999999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 131 lkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 131 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999997543222 22345579999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
. ......+.... . ..+...+..+.++|.+||+.||.+|| ++.++++|.+-
T Consensus 210 ~------~~~~~~i~~~~-~----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 210 H------ERLFELILMEE-I----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp H------HHHHHHHHHCC-C----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred H------HHHHHHHHcCC-C----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 2 12222222111 0 11223345689999999999999999 99999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=297.14 Aligned_cols=218 Identities=29% Similarity=0.507 Sum_probs=166.9
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... ...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+|
T Consensus 64 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 137 (295)
T 3ugc_A 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIH 137 (295)
T ss_dssp HHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCC---ccc
Confidence 57789999999999999653 568999999999999999986543 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++|..|+
T Consensus 138 ~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp SCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence 99999999999999999999999986643322 1223345677899999999999999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhc--------hhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEENRSLAAYFLQVINEN--------RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....... ....... .....+........+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 218 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 218 KSPPAEF--------MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp CSHHHHH--------HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCChHHH--------HhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 6432210 0000000 01111111112223344566799999999999999999999999999988
Q ss_pred HHhh
Q 045989 230 RASI 233 (295)
Q Consensus 230 ~~~~ 233 (295)
++.+
T Consensus 290 ~~~l 293 (295)
T 3ugc_A 290 RDNM 293 (295)
T ss_dssp HHC-
T ss_pred HHhc
Confidence 7654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=300.22 Aligned_cols=210 Identities=24% Similarity=0.419 Sum_probs=160.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 172 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMG---YVHRD 172 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 57889999999999999999999999999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 173 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp CCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred CCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998664332211 122245778999999999999999999999999999998 999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
..... .....+... .....+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 253 ~~~~~------~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 253 EMSNQ------DVIKAVDEG----------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TCCHH------HHHHHHHTT----------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCHH------HHHHHHHcC----------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 43321 111111111 111122234556899999999999999999999999999886543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=292.76 Aligned_cols=215 Identities=31% Similarity=0.441 Sum_probs=162.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+. +|+|||
T Consensus 87 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~D 164 (309)
T 3p86_A 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRN 164 (309)
T ss_dssp HHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTT
T ss_pred HHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCC
Confidence 46789999999999999999999999999999999999975321 1138999999999999999999999873 499999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 165 ikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp CCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997543321 22334568999999999999999999999999999999999999996443
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
..+ ......... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus 244 ~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 244 PAQ------VVAAVGFKC---------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHH------HHHHHHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHH------HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 221 111111110 0112223344568999999999999999999999999988765543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=296.59 Aligned_cols=221 Identities=15% Similarity=0.230 Sum_probs=170.5
Q ss_pred ccCCCCccccceeeEEEeC----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 3 LSQINHRNVVKLLGCCLET----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++.++||||+++++++... ...++||||+ |++|.+++..... .+++..++.++.||+.||+|||+.+ |+
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 5678999999999999875 4589999999 9999999986433 4999999999999999999999999 99
Q ss_pred eccCCCCeEEEC--CCCceEEeeccCccccccCccee------eeccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 79 HRDIKSANILLD--DKYRAKISDFGTSRSMAVDRTHL------TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 79 H~dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
||||||+|||++ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999998 88999999999997654332111 1234599999999999999999999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
++|..||....... .......... ...+...++... .....+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 255 ~~g~~Pf~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 255 LTGHLPWEDNLKDP--KYVRDSKIRY-RENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHSCCTTGGGTTCH--HHHHHHHHHH-HHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HhCCCCccccccCH--HHHHHHHHHh-hhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 99999997422111 1111111100 111111111110 01223556999999999999999999999999999987
Q ss_pred Hhhccc
Q 045989 231 ASIGAS 236 (295)
Q Consensus 231 ~~~~~~ 236 (295)
...+..
T Consensus 329 ~~~~~~ 334 (364)
T 3op5_A 329 KAIGSK 334 (364)
T ss_dssp HHTTCC
T ss_pred HHcCCC
Confidence 776544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=297.09 Aligned_cols=212 Identities=24% Similarity=0.433 Sum_probs=169.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC--------------------CCCCCHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED--------------------QLPITWEIRLGIAVE 61 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~q 61 (295)
+|++++||||+++++++..++..++||||+++|+|.+++...... ...+++..++.++.|
T Consensus 103 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 182 (343)
T 1luf_A 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182 (343)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHH
Confidence 467899999999999999999999999999999999999864321 135899999999999
Q ss_pred HHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccc
Q 045989 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 62 i~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
|+.||+|||+++ |+||||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||
T Consensus 183 i~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 259 (343)
T 1luf_A 183 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 259 (343)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCccccc
Confidence 999999999999 99999999999999999999999999976543222 22334467899999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 141 YSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 141 wslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
||||+++|+|++ |..||...... .....+.... ....+...+..+.+++.+||+.||.+|||+
T Consensus 260 ~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 260 WAYGVVLWEIFSYGLQPYYGMAHE------EVIYYVRDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHhcCCCcCCCCChH------HHHHHHhCCC----------cCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 999999999999 99998643322 1122111111 111223344568999999999999999999
Q ss_pred HHHHHHHHHhHHh
Q 045989 220 KEVALELAGIRAS 232 (295)
Q Consensus 220 ~e~~~~l~~~~~~ 232 (295)
.+++++|+.+...
T Consensus 324 ~~~~~~L~~~~~~ 336 (343)
T 1luf_A 324 CSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHHTTC-
T ss_pred HHHHHHHHHHHhh
Confidence 9999999886543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=302.70 Aligned_cols=207 Identities=22% Similarity=0.282 Sum_probs=167.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+++..++|||||+||+|.+.+.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 63 il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrD 135 (444)
T 3soa_A 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG---VVHRN 135 (444)
T ss_dssp HHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 5678999999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEEC---CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLD---DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++ .++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 136 lKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCHHHEEEeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 999999998 467899999999976544322 2334579999999999999899999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.... ......+....... ........+..+.+++.+||+.||.+|||+.|+++|.+-.
T Consensus 215 ~~~~------~~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 215 DEDQ------HRLYQQIKAGAYDF-------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp CSSH------HHHHHHHHHTCCCC-------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred CccH------HHHHHHHHhCCCCC-------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 4322 12222222111000 0011122345688999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=294.72 Aligned_cols=208 Identities=25% Similarity=0.490 Sum_probs=166.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+. .++|+||+.+|+|.+++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 70 ~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~D 142 (327)
T 3poz_A 70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 142 (327)
T ss_dssp HHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 467899999999999998754 7899999999999999986543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 143 ikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 9999999999999999999999866443322 2233456889999999999999999999999999999999 9999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ . ...... ......+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 223 ~~~~~---~----~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 223 IPASE---I----SSILEK---------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCGGG---H----HHHHHT---------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHHH---H----HHHHHc---------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 43322 1 111111 111122233445688999999999999999999999999887543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=282.65 Aligned_cols=217 Identities=15% Similarity=0.174 Sum_probs=171.4
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++ +||||+++++++..+...++||||+ +++|.+++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 59 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 131 (298)
T 1csn_A 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131 (298)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 4556 8999999999999999999999999 9999999986533 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc-----eEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 82 IKSANILLDDKYR-----AKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 82 ikp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
|||+||+++.++. +||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 132 lkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 211 (298)
T 1csn_A 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 211 (298)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999987765 999999999866543221 23345699999999999999999999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
++|+.||.......... ......... ............+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 212 ~~g~~pf~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 212 LRGSLPWQGLKAATNKQ---KYERIGEKK------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHSSCTTSSCCSCCHHH---HHHHHHHHH------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HcCCCCcchhhccccHH---HHHHHHhhc------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 99999997543222111 111111110 000011111234556999999999999999999999999999987
Q ss_pred Hhhcc
Q 045989 231 ASIGA 235 (295)
Q Consensus 231 ~~~~~ 235 (295)
...+.
T Consensus 283 ~~~~~ 287 (298)
T 1csn_A 283 ERLNT 287 (298)
T ss_dssp HHTTC
T ss_pred HhcCC
Confidence 76553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.22 Aligned_cols=218 Identities=16% Similarity=0.216 Sum_probs=172.4
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ +||||+++++++..++..++||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||
T Consensus 57 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---iiHr 129 (330)
T 2izr_A 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129 (330)
T ss_dssp HHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 45677 9999999999999999999999999 9999999986422 4999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCc-----eEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCCccchhhHHHHHH
Q 045989 81 DIKSANILLDDKYR-----AKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 81 dikp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 149 (295)
||||+||+++.++. +||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+
T Consensus 130 Dlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 209 (330)
T 2izr_A 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY 209 (330)
T ss_dssp CCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHH
Confidence 99999999998887 999999999865433221 1234579999999999999999999999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|++|..||......+ ....+..+...... .... ......+ .+.+++.+||+.||.+||++.+|.+.|+.+
T Consensus 210 ll~g~~Pf~~~~~~~---~~~~~~~i~~~~~~---~~~~---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 210 FLRGSLPWQGLKADT---LKERYQKIGDTKRA---TPIE---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHSSCTTTTCCCSS---HHHHHHHHHHHHHH---SCHH---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhcCCCCcccccccc---HHHHHHHHHhhhcc---CCHH---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 999999997543222 11111111111000 0000 0011123 699999999999999999999999999988
Q ss_pred HHhhccc
Q 045989 230 RASIGAS 236 (295)
Q Consensus 230 ~~~~~~~ 236 (295)
....+..
T Consensus 280 ~~~~~~~ 286 (330)
T 2izr_A 280 FDRKGYM 286 (330)
T ss_dssp HHHTTCC
T ss_pred HHHcCCC
Confidence 7776544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=285.58 Aligned_cols=222 Identities=35% Similarity=0.579 Sum_probs=174.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|||
T Consensus 83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 158 (307)
T 2nru_A 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRD 158 (307)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCC
Confidence 46788999999999999999999999999999999999975432 235899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 999999999999999999999986543322 22334568999999999875 4889999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhch-hhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENR-LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
..... ...+......... +...++. .....+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 238 REPQL--LLDIKEEIEDEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BSSSB--TTHHHHHHHTTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cchHH--HHHHHHHhhhhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 43221 1111111111111 1122221 2234456677889999999999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=293.76 Aligned_cols=208 Identities=25% Similarity=0.448 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++. ++..++||||+.+|+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 68 ~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 140 (325)
T 3kex_A 68 AIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRN 140 (325)
T ss_dssp HHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCc
Confidence 467889999999999986 5678999999999999999976432 4889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 141 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 141 LAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp CSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 9999999999999999999999876543322 2334567889999999999999999999999999999999 9999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ ......... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 221 ~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 221 LRLAE------VPDLLEKGE----------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp SCTTH------HHHHHHTTC----------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cCHHH------HHHHHHcCC----------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 43222 111111111 1111122333578899999999999999999999999887543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=310.54 Aligned_cols=208 Identities=26% Similarity=0.451 Sum_probs=170.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+|||
T Consensus 269 ~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrD 343 (495)
T 1opk_A 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343 (495)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 57789999999999999999999999999999999999986432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++..............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp CSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765433333333456788999999998899999999999999999999 99999754
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
...+ .. ..+. .......+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 424 ~~~~---~~----~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 424 DLSQ---VY----ELLE---------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CGGG---HH----HHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CHHH---HH----HHHH---------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 3222 11 1111 11111223344566899999999999999999999999997753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=285.93 Aligned_cols=208 Identities=28% Similarity=0.478 Sum_probs=169.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 129 (267)
T 3t9t_A 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 129 (267)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 46788999999999999999999999999999999999976533 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 130 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp CCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 99999999999999999999998654332222233456788999999998899999999999999999999 89998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
... .....+..... ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 210 ~~~------~~~~~i~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 210 SNS------EVVEDISTGFR----------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CHH------HHHHHHHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH------HHHHHHhcCCc----------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 12222211110 11122234568899999999999999999999999988764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.67 Aligned_cols=199 Identities=25% Similarity=0.363 Sum_probs=166.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+.+..++||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 59 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 131 (318)
T 1fot_A 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRD 131 (318)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999999999998644 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 132 lkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 132 LKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CChheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999865322 234569999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
. ......+..... ..+...+..+.+++.+||+.||.+|| +++++++|.+-
T Consensus 208 ~------~~~~~~i~~~~~-----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 208 T------MKTYEKILNAEL-----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp H------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred H------HHHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 2 222222222210 11222345688999999999999999 89999988653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.63 Aligned_cols=206 Identities=25% Similarity=0.348 Sum_probs=168.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++||||++++++|.+.+..|+||||++||+|.+++... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 122 il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrD 193 (410)
T 3v8s_A 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRD 193 (410)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 467789999999999999999999999999999999999754 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC----CCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ----FTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+|||++.++.+||+|||+++..............||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 194 LKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 9999999999999999999999876554444445668999999999998765 789999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~~ 228 (295)
.... ....+..+......... +.....+..+.+||.+||..+|.+ ||++.||++|.+-
T Consensus 274 ~~~~------~~~~~~~i~~~~~~~~~-------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 274 YADS------LVGTYSKIMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp CCSS------HHHHHHHHHTHHHHCCC-------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred CCCC------hhhHHHHHHhccccccC-------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 6332 22222222221100000 001123456889999999999988 9999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=294.97 Aligned_cols=206 Identities=23% Similarity=0.325 Sum_probs=165.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+.+..++||||++||+|.+.+.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 81 il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~D 153 (362)
T 2bdw_A 81 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRN 153 (362)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 4678999999999999999999999999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC---ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKY---RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 154 lkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CchHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 999999998654 59999999998654322 2334579999999999999899999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.... ......+....... ........+..+.+++.+||+.||.+|||+.++++|.+-.
T Consensus 232 ~~~~------~~~~~~i~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 232 DEDQ------HRLYAQIKAGAYDY-------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp CSSH------HHHHHHHHHTCCCC-------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred CCCH------HHHHHHHHhCCCCC-------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 4322 12222222111000 0011122345688999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.48 Aligned_cols=213 Identities=29% Similarity=0.451 Sum_probs=168.6
Q ss_pred cccCC-CCccccceeeEEEeCC-ccEEEEeecCCCCHHHHHhhhCCC---------------------------------
Q 045989 2 ILSQI-NHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTED--------------------------------- 46 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~--------------------------------- 46 (295)
+|+++ +||||+++++++...+ ..++||||+++|+|.+++......
T Consensus 78 ~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (359)
T 3vhe_A 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT 157 (359)
T ss_dssp HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------
T ss_pred HHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccC
Confidence 35566 8899999999998765 489999999999999999865431
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEE
Q 045989 47 -----------------------------QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKI 97 (295)
Q Consensus 47 -----------------------------~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl 97 (295)
...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl 234 (359)
T 3vhe_A 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKI 234 (359)
T ss_dssp --------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred ccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEE
Confidence 122899999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHH
Q 045989 98 SDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQV 175 (295)
Q Consensus 98 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 175 (295)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+ .....
T Consensus 235 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~ 308 (359)
T 3vhe_A 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRR 308 (359)
T ss_dssp CCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHH
T ss_pred EeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHH
Confidence 99999986543322 23344568999999999999999999999999999999998 999996433221 11111
Q ss_pred HhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 176 INENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
.... .....+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 309 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 309 LKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1111 11112223445689999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=302.13 Aligned_cols=206 Identities=28% Similarity=0.483 Sum_probs=167.3
Q ss_pred cccCCCCccccceeeEEEeCC-ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++.... ..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ ++||
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHr 313 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 578899999999999988765 78999999999999999986543 24789999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 314 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 314 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999754322 122357889999999999999999999999999999998 9999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ . ...+... .....+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 390 ~~~~~---~---~~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 390 IPLKD---V---VPRVEKG----------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp SCTTT---H---HHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHH---H---HHHHHcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 43222 1 1111111 11122334556799999999999999999999999999887643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.09 Aligned_cols=205 Identities=24% Similarity=0.353 Sum_probs=167.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++|++|.+++... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 166 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRD 166 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 578899999999999999999999999999999999998653 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 2334569999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.. ........... +. .......+..+.+++.+||+.||++|||+.++++|.+-.
T Consensus 246 ~~------~~~~~~~~~~~------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 246 PV------QAMKRLRDSPP------PK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HH------HHHHHHHHSSC------CC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred HH------HHHHHHhcCCC------CC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 21 11111111110 00 011112344588999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=308.31 Aligned_cols=208 Identities=23% Similarity=0.380 Sum_probs=167.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. .+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+|||
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 309 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 309 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 578999999999999986 6688999999999999999975422 13788999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++..............++..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 310 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp CSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998654332222233346788999999998999999999999999999999 99999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
...+ ....+... .....+..++..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 390 ~~~~------~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 390 SNPE------VIRALERG----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CHHH------HHHHHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CHHH------HHHHHHcC----------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 3221 11111111 1112223445679999999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=287.69 Aligned_cols=211 Identities=27% Similarity=0.439 Sum_probs=174.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++|++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 62 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 136 (288)
T 3kfa_A 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136 (288)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 46788999999999999999999999999999999999976433 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.++|+|||++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 137 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp CSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998766554444455567889999999999999999999999999999999 99998644
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
.... . ...... ......+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 217 ~~~~---~---~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 217 DLSQ---V---YELLEK----------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CGGG---H---HHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHH---H---HHHHhc----------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3221 1 111111 1111222334456899999999999999999999999998876554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=290.80 Aligned_cols=205 Identities=26% Similarity=0.343 Sum_probs=166.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++......++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 67 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~D 139 (326)
T 2y0a_A 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFD 139 (326)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCC
Confidence 4678999999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC----ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKY----RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp CCGGGEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCHHHEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 999999998877 79999999998654322 223456999999999999889999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...... .....+..... ... .......+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 218 ~~~~~~------~~~~~~~~~~~---~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 218 LGDTKQ------ETLANVSAVNY---EFE----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp CCSSHH------HHHHHHHHTCC---CCC----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCHH------HHHHHHHhcCC---CcC----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 643221 11111111110 000 11112234568899999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.43 Aligned_cols=215 Identities=25% Similarity=0.455 Sum_probs=169.6
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-------------------CCCCCHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-------------------QLPITWEIRLGIAVE 61 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~q 61 (295)
+|+++ +||||+++++++...+..++||||+++|+|.+++...... ...+++..++.++.|
T Consensus 101 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 180 (344)
T 1rjb_A 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180 (344)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred HHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHH
Confidence 45677 8999999999999999999999999999999999865321 123789999999999
Q ss_pred HHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccc
Q 045989 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 62 i~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
|+.||+|||+.+ |+||||||+||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||
T Consensus 181 i~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 257 (344)
T 1rjb_A 181 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257 (344)
T ss_dssp HHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhH
Confidence 999999999999 999999999999999999999999999866443322 2334467889999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 141 YSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 141 wslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
||||+++|+|++ |..||....... .+....... .....+...+..+.+++.+||+.||.+|||+
T Consensus 258 ~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 258 WSYGILLWEIFSLGVNPYPGIPVDA------NFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHcCCCCCcccCCcHH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 999999999998 999996443211 111111111 1111222334568999999999999999999
Q ss_pred HHHHHHHHHhHHhhc
Q 045989 220 KEVALELAGIRASIG 234 (295)
Q Consensus 220 ~e~~~~l~~~~~~~~ 234 (295)
.+++++|+.+.+...
T Consensus 323 ~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 323 PNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHHHHC----
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999988765443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=294.32 Aligned_cols=201 Identities=25% Similarity=0.323 Sum_probs=162.0
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++ +||||+++++++...+..|+||||++||+|..++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 77 l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 149 (353)
T 3txo_A 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG---IIYRD 149 (353)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 4455 79999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 150 lkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 150 LKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCHHHEEECCCCCEEEccccceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999753322 223345579999999999999899999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM------KEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~------~e~~~~l~~ 228 (295)
. ...+..+..... ..+...+..+.+++.+||+.||.+||++ .++++|.+-
T Consensus 229 ~------~~~~~~i~~~~~-----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 229 E------DDLFEAILNDEV-----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp H------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred H------HHHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 2 222222222211 1122234458899999999999999998 888888643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=290.24 Aligned_cols=211 Identities=25% Similarity=0.425 Sum_probs=168.6
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT------------EDQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+|+++ +||||+++++++...+..++||||+++|+|.+++.... .....+++..++.++.|++.||+|
T Consensus 78 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 157 (327)
T 1fvr_A 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157 (327)
T ss_dssp HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 46788 99999999999999999999999999999999997653 223358999999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
||+.+ |+||||||+||+++.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|
T Consensus 158 LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 158 LSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 99999 999999999999999999999999998743221 1122335688999999999888999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+|++ |..||...... ......... .....+...+..+.+++.+||+.||.+|||+.+++++|+
T Consensus 233 ellt~g~~pf~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCA------ELYEKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHHTTSCCTTTTCCHH------HHHHHGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCCCCCcHH------HHHHHhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9998 99999643321 111111111 111122234456899999999999999999999999998
Q ss_pred HhHHhh
Q 045989 228 GIRASI 233 (295)
Q Consensus 228 ~~~~~~ 233 (295)
.+....
T Consensus 297 ~~~~~~ 302 (327)
T 1fvr_A 297 RMLEER 302 (327)
T ss_dssp HHHHSS
T ss_pred HHHHhh
Confidence 876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=297.31 Aligned_cols=207 Identities=27% Similarity=0.411 Sum_probs=164.2
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++ +||||+++++++...+..++||||++||+|..++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 106 l~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 178 (396)
T 4dc2_A 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRD 178 (396)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 3344 89999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred CCHHHEEECCCCCEEEeecceeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999999753322 223445679999999999999999999999999999999999999996432
Q ss_pred hhhc--ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHHHH
Q 045989 162 TEEN--RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM------KEVALELA 227 (295)
Q Consensus 162 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~------~e~~~~l~ 227 (295)
..+. ........+.+.... ...+...+..+.++|.+||+.||.+||++ .|+++|.+
T Consensus 258 ~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 258 SSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp C------CCHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred cccccchhhHHHHHHHHhccc----------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 2111 111111111111111 11222344568899999999999999985 78888764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.29 Aligned_cols=219 Identities=26% Similarity=0.387 Sum_probs=170.4
Q ss_pred cccCCCCccccceeeEEEeCC--ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETE--VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++.... ..++||||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ |+|
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH 135 (319)
T 4euu_A 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG---IVH 135 (319)
T ss_dssp HHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---Eec
Confidence 467899999999999998765 779999999999999999865332 23899999999999999999999999 999
Q ss_pred ccCCCCeEEE----CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc--------cCCCCCCccchhhHHHH
Q 045989 80 RDIKSANILL----DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ--------SSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 80 ~dikp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l 147 (295)
|||||+||++ +.++.+||+|||+++....... .....||+.|+|||++. +..++.++|||||||++
T Consensus 136 ~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp SCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred CCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 9999999999 7788899999999986544322 23456899999999986 46789999999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhh--h-h-------h----hhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLF--E-V-------L----DAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~-------~----~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
|+|++|..||........ ....+..+....... . . . ............+..+.+++.+||+.||
T Consensus 214 ~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRR--NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHHHSSCSEECTTCGGG--CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHhCCCCCCCCCccch--hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 999999999975433221 122222222211100 0 0 0 0001123446677789999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 045989 214 KKRPTMKEVALELAG 228 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~ 228 (295)
++|||+.|+++|+..
T Consensus 292 ~~R~s~~ell~h~~d 306 (319)
T 4euu_A 292 EKCWGFDQFFAETSD 306 (319)
T ss_dssp TTSCCHHHHHHHHHH
T ss_pred hhhccHHHhhhccHH
Confidence 999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=285.95 Aligned_cols=208 Identities=24% Similarity=0.419 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. +..++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|||
T Consensus 66 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 138 (281)
T 3cc6_A 66 IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESIN---CVHRD 138 (281)
T ss_dssp HHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4677899999999999865 467999999999999999986543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++...............+++.|+|||++.+..++.++||||||+++|+|++ |+.||...
T Consensus 139 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 139 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp CSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 99999999999999999999998665433333344457889999999998999999999999999999998 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
...+ ... ...... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 219 ~~~~---~~~---~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 219 ENKD---VIG---VLEKGD----------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CGGG---HHH---HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ChHH---HHH---HHhcCC----------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 3222 111 111110 1111222345689999999999999999999999999887654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.54 Aligned_cols=208 Identities=25% Similarity=0.493 Sum_probs=162.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+. .++|+||+.+|+|.+++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 70 ~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 142 (327)
T 3lzb_A 70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 142 (327)
T ss_dssp HHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCC
Confidence 578899999999999998764 7899999999999999986543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 143 ikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999986543322 12233456888999999999999999999999999999999 9999975
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ . ...... ......+...+..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 223 ~~~~~---~----~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 223 IPASE---I----SSILEK---------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCGGG---H----HHHHHT---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHHH---H----HHHHHc---------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 43322 1 111111 111122223445689999999999999999999999999887543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=289.24 Aligned_cols=213 Identities=24% Similarity=0.438 Sum_probs=161.1
Q ss_pred cccCCCCccccceeeEEEeCCcc------EEEEeecCCCCHHHHHhhhCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVP------LLVYEFIPNGSLHQYIHEQTE--DQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~------~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++...... ++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 157 (323)
T 3qup_A 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN 157 (323)
T ss_dssp HHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence 47789999999999999877655 999999999999999975432 2235899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
|+||||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 158 ---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 234 (323)
T 3qup_A 158 ---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234 (323)
T ss_dssp ---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence 999999999999999999999999999865433221 1223456788999999999999999999999999999999
Q ss_pred -CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 153 -GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
|..||......+ ......... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 235 ~g~~p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 235 RGQTPYAGIENAE------IYNYLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TSCCTTTTCCGGG------HHHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccChHH------HHHHHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999987443322 111111111 112222344568999999999999999999999999988765
Q ss_pred hh
Q 045989 232 SI 233 (295)
Q Consensus 232 ~~ 233 (295)
..
T Consensus 299 ~~ 300 (323)
T 3qup_A 299 HL 300 (323)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=290.99 Aligned_cols=199 Identities=20% Similarity=0.272 Sum_probs=166.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..|+||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 166 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 5788999999999999999999999999999999999998754 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 167 lkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 9999999999999999999999865432 234568999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~~ 228 (295)
. ......+.... . ..+...+..+.++|.+||+.||.+||+ +.++++|.+-
T Consensus 243 ~------~~~~~~i~~~~-~----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 243 P------IQIYEKIVSGK-V----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp H------HHHHHHHHHCC-C----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred H------HHHHHHHHcCC-C----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 2 22222222211 0 112233456899999999999999998 9999888653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=295.47 Aligned_cols=211 Identities=29% Similarity=0.488 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++.. ++..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 216 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHR 216 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 6889999999999999754 5678999999999999999975433 4889999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p 156 (295)
||||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+|
T Consensus 217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 99999999999999999999999865432211 1233457889999999999999999999999999999999 7777
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
|......+ ... ...... ....+...+..+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 297 ~~~~~~~~---~~~---~~~~~~----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 297 YPDVNTFD---ITV---YLLQGR----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CTTSCSSC---HHH---HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCHHH---HHH---HHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 76433221 111 111111 011122344568999999999999999999999999998876554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.81 Aligned_cols=209 Identities=20% Similarity=0.298 Sum_probs=168.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||++++++|.+++.+|+|||||+||+|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 127 il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrD 200 (437)
T 4aw2_A 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQLH---YVHRD 200 (437)
T ss_dssp HHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 46678999999999999999999999999999999999976332 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+|||++.++.+||+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 201 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred cCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999876555444445567999999999997 45689999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKK--RPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rps~~e~~~~l~~ 228 (295)
|..... ...+..+........ ........+..+.+||.+||..+|++ ||+++|+++|.+-
T Consensus 281 f~~~~~------~~~~~~i~~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 281 FYAESL------VETYGKIMNHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp TCCSSH------HHHHHHHHTHHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred CCCCCh------hHHHHhhhhcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 964322 222222222110000 00111123456889999999888888 9999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=285.15 Aligned_cols=211 Identities=27% Similarity=0.447 Sum_probs=170.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++ ..+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 63 ~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 135 (287)
T 1u59_A 63 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRD 135 (287)
T ss_dssp HHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCc---cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCC
Confidence 46788999999999999 55678999999999999999975432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 136 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999998765433222 223346889999999998889999999999999999998 999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhcc
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGA 235 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~~ 235 (295)
.....+ ....+... .....+...+..+.+++.+||+.||.+||++.+++++|+.+..+...
T Consensus 216 ~~~~~~------~~~~i~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 216 KMKGPE------VMAFIEQG----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp TCCTHH------HHHHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred cCCHHH------HHHHHhcC----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 443221 11111111 11122234456699999999999999999999999999998776653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=283.96 Aligned_cols=204 Identities=30% Similarity=0.517 Sum_probs=157.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+++... .+++..++.++.|++.||+|||+++..+++|||
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~d 133 (271)
T 3dtc_A 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133 (271)
T ss_dssp HHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSC
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecC
Confidence 467789999999999999999999999999999999998643 489999999999999999999999855588999
Q ss_pred CCCCeEEECC--------CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC
Q 045989 82 IKSANILLDD--------KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 82 ikp~Nill~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 153 (295)
|||+||+++. ++.+||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 134 ikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp CSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred CchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999986 6789999999997554322 2234689999999999999999999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+.||....... ......... .....+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 211 ~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 211 EVPFRGIDGLA------VAYGVAMNK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCTTTTSCHHH------HHHHHHTSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCHHH------HHHhhhcCC---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 99996433221 111111111 1111223344568999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=293.03 Aligned_cols=206 Identities=27% Similarity=0.377 Sum_probs=164.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||++||+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 58 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~D 130 (323)
T 3tki_A 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130 (323)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 4678899999999999999999999999999999999886543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 131 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999976543222 22334579999999999988776 7789999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...... ........... .......+..+.+++.+||+.||.+|||+.|++++.+-
T Consensus 211 ~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 211 PSDSCQ-----EYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp SCTTSH-----HHHHHHTTCTT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred CchHHH-----HHHHHhccccc---------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 432210 01111111100 01112234457889999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.51 Aligned_cols=209 Identities=25% Similarity=0.385 Sum_probs=163.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. +..++||||+++|+|.+++...... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrD 305 (452)
T 1fmk_A 232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305 (452)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 5788999999999999876 6789999999999999999754222 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++..............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 306 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998664433222334457889999999999999999999999999999999 99999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
... .....+... .....+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 386 ~~~------~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 386 VNR------EVLDQVERG----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHH------HHHHHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHH------HHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 322 112111111 11122334556789999999999999999999999999876443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=289.33 Aligned_cols=210 Identities=23% Similarity=0.419 Sum_probs=164.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 99 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 172 (333)
T 1mqb_A 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRD 172 (333)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 46789999999999999999999999999999999999976433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 252 (333)
T 1mqb_A 173 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252 (333)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999865433221 1222346788999999998999999999999999999998 999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
..... .....+.... ....+...+..+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 253 ~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 253 ELSNH------EVMKAINDGF----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TCCHH------HHHHHHHTTC----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cCCHH------HHHHHHHCCC----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 43221 1122111111 11112234456899999999999999999999999998876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=284.33 Aligned_cols=216 Identities=25% Similarity=0.356 Sum_probs=164.6
Q ss_pred CCCCccccceeeEEEeC----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------
Q 045989 5 QINHRNVVKLLGCCLET----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-------- 72 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-------- 72 (295)
.++||||+++++++... ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 161 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 45999999999999987 6789999999999999999754 389999999999999999999998
Q ss_pred CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee---eeccccccCCCChhhhccCCCCCC------ccchhh
Q 045989 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL---TTQVKGTFGYLDPEYFQSSQFTEK------SDVYSF 143 (295)
Q Consensus 73 ~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Diwsl 143 (295)
+ |+||||||+||+++.++.+||+|||+++......... .....||+.|+|||++.+..++.+ +|||||
T Consensus 162 ~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 162 A---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp C---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred C---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 7 9999999999999999999999999997654332221 124468999999999988776665 999999
Q ss_pred HHHHHHHHhC----------CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 144 GVVLVELLTG----------QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 144 G~~l~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
||++|||++| ..||........ . ................... ......++..+.+++.+||+.||
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP 313 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-S-YEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNP 313 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-C-HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCC-c-hhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhCh
Confidence 9999999999 555543221111 1 1111111111111111110 11123567789999999999999
Q ss_pred CCCCCHHHHHHHHHHhHHhh
Q 045989 214 KKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~~~~~~ 233 (295)
.+|||+.+++++|+.+.+..
T Consensus 314 ~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 314 ASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GGSCCHHHHHHHHHHHHHTT
T ss_pred hhCCCHHHHHHHHHHHHhhc
Confidence 99999999999999887654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=294.75 Aligned_cols=220 Identities=20% Similarity=0.268 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++..++..++|||||++|+|.+++...... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 79 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 153 (389)
T 3gni_B 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHMG---YVHRS 153 (389)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 567899999999999999999999999999999999999865322 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc------eeeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g 153 (295)
|||+|||++.++.+||+|||.+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 154 lkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 233 (389)
T 3gni_B 154 VKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233 (389)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHC
Confidence 999999999999999999998865432211 11122368999999999987 5789999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHH----hhc------------------hhhhhh---------hhhhhhhhhHHHHHHHH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVI----NEN------------------RLFEVL---------DAQVLREAEKEEVITVA 202 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~----~~~------------------~~~~~~---------~~~~~~~~~~~~~~~~~ 202 (295)
+.||......+.. ........ ... ...... ........+...+..+.
T Consensus 234 ~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 311 (389)
T 3gni_B 234 HVPFKDMPATQML--LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311 (389)
T ss_dssp SCTTTTCCSTTHH--HHC--------------------------------------------------------CCHHHH
T ss_pred CCCCCCCCHHHHH--HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHH
Confidence 9999653322110 00000000 000 000000 00000112233456799
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 203 MVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 203 ~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+|+.+||+.||++|||+.|+++|.+-
T Consensus 312 ~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 312 HFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 99999999999999999999988653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=287.42 Aligned_cols=215 Identities=18% Similarity=0.297 Sum_probs=163.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++ +|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 72 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~D 144 (311)
T 3niz_A 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRD 144 (311)
T ss_dssp HHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 46789999999999999999999999999975 88888875433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 145 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 145 LKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CchHhEEECCCCCEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543322 2334468999999999876 56899999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhchhh----------------hhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLF----------------EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+. ...+.......... ...............+..+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 224 TDDDQ---LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp STTTH---HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHH---HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 43221 11111111110000 000000001111223456889999999999999999999998
Q ss_pred HHH
Q 045989 225 ELA 227 (295)
Q Consensus 225 ~l~ 227 (295)
|.+
T Consensus 301 hp~ 303 (311)
T 3niz_A 301 HPY 303 (311)
T ss_dssp SGG
T ss_pred Ccc
Confidence 854
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=287.37 Aligned_cols=214 Identities=27% Similarity=0.453 Sum_probs=171.5
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC--------------CCCCCHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED--------------QLPITWEIRLGIAVEVSGAL 66 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~--------------~~~~~~~~~~~i~~qi~~~l 66 (295)
+|+++ +||||+++++++..++..++||||+++|+|.+++...... ...+++..++.++.|++.||
T Consensus 79 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 158 (313)
T 1t46_A 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (313)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred HHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence 35677 9999999999999999999999999999999999865421 22489999999999999999
Q ss_pred HHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHH
Q 045989 67 SYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGV 145 (295)
Q Consensus 67 ~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 145 (295)
+|||+++ ++||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+
T Consensus 159 ~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 235 (313)
T 1t46_A 159 AFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (313)
T ss_dssp HHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHH
Confidence 9999999 999999999999999999999999999866544332 223445788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 146 VLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 146 ~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
++|+|++ |..||....... ......... .....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 236 il~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 236 FLWELFSLGSSPYPGMPVDS------KFYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHTTTCCSSTTCCSSH------HHHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCcccchh------HHHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999998 999986433211 111111111 111112233456899999999999999999999999
Q ss_pred HHHHhHHhh
Q 045989 225 ELAGIRASI 233 (295)
Q Consensus 225 ~l~~~~~~~ 233 (295)
+|+.+....
T Consensus 301 ~L~~~~~~~ 309 (313)
T 1t46_A 301 LIEKQISES 309 (313)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 998876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=291.99 Aligned_cols=210 Identities=25% Similarity=0.326 Sum_probs=146.7
Q ss_pred ccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++. ||||+++++++.++...++||||++||+|.+++.... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 131 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG---VVHRD 131 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecC
Confidence 55665 9999999999999999999999999999999998653 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCC---ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKY---RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++ .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp CCGGGEEEEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 999999997665 89999999998654332 22334568999999999999999999999999999999999999997
Q ss_pred ccchhhc-ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 159 LVETEEN-RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
....... .........+...... .........+..+.+++.+||+.||.+|||+.++++|.|
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 211 SHDRSLTCTSAVEIMKKIKKGDFS-------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp -------CCCHHHHHHHHTTTCCC-------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred CCccccccccHHHHHHHHHcCCCC-------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 5433211 1222222222211100 011111234556899999999999999999999988754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=289.11 Aligned_cols=214 Identities=24% Similarity=0.440 Sum_probs=171.3
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+|+++ +||||+++++++..++..++||||+++|+|.+++...... ...+++..++.++.||+.||+|
T Consensus 93 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 172 (334)
T 2pvf_A 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172 (334)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 35566 8999999999999999999999999999999999865421 1248899999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+.+ |+||||||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++
T Consensus 173 LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 249 (334)
T 2pvf_A 173 LASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249 (334)
T ss_dssp HHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred HHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHH
Confidence 99999 999999999999999999999999999866543222 22334568889999999988899999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||...... .......... ....+...+..+.+++.+||+.||.+|||+.+++++|
T Consensus 250 ~ellt~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPVE------ELFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHHTTSCCSSTTCCHH------HHHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCcCcCCHH------HHHHHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999 99999643322 1111111111 1112223445689999999999999999999999999
Q ss_pred HHhHHhhc
Q 045989 227 AGIRASIG 234 (295)
Q Consensus 227 ~~~~~~~~ 234 (295)
+.+.....
T Consensus 314 ~~l~~~~~ 321 (334)
T 2pvf_A 314 DRILTLTT 321 (334)
T ss_dssp HHHHHHHC
T ss_pred HHHHhccc
Confidence 98876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=294.16 Aligned_cols=203 Identities=24% Similarity=0.333 Sum_probs=164.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++++|...+..++||||+.||+|..++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 140 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR---IIHRD 140 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 5778999999999999999999999999999999999997643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 141 lkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 141 MKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcHHHeEECCCCCEEEeccceeeeccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 9999999999999999999999865432 22345679999999999964 458999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-MKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~e~~~~l~ 227 (295)
...... ........... ....+...+..+.++|.+||+.||.+||+ +.++..|.+
T Consensus 219 ~~~~~~---~~~~~~~~~~~-----------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 219 IRSSTS---SKEIVHTFETT-----------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp CCTTSC---HHHHHHHHHHC-----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred CCCCcc---HHHHHHHHhhc-----------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 433221 11111111111 11122334456899999999999999998 788777653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=290.63 Aligned_cols=224 Identities=27% Similarity=0.412 Sum_probs=172.1
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... ...++||||+++|+|.+++.... +++..++.++.|++.||+|||+.+ |+|
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~~---ivH 157 (318)
T 3lxp_A 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQH---YIH 157 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhCC---ccC
Confidence 46789999999999999984 57899999999999999997643 899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++.++.+||+|||++......... ......+|..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 158 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 999999999999999999999999876543322 223345788899999999988999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
......... .............+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 238 QSPPTKFLE-LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp GSHHHHHHH-HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccchhhhh-hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 643221100 0000000000011111222222223334455679999999999999999999999999998876654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=290.69 Aligned_cols=207 Identities=27% Similarity=0.407 Sum_probs=163.7
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++ +||||+++++++...+..|+||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 63 l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 135 (345)
T 3a8x_A 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRD 135 (345)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4455 89999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 136 lkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp CCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred CCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 99999999999999999999997533222 22345579999999999999999999999999999999999999996432
Q ss_pred hhhcc--cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH------HHHHHHHH
Q 045989 162 TEENR--SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM------KEVALELA 227 (295)
Q Consensus 162 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~------~e~~~~l~ 227 (295)
..+.. .......+.+.... ...+...+..+.+++.+||+.||.+||++ .++++|.+
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp C-------CHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred cccccccccHHHHHHHHHcCC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 21110 11111111111111 01222344568899999999999999995 78887764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.64 Aligned_cols=202 Identities=23% Similarity=0.300 Sum_probs=166.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
+|++++||||+++++++...+..++||||++||+|..++.... .+++..+..++.||+.||+|||+ .+ |+||
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHr 273 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYR 273 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCC
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEEC
Confidence 5788999999999999999999999999999999999997654 48999999999999999999998 88 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999997543222 2234467999999999999999999999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
... .....+..... ..+...+..+.++|.+||+.||.+|| +++|+++|.+-
T Consensus 353 ~~~------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 353 DHE------KLFELILMEEI-----------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp SHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred CHH------HHHHHHHhCCC-----------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 221 22222221110 11222345688999999999999999 99999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=290.73 Aligned_cols=212 Identities=19% Similarity=0.251 Sum_probs=164.1
Q ss_pred ccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 3 LSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++.++||||+++++++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---iv 173 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE---YV 173 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 567899999999999988 77899999999 999999998654 4899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCC--ceEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 79 HRDIKSANILLDDKY--RAKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 79 H~dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
||||||+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999998877 9999999999866432211 11334689999999999999999999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhh-hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLRE-AEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
++|..||........ ........ ....+....... .....+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 254 l~g~~pf~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 254 LCGKLPWEQNLKDPV--AVQTAKTN-----LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHSSCTTGGGTTCHH--HHHHHHHH-----HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HhCCCCccccccccH--HHHHHHHh-----hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 999999953211110 00000000 000011100000 0013445699999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.11 Aligned_cols=200 Identities=26% Similarity=0.351 Sum_probs=163.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+++.++||||+++++++...+..|+||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 92 ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 164 (373)
T 2r5t_A 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRD 164 (373)
T ss_dssp CBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4678999999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 165 lkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 165 LKPENILLDSQGHIVLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCGGGEEECTTSCEEECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CCHHHEEECCCCCEEEeeCccccccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999753322 222445679999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH----HHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK----EVALEL 226 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~----e~~~~l 226 (295)
. ...+..+..... ..+...+..+.++|.+||+.||.+||++. ++.+|.
T Consensus 244 ~------~~~~~~i~~~~~-----------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 244 T------AEMYDNILNKPL-----------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp H------HHHHHHHHHSCC-----------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred H------HHHHHHHHhccc-----------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 2 222222222210 11122345588999999999999999974 555543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.45 Aligned_cols=212 Identities=24% Similarity=0.350 Sum_probs=161.9
Q ss_pred CCCCccccceeeEEEeC----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hC
Q 045989 5 QINHRNVVKLLGCCLET----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLH--------SA 72 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh--------~~ 72 (295)
+++||||+++++++... ...++||||+++|+|.+++... .+++..++.++.|++.||+||| +.
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 48999999999997653 4589999999999999999643 4899999999999999999999 77
Q ss_pred CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCccee---eeccccccCCCChhhhccC------CCCCCccchhh
Q 045989 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL---TTQVKGTFGYLDPEYFQSS------QFTEKSDVYSF 143 (295)
Q Consensus 73 ~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Diwsl 143 (295)
+ |+||||||+||+++.++.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||
T Consensus 133 ~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 133 A---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp E---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 8 9999999999999999999999999997654433322 2234689999999999876 45578999999
Q ss_pred HHHHHHHHhC----------CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 144 GVVLVELLTG----------QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 144 G~~l~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
||++|+|++| ..||........ ... ................ ........+..+.+++.+||+.||
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP 284 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP-SFE-DMRKVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNP 284 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-CHH-HHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCc-chh-hhhHHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcCh
Confidence 9999999999 777753322111 111 1111111111111111 111234566789999999999999
Q ss_pred CCCCCHHHHHHHHHHh
Q 045989 214 KKRPTMKEVALELAGI 229 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~~ 229 (295)
.+|||+.++++.|+.+
T Consensus 285 ~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 285 SARLTALRIKKTLTKI 300 (301)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHhcc
Confidence 9999999999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.07 Aligned_cols=213 Identities=24% Similarity=0.442 Sum_probs=163.0
Q ss_pred cccCCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQT--EDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++++||||+++++++.... ..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 167 (313)
T 3brb_A 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN- 167 (313)
T ss_dssp HHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 467899999999999998755 3599999999999999996432 23345999999999999999999999999
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT- 152 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~- 152 (295)
|+||||||+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 168 --ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 245 (313)
T 3brb_A 168 --FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245 (313)
T ss_dssp --CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999976543322 11233457889999999999999999999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
|..||......+ ......... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 246 g~~p~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 246 GMTPYPGVQNHE------MYDYLLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp SCCSSTTCCGGG------HHHHHHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHH------HHHHHHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 889986443221 111111111 1112233445689999999999999999999999999988765
Q ss_pred h
Q 045989 233 I 233 (295)
Q Consensus 233 ~ 233 (295)
+
T Consensus 310 l 310 (313)
T 3brb_A 310 L 310 (313)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.63 Aligned_cols=207 Identities=21% Similarity=0.243 Sum_probs=167.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 212 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY---NLTELDTILFMKQICEGIRHMHQMY---ILHLD 212 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 57889999999999999999999999999999999998875432 4899999999999999999999999 99999
Q ss_pred CCCCeEEE--CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILL--DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 213 lkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 213 LKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999 567899999999998654332 22334699999999999988899999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.... ..+..+...... .. .......+..+.++|.+||+.||.+|||+.|+++|.+-.
T Consensus 291 ~~~~------~~~~~i~~~~~~---~~----~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 291 DNDA------ETLNNILACRWD---LE----DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp SSHH------HHHHHHHHTCCC---SC----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCHH------HHHHHHHhccCC---CC----hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 3322 122222221100 00 011122345689999999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=283.68 Aligned_cols=218 Identities=20% Similarity=0.343 Sum_probs=164.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE--DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++..++..++||||++ |+|.+++..... ....+++..+..++.||+.||+|||+.+ |+|
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH 131 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILH 131 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 5788999999999999999999999999997 599999875432 2234899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCGGGEEECTTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCChHHeEEcCCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543222 2234468999999999976 468999999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhc--hhhhhh------------------hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 159 LVETEENRSLAAYFLQVINEN--RLFEVL------------------DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
.....+. ...+....... ..+... ............+..+.+++.+||+.||++|||
T Consensus 211 ~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 287 (317)
T 2pmi_A 211 GTNDEEQ---LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287 (317)
T ss_dssp CSSHHHH---HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCChHHH---HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC
Confidence 5433221 11111111100 000000 000000111123456899999999999999999
Q ss_pred HHHHHHHHH
Q 045989 219 MKEVALELA 227 (295)
Q Consensus 219 ~~e~~~~l~ 227 (295)
+.|+++|.+
T Consensus 288 ~~e~l~hp~ 296 (317)
T 2pmi_A 288 AKQALHHPW 296 (317)
T ss_dssp HHHHTTSGG
T ss_pred HHHHhCChh
Confidence 999988754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.42 Aligned_cols=206 Identities=21% Similarity=0.263 Sum_probs=166.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++||+|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 174 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 57889999999999999999999999999999999999875432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECC--CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDD--KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+||+++. .+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cchHHeEEecCCCCceEEEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 9999999974 46799999999986644322 2334689999999999999999999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.... .....+...... .+ .......+..+.++|.+||+.||.+|||+.++++|.+-
T Consensus 253 ~~~~------~~~~~i~~~~~~---~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 253 EDDL------ETLQNVKRCDWE---FD----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp SSHH------HHHHHHHHCCCC---CC----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred CCHH------HHHHHHHhCCCC---CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 3221 112111111100 00 11112334568999999999999999999999998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.65 Aligned_cols=201 Identities=24% Similarity=0.337 Sum_probs=165.0
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+.+ +||||+++++++...+..|+||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+||
T Consensus 73 ~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHr 145 (353)
T 2i0e_A 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYR 145 (353)
T ss_dssp HHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred HHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEec
Confidence 35555 89999999999999999999999999999999998654 3899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 146 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999997543222 2234557999999999999999999999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
.. ...+..+..... ..+...+..+.+++.+||+.||.+||+ +.++++|.+
T Consensus 225 ~~------~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 225 DE------DELFQSIMEHNV-----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp SH------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred CH------HHHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 22 222222222110 112234456899999999999999994 688888754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=295.56 Aligned_cols=208 Identities=24% Similarity=0.288 Sum_probs=166.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|.+++||||+++++++.+.+.+|+||||++||+|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 114 il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrD 187 (412)
T 2vd5_A 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLG---YVHRD 187 (412)
T ss_dssp HHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 46678999999999999999999999999999999999986543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-------cCCCCCCccchhhHHHHHHHHhCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-------SSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|||+|||++.++.+||+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 188 LKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 9999999999999999999999876554443344567999999999997 356899999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR---PTMKEVALELAG 228 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---ps~~e~~~~l~~ 228 (295)
.||..... ...+..+........ ........+..+.++|.+||. +|.+| |+++|+++|.+-
T Consensus 268 ~Pf~~~~~------~~~~~~i~~~~~~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 268 TPFYADST------AETYGKIVHYKEHLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp CTTCCSSH------HHHHHHHHTHHHHCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred CCCCCCCH------HHHHHHHHhcccCcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 99964322 222222222110000 001112345568999999999 99998 699999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=291.38 Aligned_cols=201 Identities=24% Similarity=0.330 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+ +|+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 62 ~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~D 133 (336)
T 3h4j_B 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRD 133 (336)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 478899999999999999999999999999 789999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 134 lkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 134 LKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp CSTTTEEECTTCCEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred CchhhEEEcCCCCEEEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999998654332 2334569999999999988776 68999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
...... ..+... ....+...+..+.+++.+||+.||.+|||+.|+++|.+-.
T Consensus 212 ~~~~~~----------------~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 212 FIPNLF----------------KKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp SSTTCB----------------CCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred cHHHHH----------------HHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 221100 000000 0011222345688999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=292.48 Aligned_cols=208 Identities=23% Similarity=0.303 Sum_probs=156.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||++||+|.+++.... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 69 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~D 141 (361)
T 3uc3_A 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRD 141 (361)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCC
T ss_pred HHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4678899999999999999999999999999999999997654 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc--eEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCC-ccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYR--AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEK-SDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++. +||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus 142 lkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCHHHEEEcCCCCceEEEeecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 9999999987765 999999998743222 12334569999999999988877655 899999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... ............... ........+..+.++|.+||+.||.+|||+.|+++|.+-.
T Consensus 220 ~~~~~--~~~~~~~~~~~~~~~---------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 220 DPEEP--RDYRKTIQRILSVKY---------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp ----C--CCHHHHHHHHHTTCC---------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred CCccH--HHHHHHHHHHhcCCC---------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 43321 122222222221110 0001112334588999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=284.78 Aligned_cols=203 Identities=22% Similarity=0.348 Sum_probs=158.9
Q ss_pred cccCCCCccccceeeEEEeCC---------------------------------------------------------cc
Q 045989 2 ILSQINHRNVVKLLGCCLETE---------------------------------------------------------VP 24 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~---------------------------------------------------------~~ 24 (295)
+|++++||||+++++++.+.. ..
T Consensus 57 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (332)
T 3qd2_B 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136 (332)
T ss_dssp HHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEE
T ss_pred HHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceE
Confidence 578899999999999987643 27
Q ss_pred EEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 25 LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 25 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
++|||||+||+|.+++..... .....+..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 137 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 137 YIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCHHHHHhcccC-ccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCccc
Confidence 999999999999999986543 223577788999999999999999999 9999999999999999999999999998
Q ss_pred ccccCcc-----------eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHH
Q 045989 105 SMAVDRT-----------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173 (295)
Q Consensus 105 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 173 (295)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..|+... .....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~ 284 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIIT 284 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHH
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHH
Confidence 6654321 1123346899999999999999999999999999999999987764210 00111
Q ss_pred HHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 174 QVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
... ...........+..+.+++.+||+.||.+|||+.|+++|.
T Consensus 285 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 285 DVR----------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHH----------TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred Hhh----------ccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 110 1111122334445678999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.89 Aligned_cols=210 Identities=27% Similarity=0.437 Sum_probs=167.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.. +..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrD 461 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRN 461 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCc
Confidence 5788999999999999976 568999999999999999975432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||||+.++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 462 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp CSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999998664332211 122345689999999999999999999999999999998 999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
.....+ ....+... .....+..++..+.++|.+||+.||++||++.+|++.|+.+.....
T Consensus 542 ~~~~~~------~~~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 542 KMKGPE------VMAFIEQG----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp TCCSHH------HHHHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCHHH------HHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 543322 11111111 1112233455679999999999999999999999999988766554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=292.04 Aligned_cols=197 Identities=24% Similarity=0.319 Sum_probs=162.8
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.+||||+++++++.+.+..|+||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 147 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD 147 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChh
Confidence 399999999999999999999999999999999998654 3899999999999999999999999 999999999
Q ss_pred eEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhc
Q 045989 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165 (295)
Q Consensus 86 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 165 (295)
||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--- 223 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--- 223 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred hEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---
Confidence 9999999999999999997543222 223456799999999999999999999999999999999999999964322
Q ss_pred ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q 045989 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK-EVALELA 227 (295)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~~~~l~ 227 (295)
...+..+..... ..+...+..+.+++.+||+.||.+||++. ++++|.+
T Consensus 224 ---~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 224 ---EELFHSIRMDNP-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp ---HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred ---HHHHHHHHhCCC-----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 222222222110 11222345688999999999999999998 8877754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.93 Aligned_cols=202 Identities=23% Similarity=0.306 Sum_probs=162.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 74 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~D 146 (327)
T 3a62_A 74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG---IIYRD 146 (327)
T ss_dssp HHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEccc
Confidence 4678899999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 147 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 147 LKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999987543222 22334569999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
.. .....+.... ...+...+..+.+++.+||+.||.+|| ++.++++|.+-
T Consensus 226 ~~------~~~~~i~~~~-----------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 226 RK------KTIDKILKCK-----------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp HH------HHHHHHHHTC-----------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred HH------HHHHHHHhCC-----------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 21 1222222111 011222345688999999999999999 88999998653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.25 Aligned_cols=210 Identities=30% Similarity=0.509 Sum_probs=165.2
Q ss_pred cccCCCCccccceeeEEE-eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++. .++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++||
T Consensus 79 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~ 152 (298)
T 3f66_A 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK---FVHR 152 (298)
T ss_dssp HHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 577899999999999965 45688999999999999999975432 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcc---eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRT---HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p 156 (295)
||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+|
T Consensus 153 dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp CCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999986543321 12233457889999999999999999999999999999999 5666
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
|......+ . ........ ....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 233 ~~~~~~~~---~---~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 233 YPDVNTFD---I---TVYLLQGR----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp STTSCTTT---H---HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CccCCHHH---H---HHHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 65332221 1 11111111 11112223456899999999999999999999999999887654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.91 Aligned_cols=215 Identities=20% Similarity=0.329 Sum_probs=160.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++ +|.+++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 125 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 57889999999999999999999999999965 99999875433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 126 LKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHEEEcCCCCEEEeECccccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654322 122344689999999999764 5899999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhchh--hh------hhh-------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRL--FE------VLD-------AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~--~~------~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...+. ... .......... +. ..+ +..........+..+.+++.+||+.||++|||+.|+++|
T Consensus 205 ~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 205 SEADQ--LMR-IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp SHHHH--HHH-HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHH--HHH-HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 32211 111 1111110000 00 000 000001112234568899999999999999999999987
Q ss_pred HH
Q 045989 226 LA 227 (295)
Q Consensus 226 l~ 227 (295)
.+
T Consensus 282 p~ 283 (288)
T 1ob3_A 282 AY 283 (288)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.80 Aligned_cols=209 Identities=27% Similarity=0.427 Sum_probs=168.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++ ..+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 71 ~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 142 (291)
T 1xbb_A 71 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRD 142 (291)
T ss_dssp HHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCC
Confidence 46788999999999999 6678899999999999999998643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 143 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999998665433322 222346788999999998889999999999999999999 999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
.....+ ....+... .....+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 223 ~~~~~~------~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 223 GMKGSE------VTAMLEKG----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TCCHHH------HHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHH------HHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 433221 11111111 1112223345569999999999999999999999999998866554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=281.74 Aligned_cols=211 Identities=23% Similarity=0.398 Sum_probs=169.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. .+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|||
T Consensus 61 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 134 (279)
T 1qpc_A 61 LMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134 (279)
T ss_dssp HHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 467889999999999986 4568999999999999999975421 13899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 135 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999998765443333334457889999999998889999999999999999999 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
... .......... ....+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 215 ~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 215 TNP------EVIQNLERGY----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CHH------HHHHHHhccc----------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 322 1111111110 011122344568999999999999999999999999998766543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=281.77 Aligned_cols=211 Identities=26% Similarity=0.401 Sum_probs=167.3
Q ss_pred cccCCCCccccceeeEEEeCCcc-EEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVP-LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~-~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++...+.. ++||||+.+|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||
T Consensus 75 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~ 148 (298)
T 3pls_A 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQK---FVHR 148 (298)
T ss_dssp HHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 46789999999999999876655 999999999999999976332 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcc---eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC-
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRT---HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP- 156 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p- 156 (295)
||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 149 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp CCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 9999999999999999999999976543221 122334678899999999999999999999999999999995555
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
|......+ ... ..... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+...+.
T Consensus 229 ~~~~~~~~---~~~---~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 229 YRHIDPFD---LTH---FLAQG----------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp TTTSCGGG---HHH---HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CccCCHHH---HHH---HhhcC----------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 43222211 111 11111 1111222334568999999999999999999999999999877654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=282.91 Aligned_cols=215 Identities=28% Similarity=0.461 Sum_probs=168.1
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... ...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+|
T Consensus 76 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H 149 (302)
T 4e5w_A 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQ---YVH 149 (302)
T ss_dssp HHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCC---ccc
Confidence 46789999999999999876 668999999999999999976543 3899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++.++.+||+|||++........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+
T Consensus 150 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999987654432 2233446788899999999999999999999999999999999986
Q ss_pred cccchhhcccHHHHHHHHHh-------hchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 158 RLVETEENRSLAAYFLQVIN-------ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
...... ...... ...+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 230 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 230 SSPMAL--------FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GSHHHH--------HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhhH--------HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 422110 000000 00011111111112223345567999999999999999999999999998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.48 Aligned_cols=217 Identities=19% Similarity=0.339 Sum_probs=161.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++ |+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 125 (324)
T 3mtl_A 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQK---VLHRD 125 (324)
T ss_dssp HHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred HHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 5788999999999999999999999999996 599999876543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 126 LKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp CCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987544322 22334468999999999876 56899999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhc---hhhhhhhhh-------------hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINEN---RLFEVLDAQ-------------VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+. ...+....... ......... .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 205 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 205 TVEEQ---LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp SHHHH---HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CHHHH---HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 33221 11111111110 000000000 000111223456889999999999999999999999
Q ss_pred HHHHh
Q 045989 225 ELAGI 229 (295)
Q Consensus 225 ~l~~~ 229 (295)
|.+-.
T Consensus 282 hp~f~ 286 (324)
T 3mtl_A 282 HPFFL 286 (324)
T ss_dssp SGGGG
T ss_pred Chhhh
Confidence 87643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=291.82 Aligned_cols=214 Identities=23% Similarity=0.418 Sum_probs=169.7
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC----------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE----------DQLPITWEIRLGIAVEVSGALSYLH 70 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~Lh 70 (295)
+|+++ +||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||
T Consensus 102 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 181 (333)
T 2i1m_A 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181 (333)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 45677 899999999999999999999999999999999975421 1224799999999999999999999
Q ss_pred hCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHH
Q 045989 71 SAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 71 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 149 (295)
+.+ |+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+
T Consensus 182 ~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 258 (333)
T 2i1m_A 182 SKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258 (333)
T ss_dssp HTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHH
Confidence 999 999999999999999999999999999865433222 2334457889999999999999999999999999999
Q ss_pred HHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 150 LLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 150 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|++ |..||....... ......... .....+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 259 l~t~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 259 IFSLGLNPYPGILVNS------KFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HTTTSCCSSTTCCSSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCCCCcccchhH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 998 999986432211 111111111 1111122234568999999999999999999999999988
Q ss_pred hHHhh
Q 045989 229 IRASI 233 (295)
Q Consensus 229 ~~~~~ 233 (295)
+....
T Consensus 324 ~~~~~ 328 (333)
T 2i1m_A 324 QAQED 328 (333)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 76543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=285.57 Aligned_cols=202 Identities=24% Similarity=0.353 Sum_probs=160.3
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++.. .+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++ |+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 160 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIH 160 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 4678999999999999987 5688999999999999876432 24899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC---CCCCccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999986544322 234457999999999997655 37789999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..... ......+.... .. .......+..+.+++.+||+.||++|||+.|+++|.+
T Consensus 240 f~~~~~------~~~~~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 240 FMDERI------MCLHSKIKSQA-LE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SCCSSH------HHHHHHHHHCC-CC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CCCccH------HHHHHHHhccc-CC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 963321 11111111111 00 0011123455899999999999999999999998865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.31 Aligned_cols=219 Identities=25% Similarity=0.338 Sum_probs=164.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 85 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 161 (310)
T 2wqm_A 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRD 161 (310)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 467899999999999999999999999999999999999865444446899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 162 l~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 162 IKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CcHHHEEEcCCCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999999876543221 2233468999999999999899999999999999999999999986322
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhccch
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASV 237 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~~~~ 237 (295)
. .......... ...... ......+..+.+++.+||+.||.+|||+.++++.|+.+++......
T Consensus 241 ~----~~~~~~~~~~-~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 241 M----NLYSLCKKIE-QCDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp C----CHHHHHHHHH-TTCSCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred h----hHHHHHHHhh-cccCCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1 1111111111 111000 0112234568999999999999999999999999999988776554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=276.18 Aligned_cols=201 Identities=28% Similarity=0.400 Sum_probs=163.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~d 134 (279)
T 3fdn_A 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRD 134 (279)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECC
T ss_pred HHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---Eeccc
Confidence 4678999999999999999999999999999999999998754 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.++|+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 135 lkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 135 IKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp CCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CChHhEEEcCCCCEEEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 99999999999999999999886443222 234568999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.. .....+.... ...+...+..+.+++.+||+.||.+|||+.|+++|.+-.
T Consensus 212 ~~------~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 212 YQ------ETYKRISRVE-----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp HH------HHHHHHHHTC-----------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred HH------HHHHHHHhCC-----------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 21 1111111110 011222345588999999999999999999999998643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=284.57 Aligned_cols=210 Identities=24% Similarity=0.414 Sum_probs=168.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE------DQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++..++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+++
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 158 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 57889999999999999999999999999999999999975321 1124789999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
|+||||||+||+++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 159 -i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 159 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999997654332211 223356889999999999999999999999999999999 8
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
..||...... .......... ....+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 238 ~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 238 EQPYQGLSNE------QVLRFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp CCTTTTSCHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCccccCCHH------HHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 9998643322 1121111111 11122334556899999999999999999999999997653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.56 Aligned_cols=210 Identities=21% Similarity=0.281 Sum_probs=158.8
Q ss_pred cCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 4 SQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+..+||||+++++++.. ...+|+|||||+||+|.+++..... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 184 (400)
T 1nxk_A 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAH 184 (400)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 45689999999999986 5678999999999999999976432 24899999999999999999999999 999
Q ss_pred ccCCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 262 (400)
T 1nxk_A 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCcceEEEecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 999999999997 7899999999998654322 23345689999999999999999999999999999999999999
Q ss_pred Ccccchhhcc-cHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 157 IRLVETEENR-SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
|......... .... .+.... .. .........+..+.+||.+||+.||.+|||+.++++|.+-..
T Consensus 263 f~~~~~~~~~~~~~~---~i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 263 FYSNHGLAISPGMKT---RIRMGQ-YE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CCCCTTCSSCCSHHH---HHHHTC-CC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCCCccccccHHHHH---HHHcCc-cc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 9654322111 1111 111100 00 000011223456899999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=281.65 Aligned_cols=216 Identities=19% Similarity=0.299 Sum_probs=161.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++ +|.+.+..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~d 126 (292)
T 3o0g_A 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 57889999999999999999999999999965 67666654332 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC-CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 127 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 127 LKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred CCHHHEEEcCCCCEEEeecccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 99999999999999999999998654332 2233456899999999997765 799999999999999999988885432
Q ss_pred chhhcccHHHHHHHHHhhchhh--hhhh-------------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLF--EVLD-------------AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~--~~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
.... .....+.+........ .... ...........+..+.+++.+||+.||++|||+.|+++|
T Consensus 206 ~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 206 NDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp SSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHH--HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 2111 1111111111100000 0000 000001112344568899999999999999999999988
Q ss_pred HH
Q 045989 226 LA 227 (295)
Q Consensus 226 l~ 227 (295)
.+
T Consensus 284 p~ 285 (292)
T 3o0g_A 284 PY 285 (292)
T ss_dssp GG
T ss_pred cc
Confidence 64
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=278.91 Aligned_cols=206 Identities=23% Similarity=0.325 Sum_probs=165.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+.+.... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 130 (284)
T 3kk8_A 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRN 130 (284)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCC
Confidence 4678899999999999999999999999999999999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc---eEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYR---AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++. +||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 131 ikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 131 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 9999999986655 99999999976543322 234568999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... ............ .........+..+.+++.+||+.||++|||+.++++|.+-.
T Consensus 209 ~~~~~------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 209 DEDQH------RLYAQIKAGAYD-------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp CSSHH------HHHHHHHHTCCC-------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred CCchh------HHHHHHHhcccc-------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 43222 111111111100 00011122345588999999999999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=285.84 Aligned_cols=211 Identities=25% Similarity=0.297 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-----------------------------------
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED----------------------------------- 46 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~----------------------------------- 46 (295)
+|++++||||+++++++.+.+..++||||++||+|.+++......
T Consensus 81 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (345)
T 3hko_A 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160 (345)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEE
T ss_pred HHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 467889999999999999999999999999999999998531111
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCC--ceEEeeccCccccccCc---ceeeeccccc
Q 045989 47 -QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY--RAKISDFGTSRSMAVDR---THLTTQVKGT 120 (295)
Q Consensus 47 -~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~---~~~~~~~~gt 120 (295)
...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++...... ........||
T Consensus 161 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt 237 (345)
T 3hko_A 161 LDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCC
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCC
Confidence 112467888999999999999999999 99999999999998766 89999999998654321 1123445689
Q ss_pred cCCCChhhhcc--CCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHH
Q 045989 121 FGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEV 198 (295)
Q Consensus 121 ~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (295)
+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .............. .......+
T Consensus 238 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~ 304 (345)
T 3hko_A 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE-------NPNYNVLS 304 (345)
T ss_dssp GGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT-------SGGGGGSC
T ss_pred ccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC-------CcccccCC
Confidence 99999999975 67899999999999999999999999644322 22222222221111 01111234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 199 ITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 199 ~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 568899999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=275.90 Aligned_cols=204 Identities=21% Similarity=0.288 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++|||
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 131 (277)
T 3f3z_A 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN---VAHRD 131 (277)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 4678999999999999999999999999999999999987654 3899999999999999999999999 99999
Q ss_pred CCCCeEEE---CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILL---DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||++ +.++.++|+|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.
T Consensus 132 lkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 132 LKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp CSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCC
Confidence 99999999 788899999999997654332 23345689999999998754 8999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..... ............. .. ......+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 209 ~~~~~------~~~~~~~~~~~~~---~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 209 APTDS------EVMLKIREGTFTF---PE----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp CSSHH------HHHHHHHHCCCCC---CH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred CCCHH------HHHHHHHhCCCCC---Cc----hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 43322 1122211111000 00 0011234568999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=289.56 Aligned_cols=209 Identities=21% Similarity=0.294 Sum_probs=164.6
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|.++ +||||+++++++.+++..|+||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 69 l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrD 141 (342)
T 2qr7_A 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG---VVHRD 141 (342)
T ss_dssp HHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecc
Confidence 3344 89999999999999999999999999999999997643 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCC----CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDK----YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||++... +.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp CCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 99999998543 3599999999986543322 233456899999999998888999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
...... .....+..+.... .. .........+..+.+++.+||..||++|||+.++++|.+-.
T Consensus 221 ~~~~~~---~~~~~~~~i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 221 ANGPDD---TPEEILARIGSGK-FS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp CSSTTS---CHHHHHHHHHHCC-CC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred CCCCcC---CHHHHHHHHccCC-cc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 743221 1222222222111 10 00011123445688999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=281.12 Aligned_cols=211 Identities=26% Similarity=0.465 Sum_probs=156.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++ .....++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~D 145 (289)
T 3og7_A 73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145 (289)
T ss_dssp HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 57889999999999965 55678999999999999999965433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++.+||+|||+++...... ........||+.|+|||++. +..++.++||||||+++|+|++|..||
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999987554321 22233456899999999986 567888999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
......+ .............. .......++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 226 ~~~~~~~------~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 226 SNINNRD------QIIEMVGRGSLSPD-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SSCCCHH------HHHHHHHHTSCCCC-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccchHH------HHHHHhcccccCcc-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 6433221 11112111111100 11112234456999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=282.51 Aligned_cols=207 Identities=26% Similarity=0.366 Sum_probs=157.1
Q ss_pred cccCCCCccccceeeEEEeCCcc----EEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~----~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
++++++||||+++++++...... ++||||++|++|.+++.... .+++..++.++.|++.||+|||+++ |
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---I 137 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 57889999999999999876544 99999999999999998654 4899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999986543322 12234568999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
||...... ............. + .......+..+.+++.+||+.||.+||++.+++.+.+.
T Consensus 218 pf~~~~~~------~~~~~~~~~~~~~----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 218 PFTGDSPV------SVAYQHVREDPIP----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp SCCCSSHH------HHHHHHHHCCCCC----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCCChH------HHHHHHhcCCCCC----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 99643321 1222222211110 0 01112234568899999999999999988777766543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=295.07 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=166.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 141 (476)
T 2y94_A 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRHM---VVHRD 141 (476)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCccc
Confidence 4788999999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 142 Lkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 142 LKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccHHHEEEecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999998654322 2334569999999999988766 68999999999999999999999633
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.. ......+..... ..+...+..+.+++.+||+.||.+|||+.++++|.+-.
T Consensus 220 ~~------~~~~~~i~~~~~-----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 220 HV------PTLFKKICDGIF-----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp SS------HHHHHHHHTTCC-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred CH------HHHHHHHhcCCc-----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 22 222222222110 11112334588999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.10 Aligned_cols=210 Identities=22% Similarity=0.264 Sum_probs=158.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+|+|
T Consensus 87 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 159 (309)
T 2h34_A 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRD 159 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCC
Confidence 4678999999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++...............|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp CCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred CChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 99999999999999999999987655443333344568999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-TMKEVALELAGIRAS 232 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-s~~e~~~~l~~~~~~ 232 (295)
.. .+......... .....+...+..+.+++.+||+.||++|| ++.++++.|+.....
T Consensus 240 ~~-------~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 240 LS-------VMGAHINQAIP-------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HH-------HHHHHHHSCCC-------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HH-------HHHHHhccCCC-------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 21 11111111100 01112223445688999999999999999 999999998765433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=280.59 Aligned_cols=204 Identities=22% Similarity=0.418 Sum_probs=160.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 138 (289)
T 4fvq_A 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEENT---LIHGN 138 (289)
T ss_dssp HHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhCC---eECCC
Confidence 46789999999999999999999999999999999999986543 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc--------eEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHh
Q 045989 82 IKSANILLDDKYR--------AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 82 ikp~Nill~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~ 152 (295)
|||+||+++.++. +||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 139 lkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred cCcceEEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 9999999988876 999999998654321 23457899999999987 678999999999999999999
Q ss_pred CC-CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 153 GQ-KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 153 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
|. +||....... ......... ..+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 214 g~~~~~~~~~~~~------~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 214 GGDKPLSALDSQR------KLQFYEDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCCTTTTSCHHH------HHHHHHTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCCCCccccchHH------HHHHhhccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 54 4443222111 111111111 1111123348889999999999999999999999987755
Q ss_pred hhc
Q 045989 232 SIG 234 (295)
Q Consensus 232 ~~~ 234 (295)
..+
T Consensus 276 p~~ 278 (289)
T 4fvq_A 276 PDL 278 (289)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.60 Aligned_cols=207 Identities=27% Similarity=0.422 Sum_probs=165.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.. +..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 423 il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrD 494 (635)
T 4fl3_A 423 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRD 494 (635)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCC
Confidence 5778999999999999964 56899999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 495 Lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 495 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp CSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986644322 12233356788999999999999999999999999999998 999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
.....+ ....+... .....+..++..+.++|.+||+.||++||++.+|++.|+.+...
T Consensus 575 ~~~~~~------~~~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 575 GMKGSE------VTAMLEKG----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCHHH------HHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHHH------HHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 443321 11111111 11122334556799999999999999999999999999887554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=286.28 Aligned_cols=195 Identities=23% Similarity=0.345 Sum_probs=163.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCC-CHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG-SLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++...+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||+.+ |+||
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 154 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD---IIHR 154 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEe
Confidence 578899999999999999999999999999766 9999997654 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccCHHHEEEcCCCcEEEeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 999999999999999999999998654332 2334568999999999988877 7899999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
...... .. ...+...+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 233 ~~~~~~-----------------~~------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 233 LEETVE-----------------AA------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp GGGGTT-----------------TC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred HHHHHh-----------------hc------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 221100 00 01111234458899999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=281.46 Aligned_cols=210 Identities=21% Similarity=0.286 Sum_probs=161.9
Q ss_pred CCCCccccceeeEEEeCC-----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 5 QINHRNVVKLLGCCLETE-----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
.++||||+++++++.... ..++||||+. ++|.+++...... .+++..++.++.|++.||+|||+++ |+|
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH 143 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHANC---IVH 143 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 346999999999998765 4799999996 5999999865432 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997654322 23445789999999999999999999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhc---h---hhh-------h---hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 160 VETEENRSLAAYFLQVINEN---R---LFE-------V---LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~---~---~~~-------~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
....+ ....+.... . ... . ..+..........+..+.+++.+||+.||++|||+.|++
T Consensus 222 ~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 222 NSEAD------QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp SSHHH------HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCHHH------HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 43222 111111100 0 000 0 000000111123445689999999999999999999999
Q ss_pred HHHHH
Q 045989 224 LELAG 228 (295)
Q Consensus 224 ~~l~~ 228 (295)
+|.+-
T Consensus 296 ~h~~~ 300 (308)
T 3g33_A 296 QHSYL 300 (308)
T ss_dssp TSTTC
T ss_pred cCccc
Confidence 88653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=278.74 Aligned_cols=206 Identities=25% Similarity=0.344 Sum_probs=158.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ |+|||
T Consensus 73 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~d 149 (285)
T 3is5_A 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKD 149 (285)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECC
Confidence 477899999999999999999999999999999999999765433346999999999999999999999999 99999
Q ss_pred CCCCeEEE---CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILL---DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.
T Consensus 150 ikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp CSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEEecCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 99999999 456789999999997654322 233456899999999986 568899999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.....+ ............. ......+..+.+++.+||+.||++|||+.|+++|.+
T Consensus 227 ~~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 227 GTSLEE------VQQKATYKEPNYA--------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp CSSHHH------HHHHHHHCCCCCC--------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred CCCHHH------HHhhhccCCcccc--------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 433221 1111111110000 000112345889999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.82 Aligned_cols=194 Identities=23% Similarity=0.242 Sum_probs=155.6
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.+||||+++++++.+++..++||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 186 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPA 186 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH
Confidence 48999999999999999999999999 7799999887643 4999999999999999999999999 999999999
Q ss_pred eEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhc
Q 045989 86 NILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165 (295)
Q Consensus 86 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 165 (295)
||+++.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.....
T Consensus 187 NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--- 260 (311)
T 3p1a_A 187 NIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--- 260 (311)
T ss_dssp GEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---
T ss_pred HEEECCCCCEEEccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---
Confidence 9999999999999999987654322 2334468999999999876 789999999999999999999766532111
Q ss_pred ccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.... .... .....+...+..+.+++.+||+.||++|||+.++++|.+
T Consensus 261 ------~~~~-~~~~--------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 261 ------WQQL-RQGY--------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp ------HHHH-TTTC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ------HHHH-hccC--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 0111 1110 011122234556999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=275.77 Aligned_cols=219 Identities=19% Similarity=0.240 Sum_probs=169.7
Q ss_pred cccCCCCccccceeeEE-EeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCC-LETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~-~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++|++++..+..+ ...+..++||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 129 (296)
T 4hgt_A 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHR 129 (296)
T ss_dssp HHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 45677887777666665 5677889999999 9999999985433 4899999999999999999999999 9999
Q ss_pred cCCCCeEEE---CCCCceEEeeccCccccccCcc------eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 81 DIKSANILL---DDKYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 81 dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
||||+||++ +.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 130 Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence 999999999 7889999999999986654322 1223456899999999999999999999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
+|+.||....................... ........+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSC---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCCCCcccchhhhhhhhhhhhcccccch---------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 99999975443332222211111100000 001111234569999999999999999999999999999887
Q ss_pred hhccc
Q 045989 232 SIGAS 236 (295)
Q Consensus 232 ~~~~~ 236 (295)
..+..
T Consensus 281 ~~~~~ 285 (296)
T 4hgt_A 281 RQGFS 285 (296)
T ss_dssp HHTCC
T ss_pred HhCCC
Confidence 77644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=276.59 Aligned_cols=205 Identities=24% Similarity=0.367 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++... +..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+. +++|
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H 136 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLEP-LIPR 136 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTT
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCCC-ceec
Confidence 57889999999999999887 788999999999999999986432 258999999999999999999999763 3999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCC---CccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTE---KSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~~l~el~~g~~p 156 (295)
|||||+||+++.++.++|.|||++..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..|
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred CCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999988754222 2345899999999998765544 79999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
|......+ ......... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 211 ~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 211 FADLSNME------IGMKVALEG---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TTTSCHHH------HHHHHHHSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccccChHH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 96433221 111111111 111222334456899999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.17 Aligned_cols=213 Identities=28% Similarity=0.445 Sum_probs=168.7
Q ss_pred ccCC-CCccccceeeEEEeCC-ccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 045989 3 LSQI-NHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
|+++ +||||+++++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||+|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 4566 7999999999998754 589999999999999999865432 1238899999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+.+ |+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++
T Consensus 164 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99999 99999999999999999999999999986544332 223345678999999999999999999999999999
Q ss_pred HHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 148 VELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 148 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
|+|++ |..||......+ . +....... .....+...+..+.+++.+||+.||.+|||+.+++++|
T Consensus 241 ~~l~t~g~~p~~~~~~~~-----~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDE-----E-FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHTTSCCSSTTCCCSH-----H-HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCCCCcccchhH-----H-HHHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99998 999986433211 1 11111111 01111222345689999999999999999999999999
Q ss_pred HHhHHhh
Q 045989 227 AGIRASI 233 (295)
Q Consensus 227 ~~~~~~~ 233 (295)
+.+....
T Consensus 306 ~~~~~~~ 312 (316)
T 2xir_A 306 GNLLQAN 312 (316)
T ss_dssp HHHHHHH
T ss_pred HHHHhhh
Confidence 9876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=288.05 Aligned_cols=206 Identities=25% Similarity=0.343 Sum_probs=157.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 101 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 173 (349)
T 2w4o_A 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG---IVHRD 173 (349)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 4678999999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 174 ikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp CCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCcccEEEecCCCCCCEEEccCccccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 9999999975 889999999999765332 22334568999999999999899999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.....+ ..+..+...... .........+..+.+++.+||+.||++|||+.++++|.+-
T Consensus 252 ~~~~~~-----~~~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 252 DERGDQ-----FMFRRILNCEYY-------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp CTTCHH-----HHHHHHHTTCCC-------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCcccH-----HHHHHHHhCCCc-------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 332211 112222221110 0001112334568899999999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=288.10 Aligned_cols=225 Identities=25% Similarity=0.366 Sum_probs=169.2
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++.. ....++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|
T Consensus 77 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH 150 (327)
T 3lxl_A 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRR---CVH 150 (327)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---ccC
Confidence 4678999999999999874 5568999999999999999986443 3899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++.++.+||+|||+++........ ......||..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 151 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 230 (327)
T 3lxl_A 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230 (327)
T ss_dssp SCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999876543322 223345788899999999988999999999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
............ ..............+........+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 231 CSPSAEFLRMMG-CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp GSHHHHHHHHCC-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccchhhhhcc-cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 643221100000 000000000111111111222233445567999999999999999999999999998765443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=288.49 Aligned_cols=209 Identities=26% Similarity=0.304 Sum_probs=159.9
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
++||||+++++++...+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 35999999999999999999999999 89999999865433 4899999999999999999999999 999999999
Q ss_pred eEEECC-------------------------CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccc
Q 045989 86 NILLDD-------------------------KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 86 Nill~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++||
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccch
Confidence 999975 789999999999754322 234568999999999999999999999
Q ss_pred hhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchh---h--------hhhhhh---------------------
Q 045989 141 YSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL---F--------EVLDAQ--------------------- 188 (295)
Q Consensus 141 wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~--------------------- 188 (295)
|||||++|+|++|+.||......+. ...+......... . ......
T Consensus 243 wslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 319 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTHEHMEH---LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHH---HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh
Confidence 9999999999999999975433221 1111111110000 0 000000
Q ss_pred hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 189 VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 189 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
............+.+++.+||+.||++|||+.|+++|.+
T Consensus 320 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp CCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred cccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 000001111256889999999999999999999988753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=291.46 Aligned_cols=211 Identities=24% Similarity=0.356 Sum_probs=157.6
Q ss_pred cccCCC-CccccceeeEEEeCC--ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQIN-HRNVVKLLGCCLETE--VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|+++. ||||+++++++...+ ..|+|||||+ ++|..++... .+++..+..++.|++.||+|||+.+ |+
T Consensus 61 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---iv 131 (388)
T 3oz6_A 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG---LL 131 (388)
T ss_dssp HHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 356675 999999999998654 6899999996 5999999764 3899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccC--------------------cceeeeccccccCCCChhhhcc-CCCCCC
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVD--------------------RTHLTTQVKGTFGYLDPEYFQS-SQFTEK 137 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 137 (295)
||||||+|||++.++.+||+|||+++..... .........||+.|+|||++.+ ..++.+
T Consensus 132 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (388)
T 3oz6_A 132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211 (388)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH
T ss_pred eCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh
Confidence 9999999999999999999999999765321 1112234579999999999976 678999
Q ss_pred ccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHh---hchhh-----------hhhh---------hhhhh---
Q 045989 138 SDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN---ENRLF-----------EVLD---------AQVLR--- 191 (295)
Q Consensus 138 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-----------~~~~---------~~~~~--- 191 (295)
+|||||||++|+|++|++||......+ .+..+.. ..... ..+. .....
T Consensus 212 ~DiwSlG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (388)
T 3oz6_A 212 IDMWSLGCILGEILCGKPIFPGSSTMN------QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285 (388)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhC
Confidence 999999999999999999997543221 1111111 00000 0000 00000
Q ss_pred ----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 192 ----------EAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 192 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
......+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331 (388)
T ss_dssp HHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred cchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence 000023456899999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=285.78 Aligned_cols=212 Identities=24% Similarity=0.370 Sum_probs=167.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED---QLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|++++||||+++++++......++||||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~ 162 (327)
T 2yfx_A 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FI 162 (327)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---ee
Confidence 467889999999999999999999999999999999999865422 234899999999999999999999999 99
Q ss_pred eccCCCCeEEECC---CCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-C
Q 045989 79 HRDIKSANILLDD---KYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-G 153 (295)
Q Consensus 79 H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 153 (295)
||||||+||+++. +..+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 163 H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 242 (327)
T 2yfx_A 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 242 (327)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999984 44699999999875433222 22334567899999999999999999999999999999998 9
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
..||...... .....+.... ....+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 243 ~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 243 YMPYPSKSNQ------EVLEFVTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCSSTTCCHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCcCHH------HHHHHHhcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 9998643221 1111111111 1111223445689999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=288.68 Aligned_cols=219 Identities=25% Similarity=0.394 Sum_probs=166.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~ 80 (295)
+|++++||||+++++++..++..++||||++|++|.+++.... .+++..++.++.|++.||+|||+. + |+||
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~ 156 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHR 156 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcC
Confidence 5788999999999999999999999999999999999998754 389999999999999999999996 8 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+||+++.++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 157 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CccHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998754322 123456899999999999999999999999999999999999999754
Q ss_pred chhhcccHHHHH-----------------------HHHHhhchhhhhhhhh----hhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 161 ETEENRSLAAYF-----------------------LQVINENRLFEVLDAQ----VLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 161 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
...+........ ..........+..+.. .........+..+.+++.+||+.||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp CHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSST
T ss_pred CHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcCh
Confidence 332211000000 0000000000000000 0000111234568999999999999
Q ss_pred CCCCCHHHHHHHHHHhH
Q 045989 214 KKRPTMKEVALELAGIR 230 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~~~ 230 (295)
++|||+.++++|.+-..
T Consensus 314 ~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 314 AERADLKQLMVHAFIKR 330 (360)
T ss_dssp TTSCCHHHHHTSHHHHH
T ss_pred hhCCCHHHHhhChHhhc
Confidence 99999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.01 Aligned_cols=215 Identities=23% Similarity=0.306 Sum_probs=159.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|..++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~d 127 (311)
T 4agu_A 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRD 127 (311)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 4678899999999999999999999999999999998876543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 128 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 128 VKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CChhhEEEcCCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976543222 2234468999999999976 56899999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHh-----------hchhhhhhh---hh---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 161 ETEENRSLAAYFLQVIN-----------ENRLFEVLD---AQ---VLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~---~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
...+... ....... ......... +. .........+..+.+++.+||+.||.+|||+++++
T Consensus 207 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 207 SDVDQLY---LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp SHHHHHH---HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred CHHHHHH---HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 4332111 1111100 000000000 00 00001123445688999999999999999999999
Q ss_pred HHHH
Q 045989 224 LELA 227 (295)
Q Consensus 224 ~~l~ 227 (295)
+|.+
T Consensus 284 ~hp~ 287 (311)
T 4agu_A 284 HHPY 287 (311)
T ss_dssp TSGG
T ss_pred cChH
Confidence 8864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=283.28 Aligned_cols=213 Identities=23% Similarity=0.369 Sum_probs=164.9
Q ss_pred cccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
++++++||||+++++++.. ....++||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ |
T Consensus 79 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i 155 (317)
T 2buj_A 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---Y 155 (317)
T ss_dssp HHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 4678899999999999973 34789999999999999999875545556999999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcce--------eeeccccccCCCChhhhccCC---CCCCccchhhHHH
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--------LTTQVKGTFGYLDPEYFQSSQ---FTEKSDVYSFGVV 146 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~ 146 (295)
+||||||+||+++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++||||||++
T Consensus 156 vH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235 (317)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred ccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998754321110 012235799999999987543 6889999999999
Q ss_pred HHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 147 LVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 147 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
+|+|++|..||....... ....... .. ..........+..+.+++.+||+.||.+|||+.+++++|
T Consensus 236 l~el~~g~~p~~~~~~~~-~~~~~~~---~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 236 LYAMMFGEGPYDMVFQKG-DSVALAV---QN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHHSSCTTHHHHHTT-SCHHHHH---HC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCChhhhhccc-chhhHHh---hc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 999999999985321111 0111000 00 000111123345699999999999999999999999999
Q ss_pred HHhHH
Q 045989 227 AGIRA 231 (295)
Q Consensus 227 ~~~~~ 231 (295)
+.+..
T Consensus 302 ~~~~~ 306 (317)
T 2buj_A 302 EALQP 306 (317)
T ss_dssp HHTCC
T ss_pred hhcCC
Confidence 87643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=288.12 Aligned_cols=218 Identities=29% Similarity=0.487 Sum_probs=169.2
Q ss_pred cccCCCCccccceeeEEEeCC--ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETE--VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 95 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 168 (326)
T 2w1i_A 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKR---YIH 168 (326)
T ss_dssp HHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 467899999999999987643 78999999999999999986543 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++.++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 169 ~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred cCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999998765433221 22335677899999999888999999999999999999999997
Q ss_pred cccchhhcccHHHHHHHHHhh--------chhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 158 RLVETEENRSLAAYFLQVINE--------NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
....... . +.... ..+.+.+........+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 249 ~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 249 KSPPAEF-------M-RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp GSHHHHH-------H-HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHHH-------H-HhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5321110 0 00000 001111111111122334556799999999999999999999999999988
Q ss_pred HHhh
Q 045989 230 RASI 233 (295)
Q Consensus 230 ~~~~ 233 (295)
++.+
T Consensus 321 ~~~l 324 (326)
T 2w1i_A 321 RDQM 324 (326)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 7654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=274.28 Aligned_cols=219 Identities=20% Similarity=0.247 Sum_probs=168.9
Q ss_pred cccCCCCccccceeeEE-EeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCC-LETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~-~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++|++++..+..+ ...+..++||||+ +++|.+++..... .+++..++.++.|++.||+|||+++ |+||
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 129 (296)
T 3uzp_A 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHR 129 (296)
T ss_dssp HHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeC
Confidence 45678887766666665 5667889999999 8999999975433 4899999999999999999999999 9999
Q ss_pred cCCCCeEEEC---CCCceEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 81 DIKSANILLD---DKYRAKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 81 dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
||||+||+++ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 130 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 3uzp_A 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence 9999999994 7889999999999866543221 123456899999999999999999999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
+|+.||....................... ........+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTP---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSC---------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCCCCCcCchhhhhhhhhhcccccCCc---------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 99999975443322222211111100000 001112234569999999999999999999999999999877
Q ss_pred hhccc
Q 045989 232 SIGAS 236 (295)
Q Consensus 232 ~~~~~ 236 (295)
..+..
T Consensus 281 ~~~~~ 285 (296)
T 3uzp_A 281 RQGFS 285 (296)
T ss_dssp HTTCC
T ss_pred hcCCc
Confidence 76543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=278.39 Aligned_cols=206 Identities=27% Similarity=0.474 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||+++++++... +..++||||+++++|.+++...... .+++..++.++.|++.||+|||+++ ++|+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 141 (278)
T 1byg_A 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141 (278)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 47889999999999997654 5789999999999999999764321 3789999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
||||+||+++.++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 142 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 142 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp CCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998754322 122357889999999999999999999999999999998 9999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
....+ ........ .....+...+..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 218 ~~~~~------~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 218 IPLKD------VVPRVEKG----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp SCGGG------HHHHHTTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHhcC----------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 43221 11111111 01122233455689999999999999999999999999887643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=281.88 Aligned_cols=204 Identities=23% Similarity=0.327 Sum_probs=165.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~d 140 (321)
T 2a2a_A 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFD 140 (321)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 4678899999999999999999999999999999999997543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC----ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKY----RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CChHHEEEecCCCCcCCEEEccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 999999999887 79999999998654322 223456899999999999999999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
...... .....+..... ..++ ......+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 219 ~~~~~~------~~~~~i~~~~~---~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 219 LGDTKQ------ETLANITSVSY---DFDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp CCSSHH------HHHHHHHTTCC---CCCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred CCCCHH------HHHHHHHhccc---ccCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 643221 11222111110 0011 111223456889999999999999999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.43 Aligned_cols=209 Identities=25% Similarity=0.385 Sum_probs=167.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. +..+|||||+++|+|.+++...... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrD 388 (535)
T 2h8h_A 315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YVHRD 388 (535)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 5788999999999999876 6789999999999999999754222 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||||+.++.+||+|||+++..............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 389 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp CSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998654322222233456788999999999999999999999999999999 99999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
... .....+.... ....+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 469 ~~~------~~~~~i~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 469 VNR------EVLDQVERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CHH------HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 322 1121111111 1112234455689999999999999999999999999876433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=283.07 Aligned_cols=222 Identities=23% Similarity=0.351 Sum_probs=163.1
Q ss_pred ccCCCCccccceeeEEEe-----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q 045989 3 LSQINHRNVVKLLGCCLE-----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA----- 72 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~----- 72 (295)
++.++||||+++++.+.. ....++||||+++|+|.+++.... .++..++.++.||+.||+|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~ 135 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGD 135 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence 456899999999987653 225689999999999999997653 68899999999999999999999
Q ss_pred ----CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-------eeeeccccccCCCChhhhcc-------CCC
Q 045989 73 ----ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-------HLTTQVKGTFGYLDPEYFQS-------SQF 134 (295)
Q Consensus 73 ----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~ 134 (295)
+ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+ ..+
T Consensus 136 ~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 212 (336)
T 3g2f_A 136 HYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212 (336)
T ss_dssp GCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH
T ss_pred ccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc
Confidence 8 99999999999999999999999999986643221 11223469999999999976 456
Q ss_pred CCCccchhhHHHHHHHHhCCCCCcccchhhccc-----------HHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHH
Q 045989 135 TEKSDVYSFGVVLVELLTGQKPIRLVETEENRS-----------LAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAM 203 (295)
Q Consensus 135 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (295)
+.++|||||||++|+|++|..||.......... .................+.. ........+..+.+
T Consensus 213 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 290 (336)
T 3g2f_A 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKE 290 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHH
Confidence 778999999999999999987764332211100 00001111111100000000 00112235667999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 204 VAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 204 li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
+|.+||+.||++|||+.|+++.|+.+.....
T Consensus 291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 9999999999999999999999998875543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.71 Aligned_cols=209 Identities=22% Similarity=0.298 Sum_probs=156.4
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++...+ ..|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.+
T Consensus 114 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~-- 184 (464)
T 3ttj_A 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-- 184 (464)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 577899999999999997653 46999999965 67776643 2889999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.
T Consensus 185 -iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 185 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp -CCCCCCCGGGEEECTTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999865432 22344679999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhh---c--hh-----------------------hhhhhhhh---hhhhhHHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINE---N--RL-----------------------FEVLDAQV---LREAEKEEVITVAMV 204 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~---~--~~-----------------------~~~~~~~~---~~~~~~~~~~~~~~l 204 (295)
||......+ .+..+... . .. ........ ........+..+.+|
T Consensus 262 pF~g~~~~~------~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 335 (464)
T 3ttj_A 262 LFPGRDYID------QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 335 (464)
T ss_dssp SSCCSSHHH------HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred CCCCCCHHH------HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHH
Confidence 997543221 11111110 0 00 00000000 001122235678999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHH
Q 045989 205 AKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 205 i~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+.+||+.||++|||+.|+++|.+-
T Consensus 336 l~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 336 LSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHcCCChhhCCCHHHHhcChhh
Confidence 999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=286.54 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=163.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+. |+|.+++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 107 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 179 (348)
T 1u5q_A 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 179 (348)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 4678999999999999999999999999996 588888865433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++..... ....||+.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 180 lkp~NIll~~~~~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 180 VKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCHHHEEECCCCCEEEeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999765422 2346899999999984 5678999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
..... ........... ........+..+.+++.+||+.||++|||+.+++++.+-..
T Consensus 255 ~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 255 NMNAM------SALYHIAQNES---------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp TSCHH------HHHHHHHHSCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCChH------HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 43221 11112211110 00111223455889999999999999999999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=281.73 Aligned_cols=210 Identities=26% Similarity=0.404 Sum_probs=164.2
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA--SIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~--~~~i 77 (295)
+|++++||||+++++++.. ++..++||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ..++
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i 137 (279)
T 2w5a_A 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 137 (279)
T ss_dssp HHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------
T ss_pred HHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCee
Confidence 4678899999999998865 56789999999999999999876555556999999999999999999999976 2339
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+|+||||+||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 138 vH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeccchhhEEEcCCCCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999876543221 122346899999999999989999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
......+ ....+... .....+...+..+.+++.+||+.||.+|||+.+++++++.
T Consensus 217 ~~~~~~~------~~~~i~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 217 TAFSQKE------LAGKIREG----------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCSSHHH------HHHHHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHH------HHHHHhhc----------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 7443211 11111111 1111222345568999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=279.66 Aligned_cols=206 Identities=26% Similarity=0.391 Sum_probs=168.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 73 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 144 (303)
T 3a7i_A 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRD 144 (303)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 467889999999999999999999999999999999998653 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 145 l~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CChheEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 99999999999999999999997654332 12234568999999999999999999999999999999999999986433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
... ........ .....+...+..+.+++.+||+.||.+|||+.+++++.+-....
T Consensus 224 ~~~------~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 224 PMK------VLFLIPKN----------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHH------HHHHHHHS----------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHH------HHHHhhcC----------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 221 11111111 01111223345589999999999999999999999998765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=283.27 Aligned_cols=211 Identities=24% Similarity=0.320 Sum_probs=157.8
Q ss_pred ccC-CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQ-INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~-l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|++ ++||||+++++++..++..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 64 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 136 (316)
T 2ac3_A 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG---IAHRD 136 (316)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCC
Confidence 444 589999999999999999999999999999999998754 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc---eEEeeccCccccccCcc------eeeeccccccCCCChhhhcc-----CCCCCCccchhhHHHH
Q 045989 82 IKSANILLDDKYR---AKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQS-----SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 82 ikp~Nill~~~~~---~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l 147 (295)
|||+||+++.++. +||+|||++........ .......||+.|+|||++.+ ..++.++|||||||++
T Consensus 137 lkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp CCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred CCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 9999999988765 99999999875532211 11223458999999999975 5688999999999999
Q ss_pred HHHHhCCCCCcccchhhccc---------HHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 148 VELLTGQKPIRLVETEENRS---------LAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
|+|++|..||......+... .......+.. .... ... ......+..+.+++.+||+.||.+|||
T Consensus 217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~--~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (316)
T 2ac3_A 217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE-GKYE--FPD----KDWAHISCAAKDLISKLLVRDAKQRLS 289 (316)
T ss_dssp HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH-CCCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc-cCcc--cCc----hhcccCCHHHHHHHHHHhhCChhhCCC
Confidence 99999999997543221100 0011111111 1000 000 001123456899999999999999999
Q ss_pred HHHHHHHHH
Q 045989 219 MKEVALELA 227 (295)
Q Consensus 219 ~~e~~~~l~ 227 (295)
+.|+++|.+
T Consensus 290 ~~e~l~hp~ 298 (316)
T 2ac3_A 290 AAQVLQHPW 298 (316)
T ss_dssp HHHHHHSTT
T ss_pred HHHHhcChh
Confidence 999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=294.36 Aligned_cols=205 Identities=27% Similarity=0.350 Sum_probs=164.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++|||||+||+|.+.+.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 161 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRD 161 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 5788999999999999999999999999999999999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCC---CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.. +.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.
T Consensus 162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChhhEEEeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 99999999764 459999999998654332 234456999999999986 469999999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+....... . .......+..+.+++.+||+.||.+|||+.++++|.+-.
T Consensus 239 ~~~~~------~~~~~i~~~~~~~---~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 239 GQTDQ------EILRKVEKGKYTF---D----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp CSSHH------HHHHHHHHTCCCC---C----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred CCCHH------HHHHHHHhCCCCC---C----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 43322 2222222211100 0 011122345688999999999999999999999997653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=276.63 Aligned_cols=204 Identities=26% Similarity=0.444 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEe----------------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLE----------------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGA 65 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~ 65 (295)
+|++++||||+++++++.. ....++||||+++|+|.+++...... .+++..++.++.|++.|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~~ 134 (284)
T 2a19_B 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLALELFEQITKG 134 (284)
T ss_dssp HHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS--CCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC--CCCHHHHHHHHHHHHHH
Confidence 4678899999999999865 44589999999999999999764322 48999999999999999
Q ss_pred HHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHH
Q 045989 66 LSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGV 145 (295)
Q Consensus 66 l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 145 (295)
|+|||+.+ ++|+||||+||+++.++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+
T Consensus 135 l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (284)
T 2a19_B 135 VDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209 (284)
T ss_dssp HHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred HHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence 99999999 9999999999999999999999999987654332 123346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 146 VLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 146 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
++|+|++|..|+... ...... ..... .+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 210 il~~l~~~~~~~~~~--------~~~~~~-~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 268 (284)
T 2a19_B 210 ILAELLHVCDTAFET--------SKFFTD-LRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268 (284)
T ss_dssp HHHHHHSCCSSHHHH--------HHHHHH-HHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCcchhH--------HHHHHH-hhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999886311 011111 11111 111233458889999999999999999999999
Q ss_pred HHHhHHhh
Q 045989 226 LAGIRASI 233 (295)
Q Consensus 226 l~~~~~~~ 233 (295)
|+.+....
T Consensus 269 l~~~~~~~ 276 (284)
T 2a19_B 269 LTVWKKSP 276 (284)
T ss_dssp HHHHTC--
T ss_pred HHHHhhCC
Confidence 98876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=274.60 Aligned_cols=201 Identities=25% Similarity=0.339 Sum_probs=166.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 67 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 139 (284)
T 2vgo_A 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK---VIHRD 139 (284)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4678899999999999999999999999999999999998754 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 140 l~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 140 IKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCHHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999987544322 234468999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..+ ....+.... ...+...+..+.+++.+||+.||.+|||+.++++|.+-.
T Consensus 217 ~~~------~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 217 HTE------THRRIVNVD-----------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp HHH------HHHHHHTTC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred HhH------HHHHHhccc-----------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 221 111111111 011222345688999999999999999999999987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=287.15 Aligned_cols=206 Identities=27% Similarity=0.318 Sum_probs=164.7
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++ +||||+++++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 184 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 184 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4566 69999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+|||++.++.+||+|||+++..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 185 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999999999999998665443333445679999999999985 3478899999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
..... ............. ...+...+..+.++|.+||+.||.+|| ++.++++|++-
T Consensus 265 ~~~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 265 DGEKN--SQAEISRRILKSE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp TTSCC--CHHHHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CCccc--hHHHHHHHHhccC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 32211 1112221111111 112223445688999999999999999 99999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=276.48 Aligned_cols=204 Identities=29% Similarity=0.542 Sum_probs=160.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.... ++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ .+++|||
T Consensus 76 ~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~d 149 (287)
T 4f0f_A 76 IMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRD 149 (287)
T ss_dssp HHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSC
T ss_pred HHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCC
Confidence 467899999999999986544 799999999999998875433 4899999999999999999999987 3499999
Q ss_pred CCCCeEEECCCCc-----eEEeeccCccccccCcceeeeccccccCCCChhhhc--cCCCCCCccchhhHHHHHHHHhCC
Q 045989 82 IKSANILLDDKYR-----AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ--SSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 82 ikp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|||+||+++.++. +||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 150 ikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 150 LRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp CSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 9999999988776 99999999874432 234456899999999984 455788999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.||........ .......... .....+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 226 ~pf~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 226 GPFDEYSYGKI----KFINMIREEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CTTTTCCCCHH----HHHHHHHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCccccccHH----HHHHHHhccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 99964432211 1111111110 1112223345568999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=287.19 Aligned_cols=205 Identities=23% Similarity=0.326 Sum_probs=156.7
Q ss_pred cccCCCC--ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~H--pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++| |||+++++++..++..++|||+ .+++|.+++.... .+++..++.++.|++.||+|||+.+ |+|
T Consensus 60 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---iiH 131 (343)
T 3dbq_A 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVH 131 (343)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 3566766 9999999999999999999995 5889999998643 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhcc-----------CCCCCCccchhhHHHH
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQS-----------SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l 147 (295)
|||||+|||++ ++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 132 rDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp CCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred CCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 99999999997 578999999999866443222 2334579999999999865 6788999999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|+|++|+.||..... .......... +......+...+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 211 ~ell~g~~pf~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 211 YYMTYGKTPFQQIIN-----QISKLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHHHSSCTTTTCCS-----HHHHHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHhCCCcchhhhh-----HHHHHHHHhc---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 999999999963221 1111111111 11111222223345889999999999999999999999987
Q ss_pred Hh
Q 045989 228 GI 229 (295)
Q Consensus 228 ~~ 229 (295)
-.
T Consensus 277 ~~ 278 (343)
T 3dbq_A 277 VQ 278 (343)
T ss_dssp HH
T ss_pred cc
Confidence 64
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=300.47 Aligned_cols=207 Identities=25% Similarity=0.284 Sum_probs=168.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.+.+..|+||||++||+|.+++..... ..+++..++.++.||+.||+|||+++ |+|||
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrD 311 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER---IVYRD 311 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccC
Confidence 56789999999999999999999999999999999999976432 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 312 LKPeNILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 312 LKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred CchheEEEeCCCCeEEEecccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999998654332 2334579999999999999889999999999999999999999997533
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~~ 228 (295)
... ........+... ....+...+..+.++|.+||+.||.+|| ++.|+++|.+-
T Consensus 390 ~~~--~~~~i~~~i~~~-----------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 390 KKI--KREEVERLVKEV-----------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp SCC--CHHHHHHHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred cch--hHHHHHHHhhcc-----------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence 211 111111111111 0111223345689999999999999999 89999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=297.41 Aligned_cols=209 Identities=22% Similarity=0.279 Sum_probs=169.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..|+||||++||+|..++.........+++..++.++.||+.||+|||+++ |+|||
T Consensus 238 iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrD 314 (543)
T 3c4z_A 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRD 314 (543)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccC
Confidence 567889999999999999999999999999999999999876544556999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 315 LKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 315 LKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CChHHEEEeCCCCEEEeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 999999999999999999999986543322 2334579999999999999999999999999999999999999997432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
.. .........+.... ...+...+..+.++|.+||+.||.+||+ +.++++|.+
T Consensus 394 ~~--~~~~~~~~~i~~~~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 394 EK--VENKELKQRVLEQA-----------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp CC--CCHHHHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred cc--hhHHHHHHHHhhcc-----------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 11 11122222222111 0122234456889999999999999996 478887754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=283.11 Aligned_cols=211 Identities=19% Similarity=0.286 Sum_probs=156.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||++ |+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~D 157 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRD 157 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCC
Confidence 5788999999999999999999999999996 59999998654 3899999999999999999999999 99999
Q ss_pred CCCCeEEEC-----CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLD-----DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~-----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+||+++ .++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp CCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999994 555699999999976543322 23344689999999999874 48999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchh-----hh--------------hhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRL-----FE--------------VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
||......+ ....+...... +. ..............+..+.+++.+||+.||.+|
T Consensus 237 pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 310 (329)
T 3gbz_A 237 LFPGDSEID------QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310 (329)
T ss_dssp SSCCSSHHH------HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGS
T ss_pred CcCCCCHHH------HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhC
Confidence 996443221 11111110000 00 000000001111234568899999999999999
Q ss_pred CCHHHHHHHHH
Q 045989 217 PTMKEVALELA 227 (295)
Q Consensus 217 ps~~e~~~~l~ 227 (295)
||+.|+++|.+
T Consensus 311 ~t~~e~l~hp~ 321 (329)
T 3gbz_A 311 ISAKNALEHPY 321 (329)
T ss_dssp CCHHHHHTSGG
T ss_pred CCHHHHhCCcc
Confidence 99999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=280.56 Aligned_cols=209 Identities=31% Similarity=0.484 Sum_probs=159.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeE
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS---AASIPIY 78 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~---~~~~~i~ 78 (295)
+|++++||||+++++++. +..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ ++ |+
T Consensus 54 ~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---iv 127 (307)
T 2eva_A 54 QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LI 127 (307)
T ss_dssp HHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CC
T ss_pred HHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---ee
Confidence 467889999999999887 458999999999999999975432 2237889999999999999999999 66 99
Q ss_pred eccCCCCeEEECCCCc-eEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 79 HRDIKSANILLDDKYR-AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 79 H~dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
||||||+||+++.++. +||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 128 H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred cCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999999999988876 799999998754322 22345899999999999999999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
...... ............ ........+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 204 ~~~~~~----~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 204 DEIGGP----AFRIMWAVHNGT----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp TTTCSS----HHHHHHHHHTTC----------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred hhhCcc----HHHHHHHHhcCC----------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 643221 111111111111 111122334568899999999999999999999999998866553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=279.28 Aligned_cols=198 Identities=20% Similarity=0.274 Sum_probs=158.2
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+.++ +||||+++++++..++..++||||+++++|.+++.........+++..++.++.||+.||+|||+++ |+|||
T Consensus 64 ~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~D 140 (289)
T 1x8b_A 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMD 140 (289)
T ss_dssp HHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecC
Confidence 3455 9999999999999999999999999999999999875433335899999999999999999999999 99999
Q ss_pred CCCCeEEECC-------------------CCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccch
Q 045989 82 IKSANILLDD-------------------KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVY 141 (295)
Q Consensus 82 ikp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 141 (295)
|||+||+++. ...+||+|||.+....... ...||+.|+|||++.+. .++.++|||
T Consensus 141 ikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~ 215 (289)
T 1x8b_A 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIF 215 (289)
T ss_dssp CSGGGEEEC--------------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHH
T ss_pred CCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHH
Confidence 9999999984 4479999999988654332 23489999999999765 566899999
Q ss_pred hhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 045989 142 SFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKE 221 (295)
Q Consensus 142 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e 221 (295)
||||++|+|++|.+|+..... ...... . .....+...+..+.+++.+||+.||++|||+.+
T Consensus 216 slG~il~~l~~~~~~~~~~~~---------~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 216 ALALTVVCAAGAEPLPRNGDQ---------WHEIRQ-G---------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMA 276 (289)
T ss_dssp HHHHHHHHHTTCCCCCSSSHH---------HHHHHT-T---------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhcCCCCCcchhH---------HHHHHc-C---------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHH
Confidence 999999999999877542211 111111 1 111222234456899999999999999999999
Q ss_pred HHHHHH
Q 045989 222 VALELA 227 (295)
Q Consensus 222 ~~~~l~ 227 (295)
+++|.+
T Consensus 277 ll~h~~ 282 (289)
T 1x8b_A 277 LVKHSV 282 (289)
T ss_dssp HHTCTT
T ss_pred HhhChH
Confidence 998864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=291.80 Aligned_cols=205 Identities=25% Similarity=0.328 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++|||||.||+|.+.+.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~D 146 (486)
T 3mwu_A 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146 (486)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 5778999999999999999999999999999999999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEEC---CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLD---DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp CSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CchHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999995 45679999999997654322 2344569999999999976 58999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+........ .+.....+..+.++|.+||+.||.+|||+.++++|.+-.
T Consensus 224 ~~~~~------~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 281 (486)
T 3mwu_A 224 GKNEY------DILKRVETGKYAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (486)
T ss_dssp CSSHH------HHHHHHHHTCCCSC-------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred CCCHH------HHHHHHHhCCCCCC-------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence 43221 22222222111000 011122345688999999999999999999999997754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=278.84 Aligned_cols=202 Identities=23% Similarity=0.350 Sum_probs=166.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 94 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~d 166 (335)
T 2owb_A 94 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRD 166 (335)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecC
Confidence 4678999999999999999999999999999999999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 167 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 167 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCchhEEEcCCCCEEEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 999999999999999999999986543222 2234568999999999999899999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..+ .......... ..+...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 246 ~~~------~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 246 LKE------TYLRIKKNEY-----------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp HHH------HHHHHHHTCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHH------HHHHHhcCCC-----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 211 1111111110 1112233458889999999999999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.41 Aligned_cols=223 Identities=14% Similarity=0.214 Sum_probs=168.6
Q ss_pred cccCCCCccccc---------------eeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVK---------------LLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGA 65 (295)
Q Consensus 2 il~~l~Hpniv~---------------~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~ 65 (295)
+|++++||||++ +++++.. ++..++||||+ +++|.+++..... ..+++..++.++.||+.|
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~ 171 (352)
T 2jii_A 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDA 171 (352)
T ss_dssp HHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHH
T ss_pred HHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHH
Confidence 456778888887 6778876 67889999999 9999999986521 249999999999999999
Q ss_pred HHHHHhCCCCCeEeccCCCCeEEECCCC--ceEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCC
Q 045989 66 LSYLHSAASIPIYHRDIKSANILLDDKY--RAKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEK 137 (295)
Q Consensus 66 l~~Lh~~~~~~i~H~dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~ 137 (295)
|+|||+++ |+||||||+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.+
T Consensus 172 L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 248 (352)
T 2jii_A 172 LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR 248 (352)
T ss_dssp HHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred HHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch
Confidence 99999999 99999999999999998 8999999999865433221 1133478999999999999899999
Q ss_pred ccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 138 SDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 138 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
+|||||||++|+|++|+.||....... .............. ....... ......+..+.+++.+||+.||.+||
T Consensus 249 ~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 249 SDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDKP--GPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHSC--CCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred hhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCCh--hhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCC
Confidence 999999999999999999997443111 01111111100000 0000000 00011235689999999999999999
Q ss_pred CHHHHHHHHHHhHHhhccc
Q 045989 218 TMKEVALELAGIRASIGAS 236 (295)
Q Consensus 218 s~~e~~~~l~~~~~~~~~~ 236 (295)
|+.++++.|+.+....+..
T Consensus 323 s~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 323 PYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp CHHHHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHHHHhcCCC
Confidence 9999999999987776533
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=305.38 Aligned_cols=208 Identities=26% Similarity=0.402 Sum_probs=165.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++. ++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 444 ~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 516 (656)
T 2j0j_A 444 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKR---FVHRD 516 (656)
T ss_dssp HHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 467889999999999984 5678999999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 517 ikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999998765443333334457789999999999999999999999999999997 99998643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
...+ ....+.... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 597 ~~~~------~~~~i~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 597 KNND------VIGRIENGE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CHHH------HHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH------HHHHHHcCC----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 3221 122221111 1112233455689999999999999999999999999887543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=292.13 Aligned_cols=205 Identities=29% Similarity=0.361 Sum_probs=165.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++|||||+||+|.+++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 171 (504)
T 3q5i_A 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN---IVHRD 171 (504)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 5778999999999999999999999999999999999997654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC---ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKY---RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.++ .+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.
T Consensus 172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp CSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999998776 69999999998654332 233456999999999987 468999999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+........ . ......+..+.+++.+||+.||.+|||+.|+++|.+-.
T Consensus 249 ~~~~~------~~~~~i~~~~~~~~---~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 249 GQNDQ------DIIKKVEKGKYYFD---F----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp CSSHH------HHHHHHHHCCCCCC---H----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCHH------HHHHHHHcCCCCCC---c----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 43322 22222222111000 0 01112345689999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=276.49 Aligned_cols=202 Identities=24% Similarity=0.375 Sum_probs=143.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 64 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 137 (278)
T 3cok_A 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSHG---ILHRD 137 (278)
T ss_dssp HHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSS
T ss_pred HHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 46789999999999999999999999999999999999976432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 138 l~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 138 LTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCHHHEEEcCCCCEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 999999999999999999999986543222 1223468999999999998889999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..+. ....... . ...+...+..+.+++.+||+.||++|||+.++++|.+
T Consensus 217 ~~~~------~~~~~~~----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 217 VKNT------LNKVVLA----D-------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp CC-----------CCSS----C-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred HHHH------HHHHhhc----c-------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 2210 0000000 0 0112223456889999999999999999999988754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=279.29 Aligned_cols=208 Identities=25% Similarity=0.337 Sum_probs=155.9
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecc
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHRD 81 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~d 81 (295)
++.++||||+++++++..++..++||||++ |+|.+++.........+++..++.++.|++.||+|||++ + ++|||
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 135 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRD 135 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCC
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 677899999999999999999999999996 599888876444445699999999999999999999998 8 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhh----ccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYF----QSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++.+||+|||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred CCHHHEEECCCCCEEEeecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999997654322 22334689999999996 4567889999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
...... ............ ........+..+.+++.+||+.||++|||+.++++|.+-..
T Consensus 214 ~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 214 DSWGTP-----FQQLKQVVEEPS---------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCCSCH-----HHHHHHHHHSCC---------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccCch-----HHHHHHHhccCC---------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 643221 111111111110 01111223456899999999999999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=283.38 Aligned_cols=218 Identities=24% Similarity=0.377 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|..++.... .+++..++.++.|++.||+|||+.+ ++|||
T Consensus 77 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~d 149 (331)
T 4aaa_A 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRD 149 (331)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccC
Confidence 4678999999999999999999999999999988888765433 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 150 IKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cChheEEEcCCCcEEEEeCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997654322 223345689999999999875 7899999999999999999999999754
Q ss_pred chhhcccHHHHHHH----------HHhhchhhh------hhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 161 ETEENRSLAAYFLQ----------VINENRLFE------VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 161 ~~~~~~~~~~~~~~----------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
...+.. ...... ......... ..............+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 229 SDIDQL--YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SHHHHH--HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CcHHHH--HHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 332211 000000 000000000 00000011111234567999999999999999999999999
Q ss_pred HHHHh
Q 045989 225 ELAGI 229 (295)
Q Consensus 225 ~l~~~ 229 (295)
|.+-.
T Consensus 307 hp~f~ 311 (331)
T 4aaa_A 307 HDFFQ 311 (331)
T ss_dssp SHHHH
T ss_pred Cchhc
Confidence 97654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.93 Aligned_cols=205 Identities=25% Similarity=0.322 Sum_probs=166.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+.||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 151 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK---IVHRD 151 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 5788999999999999999999999999999999999987643 4899999999999999999999999 99999
Q ss_pred CCCCeEEE---CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILL---DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||++ +.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp CCGGGEEESSSSTTCCEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEEecCCCCCcEEEEeeeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 99999999 567899999999997654332 2334569999999999976 68999999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+........ .+.....+..+.+++.+||+.||.+|||+.++++|.+-.
T Consensus 229 ~~~~~------~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 229 GANEY------DILKKVEKGKYTFE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp CSSHH------HHHHHHHHCCCCCC-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred CCCHH------HHHHHHHcCCCCCC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 43322 22222222111100 011123345688999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=274.01 Aligned_cols=203 Identities=23% Similarity=0.420 Sum_probs=160.4
Q ss_pred cccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+|++++||||+++++++.. ....++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ .++
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i 152 (290)
T 1t4h_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 5788999999999999976 356899999999999999998754 4899999999999999999999986 239
Q ss_pred EeccCCCCeEEEC-CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 78 YHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 78 ~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
+|+||||+||+++ .++.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p 228 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCcccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCC
Confidence 9999999999997 78899999999997543322 234468999999998864 589999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|...... ........... . ....+...+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 229 f~~~~~~-----~~~~~~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 229 YSECQNA-----AQIYRRVTSGV-K--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp TTTCSSH-----HHHHHHHTTTC-C--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCcCcH-----HHHHHHHhccC-C--------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 9643221 11111111111 0 11112222345899999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=285.00 Aligned_cols=205 Identities=23% Similarity=0.295 Sum_probs=160.1
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++ +||||+++++++...+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+|||
T Consensus 82 l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~D 156 (327)
T 3lm5_A 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQNN---IVHLD 156 (327)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCc
Confidence 4455 669999999999999999999999999999999864322 25899999999999999999999999 99999
Q ss_pred CCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 157 ikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp CCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHHEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999987 7899999999998654322 2234568999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.....+ ....+.... ...........+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 235 ~~~~~~------~~~~i~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 235 GEDNQE------TYLNISQVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp CSSHHH------HHHHHHHTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred CCCchH------HHHHHHhcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 433221 111111110 00011112234456889999999999999999999988754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.15 Aligned_cols=216 Identities=25% Similarity=0.353 Sum_probs=161.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT----EDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+|++++||||+++++++...+..++||||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ +
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 142 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---Q 142 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 5788999999999999999999999999999999999987421 12235899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCc----ceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHh
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDR----THLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~ 152 (295)
+|+||||+||+++.++.+||+|||++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999987554321 111234568999999999876 568999999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..||........ ......... ................+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 223 g~~pf~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 223 GAAPYHKYPPMKV------LMLTLQNDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp SSCTTTTSCGGGH------HHHHHTSSC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred CCCCCccCchhhH------HHHHhccCC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 9999975432211 111111100 0000000000111223456889999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.76 Aligned_cols=205 Identities=25% Similarity=0.340 Sum_probs=163.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 133 (283)
T 3bhy_A 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR---IAHFD 133 (283)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 4678899999999999999999999999999999999997654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC----ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKY----RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++ .+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CChHHEEEecCCCCCCceEEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 999999998877 89999999997654322 223446899999999999889999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
......+ .......... ... .......+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 212 ~~~~~~~------~~~~~~~~~~---~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 212 LGETKQE------TLTNISAVNY---DFD----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp CCSSHHH------HHHHHHTTCC---CCC----HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred CCcchHH------HHHHhHhccc---CCc----chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 6433211 1111111110 001 11112234568999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=281.53 Aligned_cols=207 Identities=22% Similarity=0.340 Sum_probs=161.5
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++...+ ..|+||||+ +++|.+++... .+++..+..++.||+.||+|||+++
T Consensus 77 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~-- 148 (367)
T 1cm8_A 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-- 148 (367)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 467889999999999998764 459999999 88999999763 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++++|++|+
T Consensus 149 -ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 149 -IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -ccccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865432 234568999999999887 67999999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhh---c--hhhhhhh---------------hhhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINE---N--RLFEVLD---------------AQVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.||......+ .+..+... . .....+. ...........+..+.+++.+||+.||.
T Consensus 224 ~pf~~~~~~~------~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~ 297 (367)
T 1cm8_A 224 TLFKGSDHLD------QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 297 (367)
T ss_dssp CSSCCSSHHH------HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred CCCCCCCHHH------HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChh
Confidence 9997443221 11111110 0 0000000 0001111123355689999999999999
Q ss_pred CCCCHHHHHHHHH
Q 045989 215 KRPTMKEVALELA 227 (295)
Q Consensus 215 ~Rps~~e~~~~l~ 227 (295)
+|||+.++++|.+
T Consensus 298 ~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 298 QRVTAGEALAHPY 310 (367)
T ss_dssp TSCCHHHHHHSGG
T ss_pred HCCCHHHHhcChH
Confidence 9999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=289.86 Aligned_cols=197 Identities=15% Similarity=0.167 Sum_probs=153.3
Q ss_pred cccCCCCcccccee-------eEEEeCC-----------------ccEEEEeecCCCCHHHHHhhhCC---CCCCCCHHH
Q 045989 2 ILSQINHRNVVKLL-------GCCLETE-----------------VPLLVYEFIPNGSLHQYIHEQTE---DQLPITWEI 54 (295)
Q Consensus 2 il~~l~Hpniv~~~-------~~~~~~~-----------------~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~ 54 (295)
+|++++|||||+++ +++...+ ..++||||+ +|+|.+++..... ....+++..
T Consensus 129 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~ 207 (377)
T 3byv_A 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHA 207 (377)
T ss_dssp GSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHH
T ss_pred hccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHH
Confidence 46778999999999 7766553 278999999 6799999986432 111244588
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC--
Q 045989 55 RLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-- 132 (295)
Q Consensus 55 ~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 132 (295)
++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 208 ~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 208 RLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhccccc
Confidence 8899999999999999999 99999999999999999999999999985322 2344567 999999999887
Q ss_pred ---------CCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHH
Q 045989 133 ---------QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAM 203 (295)
Q Consensus 133 ---------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (295)
.++.++|||||||++|+|++|+.||........ ...... .....+..+.+
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~ 338 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRA 338 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHH
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHH
Confidence 899999999999999999999999863322110 000000 01123345889
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 204 VAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 204 li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
++.+||+.||++|||+.++++|.+-
T Consensus 339 li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 339 LLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHHcCCCchhCCCHHHHhhChHH
Confidence 9999999999999999999997653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.89 Aligned_cols=215 Identities=21% Similarity=0.263 Sum_probs=159.9
Q ss_pred cccCCCCccccceeeEEEeCCc------cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEV------PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~------~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++...+. .++||||+++ ++...+.........+++..++.++.||+.||+|||+.+
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-- 161 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-- 161 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5788999999999999976543 7899999976 555554433223335999999999999999999999999
Q ss_pred CeEeccCCCCeEEEC-CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhC
Q 045989 76 PIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g 153 (295)
|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 162 -ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 162 -ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred -ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999 78999999999998654332 23345689999999998764 589999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHh---hchhh--hhhhh-------------hhhhhhhHHHHHHHHHHHHHhhccCCCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVIN---ENRLF--EVLDA-------------QVLREAEKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~ 215 (295)
+.||......+ .+..+.. ..... ....+ ......+...+..+.+++.+||+.||.+
T Consensus 239 ~~pf~~~~~~~------~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 239 QPLFPGESGID------QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp SCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred CCCCCCCCHHH------HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 99997543221 1111111 00000 00000 0001111224457999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 045989 216 RPTMKEVALELAG 228 (295)
Q Consensus 216 Rps~~e~~~~l~~ 228 (295)
|||+.|+++|.+-
T Consensus 313 R~t~~e~l~hp~f 325 (394)
T 4e7w_A 313 RLTAIEALCHPFF 325 (394)
T ss_dssp SCCHHHHHTSGGG
T ss_pred CCCHHHHhcChhh
Confidence 9999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=274.75 Aligned_cols=205 Identities=27% Similarity=0.385 Sum_probs=163.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 130 (276)
T 2yex_A 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130 (276)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4678899999999999999999999999999999999886532 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+||+++.++.+||+|||++........ .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 131 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred CChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999976543221 12334568999999999987765 7789999999999999999999965
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
...... ........... .......+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 211 ~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 211 PSDSCQ-----EYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp SCTTSH-----HHHHHHTTCTT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CchHHH-----HHHHhhhcccc---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 432210 01111111100 0111223445889999999999999999999988754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=272.36 Aligned_cols=202 Identities=23% Similarity=0.350 Sum_probs=166.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 140 (294)
T 2rku_A 68 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRD 140 (294)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999999999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 141 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 141 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CChHhEEEcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999986543222 2233568999999999999889999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..+ ......... ...+...+..+.+++.+||+.||++|||+.+++++.+-
T Consensus 220 ~~~------~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 220 LKE------TYLRIKKNE-----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp HHH------HHHHHHTTC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHH------HHHHHhhcc-----------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 221 111111111 01112234458899999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.91 Aligned_cols=206 Identities=23% Similarity=0.310 Sum_probs=166.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 77 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 150 (314)
T 3com_A 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFMR---KIHRD 150 (314)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCC
Confidence 46789999999999999999999999999999999999975433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 151 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999976543322 2234468999999999999999999999999999999999999996433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... .......... . ....+...+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 230 ~~~------~~~~~~~~~~-~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 230 PMR------AIFMIPTNPP-P-------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp HHH------HHHHHHHSCC-C-------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred hHH------HHHHHhcCCC-c-------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 211 1111111100 0 001122234568999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.04 Aligned_cols=222 Identities=26% Similarity=0.378 Sum_probs=171.7
Q ss_pred cccCCCCccccceeeEEEeCC--ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETE--VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++...+ ..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 60 ~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 135 (396)
T 4eut_A 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG---IVH 135 (396)
T ss_dssp HHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEE
Confidence 467899999999999998765 679999999999999999864332 23899999999999999999999999 999
Q ss_pred ccCCCCeEEE----CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc--------CCCCCCccchhhHHHH
Q 045989 80 RDIKSANILL----DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS--------SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 80 ~dikp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l 147 (295)
|||||+||++ +.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 136 ~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp CCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 9999999999 777889999999998654332 2234568999999999865 5678899999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhh--h------------hhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEV--L------------DAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
|+|++|+.||....... .....+............ . ............+..+.+++.+||+.||
T Consensus 214 ~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP 291 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (396)
T ss_dssp HHHHHSSCSEECTTCTT--TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHHCCCCCCCCCccc--chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccCh
Confidence 99999999997543221 112222222222110000 0 0001123346677789999999999999
Q ss_pred CCCCCHHHHHHHHHHhHH
Q 045989 214 KKRPTMKEVALELAGIRA 231 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~~~~ 231 (295)
++||++.++++.++.+..
T Consensus 292 ~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 292 EKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTSCCHHHHHHHHHHHHT
T ss_pred hhhccHHHHHHHHHHHhh
Confidence 999999999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=278.39 Aligned_cols=217 Identities=24% Similarity=0.364 Sum_probs=166.3
Q ss_pred CCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hC
Q 045989 5 QINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLH--------SA 72 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh--------~~ 72 (295)
.++||||+++++++.... ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 166 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence 379999999999999876 789999999999999999764 3899999999999999999999 77
Q ss_pred CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCC------CCCCccchhh
Q 045989 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQ------FTEKSDVYSF 143 (295)
Q Consensus 73 ~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Diwsl 143 (295)
+ |+||||||+||+++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||
T Consensus 167 ~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 167 A---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp E---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred C---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 8 999999999999999999999999999766543322 123446899999999997652 3468999999
Q ss_pred HHHHHHHHhC----------CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 144 GVVLVELLTG----------QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 144 G~~l~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
||++|+|++| ..||......+ ....... ...........+... ......+..+.+++.+||+.||
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp 318 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSD-PSVEEMR-KVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANG 318 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-CCHHHHH-HHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCc-ccHHHHH-HHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccCh
Confidence 9999999999 67775332211 1111211 111111111111110 1123566779999999999999
Q ss_pred CCCCCHHHHHHHHHHhHHhhc
Q 045989 214 KKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~~~~~~~ 234 (295)
++|||+.+++++|+.+....+
T Consensus 319 ~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 319 AARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp GGSCCHHHHHHHHHHHHHTTC
T ss_pred hhCCCHHHHHHHHHHHHHHhc
Confidence 999999999999998876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.83 Aligned_cols=205 Identities=23% Similarity=0.319 Sum_probs=157.2
Q ss_pred cccCCC--CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~--Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++ ||||+++++++..++..++||| +.+++|.+++.... .+++..++.++.||+.||+|||+.+ |+|
T Consensus 107 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH 178 (390)
T 2zmd_A 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVH 178 (390)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT---CCC
T ss_pred HHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 355665 5999999999999999999999 55889999998654 4889999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhcc-----------CCCCCCccchhhHHHH
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQS-----------SQFTEKSDVYSFGVVL 147 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l 147 (295)
|||||+|||++ ++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++
T Consensus 179 rDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil 257 (390)
T 2zmd_A 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257 (390)
T ss_dssp CCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred cCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence 99999999996 578999999999866433222 2334579999999999865 3688999999999999
Q ss_pred HHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 148 VELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|+|++|..||..... ....+...... ......+...+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 258 ~ell~G~~Pf~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 258 YYMTYGKTPFQQIIN-----QISKLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHHHSSCTTTTCCC-----HHHHHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHCCCcchhhhH-----HHHHHHHHhCc---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 999999999963221 11112222211 1111112222446889999999999999999999999987
Q ss_pred Hh
Q 045989 228 GI 229 (295)
Q Consensus 228 ~~ 229 (295)
-.
T Consensus 324 ~~ 325 (390)
T 2zmd_A 324 VQ 325 (390)
T ss_dssp HH
T ss_pred cc
Confidence 54
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=276.18 Aligned_cols=207 Identities=26% Similarity=0.412 Sum_probs=164.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..+. .++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|+|
T Consensus 74 ~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 146 (291)
T 1u46_A 74 AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR---FIHRD 146 (291)
T ss_dssp HHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 467789999999999998764 8999999999999999986533 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||++.......... .....+|..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 147 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 147 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999999998665433221 223457888999999998889999999999999999999 999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
..... ........... ....+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 227 ~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 227 GLNGS------QILHKIDKEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TCCHH------HHHHHHHTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCHH------HHHHHHHccCC---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 44322 12222211110 01112234456999999999999999999999999997754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=290.74 Aligned_cols=219 Identities=26% Similarity=0.313 Sum_probs=154.7
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++... ..+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+
T Consensus 105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--- 176 (458)
T 3rp9_A 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAG--- 176 (458)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57789999999999999543 5689999998 579999987543 4999999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcc--------------------------eeeeccccccCCCChhhh-
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--------------------------HLTTQVKGTFGYLDPEYF- 129 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~- 129 (295)
|+||||||+||||+.++.+||+|||+++....... .......||+.|+|||++
T Consensus 177 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 99999999999999999999999999986542211 123345789999999986
Q ss_pred ccCCCCCCccchhhHHHHHHHHh-----------CCCCCcccchhh-----------------cccHHHHHHHHHhhchh
Q 045989 130 QSSQFTEKSDVYSFGVVLVELLT-----------GQKPIRLVETEE-----------------NRSLAAYFLQVINENRL 181 (295)
Q Consensus 130 ~~~~~~~~~DiwslG~~l~el~~-----------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~ 181 (295)
.+..++.++|||||||++|||++ |+++|....... .......+.........
T Consensus 257 ~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~ 336 (458)
T 3rp9_A 257 LQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336 (458)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCH
T ss_pred CCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCH
Confidence 55679999999999999999998 555554322100 00000001111100000
Q ss_pred h--hhhh---------------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 182 F--EVLD---------------AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 182 ~--~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
. ..+. ...........+..+.+|+.+||..||++|||+.|+++|.+-
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp HHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 0 0000 000001112235568899999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=285.26 Aligned_cols=215 Identities=19% Similarity=0.287 Sum_probs=162.8
Q ss_pred cccCCCCccccceeeEEEeC--------------------------------------CccEEEEeecCCCCHHHHHhhh
Q 045989 2 ILSQINHRNVVKLLGCCLET--------------------------------------EVPLLVYEFIPNGSLHQYIHEQ 43 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~--------------------------------------~~~~iv~e~~~~g~L~~~l~~~ 43 (295)
+|++++||||+++++++... ...++||||++ |+|.+.+...
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH
Confidence 57889999999999999543 34889999997 5888888764
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEEC-CCCceEEeeccCccccccCcceeeeccccccC
Q 045989 44 TEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFG 122 (295)
Q Consensus 44 ~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 122 (295)
......+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+||+|||+++...... ......||+.
T Consensus 132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~ 206 (383)
T 3eb0_A 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRF 206 (383)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSS
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCC
Confidence 444446999999999999999999999999 99999999999997 68899999999998654332 2334468999
Q ss_pred CCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHh---hchhhhhh-------------
Q 045989 123 YLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN---ENRLFEVL------------- 185 (295)
Q Consensus 123 y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------------- 185 (295)
|+|||++.+. .++.++||||+||++|+|++|..||......+ .+..+.. ........
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 280 (383)
T 3eb0_A 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID------QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280 (383)
T ss_dssp CCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCTTC--CCCCC
T ss_pred ccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCCHHHHHHhCcccccccCCc
Confidence 9999998775 48999999999999999999999997543222 1111111 00000000
Q ss_pred --hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 186 --DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 186 --~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
........+...+..+.+++.+||+.||.+|||+.|+++|.+-
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (383)
T 3eb0_A 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325 (383)
T ss_dssp CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence 0000111222345568999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.26 Aligned_cols=213 Identities=21% Similarity=0.220 Sum_probs=163.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++ +|..++..... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 137 (346)
T 1ua2_A 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRD 137 (346)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCC
Confidence 46788999999999999999999999999975 89988875432 4888999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 138 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 138 LKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCCEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999998654332 223345689999999999764 5889999999999999999999998643
Q ss_pred chhhcccHHHHHHHHHhhch---h---hh------hhh-----hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENR---L---FE------VLD-----AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~---~---~~------~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
... ..+..+..... . .. ... ...........+..+.+++.+||+.||.+|||+.|++
T Consensus 217 ~~~------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 217 SDL------DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp SHH------HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CHH------HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 322 11222211100 0 00 000 0000011123345699999999999999999999999
Q ss_pred HHHHH
Q 045989 224 LELAG 228 (295)
Q Consensus 224 ~~l~~ 228 (295)
+|.+-
T Consensus 291 ~h~~f 295 (346)
T 1ua2_A 291 KMKYF 295 (346)
T ss_dssp TSGGG
T ss_pred cChhh
Confidence 98653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=275.03 Aligned_cols=204 Identities=24% Similarity=0.304 Sum_probs=165.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 131 (304)
T 2jam_A 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG---IVHRD 131 (304)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCS
T ss_pred HHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678899999999999999999999999999999999997654 4899999999999999999999999 99999
Q ss_pred CCCCeEEE---CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILL---DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||++ +.++.+||+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 132 ikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999 77889999999998754322 1233468999999999999899999999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..... .....+...... . ........+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 209 ~~~~~------~~~~~i~~~~~~---~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 209 EETES------KLFEKIKEGYYE---F----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp TSCHH------HHHHHHHHCCCC---C----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCHH------HHHHHHHcCCCC---C----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 43221 112221111100 0 001112334568999999999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.02 Aligned_cols=210 Identities=22% Similarity=0.335 Sum_probs=160.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||++|++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|||
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 155 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 5788999999999999999999999999999999999997643 24899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc----ceeeeccccccCCCChhhhcc---------CCCCCCccchhhHHHHH
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR----THLTTQVKGTFGYLDPEYFQS---------SQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~ 148 (295)
|||+||+++ ++.+||+|||+++...... ........|++.|+|||++.+ ..++.++||||||+++|
T Consensus 156 lkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp CCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred CChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 999999998 6799999999987543211 112233458999999999874 35788999999999999
Q ss_pred HHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 149 ELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 149 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+|++|..||...... ........... .. ......+..+.+++.+||..||.+|||+.++++.|+.
T Consensus 235 el~~g~~p~~~~~~~------~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 299 (319)
T 2y4i_B 235 ELHAREWPFKTQPAE------AIIWQMGTGMK-PN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299 (319)
T ss_dssp HHHHSSCSSSSCCHH------HHHHHHHTTCC-CC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred HHHhCCCCCCCCCHH------HHHHHhccCCC-CC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 999999999643322 12222211110 00 0011123458899999999999999999999999987
Q ss_pred hHHhh
Q 045989 229 IRASI 233 (295)
Q Consensus 229 ~~~~~ 233 (295)
+....
T Consensus 300 l~~~~ 304 (319)
T 2y4i_B 300 LPKRN 304 (319)
T ss_dssp C----
T ss_pred HHHhh
Confidence 76543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=300.79 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=166.1
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|..+ +||||+++++++.+.+.+|+||||++||+|..++.... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrD 467 (674)
T 3pfq_A 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 467 (674)
T ss_dssp HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCC
T ss_pred HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 4455 89999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 468 LKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 468 LKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCSTTEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CChhhEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999998543222 22445679999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM-----KEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~-----~e~~~~l~ 227 (295)
. ...+..+..... ..+...+..+.+||.+||+.||.+||++ +||++|.+
T Consensus 547 ~------~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 547 E------DELFQSIMEHNV-----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp H------HHHHHHHHSSCC-----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred H------HHHHHHHHhCCC-----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 2 223333332211 1222345568999999999999999997 88887753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.20 Aligned_cols=204 Identities=17% Similarity=0.173 Sum_probs=164.4
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE-DQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
..|+||+++++++..++..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 124 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp 200 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKP 200 (365)
T ss_dssp GGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSG
T ss_pred hhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCH
Confidence 3499999999999999999999999999999999975322 2335999999999999999999999999 99999999
Q ss_pred CeEEECC-----------CCceEEeeccCcccccc-CcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 85 ANILLDD-----------KYRAKISDFGTSRSMAV-DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 85 ~Nill~~-----------~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
+|||++. ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 201 ~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp GGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred HHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 9999988 89999999999976542 22333455679999999999999999999999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHhHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKR-PTMKEVALELAGIRA 231 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R-ps~~e~~~~l~~~~~ 231 (295)
|+.||......... ....+. .. .....+.+++..||+.+|.+| |++.++.+.|+....
T Consensus 281 g~~pf~~~~~~~~~--------------~~~~~~-----~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 281 GTYMKVKNEGGECK--------------PEGLFR-----RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp SSCCCEEEETTEEE--------------ECSCCT-----TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCccccCCCCcee--------------echhcc-----cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 99998543221100 000000 00 113347789999999999999 788888888877655
Q ss_pred hh
Q 045989 232 SI 233 (295)
Q Consensus 232 ~~ 233 (295)
..
T Consensus 340 ~~ 341 (365)
T 3e7e_A 340 QH 341 (365)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=279.31 Aligned_cols=203 Identities=26% Similarity=0.449 Sum_probs=162.0
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
|+++ +||||+++++++...+..++||||++|++|.+++.... .+++..++.++.||+.||.|||+.+ ++|+|
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~D 225 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN---IVHRD 225 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 4556 89999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc------CCCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS------SQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 226 lkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 226 LKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 99999999999999999999987654322 2334578999999999864 358899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||...... .....+....... .. ......+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 304 pf~~~~~~------~~~~~i~~~~~~~---~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 304 PFWHRRQI------LMLRMIMEGQYQF---SS----PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp SSCCSSHH------HHHHHHHHTCCCC---CH----HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCCHH------HHHHHHHhCCCCC---CC----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 99643221 1111111111000 00 001123455889999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=280.22 Aligned_cols=209 Identities=22% Similarity=0.306 Sum_probs=154.3
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++...+ ..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+++
T Consensus 77 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~-- 147 (371)
T 2xrw_A 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-- 147 (371)
T ss_dssp HHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 467889999999999998665 67999999965 88888852 3889999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+||+++.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 148 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 148 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp -CCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -eecccCCHHHEEEcCCCCEEEEEeecccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999765432 12334568999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhc----------------------h------hhhhhhhh---hhhhhhHHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINEN----------------------R------LFEVLDAQ---VLREAEKEEVITVAMV 204 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~----------------------~------~~~~~~~~---~~~~~~~~~~~~~~~l 204 (295)
||......+ .+..+.... . +....... .........+..+.+|
T Consensus 225 pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 225 LFPGTDHID------QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp SSCCSSHHH------HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred CCCCCCHHH------HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 997543221 111111100 0 00000000 0011123346779999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHH
Q 045989 205 AKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 205 i~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+.+||+.||.+|||+.|+++|.+-
T Consensus 299 i~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHCcCChhhCCCHHHHhCCcch
Confidence 999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.39 Aligned_cols=217 Identities=21% Similarity=0.274 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEe--------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLE--------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++.. .+..++||||+++ +|.+.+..... .+++..++.++.|++.||+|||+.+
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (351)
T 3mi9_A 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK 144 (351)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678899999999999987 3468999999965 88888765433 4899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCc---ceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHH
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR---THLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~e 149 (295)
|+||||||+||+++.++.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 145 ---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 221 (351)
T 3mi9_A 145 ---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 221 (351)
T ss_dssp ---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHH
T ss_pred ---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHH
Confidence 9999999999999999999999999998654221 222344568999999999876 457999999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHHHHHhhch--hhhhhhh-h--------------hhh-hhhHHHHHHHHHHHHHhhcc
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFLQVINENR--LFEVLDA-Q--------------VLR-EAEKEEVITVAMVAKRCLNL 211 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~--------------~~~-~~~~~~~~~~~~li~~cl~~ 211 (295)
|++|..||......+. ...+........ .....+. . ... ......+..+.+|+.+||+.
T Consensus 222 ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 222 MWTRSPIMQGNTEQHQ---LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp HHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HHhCCCCCCCCChHHH---HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 9999999975432221 111111111000 0000000 0 000 00001134588999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 045989 212 NGKKRPTMKEVALELAG 228 (295)
Q Consensus 212 ~p~~Rps~~e~~~~l~~ 228 (295)
||++|||+.|+++|.+-
T Consensus 299 dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 299 DPAQRIDSDDALNHDFF 315 (351)
T ss_dssp SGGGSCCHHHHHTSGGG
T ss_pred ChhhCCCHHHHhCCCCc
Confidence 99999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.20 Aligned_cols=225 Identities=20% Similarity=0.318 Sum_probs=155.2
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQT-----EDQLPITWEIRLGIAVEVSGALSYLHSAAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~ 74 (295)
+|++++||||+++++++.. +...++||||+. |+|.+++.... .....+++..++.++.||+.||+|||+.+
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 148 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 148 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5778999999999999965 668899999995 58888876332 12224899999999999999999999999
Q ss_pred CCeEeccCCCCeEEE----CCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccC-CCCCCccchhhHHHH
Q 045989 75 IPIYHRDIKSANILL----DDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVL 147 (295)
Q Consensus 75 ~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l 147 (295)
|+||||||+|||| +.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++
T Consensus 149 --ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 149 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp --CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred --EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 9999999999999 6778999999999986643221 223445789999999999874 589999999999999
Q ss_pred HHHHhCCCCCcccchhh---cccHHHHHHHHHhhc-----hhhhhh-------------hhhhh---------hhhhHHH
Q 045989 148 VELLTGQKPIRLVETEE---NRSLAAYFLQVINEN-----RLFEVL-------------DAQVL---------REAEKEE 197 (295)
Q Consensus 148 ~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~-------------~~~~~---------~~~~~~~ 197 (295)
|+|++|..||....... .......+..+.... ..+..+ ..... .......
T Consensus 227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (405)
T 3rgf_A 227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306 (405)
T ss_dssp HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCT
T ss_pred HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCC
Confidence 99999999996443211 000011111111100 000000 00000 0000011
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 198 VITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 198 ~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
+..+.+||.+||+.||.+|||+.|+++|.+-..
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 346889999999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=287.39 Aligned_cols=215 Identities=22% Similarity=0.277 Sum_probs=160.0
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||++++++|.... .+++||||+++ +|.+++.........+++..++.++.||+.||+|||+.+
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-- 176 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 176 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 578899999999999986422 36799999965 777777654333446999999999999999999999999
Q ss_pred CeEeccCCCCeEEECCC-CceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhC
Q 045989 76 PIYHRDIKSANILLDDK-YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g 153 (295)
|+||||||+||||+.+ +.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 177 -ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G 253 (420)
T 1j1b_A 177 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253 (420)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred -ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999965 678999999998654322 22345689999999998764 789999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhh---chhhh--hhhh--------h-----hhhhhhHHHHHHHHHHHHHhhccCCCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINE---NRLFE--VLDA--------Q-----VLREAEKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~--------~-----~~~~~~~~~~~~~~~li~~cl~~~p~~ 215 (295)
+.||......+ .+..+... ..... ...+ . .........+..+.+|+.+||+.||.+
T Consensus 254 ~~pf~~~~~~~------~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 254 QPIFPGDSGVD------QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp SCSSCCSSHHH------HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred CCCCCCCCHHH------HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 99997543221 11111110 00000 0000 0 000011223456899999999999999
Q ss_pred CCCHHHHHHHHHH
Q 045989 216 RPTMKEVALELAG 228 (295)
Q Consensus 216 Rps~~e~~~~l~~ 228 (295)
|||+.|+++|.+-
T Consensus 328 R~t~~e~l~hp~f 340 (420)
T 1j1b_A 328 RLTPLEACAHSFF 340 (420)
T ss_dssp SCCHHHHHTSGGG
T ss_pred CCCHHHHhCCHhh
Confidence 9999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.32 Aligned_cols=201 Identities=25% Similarity=0.348 Sum_probs=156.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++|+|
T Consensus 64 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 136 (276)
T 2h6d_A 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM---VVHRD 136 (276)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCC
T ss_pred HHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 4678899999999999999999999999999999999998654 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 137 l~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 137 LKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChhhEEECCCCCEEEeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654322 2234468999999999987765 68999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.. ......+.... ...+...+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 215 ~~------~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 215 HV------PTLFKKIRGGV-----------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp SH------HHHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred cH------HHHHHHhhcCc-----------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 22 11111111110 01112234458899999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=272.85 Aligned_cols=207 Identities=25% Similarity=0.396 Sum_probs=162.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 72 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 147 (295)
T 2clq_A 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRD 147 (295)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccC
Confidence 4678999999999999999999999999999999999997643 2234779999999999999999999999 99999
Q ss_pred CCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC--CCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++. ++.+||+|||++....... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.
T Consensus 148 l~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 148 IKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CChhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 9999999987 8999999999997654322 1223456899999999997643 7899999999999999999999986
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
....... ........ ......+...+..+.+++.+||+.||++|||+.+++++.+
T Consensus 227 ~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 227 ELGEPQA-----AMFKVGMF---------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp GGSSHHH-----HHHHHHHH---------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred CCCchhH-----HHHhhccc---------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 3322110 01000000 0011122334456889999999999999999999988754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=288.08 Aligned_cols=205 Identities=27% Similarity=0.341 Sum_probs=153.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++.. +..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 193 ~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrD 264 (419)
T 3i6u_A 193 ILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRD 264 (419)
T ss_dssp HHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678999999999999854 56799999999999988886543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCC---ceEEeeccCccccccCcceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDKY---RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+|||++.++ .+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 265 lkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 265 LKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp CCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred CChHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999997544 5999999999865432 22344579999999999853 567889999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
||....... ..... ....... . ........+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 343 pf~~~~~~~--~~~~~----i~~~~~~--~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 343 PFSEHRTQV--SLKDQ----ITSGKYN--F----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp SSCCCSSSC--CHHHH----HHTTCCC--C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCCCCcchH--HHHHH----HhcCCCC--C----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 996432211 11111 1111000 0 001112234568999999999999999999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.52 Aligned_cols=219 Identities=21% Similarity=0.253 Sum_probs=156.2
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++... ...|+||||+. |+|.+++.... .+++..++.++.||+.||+|||+.+
T Consensus 78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~g--- 149 (432)
T 3n9x_A 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHESG--- 149 (432)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 57789999999999999876 56899999995 59999997543 4899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcc---------------------eeeeccccccCCCChhhh-ccCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT---------------------HLTTQVKGTFGYLDPEYF-QSSQF 134 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~ 134 (295)
|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++ ....+
T Consensus 150 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 229 (432)
T 3n9x_A 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229 (432)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCC
T ss_pred CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCC
Confidence 99999999999999999999999999986643221 123456799999999986 55679
Q ss_pred CCCccchhhHHHHHHHHhCCCCCcccchhh-----cc-----------------cHHHHHHH---HHhhch---------
Q 045989 135 TEKSDVYSFGVVLVELLTGQKPIRLVETEE-----NR-----------------SLAAYFLQ---VINENR--------- 180 (295)
Q Consensus 135 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----~~-----------------~~~~~~~~---~~~~~~--------- 180 (295)
+.++|||||||++|||++|..||....... +. .....+.. ......
T Consensus 230 ~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~ 309 (432)
T 3n9x_A 230 TKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK 309 (432)
T ss_dssp CTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccC
Confidence 999999999999999998655443211000 00 00111111 111000
Q ss_pred --hhhhhh------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 181 --LFEVLD------AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 181 --~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
....+. +..........+..+.+|+.+||+.||.+|||+.|+++|.+-
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 310 PEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 000000 000000112245668999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.19 Aligned_cols=212 Identities=19% Similarity=0.280 Sum_probs=160.3
Q ss_pred cccCCC-CccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQIN-HRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|++++ ||||+++++++.. ....++||||+++++|.+++.. +++..++.++.|++.||+|||+++ |+
T Consensus 83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---iv 152 (330)
T 3nsz_A 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IM 152 (330)
T ss_dssp HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 456675 9999999999998 6678999999999999998853 889999999999999999999999 99
Q ss_pred eccCCCCeEEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCC
Q 045989 79 HRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 79 H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||||||+||+++.++ .+||+|||+++....... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 153 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 230 (330)
T 3nsz_A 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230 (330)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred eCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999776 899999999986543322 334468999999999977 6789999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhh-----------------------hhhhhHHHHHHHHHHHHHhhccCC
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQV-----------------------LREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
|........ .................+.... ........+..+.+++.+||+.||
T Consensus 231 ~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 308 (330)
T 3nsz_A 231 FFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308 (330)
T ss_dssp SSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSG
T ss_pred cccCCchHH--HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCc
Confidence 853322110 0111111111111111110000 001111245678999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 045989 214 KKRPTMKEVALELA 227 (295)
Q Consensus 214 ~~Rps~~e~~~~l~ 227 (295)
.+|||+.|+++|.+
T Consensus 309 ~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 309 QSRLTAREAMEHPY 322 (330)
T ss_dssp GGSCCHHHHHTSGG
T ss_pred ccCCCHHHHhcCcc
Confidence 99999999998864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=273.25 Aligned_cols=205 Identities=23% Similarity=0.341 Sum_probs=159.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+|
T Consensus 69 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 142 (302)
T 2j7t_A 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSKR---IIHRD 142 (302)
T ss_dssp HHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCC---cccCC
Confidence 46788999999999999999999999999999999999876443 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+||+++.++.+||+|||++....... .......||+.|+|||++. +..++.++||||||+++|+|++|..|
T Consensus 143 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp CSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCHHHEEECCCCCEEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999875332111 1123346899999999983 56788999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|...... ............ . ...+...+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 222 ~~~~~~~------~~~~~~~~~~~~-~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 222 HHELNPM------RVLLKIAKSDPP-T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp TTTSCHH------HHHHHHHHSCCC-C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred CccCCHH------HHHHHHhccCCc-c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 8643321 112121111100 0 0112233456889999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=281.93 Aligned_cols=217 Identities=18% Similarity=0.272 Sum_probs=168.1
Q ss_pred cccCCCC-ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~H-pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+++.++| ++|..+..++...+..++||||+ +++|.+++..... .+++..++.|+.||+.||+|||+++ |+||
T Consensus 55 il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~g---IvHr 127 (483)
T 3sv0_A 55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS---FLHR 127 (483)
T ss_dssp HHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 4566766 66667777777888899999999 9999999985433 4999999999999999999999999 9999
Q ss_pred cCCCCeEEE---CCCCceEEeeccCccccccCcce------eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 81 DIKSANILL---DDKYRAKISDFGTSRSMAVDRTH------LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 81 dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
||||+|||| +.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 128 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell 207 (483)
T 3sv0_A 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207 (483)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 999999999 58889999999999866543221 122457999999999999999999999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
+|+.||.......... .+..+... .... .........+..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 208 tG~~Pf~~~~~~~~~~---~~~~i~~~-~~~~-----~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 208 RGSLPWQGLKAGTKKQ---KYEKISEK-KVAT-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HSSCTTSSCCCSSHHH---HHHHHHHH-HHHS-----CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCCCccccchhHHH---HHHHHhhc-cccc-----cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 9999997543322111 11111111 0000 0111112334569999999999999999999999999998866
Q ss_pred hhc
Q 045989 232 SIG 234 (295)
Q Consensus 232 ~~~ 234 (295)
..+
T Consensus 279 ~~~ 281 (483)
T 3sv0_A 279 REG 281 (483)
T ss_dssp HTT
T ss_pred HcC
Confidence 554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=279.34 Aligned_cols=215 Identities=20% Similarity=0.282 Sum_probs=161.6
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++... ...++||||+. |+|.+++... .+++..++.++.|++.||+|||+++
T Consensus 78 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--- 148 (364)
T 3qyz_A 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--- 148 (364)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46789999999999999765 36899999996 5999998764 3899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 153 (295)
|+||||||+||+++.++.+||+|||+++......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 149 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 228 (364)
T 3qyz_A 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228 (364)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence 9999999999999999999999999998654332211 234578999999998754 4589999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhhchhh---hhhh--------------hhhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINENRLF---EVLD--------------AQVLREAEKEEVITVAMVAKRCLNLNGKKR 216 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 216 (295)
+.||......+. ...+.......... .... ...........+..+.+++.+||+.||.+|
T Consensus 229 ~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 229 RPIFPGKHYLDQ---LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp SCSSCCSSGGGH---HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 999975433221 11111111100000 0000 000001112234568999999999999999
Q ss_pred CCHHHHHHHHHH
Q 045989 217 PTMKEVALELAG 228 (295)
Q Consensus 217 ps~~e~~~~l~~ 228 (295)
||+.|+++|.+-
T Consensus 306 ~t~~e~l~hp~~ 317 (364)
T 3qyz_A 306 IEVEQALAHPYL 317 (364)
T ss_dssp CCHHHHHTSGGG
T ss_pred CCHHHHhcCcch
Confidence 999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=280.03 Aligned_cols=210 Identities=21% Similarity=0.240 Sum_probs=160.7
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
.+|+||+++++++...+..++||||+. ++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 156 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~ 229 (429)
T 3kvw_A 156 DNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPE 229 (429)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGG
T ss_pred cCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 478999999999999999999999995 6999999865432 4899999999999999999999999 999999999
Q ss_pred eEEECCCCc--eEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchh
Q 045989 86 NILLDDKYR--AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163 (295)
Q Consensus 86 Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 163 (295)
|||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||......
T Consensus 230 NILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 230 NILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HeEEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999887 999999999754322 23456899999999999999999999999999999999999999754332
Q ss_pred hcccHHHHHHHHHhhc--hhh-------hhhhhh------------------------------------hhhhhhHHHH
Q 045989 164 ENRSLAAYFLQVINEN--RLF-------EVLDAQ------------------------------------VLREAEKEEV 198 (295)
Q Consensus 164 ~~~~~~~~~~~~~~~~--~~~-------~~~~~~------------------------------------~~~~~~~~~~ 198 (295)
+. ...+....... .+. ..++.. .........+
T Consensus 306 ~~---l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 382 (429)
T 3kvw_A 306 DQ---LACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382 (429)
T ss_dssp HH---HHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCC
T ss_pred HH---HHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccch
Confidence 21 11111111000 000 000000 0000011124
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 199 ITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 199 ~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..+.+||.+||+.||++|||+.|+++|.+-
T Consensus 383 ~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence 568999999999999999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.69 Aligned_cols=206 Identities=13% Similarity=0.067 Sum_probs=144.8
Q ss_pred ccCCCCcccccee-------eEEEeCC-----------------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHH---
Q 045989 3 LSQINHRNVVKLL-------GCCLETE-----------------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIR--- 55 (295)
Q Consensus 3 l~~l~Hpniv~~~-------~~~~~~~-----------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~--- 55 (295)
|+. +||||++++ +++...+ ..++||||++ |+|.+++..... .+.+..+
T Consensus 119 l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~ 193 (371)
T 3q60_A 119 LLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGI 193 (371)
T ss_dssp HHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHH
T ss_pred hcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhh
Confidence 344 799988755 5555433 3799999997 799999986532 2455555
Q ss_pred ---HHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-
Q 045989 56 ---LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS- 131 (295)
Q Consensus 56 ---~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 131 (295)
+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+
T Consensus 194 ~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~ 266 (371)
T 3q60_A 194 LALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNAS 266 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCS
T ss_pred hhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCC
Confidence 678899999999999999 99999999999999999999999999985532 1224557799999999987
Q ss_pred -CCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhc
Q 045989 132 -SQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLN 210 (295)
Q Consensus 132 -~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 210 (295)
..++.++|||||||++|+|++|+.||........... .....................+..+.+++.+||+
T Consensus 267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 338 (371)
T 3q60_A 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN 338 (371)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTC
T ss_pred CCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcC
Confidence 6799999999999999999999999975432211000 0000000000000001112334568999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 045989 211 LNGKKRPTMKEVALELAG 228 (295)
Q Consensus 211 ~~p~~Rps~~e~~~~l~~ 228 (295)
.||++|||+.++++|.+-
T Consensus 339 ~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 339 FDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp SSTTTCCCHHHHTTSHHH
T ss_pred CChhhCCCHHHHhcCHHH
Confidence 999999999999998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=280.39 Aligned_cols=211 Identities=24% Similarity=0.223 Sum_probs=159.5
Q ss_pred CCccccceeeEEE----eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecc
Q 045989 7 NHRNVVKLLGCCL----ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHRD 81 (295)
Q Consensus 7 ~Hpniv~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~d 81 (295)
+||||+++++++. .....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||++ + |+|||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrD 172 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTD 172 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 3899999999998 456789999999 6677777765432 2489999999999999999999998 8 99999
Q ss_pred CCCCeEEECCCC-------------------------------------------------ceEEeeccCccccccCcce
Q 045989 82 IKSANILLDDKY-------------------------------------------------RAKISDFGTSRSMAVDRTH 112 (295)
Q Consensus 82 ikp~Nill~~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~ 112 (295)
|||+|||++.++ .+||+|||+++.....
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--- 249 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--- 249 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---
Confidence 999999998775 7999999999765432
Q ss_pred eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHH---HHHHHhhchhhhhhhh--
Q 045989 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAY---FLQVINENRLFEVLDA-- 187 (295)
Q Consensus 113 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-- 187 (295)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....... +...............
T Consensus 250 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 328 (397)
T 1wak_A 250 -FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328 (397)
T ss_dssp -SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred -CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence 2334689999999999999999999999999999999999999975443321111111 1111111000000000
Q ss_pred --------------------------hhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 188 --------------------------QVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 188 --------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
......+...+..+.+|+.+||+.||++|||+.|+++|.+
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 0011234566778999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=275.41 Aligned_cols=205 Identities=25% Similarity=0.355 Sum_probs=154.9
Q ss_pred ccCC-CCccccceeeEEEe------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 3 LSQI-NHRNVVKLLGCCLE------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
|+++ +||||+++++++.. .+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~-- 149 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK-- 149 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4556 89999999999987 4678999999999999999986432 24899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHH
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el 150 (295)
++|+||||+||+++.++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|
T Consensus 150 -ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 227 (326)
T 2x7f_A 150 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227 (326)
T ss_dssp -CCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHH
T ss_pred -ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 1223446899999999987 56789999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
++|..||....... ......... . ........+..+.+++.+||..||.+|||+.++++|.+-
T Consensus 228 ~~g~~p~~~~~~~~------~~~~~~~~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 228 AEGAPPLCDMHPMR------ALFLIPRNP-A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HHSSCTTTTSCHHH------HHHHHHHSC-C--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred HhCCCCCCCCcHHH------HHHHhhcCc-c--------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 99999986432211 111111110 0 001112234568999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=267.61 Aligned_cols=204 Identities=22% Similarity=0.292 Sum_probs=159.3
Q ss_pred cccCCCCccccceeeEEE--eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~--~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+|++++||||+++++++. .....++||||++++ |.+++...... .+++..++.++.|++.||+|||+++ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H 132 (305)
T 2wtk_C 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK--RFPVCQAHGYFCQLIDGLEYLHSQG---IVH 132 (305)
T ss_dssp HHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTC--SCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccc--ccCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 478899999999999984 456889999999775 87877654332 5899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccC-cceeeeccccccCCCChhhhccCC--CCCCccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGTFGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||||+||+++.++.+||+|||++...... .........||+.|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus 133 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (305)
T 2wtk_C 133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212 (305)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865432 222234456899999999997643 37799999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
|..... ......+.... ...+...+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 213 ~~~~~~------~~~~~~i~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 213 FEGDNI------YKLFENIGKGS-----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp CCCSSH------HHHHHHHHHCC-----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred CCCchH------HHHHHHHhcCC-----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 964322 11222111111 01122334568899999999999999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.34 Aligned_cols=211 Identities=23% Similarity=0.333 Sum_probs=147.8
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++... ...++|+|++ +++|.+++... .+++..++.++.||+.||+|||+.+
T Consensus 81 ~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g-- 152 (367)
T 2fst_X 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD-- 152 (367)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46788999999999999754 5679999999 78999988652 4899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 153 -ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 153 -IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227 (367)
T ss_dssp -CCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred -eeeCCCCHhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999764322 334578999999999877 67899999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhc--hhhhhhh---------------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINEN--RLFEVLD---------------AQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
.||......+. ...+....... .....+. ...........+..+.+|+.+||+.||.+||
T Consensus 228 ~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 228 TLFPGTDHIDQ---LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp CSCCCSSHHHH---HHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCCCHHHH---HHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 99975432211 11111111000 0000000 0000011112345689999999999999999
Q ss_pred CHHHHHHHHHH
Q 045989 218 TMKEVALELAG 228 (295)
Q Consensus 218 s~~e~~~~l~~ 228 (295)
|+.++++|.+-
T Consensus 305 t~~e~L~hp~~ 315 (367)
T 2fst_X 305 TAAQALAHAYF 315 (367)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcChhh
Confidence 99999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=268.68 Aligned_cols=204 Identities=27% Similarity=0.398 Sum_probs=162.7
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ +||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+
T Consensus 76 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 148 (298)
T 1phk_A 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHR 148 (298)
T ss_dssp HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 35566 49999999999999999999999999999999998654 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc------cCCCCCCccchhhHHHHHHHHhCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ------SSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
||||+||+++.++.+||+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|.
T Consensus 149 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 999999999999999999999997654322 233456899999999985 456789999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.||...... .....+....... ........+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 227 ~p~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 227 PPFWHRKQM------LMLRMIMSGNYQF-------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp CSSCCSSHH------HHHHHHHHTCCCC-------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCcCccHH------HHHHHHhcCCccc-------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 999643221 1111111111000 00111234456899999999999999999999988754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.26 Aligned_cols=205 Identities=26% Similarity=0.334 Sum_probs=159.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++..+. .++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 68 ~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 139 (322)
T 2ycf_A 68 ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRD 139 (322)
T ss_dssp HHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 467889999999999987654 899999999999999987543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCc---eEEeeccCccccccCcceeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLDDKYR---AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+||+++.++. +||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 140 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999987654 9999999998654321 123446899999999974 4678899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
||....... ...... ...... ..+ ......+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 218 pf~~~~~~~--~~~~~~----~~~~~~--~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 218 PFSEHRTQV--SLKDQI----TSGKYN--FIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp SSCSTTCSS--CHHHHH----HHTCCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CCcccchHH--HHHHHH----HhCccc--cCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 996432211 111111 111000 000 1112234568999999999999999999999988653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.43 Aligned_cols=217 Identities=19% Similarity=0.286 Sum_probs=160.0
Q ss_pred ccCCCCccccceeeEEEeCCc-------cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCC
Q 045989 3 LSQINHRNVVKLLGCCLETEV-------PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLH--SAA 73 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~-------~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh--~~~ 73 (295)
+++++||||+++++++...+. .++||||+++ +|...+.........+++..++.++.|++.||.||| +.+
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ 151 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN 151 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 456799999999999976443 7899999975 666666544444446899999999999999999999 888
Q ss_pred CCCeEeccCCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHH
Q 045989 74 SIPIYHRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~ 151 (295)
|+||||||+||+++. ++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 152 ---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell 226 (360)
T 3e3p_A 152 ---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226 (360)
T ss_dssp ---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred ---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999996 8999999999998654332 23345689999999998665 4899999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhc--hhhhhhh----------------hhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINEN--RLFEVLD----------------AQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
+|..||......+. ...+.+..... ....... ...........+..+.+++.+||+.||
T Consensus 227 ~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 227 LGEPIFRGDNSAGQ---LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred hCCCCcCCCChHHH---HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence 99999975432211 11111110000 0000000 000111112245679999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 045989 214 KKRPTMKEVALELAG 228 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~ 228 (295)
.+|||+.|+++|.+-
T Consensus 304 ~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 304 EERMKPYEALCHPYF 318 (360)
T ss_dssp GGSCCHHHHTTSGGG
T ss_pred cccCCHHHHhcCccc
Confidence 999999999988654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=278.04 Aligned_cols=213 Identities=23% Similarity=0.361 Sum_probs=163.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHH------HhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQY------IHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AAS 74 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~ 74 (295)
+|++++||||+++++++...+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .+
T Consensus 96 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~- 172 (348)
T 2pml_X 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN- 172 (348)
T ss_dssp HHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC-
T ss_pred HHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC-
Confidence 46789999999999999999999999999999999998 4432 13369999999999999999999999 88
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCC-CccchhhHHHHHHHHh
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTE-KSDVYSFGVVLVELLT 152 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~el~~ 152 (295)
++|+||||+||+++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++
T Consensus 173 --i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 173 --ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred --EeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999865433 33445689999999999877 6666 9999999999999999
Q ss_pred CCCCCcccchhhcccHHHHHHHHHhhchhhh--------hhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 153 GQKPIRLVETEENRSLAAYFLQVINENRLFE--------VLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
|..||...... ......+........ ..............+..+.+++.+||+.||.+|||+.++++
T Consensus 248 g~~pf~~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 248 NVVPFSLKISL-----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCSSCCSSCS-----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCcH-----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999743321 111222211110000 00000000111334556899999999999999999999999
Q ss_pred HHH
Q 045989 225 ELA 227 (295)
Q Consensus 225 ~l~ 227 (295)
|.+
T Consensus 323 hp~ 325 (348)
T 2pml_X 323 HEW 325 (348)
T ss_dssp SGG
T ss_pred Ccc
Confidence 864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=270.90 Aligned_cols=209 Identities=23% Similarity=0.325 Sum_probs=161.0
Q ss_pred CCCCccccceeeEEE-----eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 5 QINHRNVVKLLGCCL-----ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~-----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+++||||+++++++. .....++||||+. |+|.+++...... .+++..++.++.|++.||+|||+.+ ++|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---i~H 143 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVH 143 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 458999999999997 4567899999997 5999999865432 4899999999999999999999999 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999997654322 22345689999999999999999999999999999999999999974
Q ss_pred cchhhcccHHHHHHHHHhhc------hhhhh----------hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 160 VETEENRSLAAYFLQVINEN------RLFEV----------LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~------~~~~~----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
....+ ....+.... ..... .............+..+.+++.+||+.||.+|||+.+++
T Consensus 222 ~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 222 SSDVD------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp SSHHH------HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHHH------HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 43221 111111100 00000 000001112223455688999999999999999999999
Q ss_pred HHHH
Q 045989 224 LELA 227 (295)
Q Consensus 224 ~~l~ 227 (295)
+|.+
T Consensus 296 ~hp~ 299 (326)
T 1blx_A 296 SHPY 299 (326)
T ss_dssp TSGG
T ss_pred cCcc
Confidence 8754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=269.00 Aligned_cols=206 Identities=23% Similarity=0.384 Sum_probs=153.2
Q ss_pred cccCCCCccccceeeEEEe-------------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLE-------------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+|++++||||+++++++.. .+..++||||+++|+|.+++..... .+++..++.++.|++.||+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~ 131 (303)
T 1zy4_A 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL---NQQRDEYWRLFRQILEALSY 131 (303)
T ss_dssp HHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCG---GGCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcccc---ccchHHHHHHHHHHHHHHHH
Confidence 4788999999999999865 3567999999999999999986432 47889999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCc-------------ceeeeccccccCCCChhhhccC-CC
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDR-------------THLTTQVKGTFGYLDPEYFQSS-QF 134 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~ 134 (295)
||+++ ++|+||||+||+++.++.+||+|||++....... ........||+.|+|||++.+. .+
T Consensus 132 LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 208 (303)
T 1zy4_A 132 IHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208 (303)
T ss_dssp HHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCC
T ss_pred HHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCC
Confidence 99999 9999999999999999999999999997654221 1122345689999999999764 68
Q ss_pred CCCccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 135 TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 135 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
+.++|||||||++|+|++ ||..... ........... ........+...+..+.+++.+||+.||.
T Consensus 209 ~~~~Di~slG~il~~l~~---p~~~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (303)
T 1zy4_A 209 NEKIDMYSLGIIFFEMIY---PFSTGME-----RVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273 (303)
T ss_dssp CTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred cchhhHHHHHHHHHHHHh---ccCCchh-----HHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcc
Confidence 999999999999999998 4432111 11111111111 00111122233445688999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 045989 215 KRPTMKEVALELAG 228 (295)
Q Consensus 215 ~Rps~~e~~~~l~~ 228 (295)
+|||+.++++|.+-
T Consensus 274 ~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 274 KRPGARTLLNSGWL 287 (303)
T ss_dssp GSCCHHHHHHSSCS
T ss_pred cCcCHHHHhCCCCc
Confidence 99999999988643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=276.94 Aligned_cols=210 Identities=20% Similarity=0.244 Sum_probs=142.5
Q ss_pred ccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 3 LSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
++.++||||+++++++.. +...++||||++||+|.+++..... ..+++..++.++.|++.||+|||+++ |+
T Consensus 76 ~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~---iv 150 (336)
T 3fhr_A 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN---IA 150 (336)
T ss_dssp HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 456799999999999986 4458999999999999999986532 25899999999999999999999999 99
Q ss_pred eccCCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 79 HRDIKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 79 H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
||||||+||+++. ++.+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999976 455999999999755422 2234568999999999988889999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
||.......... .......... ...........+..+.+++.+||+.||.+|||+.++++|.+-.
T Consensus 228 pf~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 228 PFYSNTGQAISP---GMKRRIRLGQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp CC------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCCccchhhhh---hHHHhhhccc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 996433221100 0000000000 0000011123345689999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=272.29 Aligned_cols=207 Identities=20% Similarity=0.288 Sum_probs=159.4
Q ss_pred CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeE
Q 045989 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANI 87 (295)
Q Consensus 8 Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Ni 87 (295)
|++|+++++++...+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||
T Consensus 76 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 149 (339)
T 1z57_A 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENI 149 (339)
T ss_dssp TTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred ceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 445999999999999999999999 8899999976542 24889999999999999999999999 99999999999
Q ss_pred EECC-------------------CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 88 LLDD-------------------KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 88 ll~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
+++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred EEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence 9987 668999999999754322 23446899999999999999999999999999999
Q ss_pred HHHhCCCCCcccchhhcccHHHHHHHHHhhchh--hhh-----------------------h-----hhhhhhhhhHHHH
Q 045989 149 ELLTGQKPIRLVETEENRSLAAYFLQVINENRL--FEV-----------------------L-----DAQVLREAEKEEV 198 (295)
Q Consensus 149 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------------~-----~~~~~~~~~~~~~ 198 (295)
+|++|..||......+. ...+......... ... . ............+
T Consensus 226 el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (339)
T 1z57_A 226 EYYLGFTVFPTHDSKEH---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302 (339)
T ss_dssp HHHHSSCSCCCSCHHHH---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhH
Confidence 99999999975443221 1111111110000 000 0 0000011123456
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 199 ITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 199 ~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..+.+++.+||+.||.+|||+.|+++|.+
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 77999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=277.70 Aligned_cols=215 Identities=22% Similarity=0.265 Sum_probs=154.1
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++... ...++||||+. |+|.+++..... .+++..++.++.||+.||+|||+.+
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--- 154 (362)
T 3pg1_A 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI---VISPQHIQYFMYHILLGLHVLHEAG--- 154 (362)
T ss_dssp HHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCc---
Confidence 46788999999999999653 35799999996 588888875432 4899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 155 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999997543222 2334568999999999877 678999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhh------------------hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEV------------------LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
||......+. ...+............ .............+..+.+++.+||+.||.+||
T Consensus 233 pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 309 (362)
T 3pg1_A 233 LFRGSTFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309 (362)
T ss_dssp SCCCSSHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCHHHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC
Confidence 9975432211 1111111111000000 000001111222345689999999999999999
Q ss_pred CHHHHHHHHHH
Q 045989 218 TMKEVALELAG 228 (295)
Q Consensus 218 s~~e~~~~l~~ 228 (295)
|+.++++|.+-
T Consensus 310 t~~ell~hp~f 320 (362)
T 3pg1_A 310 STEQALRHPYF 320 (362)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHHcCchh
Confidence 99999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.69 Aligned_cols=212 Identities=22% Similarity=0.308 Sum_probs=147.1
Q ss_pred ccCC-CCccccceeeEEEe--------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 3 LSQI-NHRNVVKLLGCCLE--------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
|+++ +||||+++++++.. ....++||||+. |+|.+++...... ..+++..++.++.||+.||+|||+.+
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT-CSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4566 49999999999953 335799999995 6999998753222 25899999999999999999999986
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-----------eeeccccccCCCChhhh---ccCCCCCCcc
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-----------LTTQVKGTFGYLDPEYF---QSSQFTEKSD 139 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~D 139 (295)
.+|+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++ .+..++.++|
T Consensus 157 -~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D 235 (337)
T 3ll6_A 157 -PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235 (337)
T ss_dssp -SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHH
T ss_pred -CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh
Confidence 24999999999999999999999999999866432221 11134589999999998 5667889999
Q ss_pred chhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 140 VYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 140 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
||||||++|+|++|..||....... ...... ........+..+.+++.+||+.||.+|||+
T Consensus 236 v~slG~il~el~~g~~p~~~~~~~~------~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 296 (337)
T 3ll6_A 236 IWALGCILYLLCFRQHPFEDGAKLR------IVNGKY-------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296 (337)
T ss_dssp HHHHHHHHHHHHHSSCCC------------------C-------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHHHHHHHhCCCCCcchhHHH------hhcCcc-------------cCCcccccchHHHHHHHHHccCChhhCcCH
Confidence 9999999999999999985322110 000000 001111122337789999999999999999
Q ss_pred HHHHHHHHHhHHhhccc
Q 045989 220 KEVALELAGIRASIGAS 236 (295)
Q Consensus 220 ~e~~~~l~~~~~~~~~~ 236 (295)
.+++++|+.+.......
T Consensus 297 ~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 297 AEVVHQLQEIAAARNVN 313 (337)
T ss_dssp HHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhccCCC
Confidence 99999999987665433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.69 Aligned_cols=204 Identities=25% Similarity=0.337 Sum_probs=161.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 74 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 146 (287)
T 2wei_A 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146 (287)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 4678999999999999999999999999999999999987654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCC---CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDK---YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||+++.+ +.+||+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 147 l~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChhhEEEecCCCcccEEEeccCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 99999999754 469999999987654322 1233458999999999876 48999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
..... .....+........ .......+..+.+++.+||+.||.+|||+.+++++.+-
T Consensus 224 ~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 224 GKNEY------DILKRVETGKYAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp CSSHH------HHHHHHHHCCCCCC-------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred CCCHH------HHHHHHHcCCCCCC-------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence 43322 11221111110000 01112234568999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=268.40 Aligned_cols=212 Identities=22% Similarity=0.310 Sum_probs=158.3
Q ss_pred cccCCCCccccceeeEEE--------------eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCL--------------ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALS 67 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~--------------~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~ 67 (295)
+|++++||||+++++++. .....++||||++ |+|.+++... .+++..++.++.|++.||+
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~ 134 (320)
T 2i6l_A 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLK 134 (320)
T ss_dssp HHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHH
Confidence 467899999999999874 3467899999997 5999998643 3899999999999999999
Q ss_pred HHHhCCCCCeEeccCCCCeEEEC-CCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhcc-CCCCCCccchhh
Q 045989 68 YLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSF 143 (295)
Q Consensus 68 ~Lh~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 143 (295)
|||+++ |+||||||+||+++ .++.+||+|||+++....... .......+|..|+|||++.+ ..++.++|||||
T Consensus 135 ~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 211 (320)
T 2i6l_A 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211 (320)
T ss_dssp HHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred HHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence 999999 99999999999997 567999999999986543211 12234467999999998865 678999999999
Q ss_pred HHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchh---------hhh----hhhh------hhhhhhHHHHHHHHHH
Q 045989 144 GVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL---------FEV----LDAQ------VLREAEKEEVITVAMV 204 (295)
Q Consensus 144 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~----~~~~------~~~~~~~~~~~~~~~l 204 (295)
|+++|+|++|+.||......+ ....+...... ... .... .........+..+.++
T Consensus 212 G~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (320)
T 2i6l_A 212 GCIFAEMLTGKTLFAGAHELE------QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285 (320)
T ss_dssp HHHHHHHHHSSCSSCCSSHHH------HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHH
Confidence 999999999999997543221 11111111000 000 0000 0011112345679999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHH
Q 045989 205 AKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 205 i~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+.+||+.||++|||+.++++|.+-
T Consensus 286 i~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 286 LEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHcCCCccccCCHHHHhCCccc
Confidence 999999999999999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=272.58 Aligned_cols=207 Identities=23% Similarity=0.336 Sum_probs=156.6
Q ss_pred cccCCCCccccceeeEEEeCCcc------EEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVP------LLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~------~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++...+.. ++||||+. ++|.+++.. .+++..++.++.|++.||+|||+.+
T Consensus 94 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~-- 164 (371)
T 4exu_A 94 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG-- 164 (371)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46788999999999999877655 99999996 688887742 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 165 -ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 165 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -CcCCCcCHHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999754322 334568999999999987 67899999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhh---c--hhhhhhhh---------------hhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINE---N--RLFEVLDA---------------QVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.||......+ ....+... . .....+.. ..........+..+.+|+.+||+.||.
T Consensus 240 ~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (371)
T 4exu_A 240 TLFKGKDYLD------QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 313 (371)
T ss_dssp CSCCCSSHHH------HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTT
T ss_pred CCCCCCChHH------HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChh
Confidence 9997443221 11111110 0 00000000 000111122356789999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 045989 215 KRPTMKEVALELAG 228 (295)
Q Consensus 215 ~Rps~~e~~~~l~~ 228 (295)
+|||+.|+++|.+-
T Consensus 314 ~Rpt~~ell~hp~f 327 (371)
T 4exu_A 314 KRLTAAQALTHPFF 327 (371)
T ss_dssp TSCCHHHHHTSGGG
T ss_pred hcCCHHHHhcCccc
Confidence 99999999998653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=281.41 Aligned_cols=210 Identities=20% Similarity=0.312 Sum_probs=150.9
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLP---ITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
|+++ +||||+++++++..++..++|||||. |+|.+++......... ..+..++.++.||+.||+|||+.+ |+
T Consensus 62 l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 137 (434)
T 2rio_A 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---II 137 (434)
T ss_dssp HHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---cc
Confidence 4444 89999999999999999999999995 6999999865432111 123345789999999999999999 99
Q ss_pred eccCCCCeEEECCC-------------CceEEeeccCccccccCcce---eeeccccccCCCChhhhcc-------CCCC
Q 045989 79 HRDIKSANILLDDK-------------YRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQS-------SQFT 135 (295)
Q Consensus 79 H~dikp~Nill~~~-------------~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~ 135 (295)
||||||+||+++.+ +.+||+|||+++........ ......||+.|+|||++.+ ..++
T Consensus 138 HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 217 (434)
T 2rio_A 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217 (434)
T ss_dssp CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc
Confidence 99999999999654 48999999999876543221 1234569999999999976 5689
Q ss_pred CCccchhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 136 EKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 136 ~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.++|||||||++|+|++ |..||......+ ..+........ ..........+..+.+++.+||+.||.
T Consensus 218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~i~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (434)
T 2rio_A 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRE--------SNIIRGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPL 285 (434)
T ss_dssp THHHHHHHHHHHHHHHTTSCCTTCSTTTHH--------HHHHHTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGG
T ss_pred hhhhhHhHHHHHHHHHhCCCCCCCCchhhH--------HHHhcCCCCcc----cccccccccchHHHHHHHHHHhhCChh
Confidence 99999999999999999 999986332111 01111110000 001112334567799999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 045989 215 KRPTMKEVALELAG 228 (295)
Q Consensus 215 ~Rps~~e~~~~l~~ 228 (295)
+|||+.++++|.+-
T Consensus 286 ~Rps~~eil~hp~f 299 (434)
T 2rio_A 286 KRPTAMKVLRHPLF 299 (434)
T ss_dssp GSCCHHHHHTSGGG
T ss_pred hCCCHHHHHhCCcc
Confidence 99999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=274.88 Aligned_cols=215 Identities=21% Similarity=0.271 Sum_probs=159.5
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++... ...++||||+. ++|.+++... .+++..++.++.|++.||+|||+++
T Consensus 62 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--- 132 (353)
T 2b9h_A 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN--- 132 (353)
T ss_dssp HHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 46788999999999998764 67899999996 5999998763 3899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcce---------eeeccccccCCCChhhhcc-CCCCCCccchhhHHH
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---------LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVV 146 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~ 146 (295)
|+||||||+||+++.++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 212 (353)
T 2b9h_A 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212 (353)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHH
T ss_pred eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHH
Confidence 999999999999999999999999999865432211 1123468999999998764 678999999999999
Q ss_pred HHHHHhCCCCCcccchhhcccHHHHHHHHHhhch------------hhhhhh------hhhhhhhhHHHHHHHHHHHHHh
Q 045989 147 LVELLTGQKPIRLVETEENRSLAAYFLQVINENR------------LFEVLD------AQVLREAEKEEVITVAMVAKRC 208 (295)
Q Consensus 147 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~------~~~~~~~~~~~~~~~~~li~~c 208 (295)
+|+|++|..||......+. ...+........ ..+... ...........+..+.+++.+|
T Consensus 213 l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 2b9h_A 213 LAELFLRRPIFPGRDYRHQ---LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM 289 (353)
T ss_dssp HHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence 9999999999975432211 111111110000 000000 0000111123456689999999
Q ss_pred hccCCCCCCCHHHHHHHHHH
Q 045989 209 LNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 209 l~~~p~~Rps~~e~~~~l~~ 228 (295)
|+.||++|||+.++++|.+-
T Consensus 290 L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 290 LVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp SCSSGGGSCCHHHHHTSGGG
T ss_pred cCcCcccCCCHHHHhcCccc
Confidence 99999999999999988653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=274.03 Aligned_cols=209 Identities=22% Similarity=0.262 Sum_probs=157.8
Q ss_pred CCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecc
Q 045989 7 NHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHRD 81 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~d 81 (295)
.||||+++++++...+ ..++||||+ +++|.+++...... .+++..++.++.||+.||+|||++ + |+|||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~D 157 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTD 157 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSC
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 4899999999998754 789999999 88999999864432 489999999999999999999998 8 99999
Q ss_pred CCCCeEEEC------CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 82 IKSANILLD------DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 82 ikp~Nill~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||+||+++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 233 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 999999994 4458999999999765432 233468999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHh---hchh------------------------------hhhhhhhhhhhhhHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVIN---ENRL------------------------------FEVLDAQVLREAEKEEVITVA 202 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~---~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~ 202 (295)
||.................+.. .... .... ......+...+..+.
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 311 (373)
T 1q8y_A 234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEIS 311 (373)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHH
T ss_pred CCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh--hhcccCCcchHHHHH
Confidence 9975432211111111111111 0000 0000 011123456778899
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 203 MVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 203 ~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
+||.+||+.||++|||+.|+++|.+
T Consensus 312 ~li~~~L~~dP~~Rpt~~ell~hp~ 336 (373)
T 1q8y_A 312 DFLSPMLQLDPRKRADAGGLVNHPW 336 (373)
T ss_dssp HHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred HHHHHHhccCccccCCHHHHhhChh
Confidence 9999999999999999999998865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=280.62 Aligned_cols=205 Identities=25% Similarity=0.402 Sum_probs=151.0
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ +|||||++++++......|+|||||. |+|.+++..... .+.+..++.++.||+.||+|||+.+ |+||
T Consensus 70 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 142 (432)
T 3p23_A 70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLN---IVHR 142 (432)
T ss_dssp HHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHCc---CEeC
Confidence 45666 89999999999999999999999995 599999986543 2444556789999999999999999 9999
Q ss_pred cCCCCeEEECC-----CCceEEeeccCccccccCcc--eeeeccccccCCCChhhhc---cCCCCCCccchhhHHHHHHH
Q 045989 81 DIKSANILLDD-----KYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQ---SSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 81 dikp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~el 150 (295)
||||+||+++. ...+||+|||+++....... .......||+.|+|||++. ...++.++|||||||++|+|
T Consensus 143 DlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~el 222 (432)
T 3p23_A 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222 (432)
T ss_dssp CCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence 99999999953 33688999999986643321 2234457999999999997 45678899999999999999
Q ss_pred Hh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 151 LT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 151 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
++ |..||....... .......... ... ......+..+.+++.+||+.||.+|||+.++++|.+
T Consensus 223 lt~g~~pf~~~~~~~-------~~~~~~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 223 ISEGSHPFGKSLQRQ-------ANILLGACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp HTTSCBTTBSTTTHH-------HHHHTTCCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred HcCCCCCcchhhHHH-------HHHHhccCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 99 999985322111 1111111100 000 111233455788999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=271.41 Aligned_cols=212 Identities=26% Similarity=0.320 Sum_probs=144.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEe
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT-EDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYH 79 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H 79 (295)
+++.++||||+++++++..++..++||||+++ +|.+++.... .....+++..++.++.|++.||.|||+. + ++|
T Consensus 74 ~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH 149 (327)
T 3aln_A 74 VMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIH 149 (327)
T ss_dssp HHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCC
T ss_pred HHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeE
Confidence 46778999999999999999999999999975 8888876421 1123589999999999999999999998 8 999
Q ss_pred ccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhh----ccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 80 RDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYF----QSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 80 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|||||+||+++.++.+||+|||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..
T Consensus 150 ~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp SCCCGGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred CCCCHHHEEEcCCCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999997654322 12233689999999998 45678999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
||....... ......... ..+..........+..+.+++.+||+.||++|||+.+++++.+-..
T Consensus 228 pf~~~~~~~-----~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 228 PYPKWNSVF-----DQLTQVVKG------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CSSCC------------CCCCCS------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCcchHH-----HHHHHHhcC------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 996432110 000000000 0000001111223456899999999999999999999999876643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=266.93 Aligned_cols=144 Identities=25% Similarity=0.333 Sum_probs=125.2
Q ss_pred CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeccCCCC
Q 045989 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS--AASIPIYHRDIKSA 85 (295)
Q Consensus 8 Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~--~~~~~i~H~dikp~ 85 (295)
|++|+++++++...+..++||||+. |+|.+++...... .+++..++.++.|++.||.|||. .+ |+||||||+
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~ 188 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPE 188 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGG
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcc
Confidence 3469999999999999999999995 5999999865432 48999999999999999999994 56 999999999
Q ss_pred eEEEC--CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 86 NILLD--DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 86 Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 189 NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 189 NILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99995 4778999999999865432 234568999999999999999999999999999999999999997543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.76 Aligned_cols=204 Identities=24% Similarity=0.337 Sum_probs=154.2
Q ss_pred ccCCC--CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 3 LSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 3 l~~l~--Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
|++++ ||||+++++++..++..++||| +.+++|.+++.... .+++..++.++.|++.||+|||+.+ ++||
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 151 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHS 151 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 45665 5999999999999999999999 45889999998643 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhcc-----------CCCCCCccchhhHHHHH
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQS-----------SQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~ 148 (295)
||||+||++++ +.+||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|
T Consensus 152 dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 152 DLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred CCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 99999999965 89999999999865433221 1234468999999999875 46788999999999999
Q ss_pred HHHhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 149 ELLTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 149 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
+|++|..||...... .......... ......+...+..+.+++.+||+.||.+|||+.+++++.+-
T Consensus 231 el~~g~~pf~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 231 YMTYGKTPFQQIINQ-----ISKLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HHHHSSCTTTTCCSH-----HHHHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHhCCCchhhHHHH-----HHHHHHHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 999999999643211 1111111111 11111122224568899999999999999999999998765
Q ss_pred h
Q 045989 229 I 229 (295)
Q Consensus 229 ~ 229 (295)
.
T Consensus 297 ~ 297 (313)
T 3cek_A 297 Q 297 (313)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=263.03 Aligned_cols=205 Identities=25% Similarity=0.407 Sum_probs=151.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSA-ASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~-~~~~i~H~ 80 (295)
+++.++||||+++++++..++..++||||+ ++.+..+...... .+++..++.++.|++.||+|||+. + ++|+
T Consensus 77 ~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~ 149 (318)
T 2dyl_A 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG---PIPERILGKMTVAIVKALYYLKEKHG---VIHR 149 (318)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCC
T ss_pred HHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeC
Confidence 456789999999999999999999999999 6677766654332 489999999999999999999995 8 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
||||+||+++.++.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..
T Consensus 150 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 150 DVKPSNILLDERGQIKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEECCCCCEEEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 999999999999999999999987554322 223346899999999994 4568899999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
||...... .............. .......+..+.+++.+||+.||.+|||+.++++|.+-
T Consensus 228 pf~~~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 228 PYKNCKTD-----FEVLTKVLQEEPPL--------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp TTTTCCSH-----HHHHHHHHHSCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCCCCCcc-----HHHHHHHhccCCCC--------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 99642211 11122222111100 00011233458899999999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=268.04 Aligned_cols=212 Identities=19% Similarity=0.290 Sum_probs=159.4
Q ss_pred ccCCCCcc------ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 3 LSQINHRN------VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 3 l~~l~Hpn------iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
|++++|++ ++.+++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++
T Consensus 70 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--- 143 (355)
T 2eu9_A 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ--- 143 (355)
T ss_dssp HHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 44555554 999999999999999999999 6688887765432 24899999999999999999999999
Q ss_pred eEeccCCCCeEEE-------------------CCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCC
Q 045989 77 IYHRDIKSANILL-------------------DDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEK 137 (295)
Q Consensus 77 i~H~dikp~Nill-------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 137 (295)
|+||||||+||++ +.++.+||+|||+++..... .....||+.|+|||++.+..++.+
T Consensus 144 ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~ 219 (355)
T 2eu9_A 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQP 219 (355)
T ss_dssp EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCc
Confidence 9999999999999 56789999999999754322 234568999999999999999999
Q ss_pred ccchhhHHHHHHHHhCCCCCcccchhhcccHHHHHHHHHhhchhh--h-----------------------hhhh-----
Q 045989 138 SDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRLF--E-----------------------VLDA----- 187 (295)
Q Consensus 138 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----------------------~~~~----- 187 (295)
+|||||||++|+|++|..||......+. ...+.......... . ....
T Consensus 220 ~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (355)
T 2eu9_A 220 CDVWSIGCILFEYYRGFTLFQTHENREH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc
Confidence 9999999999999999999975433221 11111111100000 0 0000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 188 QVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 188 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..........+..+.+++.+||+.||++|||+.|+++|.+
T Consensus 297 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 297 KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0000112234567899999999999999999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.67 Aligned_cols=192 Identities=24% Similarity=0.395 Sum_probs=157.7
Q ss_pred ccCCC--CccccceeeEEEeCCccEEEEeecCC-CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 3 LSQIN--HRNVVKLLGCCLETEVPLLVYEFIPN-GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 3 l~~l~--Hpniv~~~~~~~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
|++++ ||||+++++++...+..++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+.+ |+|
T Consensus 100 l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH 172 (320)
T 3a99_A 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VLH 172 (320)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEe
Confidence 45554 69999999999999999999999976 89999998654 4899999999999999999999999 999
Q ss_pred ccCCCCeEEEC-CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCC
Q 045989 80 RDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 80 ~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||||+||+++ .++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||
T Consensus 173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 99999999999 78899999999998654322 233468999999999987766 68899999999999999999998
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..... ...... ..+...+..+.+++.+||+.||++|||+.+++++.+
T Consensus 250 ~~~~~------------~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 250 EHDEE------------IIRGQV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CSHHH------------HHHCCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CChhh------------hhcccc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 53211 011000 011123445889999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=269.70 Aligned_cols=207 Identities=23% Similarity=0.331 Sum_probs=156.0
Q ss_pred cccCCCCccccceeeEEEeCCc------cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEV------PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~------~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++..... .++||||+. ++|.+++.. .+++..++.++.||+.||+|||+++
T Consensus 76 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~-- 146 (353)
T 3coi_A 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG-- 146 (353)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4678899999999999987654 499999996 588777642 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 147 -ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 147 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp -CCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999754322 234568999999999877 67899999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhh---c--hhhhhhh---------------hhhhhhhhHHHHHHHHHHHHHhhccCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINE---N--RLFEVLD---------------AQVLREAEKEEVITVAMVAKRCLNLNGK 214 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~ 214 (295)
.||......+ .+..+... . .....+. ...........+..+.+++.+||+.||+
T Consensus 222 ~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 295 (353)
T 3coi_A 222 TLFKGKDYLD------QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 295 (353)
T ss_dssp CSSBSSCHHH------HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTT
T ss_pred CCCCCCCHHH------HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcc
Confidence 9997543221 11111110 0 0000000 0000111223456799999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 045989 215 KRPTMKEVALELAG 228 (295)
Q Consensus 215 ~Rps~~e~~~~l~~ 228 (295)
+|||+.++++|.+-
T Consensus 296 ~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 296 KRLTAAQALTHPFF 309 (353)
T ss_dssp TSCCHHHHHTSGGG
T ss_pred cCCCHHHHhcCcch
Confidence 99999999988653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=264.31 Aligned_cols=188 Identities=28% Similarity=0.436 Sum_probs=152.2
Q ss_pred CCccccceeeEEEeCCccEEEEee-cCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 045989 7 NHRNVVKLLGCCLETEVPLLVYEF-IPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSA 85 (295)
Q Consensus 7 ~Hpniv~~~~~~~~~~~~~iv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~ 85 (295)
+||||+++++++...+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 168 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE 168 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGG
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChh
Confidence 899999999999999999999999 78999999998754 4899999999999999999999999 999999999
Q ss_pred eEEEC-CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCC-CCccchhhHHHHHHHHhCCCCCcccchh
Q 045989 86 NILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFT-EKSDVYSFGVVLVELLTGQKPIRLVETE 163 (295)
Q Consensus 86 Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~ 163 (295)
||+++ .++.+||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~- 244 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE- 244 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-
T ss_pred hEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-
Confidence 99999 88999999999998654332 2345689999999999877664 589999999999999999999853211
Q ss_pred hcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 164 ENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..... ...+...+..+.+++.+||+.||++|||+.++++|.+
T Consensus 245 -----------~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 245 -----------ILEAE-----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp -----------HHHTC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred -----------Hhhhc-----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 0111223445889999999999999999999998864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.13 Aligned_cols=189 Identities=21% Similarity=0.303 Sum_probs=144.5
Q ss_pred cCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 4 SQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+.++||||+++++++.. ....++||||++||+|.+++..... ..+++..++.++.|++.||+|||+.+ |+|
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H 140 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAH 140 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 55699999999999987 6788999999999999999987532 25899999999999999999999999 999
Q ss_pred ccCCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||||+||+++. ++.+||+|||++.... +..++.++|||||||++|+|++|..|
T Consensus 141 ~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~p 197 (299)
T 3m2w_A 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPP 197 (299)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHEEEecCCCCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999998 7889999999986432 23467899999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|.......... ..... . ...............+..+.+++.+||+.||.+|||+.|+++|.+-.
T Consensus 198 f~~~~~~~~~~------~~~~~--~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 198 FYSNHGLAISP------GMKTR--I-RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp CCC-------C------CSCCS--S-CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCCcchhhhH------HHHHH--H-hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 96432211000 00000 0 00000000011122455689999999999999999999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.93 Aligned_cols=190 Identities=22% Similarity=0.340 Sum_probs=150.4
Q ss_pred cccCCCCccccceeeEEEeCCc-----cEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEV-----PLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~-----~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
+|++++||||+++++++...+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||+++
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g--- 202 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG--- 202 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5788999999999999998765 6999999999999887654 3899999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|+||||||+||+++.+ .+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|
T Consensus 203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~ 275 (681)
T 2pzi_A 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPT 275 (681)
T ss_dssp EECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCE
T ss_pred CeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCC
Confidence 9999999999999985 8999999999865432 345689999999998765 48899999999999999999988
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHhH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-MKEVALELAGIR 230 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~e~~~~l~~~~ 230 (295)
|......... . .......+..+.++|.+||+.||.+||+ ++++...+..+.
T Consensus 276 ~~~~~~~~~~----------------~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 276 RNGRYVDGLP----------------E-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ETTEECSSCC----------------T-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Cccccccccc----------------c-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 7532111000 0 0011123345889999999999999995 555655565543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=280.90 Aligned_cols=218 Identities=24% Similarity=0.319 Sum_probs=158.4
Q ss_pred cccCCCCccccceeeEEEe------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLE------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||+++++++.. ++..++||||++||+|.+++..... ...+++..++.++.|++.||+|||+.+
T Consensus 65 iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g-- 141 (676)
T 3qa8_A 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR-- 141 (676)
T ss_dssp HHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4678899999999999765 6778999999999999999986432 234888999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCc---eEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh
Q 045989 76 PIYHRDIKSANILLDDKYR---AKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 152 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 152 (295)
|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 142 -IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 142 -IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp -BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred -CccCCCCHHHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 999999999999987664 9999999998654332 2334578999999999999999999999999999999999
Q ss_pred CCCCCcccchhhcc--cH-HHHHHHHHhhchhhhhh----hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 153 GQKPIRLVETEENR--SL-AAYFLQVINENRLFEVL----DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 153 g~~p~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
|..||......... .. ................. ............+..+.+++.+||..||++|||+.++++|
T Consensus 219 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred CCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 99999643211100 00 00000000000000000 0000112233456779999999999999999999986544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=244.60 Aligned_cols=183 Identities=15% Similarity=0.131 Sum_probs=141.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++++++||||+++++++..++..|+||||++|++|.+++... .....+..++.|++.||+|||+++ |+|||
T Consensus 84 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~D 154 (286)
T 3uqc_A 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSI 154 (286)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 367899999999999999999999999999999999999542 355678889999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||+++.++.+||++++ |++ .++.++|||||||++|+|++|+.||....
T Consensus 155 ikp~NIll~~~g~~kl~~~~---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 155 DHPSRVRVSIDGDVVLAYPA---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp CSGGGEEEETTSCEEECSCC---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CCcccEEEcCCCCEEEEecc---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 99999999999999997443 333 36889999999999999999999997543
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
........ . ...... ...........+..+.+++.+||+.||++| |+.++++.|+.....
T Consensus 207 ~~~~~~~~---~-----~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 207 VRSGLAPA---E-----RDTAGQ--PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp BCCCSEEC---C-----BCTTSC--BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cchhhHHH---H-----HHhccC--CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 22100000 0 000000 000011122344568999999999999999 999999999887544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=255.85 Aligned_cols=174 Identities=14% Similarity=0.184 Sum_probs=136.1
Q ss_pred ccEEEEeecCCCCHHHHHhhh---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEee
Q 045989 23 VPLLVYEFIPNGSLHQYIHEQ---TEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISD 99 (295)
Q Consensus 23 ~~~iv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~D 99 (295)
..+++|+++ +++|.+++... ......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEe
Confidence 457788876 67999998522 222335788899999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCcceeeeccccccCCCChhhh----------ccCCCCCCccchhhHHHHHHHHhCCCCCcccchhhcccHH
Q 045989 100 FGTSRSMAVDRTHLTTQVKGTFGYLDPEYF----------QSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLA 169 (295)
Q Consensus 100 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 169 (295)
||+++..... .....| +.|+|||++ .+..++.++|||||||++|+|++|+.||......+...
T Consensus 255 FG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-- 327 (413)
T 3dzo_A 255 FEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-- 327 (413)
T ss_dssp GGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG--
T ss_pred ccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH--
Confidence 9998754332 344567 999999999 55568889999999999999999999996433221100
Q ss_pred HHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 170 AYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
..+.. ....+..+.+++.+||+.||++||++.+++++.
T Consensus 328 -------------~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~ 365 (413)
T 3dzo_A 328 -------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 365 (413)
T ss_dssp -------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred -------------HHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 00110 012235589999999999999999999998874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=252.14 Aligned_cols=178 Identities=16% Similarity=0.133 Sum_probs=133.5
Q ss_pred CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCeEEECCCC------
Q 045989 21 TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLH-SAASIPIYHRDIKSANILLDDKY------ 93 (295)
Q Consensus 21 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh-~~~~~~i~H~dikp~Nill~~~~------ 93 (295)
.+..|+|||||++|++.+.+... .+++..++.++.||+.||+||| +.+ |+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~ 205 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHY 205 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEE
T ss_pred cCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceee
Confidence 67899999999999766666432 4899999999999999999999 899 99999999999999887
Q ss_pred --------------ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHH-HHHHHhCCCCCc
Q 045989 94 --------------RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVV-LVELLTGQKPIR 158 (295)
Q Consensus 94 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~-l~el~~g~~p~~ 158 (295)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred eccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 8999999999865422 236899999999998766 889999998777 777888999974
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA-LELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~-~~l~ 227 (295)
... .............. .............+..+.+||.+||+.| |+.|++ +|.+
T Consensus 279 ~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 279 NVL-----WLHYLTDKMLKQMT----FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHH-----HHHHHHHHHHHTCC----CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred chh-----hhhHHHHhhhhhhc----cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 110 00000111111100 0111122334567778999999999976 999999 7753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=252.59 Aligned_cols=143 Identities=20% Similarity=0.212 Sum_probs=107.0
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|+++ .|+||+++++++++++..||||||++|++|.+++.... +++.. .|+.||+.||+|+|++| |+||
T Consensus 294 ~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~G---IIHR 363 (569)
T 4azs_A 294 FLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQG---FWHD 363 (569)
T ss_dssp HHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTT---CEES
T ss_pred HHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCC---ceec
Confidence 47788 89999999999999999999999999999999998653 36654 47899999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||||+|||++.++.+||+|||+|+....... .....+||+.|+|||++.+ .+..++|+|++|++++++.++..+
T Consensus 364 DIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 364 DVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999999999999999999986544322 2345679999999999976 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=205.50 Aligned_cols=139 Identities=16% Similarity=0.235 Sum_probs=118.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++..++...+..++||||++|++|.+++.. +..++.|++.||+|||+++ |+|||
T Consensus 392 il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrD 456 (540)
T 3en9_A 392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHND 456 (540)
T ss_dssp HHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTT
T ss_pred HHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCC
Confidence 56789999999777777788889999999999999999875 3579999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee------eeccccccCCCChhhhcc--CCCCCCccchhhHHHHHHHHhC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL------TTQVKGTFGYLDPEYFQS--SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g 153 (295)
|||+|||++. .+||+|||+++......... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.+
T Consensus 457 iKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 457 LTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp CCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred CCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 9999999999 99999999998765432211 235579999999999987 6688889999999988888777
Q ss_pred CCCC
Q 045989 154 QKPI 157 (295)
Q Consensus 154 ~~p~ 157 (295)
+.+|
T Consensus 535 r~rY 538 (540)
T 3en9_A 535 RARY 538 (540)
T ss_dssp CSCC
T ss_pred cccc
Confidence 7665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-19 Score=149.74 Aligned_cols=97 Identities=16% Similarity=0.100 Sum_probs=78.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++ | +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||+|||+.+ |+|||
T Consensus 157 ~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrD 218 (282)
T 1zar_A 157 ALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGD 218 (282)
T ss_dssp HHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCC
Confidence 355666 5 677776654 56799999999999988 421 123469999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS 131 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 131 (295)
|||+|||++ ++.+||+|||+++ .+..+.|||.+..
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 999999999 9999999999986 2445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=8.7e-15 Score=121.38 Aligned_cols=88 Identities=23% Similarity=0.260 Sum_probs=67.5
Q ss_pred ccCCCCccc--cceeeEEEeCCccEEEEeecCC-C----CHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCC
Q 045989 3 LSQINHRNV--VKLLGCCLETEVPLLVYEFIPN-G----SLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLH-SAAS 74 (295)
Q Consensus 3 l~~l~Hpni--v~~~~~~~~~~~~~iv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh-~~~~ 74 (295)
|+++.|++| +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 456667654 333332 367899999942 3 77776532 223456789999999999999 888
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCcccc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSRSM 106 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~ 106 (295)
|+||||||+|||++. .++|+|||++...
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.4e-12 Score=111.57 Aligned_cols=86 Identities=14% Similarity=0.142 Sum_probs=63.3
Q ss_pred CCccccceeeEEE------eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 7 NHRNVVKLLGCCL------ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 7 ~Hpniv~~~~~~~------~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
.|+|+++++.... .....+|||||++|++|..+.. . .....++.|++.+|.|||+.| ||||
T Consensus 163 E~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHr 229 (397)
T 4gyi_A 163 EFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHG 229 (397)
T ss_dssp HHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence 3666666653321 1123479999999988755432 1 123467899999999999999 9999
Q ss_pred cCCCCeEEECCCC----------ceEEeeccCccc
Q 045989 81 DIKSANILLDDKY----------RAKISDFGTSRS 105 (295)
Q Consensus 81 dikp~Nill~~~~----------~~kl~Dfg~a~~ 105 (295)
||||.|||++.++ .+.|+||+-+..
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999998766 388999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=4.8e-09 Score=86.68 Aligned_cols=88 Identities=17% Similarity=0.113 Sum_probs=69.6
Q ss_pred CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------
Q 045989 8 HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA-------------- 73 (295)
Q Consensus 8 Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-------------- 73 (295)
|..+.++++++...+..|+||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 139 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRL 139 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHH
Confidence 67788999999998899999999999998876321 1123467889999999999811
Q ss_pred ------------------------------------------CCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 74 ------------------------------------------SIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 74 ------------------------------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
...++|+|++|.||+++....+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 140 AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1238999999999999876666799998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.61 E-value=3.2e-08 Score=85.63 Aligned_cols=92 Identities=17% Similarity=0.243 Sum_probs=71.4
Q ss_pred CccccceeeEEEeC---CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------
Q 045989 8 HRNVVKLLGCCLET---EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA----------- 73 (295)
Q Consensus 8 Hpniv~~~~~~~~~---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~----------- 73 (295)
+..+++++.++... +..++||||++|..+.+.. . ..++...+..++.+++.+|+.||+..
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---L---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---C---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---c---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 45688899988776 4589999999987764311 1 12678888889999999999999731
Q ss_pred --------------------------------------------CCCeEeccCCCCeEEECCCCc--eEEeeccCccc
Q 045989 74 --------------------------------------------SIPIYHRDIKSANILLDDKYR--AKISDFGTSRS 105 (295)
Q Consensus 74 --------------------------------------------~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~ 105 (295)
...++|+|++|.||+++.++. +.|.||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997653 68999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.55 E-value=2.4e-08 Score=84.42 Aligned_cols=136 Identities=18% Similarity=0.209 Sum_probs=86.2
Q ss_pred ccceeeEEEeCC---ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------
Q 045989 11 VVKLLGCCLETE---VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA-------------- 73 (295)
Q Consensus 11 iv~~~~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~-------------- 73 (295)
+.+++....... ..|+||++++|.+|...... .++...+..++.+++..++.||+..
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~ 148 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFRE 148 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHH
Confidence 344444433333 34899999999887654321 2677777888888888888888621
Q ss_pred -----------------------------------------CCCeEeccCCCCeEEECC--CCceEEeeccCccccccCc
Q 045989 74 -----------------------------------------SIPIYHRDIKSANILLDD--KYRAKISDFGTSRSMAVDR 110 (295)
Q Consensus 74 -----------------------------------------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~ 110 (295)
...++|+|++|.||+++. ...+.|+||+.+..... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~ 227 (304)
T 3sg8_A 149 KINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-D 227 (304)
T ss_dssp HHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-T
T ss_pred HHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-H
Confidence 123899999999999998 55678999998754211 0
Q ss_pred ceeeeccccccCC---CChhhhcc--CCC------------CCCccchhhHHHHHHHHhCCCCC
Q 045989 111 THLTTQVKGTFGY---LDPEYFQS--SQF------------TEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 111 ~~~~~~~~gt~~y---~aPE~~~~--~~~------------~~~~DiwslG~~l~el~~g~~p~ 157 (295)
.... ..... ..|+.... ..| ....+.|++|.++|.+.+|..+|
T Consensus 228 ~Dl~----~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 228 NDFI----SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHH----TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHH----HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000 00111 23332211 001 11257899999999999998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-07 Score=77.62 Aligned_cols=82 Identities=17% Similarity=0.213 Sum_probs=61.7
Q ss_pred ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------
Q 045989 11 VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA----------------- 73 (295)
Q Consensus 11 iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~----------------- 73 (295)
+.+++++...++..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~ 144 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERA 144 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Confidence 567888888888899999999998873 211 11 1246677777888888643
Q ss_pred --------------------------------------CCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 74 --------------------------------------SIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 74 --------------------------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 145 RTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.88 E-value=4.5e-05 Score=60.14 Aligned_cols=102 Identities=18% Similarity=0.144 Sum_probs=66.8
Q ss_pred CHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceee
Q 045989 35 SLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT 114 (295)
Q Consensus 35 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 114 (295)
+|.++|..... ++++.++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 79999987655 69999999999999999877632110 11333457899999999988764 1110
Q ss_pred eccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 115 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123456888653 3446777899999999999874443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=3.2e-05 Score=63.79 Aligned_cols=86 Identities=19% Similarity=0.188 Sum_probs=63.6
Q ss_pred ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------
Q 045989 11 VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA----------------- 73 (295)
Q Consensus 11 iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~----------------- 73 (295)
|.++++++...+..++|||+++|.++.+...... .....+..++...|+-||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 6788899999999999999999988877654321 122345556666666666421
Q ss_pred --------------------------------------CCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 74 --------------------------------------SIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 74 --------------------------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
...++|+|+.+.||+++..+.+-|.||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0127999999999999988777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=61.87 Aligned_cols=88 Identities=14% Similarity=0.172 Sum_probs=58.2
Q ss_pred ccceeeEEE-eCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------
Q 045989 11 VVKLLGCCL-ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA---------------- 73 (295)
Q Consensus 11 iv~~~~~~~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~---------------- 73 (295)
|.+++.+.. ..+..++|||+++|..|....-. .++......++.++...|+.||+..
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~ 147 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKN 147 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHH
Confidence 566666664 34567899999999877653211 1344444455555555555555422
Q ss_pred -----------------------------------------CCCeEeccCCCCeEEECC---CCc-eEEeeccCcc
Q 045989 74 -----------------------------------------SIPIYHRDIKSANILLDD---KYR-AKISDFGTSR 104 (295)
Q Consensus 74 -----------------------------------------~~~i~H~dikp~Nill~~---~~~-~kl~Dfg~a~ 104 (295)
...++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 148 KILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 123799999999999987 344 5899998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00023 Score=61.12 Aligned_cols=30 Identities=17% Similarity=0.203 Sum_probs=25.1
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
..++|+|+.|.||++++...+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 349999999999999965457899998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0071 Score=51.16 Aligned_cols=29 Identities=24% Similarity=0.375 Sum_probs=26.1
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 49999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.17 E-value=0.031 Score=46.90 Aligned_cols=28 Identities=18% Similarity=0.125 Sum_probs=23.5
Q ss_pred ccccceeeEEEeCCccEEEEeecCCCCH
Q 045989 9 RNVVKLLGCCLETEVPLLVYEFIPNGSL 36 (295)
Q Consensus 9 pniv~~~~~~~~~~~~~iv~e~~~~g~L 36 (295)
..+.+++.+....+..++||||++|..+
T Consensus 91 v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 91 INVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4678888888888889999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.95 E-value=0.024 Score=49.72 Aligned_cols=29 Identities=14% Similarity=0.277 Sum_probs=25.7
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRS 105 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~ 105 (295)
.++|+|++|.||+++.++ +.|.||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 399999999999998876 99999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.039 Score=45.89 Aligned_cols=28 Identities=32% Similarity=0.274 Sum_probs=23.8
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.+.||+ ..++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 556678999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.47 E-value=0.1 Score=43.92 Aligned_cols=30 Identities=27% Similarity=0.419 Sum_probs=26.0
Q ss_pred CeEeccCCCCeEEECCC----CceEEeeccCccc
Q 045989 76 PIYHRDIKSANILLDDK----YRAKISDFGTSRS 105 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~ 105 (295)
.++|+|+.+.||+++.+ +.+.|.||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999874 6789999997753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.59 E-value=0.042 Score=46.02 Aligned_cols=43 Identities=16% Similarity=0.254 Sum_probs=30.7
Q ss_pred HHHHHHHHHhC----CCCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 62 VSGALSYLHSA----ASIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 62 i~~~l~~Lh~~----~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
+...++.+.+. ....++|+|+++.||+++.+..+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 33445555532 12349999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.47 E-value=0.14 Score=42.86 Aligned_cols=27 Identities=26% Similarity=0.346 Sum_probs=23.8
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+++.||+++ + .+.|.||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 389999999999999 4 89999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.11 E-value=0.18 Score=39.50 Aligned_cols=118 Identities=7% Similarity=0.068 Sum_probs=75.4
Q ss_pred CCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 045989 5 QINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKS 84 (295)
Q Consensus 5 ~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~dikp 84 (295)
...||+.+.. .+-...+.+.+.++.-+ +...+-.-. ..+...++.++..|+....+++. -+|--+.|
T Consensus 41 ~~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 41 EQHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp GSCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred hccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 4467888876 45555665555555433 233332211 27888999999999988866655 46888999
Q ss_pred CeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 85 ANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
+||+++.++.+++.-.|+.-. ++|..+ +...=.-.+=|++..+++++..|.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~------------------l~P~~~-----~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV------------------VDPLPV-----SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT------------------BSCCCC-----CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccC------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987665321 122110 111112256678888888888764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.52 E-value=0.48 Score=37.26 Aligned_cols=83 Identities=8% Similarity=-0.019 Sum_probs=56.8
Q ss_pred CCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeccCCC
Q 045989 6 INHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALS-YLHSAASIPIYHRDIKS 84 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~-~Lh~~~~~~i~H~dikp 84 (295)
-.||++ -..+-.+++.+.+.++.-+++.=...+. ..+...+++++..|+.... +++. -+|--+.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 356776 3333455666666666553332222332 2778889989988887766 5544 56888999
Q ss_pred CeEEECCCCceEEeeccC
Q 045989 85 ANILLDDKYRAKISDFGT 102 (295)
Q Consensus 85 ~Nill~~~~~~kl~Dfg~ 102 (295)
+||+++.++.+++.-.|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp GGEEECTTCCEEESCCEE
T ss_pred ceEEEeCCCcEEEEEcCC
Confidence 999999999999987765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.30 E-value=0.15 Score=43.15 Aligned_cols=29 Identities=24% Similarity=0.424 Sum_probs=26.1
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 49999999999999988889999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.69 E-value=0.12 Score=44.32 Aligned_cols=28 Identities=29% Similarity=0.466 Sum_probs=23.5
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+++.||+++.+. +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 499999999999998654 8999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.67 E-value=0.25 Score=43.81 Aligned_cols=15 Identities=33% Similarity=0.459 Sum_probs=14.1
Q ss_pred CeEeccCCCCeEEEC
Q 045989 76 PIYHRDIKSANILLD 90 (295)
Q Consensus 76 ~i~H~dikp~Nill~ 90 (295)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=89.69 E-value=0.12 Score=45.30 Aligned_cols=17 Identities=35% Similarity=0.624 Sum_probs=14.8
Q ss_pred CeEeccCCCCeEEECCC
Q 045989 76 PIYHRDIKSANILLDDK 92 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~ 92 (295)
.++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 48999999999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=89.23 E-value=0.18 Score=43.53 Aligned_cols=28 Identities=18% Similarity=0.336 Sum_probs=24.2
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.||+++.+ .++|.||..+.
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 39999999999999876 48899998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=88.66 E-value=0.2 Score=43.18 Aligned_cols=29 Identities=34% Similarity=0.422 Sum_probs=25.6
Q ss_pred CeEeccCCCCeEEECCC----CceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDK----YRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~----~~~kl~Dfg~a~ 104 (295)
.++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 49999999999999876 689999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.62 E-value=0.34 Score=42.05 Aligned_cols=28 Identities=36% Similarity=0.539 Sum_probs=24.1
Q ss_pred eEeccCCCCeEEE------CCCCceEEeeccCcc
Q 045989 77 IYHRDIKSANILL------DDKYRAKISDFGTSR 104 (295)
Q Consensus 77 i~H~dikp~Nill------~~~~~~kl~Dfg~a~ 104 (295)
++|+|+.+.||++ +.+..+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 456679999998775
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.38 E-value=0.57 Score=41.01 Aligned_cols=28 Identities=21% Similarity=0.423 Sum_probs=25.0
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 778899999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 295 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-58
Identities = 54/236 (22%), Positives = 102/236 (43%), Gaps = 22/236 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H N++ +G ++ +V ++ SL+ ++H + + IA +
Sbjct: 57 VLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA-VDRTHLTTQVKGT 120
+ + YLH+ I HRD+KS NI L + KI DFG + + +H Q+ G+
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 121 FGYLDPEYFQSSQ---FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
++ PE + ++ +SDVY+FG+VL EL+TGQ P N + + ++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVG 223
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233
L L + + + CL +RP ++ + + S+
Sbjct: 224 RGYLSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-53
Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 36/248 (14%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + N +V G + E + GSL Q + + I +I +++
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIA 112
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V L+YL I HRD+K +NIL++ + K+ DFG S + + GT
Sbjct: 113 VIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTR 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE----------------- 164
Y+ PE Q + ++ +SD++S G+ LVE+ G+ PI + +E
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 165 ------NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAK----RCLNLNGK 214
R L++Y + +FE+LD V K ++ + +CL N
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 215 KRPTMKEV 222
+R +K++
Sbjct: 288 ERADLKQL 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-52
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 21/231 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +++H +V+L G CLE LV+EF+ +G L Y+ Q E LG+ ++
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLD 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V ++YL A + HRD+ + N L+ + K+SDFG +R + D+ +T K
Sbjct: 110 VCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
+ PE F S+++ KSDV+SFGV++ E+ + K ENRS + + RL
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-----ENRSNSEVVEDISTGFRL 221
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
++ + V + C + RP + +LA I S
Sbjct: 222 YK----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-51
Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ Q+ H+ +V+L + + ++ E++ NGSL ++ + +T L +A +
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQ 117
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++++ HRD+++ANIL+ D KI+DFG +R + + K
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
+ PE FT KSDV+SFG++L E++T + + + R+
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLERGYRM 229
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
V E + + + C + RPT + L
Sbjct: 230 --VRPDNCPEELYQ--------LMRLCWKERPEDRPTFDYLRSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-51
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETE--VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L ++ H N+V+ ++ +V E+ G L I + T+++ + E L +
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 60 VEVSGALSYLH--SAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQV 117
+++ AL H S + HRD+K AN+ LD K K+ DFG +R + D +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-F 174
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT Y+ PE + EKSD++S G +L EL P S ++
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIRE 228
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + E + + R LNL RP+++E+
Sbjct: 229 GKFRR--IPYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-50
Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 25/230 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+++Q+ H N+V+LLG +E + L +V E++ GSL Y+ + + + + L ++
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSL 110
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+V A+ YL HRD+ + N+L+ + AK+SDFG ++ + + K
Sbjct: 111 DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLP 163
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
+ PE + +F+ KSDV+SFG++L E+ + + L +V +
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-----YPRIPLKDVVPRVEKGYK 218
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230
+ +A V V K C +L+ RP+ ++ +L I+
Sbjct: 219 M----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 5e-50
Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 22/241 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ +I H N+V+LLG C ++ EF+ G+L Y+ E ++ + L +A +
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS--AVVLLYMATQ 123
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+S A+ YL HRD+ + N L+ + + K++DFG SR M D K
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
+ PE ++F+ KSDV++FGV+L E+ T I+ +++
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQV 225
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI--RASIGASVLR 239
+E+L+ E + V + + C N RP+ E+ + +SI V +
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
Query: 240 Q 240
+
Sbjct: 286 E 286
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-49
Identities = 49/256 (19%), Positives = 97/256 (37%), Gaps = 28/256 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+ H N++ + + LV ++ +GSL Y++ +T E +
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIK 104
Query: 58 IAVEVSGALSYLHSAA-----SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH 112
+A+ + L++LH I HRD+KS NIL+ I+D G +
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 113 L---TTQVKGTFGYLDPEYFQSS------QFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163
+ GT Y+ PE S + +++D+Y+ G+V E+ + E
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 164 E----NRSLAAYFLQVINENRLFEVLDAQVL-REAEKEEVITVAMVAKRCLNLNGKKRPT 218
+ + + ++ + + + L + R E + +A + + C NG R T
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 219 MKEVALELAGIRASIG 234
+ L+ + G
Sbjct: 285 ALRIKKTLSQLSQQEG 300
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-49
Identities = 49/226 (21%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 2 ILSQINHRNVVKLLGCCLET----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+L + H N+V+ T + +LV E + +G+L Y+ + ++
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRS 116
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDK-YRAKISDFGTSRSMAVDRTHLTTQ 116
++ L +LH+ + PI HRD+K NI + KI D G + + R
Sbjct: 117 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA 172
Query: 117 VKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
V GT ++ PE ++ ++ E DVY+FG+ ++E+ T + P AA + +
Sbjct: 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRV 225
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
D + E ++ + + C+ N +R ++K++
Sbjct: 226 TSGVKPASFDKVAIPEVKE--------IIEGCIRQNKDERYSIKDL 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-49
Identities = 46/225 (20%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ ++ H +V+L E + +V E++ GSL ++ +T + + +A +
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQ 121
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ++Y+ HRD+++ANIL+ + K++DFG +R + + K
Sbjct: 122 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
+ PE +FT KSDV+SFG++L EL T + + +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREV 223
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
+ ++ E ++ + +C ++RPT + + L
Sbjct: 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-48
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I S + H N+++L G + L+ E+ P G++++ + + + + E
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITE 114
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
++ ALSY HS + HRDIK N+LL KI+DFG S R + GT
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTL 168
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
YL PE + EK D++S GV+ E L G+ P E + + ++
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANTYQETYKRISRVEFT 222
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F + R+ + R L N +RP ++EV
Sbjct: 223 FPDFVTEGARD-----------LISRLLKHNPSQRPMLREV 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 8e-48
Identities = 50/249 (20%), Positives = 108/249 (43%), Gaps = 39/249 (15%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL------------- 48
++++ ++ N+VKLLG C + L++E++ G L++++ + +
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 49 -------PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101
P++ +L IA +V+ ++YL HRD+ + N L+ + KI+DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 102 TSRSMA-VDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160
SR++ D ++ PE +++T +SDV+++GVVL E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---- 241
Query: 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK 220
+ + +E ++ V D +L + + + + + C + RP+
Sbjct: 242 ----------PYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 221 EVALELAGI 229
+ L +
Sbjct: 291 SIHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-47
Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 25/235 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I+ +H NV+ LLG CL +E PL+V ++ +G L +I +T T + +G +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGL 137
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA---VDRTHLTTQV 117
+V+ + +L S HRD+ + N +LD+K+ K++DFG +R M D H T
Sbjct: 138 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
K ++ E Q+ +FT KSDV+SFGV+L EL+T P + + + ++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQ 249
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
RL + + + V +C + + RP+ E+ ++ I ++
Sbjct: 250 GRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-47
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 27/228 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ Q+++ +V+++G C E E +LV E G L++Y+ + + + + + +
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQ 115
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQ--VKG 119
VS + YL + HRD+ + N+LL ++ AKISDFG S+++ D + Q K
Sbjct: 116 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINE 178
+ PE +F+ KSDV+SFGV++ E + GQKP + +
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY------RGMKGSEVTAMLEKG 226
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
R+ A RE + C + + RP V L L
Sbjct: 227 ERMG--CPAGCPREMYD--------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-47
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ ++H +V+L G C + ++ E++ NG L Y+ E + L + +
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKD 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V A+ YL S HRD+ + N L++D+ K+SDFG SR + D + K
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
+ PE S+F+ KSD+++FGV++ E+ + K + +
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSET 210
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
E + + V + C + +RPT K +
Sbjct: 211 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 7e-47
Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 25/232 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H NV+ L G ++ +++ EF+ NGSL ++ + T +G+
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRG 136
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT----QV 117
++ + YL HRD+ + NIL++ K+SDFG SR + D + T
Sbjct: 137 IAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
K + PE Q +FT SDV+S+G+V+ E+++ + +
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMT 238
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
+ ++ + + + C + RP ++ L +
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-47
Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 26/239 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q+++ +V+L+G C + E +LV E G LH+++ + E I + +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQ 117
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT--TQVKG 119
VS + YL HRD+ + N+LL +++ AKISDFG S+++ D ++ T + K
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINE 178
+ PE +F+ +SDV+S+GV + E L+ GQKP + ++ E + I +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIGASV 237
+ E + E + C + RP V + S+ + V
Sbjct: 228 GKRME-CPPECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 53/244 (21%), Positives = 105/244 (43%), Gaps = 33/244 (13%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ--------------TED 46
+LS + NH N+V LLG C L++ E+ G L ++ + +D
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 47 QLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM 106
+L + E L + +V+ +++L S HRD+ + NILL KI DFG +R +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 107 AVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEEN 165
D + + + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------- 246
Query: 166 RSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225
+ + +++ ++++ + + + + K C + + KRPT K++
Sbjct: 247 -----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 226 LAGI 229
+
Sbjct: 302 IEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 49/247 (19%), Positives = 100/247 (40%), Gaps = 38/247 (15%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQ----------------- 43
+++Q+ +H N+V LLG C + L++E+ G L Y+ +
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 44 --TEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFG 101
ED +T+E L A +V+ + +L HRD+ + N+L+ KI DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 102 TSR-SMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160
+R M+ + + ++ PE +T KSDV+S+G++L E+ +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--- 266
Query: 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK 220
+ + + ++++ + + ++ + C + +KRP+
Sbjct: 267 -----------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 221 EVALELA 227
+ L
Sbjct: 316 NLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-46
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 26/226 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL+ +H N+VKLL ++ EF G++ + E P+T + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQ 118
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
AL+YLH I HRD+K+ NIL K++DFG S + + GT
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTP 174
Query: 122 GYLDPEYFQSSQ-----FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
++ PE + K+DV+S G+ L+E+ + P + L++
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIA 228
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ + K+CL N R T ++
Sbjct: 229 KSEPPTLAQPSRWSSNFKD--------FLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-46
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 23/223 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I +NH NVVK G E + L E+ G L I + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGT 120
+ + YLH I HRDIK N+LLD++ KISDFG + + R L ++ GT
Sbjct: 112 LMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 121 FGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
Y+ PE + +F E DV+S G+VL +L G+ P + S + E
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEK 222
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + ++ + + L N R T+ ++
Sbjct: 223 KTYLNPWKKIDSAPLA--------LLHKILVENPSARITIPDI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-46
Identities = 48/233 (20%), Positives = 104/233 (44%), Gaps = 23/233 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I+ Q +H N+++L G + + +++ E++ NG+L +++ E+ + +G+
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRG 118
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD--RTHLTTQVKG 119
++ + YL + HRD+ + NIL++ K+SDFG SR + D T+ T+ K
Sbjct: 119 IAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
+ PE +FT SDV+SFG+V+ E++T + ++ +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNH 220
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232
+ + ++ + + + +C +RP ++ L + +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-46
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 23/221 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++ + + N+V L L + +V E++ GSL + E + + E
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE 124
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
AL +LHS + HRDIKS NILL K++DFG + +++ +T V GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 180
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
++ PE + K D++S G++ +E++ G+ P N + +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTP 234
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ RCL+++ +KR + KE+
Sbjct: 235 ELQNPEKLSAIFRD--------FLNRCLDMDVEKRGSAKEL 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (386), Expect = 5e-45
Identities = 49/224 (21%), Positives = 81/224 (36%), Gaps = 30/224 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
L ++ H N ++ GC L LV E+ + + P+ +
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHG 123
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L+YLHS + HRD+K+ NILL + K+ DFG++ M GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTP 175
Query: 122 GYLDPEYFQSS---QFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINE 178
++ PE + Q+ K DV+S G+ +EL + P+ + L I +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQ 228
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
N + CL + RPT + +
Sbjct: 229 NESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 5e-45
Identities = 49/226 (21%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+++ +++ +V +LLG CL + V L+ + +P G L Y+ E ++ + L V+
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQ 119
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV-DRTHLTTQVKGT 120
++ ++YL + HRD+ + N+L+ KI+DFG ++ + ++ + K
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
++ E +T +SDV+S+GV + EL+T I +
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASE 221
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
+ +L+ I V M+ +C ++ RP +E+ +E
Sbjct: 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 34/263 (12%)
Query: 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL------------ 48
+L ++ +H N++ LLG C L E+ P+G+L ++ + +
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
++ + L A +V+ + YL HRD+ + NIL+ + Y AKI+DFG SR V
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 109 DRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSL 168
T + ++ E S +T SDV+S+GV+L E+++
Sbjct: 180 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------ 225
Query: 169 AAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228
+ L+E L E V + ++C +RP+ ++ + L
Sbjct: 226 ---PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 229 IRASIGASVLRQC-EEIDFVNYD 250
+ V E+ + D
Sbjct: 283 MLEERKTYVNTTLYEKFTYAGID 305
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-43
Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 22/228 (9%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ Q +H ++VKL+G E V ++ E G L ++ + + + + A +
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQ 116
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+S AL+YL S HRDI + N+L+ K+ DFG SR M + ++ K
Sbjct: 117 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
++ PE +FT SDV+ FGV + E+L + ++ N RL
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERL 228
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
+ + +C + +RP E+ +L+ I
Sbjct: 229 P--MPPNCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-43
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 23/227 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ ++HRN+++L G L + +V E P GSL + + AV+
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQ 119
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKG 119
V+ + YL S HRD+ + N+LL + KI DFG R++ + H + K
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
F + PE ++ F+ SD + FGV L E+ T + + + ++ E
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEG 231
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
++ V +C + RPT + L
Sbjct: 232 ERLP-RPEDCPQDIYN--------VMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-42
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++S+++H VKL + E + NG L +YI + E
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAE 116
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVD-RTHLTTQVKGT 120
+ AL YLH I HRD+K NILL++ +I+DFGT++ ++ + + GT
Sbjct: 117 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y+ PE + SD+++ G ++ +L+ G P R + F ++I
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEY 227
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F + +A + ++ L L+ KR +E+
Sbjct: 228 DF---PEKFFPKARD--------LVEKLLVLDATKRLGCEEM 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-41
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 31/243 (12%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGSLHQYIHEQTEDQLP---------- 49
I++ +H NVV LLG C + PL ++ EF G+L Y+ + + +P
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 50 --ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMA 107
+T E + + +V+ + +L S HRD+ + NILL +K KI DFG +R +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 108 VDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENR 166
D ++ + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGV 240
Query: 167 SLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226
+ F + + E D E + C + +RPT E+ L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPD-YTTPEMYQ--------TMLDCWHGEPSQRPTFSELVEHL 291
Query: 227 AGI 229
+
Sbjct: 292 GNL 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 141 bits (356), Expect = 5e-41
Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 27/236 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLG 57
+ +NH +V + +P +V E++ +L +H + P+T + +
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIE 115
Query: 58 IAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TT 115
+ + AL++ H I HRD+K ANI++ K+ DFG +R++A + T
Sbjct: 116 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQV 175
V GT YL PE + +SDVYS G VL E+LTG+ P S + Q
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQH 226
Query: 176 INENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-TMKEVALELAGIR 230
+ E+ + + L V + L N + R T E+ +L +
Sbjct: 227 VREDPIPPSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (361), Expect = 6e-41
Identities = 41/223 (18%), Positives = 85/223 (38%), Gaps = 23/223 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+S + H +V L + +++YEF+ G L + + ++ ++ + + +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQ 132
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKY--RAKISDFGTSRSMAVDRTHLTTQVKG 119
V L ++H H D+K NI+ K K+ DFG + + ++ T G
Sbjct: 133 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TG 187
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
T + PE + +D++S GV+ LL+G P + V + +
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF------GGENDDETLRNVKSCD 241
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + E K+ ++ L + R T+ +
Sbjct: 242 WNMDDSAFSGISEDGKD-------FIRKLLLADPNTRMTIHQA 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 2e-40
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
IL +++ H N+++L LV++ + G L Y+ E+ ++ + I
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMR 117
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
+ + LH I HRD+K NILLDD K++DFG S + D +V GT
Sbjct: 118 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGT 172
Query: 121 FGYLDPEYFQSSQ------FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
YL PE + S + ++ D++S GV++ LL G P +R
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRM 226
Query: 175 VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+++ N F + + K+ + R L + +KR T +E
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-40
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 27/225 (12%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL+ HRN++ L E ++++EFI + + I+ + + +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDK--YRAKISDFGTSRSMAVDRTHLTTQVKG 119
V AL +LHS I H DI+ NI+ + KI +FG +R +
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--T 165
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
Y PE Q + +D++S G ++ LL+G P FL N+
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FLAETNQQ 210
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVA--KRCLNLNGKKRPTMKEV 222
+ +++A+ + E + I++ + R L K R T E
Sbjct: 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-40
Identities = 50/235 (21%), Positives = 97/235 (41%), Gaps = 25/235 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIH------EQTEDQLPITWEIR 55
++ + N +VV+LLG + + L++ E + G L Y+ P +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM-AVDRTHLT 114
+ +A E++ ++YL++ HRD+ + N ++ + + KI DFG +R + D
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
+ ++ PE + FT SDV+SFGVVL E+ T + Q
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---------------PYQ 237
Query: 175 VINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229
++ ++ + L + + + + C N K RP+ E+ +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-39
Identities = 53/244 (21%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQL------------ 48
++ H+N++ LLG C + ++ E+ G+L +Y+ + L
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 49 PITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAV 108
++ + + A +V+ + YL S HRD+ + N+L+ + KI+DFG +R +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 109 DRTHLTTQVK-GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRS 167
+ T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----------- 236
Query: 168 LAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227
+ LF++L + + M+ + C + +RPT K++ +L
Sbjct: 237 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 228 GIRA 231
I A
Sbjct: 293 RIVA 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 3e-39
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 19/221 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L +I H N+V L L+ + + G L I E+ T + +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQ 115
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
V A+ YLH + + LD+ + ISDFG S+ D + + GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTP 173
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENRL 181
GY+ PE +++ D +S GV+ LL G P + + A F Q++
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKAEYE 227
Query: 182 FEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F+ + ++ K+ + + + +KR T ++
Sbjct: 228 FDSPYWDDISDSAKD-------FIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 1e-38
Identities = 54/290 (18%), Positives = 99/290 (34%), Gaps = 34/290 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I++Q++H ++ L + +L+ EF+ G L I + ++ + +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQ 135
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLD--DKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
L ++H I H DIK NI+ + KI DFG + + + +
Sbjct: 136 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTA 190
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINEN 179
T + PE +D+++ GV+ LL+G P V +
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF------AGEDDLETLQNVKRCD 244
Query: 180 RLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE---LAGIRASIGAS 236
F+ + K+ K L +KR T+ + ALE L G +++
Sbjct: 245 WEFDEDAFSSVSPEAKD-------FIKNLLQKEPRKRLTVHD-ALEHPWLKGDHSNLT-- 294
Query: 237 VLRQCEEIDFVNYDNARHFKTGSSSTGSFFNSYSSSLRNLSNRESMEPQD 286
I Y+ R + + N S+ PQ+
Sbjct: 295 -----SRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQE 339
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-35
Identities = 50/225 (22%), Positives = 83/225 (36%), Gaps = 25/225 (11%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++ H + + E V E++ G L +I A
Sbjct: 55 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAA 110
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ L +LHS I +RD+K NILLD KI+DFG + + T GT
Sbjct: 111 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GT 166
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y+ PE ++ D +SFGV+L E+L GQ P + F + +N
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSIRMDNP 220
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225
+ + +EA+ + + +KR ++ +
Sbjct: 221 FY---PRWLEKEAKD--------LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 45/233 (19%), Positives = 82/233 (35%), Gaps = 17/233 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQ--YIHEQTEDQLPITWEIRLGIA 59
L H NVV+L C + + + Q + + + E +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKG 119
++ L +LHS + HRD+K NIL+ + K++DFG +R + T V
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV 177
Query: 120 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI----------RLVETEENRSLA 169
T Y PE S + D++S G + E+ + ++++
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 170 AYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ V + F AQ + + + + +CL N KR +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (314), Expect = 4e-34
Identities = 45/225 (20%), Positives = 85/225 (37%), Gaps = 25/225 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
++S + +V + + + + + G LH ++ + I +
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL- 118
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L ++H+ + +RD+K ANILLD+ +ISD G + + + H GT
Sbjct: 119 ---GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 169
Query: 122 GYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
GY+ PE Q + +D +S G +L +LL G P R +T++ + L + E
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-- 227
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225
L E + + L + +R +
Sbjct: 228 ----LPDSFSPELRS--------LLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 44/233 (18%), Positives = 78/233 (33%), Gaps = 20/233 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L +++H N++ LL LV++F+ L
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT--- 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L L I HRD+K N+LLD+ K++DFG ++S T QV T
Sbjct: 110 ----LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTR 164
Query: 122 GYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y PE ++ + D+++ G +L ELL + + + L E +
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224
Query: 181 LFEVLDAQVLREAEKEEVITVAMVA-----------KRCLNLNGKKRPTMKEV 222
++ + I + + + N R T +
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 46/229 (20%), Positives = 83/229 (36%), Gaps = 23/229 (10%)
Query: 1 IILSQINHRNVVKLLGCC----LETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRL 56
+ ++V+++ + L+V E + G L I ++ + T
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREAS 114
Query: 57 GIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKY---RAKISDFGTSRSMAVDRTHL 113
I + A+ YLHS I HRD+K N+L K K++DFG ++ +
Sbjct: 115 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171
Query: 114 TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFL 173
T T Y+ PE ++ + D++S GV++ LL G P
Sbjct: 172 TPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY--SNHGLAISPGMKT 227
Query: 174 QVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ F + + E K + + L +R T+ E
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (304), Expect = 3e-33
Identities = 41/233 (17%), Positives = 87/233 (37%), Gaps = 19/233 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL ++ H N+VKL + +LV+E + + + ++
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQ 108
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ ++Y H + HRD+K N+L++ + KI+DFG +R+ + T ++ +
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP------------IRLVETEENRSLA 169
S +++ D++S G + E++ G I + N
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 170 AYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ + F V + K + + + L L+ +R T K+
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-33
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 26/225 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL +I H NV+ L +L+ E + G L ++ E+ +T E +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQ 121
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDD----KYRAKISDFGTSRSMAVDRTHLTTQV 117
+ + YLHS I H D+K NI+L D K R KI DFG + + D + +
Sbjct: 122 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 176
Query: 118 KGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT ++ PE ++D++S GV+ LL+G P + V
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------LGDTKQETLANVSA 230
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
N FE K+ +R L + KKR T+++
Sbjct: 231 VNYEFEDEYFSNTSALAKD-------FIRRLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 5e-33
Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 28/225 (12%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
++LS + H ++++ G + + ++ ++I G L + + + A
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAA 111
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
EV AL YLHS I +RD+K NILLD KI+DFG ++ + +T + GT
Sbjct: 112 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGT 164
Query: 121 FGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINENR 180
Y+ PE + + + D +SFG+++ E+L G P + + + +++N
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF------YDSNTMKTYEKILNAEL 218
Query: 181 LFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225
F E K+ + R + + +R + E
Sbjct: 219 RFP----PFFNEDVKDLL-------SRLITRDLSQRLGNLQNGTE 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-32
Identities = 43/233 (18%), Positives = 88/233 (37%), Gaps = 18/233 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L ++NH N+VKLL LV+EF + L +++ +P + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIP--LPLIKSYLFQ 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L++ HS + HRD+K N+L++ + K++DFG +R+ V T +V +
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP------------IRLVETEENRSLA 169
++ D++S G + E++T + I + +
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 170 AYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + F Q + + + L+ + KR + K
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-31
Identities = 38/234 (16%), Positives = 80/234 (34%), Gaps = 20/234 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L ++ H+N+V+L + LV+EF + + I +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL--- 110
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
L L S + HRD+K N+L++ K+++FG +R+ + + +V +
Sbjct: 111 ----LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-------------IRLVETEENRSL 168
F + ++ D++S G + EL +P I +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 169 AAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
++ + L + T + + L N +R + +E
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 3e-30
Identities = 40/230 (17%), Positives = 72/230 (31%), Gaps = 24/230 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
I + + + C ++ + SL + + + + L +A +
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQ 111
Query: 62 VSGALSYLHSAASIPIYHRDIKSANIL---LDDKYRAKISDFGTSRSMAVDRTH------ 112
+ + Y+HS HRD+K N L I DFG ++ RTH
Sbjct: 112 MISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168
Query: 113 LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYF 172
+ GT Y + + + D+ S G VL+ G P + ++ R
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ + EVL E C +L +P +
Sbjct: 229 SEKKMSTPI-EVLCKGYPSEFAT--------YLNFCRSLRFDDKPDYSYL 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-30
Identities = 45/238 (18%), Positives = 89/238 (37%), Gaps = 21/238 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL + H N++ + + + ++ + +++ + Q ++ + +
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQ 117
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLT--TQVKG 119
+ L Y+HSA + HRD+K +N+LL+ KI DFG +R D H T+
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 120 TFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIR--------------LVETEE 164
T Y PE +S+ +T+ D++S G +L E+L+ + L +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 165 NRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
L+ N + + + L N KR +++
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-30
Identities = 52/240 (21%), Positives = 89/240 (37%), Gaps = 24/240 (10%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP------LLVYEFIPNGSLHQYIHEQTEDQLPITWEIR 55
I+ +++H N+V+L + LV +++P H Q +
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYV 124
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLT 114
++ +L+Y+HS I HRDIK N+LLD D K+ DFG+++ + V
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV 180
Query: 115 TQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQ 174
+ + + F ++ +T DV+S G VL ELL GQ + L
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240
Query: 175 VINENRL-----------FEVLDAQVLREAEKEEVITVAM-VAKRCLNLNGKKRPTMKEV 222
++ F + A + + A+ + R L R T E
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-29
Identities = 47/225 (20%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 2 ILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIA 59
+L +++ V++LL + +L+ E + + + E+
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFF 116
Query: 60 VEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVK 118
+V A+ + H+ + HRDIK NIL+D ++ K+ DFG+ + + + T
Sbjct: 117 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFD 170
Query: 119 GTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVIN 177
GT Y PE+ + ++ + V+S G++L +++ G P E ++I
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR 218
Query: 178 ENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
F +V E + + + CL L RPT +E+
Sbjct: 219 GQVFF---RQRVSSECQH--------LIRWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 5e-29
Identities = 44/248 (17%), Positives = 93/248 (37%), Gaps = 34/248 (13%)
Query: 2 ILSQINHRNVVKLLGCCLETEVP--------LLVYEFIPNGSLHQYIHEQTEDQLPITWE 53
IL + H NVV L+ C P LV++F + + + L
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 54 IRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-- 111
+ + L+ L+ I HRD+K+AN+L+ K++DFG +R+ ++ +
Sbjct: 122 VMQML-------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 112 -HLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKP--------IRLVE 161
+ T T Y PE + + D++ G ++ E+ T +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVA-------KRCLNLNGK 214
++ S+ ++ L+E L+ ++ + ++ + + + L L+
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 215 KRPTMKEV 222
+R +
Sbjct: 295 QRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 6e-28
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 8/155 (5%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L H + L + V E+ G L ++ + T E E
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAE 113
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ AL YLHS + +RDIK N++LD KI+DFG + D + T GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
YL PE + + + D + GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-27
Identities = 43/235 (18%), Positives = 89/235 (37%), Gaps = 20/235 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H NV+ LL E +F + + + + +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L Y+H+A I HRD+K N+ +++ KI DFG +R + +T V +
Sbjct: 130 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRW 183
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEE--------NRSLAAYFL 173
++T+ D++S G ++ E++TG+ + + + + A F+
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 174 QVINENRLFEVLDAQVLREAEKEEVITVAM------VAKRCLNLNGKKRPTMKEV 222
Q + + + E + I + ++ L L+ ++R T E
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (260), Expect = 6e-27
Identities = 29/232 (12%), Positives = 66/232 (28%), Gaps = 26/232 (11%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+ + + + + ++ + SL + + + A +
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQ 109
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYR-----AKISDFGTSRSMAVDRT----- 111
+ + +H + +RDIK N L+ + DFG + T
Sbjct: 110 MLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 112 -HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAA 170
+ GT Y+ + + + D+ + G V + L G P + + +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW---QGLKAATNKQ 223
Query: 171 YFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222
+ ++ + + LRE NL P +
Sbjct: 224 KYERIGEKKQSTP------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (254), Expect = 9e-26
Identities = 44/249 (17%), Positives = 88/249 (35%), Gaps = 42/249 (16%)
Query: 2 ILSQIN-HRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGI 58
IL + N++ L + + P LV+E + N Q T+ +
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-------RFY 134
Query: 59 AVEVSGALSYLHSAASIPIYHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQV 117
E+ AL Y HS I HRD+K N+++D + + ++ D+G + + +
Sbjct: 135 MYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVR 189
Query: 118 KGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVI 176
+ + PE Q + D++S G +L ++ ++P +N +V+
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVRIAKVL 247
Query: 177 NENRLFEVLDAQVLREAEKEEVITVAMVAK-----------------------RCLNLNG 213
L++ +D + + I K + L +
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307
Query: 214 KKRPTMKEV 222
+ R T +E
Sbjct: 308 QSRLTAREA 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (253), Expect = 1e-25
Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 11/155 (7%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
IL +N +VKL + +V E++ G + ++ + A +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQ 149
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ YLHS + +RD+K N+L+D + +++DFG A T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTP 202
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156
L PE S + + D ++ GV++ E+ G P
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 5e-24
Identities = 53/223 (23%), Positives = 83/223 (37%), Gaps = 27/223 (12%)
Query: 2 ILSQINHR-NVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
+L I +V L L+ ++I G L ++ ++ T
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVG 136
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGT 120
E+ AL +LH I +RDIK NILLD ++DFG S+ D T GT
Sbjct: 137 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 121 FGYLDPEYFQSSQ--FTEKSDVYSFGVVLVELLTGQKPIRLVETEENRSLAAYFLQVINE 178
Y+ P+ + + D +S GV++ ELLTG P F +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---------------FTVDGEK 238
Query: 179 NRLFEVLDAQVLREAEKEEVITVAMVA--KRCLNLNGKKRPTM 219
N E+ + E + ++ +R L + KKR
Sbjct: 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 2e-22
Identities = 50/252 (19%), Positives = 92/252 (36%), Gaps = 43/252 (17%)
Query: 2 ILSQINHRNVVKLLGCCL------ETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIR 55
++ +NH+N++ LL E + LV E + E +++
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM------- 121
Query: 56 LGIAVEVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTT 115
+ ++ + +LHS I HRD+K +NI++ KI DFG +R+ + + T
Sbjct: 122 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMT 176
Query: 116 QVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP---------------IRLV 160
T Y PE + E D++S G ++ E++ +
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 161 ETEENRSLAAYFLQVINENRL------FEVLDAQVLREAEKEEVITVAMVAK----RCLN 210
E ++ ENR F L L A+ E A A+ + L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 211 LNGKKRPTMKEV 222
++ KR ++ +
Sbjct: 297 IDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 7e-21
Identities = 45/235 (19%), Positives = 85/235 (36%), Gaps = 20/235 (8%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVE 61
+L + H NV+ LL + L +T + + +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTF 121
+ L Y+HSA I HRD+K +N+ +++ KI DFG +R +T V +
Sbjct: 130 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRW 183
Query: 122 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP---------IRLVETEENRSLAAYF 172
+ + D++S G ++ ELLTG+ ++L+ A
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 173 LQVINENRLFEVLDAQVLREAEKEEVITVAMVA-----KRCLNLNGKKRPTMKEV 222
++ +E+ + + + V A ++ L L+ KR T +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.8 bits (198), Expect = 5e-18
Identities = 48/270 (17%), Positives = 82/270 (30%), Gaps = 55/270 (20%)
Query: 2 ILSQINHRNVVKLLGCCLETEVPLLVY--EFIPNGSLHQYIHE----------QTEDQLP 49
+L ++N + K + LL + PNG + E + +
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 50 ITWEIRLGIAVEVSGALSYLHSAASIPIYHRDIKSANILLD------DKYRAKISDFGTS 103
I I+ ++ L Y+H I H DIK N+L++ + + KI+D G +
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 104 RSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVETE 163
T+ T Y PE + + +D++S ++ EL+TG E
Sbjct: 180 CWYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235
Query: 164 ------------------------ENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVI 199
N F R L L + E+
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
Query: 200 TVAMVA-------KRCLNLNGKKRPTMKEV 222
A L L+ +KR +
Sbjct: 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 49.4 bits (117), Expect = 6e-08
Identities = 18/106 (16%), Positives = 38/106 (35%), Gaps = 11/106 (10%)
Query: 1 IILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAV 60
I ++ R + KL G + Y + N L + I + ++ + +
Sbjct: 58 IRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLD 110
Query: 61 EVSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSM 106
+ ++ + I H D+ N+L+ + I DF S +
Sbjct: 111 MILEEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 88.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 82.97 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=335.48 Aligned_cols=200 Identities=28% Similarity=0.402 Sum_probs=169.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrD 131 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRD 131 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeee
Confidence 5788999999999999999999999999999999999998654 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||....
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eccccceecCCCCEeecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999997654332 334579999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
....+..+..... ..+...+..+.+++.+||+.||++|||++|+++|.+-
T Consensus 209 ------~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 209 ------YQETYKRISRVEF-----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp ------HHHHHHHHHTTCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred ------HHHHHHHHHcCCC-----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 2222222222110 1122344568899999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=337.54 Aligned_cols=209 Identities=28% Similarity=0.465 Sum_probs=160.6
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++..++..++|||||++|+|.+++..... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~~---iiHrD 126 (263)
T d1sm2a_ 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 126 (263)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTT
T ss_pred HHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhccc---eeecc
Confidence 46789999999999999999999999999999999999876433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhC-CCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTG-QKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............||+.|+|||++.+..|+.++|||||||++|||+++ .+||...
T Consensus 127 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp CSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred cchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999987655444444456789999999999999999999999999999999995 5555422
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
. .......+.... ....+...+..+.+++.+||+.||++|||+++|+++|+.+.++
T Consensus 207 ~------~~~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 207 S------NSEVVEDISTGF----------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp C------HHHHHHHHHHTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------HHHHHHHHHhcC----------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 2 122222222211 1112233445689999999999999999999999999987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=337.51 Aligned_cols=215 Identities=25% Similarity=0.419 Sum_probs=166.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+ +..++|||||+||+|.+++..... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrD 129 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129 (276)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCC---Eeccc
Confidence 5789999999999998754 568999999999999999975433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+|||++.++.+||+|||+++...... ........||+.|+|||++.+ ..|+.++|||||||++|||++|+.||
T Consensus 130 lKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp CCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999998654322 223445679999999999864 35789999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhhc
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASIG 234 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~~ 234 (295)
....... .+.......... ......+..++..+.+++.+||+.||++|||+++|+++|+.++++++
T Consensus 210 ~~~~~~~------~~~~~~~~~~~~-----p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 210 SNINNRD------QIIFMVGRGYLS-----PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp TTCCCHH------HHHHHHHHTSCC-----CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCChHH------HHHHHHhcCCCC-----CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 6432211 111111111100 01112233445679999999999999999999999999998877653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=340.64 Aligned_cols=208 Identities=25% Similarity=0.412 Sum_probs=157.3
Q ss_pred cccCCCCccccceeeEEEe--CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCe
Q 045989 2 ILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAAS--IPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~--~~i 77 (295)
+|++++|||||++++++.+ ++.+|+|||||+||+|.+++......+..+++..++.++.|++.||+|||+.+. .+|
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 5789999999999999964 456899999999999999997654444469999999999999999999998651 239
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus 136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp ----CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EeCcCchhhcCcCCCCcEEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 999999999999999999999999998764332 2234567999999999999999999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALEL 226 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l 226 (295)
...... .....+.... ....+...+..+.+++.+||+.||.+|||+.|+++|.
T Consensus 215 ~~~~~~------~~~~~i~~~~----------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 215 TAFSQK------ELAGKIREGK----------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp CCSSHH------HHHHHHHHTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CCCCHH------HHHHHHHcCC----------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 643222 2222222111 1122233455699999999999999999999998875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-50 Score=340.26 Aligned_cols=208 Identities=24% Similarity=0.420 Sum_probs=162.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++..++..++|||||++|+|.+++..... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~---iiHrD 153 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMN---YVHRD 153 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCC---CccCc
Confidence 57899999999999999999999999999999999998876433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee----eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL----TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p 156 (295)
|||+||||+.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 99999999999999999999998664432211 222457899999999999999999999999999999998 8999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
|...... .....+... ...+.+...+..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 234 f~~~~~~------~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 234 YWDMTNQ------DVINAIEQD----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTTCCHH------HHHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHH------HHHHHHHcC----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 8643322 222222211 1112233455679999999999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=334.98 Aligned_cols=204 Identities=24% Similarity=0.359 Sum_probs=168.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..|+|||||+||+|.+++... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrD 141 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 578899999999999999999999999999999999988654 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||....
T Consensus 142 iKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcHHHeEECCCCcEeeccchhheeecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999998764432 22345579999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
.. ............. ...+...+..+.++|.+||+.||.+|||+.|+++|.+-
T Consensus 221 ~~------~~~~~~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 221 PL------RALYLIATNGTPE--------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp HH------HHHHHHHHHCSCC--------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred HH------HHHHHHHhCCCCC--------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 21 1222222211100 01122344568999999999999999999999988653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=337.52 Aligned_cols=205 Identities=27% Similarity=0.384 Sum_probs=166.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrD 128 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 128 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCc
Confidence 5789999999999999999999999999999999999986533 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 129 iKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987644332 22345679999999999988776 5789999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
..... ............ .......+..+.+|+.+||+.||++|||++|+++|.|
T Consensus 209 ~~~~~-----~~~~~~~~~~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 209 PSDSC-----QEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp SSTTS-----HHHHHHHTTCTT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CChHH-----HHHHHHhcCCCC---------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 33221 111111111110 1111223456889999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=334.69 Aligned_cols=209 Identities=26% Similarity=0.411 Sum_probs=172.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++++|.+++..++|||||++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrD 140 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 140 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC---cccCc
Confidence 57889999999999999999999999999999999999976433 25899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||||+.++.+||+|||+++..............|++.|+|||++.+..|+.++|||||||++|||++|..|+....
T Consensus 141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp CSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999998776555555555678999999999999999999999999999999999766653221
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
..... .+.+.. ......+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 221 -----~~~~~-~~~i~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 221 -----DLSQV-YELLEK---------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -----CHHHH-HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----hHHHH-HHHHhc---------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11111 111111 1112223345567999999999999999999999999887653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=331.16 Aligned_cols=204 Identities=27% Similarity=0.426 Sum_probs=166.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|+|.. +..++|||||++|+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 61 il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrD 132 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRD 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCC
Confidence 5789999999999999965 56789999999999999997644 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+|||++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 99999999999999999999998765443322 234568999999999999999999999999999999998 899997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
..... .....+... .....+..++..+.+|+.+||+.||++|||+.+|.+.|+..
T Consensus 213 ~~~~~------~~~~~i~~~----------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 213 GMKGS------EVTAMLEKG----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCHH------HHHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHH------HHHHHHHcC----------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 43322 112222111 11223334556799999999999999999999998888664
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=333.27 Aligned_cols=209 Identities=28% Similarity=0.442 Sum_probs=170.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++.. +..|+|||||++|+|.+++..... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 62 il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrD 134 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRD 134 (285)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCc
Confidence 5788999999999999865 568999999999999999865433 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCccee--eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHL--TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 99999999999999999999998765433322 233468999999999999999999999999999999998 999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHhh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRASI 233 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~~ 233 (295)
.....+ ....+... .....+...+..+.+|+.+||+.||++|||+.+|++.|+.....+
T Consensus 215 ~~~~~~------~~~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 215 KMKGPE------VMAFIEQG----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCCTHH------HHHHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHH------HHHHHHcC----------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 443221 12222111 112233445567999999999999999999999999988765443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=338.32 Aligned_cols=218 Identities=25% Similarity=0.388 Sum_probs=166.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~ 80 (295)
+|++++|||||+++++|.+++..|+|||||+||+|.+++.+.. .+++..++.++.|++.||.|||+ ++ |+||
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHR 129 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHR 129 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcc
Confidence 6899999999999999999999999999999999999998654 48999999999999999999997 48 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
||||+|||++.++.+||+|||+|+...... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 130 DiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ccCHHHeeECCCCCEEEeeCCCccccCCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999998654322 33457999999999999999999999999999999999999999754
Q ss_pred chhhcccH--HHHH---------------------HHHHhhchhhhhhhhhhh----hhhhHHHHHHHHHHHHHhhccCC
Q 045989 161 ETEENRSL--AAYF---------------------LQVINENRLFEVLDAQVL----REAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 161 ~~~~~~~~--~~~~---------------------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p 213 (295)
...+.... .... ..........+....... .......+..+.+++.+||+.||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 286 (322)
T d1s9ja_ 207 DAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286 (322)
T ss_dssp CTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCCh
Confidence 32211000 0000 000000000000000000 00001124568999999999999
Q ss_pred CCCCCHHHHHHHHHHh
Q 045989 214 KKRPTMKEVALELAGI 229 (295)
Q Consensus 214 ~~Rps~~e~~~~l~~~ 229 (295)
++|||++|+++|.+-.
T Consensus 287 ~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 287 AERADLKQLMVHAFIK 302 (322)
T ss_dssp TTSCCHHHHHTSHHHH
T ss_pred hHCcCHHHHhhCHhhC
Confidence 9999999999997653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=338.75 Aligned_cols=209 Identities=25% Similarity=0.472 Sum_probs=169.6
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC-------------------CCCCCHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED-------------------QLPITWEIRLGIAVE 61 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~q 61 (295)
+|+++ +|||||++++++.+.+..++|||||++|+|.+++...... ...+++..++.++.|
T Consensus 93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 172 (325)
T d1rjba_ 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172 (325)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred HHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHH
Confidence 35566 8999999999999999999999999999999999764321 234899999999999
Q ss_pred HHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccc
Q 045989 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 62 i~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
|+.||+|||+++ |+||||||+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++||
T Consensus 173 i~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di 249 (325)
T d1rjba_ 173 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249 (325)
T ss_dssp HHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceec
Confidence 999999999999 999999999999999999999999999866544332 3345568999999999999999999999
Q ss_pred hhhHHHHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 141 YSFGVVLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 141 wslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
|||||++|||++ |..||....... .+....... ...+.+...+..+.+||.+||+.||++|||+
T Consensus 250 wS~Gvil~emlt~g~~Pf~~~~~~~------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPGIPVDA------NFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cchhHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999998 899996433221 122222211 1112233455679999999999999999999
Q ss_pred HHHHHHHHH
Q 045989 220 KEVALELAG 228 (295)
Q Consensus 220 ~e~~~~l~~ 228 (295)
+||+++|..
T Consensus 315 ~ei~~~L~~ 323 (325)
T d1rjba_ 315 PNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhC
Confidence 999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=324.35 Aligned_cols=203 Identities=23% Similarity=0.435 Sum_probs=161.8
Q ss_pred cccCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+|++++|||||++++++.. +..+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ .+|
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~I 135 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPI 135 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 5789999999999999975 346799999999999999998754 4899999999999999999999986 349
Q ss_pred EeccCCCCeEEEC-CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 78 YHRDIKSANILLD-DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 78 ~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCC
Confidence 9999999999996 5789999999999754332 2345679999999999875 599999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..... .......+..... ....+...+..+.+++.+||+.||++|||+.|+++|.+
T Consensus 212 f~~~~~-----~~~~~~~i~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 212 YSECQN-----AAQIYRRVTSGVK---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp TTTCSS-----HHHHHHHHTTTCC---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCccc-----HHHHHHHHHcCCC---------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 963221 1122222222111 01112223445889999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=331.65 Aligned_cols=205 Identities=25% Similarity=0.336 Sum_probs=165.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..++|||||+||+|.+++..... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrD 135 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDNK---IIHRD 135 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEee
Confidence 57889999999999999999999999999999999999876433 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhc-----cCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQ-----SSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++. +..|+.++|||||||++|+|++|+.|
T Consensus 136 iKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P 214 (288)
T d2jfla1 136 LKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred cChhheeECCCCCEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence 99999999999999999999997543221 1233457999999999984 45688999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|......+ .+..+...... ....+...+..+.+||.+||+.||.+|||+.|+++|.+
T Consensus 215 f~~~~~~~------~~~~i~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 215 HHELNPMR------VLLKIAKSEPP--------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp TTTSCGGG------HHHHHHHSCCC--------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred CCCCCHHH------HHHHHHcCCCC--------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 96433222 12222221110 01112234556899999999999999999999988754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=325.54 Aligned_cols=205 Identities=25% Similarity=0.417 Sum_probs=171.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|+|.+++..++||||+++|+|..++..... .+++..++.++.|+++||+|||+.+ |+|||
T Consensus 52 ~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~d 125 (258)
T d1k2pa_ 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRD 125 (258)
T ss_dssp HHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSC
T ss_pred HHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhcC---ccccc
Confidence 57789999999999999999999999999999999999876544 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 126 lk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp CSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 99999999999999999999998765544444445678999999999999999999999999999999998 89999744
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... .....+.... ....+...+..+.+++.+||+.||++|||+.+++++|..
T Consensus 206 ~~~------~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 206 TNS------ETAEHIAQGL----------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CHH------HHHHHHHhCC----------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 332 2222222211 112223344579999999999999999999999999853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=328.56 Aligned_cols=207 Identities=23% Similarity=0.365 Sum_probs=166.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++. ++..++|||||++|+|.+++...... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 61 ~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~--~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrD 134 (272)
T d1qpca_ 61 LMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134 (272)
T ss_dssp HHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHH--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCc
Confidence 578899999999999875 45779999999999999987654322 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC-Cccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP-IRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~~ 160 (295)
|||+||||+.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|..| +...
T Consensus 135 iKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999987765544444556789999999999988999999999999999999996554 4322
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
. .......+.... ....+...+..+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 215 ~------~~~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 215 T------NPEVIQNLERGY----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp C------HHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C------HHHHHHHHHhcC----------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2 111222221111 11222334556899999999999999999999999988654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=331.68 Aligned_cols=204 Identities=25% Similarity=0.325 Sum_probs=156.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..|+|||||+||+|.+++.... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 132 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG---IVHRD 132 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEE
Confidence 5789999999999999999999999999999999999997543 4999999999999999999999999 99999
Q ss_pred CCCCeEEEC---CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLD---DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+||++. .++.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.
T Consensus 133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp CCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccceeecccCCCceEEEeccceeEEccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 999999995 5789999999999855432 22344579999999999999999999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.... ......+....... ........+..+.+++.+||+.||++|||+.|+++|.+
T Consensus 211 ~~~~------~~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 211 DEND------AKLFEQILKAEYEF-------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp CSSH------HHHHHHHHTTCCCC-------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred CCCH------HHHHHHHhccCCCC-------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 3322 22222222221100 01112234456899999999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=330.43 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=165.5
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++||||+++++++.+++..|+|||||+||+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 133 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRD 133 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCc
Confidence 5788999999999999999999999999999999999988665 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCc-ceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDR-THLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||...
T Consensus 134 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 99999999999999999999998765432 22334557999999999999999999999999999999999999999643
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
. ....+..+..... ..+...+..+.+||.+||+.||++|||++|++.+.+
T Consensus 214 ~------~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 214 N------EYLIFQKIIKLEY-----------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp S------HHHHHHHHHTTCC-----------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred C------HHHHHHHHHcCCC-----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 2 2222222222210 112233456899999999999999999999876644
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=327.00 Aligned_cols=208 Identities=26% Similarity=0.404 Sum_probs=160.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++. ++..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 133 (273)
T d1mp8a_ 61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKR---FVHRD 133 (273)
T ss_dssp HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcccC---eeccc
Confidence 578899999999999995 5678999999999999998875443 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 160 (295)
|||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 134 lKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 134 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp CSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999998765444444455678999999999999999999999999999999998 89998654
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
...+ ....+.... ....+...+..+.+||.+||+.||++|||+.||+++|+.+...
T Consensus 214 ~~~~------~~~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 214 KNND------VIGRIENGE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CGGG------HHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH------HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 3322 112222211 1122334556799999999999999999999999999887543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-48 Score=329.90 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=164.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..|+|||||.+|+|..++.... .+++..++.++.||+.||.|||+++ |+|||
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrD 140 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 140 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccC
Confidence 5789999999999999999999999999999999877665433 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc---CCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS---SQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
|||+|||++.++.+||+|||+++.... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.
T Consensus 141 iKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 141 VKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999986433 234569999999999864 458999999999999999999999996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.... ...+..+...... ...+...+..+.+|+.+||+.||.+|||+.|+++|.+-.
T Consensus 216 ~~~~------~~~~~~i~~~~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 216 NMNA------MSALYHIAQNESP---------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp TSCH------HHHHHHHHHSCCC---------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCH------HHHHHHHHhCCCC---------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 3322 1222222222110 011122345689999999999999999999999986643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=324.33 Aligned_cols=209 Identities=23% Similarity=0.374 Sum_probs=163.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++.+.+..++|||||.+|++.+++..... .+++..+..++.||+.||+|||+.+ |+|||
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrD 135 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMN---YVHRD 135 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccc---cccCc
Confidence 57889999999999999999999999999999999998876543 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 999999999999999999999986643322 122334689999999999999999999999999999999996555432
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
.. .....+..+... .....+...+..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 216 ~~-----~~~~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 216 EL-----SNHEVMKAINDG----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TC-----CHHHHHHHHHTT----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cC-----CHHHHHHHHhcc----------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11 111122222111 1122333455679999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-48 Score=333.90 Aligned_cols=205 Identities=20% Similarity=0.261 Sum_probs=168.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++++|.+++.+|||||||+||+|.+.+..... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRD 152 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHEHS---IVHLD 152 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC---CBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 57899999999999999999999999999999999988765432 4999999999999999999999999 99999
Q ss_pred CCCCeEEEC--CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLD--DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+||||+ .++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||..
T Consensus 153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 153 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cccccccccccCCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 999999998 57899999999998765432 23445689999999999999999999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.... ..+..+...... .........+..+.+||.+||+.||.+|||+.|+++|.+
T Consensus 231 ~~~~------~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 231 EDDL------ETLQNVKRCDWE-------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp SSHH------HHHHHHHHCCCC-------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CCHH------HHHHHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 3322 222222221100 011112234456899999999999999999999999854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-47 Score=330.63 Aligned_cols=205 Identities=19% Similarity=0.247 Sum_probs=167.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++..|+|||||+||+|.+++..... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrD 149 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---Ceeee
Confidence 57889999999999999999999999999999999999865432 4999999999999999999999999 99999
Q ss_pred CCCCeEEEC--CCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLD--DKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||..
T Consensus 150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp CCGGGEEESSTTSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred echhHeeeccCCCCeEEEeecchheeccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 999999996 46789999999998665433 23445799999999999999999999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
... ...+..+...... .........+..+.+||.+||+.||++|||+.|+++|.+
T Consensus 228 ~~~------~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 228 END------DETLRNVKSCDWN-------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp SSH------HHHHHHHHHTCCC-------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred CCH------HHHHHHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 322 2222222221110 001111223456889999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=324.66 Aligned_cols=201 Identities=25% Similarity=0.311 Sum_probs=168.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++||||+++++++.+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~---iiHRD 130 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRD 130 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccc
Confidence 5789999999999999999999999999999999999998765 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+|+...... .......||+.|+|||++.+..|+.++|||||||++|||++|++||....
T Consensus 131 lKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 131 IKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCHHHeEecCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 99999999999999999999998654322 23445679999999999999999999999999999999999999997433
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
. ...+..+.... ...+...+..+.+||.+||++||.+||+ +.|+++|.+
T Consensus 210 ~------~~~~~~i~~~~-----------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 210 H------ERLFELILMEE-----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp H------HHHHHHHHHCC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred H------HHHHHHHhcCC-----------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 2 22222222111 1122334556889999999999999994 899998865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=321.83 Aligned_cols=204 Identities=26% Similarity=0.338 Sum_probs=167.0
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++++|.+++.+|||||||+||+|.+++.... .+++..++.++.|++.||+|||+.+ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrD 138 (293)
T d1jksa_ 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFD 138 (293)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc---eeecc
Confidence 5778999999999999999999999999999999999998754 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCC----ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 82 IKSANILLDDKY----RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 82 ikp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
|||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 216 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCC
Confidence 999999998776 59999999998654332 234456899999999999999999999999999999999999999
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
...... ..+..+...... .....+...+..+.+||.+||+.||++|||++|+++|.+
T Consensus 217 ~~~~~~------~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 217 LGDTKQ------ETLANVSAVNYE-------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp CCSSHH------HHHHHHHTTCCC-------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCCCHH------HHHHHHHhcCCC-------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 743222 222222221100 011112234456889999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-46 Score=319.75 Aligned_cols=198 Identities=25% Similarity=0.367 Sum_probs=166.8
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++.+|+|||||+||+|..++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrD 129 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRD 129 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc---EEccc
Confidence 5789999999999999999999999999999999999988655 3889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||....
T Consensus 130 iKp~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 130 LKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCchheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 9999999999999999999999865432 234579999999999999999999999999999999999999996432
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.......+..... ..+...+..+.+++.+||+.||.+|+ |++++++|.+
T Consensus 206 ------~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 206 ------TMKTYEKILNAEL-----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp ------HHHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ------HHHHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 2222333222211 11222345588999999999999996 9999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=320.33 Aligned_cols=208 Identities=23% Similarity=0.335 Sum_probs=160.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++. ++..++|||||++|+|..++...... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 65 ~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~--~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~D 138 (285)
T d1fmka3 65 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YVHRD 138 (285)
T ss_dssp HHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccc--cchHHHHHHHHHHHHHHHHHHhhhh---eeccc
Confidence 578899999999999985 56689999999999999998764322 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+||||+.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|..|+....
T Consensus 139 lKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 139 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765444444445678999999999999999999999999999999999665543221
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
.....+..+... ...+.+...+.++.+++.+||+.||++|||+++|++.|+...
T Consensus 219 -----~~~~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 219 -----VNREVLDQVERG----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -----CHHHHHHHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----CHHHHHHHHHhc----------CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 111122221111 111223344567999999999999999999999998887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=314.75 Aligned_cols=205 Identities=27% Similarity=0.476 Sum_probs=160.8
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++|||||+++|++.+ ++.+++||||+++|+|.+++...... .+++..++.++.||+.||+|||+.+ |+||
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~--~l~~~~~~~i~~~i~~al~ylH~~~---ivH~ 127 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 127 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHhhccccccCc---eecc
Confidence 5789999999999999865 46789999999999999999754321 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
||||+||+++.++.+||+|||+++..... .....+|..|+|||++.+..++.++|||||||++|||++ |++||..
T Consensus 128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 128 DLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp CCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999854322 223457899999999999999999999999999999998 7888764
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
....+ ....+.. ....+.+...+.++.+++.+||+.||.+|||+.+++++|+.++.
T Consensus 204 ~~~~~------~~~~i~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 204 IPLKD------VVPRVEK----------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp SCGGG------HHHHHTT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHc----------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 33222 1111111 11222333445679999999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=322.39 Aligned_cols=207 Identities=25% Similarity=0.496 Sum_probs=166.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|+|.++ ..++++||+.+|+|.+.+..... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrD 136 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 136 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHcC---cccCc
Confidence 57889999999999999865 56788999999999998876543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCcc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 159 (295)
|||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||..
T Consensus 137 lKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp CCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999876543332 2334568999999999999999999999999999999998 8888864
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
....+ ... .+. .......+...+..+.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus 217 ~~~~~---~~~----~i~---------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 217 IPASE---ISS----ILE---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp SCGGG---HHH----HHH---------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH---HHH----HHH---------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 43222 111 111 111112233445668999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-46 Score=326.38 Aligned_cols=202 Identities=22% Similarity=0.270 Sum_probs=165.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|+.++|||||++++++.+.+.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+|||
T Consensus 60 ~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrD 132 (364)
T d1omwa3 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRD 132 (364)
T ss_dssp HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC---cccee
Confidence 4677899999999999999999999999999999999998754 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++...... .....||+.|+|||++.. ..|+.++|||||||++|+|++|+.||...
T Consensus 133 lKP~NILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 133 LKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp CSGGGEEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eccceeEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998665432 334579999999999964 56899999999999999999999999754
Q ss_pred chhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT-----MKEVALELA 227 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-----~~e~~~~l~ 227 (295)
...+ ....... .... ....+...+..+.+||.+||+.||.+||| ++|+++|.+
T Consensus 210 ~~~~---~~~~~~~-~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 210 KTKD---KHEIDRM-TLTM----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp CSSC---HHHHHHH-SSSC----------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred CHHH---HHHHHHh-cccC----------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 3222 1111111 1000 01112234456899999999999999999 799998865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=318.55 Aligned_cols=208 Identities=27% Similarity=0.408 Sum_probs=159.1
Q ss_pred CCCccccceeeEEEeC-CccEEEEeecCCCCHHHHHhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 045989 6 INHRNVVKLLGCCLET-EVPLLVYEFIPNGSLHQYIHEQTE------------DQLPITWEIRLGIAVEVSGALSYLHSA 72 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~Lh~~ 72 (295)
.+||||+++++++... ..+++|||||++|+|.+++..... ....+++..++.++.||+.||+|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4789999999998765 468999999999999999975432 123489999999999999999999999
Q ss_pred CCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 73 ASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 73 ~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
+ |+||||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 154 K---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp T---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 9 999999999999999999999999999865443322 233457999999999999999999999999999999999
Q ss_pred hC-CCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 152 TG-QKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 152 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
+| .+||......+ .+...+... .....+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 231 t~~~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 231 SLGASPYPGVKIDE------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TTSCCSSTTCCCSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH------HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 86 56775332211 111111111 111222334556899999999999999999999999998875
Q ss_pred H
Q 045989 231 A 231 (295)
Q Consensus 231 ~ 231 (295)
+
T Consensus 296 q 296 (299)
T d1ywna1 296 Q 296 (299)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=317.77 Aligned_cols=206 Identities=26% Similarity=0.325 Sum_probs=167.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++.+++.+|+|||||+||+|.+++..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~~---iiHrD 127 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CCccc
Confidence 57889999999999999999999999999999999999975432 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCC--CceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcc
Q 045989 82 IKSANILLDDK--YRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRL 159 (295)
Q Consensus 82 ikp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 159 (295)
|||+|||++.+ ..+||+|||+++..... .......||+.|+|||...+..|+.++|||||||++|+|++|..||..
T Consensus 128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccceeecCCCceEEEEcccchhhccccC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 99999999854 58999999999865432 223445689999999999999999999999999999999999999964
Q ss_pred cchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 045989 160 VETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~ 228 (295)
... ...+..+....... +. ......+..+.+|+.+||..||.+|||+.|+++|.+-
T Consensus 206 ~~~------~~~~~~i~~~~~~~---~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 206 ETN------QQIIENIMNAEYTF---DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp SSH------HHHHHHHHHTCCCC---CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred CCH------HHHHHHHHhCCCCC---Ch----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 322 22233332221110 01 1111234568899999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=316.28 Aligned_cols=209 Identities=25% Similarity=0.421 Sum_probs=168.0
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC------------CCCCCCCHHHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT------------EDQLPITWEIRLGIAVEVSGALSY 68 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~ 68 (295)
+|+++ +|||||++++++.+++..++||||++||+|.++++... .....+++..+++++.||+.||.|
T Consensus 63 ~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~ 142 (309)
T d1fvra_ 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142 (309)
T ss_dssp HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence 46777 79999999999999999999999999999999997541 233469999999999999999999
Q ss_pred HHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 69 LHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 69 Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
||+.+ |+||||||+|||++.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|
T Consensus 143 lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 143 LSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hhcCC---ccccccccceEEEcCCCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 99999 99999999999999999999999999975433221 23346899999999999999999999999999999
Q ss_pred HHHhCC-CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLTGQ-KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||++|. +||.... .......+... .....+...+..+.+||.+||+.||++|||++||+++|+
T Consensus 218 ell~~~~~p~~~~~------~~~~~~~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 218 EIVSLGGTPYCGMT------CAELYEKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHTTSCCTTTTCC------HHHHHHHGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcCCCCCCCCC------HHHHHHHHHhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999965 5665322 22222222211 111223344567999999999999999999999999998
Q ss_pred HhHH
Q 045989 228 GIRA 231 (295)
Q Consensus 228 ~~~~ 231 (295)
.+..
T Consensus 282 ~i~~ 285 (309)
T d1fvra_ 282 RMLE 285 (309)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 8754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=315.77 Aligned_cols=211 Identities=27% Similarity=0.438 Sum_probs=171.3
Q ss_pred ccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHH
Q 045989 3 LSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTED------------QLPITWEIRLGIAVEVSGALSYL 69 (295)
Q Consensus 3 l~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~L 69 (295)
+.++ +|||||+++++|.+++..++|||||++|+|.+++...... ...+++..++.++.||+.||+||
T Consensus 72 l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl 151 (299)
T d1fgka_ 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 151 (299)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh
Confidence 3445 8999999999999999999999999999999999755321 23589999999999999999999
Q ss_pred HhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce-eeeccccccCCCChhhhccCCCCCCccchhhHHHHH
Q 045989 70 HSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH-LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLV 148 (295)
Q Consensus 70 h~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 148 (295)
|+.+ |+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..|+.++|||||||++|
T Consensus 152 H~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ 228 (299)
T d1fgka_ 152 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228 (299)
T ss_dssp HHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHH
Confidence 9999 999999999999999999999999999866543322 234456899999999999999999999999999999
Q ss_pred HHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 149 ELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 149 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
||++ |.+||...... ..+..+... .....+...+..+.+||.+||+.||.+|||+.||++.|+
T Consensus 229 ell~~g~~p~~~~~~~------~~~~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 229 EIFTLGGSPYPGVPVE------ELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp HHHTTSCCSSTTCCHH------HHHHHHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHH------HHHHHHHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 9998 78888633322 122111111 111223334556999999999999999999999999998
Q ss_pred HhHHh
Q 045989 228 GIRAS 232 (295)
Q Consensus 228 ~~~~~ 232 (295)
.+.+.
T Consensus 293 ~i~a~ 297 (299)
T d1fgka_ 293 RIVAL 297 (299)
T ss_dssp HHHHH
T ss_pred HHhhc
Confidence 87654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-46 Score=319.19 Aligned_cols=198 Identities=20% Similarity=0.272 Sum_probs=167.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++|||||++++++...+..++||||+.||+|..++.... .+++..++.++.||+.||.|||+++ |+|||
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRD 166 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCc
Confidence 5789999999999999999999999999999999999998764 3899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVE 161 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 161 (295)
|||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 167 IKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCHHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999876432 234579999999999999999999999999999999999999996332
Q ss_pred hhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 162 TEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.......+..... ..+...+..+.++|.+||+.||.+|+ |++++++|.+
T Consensus 243 ------~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 243 ------PIQIYEKIVSGKV-----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ------HHHHHHHHHHCCC-----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ------HHHHHHHHhcCCC-----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 2222222222211 11223445689999999999999994 8999998865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=321.36 Aligned_cols=210 Identities=22% Similarity=0.282 Sum_probs=163.3
Q ss_pred cCCCCccccceeeEEEe----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 045989 4 SQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYH 79 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H 79 (295)
+.++|||||+++++|.+ +..+|+|||||+||+|.+++..... ..+++..++.++.||+.||+|||+.+ |+|
T Consensus 60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---iiH 134 (335)
T d2ozaa1 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAH 134 (335)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccc
Confidence 34589999999999976 4678999999999999999975432 25999999999999999999999999 999
Q ss_pred ccCCCCeEEECC---CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 80 RDIKSANILLDD---KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 80 ~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
|||||+|||++. .+.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.|
T Consensus 135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~P 212 (335)
T d2ozaa1 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212 (335)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCS
T ss_pred ccccccccccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCC
Confidence 999999999985 4579999999998654432 23455799999999999999999999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
|........ ...+......... ..........+..+.+||.+||+.||++|||+.|+++|.+-.
T Consensus 213 f~~~~~~~~---~~~~~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 213 FYSNHGLAI---SPGMKTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp CEETTCC-----------CCCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred CCCCCHHHH---HHHHHHHHhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 964322110 0000000000000 001112234456799999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-46 Score=310.48 Aligned_cols=204 Identities=26% Similarity=0.390 Sum_probs=165.6
Q ss_pred cccCCC-CccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~-Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++ ||||+++++++.+++..|||||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+||
T Consensus 62 ~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---ivHr 134 (277)
T d1phka_ 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHR 134 (277)
T ss_dssp HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC---Cccc
Confidence 466775 9999999999999999999999999999999998654 4999999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc------CCCCCCccchhhHHHHHHHHhCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS------SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~ 154 (295)
||||+||+++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+
T Consensus 135 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 999999999999999999999998764432 2344579999999999864 34688999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.||..... ......+...... .........+.++.+++.+||+.||++|||+.|+++|.+
T Consensus 213 ~Pf~~~~~------~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 213 PPFWHRKQ------MLMLRMIMSGNYQ-------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CSSCCSSH------HHHHHHHHHTCCC-------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCCCCH------HHHHHHHHhCCCC-------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 99974332 2222222222110 011112234456999999999999999999999988753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=311.74 Aligned_cols=206 Identities=26% Similarity=0.414 Sum_probs=165.3
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||+++|++.+ ...++|||||++|++.+++..... .+++..+..++.||+.||+|||+++ |+|||
T Consensus 64 ~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 136 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR---FIHRD 136 (273)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhCC---Eeeee
Confidence 5788999999999999965 577999999999999998876544 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHh-CCCCCc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT-GQKPIR 158 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 158 (295)
|||+||+++.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543322 2234467889999999999999999999999999999998 899996
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
.... ......+..... ..+.+...+..+.+|+.+||+.||++|||+.+|.+.|+..
T Consensus 217 ~~~~------~~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 217 GLNG------SQILHKIDKEGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCH------HHHHHHHHTSCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCH------HHHHHHHHhCCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3322 222222222211 1122233445689999999999999999999999888653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=319.35 Aligned_cols=200 Identities=24% Similarity=0.307 Sum_probs=166.0
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
++.++|||||++++++.+++..|||||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||
T Consensus 57 ~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDi 129 (320)
T d1xjda_ 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDL 129 (320)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 346899999999999999999999999999999999998755 3899999999999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCcccch
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIRLVET 162 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 162 (295)
||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.....
T Consensus 130 kp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 130 KLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999998654332 223445799999999999999999999999999999999999999964322
Q ss_pred hhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q 045989 163 EENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMK-EVALELA 227 (295)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~~~~l~ 227 (295)
......+..... ..+...+..+.+||.+||+.||.+|||+. ++++|.+
T Consensus 209 ------~~~~~~i~~~~~-----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 209 ------EELFHSIRMDNP-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp ------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred ------HHHHHHHHcCCC-----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 222222222111 11223445689999999999999999995 7877643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-45 Score=309.26 Aligned_cols=209 Identities=27% Similarity=0.423 Sum_probs=161.7
Q ss_pred cccCCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
+|++++|||||++++++...+ ..|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |
T Consensus 60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---i 132 (277)
T d1o6ya_ 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---I 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 578899999999999998754 3799999999999999987664 4899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcc--eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT--HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
+||||||+||+++.++..+++|||.+........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 133 iHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp ECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence 9999999999999999999999999875533222 23345579999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhH
Q 045989 156 PIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-TMKEVALELAGIR 230 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-s~~e~~~~l~~~~ 230 (295)
||.... ................ .......+..+.++|.+||+.||.+|| |++++++.|.+++
T Consensus 213 Pf~~~~------~~~~~~~~~~~~~~~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 213 PFTGDS------PVSVAYQHVREDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SCCCSS------HHHHHHHHHHCCCCCG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCcC------HHHHHHHHHhcCCCCC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 996432 2222333333221110 111223445689999999999999999 8999998887654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-46 Score=315.77 Aligned_cols=210 Identities=23% Similarity=0.421 Sum_probs=168.4
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC--------------------CCCCCCHHHHHHHHHH
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE--------------------DQLPITWEIRLGIAVE 61 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~q 61 (295)
+|++++||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 57889999999999999999999999999999999999975321 1234889999999999
Q ss_pred HHHHHHHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccc
Q 045989 62 VSGALSYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDV 140 (295)
Q Consensus 62 i~~~l~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 140 (295)
++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..|+.++||
T Consensus 149 i~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 999999999999 99999999999999999999999999986543322 22344568999999999999999999999
Q ss_pred hhhHHHHHHHHhCC-CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 045989 141 YSFGVVLVELLTGQ-KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTM 219 (295)
Q Consensus 141 wslG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 219 (295)
|||||++|||++|. +||...... .....+.... ....+...+..+.+|+.+||+.||++|||+
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~~------e~~~~v~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAHE------EVIYYVRDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccchhhHHHHHccCCCCCCCCCHH------HHHHHHHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999985 567543322 2222222211 112233445569999999999999999999
Q ss_pred HHHHHHHHHhH
Q 045989 220 KEVALELAGIR 230 (295)
Q Consensus 220 ~e~~~~l~~~~ 230 (295)
.||++.|+.+.
T Consensus 290 ~ev~~~L~~i~ 300 (301)
T d1lufa_ 290 CSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHhc
Confidence 99999998763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=313.71 Aligned_cols=210 Identities=29% Similarity=0.465 Sum_probs=167.6
Q ss_pred cccCCCCccccceeeEEEe-CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++||||++++|++.. ++..++|||||++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~---iiHr 154 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHR 154 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcccC---cccC
Confidence 5789999999999999876 4578999999999999999875543 4788899999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCC
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 157 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 157 (295)
||||+|||+++++.+||+|||+++........ ......||+.|+|||.+....++.++||||||+++|||++|..||
T Consensus 155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999999866443221 122346899999999999999999999999999999999988776
Q ss_pred cccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHHh
Q 045989 158 RLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRAS 232 (295)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~~ 232 (295)
...... .. ....+....+ ...+...+..+.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 235 ~~~~~~--~~---~~~~i~~g~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 235 YPDVNT--FD---ITVYLLQGRR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CC-----------CHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCH--HH---HHHHHHcCCC----------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 532211 11 1111111111 112223445689999999999999999999999999988654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=315.40 Aligned_cols=212 Identities=20% Similarity=0.208 Sum_probs=162.2
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++..++..|+|||||.++++..+.... ..+++..+..++.||+.||+|||+++ |+|||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrD 125 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRD 125 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc---eeccc
Confidence 578899999999999999999999999999887766655432 24889999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...
T Consensus 126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 126 LKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcceEEecCCCccccccCccccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 999999999999999999999986544322 2334579999999999865 46799999999999999999999999644
Q ss_pred chhhcccHHHHHHHHHhh---chhh--------------hhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 045989 161 ETEENRSLAAYFLQVINE---NRLF--------------EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVA 223 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~ 223 (295)
...+ .+..+... .... ...............+..+.+|+.+||+.||++|||++|++
T Consensus 205 ~~~~------~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 205 SDLD------QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp SHHH------HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CHHH------HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3222 11111110 0000 00000000111112345689999999999999999999999
Q ss_pred HHHH
Q 045989 224 LELA 227 (295)
Q Consensus 224 ~~l~ 227 (295)
+|.+
T Consensus 279 ~Hp~ 282 (299)
T d1ua2a_ 279 KMKY 282 (299)
T ss_dssp TSGG
T ss_pred CCHh
Confidence 8854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=308.34 Aligned_cols=223 Identities=23% Similarity=0.325 Sum_probs=167.4
Q ss_pred ccCCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----
Q 045989 3 LSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA----- 73 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~----- 73 (295)
+++++|||||++++++.+.+ .+|+|||||++|+|.++++.. .+++..++.++.|++.||+|||+..
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~ 125 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 56789999999999998754 579999999999999999864 3899999999999999999999741
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcce---eeeccccccCCCChhhhccCC------CCCCccchhhH
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH---LTTQVKGTFGYLDPEYFQSSQ------FTEKSDVYSFG 144 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG 144 (295)
..+|+||||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+.. ++.++||||||
T Consensus 126 ~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 123999999999999999999999999999876543322 233457999999999987643 57789999999
Q ss_pred HHHHHHHhCCCCCcccchhhc--------ccHHHHHHHHHhhchhhhhhhhhhh-hhhhHHHHHHHHHHHHHhhccCCCC
Q 045989 145 VVLVELLTGQKPIRLVETEEN--------RSLAAYFLQVINENRLFEVLDAQVL-REAEKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 145 ~~l~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~ 215 (295)
|++|||++|..|+........ ................ ++... .......+..+.+++.+||+.||++
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 281 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGG
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhH
Confidence 999999999988754322111 1111112222211111 11111 1113345567899999999999999
Q ss_pred CCCHHHHHHHHHHhHHhhc
Q 045989 216 RPTMKEVALELAGIRASIG 234 (295)
Q Consensus 216 Rps~~e~~~~l~~~~~~~~ 234 (295)
|||+.||+++|+.+.+..+
T Consensus 282 Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 282 RLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCCHHHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHHHhcC
Confidence 9999999999998876654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=311.62 Aligned_cols=212 Identities=27% Similarity=0.464 Sum_probs=169.4
Q ss_pred cccCC-CCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCC--------------CCCCCCHHHHHHHHHHHHHHH
Q 045989 2 ILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTE--------------DQLPITWEIRLGIAVEVSGAL 66 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~l 66 (295)
+++++ +|||||++++++.++...++|||||++|+|.+++..... ....+++..+..++.||+.||
T Consensus 79 ~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl 158 (311)
T d1t46a_ 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (311)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred HHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence 35566 799999999999999999999999999999999976532 223589999999999999999
Q ss_pred HHHHhCCCCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc-eeeeccccccCCCChhhhccCCCCCCccchhhHH
Q 045989 67 SYLHSAASIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT-HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGV 145 (295)
Q Consensus 67 ~~Lh~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 145 (295)
+|||+++ ++||||||+||+++.++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||
T Consensus 159 ~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 159 AFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (311)
T ss_dssp HHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence 9999999 99999999999999999999999999987654333 3344567899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 045989 146 VLVELLT-GQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVAL 224 (295)
Q Consensus 146 ~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~ 224 (295)
++|||++ |.+||......+ .+...+.. ......+...+..+.+||.+||+.||++|||+.+|++
T Consensus 236 ~l~ellt~g~p~~~~~~~~~------~~~~~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGMPVDS------KFYKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTTTCCSSTTCCSSH------HHHHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH------HHHHHHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999 555554322211 11122211 1111222334556999999999999999999999999
Q ss_pred HHHHhHH
Q 045989 225 ELAGIRA 231 (295)
Q Consensus 225 ~l~~~~~ 231 (295)
.|+....
T Consensus 301 ~L~~~i~ 307 (311)
T d1t46a_ 301 LIEKQIS 307 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHhhc
Confidence 9987543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=307.70 Aligned_cols=209 Identities=24% Similarity=0.402 Sum_probs=169.7
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQT------EDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++|||||++++++..++..++|||||++|+|.+++.... .....+++..+..++.|++.||.|||+++
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-- 153 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 153 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 5789999999999999999999999999999999999986432 22234789999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCccee-eeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHL-TTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 154 -ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 154 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999999999999999999999999998665443322 23346899999999999999999999999999999999984
Q ss_pred -CCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 045989 155 -KPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGI 229 (295)
Q Consensus 155 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~ 229 (295)
+||..... ...+..+.+.. ....+...+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus 233 ~~p~~~~~~------~~~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 233 EQPYQGLSN------EQVLRFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCTTTTSCH------HHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCCCCCH------HHHHHHHHhCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 77753322 22222222221 1122233455699999999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=304.74 Aligned_cols=193 Identities=24% Similarity=0.394 Sum_probs=157.8
Q ss_pred cccCCC--CccccceeeEEEeCCccEEEEeecCC-CCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPN-GSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l~--Hpniv~~~~~~~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|++++ |||||++++++.+++..++||||+.+ +++.+++.... .+++..++.++.||+.||+|||+++ |+
T Consensus 60 il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---ii 132 (273)
T d1xwsa_ 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG---VL 132 (273)
T ss_dssp HHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 345554 89999999999999999999999976 68888887654 4999999999999999999999999 99
Q ss_pred eccCCCCeEEECC-CCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCC-CCCccchhhHHHHHHHHhCCCC
Q 045989 79 HRDIKSANILLDD-KYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQF-TEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 79 H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p 156 (295)
||||||+|||++. ++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.|
T Consensus 133 HrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 133 HRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCcccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 9999999999985 479999999999765432 2344679999999999987765 5778999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
|..... +..... ..+...+..+.++|.+||+.||++|||++|+++|.+
T Consensus 210 f~~~~~------------i~~~~~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 210 FEHDEE------------IIRGQV-----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp CCSHHH------------HHHCCC-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCchH------------Hhhccc-----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 963211 111100 111223456899999999999999999999998864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=302.52 Aligned_cols=213 Identities=21% Similarity=0.339 Sum_probs=161.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
||++++|||||++++++.++...|+||||+.+ ++..++...... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~--~l~e~~~~~~~~qil~~L~yLH~~~---IiHrD 127 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRD 127 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcCC---EEccc
Confidence 57899999999999999999999999999965 555555433222 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC-CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++.... ++.++||||+||++|+|++|+.||...
T Consensus 128 iKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 128 LKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp CCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 99999999999999999999998654332 2233456999999999987765 478999999999999999999999743
Q ss_pred chhhcccHHHHHHHHHh----hch-hhhhhh-------------hhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 161 ETEENRSLAAYFLQVIN----ENR-LFEVLD-------------AQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~----~~~-~~~~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
...+ .+..+.. ... ...... ...........+..+.+|+.+||+.||++|||+.|+
T Consensus 207 ~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 207 SEID------QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp SHHH------HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CHHH------HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 3221 1111111 000 000000 000001111234568999999999999999999999
Q ss_pred HHHHH
Q 045989 223 ALELA 227 (295)
Q Consensus 223 ~~~l~ 227 (295)
++|.+
T Consensus 281 l~H~f 285 (298)
T d1gz8a_ 281 LAHPF 285 (298)
T ss_dssp HTSGG
T ss_pred hCCHh
Confidence 98844
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=303.64 Aligned_cols=210 Identities=21% Similarity=0.274 Sum_probs=158.6
Q ss_pred cCCCCccccceeeEEEe-----CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 4 SQINHRNVVKLLGCCLE-----TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 4 ~~l~Hpniv~~~~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+.++||||++++++|.. ....+++|||++++++........ ..+++..++.++.|++.||+|||+++ |+
T Consensus 65 ~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~---iv 138 (305)
T d1blxa_ 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VV 138 (305)
T ss_dssp HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred hhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 34589999999999964 246899999998876654443322 24899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 79 HRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 79 H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.
T Consensus 139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 9999999999999999999999998754332 22345679999999999999999999999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHh---hchhh-------------hhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 045989 159 LVETEENRSLAAYFLQVIN---ENRLF-------------EVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEV 222 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~---~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 222 (295)
.....+ .+..+.. ..... ...............+..+.+|+.+||+.||++|||+.|+
T Consensus 217 ~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 217 GSSDVD------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp CSSHHH------HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCHHH------HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 443222 1111111 00000 0000000111222334568899999999999999999999
Q ss_pred HHHHH
Q 045989 223 ALELA 227 (295)
Q Consensus 223 ~~~l~ 227 (295)
++|.+
T Consensus 291 L~Hpf 295 (305)
T d1blxa_ 291 LSHPY 295 (305)
T ss_dssp HTSGG
T ss_pred hcChh
Confidence 98854
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-43 Score=295.11 Aligned_cols=215 Identities=20% Similarity=0.286 Sum_probs=159.1
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++|||||++++++..++..+++||++.++.+..+..... .+++..++.++.||+.||+|||+.+ |+|||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrD 125 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccCc---EEecC
Confidence 6889999999999999999999999999998766666654332 4999999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||.+....... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 126 iKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 126 LKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCceeeEcCCCCEEecccccceecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 99999999999999999999998654332 223344689999999998764 5689999999999999999999999743
Q ss_pred chhhcccHHHHHHHHHhhchhhhh---------------hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENRLFEV---------------LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
...+. .... ............ ..+..........+..+.+++.+||+.||++|||++|+++|
T Consensus 205 ~~~~~--~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 205 SEADQ--LMRI-FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp SHHHH--HHHH-HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHH--HHHH-HHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 32211 1111 111100000000 00000011122234568899999999999999999999987
Q ss_pred HH
Q 045989 226 LA 227 (295)
Q Consensus 226 l~ 227 (295)
.+
T Consensus 282 p~ 283 (286)
T d1ob3a_ 282 AY 283 (286)
T ss_dssp GG
T ss_pred cc
Confidence 53
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=298.45 Aligned_cols=214 Identities=22% Similarity=0.279 Sum_probs=157.5
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++||||++++++|... .++++|||||+++ +...+.........+++..++.++.||+.||+|||+++
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-- 142 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 142 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 57889999999999999653 2478999999765 44444433333346999999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhC
Q 045989 76 PIYHRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTG 153 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 153 (295)
|+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|
T Consensus 143 -IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g 219 (350)
T d1q5ka_ 143 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219 (350)
T ss_dssp -EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT
T ss_pred -CcccCCCcceEEEecCCCceeEecccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhC
Confidence 99999999999999775 89999999998654332 2334579999999998765 5789999999999999999999
Q ss_pred CCCCcccchhhcccHHHHHHHHHhh--chhhhhh----------------hhhhhhhhhHHHHHHHHHHHHHhhccCCCC
Q 045989 154 QKPIRLVETEENRSLAAYFLQVINE--NRLFEVL----------------DAQVLREAEKEEVITVAMVAKRCLNLNGKK 215 (295)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 215 (295)
..||......+ .+..+... ....+.. ............+..+.+|+.+||+.||++
T Consensus 220 ~~pf~~~~~~~------~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 220 QPIFPGDSGVD------QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293 (350)
T ss_dssp SCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred CCCCCCCCHHH------HHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhH
Confidence 99997443221 11111100 0000000 000000111223456889999999999999
Q ss_pred CCCHHHHHHHHH
Q 045989 216 RPTMKEVALELA 227 (295)
Q Consensus 216 Rps~~e~~~~l~ 227 (295)
|||+.|+++|.+
T Consensus 294 R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 294 RLTPLEACAHSF 305 (350)
T ss_dssp SCCHHHHHTSGG
T ss_pred CcCHHHHhcCHh
Confidence 999999998854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=293.52 Aligned_cols=206 Identities=26% Similarity=0.324 Sum_probs=166.3
Q ss_pred cccCCCC-ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~H-pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
+|++++| |||+++++++.+....++||||+.+|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||
T Consensus 81 il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHr 153 (322)
T d1vzoa_ 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYR 153 (322)
T ss_dssp HHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC---EEec
Confidence 4678866 899999999999999999999999999999998765 3788999999999999999999999 9999
Q ss_pred cCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC--CCCCCccchhhHHHHHHHHhCCCCCc
Q 045989 81 DIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS--QFTEKSDVYSFGVVLVELLTGQKPIR 158 (295)
Q Consensus 81 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~ 158 (295)
||||+||+++.++.+||+|||+++.+............|++.|+|||.+.+. .++.++|||||||++|+|++|..||.
T Consensus 154 DiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987655544445556799999999999764 46789999999999999999999997
Q ss_pred ccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 045989 159 LVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP-----TMKEVALELA 227 (295)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~~~~l~ 227 (295)
.....+ ............ ....+...+..+.+++.+||+.||++|| |++|+++|.+
T Consensus 234 ~~~~~~--~~~~i~~~~~~~-----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 234 VDGEKN--SQAEISRRILKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp CTTSCC--CHHHHHHHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCCHHH--HHHHHHHhcccC-----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 543322 111111111111 1122334556799999999999999999 5899988765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=293.36 Aligned_cols=210 Identities=22% Similarity=0.335 Sum_probs=159.7
Q ss_pred cccCCCCccccceeeEEEeCC------ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
+|++++|||||+++++|...+ .+|+||||| +.+|..+.... .+++..++.++.||+.||+|||+++
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~-- 141 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG-- 141 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 578899999999999998655 469999999 67888887653 3999999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~ 154 (295)
|+||||||+|||++.++.+|++|||+++..... .....||+.|+|||++.+. .++.++||||+||++|+|++|+
T Consensus 142 -IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~ 216 (346)
T d1cm8a_ 142 -IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216 (346)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -CcccccCcchhhcccccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCc
Confidence 999999999999999999999999999865432 2345789999999998764 5689999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhc--hhhhh---------------hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINEN--RLFEV---------------LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
.||......+... ......... ..... .............+..+.+||.+||..||.+||
T Consensus 217 ~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 293 (346)
T d1cm8a_ 217 TLFKGSDHLDQLK---EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293 (346)
T ss_dssp CSSCCSSHHHHHH---HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCChHHHHH---HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc
Confidence 9997543222110 000000000 00000 000000111122344588999999999999999
Q ss_pred CHHHHHHHHH
Q 045989 218 TMKEVALELA 227 (295)
Q Consensus 218 s~~e~~~~l~ 227 (295)
|+.|+++|.+
T Consensus 294 ta~eiL~Hp~ 303 (346)
T d1cm8a_ 294 TAGEALAHPY 303 (346)
T ss_dssp CHHHHHHSGG
T ss_pred CHHHHhcChh
Confidence 9999999854
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=294.55 Aligned_cols=215 Identities=20% Similarity=0.281 Sum_probs=158.3
Q ss_pred cccCCCCccccceeeEEEeCC----ccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045989 2 ILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPI 77 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i 77 (295)
||++++||||+++++++.... ..+++++|+.||+|.+++... .+++..++.++.|++.||+|||+++ |
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~---i 130 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---V 130 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 578899999999999997654 234555666799999999754 3899999999999999999999999 9
Q ss_pred EeccCCCCeEEECCCCceEEeeccCccccccCcce--eeeccccccCCCChhhhcc-CCCCCCccchhhHHHHHHHHhCC
Q 045989 78 YHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTH--LTTQVKGTFGYLDPEYFQS-SQFTEKSDVYSFGVVLVELLTGQ 154 (295)
Q Consensus 78 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~ 154 (295)
+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.. ..++.++||||+||++|+|++|.
T Consensus 131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence 99999999999999999999999999865443222 2344578999999999854 56789999999999999999999
Q ss_pred CCCcccchhhcccHHHHHHHHHhhchhh--------------hhhhhh---hhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 045989 155 KPIRLVETEENRSLAAYFLQVINENRLF--------------EVLDAQ---VLREAEKEEVITVAMVAKRCLNLNGKKRP 217 (295)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 217 (295)
.||......+... ............ ...... .........+..+.+|+.+||+.||.+||
T Consensus 211 ~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 211 PIFPGKHYLDQLN---HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp CSCCCSSHHHHHH---HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCCHHHHHH---HHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 9996443222111 111100000000 000000 00001112234688999999999999999
Q ss_pred CHHHHHHHHH
Q 045989 218 TMKEVALELA 227 (295)
Q Consensus 218 s~~e~~~~l~ 227 (295)
|+.|+++|.+
T Consensus 288 ta~e~L~hpf 297 (345)
T d1pmea_ 288 EVEQALAHPY 297 (345)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcCHh
Confidence 9999998853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-41 Score=282.97 Aligned_cols=215 Identities=19% Similarity=0.223 Sum_probs=159.3
Q ss_pred cccCCCCcc-ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 045989 2 ILSQINHRN-VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHR 80 (295)
Q Consensus 2 il~~l~Hpn-iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~ 80 (295)
++++++|+| |+.+.+++..++..++||||+ +++|...+..... .+++..+..++.|++.||+|||+++ |+||
T Consensus 55 i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---iiHr 127 (299)
T d1ckia_ 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN---FIHR 127 (299)
T ss_dssp HHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 467787765 455556667788899999999 6677777665433 4899999999999999999999999 9999
Q ss_pred cCCCCeEEECC---CCceEEeeccCccccccCcc------eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHH
Q 045989 81 DIKSANILLDD---KYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 151 (295)
Q Consensus 81 dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 151 (295)
||||+|||++. +..++|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 128 DiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred cCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence 99999999864 45799999999987654322 1233457999999999999999999999999999999999
Q ss_pred hCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHH
Q 045989 152 TGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIRA 231 (295)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~~ 231 (295)
+|..||......+.............. ..........+.++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMS---------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHH---------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCcccccchHHHHHHHHHhhcccCC---------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 999999754433222111111000000 00111122344568999999999999999999999888877644
Q ss_pred h
Q 045989 232 S 232 (295)
Q Consensus 232 ~ 232 (295)
.
T Consensus 279 ~ 279 (299)
T d1ckia_ 279 R 279 (299)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-40 Score=280.75 Aligned_cols=216 Identities=15% Similarity=0.171 Sum_probs=167.6
Q ss_pred ccCCCC-ccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 3 LSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 3 l~~l~H-pniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
++.|+| +||+++++++..+...++||||+ +++|.+++..... .+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrD 126 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 456755 89999999999999999999999 7899999876443 4899999999999999999999999 99999
Q ss_pred CCCCeEEECC-----CCceEEeeccCccccccCcc------eeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHH
Q 045989 82 IKSANILLDD-----KYRAKISDFGTSRSMAVDRT------HLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVEL 150 (295)
Q Consensus 82 ikp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 150 (295)
|||+||+++. ++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence 9999999974 56899999999987643221 123345799999999999999999999999999999999
Q ss_pred HhCCCCCcccchhhcccHHHHHHHHHhhchhhhhhhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 045989 151 LTGQKPIRLVETEENRSLAAYFLQVINENRLFEVLDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALELAGIR 230 (295)
Q Consensus 151 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~l~~~~ 230 (295)
++|..||........... ...+..... ...........+.++.+++..|+..+|++||+++.+.+.++.+.
T Consensus 207 ltg~~Pf~~~~~~~~~~~---~~~i~~~~~------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQK---YERIGEKKQ------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHSSCTTSSCCSCCHHHH---HHHHHHHHH------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HhCCCcCCCccchhHHHH---HHHHHhccC------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 999999975433222111 111111100 00011112233456899999999999999999999988888765
Q ss_pred Hhhc
Q 045989 231 ASIG 234 (295)
Q Consensus 231 ~~~~ 234 (295)
...+
T Consensus 278 ~~~~ 281 (293)
T d1csna_ 278 ERLN 281 (293)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 5543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=290.18 Aligned_cols=216 Identities=21% Similarity=0.277 Sum_probs=156.0
Q ss_pred cccCCCCccccceeeEEEe--------CCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045989 2 ILSQINHRNVVKLLGCCLE--------TEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA 73 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~ 73 (295)
+|++++||||+++++++.. ++..++||||+.++.+........ .+++..++.++.|++.||.|||+.+
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~~ 137 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNK 137 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccCC
Confidence 5788999999999999865 346899999997765554433322 4899999999999999999999999
Q ss_pred CCCeEeccCCCCeEEECCCCceEEeeccCccccccCcc---eeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHH
Q 045989 74 SIPIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRT---HLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVE 149 (295)
Q Consensus 74 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~e 149 (295)
|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++||||+||++|+
T Consensus 138 ---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 138 ---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeee
Confidence 99999999999999999999999999976543221 122334689999999998765 68999999999999999
Q ss_pred HHhCCCCCcccchhhcccHHHHHHHHHhhch--h---------hhhhhhh------hh-hhhhHHHHHHHHHHHHHhhcc
Q 045989 150 LLTGQKPIRLVETEENRSLAAYFLQVINENR--L---------FEVLDAQ------VL-REAEKEEVITVAMVAKRCLNL 211 (295)
Q Consensus 150 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---------~~~~~~~------~~-~~~~~~~~~~~~~li~~cl~~ 211 (295)
|++|+.||......+. ...+.+...... . ....... .. ..........+.+|+.+||+.
T Consensus 215 l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~ 291 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQ---LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291 (318)
T ss_dssp HHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HhhCCCCCCCCCHHHH---HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence 9999999964332221 111111111000 0 0000000 00 000111234578899999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 045989 212 NGKKRPTMKEVALELA 227 (295)
Q Consensus 212 ~p~~Rps~~e~~~~l~ 227 (295)
||++|||++|+++|.+
T Consensus 292 dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 292 DPAQRIDSDDALNHDF 307 (318)
T ss_dssp STTTSCCHHHHHHSGG
T ss_pred ChhHCcCHHHHHcChh
Confidence 9999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=286.36 Aligned_cols=213 Identities=21% Similarity=0.275 Sum_probs=153.1
Q ss_pred cccCCCCccccceeeEEEeC------CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASI 75 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~ 75 (295)
||++++|||||+++++|... ..+|+|||||.+ ++.+.+.. .+++..++.++.||+.||+|||+.|
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~g-- 139 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG-- 139 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhcc--
Confidence 57889999999999999643 578999999966 45554432 3899999999999999999999999
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCC
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+|||++.++.++++|||+++..... .......||+.|+|||++.+..++.++||||+||++++|++|+.
T Consensus 140 -iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -cccccCCccccccccccceeeechhhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCC
Confidence 999999999999999999999999998754432 23344568999999999999999999999999999999999999
Q ss_pred CCcccchhhcccHHHHHH------------------HHHhhch------hhhhhhh---hhhhhhhHHHHHHHHHHHHHh
Q 045989 156 PIRLVETEENRSLAAYFL------------------QVINENR------LFEVLDA---QVLREAEKEEVITVAMVAKRC 208 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~------------------~~~~~~~------~~~~~~~---~~~~~~~~~~~~~~~~li~~c 208 (295)
||........ ...... ....... ....... ..........+..+.+|+.+|
T Consensus 217 pF~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~m 294 (355)
T d2b1pa1 217 LFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294 (355)
T ss_dssp SSCCSSHHHH--HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHH--HHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence 9964322111 000000 0000000 0000000 001112334567799999999
Q ss_pred hccCCCCCCCHHHHHHHHHH
Q 045989 209 LNLNGKKRPTMKEVALELAG 228 (295)
Q Consensus 209 l~~~p~~Rps~~e~~~~l~~ 228 (295)
|..||++|||++|+++|.+-
T Consensus 295 L~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 295 LVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp SCSSTTTSCCHHHHHTSTTT
T ss_pred CcCChhHCcCHHHHhcCccc
Confidence 99999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=280.43 Aligned_cols=216 Identities=18% Similarity=0.271 Sum_probs=162.9
Q ss_pred cccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 045989 2 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRD 81 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~d 81 (295)
+|++++||||+++++++......++|++++.+++|..++.... .+++..++.++.|++.||+|||+++ |+|||
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrD 126 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcCC---Eeeec
Confidence 5789999999999999999999999999999988888776543 4899999999999999999999999 99999
Q ss_pred CCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCC-CCCCccchhhHHHHHHHHhCCCCCccc
Q 045989 82 IKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQ-FTEKSDVYSFGVVLVELLTGQKPIRLV 160 (295)
Q Consensus 82 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~ 160 (295)
|||+|||++.++.+||+|||.++....... ......+++.|+|||++.+.. ++.++||||+||++|||++|+.||...
T Consensus 127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 127 LKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred ccCcccccccCCceeeeecchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 999999999999999999999987654322 223345788999999987664 689999999999999999999997432
Q ss_pred chhhcccHHHHHHHHHhhch--h----hhh---------hhhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 045989 161 ETEENRSLAAYFLQVINENR--L----FEV---------LDAQVLREAEKEEVITVAMVAKRCLNLNGKKRPTMKEVALE 225 (295)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~--~----~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~~~~ 225 (295)
..... ....+........ . ... .............+..+.+|+.+||+.||.+|||++|+++|
T Consensus 206 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 206 NDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp SSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHH--HHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22111 1111111111000 0 000 00000111122334568899999999999999999999988
Q ss_pred HH
Q 045989 226 LA 227 (295)
Q Consensus 226 l~ 227 (295)
.+
T Consensus 284 p~ 285 (292)
T d1unla_ 284 PY 285 (292)
T ss_dssp GG
T ss_pred hh
Confidence 53
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=283.96 Aligned_cols=212 Identities=20% Similarity=0.281 Sum_probs=157.2
Q ss_pred cccCC-CCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 045989 2 ILSQI-NHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIY 78 (295)
Q Consensus 2 il~~l-~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~ 78 (295)
+|+++ .||||++++++|... ...++|||||.+++|..+.. .+++..+..++.||+.||+|||+++ |+
T Consensus 82 il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---Iv 151 (328)
T d3bqca1 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IM 151 (328)
T ss_dssp HHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cc
Confidence 46777 499999999999854 56899999999999876532 3899999999999999999999999 99
Q ss_pred eccCCCCeEEECCCC-ceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCCC
Q 045989 79 HRDIKSANILLDDKY-RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 79 H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||||||+|||++.++ .+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||++++|++|+.|
T Consensus 152 HrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p 229 (328)
T d3bqca1 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229 (328)
T ss_dssp CCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cccccccceEEcCCCCeeeecccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence 999999999998655 69999999998654332 23445689999999998765 479999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHHhhchhhhh---------------h--------hhhhhhhhhHHHHHHHHHHHHHhhccCC
Q 045989 157 IRLVETEENRSLAAYFLQVINENRLFEV---------------L--------DAQVLREAEKEEVITVAMVAKRCLNLNG 213 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~--------~~~~~~~~~~~~~~~~~~li~~cl~~~p 213 (295)
|......... ...+............ . ............+.++.+||.+||+.||
T Consensus 230 f~~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 307 (328)
T d3bqca1 230 FFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307 (328)
T ss_dssp SSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSG
T ss_pred CCCCchhHHH--HHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCCh
Confidence 8754332111 0001111100000000 0 0000011112234568999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 045989 214 KKRPTMKEVALELA 227 (295)
Q Consensus 214 ~~Rps~~e~~~~l~ 227 (295)
++|||++|+++|.+
T Consensus 308 ~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 308 QSRLTAREAMEHPY 321 (328)
T ss_dssp GGSCCHHHHHTSGG
T ss_pred hHCcCHHHHhcCcc
Confidence 99999999998864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=280.88 Aligned_cols=211 Identities=22% Similarity=0.313 Sum_probs=153.8
Q ss_pred cccCCCCccccceeeEEEeC-----CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045989 2 ILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIP 76 (295)
Q Consensus 2 il~~l~Hpniv~~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~ 76 (295)
||++++|||||++++++... ...++|++|+.||+|.+++... .+++..++.++.||+.||+|||+++
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g--- 141 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD--- 141 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 57889999999999999743 3346677788899999998643 3999999999999999999999999
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccC-CCCCCccchhhHHHHHHHHhCCC
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSS-QFTEKSDVYSFGVVLVELLTGQK 155 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~ 155 (295)
|+||||||+|||++.++.+|++|||++...... .....||+.|+|||+..+. .++.++|||||||++|+|++|..
T Consensus 142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCC----CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CcccccCCccccccccccccccccchhcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCC
Confidence 999999999999999999999999998754322 3345689999999987765 46889999999999999999999
Q ss_pred CCcccchhhcccHHHHHHHHHhhch--hhhhh---------------hhhhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 045989 156 PIRLVETEENRSLAAYFLQVINENR--LFEVL---------------DAQVLREAEKEEVITVAMVAKRCLNLNGKKRPT 218 (295)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps 218 (295)
||........ ...+........ ..... ............+..+.+||.+||+.||.+|||
T Consensus 218 pF~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 294 (348)
T d2gfsa1 218 LFPGTDHIDQ---LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294 (348)
T ss_dssp SCCCSSHHHH---HHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCHHHH---HHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC
Confidence 9974432211 011111000000 00000 000000011123456889999999999999999
Q ss_pred HHHHHHHHH
Q 045989 219 MKEVALELA 227 (295)
Q Consensus 219 ~~e~~~~l~ 227 (295)
+.|+++|.+
T Consensus 295 a~elL~Hp~ 303 (348)
T d2gfsa1 295 AAQALAHAY 303 (348)
T ss_dssp HHHHHTSGG
T ss_pred HHHHhcCHh
Confidence 999999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-34 Score=249.62 Aligned_cols=214 Identities=20% Similarity=0.201 Sum_probs=148.3
Q ss_pred CCCccccceeeEEEeC--CccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccC
Q 045989 6 INHRNVVKLLGCCLET--EVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHS-AASIPIYHRDI 82 (295)
Q Consensus 6 l~Hpniv~~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~-~~~~~i~H~di 82 (295)
+.||||+++++++... ...+++++++..+......... .....+++..+..++.||+.||+|||+ .+ |+||||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDl 152 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDI 152 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCC
T ss_pred cCcCceEEEEEEeeeccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccC
Confidence 4679999999998753 4556677766554332222221 222258899999999999999999998 77 999999
Q ss_pred CCCeEEECCCC------ceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHHHHHHhCCCC
Q 045989 83 KSANILLDDKY------RAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKP 156 (295)
Q Consensus 83 kp~Nill~~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 156 (295)
||+|||++.++ .++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.|
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 228 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred ChhHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence 99999997654 4899999998754322 2345699999999999999999999999999999999999999
Q ss_pred CcccchhhcccHHHHHHHHH---hhchh---------hhhhh-------------------hhhhhhhhHHHHHHHHHHH
Q 045989 157 IRLVETEENRSLAAYFLQVI---NENRL---------FEVLD-------------------AQVLREAEKEEVITVAMVA 205 (295)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~---~~~~~---------~~~~~-------------------~~~~~~~~~~~~~~~~~li 205 (295)
|................... ..... ....+ ...........+..+.+|+
T Consensus 229 F~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 308 (362)
T d1q8ya_ 229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308 (362)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHH
Confidence 97543322111111111110 00000 00000 0011122355677899999
Q ss_pred HHhhccCCCCCCCHHHHHHHHH
Q 045989 206 KRCLNLNGKKRPTMKEVALELA 227 (295)
Q Consensus 206 ~~cl~~~p~~Rps~~e~~~~l~ 227 (295)
.+||+.||.+|||++|+++|.+
T Consensus 309 ~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 309 SPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp GGGGCSSTTTCBCHHHHHTCGG
T ss_pred HHHCCCChhHCcCHHHHhcCcc
Confidence 9999999999999999998864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.69 E-value=3.5e-18 Score=133.59 Aligned_cols=122 Identities=16% Similarity=0.117 Sum_probs=84.2
Q ss_pred ccCCCCccccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 045989 3 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAASIPIYHRDI 82 (295)
Q Consensus 3 l~~l~Hpniv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~~~~i~H~di 82 (295)
|.++.|+++++.+++. ..+++|||++++.+.. ++......++.|++.+|+|||+++ |+||||
T Consensus 68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDi 129 (191)
T d1zara2 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDL 129 (191)
T ss_dssp HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHccCCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccC
Confidence 4567888988877653 3479999998754322 334445678999999999999999 999999
Q ss_pred CCCeEEECCCCceEEeeccCccccccCcceeeeccccccCCCChhhhccCCCCCCccchhhHHHH
Q 045989 83 KSANILLDDKYRAKISDFGTSRSMAVDRTHLTTQVKGTFGYLDPEYFQSSQFTEKSDVYSFGVVL 147 (295)
Q Consensus 83 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 147 (295)
||+|||++++ .++|+|||.|+....+.....-.. ... .-.+ +....|+.++|+||+.--+
T Consensus 130 KP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~r--d~~-~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 130 SQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILER--DVR-NIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp STTSEEEETT-EEEECCCTTCEETTSTTHHHHHHH--HHH-HHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred ChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHH--HHH-HHHH-HHcCCCCCcccHHHHHHHH
Confidence 9999999965 588999999976543322110000 000 0001 1235678899999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.63 E-value=5.5e-05 Score=60.02 Aligned_cols=85 Identities=18% Similarity=0.149 Sum_probs=59.3
Q ss_pred ccceeeEEEeCCccEEEEeecCCCCHHHHHhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------
Q 045989 11 VVKLLGCCLETEVPLLVYEFIPNGSLHQYIHEQTEDQLPITWEIRLGIAVEVSGALSYLHSAA----------------- 73 (295)
Q Consensus 11 iv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~Lh~~~----------------- 73 (295)
+.+++.+...++..++||++++|.++.+..... .. ...++.++.+.++.||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 142 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence 577888888888999999999998876554221 11 1223444555555555421
Q ss_pred ---------------------------------------CCCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 74 ---------------------------------------SIPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 74 ---------------------------------------~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
...++|+|+.|.||++++++..-|.||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0127899999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.85 E-value=0.00024 Score=55.85 Aligned_cols=28 Identities=21% Similarity=0.277 Sum_probs=24.7
Q ss_pred eEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 77 IYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 77 i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.48 E-value=0.013 Score=48.77 Aligned_cols=28 Identities=18% Similarity=0.299 Sum_probs=24.4
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
.++|+|+.|.|||++++. ++|.||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 389999999999998764 8999998765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.55 E-value=0.01 Score=47.74 Aligned_cols=29 Identities=17% Similarity=0.212 Sum_probs=26.0
Q ss_pred CeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 76 PIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 76 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
++||+|+.++||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999998877899999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=88.42 E-value=0.26 Score=39.40 Aligned_cols=28 Identities=29% Similarity=0.419 Sum_probs=22.7
Q ss_pred CCeEeccCCCCeEEECCCCceEEeeccCcc
Q 045989 75 IPIYHRDIKSANILLDDKYRAKISDFGTSR 104 (295)
Q Consensus 75 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~ 104 (295)
..++|+|+.|.|||++++ ..+.||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 348999999999999753 4578998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=82.97 E-value=0.22 Score=40.95 Aligned_cols=16 Identities=38% Similarity=0.661 Sum_probs=13.5
Q ss_pred eEeccCCCCeEEECCC
Q 045989 77 IYHRDIKSANILLDDK 92 (295)
Q Consensus 77 i~H~dikp~Nill~~~ 92 (295)
++|+|+.+.||++.+.
T Consensus 220 ~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKA 235 (395)
T ss_dssp EECSCCCGGGEEEEC-
T ss_pred EEecCCCcccEeeccc
Confidence 6899999999999553
|